##GENOME_BUILD=GRCh38
##ANALYSISTYPE=GERMLINE_MULTISAMPLE
##PIPELINE=megSAP 2022_08-99-g2fa51fa2
##SAMPLE=<ID=GS140127_01,Gender=male,ExternalSampleName=131787,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##SAMPLE=<ID=GS140549_01,Gender=female,ExternalSampleName=131752,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##SAMPLE=<ID=GS140550_01,Gender=male,ExternalSampleName=131751,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##FILTER=off-target=Variant marked as 'off-target'.
##FILTER=low_conf_region=Variant marked as 'low_conf_region'.
##DESCRIPTION=GS140127_01=genotype of sample GS140127_01
##DESCRIPTION=GS140549_01=genotype of sample GS140549_01
##DESCRIPTION=GS140550_01=genotype of sample GS140550_01
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), quality divided by depth (QD), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_het=Heterozygous counts of the gnomAD project (genome data).
##DESCRIPTION=gnomAD_wt=Wildtype counts of the gnomAD project (genome data).
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=SpliceAI=SpliceAI prediction of splice-site variations. Probability of the variant being splice-altering (range from 0-1). The score is the maximum value of acceptor/donor gain/loss of all effected genes.
##DESCRIPTION=PubMed=PubMed ids to publications on the given variant.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	GS140127_01	GS140549_01	GS140550_01	filter	quality	gene	variant_type	coding_and_splicing	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	gnomAD	gnomAD_sub	gnomAD_hom_hemi	gnomAD_het	gnomAD_wt	phyloP	Sift	PolyPhen	CADD	REVEL	MaxEntScan	COSMIC	SpliceAI	PubMed	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	1022518	1022518	G	T	hom	hom	het	off-target	QUAL=3744;DP=63,45,56;AF=0.98,1.00,0.64;MQM=60;SAP=305;ABP=13;SAR=142;SAF=1	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron2/35:c.463+56G>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron2/38:c.49+56G>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677944 [benign DISEASE=not provided];			rs2799064	0.3451	0.3594,0.2505,0.1891,0.3545,0.3717	9381,.	33649	99475	-0.4950			2.94			COSV65071508	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1022587	1022587	-	TGTAGTCTGACCTGTGGTCTGAC	wt	het	het	off-target	QUAL=121;DP=15,9,6;AF=0.00,0.44,0.83;MQM=60;SAP=23;ABP=4;SAR=9;SAF=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron2/35:c.463+128_463+129insAGTCTGACCTGTGGTCTGACTGT::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron2/38:c.49+128_49+129insAGTCTGACCTGTGGTCTGACTGT::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs6143083	0.9131	0.7174,0.9645,0.9217,0.9973,0.9880	64471,.	9777	13201				7.54				0.1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1035170	1035171	GG	-	n/a	het	het	off-target	QUAL=276;DP=0,14,8;AF=,0.57,0.50;MQM=60;SAP=29;ABP=3;SAR=0;SAF=12	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron2/35:c.464-96_464-95del::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron2/38:c.50-96_50-95del::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs56001364	0.3266	0.3416,0.3492,0.2383,0.3168,0.3693	2279,.	16597	43629	-0.2380			1.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1035170	1035172	GGG	-	n/a	het	het	off-target	QUAL=276;DP=0,14,8;AF=,0.21,0.13;MQM=60;SAP=12;ABP=22;SAR=0;SAF=4	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron2/35:c.464-97_464-95del::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron2/38:c.50-97_50-95del::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs56001364	0.0218	0.0622,0.0123,0.0038,0.0088,0.0033	15,.	1370	62796	-0.2380			1.06				0		8	37	0 / 0					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1035385	1035385	C	T	wt	het	wt	off-target	QUAL=3175;DP=51,254,387;AF=0.00,0.54,0.00;MQM=60;SAP=3;ABP=6;SAR=66;SAF=71	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron3/35:c.511+61C>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron3/38:c.97+61C>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs377303595	0.0010	0.0006,0.0004,0.0000,0.0018,0.0000	0,.	156	152034	-2.2080			1.16				0		0	32	0 / 0					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1035498	1035498	C	T	het	wt	het	off-target	QUAL=2263;DP=67,125,185;AF=0.54,0.00,0.43;MQM=60;SAP=253;ABP=7;SAR=115;SAF=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron3/35:c.511+174C>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron3/38:c.97+174C>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs151122070	0.0002	0.0001,0.0001,0.0002,0.0002,0.0000	0,.	24	152118	-0.9310			1.12				0		0	3	0 / 0					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1041823	1041823	G	C	hom	hom	hom	off-target;low_conf_region	QUAL=818;DP=9,8,14;AF=1.00,1.00,1.00;MQM=55;SAP=11;ABP=0;SAR=21;SAF=10	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron6/35:c.1177+121G>C::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron6/38:c.763+121G>C::	regulatory_region_variant:enhancer	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677945 [benign DISEASE=not provided];			rs3121552	0.4190	0.3809,0.4794,0.6923,0.4489,0.5000	1045,.	1498	4976	-2.5600			0.55			COSV65071601	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1041950	1041950	T	C	hom	hom	hom		QUAL=1742;DP=13,20,26;AF=1.00,1.00,1.00;MQM=60;SAP=84;ABP=0;SAR=6;SAF=53	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron6/35:c.1178-6T>C::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron6/38:c.764-6T>C::	regulatory_region_variant:enhancer	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128292 [benign DISEASE=Congenital myasthenic syndrome 8,not specified];			rs2799066	0.8731	0.7172,0.9217,0.9998,0.9218,0.9573	58337,.	15313	19177	-0.8440			0.67		6.81>6.95		0.12	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1042190	1042190	G	A	hom	hom	hom	off-target	QUAL=1524;DP=18,15,21;AF=1.00,1.00,1.00;MQM=60;SAP=104;ABP=0;SAR=52;SAF=2	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron7/35:c.1384+28G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron7/38:c.970+28G>A::	regulatory_region_variant:enhancer	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263159 [benign DISEASE=Congenital myasthenic syndrome 8,not specified,not provided];			rs2710876	0.7880	0.4415,0.8833,0.9680,0.9176,0.9466	50662,.	18508	32242	-1.7260			0.18				0.02	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1043224	1043225	CT	-	wt	wt	het	off-target	QUAL=1477;DP=58,167,186;AF=0.00,0.00,0.46;MQM=60;SAP=132;ABP=6;SAR=7;SAF=78	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron7/35:c.1385-15_1385-14del::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron7/38:c.971-15_971-14del::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263160 [benign DISEASE=Congenital myasthenic syndrome 8,not specified,not provided];			rs35881187	0.4432	0.1099,0.6221,0.7857,0.5485,0.5552	18381,.	30472	84478	-0.1120			4.43				0.11	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1045080	1045080	G	A	hom	hom	hom	off-target	QUAL=785;DP=4,9,14;AF=1.00,1.00,1.00;MQM=60;SAP=26;ABP=0;SAR=5;SAF=22	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron12/35:c.2255-81G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron12/38:c.1841-81G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677948 [benign DISEASE=Congenital myasthenic syndrome 8,not provided];			rs3128097	0.8986	0.7947,0.9330,0.9998,0.9293,0.9625	61714,.	13154	15408	2.3760			8.34				0.43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1045707	1045707	A	G	hom	hom	hom	off-target	QUAL=5739;DP=67,51,64;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0;SAR=90;SAF=92	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron14/35:c.2537-26A>G::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron14/38:c.2123-26A>G::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263172 [benign DISEASE=Congenital myasthenic syndrome 8,not specified,not provided];			rs3128098	0.8538	0.6440,0.9103,0.9998,0.9278,0.9618	56727,.	16419	22233	-0.8630			1.44				0.11	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1046551	1046551	A	G	hom	hom	hom		QUAL=6187;DP=51,70,93;AF=1.00,1.00,1.00;MQM=60;SAP=5;ABP=0;SAR=100;SAF=114	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon18/36:c.3066A>G:p.Ser1022=:,AGRN:ENST00000620552.4:synonymous_variant:LOW:exon18/39:c.2652A>G:p.Ser884=:		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128297 [benign DISEASE=Congenital myasthenic syndrome 8,not specified];			rs2465128	0.8016	0.5141,0.8811,0.9618,0.9099,0.8918	51078,.	19390	30092	-1.0320			0.11			COSV65068047	0.01	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047064	1047064	A	G	hom	hom	hom	off-target	QUAL=9351;DP=67,113,155;AF=1.00,0.99,1.00;MQM=60;SAP=686;ABP=0;SAR=329;SAF=5	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron19/35:c.3388+107A>G::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron19/38:c.2974+107A>G::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677950 [benign DISEASE=not provided];			rs3128099	0.8173	0.5436,0.8928,0.9679,0.9181,0.9477	52914,.	18385	27763	1.1180			7.41				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047082	1047082	T	C	hom	hom	hom	off-target	QUAL=9022;DP=76,105,139;AF=1.00,1.00,1.00;MQM=60;SAP=655;ABP=0;SAR=315;SAF=5	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron19/35:c.3388+125T>C::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron19/38:c.2974+125T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677951 [benign DISEASE=not provided];			rs3128100	0.9859	0.9538,0.9909,0.9998,0.9991,0.9990	73957,.	2057	2149	-4.5630			0.01				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047133	1047133	T	C	hom	hom	hom	off-target	QUAL=5690;DP=44,70,77;AF=1.00,1.00,1.00;MQM=60;SAP=320;ABP=0;SAR=179;SAF=12	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron19/35:c.3388+176T>C::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron19/38:c.2974+176T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677952 [benign DISEASE=not provided];			rs3128101	0.9129	0.8451,0.9367,0.9998,0.9293,0.9632	63556,.	11765	13255	-0.0520			10.24				0.13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047561	1047561	T	C	hom	hom	hom	off-target	QUAL=9183;DP=47,105,149;AF=1.00,1.00,1.00;MQM=60;SAP=58;ABP=0;SAR=107;SAF=194	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron20/35:c.3517-12T>C::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron20/38:c.3103-12T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263181 [benign DISEASE=Congenital myasthenic syndrome 8,not specified];			rs3128102	0.7939	0.4640,0.8833,0.9678,0.9171,0.9470	51078,.	18612	31360	-0.1470			2.44		6.84>6.29		0.04	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047614	1047614	T	C	hom	hom	hom		QUAL=15498;DP=140,142,208;AF=0.99,1.00,1.00;MQM=60;SAP=11;ABP=0;SAR=223;SAF=265	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon21/36:c.3558T>C:p.Phe1186=:PF01390 [SEA domain],AGRN:ENST00000620552.4:synonymous_variant:LOW:exon21/39:c.3144T>C:p.Phe1048=:PF01390 [SEA domain]		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128302 [benign DISEASE=Congenital myasthenic syndrome 8,not specified];			rs10267	0.8196	0.5382,0.8959,0.9992,0.9200,0.9566	53403,.	17888	27446	2.1470			7.24			COSV65071416	0.01	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1048922	1048922	T	C	het	wt	hom		QUAL=588;DP=9,17,19;AF=0.67,0.00,1.00;MQM=60;SAP=7;ABP=5;SAR=16;SAF=9	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon24/36:c.4161T>C:p.Thr1387=:,AGRN:ENST00000620552.4:synonymous_variant:LOW:exon24/39:c.3747T>C:p.Thr1249=:		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128307 [benign DISEASE=Congenital myasthenic syndrome 8,not specified];			rs9442391	0.5042	0.2925,0.6466,0.8185,0.5620,0.5668	20786,.	34643	74961	-1.2460			0.61				0	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1049886	1049886	C	T	het	wt	hom	off-target	QUAL=584;DP=8,11,20;AF=0.50,0.00,1.00;MQM=60;SAP=3;ABP=3;SAR=13;SAF=11	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron26/35:c.4745-17C>T::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron26/38:c.4331-17C>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263188 [benign DISEASE=Congenital myasthenic syndrome 8,not specified];			rs2275813	0.4522	0.1607,0.6244,0.8089,0.5373,0.5487	18221,.	31986	82908	-1.7470			1.60		11.49>11.28		0.14	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050064	1050064	G	-	hom	hom	wt	off-target;low_conf_region	QUAL=303;DP=4,8,6;AF=0.75,1.00,0.00;MQM=60;SAP=13;ABP=0;SAR=2;SAF=9	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+41del::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+41del::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1292619 [benign DISEASE=not provided];			rs71576592	0.5472	0.7306,0.4961,0.6491,0.4534,0.4865	19472,.	34173	60513	0.0280			0.38				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050066	1050066	G	T	wt	wt	het	off-target;low_conf_region	QUAL=303;DP=4,8,6;AF=0.75,1.00,0.00;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+29G>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+29G>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263191 [benign DISEASE=not specified,not provided];			rs2275812	0.3517	0.1098,0.4489,0.1681,0.4531,0.4693	9412,.	30480	90870	-1.2390			0.55			COSV65067816	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050069	1050069	G	A	wt	wt	hom	off-target;low_conf_region	QUAL=303;DP=4,8,6;AF=0.75,1.00,0.00;MQM=60;SAP=4;ABP=3;SAR=1;SAF=2	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+32G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+32G>A::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263192 [benign DISEASE=not specified,not provided];			rs2799067	0.5613	0.3345,0.6051,0.5543,0.6237,0.6290	13928,.	32696	47336	0.1660			1.25			COSV65067820	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050070	1050070	G	A	hom	hom	wt	off-target;low_conf_region	QUAL=303;DP=4,8,6;AF=0.75,1.00,0.00;MQM=60;SAP=13;ABP=0;SAR=2;SAF=9	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+33G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+33G>A::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1232566 [benign DISEASE=not provided];			rs397834473	0.5028	0.6831,0.4694,0.5832,0.4121,0.4316	19437,.	34644	72688	-0.3950			0.59			COSV65068887	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1051063	1051063	C	T	hom	hom	hom	off-target	QUAL=1097;DP=18,12,7;AF=1.00,1.00,1.00;MQM=59;SAP=13;ABP=0;SAR=25;SAF=12	AGRN	intron,splice_region&intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron30/35:c.5254-190C>T::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron31/38:c.4851+20C>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677954 [benign DISEASE=Congenital myasthenic syndrome 8,not provided];			rs2710887	0.7824	0.4338,0.8825,0.9950,0.9104,0.9022	50077,.	18720	33058	-0.0930			0.84				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1051820	1051820	C	T	hom	hom	hom		QUAL=10531;DP=63,134,150;AF=0.97,1.00,0.99;MQM=60;SAP=113;ABP=0;SAR=238;SAF=106	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron33/35:c.5651+5C>T::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron34/38:c.5249+5C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128317 [benign DISEASE=Congenital myasthenic syndrome 8,not specified];			rs9803031	0.7873	0.4525,0.8855,0.9946,0.9107,0.8870	50443,.	18847	32349	-1.1710			0.73		9.65>8.73		0	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1053552	1053552	G	C	hom	het	hom	off-target	QUAL=496;DP=11,4,7;AF=1.00,0.50,1.00;MQM=60;SAP=46;ABP=3;SAR=0;SAF=20	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron33/35:c.5652-201G>C::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron36/38:c.5306+59G>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677955 [benign DISEASE=Congenital myasthenic syndrome 8,not provided];			rs2710871	0.7512	0.4301,0.8677,0.9946,0.8592,0.8913	45926,.	22286	37800	-0.5450			0.04			COSV65071518	0	33589840	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1054900	1054900	C	T	wt	het	het		QUAL=4766;DP=100,174,207;AF=0.00,0.51,0.59;MQM=60;SAP=309;ABP=12;SAR=19;SAF=191	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon36/36:c.6057C>T:p.Asp2019=:PF00054 [Laminin G domain],AGRN:ENST00000620552.4:synonymous_variant:LOW:exon39/39:c.5712C>T:p.Asp1904=:PF00054 [Laminin G domain]	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128319 [benign DISEASE=Congenital myasthenic syndrome 8,not specified];			rs4275402	0.5913	0.3227,0.7196,0.8119,0.6961,0.6072	28830,.	32220	62120	-0.7120			0.31			COSV65070964	0	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055000	1055000	C	T	hom	het	het		QUAL=12295;DP=158,330,428;AF=0.97,0.44,0.49;MQM=60;SAP=121;ABP=10;SAR=171;SAF=337	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*19C>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263157 [benign DISEASE=not specified];			rs3121561	0.3513	0.5072,0.2538,0.1829,0.2946,0.3190	10237,.	32927	98619	-0.4130			0.50			COSV65069616	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055037	1055037	T	C	hom	het	het		QUAL=16508;DP=186,389,502;AF=0.99,0.46,0.49;MQM=60;SAP=15;ABP=8;SAR=276;SAF=333	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*56T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1292868 [benign DISEASE=not provided];			rs2465136	0.3856	0.6015,0.2705,0.1879,0.3030,0.3683	12824,.	32989	93421	0.2810			13.13			COSV65069776	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055137	1055137	C	T	hom	het	hom		QUAL=18346;DP=119,285,371;AF=0.99,0.48,1.00;MQM=60;SAP=198;ABP=4;SAR=431;SAF=194	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*156C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1185529 [benign DISEASE=Congenital myasthenic syndrome 8,not provided];			rs2710872	0.8800	0.8408,0.9221,0.9996,0.8754,0.9452	59057,.	15807	18271	0.1560			6.08				0.05	32314116	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055393	1055393	C	T	hom	het	hom		QUAL=22413;DP=180,296,404;AF=1.00,0.54,1.00;MQM=60;SAP=86;ABP=7;SAR=287;SAF=456	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*412C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs2799072	0.8172	0.6444,0.8985,0.9948,0.8670,0.8986	51702,.	20907	27811	-1.0550			5.67				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055426	1055426	G	A	hom	het	hom		QUAL=24597;DP=214,311,448;AF=0.99,0.54,1.00;MQM=60;SAP=60;ABP=7;SAR=340;SAF=488	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*445G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs2799073	0.8173	0.6447,0.8986,0.9948,0.8670,0.8990	51712,.	20902	27798	-0.1780			2.88				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055604	1055604	G	A	hom	het	hom		QUAL=15857;DP=145,190,272;AF=1.00,0.59,1.00;MQM=60;SAP=270;ABP=16;SAR=392;SAF=137	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*623G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs8014	0.8838	0.8530,0.9241,0.9996,0.8759,0.9464	59543,.	15418	17680	-1.8980			0.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1056279	1056279	C	-	hom	het	hom	off-target	QUAL=3771;DP=10,66,98;AF=1.00,0.52,1.00;MQM=60;SAP=294;ABP=3;SAR=140;SAF=2	AGRN	downstream_gene	AGRN:ENST00000379370.7:downstream_gene_variant:MODIFIER::::,AGRN:ENST00000620552.4:downstream_gene_variant:MODIFIER::::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs60286592	0.8840	0.8535,0.9241,0.9996,0.8759,0.9468	59496,.	15396	17638	0.3350			1.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	2024923	2024923	G	A	hom	het	het	off-target	QUAL=6547;DP=80,172,170;AF=1.00,0.49,0.48;MQM=60;SAP=84;ABP=4;SAR=75;SAF=171	GABRD	splice_region&intron	GABRD:ENST00000378585.7:splice_region_variant&intron_variant:LOW:intron1/8:c.69-19G>A::,GABRD:ENST00000640067.1:splice_region_variant&intron_variant:LOW:intron1/8:c.69-19G>A::,GABRD:ENST00000638771.1:splice_region_variant&intron_variant:LOW:intron1/7:c.69-19G>A::,GABRD:ENST00000640949.1:splice_region_variant&intron_variant:LOW:intron1/8:c.69-19G>A::		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256824 [benign DISEASE=Idiopathic generalized epilepsy,not specified];			rs2376805	0.8127	0.7951,0.7677,0.7193,0.8305,0.7813	50293,.	23074	28492	-0.2210			4.09		7.68>6.22	COSV66080160	0.02	25741868,20561060,33887383,34160285	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2025598	2025598	T	C	het	wt	het		QUAL=6779;DP=156,340,399;AF=0.53,0.00,0.49;MQM=60;SAP=77;ABP=3;SAR=189;SAF=91	GABRD	synonymous	GABRD:ENST00000378585.7:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000640067.1:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000638771.1:synonymous_variant:LOW:exon4/8:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000640949.1:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain]		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256823 [benign DISEASE=Idiopathic generalized epilepsy,not specified,not provided];			rs2229110	0.6546	0.7293,0.5998,0.3397,0.6556,0.4664	33171,.	33152	52502	-1.2170			12.60			COSV66080001	0.01	25741868,33887383,34160285	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2025781	2025781	G	-	het	wt	het	off-target	QUAL=1292;DP=52,54,75;AF=0.44,0.00,0.52;MQM=60;SAP=138;ABP=3;SAR=62;SAF=0	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron4/8:c.470+45del::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron4/8:c.470+45del::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron4/7:c.470+45del::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron4/8:c.470+45del::	regulatory_region_variant:promoter	137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs3831907	0.1288	0.2060,0.0805,0.0335,0.1153,0.0724	1489,.	16610	132514	-3.0860			0.76				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2027822	2027822	A	G	hom	het	het	off-target	QUAL=6011;DP=70,136,180;AF=0.97,0.55,0.55;MQM=60;SAP=503;ABP=10;SAR=239;SAF=3	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron5/8:c.553+163A>G::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron5/8:c.553+163A>G::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron5/7:c.553+163A>G::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron5/8:c.553+163A>G::		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs28574670	0.8648	0.9635,0.7946,0.7974,0.8328,0.8223	57226,.	17084	20562	-0.0360			4.86			COSV66080172	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2028422	2028422	-	C	n/a	het	het	off-target	QUAL=201;DP=0,6,10;AF=,0.67,0.60;MQM=60;SAP=25;ABP=5;SAR=10;SAF=0	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron6/8:c.691+131dup::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron6/8:c.775+131dup::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron6/7:c.691+131dup::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron6/8:c.691+131dup::		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs138736063	0.2333	0.2177,0.2154,0.4878,0.2170,0.3917	4472,.	26251	115681				5.48				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2029235	2029235	C	T	het	het	wt		QUAL=4927;DP=119,265,386;AF=0.49,0.56,0.01;MQM=60;SAP=18;ABP=7;SAR=123;SAF=85	GABRD	synonymous	GABRD:ENST00000378585.7:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000640067.1:synonymous_variant:LOW:exon7/9:c.900C>T:p.Ser300=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000638771.1:synonymous_variant:LOW:exon7/8:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000640949.1:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256825 [benign DISEASE=Idiopathic generalized epilepsy,not specified,not provided];			rs28408173	0.1263	0.0316,0.1583,0.4326,0.1359,0.2665	1790,.	15636	132968	-0.4760			3.35			COSV66080067	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2029487	2029487	T	C	hom	het	het	off-target	QUAL=4880;DP=51,118,191;AF=1.00,0.37,0.52;MQM=60;SAP=237;ABP=6;SAR=25;SAF=170	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron7/8:c.848-64T>C::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron7/8:c.932-64T>C::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron7/7:c.848-64T>C::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron7/8:c.848-133T>C::		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs28581504	0.8374	0.8680,0.7850,0.7982,0.8323,0.8218	53391,.	20553	24727	-1.4640			0.88			COSV66081616	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2029969	2029969	C	T	het	het	wt	off-target	QUAL=1614;DP=67,64,73;AF=0.57,0.50,0.01;MQM=60;SAP=45;ABP=4;SAR=54;SAF=17	GABRD	splice_region&intron,synonymous	GABRD:ENST00000378585.7:splice_region_variant&intron_variant:LOW:intron8/8:c.1060-14C>T::,GABRD:ENST00000640067.1:splice_region_variant&intron_variant:LOW:intron8/8:c.1144-14C>T::,GABRD:ENST00000638771.1:synonymous_variant:LOW:exon8/8:c.1266C>T:p.Thr422=:,GABRD:ENST00000640949.1:splice_region_variant&intron_variant:LOW:intron8/8:c.991-14C>T::		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256822 [benign DISEASE=Idiopathic generalized epilepsy,not specified];			rs28431879	0.1262	0.0316,0.1577,0.4544,0.1350,0.2589	1826,.	15558	132994	-0.9510			0.64		7.61>6.94	COSV66079834	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2405838	2405838	C	T	het	n/a	n/a		QUAL=108;DP=20,1,1;AF=0.40,0.00,0.00;MQM=60;SAP=20;ABP=5;SAR=8;SAF=0	PEX10	splice_region&intron	PEX10:ENST00000288774.8:splice_region_variant&intron_variant:LOW:intron5/5:c.973-4G>A::,PEX10:ENST00000447513.7:splice_region_variant&intron_variant:LOW:intron5/5:c.913-4G>A::,PEX10:ENST00000507596.5:splice_region_variant&intron_variant:LOW:intron5/5:c.913-10G>A::		602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	262791 [benign DISEASE=Peroxisome biogenesis disorder 6A (Zellweger),Peroxisome biogenesis disorder 6B,Zellweger spectrum disorders,Peroxisome biogenesis disorder, complementation group 7,not specified,not provided];			rs11586985	0.0878	0.0222,0.0801,0.1164,0.1176,0.1008	808,.	11752	138850	-1.5970			0.04		13.68>13.46,-18.79>-18.77	COSV56580725	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2406687	2406687	C	A	wt	het	het	off-target	QUAL=1037;DP=46,44,55;AF=0.00,0.48,0.49;MQM=60;SAP=34;ABP=3;SAR=11;SAF=37	PEX10	intron	PEX10:ENST00000288774.8:intron_variant:MODIFIER:intron4/5:c.836+33G>T::,PEX10:ENST00000447513.7:intron_variant:MODIFIER:intron4/5:c.776+33G>T::,PEX10:ENST00000507596.5:intron_variant:MODIFIER:intron4/5:c.776+33G>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	1180486 [benign DISEASE=Peroxisome biogenesis disorder 6A (Zellweger),Peroxisome biogenesis disorder 6B,not provided];			rs3795269	0.3878	0.2882,0.4248,0.2726,0.4330,0.3672	12033,.	34868	93054	0.5960			3.45			COSV56579855	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2407130	2407130	T	C	het	het	hom	off-target	QUAL=272;DP=12,5,4;AF=0.58,0.60,1.00;MQM=60;SAP=33;ABP=4;SAR=14;SAF=0	PEX10	intron	PEX10:ENST00000288774.8:intron_variant:MODIFIER:intron3/5:c.601-175A>G::,PEX10:ENST00000447513.7:intron_variant:MODIFIER:intron3/5:c.601-235A>G::,PEX10:ENST00000507596.5:intron_variant:MODIFIER:intron3/5:c.601-235A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	1259297 [benign DISEASE=not provided];			rs2494427	0.8128	0.6365,0.8195,0.8305,0.8944,0.8242	51211,.	21209	28477	-1.9020			0.52				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2408761	2408761	T	C	wt	het	het		QUAL=985;DP=41,39,48;AF=0.02,0.44,0.54;MQM=60;SAP=47;ABP=3;SAR=37;SAF=7	PEX10	synonymous	PEX10:ENST00000288774.8:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000447513.7:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000507596.5:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region]	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	129884 [benign DISEASE=Peroxisome biogenesis disorder 6A (Zellweger),Peroxisome biogenesis disorder 6B,Zellweger spectrum disorders,Peroxisome biogenesis disorder, complementation group 7,not specified,not provided];			rs2494598	0.7431	0.5990,0.7702,0.7259,0.8120,0.7325	42746,.	27445	39037	-6.5220			0.15			COSV56581176	0	25741868,15542397	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	5862774	5862774	C	A	het	wt	hom	off-target	QUAL=1524;DP=54,26,42;AF=0.35,0.00,1.00;MQM=60;SAP=127;ABP=13;SAR=1;SAF=60	MIR4689,NPHP4	upstream_gene,downstream_gene	MIR4689:ENST00000582517.1:upstream_gene_variant:MODIFIER::::,NPHP4:ENST00000378156.9:downstream_gene_variant:MODIFIER::::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]				rs12133533	0.1268	0.0344,0.1190,0.0830,0.1777,0.1427	1586,.	16125	132849	-0.3670			0.69						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5863728	5863728	T	G	hom	het	hom	off-target	QUAL=832;DP=15,9,11;AF=1.00,0.56,1.00;MQM=60;SAP=70;ABP=3;SAR=0;SAF=31	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron29/29:c.4140+162A>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1290771 [benign DISEASE=not provided];			rs11121648	0.5663	0.5977,0.5102,0.2851,0.5792,0.5466	24692,.	36685	65907	-1.7180			0.22				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5864686	5864686	T	C	het	wt	hom	off-target	QUAL=233;DP=10,3,4;AF=0.90,0.00,1.00;MQM=60;SAP=31;ABP=17;SAR=13;SAF=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron27/29:c.3817-169A>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1287643 [benign DISEASE=not provided];			rs1287635	0.3642	0.2449,0.3739,0.2734,0.4194,0.4326	10585,.	34184	96632	-2.0590			0.62			COSV65394658	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5866447	5866447	T	C	het	wt	hom		QUAL=8932;DP=271,153,183;AF=0.50,0.00,0.99;MQM=60;SAP=31;ABP=3;SAR=191;SAF=127	NPHP4	synonymous	NPHP4:ENST00000378156.9:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:	regulatory_region_variant:open_chromatin_region	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95683 [benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified,not provided];			rs555164	0.3538	0.2083,0.3694,0.2711,0.4197,0.4301	10237,.	33267	98163	0.3050			2.05			COSV65394708	0.01	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5866971	5866971	A	G	het	wt	hom	off-target	QUAL=3779;DP=81,65,97;AF=0.48,0.00,1.00;MQM=60;SAP=150;ABP=3;SAR=20;SAF=116	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1233249 [benign DISEASE=not provided];			rs12122135	0.1287	0.0406,0.1222,0.0834,0.1773,0.1484	1581,.	16413	132519	-0.2330			1.83			COSV65397177	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5867678	5867678	G	A	het	wt	hom	off-target	QUAL=7243;DP=126,155,193;AF=0.50,0.01,1.00;MQM=60;SAP=394;ABP=3;SAR=21;SAF=236	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron24/29:c.3472+62C>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1289471 [benign DISEASE=not provided];			rs2297791	0.1342	0.0537,0.1342,0.1028,0.1770,0.1517	1629,.	17154	131716	0.0360			2.09			COSV65397184	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5867883	5867883	G	A	wt	wt	het		QUAL=3638;DP=132,269,358;AF=0.00,0.00,0.48;MQM=60;SAP=44;ABP=5;SAR=114;SAF=57	NPHP4	missense	NPHP4:ENST00000378156.9:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95682 [benign/likely benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified,not provided];	CM125782 [CLASS=DM MUT=ALT PHEN="Cardiovascular malformations" GENE=NPHP4];		rs139767853	0.0036	0.0014,0.0029,0.0000,0.0061,0.0006	2,.	547	151633	0.0440	T(0.55)	B(0.01)	0.12	0.32		COSV65394401	0.01	23757202	2	202	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5874430	5874430	A	G	hom	het	hom	off-target	QUAL=5942;DP=73,68,112;AF=0.99,0.49,1.00;MQM=60;SAP=474;ABP=3;SAR=0;SAF=217	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	260554 [benign DISEASE=Nephronophthisis 4,not specified,not provided];			rs868163	0.6401	0.7056,0.5621,0.2885,0.6450,0.6142	31634,.	33692	54506	-4.9310			0.03			COSV65397189	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5874777	5874777	C	T	hom	het	hom	off-target	QUAL=10915;DP=92,167,191;AF=0.98,0.50,1.00;MQM=60;SAP=3;ABP=3;SAR=185;SAF=180	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron21/29:c.3044+97G>A::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1294884 [benign DISEASE=not provided];			rs1287638	0.5124	0.5950,0.3759,0.0851,0.5276,0.4319	20800,.	36074	73910	-1.6980			0.09			COSV65398749	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5875102	5875102	T	A	het	wt	het		QUAL=2668;DP=88,87,127;AF=0.61,0.00,0.47;MQM=60;SAP=225;ABP=5;SAR=111;SAF=3	NPHP4	splice_acceptor	NPHP4:ENST00000378156.9:splice_acceptor_variant:HIGH:intron20/29:c.2818-2A>T:p.?:		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]		CS057899 [CLASS=FP MUT=ALT PHEN="Altered splicing" GENE=NPHP4];		rs1287637	0.1543	0.1091,0.1874,0.1828,0.1774,0.1656	1975,.	19525	128629	5.3340			24.40		9.27>0.90		1	20844548,26578562,23402433	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5875162	5875162	T	C	hom	hom	hom	off-target	QUAL=5335;DP=48,66,69;AF=1.00,1.00,1.00;MQM=60;SAP=392;ABP=0;SAR=182;SAF=1	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron20/29:c.2818-62A>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1269681 [benign DISEASE=not provided];			rs963030	0.4364	0.3920,0.3890,0.2503,0.4951,0.3659	14816,.	36660	85602	-1.5800			0.18			COSV65393027	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5877331	5877331	C	T	n/a	n/a	hom	off-target	QUAL=158;DP=1,0,4;AF=1.00,,1.00;MQM=60;SAP=7;ABP=0;SAR=4;SAF=1	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::	regulatory_region_variant:CTCF_binding_site	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	260547 [benign DISEASE=Nephronophthisis 4,not specified,not provided];			rs3747989	0.8314	0.9329,0.7722,0.8351,0.7984,0.7378	52841,.	20832	25648	-2.4900			0.18				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5887157	5887157	G	C	wt	wt	het	off-target	QUAL=706;DP=16,53,77;AF=0.00,0.00,0.45;MQM=60;SAP=79;ABP=4;SAR=0;SAF=35	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron18/29:c.2485+129C>G::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron18/19:c.2482+129C>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1239115 [benign DISEASE=not provided];			rs41280812	0.1181	0.0332,0.1130,0.0753,0.1653,0.1188	1359,.	15247	134123	-0.3970			0.20				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5887248	5887248	G	A	wt	wt	het	off-target	QUAL=1781;DP=129,147,187;AF=0.00,0.01,0.42;MQM=60;SAP=88;ABP=13;SAR=12;SAF=68	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron18/19:c.2482+38C>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	260546 [benign DISEASE=Nephronophthisis 4,not specified,not provided];			rs41280814	0.1182	0.0333,0.1128,0.0756,0.1653,0.1197	1363,.	15262	134166	-2.0980			0.01			COSV65397198	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5904931	5904931	T	C	hom	hom	hom	off-target	QUAL=7804;DP=61,91,121;AF=1.00,1.00,1.00;MQM=60;SAP=562;ABP=0;SAR=269;SAF=4	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron15/29:c.1956-127A>G::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron15/19:c.1953-127A>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1277940 [benign DISEASE=not provided];			rs3737234	0.8353	0.9347,0.7653,0.8297,0.8046,0.7491	53310,.	20405	25039	-0.1200			2.79				0.09		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5905119	5905119	A	G	het	het	het	off-target	QUAL=2288;DP=106,26,27;AF=0.55,0.58,0.67;MQM=60;SAP=130;ABP=10;SAR=9;SAF=82	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron15/29:c.1955+173T>C::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron15/19:c.1952+173T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1252595 [benign DISEASE=not provided];			rs11122125	0.4038	0.3121,0.4702,0.7463,0.4078,0.4822	12981,.	35383	90585	0.0030			2.08			COSV65393924	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5905321	5905321	C	T	wt	wt	het		QUAL=2693;DP=207,206,262;AF=0.00,0.00,0.43;MQM=60;SAP=34;ABP=15;SAR=36;SAF=76	NPHP4	synonymous	NPHP4:ENST00000378156.9:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:,NPHP4:ENST00000622020.4:synonymous_variant:LOW:exon15/20:c.1923G>A:p.Glu641=:		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95673 [benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified,not provided];			rs12120967	0.1180	0.0328,0.1136,0.0743,0.1657,0.1185	1357,.	15233	134185	-0.7400			1.57			COSV65395162	0	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5907004	5907004	G	T	het	het	wt	off-target	QUAL=1030;DP=44,68,69;AF=0.55,0.38,0.00;MQM=60;SAP=112;ABP=6;SAR=0;SAF=50	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron13/29:c.1611+111C>A::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron13/19:c.1611+111C>A::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1242867 [benign DISEASE=not provided];			rs9628990	0.1430	0.0591,0.1216,0.0083,0.2032,0.1156	1862,.	18020	130300	-2.2950			0.00				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927636	5927636	T	C	wt	wt	het	off-target	QUAL=2465;DP=132,152,186;AF=0.00,0.02,0.54;MQM=60;SAP=33;ABP=6;SAR=33;SAF=71	NPHP4	splice_region&intron	NPHP4:ENST00000378156.9:splice_region_variant&intron_variant:LOW:intron11/29:c.1441+13A>G::,NPHP4:ENST00000622020.4:splice_region_variant&intron_variant:LOW:intron11/19:c.1441+13A>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95671 [benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified,not provided];			rs7520105	0.1709	0.2146,0.1337,0.0751,0.1670,0.1215	2301,.	21383	126057	0.5400			12.77			COSV65395165	0	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927918	5927918	A	G	wt	wt	het	off-target	QUAL=1019;DP=181,57,68;AF=0.00,0.00,0.62;MQM=60;SAP=94;ABP=11;SAR=42;SAF=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron10/29:c.1303-131T>C::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron10/19:c.1303-131T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1241872 [benign DISEASE=not provided];			rs17432975	0.0407	0.0114,0.0447,0.0004,0.0599,0.0242	178,.	5829	145977	-1.8320			0.03				0		3	41	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5947386	5947386	C	T	hom	hom	hom	off-target	QUAL=922;DP=18,9,7;AF=1.00,1.00,1.00;MQM=60;SAP=77;ABP=0;SAR=34;SAF=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron8/29:c.993-156G>A::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron8/19:c.993-156G>A::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1235266 [benign DISEASE=not provided];			rs551207	0.8498	0.8446,0.8009,0.7509,0.8682,0.8207	55034,.	19227	22847	-1.1100			0.22				0	17903299	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5947414	5947414	G	A	het	het	hom	off-target	QUAL=166;DP=11,7,4;AF=0.45,0.29,1.00;MQM=60;SAP=27;ABP=5;SAR=11;SAF=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron8/29:c.993-184C>T::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron8/19:c.993-184C>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1287789 [benign DISEASE=not provided];			rs10779677	0.5272	0.6641,0.5052,0.9771,0.4256,0.5050	22619,.	34932	71908	-0.8700			0.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5967107	5967107	C	A	hom	hom	het	off-target	QUAL=843;DP=20,7,7;AF=1.00,1.00,0.71;MQM=60;SAP=64;ABP=6;SAR=1;SAF=31	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron5/29:c.517+192G>T::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron5/19:c.517+192G>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1249471 [benign DISEASE=not provided];			rs875574	0.6609	0.6986,0.6382,0.7590,0.6370,0.6289	33155,.	34168	51562	0.4750			4.76				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5967192	5967192	A	G	hom	hom	het	off-target	QUAL=1972;DP=28,25,29;AF=1.00,1.00,0.55;MQM=60;SAP=113;ABP=4;SAR=5;SAF=64	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron5/29:c.517+107T>C::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron5/19:c.517+107T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1250302 [benign DISEASE=not provided];			rs875573	0.6406	0.6286,0.6314,0.7592,0.6366,0.6287	31109,.	35168	54638	-1.2340			0.07			COSV65394014	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5967533	5967533	G	A	het	wt	het	off-target	QUAL=294;DP=21,12,27;AF=0.43,0.00,0.30;MQM=60;SAP=40;ABP=12;SAR=17;SAF=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron4/29:c.453-170C>T::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron4/19:c.453-170C>T::	regulatory_region_variant:open_chromatin_region	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1233320 [benign DISEASE=not provided];			rs75504751	0.0452	0.0121,0.0478,0.0004,0.0688,0.0203	242,.	6393	145353	-0.1060			1.01				0		2	42	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5969027	5969027	A	-	het	het	het	off-target;low_conf_region	QUAL=2726;DP=82,31,37;AF=0.66,0.58,0.51;MQM=60;SAP=192;ABP=18;SAR=1;SAF=90	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron4/29:c.452+60del::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron4/19:c.452+60del::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1273587 [benign DISEASE=not provided];		AluSz6 (SINE/Alu)	rs34702999	0.6517	0.6404,0.6473,0.7649,0.6495,0.6474	26914,.	34368	47130	-0.3090			0.57				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5969027	5969028	AA	-	het	het	wt	off-target;low_conf_region	QUAL=2726;DP=82,31,37;AF=0.17,0.29,0.08;MQM=60;SAP=51;ABP=142;SAR=1;SAF=25	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron4/29:c.452+59_452+60del::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron4/19:c.452+59_452+60del::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]			AluSz6 (SINE/Alu)	rs34702999	0.0075	0.0205,0.0053,0.0004,0.0016,0.0005	8,.	1000	134332	0.1920			0.57				0		3	855	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5978523	5978523	G	C	hom	hom	hom	off-target	QUAL=10141;DP=77,118,157;AF=1.00,1.00,1.00;MQM=60;SAP=767;ABP=0;SAR=352;SAF=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron2/29:c.136-110C>G::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron2/19:c.136-110C>G::	regulatory_region_variant:CTCF_binding_site	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1244964 [benign DISEASE=not provided];			rs4908639	0.8394	0.9377,0.7791,0.8359,0.8069,0.7567	53729,.	19934	24376	-0.7120			0.72				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5986372	5986372	C	G	wt	wt	het	off-target	QUAL=795;DP=53,46,52;AF=0.00,0.02,0.63;MQM=60;SAP=40;ABP=11;SAR=29;SAF=5	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron1/19:c.-38-45G>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1263812 [benign DISEASE=not provided];			rs1295111	0.4116	0.4902,0.3925,0.2458,0.3890,0.3981	13024,.	36420	89300	-0.1890			2.27				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5992511	5992511	G	A	wt	wt	het	off-target	QUAL=398;DP=3,29,39;AF=0.00,0.00,0.51;MQM=60;SAP=46;ABP=3;SAR=20;SAF=0	KCNAB2	5'UTR	KCNAB2:ENST00000378097.6:5_prime_UTR_variant:MODIFIER:exon1/16:c.-330G>A::	regulatory_region_variant:promoter	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1258554 [benign DISEASE=not provided];			rs61760765	0.0406	0.0123,0.0485,0.0004,0.0616,0.0230	183,.	5811	145999	-0.1670			10.42				0		1	24	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2 (inh=n/a oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	5992521	5992521	G	A	n/a	het	hom	off-target	QUAL=1335;DP=1,28,33;AF=1.00,0.68,1.00;MQM=60;SAP=118;ABP=11;SAR=53;SAF=0	KCNAB2	5'UTR	KCNAB2:ENST00000378097.6:5_prime_UTR_variant:MODIFIER:exon1/16:c.-320G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1252161 [benign DISEASE=not provided];			rs806109	0.8360	0.9451,0.8587,0.9913,0.7618,0.8639	53596,.	19943	24943	-0.3260			7.55				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2 (inh=n/a oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	6465948	6465948	A	G	het	wt	het	off-target	QUAL=100;DP=8,5,7;AF=0.50,0.00,0.43;MQM=60;SAP=18;ABP=3;SAR=0;SAF=7	TNFRSF25	intron	TNFRSF25:ENST00000356876.8:intron_variant:MODIFIER:intron1/9:c.39+121T>C::,TNFRSF25:ENST00000377782.7:intron_variant:MODIFIER:intron1/9:c.39+121T>C::,TNFRSF25:ENST00000351959.9:intron_variant:MODIFIER:intron1/8:c.39+121T>C::,TNFRSF25:ENST00000348333.7:intron_variant:MODIFIER:intron1/8:c.39+121T>C::,TNFRSF25:ENST00000351748.7:intron_variant:MODIFIER:intron1/4:c.39+121T>C::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]				rs3007416	0.1896	0.4969,0.1048,0.0008,0.0686,0.0868	5488,.	17817	123055	0.1330			9.03				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466123	6466123	G	A	het	wt	het		QUAL=380;DP=12,5,20;AF=0.50,0.00,0.70;MQM=60;SAP=7;ABP=7;SAR=13;SAF=7	TNFRSF25	5'UTR	TNFRSF25:ENST00000356876.8:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:ENST00000377782.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:ENST00000351959.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297904 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset];			rs3007417	0.1886	0.4941,0.1043,0.0008,0.0686,0.0862	5413,.	17773	123059	-0.6470			9.16			COSV61068166	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466143	6466150	CGTGCTCT	-	het	wt	het		QUAL=349;DP=11,6,20;AF=0.55,0.00,0.65;MQM=60;SAP=6;ABP=6;SAR=12;SAF=7	TNFRSF25	5'UTR	TNFRSF25:ENST00000356876.8:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,TNFRSF25:ENST00000377782.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,TNFRSF25:ENST00000351959.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297905 [benign DISEASE=Distal spinal muscular atrophy];			rs45616733	0.1889	0.4945,0.1045,0.0008,0.0693,0.0867	5410,.	17842	123038	0.5380			8.04				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466181	6466184	CGCC	-	hom	wt	het		QUAL=317;DP=4,3,15;AF=1.00,0.00,0.73;MQM=60;SAP=4;ABP=10;SAR=6;SAF=9	TNFRSF25,PLEKHG5	upstream_gene,downstream_gene	TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297906 [benign DISEASE=Distal spinal muscular atrophy];			rs45542640	0.1884	0.4942,0.1043,0.0008,0.0684,0.0863	5413,.	17771	123179	1.5390			11.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466259	6466259	C	T	het	wt	het		QUAL=296;DP=30,30,32;AF=0.37,0.00,0.38;MQM=60;SAP=53;ABP=12;SAR=0;SAF=23	TNFRSF25,PLEKHG5	upstream_gene,downstream_gene	TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297910 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset];			rs45604837	0.0883	0.1758,0.0659,0.0006,0.0591,0.0753	827,.	11777	138663	-1.4900			3.58				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466405	6466405	C	G	het	wt	het		QUAL=3444;DP=82,150,199;AF=0.49,0.00,0.54;MQM=60;SAP=110;ABP=4;SAR=31;SAF=116	TNFRSF25,PLEKHG5	upstream_gene,downstream_gene	TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297912 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset];		MIR3 (SINE/MIR)	rs2986754	0.1881	0.5042,0.1068,0.0008,0.0681,0.0863	5643,.	17316	123472	-0.5600			3.06				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466798	6466798	A	-	het	het	het		QUAL=265;DP=44,6,7;AF=0.25,0.50,0.14;MQM=60;SAP=7;ABP=31;SAR=5;SAF=10	TNFRSF25,PLEKHG5	upstream_gene,downstream_gene	TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297922 [uncertain significance DISEASE=Distal spinal muscular atrophy];		AluSz (SINE/Alu)	rs372197062	0.0703	0.2094,0.0318,0.0023,0.0119,0.0294	880,.	7980	128752	-2.9370			0.44				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6467273	6467273	A	G	het	wt	het		QUAL=1562;DP=75,53,59;AF=0.49,0.00,0.47;MQM=60;SAP=3;ABP=3;SAR=32;SAF=33	PLEKHG5	3'UTR	PLEKHG5:ENST00000535355.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000400913.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377725.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*318T>C::,PLEKHG5:ENST00000340850.10:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377728.8:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377748.6:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377732.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000400915.8:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000673471.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377740.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000675694.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000675123.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*290T>C::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297928 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset,not provided];			rs14708	0.2613	0.5797,0.1590,0.0048,0.1426,0.1607	8164,.	23413	112333	2.4130			12.38				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6467685	6467685	C	T	het	wt	het	off-target	QUAL=3182;DP=81,136,169;AF=0.44,0.00,0.56;MQM=60;SAP=6;ABP=4;SAR=58;SAF=72	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron20/20:c.3219-113G>A::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron20/20:c.3012-113G>A::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron21/21:c.*19-113G>A::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron20/20:c.3012-113G>A::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron20/20:c.3012-113G>A::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron21/21:c.3186-113G>A::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron20/20:c.3123-113G>A::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron21/21:c.3123-113G>A::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron21/21:c.3309-113G>A::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron21/21:c.3012-113G>A::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron20/20:c.3012-113G>A::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron19/19:c.2319-113G>A::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron21/21:c.3123-113G>A::		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667940 [benign DISEASE=not provided];			rs9435269	0.1937	0.5250,0.1090,0.0008,0.0669,0.0960	6102,.	17265	122647	-3.0990			0.02				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469123	6469125	TCC	-	het	wt	het		QUAL=1322;DP=47,63,106;AF=0.38,0.05,0.45;MQM=60;SAP=37;ABP=9;SAR=18;SAF=51	PLEKHG5	inframe_deletion	PLEKHG5:ENST00000535355.6:inframe_deletion:MODERATE:exon19/21:c.2373_2375del:p.Glu792del:,PLEKHG5:ENST00000400913.6:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377725.5:inframe_deletion:MODERATE:exon19/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000340850.10:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377728.8:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377748.6:inframe_deletion:MODERATE:exon20/22:c.2340_2342del:p.Glu781del:,PLEKHG5:ENST00000377732.5:inframe_deletion:MODERATE:exon19/21:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000400915.8:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000673471.2:inframe_deletion:MODERATE:exon20/22:c.2463_2465del:p.Glu822del:,PLEKHG5:ENST00000377740.5:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000675694.1:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000675123.1:inframe_deletion:MODERATE:exon18/20:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000537245.6:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	194979 [benign/likely benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset,Charcot-Marie-Tooth disease recessive intermediate C,Distal spinal muscular atrophy,not specified,not provided];		(TCC)n (Simple_repeat)	rs113541584	0.0876	0.1815,0.0691,0.0041,0.0598,0.0857	707,.	11301	132517	0.9800			10.16				0	28993730	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469383	6469383	A	G	het	wt	het		QUAL=9691;DP=312,391,487;AF=0.48,0.00,0.48;MQM=60;SAP=16;ABP=6;SAR=168;SAF=216	PLEKHG5	synonymous	PLEKHG5:ENST00000535355.6:synonymous_variant:LOW:exon18/21:c.2208T>C:p.Ser736=:,PLEKHG5:ENST00000400913.6:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377725.5:synonymous_variant:LOW:exon18/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000340850.10:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377728.8:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377748.6:synonymous_variant:LOW:exon19/22:c.2175T>C:p.Ser725=:,PLEKHG5:ENST00000377732.5:synonymous_variant:LOW:exon18/21:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000400915.8:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000673471.2:synonymous_variant:LOW:exon19/22:c.2298T>C:p.Ser766=:,PLEKHG5:ENST00000377740.5:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000675694.1:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000675123.1:synonymous_variant:LOW:exon17/20:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000537245.6:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	194881 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset,Charcot-Marie-Tooth disease recessive intermediate C,not specified,not provided];			rs730600	0.2624	0.5809,0.1585,0.0050,0.1432,0.1779	8213,.	23479	112199	-0.1930			5.83				0.02	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469747	6469747	C	T	het	wt	het	off-target	QUAL=2436;DP=133,59,88;AF=0.53,0.00,0.47;MQM=60;SAP=227;ABP=3;SAR=109;SAF=2	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron16/20:c.2008-71G>A::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron16/20:c.1801-71G>A::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron16/21:c.1801-71G>A::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron16/20:c.1801-71G>A::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron16/20:c.1801-71G>A::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron17/21:c.1975-71G>A::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron16/20:c.1912-71G>A::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron17/21:c.1912-71G>A::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron17/21:c.2098-71G>A::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron17/21:c.1801-71G>A::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron16/20:c.1801-71G>A::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron15/19:c.1801-71G>A::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron17/21:c.1912-71G>A::		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1233170 [benign DISEASE=not provided];			rs77492523	0.0691	0.1082,0.0593,0.0006,0.0592,0.0737	429,.	9651	141625	0.6490			6.32				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469763	6469763	G	C	het	wt	het	off-target	QUAL=2447;DP=130,42,70;AF=0.57,0.00,0.47;MQM=60;SAP=227;ABP=5;SAR=106;SAF=1	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron16/20:c.2008-87C>G::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron16/20:c.1801-87C>G::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron16/21:c.1801-87C>G::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron16/20:c.1801-87C>G::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron16/20:c.1801-87C>G::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron17/21:c.1975-87C>G::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron16/20:c.1912-87C>G::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron17/21:c.1912-87C>G::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron17/21:c.2098-87C>G::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron17/21:c.1801-87C>G::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron16/20:c.1801-87C>G::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron15/19:c.1801-87C>G::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron17/21:c.1912-87C>G::		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1180014 [benign DISEASE=not provided];			rs3007420	0.0696	0.1087,0.0592,0.0006,0.0592,0.0861	429,.	9732	141538	0.8840			6.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6470129	6470129	G	A	het	wt	het	off-target	QUAL=244;DP=22,5,10;AF=0.41,0.00,0.50;MQM=60;SAP=33;ABP=4;SAR=0;SAF=14	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron16/20:c.2007+107C>T::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron16/20:c.1800+107C>T::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron16/21:c.1800+107C>T::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron16/20:c.1800+107C>T::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron16/20:c.1800+107C>T::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron17/21:c.1974+107C>T::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron16/20:c.1911+107C>T::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron17/21:c.1911+107C>T::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron17/21:c.2097+107C>T::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron17/21:c.1800+107C>T::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron16/20:c.1800+107C>T::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron15/19:c.1800+107C>T::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron17/21:c.1911+107C>T::		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667938 [benign DISEASE=not provided];			rs3007421	0.1763	0.3178,0.1262,0.0048,0.1317,0.1550	2961,.	20890	125252	0.9560			6.98				0	19136949,21537399,21537453,28628558,24076602	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6470375	6470375	A	G	het	wt	het	off-target	QUAL=1086;DP=40,49,55;AF=0.45,0.00,0.53;MQM=60;SAP=3;ABP=3;SAR=25;SAF=22	PLEKHG5	splice_region&intron	PLEKHG5:ENST00000535355.6:splice_region_variant&intron_variant:LOW:intron15/20:c.1888-20T>C::,PLEKHG5:ENST00000400913.6:splice_region_variant&intron_variant:LOW:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377725.5:splice_region_variant&intron_variant:LOW:intron15/21:c.1681-20T>C::,PLEKHG5:ENST00000340850.10:splice_region_variant&intron_variant:LOW:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377728.8:splice_region_variant&intron_variant:LOW:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377748.6:splice_region_variant&intron_variant:LOW:intron16/21:c.1855-20T>C::,PLEKHG5:ENST00000377732.5:splice_region_variant&intron_variant:LOW:intron15/20:c.1792-20T>C::,PLEKHG5:ENST00000400915.8:splice_region_variant&intron_variant:LOW:intron16/21:c.1792-20T>C::,PLEKHG5:ENST00000673471.2:splice_region_variant&intron_variant:LOW:intron16/21:c.1978-20T>C::,PLEKHG5:ENST00000377740.5:splice_region_variant&intron_variant:LOW:intron16/21:c.1681-20T>C::,PLEKHG5:ENST00000675694.1:splice_region_variant&intron_variant:LOW:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000675123.1:splice_region_variant&intron_variant:LOW:intron14/19:c.1681-20T>C::,PLEKHG5:ENST00000537245.6:splice_region_variant&intron_variant:LOW:intron16/21:c.1792-20T>C::		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1260549 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset,Charcot-Marie-Tooth disease recessive intermediate C,not provided];			rs2986753	0.1818	0.3368,0.1273,0.0044,0.1319,0.1545	3225,.	21169	124335	-0.3690			0.44		7.80>7.76		0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6470905	6470905	-	G	hom	hom	hom	off-target	QUAL=6021;DP=42,84,117;AF=0.98,0.99,1.00;MQM=60;SAP=18;ABP=0;SAR=141;SAF=100	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron13/20:c.1600-22dup::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron13/21:c.1393-22dup::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron14/21:c.1567-22dup::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron13/20:c.1504-22dup::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron14/21:c.1504-22dup::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron14/21:c.1690-22dup::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron14/21:c.1393-22dup::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron12/19:c.1393-22dup::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron14/21:c.1504-22dup::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	670557 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset,Charcot-Marie-Tooth disease recessive intermediate C,not provided];			rs111312565	1.0000	1.0000,1.0000,1.0000,0.9999,1.0000	75882,.	4	4				2.28				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6471529	6471529	C	T	het	wt	het		QUAL=1642;DP=35,115,114;AF=0.66,0.00,0.45;MQM=60;SAP=50;ABP=3;SAR=17;SAF=57	PLEKHG5	missense	PLEKHG5:ENST00000535355.6:missense_variant:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400913.6:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377725.5:missense_variant:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000340850.10:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377728.8:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377748.6:missense_variant:MODERATE:exon13/22:c.1414G>A:p.Ala472Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377732.5:missense_variant:MODERATE:exon12/21:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400915.8:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000673471.2:missense_variant:MODERATE:exon13/22:c.1537G>A:p.Ala513Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377740.5:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000675694.1:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000675123.1:missense_variant:MODERATE:exon11/20:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000537245.6:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain]	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297959 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset,Charcot-Marie-Tooth disease recessive intermediate C,not provided];			rs74809741	0.0610	0.0838,0.0550,0.0006,0.0587,0.0552	308,.	8674	142914	0.9380	T(0.41),T(0.45),T(0.44),T(0.45),T(0.45),T(0.42),T(0.43),T(0.43),T(0.44),T(0.45),T(0.45),T(0.47),T(0.43)	B(0.01),B(0.01),B(0.00),B(0.01),B(0.01),B(0.00),B(0.01),B(0.01),B(0.00),B(0.01),B(0.01),B(0.00),B(0.01)	18.48	0.04		COSV61699881	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6471906	6471906	C	T	het	wt	het	off-target	QUAL=2789;DP=78,120,185;AF=0.47,0.00,0.47;MQM=60;SAP=171;ABP=5;SAR=111;SAF=13	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron10/20:c.1288-98G>A::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron10/20:c.1081-98G>A::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron10/21:c.1081-98G>A::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron10/20:c.1081-98G>A::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron10/20:c.1081-98G>A::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron11/21:c.1255-98G>A::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron10/20:c.1192-98G>A::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron11/21:c.1192-98G>A::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron11/21:c.1378-98G>A::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron11/21:c.1081-98G>A::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron10/20:c.1081-98G>A::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron9/19:c.1081-98G>A::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron11/21:c.1192-98G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1253676 [benign DISEASE=not provided];			rs75682285	0.0470	0.0560,0.0440,0.0004,0.0500,0.0505	181,.	6791	145033	-0.2320			3.14				0.03		4	36	0 / 0					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6473333	6473333	G	C	het	wt	het		QUAL=479;DP=25,19,25;AF=0.44,0.00,0.56;MQM=60;SAP=57;ABP=3;SAR=25;SAF=0	PLEKHG5	missense	PLEKHG5:ENST00000535355.6:missense_variant:MODERATE:exon8/21:c.920C>G:p.Thr307Ser:,PLEKHG5:ENST00000400913.6:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377725.5:missense_variant:MODERATE:exon8/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000340850.10:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377728.8:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377748.6:missense_variant:MODERATE:exon9/22:c.887C>G:p.Thr296Ser:,PLEKHG5:ENST00000377732.5:missense_variant:MODERATE:exon8/21:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000400915.8:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000673471.2:missense_variant:MODERATE:exon9/22:c.1010C>G:p.Thr337Ser:,PLEKHG5:ENST00000377740.5:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000675694.1:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000675123.1:missense_variant:MODERATE:exon7/20:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000537245.6:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	198895 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset,Charcot-Marie-Tooth disease recessive intermediate C,not specified,not provided];			rs61741379	0.2765	0.6311,0.1636,0.0073,0.1431,0.1677	9529,.	23016	110106	0.8540	T(0.78),T(0.68),T(0.69),T(0.68),T(0.68),T(0.76),T(0.70),T(0.70),T(0.66),T(0.68),T(0.68),T(0.66),T(0.70)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	4.56	0.07		COSV61700195	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6474721	6474721	G	A	het	wt	het	off-target	QUAL=72;DP=5,6,6;AF=0.40,0.00,0.50;MQM=60;SAP=3;ABP=3;SAR=2;SAF=3	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron5/20:c.510-134C>T::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron5/20:c.303-134C>T::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron5/21:c.303-134C>T::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron5/20:c.303-134C>T::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron5/20:c.303-134C>T::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron6/21:c.477-134C>T::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron5/20:c.414-134C>T::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron6/21:c.414-134C>T::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron6/21:c.600-134C>T::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron6/21:c.303-134C>T::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron5/20:c.303-134C>T::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron4/19:c.303-134C>T::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron6/21:c.414-134C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667937 [benign DISEASE=not provided];			rs2986751	0.1643	0.3739,0.1358,0.0012,0.0719,0.0859	2588,.	15529	105321	-1.6160			0.65			COSV100556630	0.25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6475695	6475695	C	T	wt	het	wt	off-target	QUAL=585;DP=170,61,77;AF=0.00,0.48,0.00;MQM=60;SAP=66;ABP=3;SAR=29;SAF=0	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron3/20:c.357-173G>A::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron3/20:c.150-173G>A::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron3/21:c.150-173G>A::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron3/20:c.150-173G>A::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron3/20:c.150-173G>A::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron4/21:c.324-173G>A::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron3/20:c.261-173G>A::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron4/21:c.261-173G>A::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron4/21:c.447-173G>A::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron4/21:c.150-173G>A::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron3/20:c.150-173G>A::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron2/19:c.150-173G>A::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron4/21:c.261-173G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]				rs147010314	0.0019	0.0006,0.0017,0.0000,0.0030,0.0000	0,.	289	151921	-1.6440			0.16				0.01		0	30	0 / 0					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6519461	6519461	G	C	het	het	het		QUAL=3428;DP=121,76,91;AF=0.53,0.46,0.52;MQM=60;SAP=320;ABP=3;SAR=0;SAF=146	PLEKHG5	5'UTR	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-181C>G::	regulatory_region_variant:enhancer	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	670484 [likely benign DISEASE=not provided];			rs17438786	0.0220	0.0056,0.0197,0.0000,0.0324,0.0166	48,.	3253	148755	0.1090			6.88	0.09					22	912	0 / 0					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6519547	6519547	C	T	hom	hom	hom		QUAL=20041;DP=176,204,269;AF=1.00,1.00,1.00;MQM=60;SAP=739;ABP=0;SAR=90;SAF=559	PLEKHG5	5'UTR	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-267G>A::	regulatory_region_variant:enhancer	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	380860 [benign DISEASE=Autosomal recessive lower motor neuron disease with childhood onset,Charcot-Marie-Tooth disease recessive intermediate C,not specified];			rs1556035	0.7833	0.5287,0.8645,0.8090,0.8843,0.8670	48522,.	22035	32943	0.6350			7.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6519783	6519783	C	T	hom	hom	hom		QUAL=41973;DP=291,456,585;AF=0.99,1.00,1.00;MQM=60;SAP=143;ABP=0;SAR=811;SAF=518	PLEKHG5	5'UTR	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-503G>A::	regulatory_region_variant:enhancer	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667919 [benign DISEASE=not provided];			rs1010584	0.7731	0.5245,0.8487,0.7881,0.8734,0.8525	47329,.	22983	34527	-0.5550			1.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6520176	6520176	G	C	hom	hom	hom	off-target	QUAL=790;DP=19,4,6;AF=1.00,1.00,1.00;MQM=60;SAP=66;ABP=0;SAR=29;SAF=0	PLEKHG5,NOL9	upstream_gene,downstream_gene	PLEKHG5:ENST00000377740.5:upstream_gene_variant:MODIFIER::::,NOL9:ENST00000377705.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	679849 [benign DISEASE=not provided];			rs4908903	0.9751	0.9172,0.9932,0.9645,0.9997,0.9969	72502,.	3477	3797	0.0970			3.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6520190	6520190	C	T	hom	hom	n/a	off-target	QUAL=387;DP=12,3,2;AF=0.92,1.00,1.00;MQM=60;SAP=38;ABP=0;SAR=16;SAF=0	PLEKHG5,NOL9	upstream_gene,downstream_gene	PLEKHG5:ENST00000377740.5:upstream_gene_variant:MODIFIER::::,NOL9:ENST00000377705.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	679848 [benign DISEASE=not provided];			rs4908904	0.7731	0.5243,0.8487,0.7878,0.8737,0.8528	47334,.	22976	34524	0.6950			6.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	10258594	10258594	C	G	wt	het	wt		QUAL=2875;DP=316,229,251;AF=0.00,0.50,0.00;MQM=60;SAP=5;ABP=3;SAR=52;SAF=62	KIF1B	synonymous	KIF1B:ENST00000377093.9:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000676179.1:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000696501.1:synonymous_variant:LOW:exon4/6:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000263934.10:synonymous_variant:LOW:exon4/47:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000696502.1:synonymous_variant:LOW:exon4/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000696503.1:synonymous_variant:LOW:exon4/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000696504.1:synonymous_variant:LOW:exon4/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377086.5:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377083.5:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377081.5:synonymous_variant:LOW:exon3/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000620295.2:synonymous_variant:LOW:exon3/47:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000622724.3:synonymous_variant:LOW:exon3/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain]	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	129399 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease type 2A1,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease type 2,not specified,not provided];			rs12402052	0.2372	0.0922,0.3097,0.2835,0.2936,0.2397	4955,.	26135	115909	0.0670			10.86			COSV55805367	0.04	25741868,24033266,17418584	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10261996	10261996	G	A	wt	het	wt	off-target	QUAL=2023;DP=317,179,272;AF=0.00,0.46,0.00;MQM=60;SAP=10;ABP=5;SAR=50;SAF=34	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron5/20:c.429+26G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:ENST00000696501.1:intron_variant:MODIFIER:intron5/5:c.429+26G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron5/46:c.429+26G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron5/47:c.429+26G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron5/47:c.429+26G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron5/47:c.429+26G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron5/20:c.429+26G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron4/47:c.429+26G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron4/46:c.429+26G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron4/47:c.429+26G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1266483 [benign DISEASE=not provided];			rs4846209	0.3477	0.3369,0.3815,0.3584,0.3448,0.2686	9287,.	34204	99036	0.2760			1.71			COSV55815439	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10262095	10262095	A	G	wt	het	wt	off-target	QUAL=860;DP=182,87,156;AF=0.00,0.46,0.00;MQM=60;SAP=40;ABP=4;SAR=33;SAF=7	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron5/20:c.429+125A>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron5/48:c.429+125A>G::,KIF1B:ENST00000696501.1:intron_variant:MODIFIER:intron5/5:c.429+125A>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron5/46:c.429+125A>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron5/47:c.429+125A>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron5/47:c.429+125A>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron5/47:c.429+125A>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron5/48:c.429+125A>G::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron5/20:c.429+125A>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron4/47:c.429+125A>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron4/46:c.429+125A>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron4/47:c.429+125A>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1178036 [benign DISEASE=not provided];			rs4846210	0.2376	0.0926,0.3094,0.2853,0.2939,0.2402	4961,.	26155	115783	1.8680			8.82			COSV55805380	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10267349	10267349	A	T	wt	het	wt	off-target	QUAL=1116;DP=256,100,130;AF=0.00,0.50,0.00;MQM=60;SAP=55;ABP=3;SAR=8;SAF=43	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron5/20:c.430-31A>T::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron5/46:c.430-31A>T::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron5/47:c.430-31A>T::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron5/47:c.430-31A>T::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron5/47:c.430-31A>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron5/20:c.430-31A>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron4/47:c.430-31A>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron4/46:c.430-31A>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron4/47:c.430-31A>T::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1181451 [benign DISEASE=not provided];			rs12141246	0.3717	0.4131,0.3880,0.3970,0.3457,0.2738	10656,.	35078	95316	-1.5780			0.98			COSV55808764	0	17418584	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10268280	10268280	C	T	wt	het	wt	off-target	QUAL=2383;DP=239,186,187;AF=0.00,0.52,0.00;MQM=60;SAP=46;ABP=4;SAR=71;SAF=27	KIF1B	splice_region&intron	KIF1B:ENST00000377093.9:splice_region_variant&intron_variant:LOW:intron7/20:c.720+17C>T::,KIF1B:ENST00000676179.1:splice_region_variant&intron_variant:LOW:intron7/48:c.720+17C>T::,KIF1B:ENST00000263934.10:splice_region_variant&intron_variant:LOW:intron7/46:c.720+17C>T::,KIF1B:ENST00000696502.1:splice_region_variant&intron_variant:LOW:intron7/47:c.720+17C>T::,KIF1B:ENST00000696503.1:splice_region_variant&intron_variant:LOW:intron7/47:c.720+17C>T::,KIF1B:ENST00000696504.1:splice_region_variant&intron_variant:LOW:intron7/47:c.720+17C>T::,KIF1B:ENST00000377086.5:splice_region_variant&intron_variant:LOW:intron7/48:c.720+17C>T::,KIF1B:ENST00000377083.5:splice_region_variant&intron_variant:LOW:intron7/20:c.720+17C>T::,KIF1B:ENST00000377081.5:splice_region_variant&intron_variant:LOW:intron6/47:c.720+17C>T::,KIF1B:ENST00000620295.2:splice_region_variant&intron_variant:LOW:intron6/46:c.720+17C>T::,KIF1B:ENST00000622724.3:splice_region_variant&intron_variant:LOW:intron6/47:c.720+17C>T::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	260542 [benign DISEASE=Pheochromocytoma,Charcot-Marie-Tooth disease type 2A1,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease type 2,not specified,not provided];			rs1339458	0.2567	0.1579,0.3198,0.2848,0.2941,0.2405	5356,.	28278	112918	-1.5610			2.36			COSV55802811	0	25741868,17418584	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10275257	10275257	G	A	hom	hom	hom	off-target	QUAL=5032;DP=132,16,16;AF=0.99,1.00,1.00;MQM=60;SAP=357;ABP=0;SAR=0;SAF=163	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron9/20:c.865-171G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron10/48:c.883-171G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron9/46:c.865-171G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron9/47:c.865-171G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron9/47:c.865-171G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron9/47:c.865-171G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron10/48:c.883-171G>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron9/20:c.865-171G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron9/47:c.883-171G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron9/46:c.883-171G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron9/47:c.883-171G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1226716 [benign DISEASE=not provided];			rs6685773	0.9924	0.9978,0.9939,1.0000,0.9878,0.9963	74972,.	1133	1151	-0.2060			0.23				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10282294	10282294	C	T	wt	het	wt	off-target	QUAL=962;DP=137,88,110;AF=0.00,0.49,0.00;MQM=60;SAP=96;ABP=3;SAR=0;SAF=43	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron12/20:c.1163-106C>T::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron14/48:c.1223-28C>T::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron12/46:c.1163-106C>T::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron12/47:c.1163-106C>T::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron12/47:c.1163-106C>T::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron12/47:c.1163-106C>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron14/48:c.1223-28C>T::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron12/20:c.1163-106C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron13/47:c.1223-28C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron12/46:c.1181-28C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron13/47:c.1223-106C>T::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	917113 [benign DISEASE=Charcot-Marie-Tooth disease,not provided];			rs3748575	0.5443	0.7136,0.5102,0.3644,0.4773,0.4474	23479,.	35745	69245	0.4840			10.03				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10282571	10282571	G	A	wt	het	het	off-target	QUAL=5608;DP=180,218,224;AF=0.01,0.50,0.50;MQM=60;SAP=99;ABP=3;SAR=160;SAF=61	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron13/46:c.1296+38G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron13/47:c.1296+38G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron13/47:c.1296+38G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron13/47:c.1296+38G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron14/47:c.1434+38G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron13/46:c.1392+38G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron14/47:c.1356+38G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292705 [benign DISEASE=not provided];		L3 (LINE/CR1)	rs3748576	0.7041	0.9263,0.6892,0.5225,0.6017,0.6215	39359,.	28328	44992	-0.5210			0.35			COSV55814192	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10295776	10295776	C	T	wt	het	wt		QUAL=1539;DP=135,128,157;AF=0.01,0.48,0.00;MQM=60;SAP=11;ABP=3;SAR=39;SAF=24	KIF1B	splice_region&intron	KIF1B:ENST00000377093.9:splice_region_variant&intron_variant:LOW:intron17/20:c.1639+10C>T::,KIF1B:ENST00000676179.1:splice_region_variant&intron_variant:LOW:intron19/48:c.1777+10C>T::,KIF1B:ENST00000263934.10:splice_region_variant&intron_variant:LOW:intron17/46:c.1639+10C>T::,KIF1B:ENST00000696502.1:splice_region_variant&intron_variant:LOW:intron17/47:c.1639+10C>T::,KIF1B:ENST00000696503.1:splice_region_variant&intron_variant:LOW:intron18/47:c.1702+10C>T::,KIF1B:ENST00000696504.1:splice_region_variant&intron_variant:LOW:intron18/47:c.1702+10C>T::,KIF1B:ENST00000377086.5:splice_region_variant&intron_variant:LOW:intron19/48:c.1777+10C>T::,KIF1B:ENST00000377083.5:splice_region_variant&intron_variant:LOW:intron17/20:c.1639+10C>T::,KIF1B:ENST00000377081.5:splice_region_variant&intron_variant:LOW:intron18/47:c.1777+10C>T::,KIF1B:ENST00000620295.2:splice_region_variant&intron_variant:LOW:intron17/46:c.1735+10C>T::,KIF1B:ENST00000622724.3:splice_region_variant&intron_variant:LOW:intron18/47:c.1699+10C>T::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	177960 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease type 2A1,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease type 2,not specified,not provided];			rs3753037	0.2659	0.1895,0.3232,0.2845,0.2944,0.2393	5574,.	29250	111510	0.2620			6.71			COSV55805392	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10296504	10296504	C	A	wt	het	wt	off-target	QUAL=1191;DP=215,115,156;AF=0.00,0.45,0.00;MQM=60;SAP=70;ABP=5;SAR=6;SAF=46	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron17/20:c.1640-78C>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron19/48:c.1778-78C>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron17/46:c.1640-78C>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron17/47:c.1640-78C>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron18/47:c.1703-78C>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron18/47:c.1703-78C>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron19/48:c.1778-78C>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron17/20:c.1640-78C>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron18/47:c.1778-78C>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron17/46:c.1736-78C>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron18/47:c.1700-78C>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292717 [benign DISEASE=not provided];			rs2275424	0.2374	0.0925,0.3089,0.2834,0.2938,0.2394	4957,.	26142	115850	-0.0170			2.97			COSV55818663	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10296790	10296790	A	G	wt	het	wt	off-target	QUAL=801;DP=256,65,97;AF=0.00,0.54,0.00;MQM=60;SAP=42;ABP=4;SAR=30;SAF=5	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron18/20:c.1724-107A>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron20/48:c.1862-107A>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron18/46:c.1724-107A>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron18/47:c.1724-107A>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron19/47:c.1787-107A>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron19/47:c.1787-107A>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron20/48:c.1862-107A>G::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron18/20:c.1724-107A>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron19/47:c.1862-107A>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron18/46:c.1820-107A>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron19/47:c.1784-107A>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1182225 [benign DISEASE=not provided];			rs912961	0.3183	0.2978,0.3621,0.3575,0.3164,0.2656	7810,.	32734	103546	-0.4830			1.22			COSV55805404	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10297149	10297149	T	-	het	het	het	off-target;low_conf_region	QUAL=3797;DP=178,164,233;AF=0.34,0.29,0.32;MQM=60;SAP=3;ABP=168;SAR=89;SAF=94	KIF1B	splice_region&intron	KIF1B:ENST00000377093.9:splice_region_variant&intron_variant:LOW:intron19/20:c.1905-9del::,KIF1B:ENST00000676179.1:splice_region_variant&intron_variant:LOW:intron21/48:c.2043-9del::,KIF1B:ENST00000263934.10:splice_region_variant&intron_variant:LOW:intron19/46:c.1905-9del::,KIF1B:ENST00000696502.1:splice_region_variant&intron_variant:LOW:intron19/47:c.1905-9del::,KIF1B:ENST00000696503.1:splice_region_variant&intron_variant:LOW:intron20/47:c.1968-9del::,KIF1B:ENST00000696504.1:splice_region_variant&intron_variant:LOW:intron20/47:c.1968-9del::,KIF1B:ENST00000377086.5:splice_region_variant&intron_variant:LOW:intron21/48:c.2043-9del::,KIF1B:ENST00000377083.5:splice_region_variant&intron_variant:LOW:intron19/20:c.1905-9del::,KIF1B:ENST00000377081.5:splice_region_variant&intron_variant:LOW:intron20/47:c.2043-9del::,KIF1B:ENST00000620295.2:splice_region_variant&intron_variant:LOW:intron19/46:c.2001-9del::,KIF1B:ENST00000622724.3:splice_region_variant&intron_variant:LOW:intron20/47:c.1965-9del::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	917114 [benign DISEASE=Charcot-Marie-Tooth disease];		(T)n (Simple_repeat)	rs58344165	0.0069	0.0022,0.0065,0.0024,0.0086,0.0018	1,.	982	142408	0.1110			0.09				0.01		0	290	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10297348	10297348	A	G	wt	het	wt	off-target	QUAL=1824;DP=194,133,184;AF=0.00,0.56,0.00;MQM=60;SAP=84;ABP=8;SAR=64;SAF=11	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron20/20:c.1977+102A>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+102A>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+102A>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron20/47:c.1977+102A>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron21/47:c.2040+102A>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron21/47:c.2040+102A>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+102A>G::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron20/20:c.1977+102A>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+102A>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+102A>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+102A>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1248254 [benign DISEASE=not provided];			rs3748577	0.3184	0.2979,0.3621,0.3587,0.3163,0.2667	7806,.	32715	103441	-1.5910			0.02			COSV55805274	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10306429	10306429	T	G	wt	het	wt		QUAL=2589;DP=248,230,227;AF=0.00,0.45,0.00;MQM=60;SAP=4;ABP=8;SAR=56;SAF=49	KIF1B	3'UTR,intron	KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+9183T>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron20/47:c.1977+9183T>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron21/47:c.2040+9183T>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron21/47:c.2040+9183T>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:ENST00000377083.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+9183T>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+9183T>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+9183T>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]				rs8019	0.3932	0.4695,0.4036,0.3591,0.3579,0.2803	11978,.	35760	92170	0.5490			7.79				0	22363396	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10306634	10306634	C	G	wt	het	wt		QUAL=2901;DP=289,253,279;AF=0.00,0.47,0.00;MQM=60;SAP=84;ABP=4;SAR=94;SAF=27	KIF1B,RN7SL731P	3'UTR,intron,non_coding_transcript_exon	KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+9388C>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron20/47:c.1977+9388C>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron21/47:c.2040+9388C>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron21/47:c.2040+9388C>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:ENST00000377083.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+9388C>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+9388C>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+9388C>G::,RN7SL731P:ENST00000584329.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.170C>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			7SLRNA (srpRNA)	rs4623	0.3398	0.3090,0.3791,0.3579,0.3448,0.2744	8848,.	33550	99552	-0.5050			2.10				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10307366	10307366	G	A	wt	het	wt		QUAL=344;DP=114,43,45;AF=0.01,0.42,0.00;MQM=60;SAP=29;ABP=5;SAR=17;SAF=2	KIF1B	3'UTR,intron	KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+10120G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron20/47:c.1977+10120G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron21/47:c.2040+10120G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron21/47:c.2040+10120G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+10120G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+10120G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+10120G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			AluSx (SINE/Alu)	rs2004034	0.2379	0.0920,0.3118,0.2842,0.2942,0.2465	5002,.	26178	115880	0.6790			3.12				0	23032637	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10307533	10307533	T	C	wt	het	wt		QUAL=1161;DP=190,87,99;AF=0.00,0.59,0.01;MQM=60;SAP=116;ABP=9;SAR=0;SAF=52	KIF1B	3'UTR,intron	KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+10287T>C::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron20/47:c.1977+10287T>C::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron21/47:c.2040+10287T>C::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron21/47:c.2040+10287T>C::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+10287T>C::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+10287T>C::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+10287T>C::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			AluSx (SINE/Alu)	rs1065828	0.3397	0.3088,0.3794,0.3582,0.3447,0.2733	8901,.	33744	100212	-0.5710			2.54				0	31477794	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10324118	10324118	-	TTGAAA	het	het	het	off-target;low_conf_region	QUAL=4473;DP=227,136,185;AF=0.42,0.42,0.38;MQM=60;SAP=437;ABP=44;SAR=217;SAF=6	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron23/46:c.2399+57_2399+58insTGAAAT::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron23/47:c.2399+57_2399+58insTGAAAT::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron24/47:c.2462+57_2462+58insTGAAAT::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron24/47:c.2462+57_2462+58insTGAAAT::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron24/47:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron23/46:c.2495+57_2495+58insTGAAAT::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron24/47:c.2459+57_2459+58insTGAAAT::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1241982 [benign DISEASE=not provided];			rs3831405	0.2394	0.0928,0.3110,0.2796,0.2963,0.2504	4994,.	26340	115448				3.98				0.1	32986753	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10324654	10324654	T	-	het	het	wt	off-target	QUAL=40;DP=98,25,36;AF=0.13,0.16,0.06;MQM=59;SAP=44;ABP=143;SAR=0;SAF=19	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron25/48:c.2538-92del::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron23/46:c.2400-92del::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron23/47:c.2400-92del::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron24/47:c.2463-92del::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron24/47:c.2463-92del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron25/48:c.2538-92del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron24/47:c.2538-92del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron23/46:c.2496-92del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron24/47:c.2460-92del::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]				rs201407650	0.0018	0.0007,0.0016,0.0002,0.0019,0.0009	0,.	257	143595	0.2880			0.60				0		0	11	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10334478	10334478	C	G	het	het	het	off-target	QUAL=8213;DP=247,151,219;AF=0.53,0.48,0.53;MQM=60;SAP=434;ABP=5;SAR=34;SAF=286	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron25/46:c.2787-42C>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron25/47:c.2787-42C>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron26/47:c.2850-42C>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron26/47:c.2850-42C>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron26/47:c.2925-42C>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron25/46:c.2883-42C>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron26/47:c.2847-42C>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1179832 [benign DISEASE=not provided];			rs2276100	0.3280	0.3200,0.3680,0.3575,0.3204,0.2782	8308,.	33236	102156	-0.1170			3.79			COSV55805280	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10337022	10337022	A	G	wt	wt	het	off-target	QUAL=1132;DP=202,79,101;AF=0.00,0.00,0.47;MQM=60;SAP=47;ABP=4;SAR=8;SAF=39	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron27/46:c.2992-52A>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron27/47:c.2992-52A>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron28/47:c.3055-52A>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron28/47:c.3055-52A>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron28/47:c.3130-52A>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron27/46:c.3088-52A>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron28/47:c.3052-52A>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]				rs71643087	0.0210	0.0054,0.0082,0.0004,0.0320,0.0213	51,.	3087	148999	0.3500			0.68				0		8	850	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10341952	10341952	A	-	het	het	het	off-target;low_conf_region	QUAL=1555;DP=53,41,54;AF=0.43,0.34,0.54;MQM=59;SAP=146;ABP=7;SAR=0;SAF=66	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron32/48:c.3514-82del::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron30/46:c.3376-82del::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron30/47:c.3376-82del::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron31/47:c.3439-82del::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron31/47:c.3439-82del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron32/48:c.3514-82del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron31/47:c.3514-82del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron30/46:c.3472-82del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron31/47:c.3436-82del::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1251637 [benign DISEASE=not provided];		AluJb (SINE/Alu)	rs33942183	0.5099	0.5291,0.5308,0.4356,0.4960,0.5220	12740,.	36235	59323	1.0050			0.81				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10343424	10343424	G	A	het	het	het	off-target	QUAL=4707;DP=181,99,125;AF=0.51,0.46,0.48;MQM=60;SAP=433;ABP=3;SAR=198;SAF=0	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron34/48:c.3688+137G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron32/46:c.3550+137G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron32/47:c.3550+137G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron33/47:c.3613+137G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron33/47:c.3613+137G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron34/48:c.3688+137G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron33/47:c.3688+137G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron32/46:c.3646+137G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron33/47:c.3610+137G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1233883 [benign DISEASE=not provided];			rs1556916	0.3471	0.3251,0.3826,0.3581,0.3487,0.2783	9303,.	34096	99128	0.1300			1.33			COSV55805410	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10348780	10348780	T	-	het	het	het	off-target;low_conf_region	QUAL=304;DP=135,134,144;AF=0.19,0.17,0.10;MQM=60;SAP=61;ABP=436;SAR=52;SAF=11	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron37/48:c.3949+60del::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron35/46:c.3811+60del::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron36/47:c.4012+60del::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron36/47:c.3874+60del::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron36/47:c.3874+60del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron37/48:c.3949+60del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron36/47:c.3949+60del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron35/46:c.3907+60del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron36/47:c.3871+60del::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			FRAM (SINE/Alu)	rs35253111	0.0104	0.0287,0.0075,0.0042,0.0021,0.0011	11,.	1491	143965	0.2760			0.70				0.02		0	13	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10360860	10360860	G	A	het	het	het	off-target	QUAL=10096;DP=216,259,308;AF=0.55,0.50,0.49;MQM=60;SAP=456;ABP=3;SAR=55;SAF=343	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron38/48:c.4056-69G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron36/46:c.3918-69G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron37/47:c.4119-69G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron37/47:c.3981-69G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron37/47:c.3981-69G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron38/48:c.4056-69G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron37/47:c.4056-69G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron36/46:c.4014-69G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron37/47:c.3978-69G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292713 [benign DISEASE=not provided];			rs3748578	0.2921	0.2708,0.3362,0.2762,0.2983,0.2508	6576,.	31218	107544	-0.6940			1.39			COSV55805417	0	23028799,27122668,31475028	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10360879	10360879	C	T	het	het	het	off-target	QUAL=11881;DP=257,298,372;AF=0.52,0.51,0.49;MQM=60;SAP=367;ABP=3;SAR=94;SAF=374	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron36/46:c.3918-50C>T::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron37/47:c.4119-50C>T::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron37/47:c.3981-50C>T::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron37/47:c.3981-50C>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron37/47:c.4056-50C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron36/46:c.4014-50C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron37/47:c.3978-50C>T::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1248757 [benign DISEASE=not provided];			rs3748579	0.3279	0.3201,0.3689,0.3573,0.3201,0.2778	8292,.	33211	102063	-0.6290			1.47			COSV55805298	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10365005	10365005	-	A	wt	wt	het	off-target;low_conf_region	QUAL=396;DP=47,17,25;AF=0.26,0.12,0.08;MQM=56;SAP=44;ABP=66;SAR=0;SAF=19	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron41/48:c.4367-79dup::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron39/46:c.4229-79dup::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron40/47:c.4430-79dup::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron40/47:c.4292-79dup::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron40/47:c.4292-79dup::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron41/48:c.4367-79dup::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron40/47:c.4367-79dup::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron39/46:c.4325-79dup::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron40/47:c.4289-79dup::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1241038 [benign DISEASE=not provided];		AluY (SINE/Alu)	rs57088720	0.3661	0.6578,0.2940,0.3340,0.2258,0.3420	9260,.	23912	73474				2.20				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10365006	10365006	A	-	het	het	wt	off-target;low_conf_region	QUAL=396;DP=47,17,25;AF=0.17,0.12,0.36;MQM=59;SAP=38;ABP=82;SAR=0;SAF=16	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron41/48:c.4367-79del::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron39/46:c.4229-79del::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron40/47:c.4430-79del::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron40/47:c.4292-79del::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron40/47:c.4292-79del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron41/48:c.4367-79del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron40/47:c.4367-79del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron39/46:c.4325-79del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron40/47:c.4289-79del::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			AluY (SINE/Alu)	rs57088720	0.0012	0.0003,0.0015,0.0003,0.0010,0.0012	0,.	139	115977	-0.0900			1.86				0		2	24	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10365060	10365060	T	-	het	het	het	off-target	QUAL=3187;DP=97,87,111;AF=0.45,0.46,0.52;MQM=60;SAP=150;ABP=4;SAR=22;SAF=120	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron39/46:c.4229-33del::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron40/47:c.4430-33del::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron40/47:c.4292-33del::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron40/47:c.4292-33del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron40/47:c.4367-33del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron39/46:c.4325-33del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron40/47:c.4289-33del::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1260773 [benign DISEASE=not provided];			rs34161257	0.5276	0.6592,0.5059,0.3630,0.4753,0.4610	21584,.	36162	71034	1.3520			2.77				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10365808	10365808	C	T	wt	wt	het	off-target	QUAL=204;DP=62,36,38;AF=0.00,0.00,0.34;MQM=60;SAP=31;ABP=11;SAR=13;SAF=0	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron43/48:c.4752+160C>T::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron41/46:c.4614+160C>T::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron42/47:c.4815+160C>T::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron42/47:c.4677+160C>T::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron42/47:c.4677+160C>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron43/48:c.4752+160C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron42/47:c.4752+160C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron41/46:c.4710+160C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron42/47:c.4674+160C>T::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292731 [benign DISEASE=not provided];		L2c (LINE/L2)	rs11121549	0.0864	0.0211,0.1473,0.1573,0.0959,0.1550	756,.	11627	138957	0.0260			1.54				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10368394	10368394	G	A	het	het	het	off-target	QUAL=8650;DP=185,253,306;AF=0.51,0.46,0.49;MQM=60;SAP=364;ABP=4;SAR=58;SAF=303	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron43/48:c.4753-73G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron41/46:c.4615-73G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron42/47:c.4816-73G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron42/47:c.4678-73G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron42/47:c.4678-73G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron43/48:c.4753-73G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron42/47:c.4753-73G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron41/46:c.4711-73G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron42/47:c.4675-73G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292718 [benign DISEASE=not provided];		MER21B (LTR/ERVL)	rs12130563	0.3280	0.3200,0.3685,0.3569,0.3202,0.2783	8310,.	33210	102112	-0.1800			0.68			COSV55805423	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10371100	10371100	T	C	het	het	het	off-target	QUAL=7053;DP=218,156,224;AF=0.45,0.47,0.53;MQM=60;SAP=385;ABP=4;SAR=32;SAF=258	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron42/46:c.4687-41T>C::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron43/47:c.4888-41T>C::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron43/47:c.4750-41T>C::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron43/47:c.4750-41T>C::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron43/47:c.4825-41T>C::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron42/46:c.4783-41T>C::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron43/47:c.4747-41T>C::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1228335 [benign DISEASE=not provided];			rs17411502	0.2578	0.1532,0.3207,0.2764,0.2979,0.2509	5473,.	28257	112885	-0.5520			5.68			COSV55805429	0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10375112	10375112	T	C	het	het	het	off-target	QUAL=7784;DP=272,182,218;AF=0.47,0.50,0.45;MQM=60;SAP=405;ABP=8;SAR=279;SAF=37	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron47/48:c.5289+66T>C::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron45/46:c.5151+66T>C::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron46/47:c.5352+66T>C::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron46/47:c.5214+66T>C::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron46/47:c.5214+66T>C::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron47/48:c.5289+66T>C::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron46/47:c.5289+66T>C::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron45/46:c.5247+66T>C::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron46/47:c.5211+66T>C::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1239662 [benign DISEASE=not provided];			rs11121551	0.3470	0.3242,0.3827,0.3585,0.3488,0.2789	9311,.	34089	99193	0.5700			6.62			COSV55805435	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10375266	10375266	C	A	het	het	het		QUAL=7267;DP=295,115,148;AF=0.45,0.57,0.52;MQM=60;SAP=4;ABP=3;SAR=143;SAF=134	KIF1B	synonymous	KIF1B:ENST00000676179.1:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000263934.10:synonymous_variant:LOW:exon46/47:c.5163C>A:p.Thr1721=:PF00169 [PH domain],KIF1B:ENST00000696502.1:synonymous_variant:LOW:exon47/48:c.5364C>A:p.Thr1788=:PF00169 [PH domain],KIF1B:ENST00000696503.1:synonymous_variant:LOW:exon47/48:c.5226C>A:p.Thr1742=:PF00169 [PH domain],KIF1B:ENST00000696504.1:synonymous_variant:LOW:exon47/48:c.5226C>A:p.Thr1742=:PF00169 [PH domain],KIF1B:ENST00000377086.5:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000377081.5:synonymous_variant:LOW:exon47/48:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000620295.2:synonymous_variant:LOW:exon46/47:c.5259C>A:p.Thr1753=:PF00169 [PH domain],KIF1B:ENST00000622724.3:synonymous_variant:LOW:exon47/48:c.5223C>A:p.Thr1741=:PF00169 [PH domain]		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	129401 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease type 2A1,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease type 2,not specified,not provided];			rs11121552	0.2402	0.0929,0.3118,0.2767,0.2976,0.2504	5097,.	26330	115552	-0.5900			5.52			COSV55805449	0.01	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10376834	10376834	-	AC	het	het	wt		QUAL=4734;DP=120,108,127;AF=0.40,0.31,0.01;MQM=60;SAP=28;ABP=222;SAR=26;SAF=57	KIF1B	3'UTR,intron	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:ENST00000263934.10:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279_*280dup::,KIF1B:ENST00000696502.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279_*280dup::,KIF1B:ENST00000696503.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279_*280dup::,KIF1B:ENST00000696504.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279_*280dup::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-1473_5409-1472dup::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-1473_5367-1472dup::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-1473_5331-1472dup::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291586 [uncertain significance DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease type 2];			rs111663673	0.0543	0.0599,0.0443,0.0471,0.0554,0.0227	195,.	7430	136094				2.16				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10376866	10376866	C	T	het	wt	het		QUAL=4734;DP=120,108,127;AF=0.40,0.31,0.01;MQM=60;SAP=15;ABP=6;SAR=45;SAF=70	KIF1B	3'UTR,intron	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:ENST00000263934.10:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279C>T::,KIF1B:ENST00000696502.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279C>T::,KIF1B:ENST00000696503.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279C>T::,KIF1B:ENST00000696504.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279C>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-1473C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-1473C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-1473C>T::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291594 [benign DISEASE=Neuroblastoma];		(AC)n (Simple_repeat)	rs78490707	0.0079	0.0011,0.0017,0.1190,0.0032,0.0349	49,.	1006	138404	-1.7410			0.41				0		2	79	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10377948	10377948	A	T	het	het	wt		QUAL=1163;DP=76,54,72;AF=0.41,0.48,0.00;MQM=60;SAP=80;ABP=7;SAR=6;SAF=51	KIF1B	3'UTR,intron	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-391A>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-391A>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-391A>T::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291610 [benign DISEASE=Neuroblastoma];		AluSg (SINE/Alu)	rs2847347	0.0380	0.0110,0.0354,0.0060,0.0600,0.0112	153,.	5477	146357	0.2090			2.28						1	25	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10378629	10378629	C	T	het	het	het		QUAL=12151;DP=253,281,354;AF=0.56,0.51,0.51;MQM=60;SAP=4;ABP=7;SAR=240;SAF=224	KIF1B	3'UTR	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*227C>T::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291618 [benign DISEASE=Neuroblastoma];			rs1536262	0.5518	0.7379,0.5153,0.3644,0.4766,0.4582	24286,.	35278	68098	-1.2380			0.55					27980619,31477794	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10378834	10378834	G	A	het	het	het		QUAL=8764;DP=281,160,191;AF=0.52,0.57,0.52;MQM=60;SAP=71;ABP=9;SAR=220;SAF=117	KIF1B	3'UTR	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*432G>A::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291619 [benign DISEASE=Neuroblastoma];			rs1002076	0.3278	0.3198,0.3684,0.3577,0.3202,0.2782	8298,.	33216	102130	0.4980			2.91					25854172	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10380498	10380498	A	G	het	het	het		QUAL=9089;DP=324,182,224;AF=0.51,0.49,0.48;MQM=51;SAP=11;ABP=3;SAR=200;SAF=163	KIF1B	3'UTR	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*2096A>G::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291652 [benign DISEASE=Neuroblastoma];		AluSx (SINE/Alu)	rs1138791	0.3571	0.3587,0.3870,0.3587,0.3490,0.2789	9821,.	34607	97663	-1.5530			2.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10381606	10381606	T	C	het	het	het		QUAL=13658;DP=453,272,349;AF=0.53,0.44,0.50;MQM=60;SAP=304;ABP=3;SAR=403;SAF=131	KIF1B	downstream_gene	KIF1B:ENST00000676179.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000263934.10:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696502.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696503.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696504.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377086.5:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377081.5:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000620295.2:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000622724.3:downstream_gene_variant:MODIFIER::::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	368794 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease type 2];			rs3748581	0.5321	0.6698,0.5086,0.3644,0.4758,0.4630	22184,.	36444	71054	0.4330			9.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	11012522	11012522	T	C	hom	hom	hom	off-target	QUAL=805;DP=5,10,11;AF=1.00,1.00,1.00;MQM=60;SAP=59;ABP=0;SAR=0;SAF=26	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron1/5:c.-13+42T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]				rs968545	0.9502	0.9885,0.9639,0.9996,0.9323,0.9504	68833,.	6940	7586	-0.9450			7.05				0	18068872,18802454,34002018	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06)
chr1	11012828	11012828	C	T	het	het	hom	off-target	QUAL=358;DP=13,4,12;AF=0.23,0.50,1.00;MQM=60;SAP=40;ABP=9;SAR=17;SAF=0	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron1/5:c.-13+348C>T::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron1/6:c.-13+85C>T::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron1/5:c.-13+85C>T::	regulatory_region_variant:promoter	605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]				rs4133584	0.6390	0.2572,0.7263,0.6527,0.8120,0.6937	35456,.	26280	54912	0.3350			11.79				0.01	18802454,21832997,17434264	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06)
chr1	11017202	11017202	C	T	het	n/a	n/a	off-target	QUAL=99;DP=39,0,2;AF=0.28,,0.00;MQM=57;SAP=27;ABP=19;SAR=11;SAF=0	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron3/5:c.402+195C>T::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron3/6:c.402+195C>T::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron3/5:c.402+195C>T::,TARDBP:ENST00000315091.7:intron_variant:MODIFIER:intron2/5:c.402+195C>T::,TARDBP:ENST00000649624.1:intron_variant:MODIFIER:intron2/5:c.402+195C>T::,TARDBP:ENST00000616545.4:intron_variant:MODIFIER:intron2/5:c.402+195C>T::,TARDBP:ENST00000621790.4:intron_variant:MODIFIER:intron2/5:c.402+195C>T::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs1002487715	0.0001	0.0001,0.0000,0.0000,0.0001,0.0000	0,.	4	105870	-2.1360			1.43			COSV53570701	0		0	0	0 / 0					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11019020	11019020	A	G	het	het	hom	off-target	QUAL=3368;DP=102,39,52;AF=0.54,0.51,1.00;MQM=60;SAP=279;ABP=4;SAR=127;SAF=0	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron4/5:c.543+147A>G::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron4/6:c.543+147A>G::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron4/5:c.543+147A>G::,TARDBP:ENST00000315091.7:intron_variant:MODIFIER:intron3/5:c.543+147A>G::,TARDBP:ENST00000649624.1:intron_variant:MODIFIER:intron3/5:c.543+147A>G::,TARDBP:ENST00000616545.4:intron_variant:MODIFIER:intron3/5:c.543+147A>G::,TARDBP:ENST00000621790.4:intron_variant:MODIFIER:intron3/5:c.543+147A>G::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	1293144 [benign DISEASE=not provided];			rs2273348	0.6398	0.2589,0.7268,0.6573,0.8122,0.6932	35491,.	26279	54755	0.1640			3.71				0	19005574,21937999,18545701,17614162,17434264,22550220,33462484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11020666	11020666	-	G	het	het	hom	off-target	QUAL=4287;DP=95,61,95;AF=0.45,0.62,1.00;MQM=59;SAP=385;ABP=4;SAR=176;SAF=0	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron5/5:c.714+69dup::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron5/6:c.714+69dup::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron5/5:c.714+69dup::,TARDBP:ENST00000315091.7:intron_variant:MODIFIER:intron4/5:c.714+69dup::,TARDBP:ENST00000649624.1:intron_variant:MODIFIER:intron4/5:c.714+69dup::,TARDBP:ENST00000616545.4:intron_variant:MODIFIER:intron4/5:c.714+69dup::,TARDBP:ENST00000621790.4:intron_variant:MODIFIER:intron4/5:c.714+69dup::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	522225 [benign DISEASE=Amyotrophic lateral sclerosis type 10,not specified,not provided];		AluSc (SINE/Alu)	rs143130606	0.8801	0.9681,0.8990,0.9244,0.8345,0.8684	58908,.	15406	18154				0.94				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11020751	11020751	A	-	het	het	het	off-target	QUAL=136;DP=39,8,11;AF=0.31,0.13,0.27;MQM=56;SAP=38;ABP=28;SAR=16;SAF=0	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron5/5:c.714+166del::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron5/6:c.714+166del::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron5/5:c.714+166del::,TARDBP:ENST00000315091.7:intron_variant:MODIFIER:intron4/5:c.714+166del::,TARDBP:ENST00000649624.1:intron_variant:MODIFIER:intron4/5:c.714+166del::,TARDBP:ENST00000616545.4:intron_variant:MODIFIER:intron4/5:c.714+166del::,TARDBP:ENST00000621790.4:intron_variant:MODIFIER:intron4/5:c.714+166del::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	1283048 [benign DISEASE=not provided];		AluSc (SINE/Alu)	rs57781131	0.0981	0.2067,0.0583,0.2377,0.0340,0.1159	926,.	10590	114448	0.4500			1.20				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11021998	11021998	G	-	het	het	hom	off-target	QUAL=3632;DP=126,47,64;AF=0.51,0.49,1.00;MQM=60;SAP=331;ABP=3;SAR=0;SAF=151	TARDBP	intron	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron5/5:c.715-126del::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron5/6:c.715-126del::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron5/5:c.715-126del::,TARDBP:ENST00000315091.7:intron_variant:MODIFIER:intron4/5:c.715-126del::,TARDBP:ENST00000649624.1:intron_variant:MODIFIER:intron4/5:c.715-126del::,TARDBP:ENST00000616545.4:intron_variant:MODIFIER:intron4/5:c.715-126del::,TARDBP:ENST00000621790.4:intron_variant:MODIFIER:intron4/5:c.715-126del::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	1221094 [benign DISEASE=not provided];			rs3835416	0.6389	0.2572,0.7267,0.6553,0.8118,0.6917	35414,.	26291	54885	0.1340			1.10				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11024947	11024947	-	TGTTT	het	het	hom		QUAL=16206;DP=371,256,267;AF=0.49,0.50,1.00;MQM=60;SAP=32;ABP=3;SAR=332;SAF=244	TARDBP,MASP2	3'UTR,intron	TARDBP:ENST00000240185.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2294_*2295insGTTTT::,MASP2:ENST00000700088.1:intron_variant:MODIFIER:intron11/11:c.1396+1802_1396+1803insAAACA::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	291763 [benign DISEASE=Frontotemporal dementia,Immunodeficiency due to MASP-2 deficiency,Amyotrophic Lateral Sclerosis, Dominant];			rs3059695	0.8802	0.9697,0.8984,0.9252,0.8341,0.8697	59078,.	15398	18178				4.86				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11786035	11786035	-	T	het	hom	het		QUAL=4368;DP=116,37,50;AF=0.75,0.89,0.90;MQM=60;SAP=250;ABP=129;SAR=14;SAF=151	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3081+757dup::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3567+757dup::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4644dup::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292153 [benign DISEASE=Neural tube defects, folate-sensitive];			rs55740775	0.9840	0.9619,0.9942,0.9969,0.9931,0.9994	72488,.	2333	2393				1.54				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786195	11786195	G	A	hom	het	het		QUAL=15057;DP=330,159,181;AF=1.00,0.50,0.54;MQM=60;SAP=44;ABP=5;SAR=205;SAF=303	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3081+906G>A::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3567+906G>A::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4485C>T::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]			Tigger15a (DNA/TcMar-Tigger)	rs4846048	0.6780	0.5449,0.7760,0.8955,0.7061,0.6684	35684,.	31653	48935	0.4760			3.52				0	31637880,21273288,19493349,19593234,20056627,22747749,26046315,28963520,20692813,24853127,25566964,32117640,18221821,24687778,28969008,29299150,29340069,31694048,32073761,18180959,31601265,31750632,31737664,31671528,25165408,26770518,23430981,23166529,25349462,23848401,34126931,34163215,33223666	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786390	11786390	G	A	hom	hom	hom		QUAL=25307;DP=382,181,214;AF=1.00,1.00,1.00;MQM=60;SAP=30;ABP=0;SAR=438;SAF=339	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3082-998G>A::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3568-998G>A::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4290C>T::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs4845884	0.9395	0.7906,0.9745,1.0000,0.9993,0.9996	67802,.	7342	9214	-0.8090			0.77				0.01	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786603	11786606	TTTT	-	het	het	het		QUAL=2020;DP=69,21,28;AF=0.64,0.48,0.61;MQM=58;SAP=29;ABP=14;SAR=50;SAF=21	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3082-770_3082-767del::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3568-770_3568-767del::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4074_*4077del::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292164 [likely benign DISEASE=Neural tube defects, folate-sensitive];		AluJr (SINE/Alu)	rs55780505	0.5416	0.3865,0.6894,0.7587,0.5752,0.4538	21344,.	34207	65093	0.3080			0.58				0.02	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786603	11786607	TTTTT	-	het	het	het		QUAL=2020;DP=69,21,28;AF=0.23,0.38,0.11;MQM=59;SAP=3;ABP=78;SAR=14;SAF=13	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3082-771_3082-767del::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3568-771_3568-767del::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4073_*4077del::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]			AluJr (SINE/Alu)	rs55780505	0.0017	0.0005,0.0026,0.0017,0.0014,0.0002	0,.	241	141893	0.3080			0.57				0.02	26046315	2	56	0 / 0					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11787277	11787277	-	GAA	hom	het	het		QUAL=9454;DP=223,132,220;AF=0.96,0.58,0.40;MQM=60;SAP=71;ABP=5;SAR=136;SAF=245	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3082-108_3082-106dup::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3568-108_3568-106dup::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*3400_*3402dup::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs35134728	0.5655	0.3989,0.7046,0.7699,0.6083,0.4733	25339,.	35163	65945				0.59				0.02	26046315,21478897,28990296	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11787702	11787702	C	T	hom	het	het		QUAL=11991;DP=189,243,289;AF=0.99,0.51,0.52;MQM=60;SAP=40;ABP=4;SAR=186;SAF=274	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron17/20:c.3188-171C>T::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron17/20:c.3674-171C>T::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2978G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs3737966	0.5525	0.3739,0.6938,0.7736,0.5999,0.4500	24365,.	35269	68041	0.6820			4.70			COSV57172225	0.01	26046315,30339177,32117640,21478897,28990296	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11788082	11788082	G	A	wt	het	het		QUAL=2663;DP=122,84,122;AF=0.01,0.55,0.48;MQM=60;SAP=4;ABP=3;SAR=55;SAF=50	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron18/20:c.3362+35G>A::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron18/20:c.3848+35G>A::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2598C>T::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs11559040	0.1354	0.0392,0.1111,0.1015,0.1818,0.2419	1758,.	17084	131552	-1.3250			2.70			COSV57171817	0.01	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11788822	11788822	A	G	hom	hom	hom		QUAL=19132;DP=244,151,217;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0;SAR=328;SAF=283	C1orf167,MTHFR	intron,3'UTR	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron20/20:c.3672+76A>G::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron20/20:c.4173+76A>G::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1858T>C::	regulatory_region_variant:promoter	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs2077360	0.9371	0.7822,0.9740,1.0000,0.9993,0.9998	67508,.	7562	9574	-0.5450			0.76				0	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11789390	11789390	A	G	hom	hom	hom		QUAL=17765;DP=149,188,226;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0;SAR=302;SAF=260	C1orf167,MTHFR	missense,3'UTR	C1orf167:ENST00000433342.6:missense_variant:MODERATE:exon21/21:c.3793A>G:p.Arg1265Gly:,C1orf167:ENST00000688073.1:missense_variant:MODERATE:exon21/21:c.4294A>G:p.Arg1432Gly:,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1290T>C::	regulatory_region_variant:promoter	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs868014	0.9396	0.7909,0.9747,1.0000,0.9993,0.9998	67781,.	7318	9188	-5.2110	T(0.26),T(0.26), , , , 	B(0.00),B(0.00), , , , 	0.01	0.03		COSV57171235	0	28171870,26046315,31671528,23292069,30182779,34298760,33239899,34953598	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11790308	11790308	T	G	hom	het	het		QUAL=19144;DP=316,347,383;AF=1.00,0.49,0.49;MQM=60;SAP=228;ABP=4;SAR=468;SAF=204	MTHFR	3'UTR	MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*372A>C::,MTHFR:ENST00000423400.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292223 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency];			rs4846049	0.6320	0.4938,0.7509,0.7753,0.6741,0.5447	31075,.	33888	55934	-0.8740			1.52				0	22100073,31637880,20556870,24991086,31469255,19683694,21448238,19593234,20056627,20962791,26046315,28657672,28722783,28963520,24391914,23227261,25723397,32117640,24315498,31601265,21515602,22647417,25882505,26690224,27454313,29379315,31737664,27106592,28855605,29657307,30781868,29434917,29666641,24006081,29534533,23303660,27980618,28587112,29871275,33223666,34707639,34885097	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11790946	11790946	G	C	wt	het	het	off-target	QUAL=3881;DP=208,168,179;AF=0.00,0.48,0.43;MQM=60;SAP=43;ABP=9;SAR=106;SAF=52	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron11/11:c.1876-48C>G::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron12/12:c.1876-48C>G::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron11/11:c.1873-48C>G::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron10/10:c.1753-230C>G::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron7/7:c.1018-48C>G::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1224887 [benign DISEASE=Homocystinuria due to MTHFR deficiency,not provided];			rs3818762	0.2350	0.1475,0.1732,0.2228,0.2782,0.4164	4602,.	26511	116241	-2.2640			0.05			COSV100453746	0.04	22100073,21273288,22241680,31502714,23874907	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11791061	11791061	A	G	hom	hom	hom	off-target	QUAL=13730;DP=178,125,128;AF=0.99,1.00,1.00;MQM=60;SAP=77;ABP=0;SAR=154;SAF=275	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron11/11:c.1752+146T>C::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron11/11:c.1752+146T>C::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron11/11:c.1875+146T>C::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron12/12:c.1875+146T>C::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron11/11:c.1872+146T>C::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron10/10:c.1752+146T>C::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron7/7:c.1017+146T>C::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1177028 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,not provided];			rs7518348	0.9092	0.6882,0.9615,0.9987,0.9985,0.9988	64264,.	9749	13809	0.0820			6.51				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11792243	11792243	C	T	wt	het	het	off-target	QUAL=4655;DP=170,197,207;AF=0.01,0.47,0.48;MQM=60;SAP=13;ABP=5;SAR=82;SAF=112	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron11/12:c.1755+35G>A::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron10/11:c.1752+35G>A::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron9/10:c.1632+35G>A::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron6/7:c.897+35G>A::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1170841 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,not provided];			rs1476413	0.2344	0.1605,0.1729,0.2312,0.2700,0.4124	4505,.	26634	116410	-1.1200			1.21			COSV57171175	0	21273288,27437086,19493349,19048631,21254358,21254359,19593234,20056627,20962791,22039442,22155867,22241680,22747749,22903727,23893618,26646537,20692813,22495907,28266606,30339177,29421402,29732742,31502714,19064567,24314549,23430981,23166529,19075497,20356773,34126931,32993083,33195260,32825595,25084201,28361099,34734498	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794400	11794400	G	A	hom	hom	hom		QUAL=18568;DP=120,204,264;AF=1.00,1.00,1.00;MQM=60;SAP=65;ABP=0;SAR=229;SAF=358	MTHFR	synonymous	MTHFR:ENST00000376592.6:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000376590.9:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000376583.7:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376585.6:synonymous_variant:LOW:exon9/13:c.1428C>T:p.Phe476=:,MTHFR:ENST00000423400.7:synonymous_variant:LOW:exon8/12:c.1425C>T:p.Phe475=:,MTHFR:ENST00000641407.1:synonymous_variant:LOW:exon7/11:c.1305C>T:p.Phe435=:,MTHFR:ENST00000641820.1:synonymous_variant:LOW:exon4/8:c.570C>T:p.Phe190=:		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	167306 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,Homocystinuria due to MTHFR deficiency,not specified];			rs4846051	0.9094	0.6888,0.9612,0.9986,0.9985,0.9986	64232,.	9718	13764	0.6480			4.72				0.01	28871186,19591822,19493349,25110414,29193749,22241680,31208817,16439441,18483346,23300409,25982422,19144510,34126931,34169999,32993083	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794419	11794419	T	G	wt	het	het		QUAL=7183;DP=166,228,287;AF=0.01,0.54,0.54;MQM=60;SAP=7;ABP=11;SAR=129;SAF=151	MTHFR	missense	MTHFR:ENST00000376592.6:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000376590.9:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000376583.7:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376585.6:missense_variant:MODERATE:exon9/13:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000423400.7:missense_variant:MODERATE:exon8/12:c.1406A>C:p.Glu469Ala:,MTHFR:ENST00000641407.1:missense_variant:MODERATE:exon7/11:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000641820.1:missense_variant:MODERATE:exon4/8:c.551A>C:p.Glu184Ala:		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	3521 [conflicting interpretations of pathogenicity, other DISEASE=Schizophrenia, susceptibility to,Stroke,Gastrointestinal stromal tumor,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,Neural tube defects, folate-sensitive,MTHFR THERMOLABILE POLYMORPHISM,Homocystinuria due to MTHFR deficiency,not specified,not provided];	CM981315 [CLASS=DFP MUT=ALT PHEN="Neural tube defect increased risk association with" GENE=MTHFR];		rs1801131	0.2634	0.1671,0.2070,0.2205,0.3159,0.4068	5754,.	28495	111877	3.7560	T(0.14),T(0.14),T(0.15),T(0.15),T(0.16),T(0.19),T(0.12)	B(0.01),B(0.01),B(0.07),B(0.07),B(0.01),B(0.01),B(0.01)	20.90	0.20		COSV57171183	0	21467728,18603647,21146954,21533139,21919968,22100073,23205182,27348238,29972410,30409984,30571812,20078877,26446360,26451011,22281051,18992148,16642433,21273288,24944790,21514219,23946381,25928231,25294155,18936436,19538716,19591822,20417488,20556870,21857382,21935354,22540831,22707612,22992668,23776350,25266489,26091847,27018927,27233804,28086795,31646966,25214541,28827732,30337837,30793520,31361092,19493349,23736036,24167597,24590654,25110414,25691056,29193749,21658613,22486600,12970910,28253266,19048631,26884752,30877365,21254358,21254359,22927710,26843965,22496743,30235667,28927418,27369588,22022476,18191955,21204206,19442614,29694444,19064578,22655231,23175176,27583843,26870349,30203425,19683694,21274745,27808252,24340057,27217270,20718043,28822116,19593234,20056627,20962791,22155867,22241680,22747749,22903727,22792358,24130171,21748308,19062539,24048206,18182569,30139066,19700502,25980667,23049672,9545395,10677336,10958762,11590551,11742092,11752418,11781870,11938441,12560871,14724163,15103709,15951337	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794614	11794614	C	A	wt	het	het	off-target	QUAL=2492;DP=59,100,108;AF=0.02,0.51,0.52;MQM=60;SAP=212;ABP=3;SAR=105;SAF=3	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron7/11:c.1167-76G>T::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron7/11:c.1167-76G>T::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron7/11:c.1290-76G>T::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron8/12:c.1290-76G>T::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron7/11:c.1287-76G>T::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron6/10:c.1167-76G>T::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron3/7:c.432-76G>T::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1177041 [benign/likely benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,not specified,not provided];			rs12121543	0.2134	0.1434,0.1563,0.2076,0.2486,0.3361	3726,.	24967	119503	-0.1370			5.40			COSV64877122	0.02	21273288,20056627,22039442,22241680,22933837,24853127,25566964,22103680,22649255,25165408,24006081	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794698	11794698	G	A	hom	het	het	off-target	QUAL=3045;DP=70,57,54;AF=1.00,0.46,0.39;MQM=60;SAP=192;ABP=9;SAR=109;SAF=8	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron8/12:c.1289+31C>T::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron7/11:c.1286+31C>T::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron6/10:c.1166+31C>T::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron3/7:c.431+31C>T::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1177042 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,not specified,not provided];			rs1994798	0.5620	0.4362,0.6879,0.7596,0.5855,0.4836	24771,.	35822	66524	-4.4220			0.05			COSV64877997	0.04	20718043,20056627,22241680,11781870,18538037,32073761,20356773	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11800063	11800063	T	C	hom	het	het	off-target	QUAL=4621;DP=73,102,134;AF=0.99,0.55,0.46;MQM=60;SAP=413;ABP=3;SAR=0;SAF=189	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron4/11:c.586+149A>G::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron4/11:c.586+149A>G::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron4/11:c.709+149A>G::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron5/12:c.709+149A>G::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron4/11:c.706+149A>G::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron3/10:c.586+149A>G::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1295234 [benign DISEASE=not provided];			rs11121832	0.7467	0.6917,0.8150,0.8944,0.7524,0.6952	42537,.	28256	38438	-0.9060			0.52				0	20056627,22039442,20692813,28266606,22252258	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11800401	11800401	C	T	wt	het	het	off-target	QUAL=7119;DP=176,242,316;AF=0.00,0.54,0.49;MQM=60;SAP=266;ABP=4;SAR=236;SAF=50	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron3/11:c.476-79G>A::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron3/11:c.476-79G>A::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron3/11:c.599-79G>A::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron4/12:c.599-79G>A::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron3/11:c.596-79G>A::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron2/10:c.476-79G>A::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1180162 [benign DISEASE=not provided];			rs2066471	0.1226	0.0303,0.1022,0.0977,0.1660,0.2044	1446,.	15753	133391	0.2400			5.22			COSV64701666	0.06	18778477,21085059,20692813,30339177,31671528,23292069	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11949898	11949898	C	T	het	het	het		QUAL=6852;DP=125,190,248;AF=0.46,0.53,0.49;MQM=60;SAP=59;ABP=3;SAR=182;SAF=97	PLOD1	synonymous	PLOD1:ENST00000196061.5:synonymous_variant:LOW:exon3/19:c.294C>T:p.Phe98=:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	255803 [benign DISEASE=Ehlers-Danlos syndrome, kyphoscoliotic type 1,not specified,Cardiovascular phenotype];			rs7529452	0.2540	0.0637,0.2889,0.3777,0.3147,0.4316	6298,.	25999	113363	1.0800			13.23			COSV52144592	0.05	25741868,20357209,20072119,19442614,21527992	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11949899	11949899	G	A	wt	het	wt		QUAL=1997;DP=151,186,243;AF=0.00,0.47,0.00;MQM=60;SAP=4;ABP=5;SAR=41;SAF=46	PLOD1	missense	PLOD1:ENST00000196061.5:missense_variant:MODERATE:exon3/19:c.295G>A:p.Ala99Thr:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	196247 [benign DISEASE=Ehlers-Danlos syndrome, kyphoscoliotic type 1,Ehlers-Danlos syndrome,not specified,Cardiovascular phenotype];	CM068658 [CLASS=DP MUT=ALT PHEN="Bone mineral density association with" GENE=PLOD1];		rs7551175	0.2590	0.5402,0.1421,0.2548,0.1499,0.2141	7475,.	24404	112578	1.2640	T(1.00)	B(0.00)	15.53	0.15		COSV52140857	0.05	25741868,19442614,21527992,34707639	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11950721	11950721	A	G	het	hom	het	off-target	QUAL=726;DP=36,8,13;AF=0.50,1.00,0.46;MQM=60;SAP=72;ABP=3;SAR=32;SAF=0	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron4/18:c.466+201A>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1265885 [benign DISEASE=not provided];		L2 (LINE/L2)	rs60895266	0.5562	0.7014,0.4518,0.7066,0.4821,0.6674	24567,.	35306	67372	0.1120			4.78				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11952923	11952923	G	A	het	het	het	off-target	QUAL=805;DP=45,15,18;AF=0.53,0.40,0.44;MQM=60;SAP=86;ABP=3;SAR=38;SAF=0	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron5/18:c.579+188G>A::	regulatory_region_variant:open_chromatin_region	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1290288 [benign DISEASE=not provided];		MLT1A0 (LTR/ERVL-MaLR)	rs58495963	0.2814	0.1228,0.3048,0.4096,0.3315,0.4444	7070,.	28619	109173	0.3250			4.51				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11955097	11955097	G	A	het	het	het	off-target	QUAL=2555;DP=86,54,74;AF=0.60,0.44,0.54;MQM=60;SAP=255;ABP=6;SAR=116;SAF=0	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron6/18:c.643+204G>A::	regulatory_region_variant:enhancer	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1250242 [benign DISEASE=not provided];			rs2273288	0.2821	0.1259,0.3049,0.4074,0.3313,0.4439	7084,.	28739	109195	-0.9050			1.65				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11956715	11956715	T	C	wt	het	wt	off-target	QUAL=381;DP=50,48,51;AF=0.02,0.44,0.00;MQM=60;SAP=51;ABP=5;SAR=0;SAF=22	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron6/18:c.644-202T>C::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1273224 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs6665648	0.2642	0.5567,0.1439,0.2686,0.1495,0.2159	7868,.	24382	111760	0.3040			5.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11956900	11956900	T	G	wt	het	wt	off-target	QUAL=3761;DP=108,311,391;AF=0.00,0.50,0.00;MQM=60;SAP=70;ABP=3;SAR=43;SAF=112	PLOD1	splice_region&intron	PLOD1:ENST00000196061.5:splice_region_variant&intron_variant:LOW:intron6/18:c.644-17T>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	384719 [benign DISEASE=Ehlers-Danlos syndrome, kyphoscoliotic type 1,not specified];			rs41307745	0.0472	0.0124,0.0277,0.1475,0.0560,0.1332	271,.	6630	144896	1.9980			17.56		10.55>8.84	COSV52140829	0.02		12	183	0 / 0					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11958321	11958321	C	G	het	het	het	off-target	QUAL=406;DP=17,10,11;AF=0.41,0.50,0.73;MQM=60;SAP=46;ABP=3;SAR=0;SAF=20	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron8/18:c.844-195C>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1231062 [benign DISEASE=not provided];			rs2273290	0.2810	0.1227,0.3045,0.4026,0.3314,0.4425	7048,.	28578	109172	-0.5240			1.52				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11964178	11964178	C	T	het	het	het		QUAL=1167;DP=17,35,53;AF=0.59,0.40,0.53;MQM=60;SAP=3;ABP=3;SAR=26;SAF=26	PLOD1	synonymous	PLOD1:ENST00000196061.5:synonymous_variant:LOW:exon12/19:c.1206C>T:p.Asn402=:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	255799 [benign DISEASE=Ehlers-Danlos syndrome, kyphoscoliotic type 1,not specified,Cardiovascular phenotype];			rs1130529	0.3312	0.2951,0.3195,0.3952,0.3252,0.4505	8715,.	32864	101562	-0.7380			6.42			COSV52140468	0.01	25741868,20357209,19442614,21527992	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11965296	11965296	T	C	het	hom	het	off-target	QUAL=1305;DP=34,21,26;AF=0.53,1.00,0.46;MQM=60;SAP=114;ABP=3;SAR=0;SAF=51	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron13/18:c.1471-184T>C::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1263662 [benign DISEASE=not provided];		L2b (LINE/L2)	rs2273291	0.5775	0.8082,0.4653,0.6817,0.4688,0.6577	27325,.	32973	64117	-2.0320			0.15				0.02	20357209,19442614,21527992,29273593	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11967147	11967147	C	T	het	hom	het	off-target	QUAL=9535;DP=39,205,211;AF=0.46,1.00,0.52;MQM=60;SAP=125;ABP=3;SAR=235;SAF=98	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron16/18:c.1755+56C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1297286 [benign DISEASE=not provided];			rs2273293	0.5040	0.5753,0.4349,0.6380,0.4613,0.6297	19900,.	36738	75326	-3.2240			0.01			COSV52142788	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11967251	11967251	G	A	het	hom	het	off-target	QUAL=5770;DP=149,82,81;AF=0.58,1.00,0.60;MQM=60;SAP=476;ABP=20;SAR=218;SAF=0	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron16/18:c.1755+160G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1285712 [benign DISEASE=not provided];			rs3818157	0.5059	0.5763,0.4351,0.6355,0.4645,0.6297	20004,.	36690	74920	0.7040			3.71				0.01	19005574,21937999,21527992	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11970938	11970938	A	G	het	hom	het	off-target;low_conf_region	QUAL=911;DP=29,23,31;AF=0.45,0.96,0.29;MQM=59;SAP=99;ABP=12;SAR=44;SAF=0	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron17/18:c.1902+122A>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1257523 [benign DISEASE=not provided];			rs59235751	0.4247	0.6250,0.4087,0.6610,0.3543,0.6474	2948,.	6516	16816	0.3120			0.84				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11973056	11973056	A	G	het	hom	het	off-target	QUAL=11278;DP=134,209,263;AF=0.51,1.00,0.48;MQM=60;SAP=389;ABP=3;SAR=336;SAF=68	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron18/18:c.2028+59A>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1278494 [benign DISEASE=not provided];			rs3737961	0.5670	0.7762,0.4625,0.6797,0.4672,0.6588	26077,.	33653	65519	-0.1100			3.69			COSV52144992	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11973063	11973063	G	C	het	hom	het	off-target	QUAL=10103;DP=113,197,251;AF=0.56,0.99,0.48;MQM=60;SAP=432;ABP=3;SAR=327;SAF=53	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron18/18:c.2028+66G>C::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1280245 [benign DISEASE=not provided];			rs3820190	0.5748	0.8037,0.4646,0.6793,0.4672,0.6594	26988,.	33017	64343	0.8350			2.81			COSV52151982	0	32221480	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11980146	11980146	A	G	het	hom	het	off-target	QUAL=880;DP=23,20,24;AF=0.43,1.00,0.46;MQM=60;SAP=84;ABP=4;SAR=1;SAF=40	PLOD1,MFN2	downstream_gene,upstream_gene	PLOD1:ENST00000196061.5:downstream_gene_variant:MODIFIER::::,MFN2:ENST00000444836.5:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674817.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675053.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675817.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675298.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674548.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674658.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674910.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675231.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675113.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000235329.10:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675919.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000676293.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1290963 [benign DISEASE=not provided];			rs2236053	0.5015	0.5908,0.4279,0.6400,0.4482,0.6250	19724,.	36612	75598	-0.8990			3.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11980267	11980267	A	G	het	hom	het		QUAL=4117;DP=30,101,123;AF=0.47,1.00,0.36;MQM=60;SAP=111;ABP=22;SAR=35;SAF=124	MFN2	5'UTR	MFN2:ENST00000444836.5:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::,MFN2:ENST00000674817.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::,MFN2:ENST00000675053.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-270A>G::,MFN2:ENST00000675817.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-367A>G::,MFN2:ENST00000675298.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-367A>G::,MFN2:ENST00000674548.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-312A>G::	regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292362 [benign DISEASE=Hereditary motor and sensory neuropathy,Ehlers-Danlos syndrome, kyphoscoliotic type 1,Charcot-Marie-Tooth disease type 2,Hereditary motor and sensory neuropathy with optic atrophy,not provided];			rs2236054	0.5066	0.6108,0.4297,0.6400,0.4474,0.6240	20255,.	36400	74898	-0.9010			3.28				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11980422	11980422	T	C	het	hom	het		QUAL=5098;DP=54,113,128;AF=0.43,1.00,0.43;MQM=60;SAP=138;ABP=11;SAR=150;SAF=41	MFN2	5'UTR	MFN2:ENST00000444836.5:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::,MFN2:ENST00000674817.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::,MFN2:ENST00000675053.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-115T>C::,MFN2:ENST00000675817.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-212T>C::,MFN2:ENST00000675298.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-212T>C::,MFN2:ENST00000674548.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-157T>C::,MFN2:ENST00000674658.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-310T>C::,MFN2:ENST00000674910.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-189T>C::,MFN2:ENST00000675231.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-440T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292368 [benign DISEASE=Hereditary motor and sensory neuropathy,Ehlers-Danlos syndrome, kyphoscoliotic type 1,Charcot-Marie-Tooth disease type 2,Hereditary motor and sensory neuropathy with optic atrophy,not provided];			rs2180183	0.5325	0.6932,0.4413,0.6821,0.4480,0.6346	22800,.	35289	71003	-0.2290			9.63				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11981920	11981920	-	TTTTTT	het	het	wt	off-target	QUAL=274;DP=86,34,137;AF=0.06,0.26,0.11;MQM=59;SAP=49;ABP=365;SAR=1;SAF=24	MFN2	intron,5'UTR	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron1/17:c.-5+1443_-5+1448dup::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron1/17:c.-5+1443_-5+1448dup::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron1/18:c.-52-140_-52-135dup::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron1/19:c.-149-43_-149-38dup::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron1/18:c.-149-43_-149-38dup::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron1/18:c.-95+1443_-95+1448dup::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron1/17:c.-247-43_-247-38dup::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron1/18:c.-127+1443_-127+1448dup::,MFN2:ENST00000675231.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-260_-255dup::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron1/19:c.-211-43_-211-38dup::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron1/18:c.-149-43_-149-38dup::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron1/19:c.-239-43_-239-38dup::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron1/19:c.-271-43_-271-38dup::	regulatory_region_variant:promoter	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1251375 [benign DISEASE=not provided];			rs34602102	0.0259	0.0840,0.0102,0.0013,0.0050,0.0016	202,.	3166	134388				3.98				0.01		2	26	0 / 0					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11981920	11981920	-	TTTTTTT	wt	het	het	off-target	QUAL=274;DP=86,34,137;AF=0.08,0.21,0.08;MQM=58;SAP=58;ABP=338;SAR=1;SAF=28	MFN2	intron,5'UTR	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron1/17:c.-5+1442_-5+1448dup::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron1/17:c.-5+1442_-5+1448dup::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron1/18:c.-52-141_-52-135dup::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron1/19:c.-149-44_-149-38dup::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron1/18:c.-149-44_-149-38dup::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron1/18:c.-95+1442_-95+1448dup::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron1/17:c.-247-44_-247-38dup::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron1/18:c.-127+1442_-127+1448dup::,MFN2:ENST00000675231.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-261_-255dup::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron1/19:c.-211-44_-211-38dup::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron1/18:c.-149-44_-149-38dup::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron1/19:c.-239-44_-239-38dup::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron1/19:c.-271-44_-271-38dup::	regulatory_region_variant:promoter	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1238604 [benign DISEASE=not provided];			rs34602102	0.3259	0.3470,0.3113,0.4116,0.3080,0.3708	8015,.	28707	92547				3.93				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11982204	11982204	A	G	het	hom	het	off-target	QUAL=7703;DP=208,102,154;AF=0.53,1.00,0.49;MQM=60;SAP=584;ABP=3;SAR=282;SAF=5	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron1/17:c.-5+1720A>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron1/17:c.-5+1720A>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron2/18:c.-5+90A>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron2/19:c.-5+90A>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron2/18:c.-5+90A>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron1/18:c.-95+1720A>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron2/17:c.-103+90A>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron1/18:c.-127+1720A>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron2/19:c.-73+90A>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron2/19:c.-67+90A>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron2/18:c.-5+90A>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron2/19:c.-95+90A>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron2/19:c.-127+90A>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1279097 [benign DISEASE=not provided];			rs2236055	0.5712	0.7831,0.4632,0.6793,0.4704,0.6098	26525,.	33694	65128	1.7780			11.88				0	20940517,26816493,28513770,30940795,32782719,34469753,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11992348	11992348	G	A	hom	hom	hom	off-target	QUAL=5787;DP=127,37,31;AF=1.00,1.00,1.00;MQM=60;SAP=426;ABP=0;SAR=0;SAF=195	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron2/17:c.176-207G>A::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron2/17:c.176-207G>A::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron3/19:c.176-207G>A::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron3/17:c.-34-3808G>A::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron4/19:c.176-207G>A::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron4/19:c.176-207G>A::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron4/19:c.176-207G>A::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron4/19:c.176-207G>A::		608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	683180 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs6675934	0.8858	0.9704,0.8801,0.9996,0.8309,0.9719	60097,.	14585	17385	0.7390			3.93				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11996383	11996383	C	T	hom	hom	hom	off-target	QUAL=14838;DP=159,176,169;AF=1.00,0.99,1.00;MQM=60;SAP=928;ABP=0;SAR=483;SAF=20	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron4/17:c.474+65C>T::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron4/17:c.474+65C>T::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron5/19:c.474+65C>T::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron4/17:c.129+65C>T::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron6/19:c.474+65C>T::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron6/19:c.474+65C>T::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron6/19:c.474+65C>T::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron6/19:c.474+65C>T::	regulatory_region_variant:CTCF_binding_site	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1180064 [benign DISEASE=not provided];			rs2236056	0.6496	0.6862,0.5446,0.6376,0.6478,0.6812	32482,.	33802	53274	-1.0310			0.07			COSV52421940	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12001293	12001293	G	A	het	wt	het	off-target	QUAL=1820;DP=94,44,75;AF=0.49,0.00,0.49;MQM=58;SAP=183;ABP=3;SAR=0;SAF=83	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron7/17:c.817-108G>A::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron7/17:c.817-108G>A::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron8/19:c.817-108G>A::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron7/17:c.472-108G>A::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron9/19:c.817-108G>A::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron9/19:c.817-108G>A::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron9/19:c.817-108G>A::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron9/19:c.817-108G>A::		608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1200078 [likely benign DISEASE=not provided];		AluSx1 (SINE/Alu)	rs139807696	0.0242	0.0084,0.0147,0.0000,0.0406,0.0029	62,.	3563	148525	-0.2120			0.53				0		2	33	0 / 0					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12002148	12002148	A	G	hom	hom	hom	off-target	QUAL=14610;DP=179,138,190;AF=0.98,0.99,0.99;MQM=60;SAP=1067;ABP=0;SAR=499;SAF=3	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron11/19:c.1160+45A>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron10/17:c.815+45A>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]				rs2236057	0.6489	0.6472,0.5531,0.6811,0.6629,0.7079	32381,.	33932	53404	-2.3750			0.13			COSV52420984	0.01	26816493,26916081,30940795,32782719	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12002304	12002304	C	G	hom	hom	hom	off-target	QUAL=3712;DP=56,31,48;AF=1.00,1.00,0.98;MQM=60;SAP=294;ABP=0;SAR=134;SAF=0	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron10/17:c.1160+201C>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron10/17:c.1160+201C>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron11/19:c.1160+201C>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron10/17:c.815+201C>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron12/19:c.1160+201C>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron12/19:c.1160+201C>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron12/19:c.1160+201C>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron12/19:c.1160+201C>G::	regulatory_region_variant:enhancer,TF_binding_site_variant	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	683181 [benign DISEASE=not provided];			rs2236058	0.5739	0.5281,0.4986,0.5548,0.6057,0.6326	25486,.	36294	64782	0.0370			5.11				0	26816493,22778543,30940795,34163214	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12006987	12006987	T	G	hom	hom	hom	off-target	QUAL=6053;DP=104,38,66;AF=1.00,1.00,0.98;MQM=60;SAP=386;ABP=0;SAR=8;SAF=199	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron15/17:c.1873-66T>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron15/17:c.1873-66T>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron17/19:c.2005-66T>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron15/17:c.1528-66T>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron17/19:c.1873-66T>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron17/19:c.1873-66T>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron17/19:c.1873-66T>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron17/19:c.1873-66T>G::		608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	676150 [benign DISEASE=not provided];			rs7550536	0.5445	0.4419,0.4890,0.5550,0.5966,0.6206	23202,.	36340	69208	-0.1560			1.88			COSV52424175	0.04	20031578	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12011376	12011376	C	G	wt	het	wt	off-target	QUAL=1455;DP=219,157,167;AF=0.00,0.43,0.00;MQM=60;SAP=144;ABP=9;SAR=1;SAF=68	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron17/17:c.2205-120C>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron17/17:c.2205-120C>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron18/18:c.2205-120C>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron19/19:c.2337-120C>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2204+1650C>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron18/18:c.2205-120C>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron17/17:c.1860-120C>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron18/18:c.2205-120C>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron19/19:c.2205-120C>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron19/19:c.2205-120C>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron18/18:c.2205-120C>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron19/19:c.2205-120C>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron19/19:c.2205-120C>G::	regulatory_region_variant:open_chromatin_region	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1284248 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs3766741	0.0801	0.1104,0.0410,0.1441,0.0644,0.1476	590,.	11007	139921	-0.8280			0.13			COSV52422123	0	26816493,22778543,30940795	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12011623	12011623	A	G	hom	hom	hom		QUAL=29424;DP=256,323,417;AF=0.99,0.99,1.00;MQM=60;SAP=135;ABP=0;SAR=618;SAF=373	MFN2	3'UTR,intron	MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2204+1897A>G::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::		608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292381 [benign DISEASE=Charcot-Marie-Tooth disease type 2,Hereditary motor and sensory neuropathy with optic atrophy,not specified,not provided];			rs1042842	0.7082	0.8490,0.5827,0.6921,0.6638,0.7044	39029,.	29587	44347	-0.7360			1.04			COSV52422477	0	29352517,17940179,21686698	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12012461	12012461	G	C	hom	hom	hom		QUAL=12738;DP=105,142,172;AF=0.99,1.00,1.00;MQM=60;SAP=78;ABP=0;SAR=149;SAF=269	MFN2	3'UTR,intron	MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2205-1796G>C::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::	regulatory_region_variant:enhancer	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292393 [benign DISEASE=Charcot-Marie-Tooth disease type 2,Hereditary motor and sensory neuropathy with optic atrophy];			rs3088064	0.5546	0.4663,0.4940,0.5925,0.5996,0.6259	23926,.	36315	67589	0.1930			4.22				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12012477	12012477	C	T	wt	het	wt		QUAL=1661;DP=101,143,189;AF=0.00,0.50,0.00;MQM=60;SAP=4;ABP=3;SAR=33;SAF=38	MFN2	3'UTR,intron	MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2205-1780C>T::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::	regulatory_region_variant:enhancer	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292394 [benign DISEASE=Charcot-Marie-Tooth disease type 2,Hereditary motor and sensory neuropathy with optic atrophy];			rs14305	0.0535	0.0188,0.0318,0.1463,0.0664,0.1455	318,.	7500	143932	0.1590			6.51				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	16043933	16043937	GGGGG	-	n/a	n/a	hom	off-target	QUAL=51;DP=0,0,3;AF=,,1.00;MQM=60;SAP=10;ABP=0;SAR=3;SAF=0	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron4/22:c.-8+61_-8+65del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron1/19:c.-7-545_-7-541del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron2/20:c.-7-545_-7-541del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron3/21:c.-8+61_-8+65del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron1/19:c.-7-545_-7-541del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron1/19:c.-8+61_-8+65del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs140434107	0.4818	0.4212,0.4851,0.7322,0.4828,0.4892	10009,.	28607	52301	0.2600			0.91				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16043984	16043984	T	C	n/a	n/a	hom	off-target	QUAL=85;DP=0,0,3;AF=,,1.00;MQM=60;SAP=10;ABP=0;SAR=3;SAF=0	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron4/22:c.-8+104T>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron1/19:c.-7-502T>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron2/20:c.-7-502T>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron3/21:c.-8+104T>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron1/19:c.-7-502T>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron1/19:c.-8+104T>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs945393	0.5064	0.4526,0.4757,0.7177,0.5322,0.4642	18423,.	35980	70992	-2.5450			0.03			COSV65160122	0	22578033	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16044404	16044404	G	A	het	n/a	n/a	off-target	QUAL=74;DP=6,1,2;AF=0.67,0.00,1.00;MQM=53;SAP=16;ABP=4;SAR=0;SAF=6	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron4/22:c.-7-82G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron1/19:c.-7-82G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron2/20:c.-7-82G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron3/21:c.-7-82G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron1/19:c.-7-82G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron1/19:c.-7-82G>A::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1277450 [benign DISEASE=not provided];			rs945394	0.5339	0.2768,0.6583,0.7117,0.6232,0.6716	22476,.	33894	68848	-1.2310			0.73			COSV65160124	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16044572	16044572	G	T	het	n/a	hom		QUAL=235;DP=4,1,5;AF=0.75,1.00,1.00;MQM=60;SAP=3;ABP=5;SAR=5;SAF=4	CLCNKB	missense	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon5/23:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon3/21:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon4/22:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447107 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not specified,not provided];			rs2015352	0.5482	0.3008,0.6668,0.6642,0.6411,0.6817	24634,.	33907	68537	0.0080	D(0.01),D(0.01),D(0.02),D(0.01),D(0.01),D(0.01)	B(0.16),B(0.16),B(0.01),B(0.16),B(0.16),B(0.16)	18.63	0.30		COSV65159885	0	23550235,16109321,32327693	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045377	16045377	C	G	het	het	hom	off-target	QUAL=2492;DP=70,36,40;AF=0.56,0.50,1.00;MQM=60;SAP=214;ABP=4;SAR=0;SAF=97	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron5/22:c.101-181C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron2/19:c.101-181C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron3/20:c.101-181C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron4/21:c.101-181C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron2/19:c.101-181C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron2/19:c.101-181C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1287171 [benign DISEASE=not provided];			rs6604908	0.5454	0.2799,0.6653,0.7044,0.6417,0.7106	24671,.	33483	69051	-0.8840			0.47			COSV65160125	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045437	16045437	A	C	hom	hom	hom	off-target	QUAL=5737;DP=55,75,76;AF=1.00,1.00,1.00;MQM=60;SAP=450;ABP=0;SAR=0;SAF=206	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron5/22:c.101-121A>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron2/19:c.101-121A>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron3/20:c.101-121A>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron4/21:c.101-121A>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron2/19:c.101-121A>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron2/19:c.101-121A>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1183407 [benign DISEASE=not provided];			rs6604909	0.8273	0.5443,0.9028,0.9996,0.9415,0.9379	54456,.	16882	26262	-1.9550			0.55				0.05		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045508	16045508	G	C	het	het	hom	off-target	QUAL=6436;DP=55,128,148;AF=0.42,0.48,1.00;MQM=60;SAP=355;ABP=6;SAR=19;SAF=213	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron5/22:c.101-50G>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron2/19:c.101-50G>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron3/20:c.101-50G>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron4/21:c.101-50G>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron2/19:c.101-50G>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron2/19:c.101-50G>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209775 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided];			rs6604910	0.5452	0.2800,0.6657,0.7029,0.6416,0.7093	24662,.	33514	69114	-0.4740			4.26			COSV65160072	0.04	17652939	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045788	16045788	T	-	het	het	wt	off-target	QUAL=3380;DP=22,52,72;AF=0.59,0.50,0.90;MQM=60;SAP=86;ABP=3;SAR=41;SAF=1	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron6/22:c.229+102del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron3/19:c.229+102del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron4/20:c.229+102del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron5/21:c.229+102del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron3/19:c.229+102del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron3/19:c.229+102del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1238992 [benign DISEASE=not provided];			rs67016480	0.2807	0.2611,0.2377,0.2947,0.3001,0.2257	6012,.	30115	107985	0.0300			1.52				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045788	16045788	T	G	het	het	hom	off-target	QUAL=3380;DP=22,52,72;AF=0.59,0.50,0.90;MQM=60;SAP=165;ABP=3;SAR=96;SAF=8	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron6/22:c.229+102T>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron3/19:c.229+102T>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron4/20:c.229+102T>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron5/21:c.229+102T>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron3/19:c.229+102T>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron3/19:c.229+102T>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1281750 [benign DISEASE=not provided];			rs6604911	0.6562	0.4062,0.7372,0.7693,0.7288,0.7701	24051,.	33253	42627	0.0300			4.17				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046416	16046416	G	A	hom	hom	hom	off-target	QUAL=7893;DP=97,88,92;AF=0.99,1.00,1.00;MQM=59;SAP=602;ABP=0;SAR=0;SAF=276	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron6/22:c.230-119G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron3/19:c.230-119G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron4/20:c.230-119G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron5/21:c.230-119G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron3/19:c.230-119G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron3/19:c.230-119G>A::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1279049 [benign DISEASE=not provided];			rs2014848	0.7024	0.3888,0.8289,0.9880,0.8091,0.8910	40482,.	25634	45172	0.3310			3.75				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046476	16046476	G	A	hom	hom	hom	off-target	QUAL=12404;DP=78,142,182;AF=1.00,1.00,1.00;MQM=60;SAP=439;ABP=0;SAR=59;SAF=343	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron6/22:c.230-59G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron3/19:c.230-59G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron4/20:c.230-59G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron5/21:c.230-59G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron3/19:c.230-59G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron3/19:c.230-59G>A::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209776 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided];			rs2014841	0.7025	0.3889,0.8291,0.9880,0.8092,0.8914	40551,.	25638	45198	0.0580			1.12				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046629	16046629	A	G	hom	hom	hom		QUAL=23205;DP=180,247,314;AF=0.99,1.00,1.00;MQM=60;SAP=5;ABP=0;SAR=382;SAF=357	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon7/23:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon5/21:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon6/22:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447104 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not specified,not provided];			rs5257	0.7027	0.3894,0.8290,0.9878,0.8091,0.8914	40534,.	25628	45140	-3.8900			0.63				0.88	23550235,26045835	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046705	16046707	CTT	-	hom	het	hom	off-target;low_conf_region	QUAL=9620;DP=108,146,205;AF=1.00,0.49,1.00;MQM=60;SAP=347;ABP=3;SAR=316;SAF=69	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron7/22:c.358+44_358+46del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron5/20:c.358+44_358+46del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron6/21:c.358+44_358+46del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1280604 [benign DISEASE=not provided];			rs35820664	0.6761	0.3674,0.8107,0.9878,0.7802,0.8697	37662,.	27213	49121	1.7440			8.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046787	16046787	A	G	hom	hom	hom	off-target	QUAL=8085;DP=113,77,91;AF=0.97,1.00,1.00;MQM=60;SAP=607;ABP=0;SAR=278;SAF=0	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron7/22:c.358+124A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron4/19:c.358+124A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron5/20:c.358+124A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron6/21:c.358+124A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron4/19:c.358+124A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron4/19:c.358+124A>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1230357 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs2095540	0.7019	0.3890,0.8284,0.9878,0.8082,0.8911	40508,.	25698	45316	-2.1740			0.02				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16047835	16047835	A	G	hom	hom	hom	off-target;low_conf_region	QUAL=610;DP=11,4,5;AF=1.00,1.00,1.00;MQM=60;SAP=38;ABP=0;SAR=1;SAF=19	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron7/22:c.359-70A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron4/19:c.359-70A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron5/20:c.359-70A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron6/21:c.359-70A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron4/19:c.359-70A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron4/19:c.359-70A>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209691 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided];			rs945403	0.8447	0.6037,0.9118,0.9996,0.9417,0.9380	56038,.	16338	23614	-3.8870			0.18				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048038	16048038	G	C	hom	hom	hom		QUAL=383;DP=5,5,3;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0;SAR=12;SAF=1	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon8/23:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon6/21:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon7/22:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel]	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447105 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not specified,not provided];			rs2014562	0.8906	0.7636,0.9278,0.9996,0.9422,0.9384	60802,.	13717	16629	-0.5020			7.47				0.12	23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048127	16048127	C	G	hom	n/a	n/a	off-target	QUAL=383;DP=11,1,1;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0;SAR=6;SAF=7	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron8/22:c.498+83C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron5/19:c.498+83C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron6/20:c.498+83C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron7/21:c.498+83C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron5/19:c.498+83C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron5/19:c.498+83C>G::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1183733 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided];			rs2863440	0.7028	0.3902,0.8292,0.9881,0.8091,0.8912	40588,.	25645	45165	-0.4220			1.67				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048161	16048161	A	G	hom	n/a	hom	off-target	QUAL=618;DP=13,2,5;AF=1.00,1.00,1.00;MQM=60;SAP=14;ABP=0;SAR=5;SAF=15	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron8/22:c.498+117A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron5/19:c.498+117A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron6/20:c.498+117A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron7/21:c.498+117A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron5/19:c.498+117A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron5/19:c.498+117A>G::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1265585 [benign DISEASE=not provided];		L2c (LINE/L2)	rs2902490	0.7029	0.3901,0.8293,0.9880,0.8092,0.8913	40586,.	25629	45137	-0.2570			2.10				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048499	16048499	C	T	hom	hom	hom		QUAL=17965;DP=155,203,244;AF=0.99,1.00,1.00;MQM=46;SAP=4;ABP=0;SAR=292;SAF=309	CLCNKB	splice_region&intron	CLCNKB:ENST00000684324.1:splice_region_variant&intron_variant:LOW:intron9/22:c.577-5C>T::,CLCNKB:ENST00000684545.1:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::,CLCNKB:ENST00000683578.1:splice_region_variant&intron_variant:LOW:intron7/20:c.577-5C>T::,CLCNKB:ENST00000682338.1:splice_region_variant&intron_variant:LOW:intron8/21:c.577-5C>T::,CLCNKB:ENST00000682793.1:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::,CLCNKB:ENST00000375679.9:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	381050 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not specified,not provided];			rs1889788	0.7006	0.3866,0.8267,0.9878,0.8075,0.8889	40322,.	25719	45457	-0.3220			5.31		4.28>4.16	COSV65161773	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048568	16048568	C	G	hom	hom	hom		QUAL=16977;DP=185,174,215;AF=0.98,1.00,1.00;MQM=52;SAP=213;ABP=0;SAR=403;SAF=168	CLCNKB	missense	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon10/23:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon8/21:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon9/22:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel]	regulatory_region_variant:promoter,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	504916 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not specified,not provided];			rs1889789	0.8256	0.5705,0.8959,0.9992,0.9241,0.9359	53660,.	17877	26439	-0.2280	T(0.79),T(0.79),T(1.00),T(0.79),T(0.79),T(0.79)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	5.97	0.22		COSV65159497	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048569	16048569	A	C	hom	hom	hom		QUAL=16977;DP=185,174,215;AF=0.98,1.00,1.00;MQM=52;SAP=213;ABP=0;SAR=403;SAF=168	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon10/23:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon8/21:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon9/22:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel]	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	504915 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not specified,not provided];			rs1889790	0.8257	0.5707,0.8958,0.9992,0.9241,0.9360	53659,.	17878	26434	-2.9260			2.40			COSV65161020	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048715	16048715	G	A	het	wt	hom	off-target	QUAL=4177;DP=96,103,100;AF=0.48,0.00,0.99;MQM=60;SAP=11;ABP=3;SAR=61;SAF=84	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron10/22:c.655+133G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron7/19:c.655+133G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron8/20:c.655+133G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron9/21:c.655+133G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron7/19:c.655+133G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron7/19:c.655+133G>A::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1290690 [benign DISEASE=not provided];			rs9633514	0.2987	0.1059,0.3628,0.7045,0.3612,0.3745	8204,.	28923	106427	0.0370			7.21				0	32888494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048859	16048859	C	T	hom	hom	hom		QUAL=18683;DP=167,201,235;AF=1.00,1.00,1.00;MQM=60;SAP=29;ABP=0;SAR=259;SAF=344	CLCNKB	intron,5'UTR	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron10/22:c.656-261C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron8/20:c.656-261C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron9/21:c.656-261C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:ENST00000375667.7:5_prime_UTR_variant:MODIFIER:exon1/13:c.-113C>T::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1259614 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs9442227	0.6911	0.3713,0.8141,0.9880,0.7992,0.8887	39478,.	26091	46943	0.4180			8.65				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049343	16049343	C	G	hom	hom	hom	off-target	QUAL=1470;DP=22,14,17;AF=1.00,1.00,1.00;MQM=60;SAP=110;ABP=0;SAR=1;SAF=52	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron11/22:c.781+98C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron8/19:c.781+98C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron9/20:c.781+98C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron10/21:c.781+98C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron8/19:c.781+98C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron8/19:c.781+98C>G::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron1/12:c.274+98C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1279349 [benign DISEASE=not provided];			rs7545067	0.7122	0.3953,0.8335,0.9880,0.8226,0.8929	41697,.	24864	43740	-2.2830			0.26			COSV65162067	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049696	16049696	C	T	hom	hom	hom		QUAL=25484;DP=176,312,402;AF=1.00,1.00,1.00;MQM=45;SAP=275;ABP=0;SAR=278;SAF=612	CLCNKB	missense	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon12/23:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon10/21:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon11/22:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon2/13:c.353C>T:p.Ala118Val:PF00654 [Voltage gated chloride channel]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447108 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not specified,not provided];			rs7367494	0.8348	0.5692,0.9065,0.9978,0.9411,0.9363	54670,.	16546	24918	-0.1040	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.01),B(0.01),B(0.00),B(0.01),B(0.01),B(0.01),B(0.00)	0.08	0.22		COSV65159503	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049735	16049735	-	T	hom	hom	hom	off-target	QUAL=26382;DP=84,345,451;AF=0.99,1.00,1.00;MQM=51;SAP=34;ABP=0;SAR=383;SAF=495	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+33_866+34insT::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+33_866+34insT::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+33_866+34insT::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+33_359+34insT::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1277184 [benign DISEASE=not provided];			rs59006537	0.8346	0.5685,0.9068,0.9990,0.9412,0.9373	54700,.	16575	24959				1.60				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049737	16049737	A	T	hom	hom	hom	off-target	QUAL=26382;DP=84,345,451;AF=0.99,1.00,1.00;MQM=51;SAP=34;ABP=0;SAR=383;SAF=495	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+35A>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+35A>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+35A>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+35A>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209692 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided];			rs59924562	0.8346	0.5685,0.9069,0.9990,0.9412,0.9373	54726,.	16582	24972	-2.4980			0.10			COSV65161540	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049744	16049744	C	-	hom	hom	hom	off-target	QUAL=24247;DP=81,335,440;AF=0.96,0.99,0.99;MQM=52;SAP=12;ABP=0;SAR=393;SAF=453	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+47del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+47del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+47del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+47del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209750 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided];			rs34589727	0.8350	0.5695,0.9071,0.9992,0.9412,0.9373	54759,.	16533	24903	-0.1770			1.35				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049783	16049783	G	A	hom	hom	hom	off-target	QUAL=30508;DP=136,364,499;AF=1.00,1.00,1.00;MQM=57;SAP=40;ABP=0;SAR=564;SAF=434	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.867-32G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.867-32G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.867-32G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.360-32G>A::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209751 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided];			rs7365182	0.8329	0.5631,0.9063,0.9996,0.9413,0.9366	54745,.	16712	25312	0.7450			5.09				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049824	16049824	T	C	hom	hom	hom		QUAL=32735;DP=180,361,483;AF=1.00,1.00,1.00;MQM=60;SAP=174;ABP=0;SAR=653;SAF=369	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon13/23:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon11/21:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon12/22:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon3/13:c.369T>C:p.Cys123=:PF00654 [Voltage gated chloride channel]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	377683 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not specified,not provided];			rs7368151	0.8347	0.5697,0.9065,0.9994,0.9412,0.9369	54977,.	16636	25062	-4.6600			0.08			COSV65161411	0.07		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049963	16049963	T	C	hom	hom	hom	off-target	QUAL=17634;DP=127,192,273;AF=0.99,1.00,1.00;MQM=59;SAP=231;ABP=0;SAR=420;SAF=171	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron13/22:c.968+47T>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron11/20:c.968+47T>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron12/21:c.968+47T>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron3/12:c.461+47T>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209752 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided];			rs7368166	0.8326	0.5655,0.9035,0.9981,0.9389,0.9324	54369,.	16889	25259	-3.1490			1.04			COSV65161797	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049999	16049999	C	G	het	het	wt	off-target	QUAL=2733;DP=122,123,186;AF=0.46,0.56,0.00;MQM=57;SAP=166;ABP=3;SAR=111;SAF=14	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron13/22:c.968+83C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron10/19:c.968+83C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron11/20:c.968+83C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron12/21:c.968+83C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron10/19:c.968+83C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron10/19:c.968+83C>G::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron3/12:c.461+83C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1288632 [benign DISEASE=not provided];			rs72651918	0.3590	0.1495,0.4701,0.5831,0.4728,0.5076	1921,.	18744	40322	-1.0310			0.56			COSV65161943	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16050336	16050336	C	T	hom	hom	hom	off-target	QUAL=3574;DP=36,40,44;AF=1.00,1.00,1.00;MQM=60;SAP=264;ABP=0;SAR=0;SAF=120	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron13/22:c.969-180C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron10/19:c.969-180C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron11/20:c.969-180C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron12/21:c.969-180C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron10/19:c.969-180C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron10/19:c.969-180C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron3/12:c.462-180C>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1249220 [benign DISEASE=not provided];			rs10803412	0.7131	0.3927,0.8344,0.9882,0.8245,0.8926	41831,.	24670	43578	-0.3660			2.89				0	20975947,33398198	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052154	16052154	C	G	het	het	wt	off-target	QUAL=482;DP=19,19,10;AF=0.58,0.68,0.00;MQM=60;SAP=39;ABP=9;SAR=2;SAF=22	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron17/22:c.1409-44C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron15/20:c.1409-44C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron16/21:c.1409-44C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron7/12:c.902-44C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1232843 [benign DISEASE=not provided];			rs2297726	0.1454	0.0697,0.1571,0.2791,0.1673,0.1812	1846,.	18427	130027	0.0340			8.76			COSV65160804	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052244	16052244	G	A	wt	het	wt		QUAL=108;DP=27,22,16;AF=0.00,0.36,0.00;MQM=60;SAP=4;ABP=7;SAR=5;SAF=3	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon18/23:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon16/21:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon17/22:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon8/13:c.948G>A:p.Ala316=:PF00654 [Voltage gated chloride channel]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	585703 [benign DISEASE=not specified,not provided];			rs34652156	0.0366	0.0588,0.0215,0.0002,0.0287,0.0209	145,.	5274	146618	-4.4550			0.08			COSV65160149	0.01	21631963	27	1237	0 / 0					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052513	16052513	C	T	hom	hom	hom	off-target	QUAL=632;DP=11,4,8;AF=1.00,1.00,1.00;MQM=59;SAP=53;ABP=0;SAR=23;SAF=0	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron18/22:c.1622+102C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron15/19:c.1622+102C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron16/20:c.1622+102C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron17/21:c.1622+102C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron15/19:c.1622+102C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron15/19:c.1622+102C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron8/12:c.1115+102C>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1252498 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs2050522	0.7203	0.4159,0.8399,0.9882,0.8244,0.8926	42290,.	24875	42499	-2.4820			0.01				0	23550235,17652939	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052520	16052520	-	GGGGCTGGGA	wt	hom	wt	off-target	QUAL=55;DP=5,4,7;AF=0.00,1.00,0.00;MQM=60;SAP=12;ABP=0;SAR=4;SAF=0	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron18/22:c.1622+116_1622+117insGGAGGGGCTG::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron15/19:c.1622+116_1622+117insGGAGGGGCTG::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron16/20:c.1622+116_1622+117insGGAGGGGCTG::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron17/21:c.1622+116_1622+117insGGAGGGGCTG::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron15/19:c.1622+116_1622+117insGGAGGGGCTG::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron15/19:c.1622+116_1622+117insGGAGGGGCTG::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron8/12:c.1115+116_1115+117insGGAGGGGCTG::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1269731 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs199907733	0.1707	0.0905,0.1718,0.2793,0.1959,0.2030	2475,.	20988	125986				8.61				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16053538	16053538	C	T	wt	het	wt	off-target	QUAL=988;DP=117,79,120;AF=0.00,0.57,0.00;MQM=60;SAP=101;ABP=6;SAR=0;SAF=45	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron18/22:c.1623-101C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron15/19:c.1623-101C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron16/20:c.1623-101C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron17/21:c.1623-101C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron15/19:c.1623-101C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron15/19:c.1623-101C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron8/12:c.1116-101C>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1188481 [likely benign DISEASE=not provided];			rs34119714	0.0194	0.0051,0.0142,0.0002,0.0279,0.0203	49,.	2849	149157	1.0120			6.65				0.03		9	356	0 / 0					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053701	16053701	T	C	hom	hom	hom		QUAL=28466;DP=297,251,371;AF=1.00,1.00,1.00;MQM=51;SAP=166;ABP=0;SAR=328;SAF=591	CLCNKB	missense	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon19/23:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon17/21:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon18/22:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon9/13:c.1178T>C:p.Met393Thr:PF00571 [CBS domain]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447094 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not specified,not provided];			rs5253	0.8879	0.6961,0.9285,0.8196,0.9849,0.9191	61122,.	12747	17037	-1.3380	T(0.46),T(0.46),T(0.63),T(0.46),T(0.46),T(0.46),T(0.49)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.03	0.28			0.04	25919862,23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053748	16053748	A	G	hom	het	hom		QUAL=15672;DP=139,232,313;AF=1.00,0.42,0.99;MQM=49;SAP=9;ABP=15;SAR=292;SAF=254	CLCNKB	missense	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon19/23:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon17/21:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon18/22:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu:PF00571 [CBS domain]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447096 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not specified,not provided];	CM1514575 [CLASS=DM? MUT=ALT PHEN="Migraine without aura" GENE=CLCNKB];		rs2275166	0.6948	0.7986,0.5767,0.8060,0.6611,0.5822	37116,.	31137	46283	1.0120	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	7.04	0.16			0.16	25919862,23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053757	16053757	C	T	hom	het	hom		QUAL=14504;DP=119,217,303;AF=1.00,0.43,1.00;MQM=49;SAP=18;ABP=13;SAR=287;SAF=227	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon19/23:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon17/21:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon18/22:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon9/13:c.1234C>T:p.Leu412=:PF00571 [CBS domain]		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447097 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not specified,not provided];			rs2275167	0.6207	0.5852,0.5345,0.7996,0.6456,0.5316	29518,.	35073	57501	0.5150			8.01			COSV65152867	0.31	23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053908	16053908	A	T	hom	het	hom	off-target	QUAL=5493;DP=63,108,96;AF=1.00,0.47,1.00;MQM=52;SAP=459;ABP=4;SAR=210;SAF=0	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron19/22:c.1756+136A>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron16/19:c.1756+136A>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron17/20:c.1756+136A>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron18/21:c.1756+136A>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron16/19:c.1756+136A>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron16/19:c.1756+136A>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron9/12:c.1249+136A>T::	regulatory_region_variant:TF_binding_site	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1231115 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs2275168	0.5536	0.3494,0.4940,0.8086,0.6517,0.5209	24850,.	34236	67674	-0.1600			5.86				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16055227	16055227	C	T	hom	het	hom	off-target	QUAL=2087;DP=45,23,23;AF=1.00,0.39,1.00;MQM=60;SAP=170;ABP=5;SAR=0;SAF=77	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron19/22:c.1757-208C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron16/19:c.1757-208C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron17/20:c.1757-208C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron18/21:c.1757-208C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron16/19:c.1757-208C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron16/19:c.1757-208C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron9/12:c.1250-208C>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1251205 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs12691552	0.4060	0.2289,0.4156,0.8039,0.4671,0.4436	13712,.	34231	90207	0.2610			8.59			COSV65153247	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16055297	16055297	T	A	hom	het	hom	off-target	QUAL=2414;DP=29,43,46;AF=1.00,0.33,1.00;MQM=60;SAP=196;ABP=14;SAR=0;SAF=89	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron19/22:c.1757-138T>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron16/19:c.1757-138T>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron17/20:c.1757-138T>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron18/21:c.1757-138T>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron16/19:c.1757-138T>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron16/19:c.1757-138T>A::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron9/12:c.1250-138T>A::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1295187 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs12047858	0.4254	0.2963,0.4205,0.8042,0.4677,0.4438	14488,.	35589	87213	-0.4460			1.84				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16055321	16055321	C	T	hom	het	hom	off-target	QUAL=3250;DP=40,43,57;AF=1.00,0.35,1.00;MQM=60;SAP=221;ABP=12;SAR=3;SAF=109	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron19/22:c.1757-114C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron16/19:c.1757-114C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron17/20:c.1757-114C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron18/21:c.1757-114C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron16/19:c.1757-114C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron16/19:c.1757-114C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron9/12:c.1250-114C>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1297841 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs12029508	0.4255	0.2966,0.4206,0.8044,0.4677,0.4436	14503,.	35595	87215	-0.6690			2.35				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16055591	16055591	C	T	hom	het	hom	off-target	QUAL=4838;DP=46,59,93;AF=0.98,0.51,1.00;MQM=60;SAP=70;ABP=3;SAR=48;SAF=120	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron20/22:c.1845+68C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron17/19:c.1845+68C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron18/20:c.1845+68C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron19/21:c.1845+68C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron17/19:c.1845+68C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron17/19:c.1845+68C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron10/12:c.1338+68C>T::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1229089 [benign DISEASE=not provided];			rs2297727	0.4256	0.2979,0.4201,0.8050,0.4674,0.4422	14479,.	35520	87030	-1.2050			0.05				0	19058262	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056223	16056223	T	C	hom	het	hom	off-target	QUAL=2809;DP=25,42,55;AF=1.00,0.48,1.00;MQM=60;SAP=156;ABP=3;SAR=8;SAF=92	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-199T>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-199T>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-199T>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-199T>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-199T>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-199T>C::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-199T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1277187 [benign DISEASE=not provided];			rs12048851	0.4377	0.3452,0.4260,0.8026,0.4669,0.4427	14975,.	36388	85212	-0.0840			6.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056235	16056235	C	T	hom	het	hom	off-target	QUAL=3324;DP=30,46,66;AF=1.00,0.48,1.00;MQM=60;SAP=202;ABP=3;SAR=7;SAF=111	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-187C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-187C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-187C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-187C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-187C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-187C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-187C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1241174 [benign DISEASE=not provided];			rs12030469	0.4186	0.2837,0.4203,0.8020,0.4636,0.4420	14039,.	35363	88113	-2.4240			0.55				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056296	16056296	G	C	hom	het	hom	off-target	QUAL=5270;DP=49,77,102;AF=1.00,0.51,1.00;MQM=60;SAP=416;ABP=3;SAR=0;SAF=190	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-126G>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-126G>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-126G>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-126G>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-126G>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-126G>C::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-126G>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1295162 [benign DISEASE=not provided];			rs12023153	0.4220	0.2847,0.4226,0.8041,0.4672,0.4422	14300,.	35375	87613	-1.7360			0.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056333	16056335	TCT	-	hom	het	hom	off-target	QUAL=6547;DP=53,104,129;AF=0.98,0.49,0.99;MQM=60;SAP=235;ABP=3;SAR=37;SAF=194	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-87_1930-85del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-87_1930-85del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-87_1927-85del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-87_1930-85del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-87_1930-85del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-87_1930-85del::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-87_1420-85del::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1180108 [benign DISEASE=not provided];			rs77508204	0.3717	0.1165,0.4003,0.8027,0.4647,0.4355	12645,.	31077	95297	0.3780			4.85				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056336	16056336	T	A	hom	het	hom	off-target	QUAL=6547;DP=53,104,129;AF=0.98,0.49,0.99;MQM=60;SAP=235;ABP=3;SAR=37;SAF=194	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-86T>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-86T>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-86T>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-86T>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-86T>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-86T>A::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-86T>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1295221 [benign DISEASE=not provided];			rs61769890	0.3718	0.1165,0.4006,0.8027,0.4647,0.4359	12645,.	31082	95238	-0.0050			6.71				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056339	16056339	T	A	hom	het	hom	off-target	QUAL=6547;DP=53,104,129;AF=0.98,0.49,0.99;MQM=60;SAP=235;ABP=3;SAR=37;SAF=194	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-83T>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-83T>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-83T>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-83T>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-83T>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-83T>A::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-83T>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1266107 [benign DISEASE=not provided];			rs61769891	0.3717	0.1164,0.4006,0.8021,0.4647,0.4359	12644,.	31089	95285	-0.3090			2.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056382	16056382	A	G	hom	hom	hom	off-target	QUAL=11604;DP=50,147,203;AF=1.00,0.99,1.00;MQM=60;SAP=31;ABP=0;SAR=163;SAF=235	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-40A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-40A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-40A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-40A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209753 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided];			rs7517792	0.7686	0.7077,0.8467,0.8153,0.7858,0.8370	45030,.	26537	35107	-2.2960			0.23				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056834	16056834	-	C	hom	het	hom	off-target;low_conf_region	QUAL=45;DP=3,22,6;AF=0.00,0.18,0.67;MQM=45;SAP=7;ABP=22;SAR=2;SAF=6	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron22/22:c.2017-29dup::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron20/20:c.2014-29dup::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron21/21:c.2017-29dup::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron12/12:c.1507-29dup::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1246688 [benign DISEASE=not provided];			rs138507185	0.6602	0.4387,0.7763,0.8045,0.7336,0.7940	29214,.	27005	43981				0.54				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056841	16056841	G	C	hom	het	hom	off-target;low_conf_region	QUAL=45;DP=3,22,6;AF=0.00,0.18,0.67;MQM=45;SAP=7;ABP=22;SAR=2;SAF=6	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron22/22:c.2017-28G>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron20/20:c.2014-28G>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron21/21:c.2017-28G>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron12/12:c.1507-28G>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209827 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided];			rs12746138	0.7212	0.5782,0.8152,0.8123,0.7635,0.8206	32995,.	27312	36064	-2.2870			0.07				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056907	16056907	C	T	het	wt	wt		QUAL=698;DP=257,140,144;AF=0.26,0.00,0.07;MQM=35;SAP=168;ABP=135;SAR=0;SAF=76	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon23/23:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon21/21:c.2052C>T:p.Ala684=:,CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon22/22:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon13/13:c.1545C>T:p.Ala515=:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	785932 [likely benign DISEASE=not provided];			rs6698427	0.0714	0.1300,0.0478,0.2081,0.0409,0.0881	1,.	6814	88636	-0.0040			4.92			COSV65152730	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056953	16056953	A	C	het	hom	hom	low_conf_region	QUAL=15870;DP=218,241,287;AF=0.70,1.00,0.90;MQM=40;SAP=906;ABP=77;SAR=65;SAF=585	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*37A>C::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*37A>C::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*37A>C::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*37A>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209828 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided];			rs10803415	0.7270	0.6476,0.7785,0.5330,0.7737,0.6921	29942,.	34903	35599	-1.8020			0.48				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057052	16057052	T	C	wt	wt	het		QUAL=542;DP=234,394,594;AF=0.05,0.00,0.19;MQM=31;SAP=272;ABP=509;SAR=0;SAF=124	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*136T>C::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*136T>C::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*136T>C::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*136T>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057839	0.2225	0.3265,0.1581,0.4007,0.1795,0.2446	8,.	22599	79035	0.2550			5.43			COSV65152725	0.02	23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057079	16057079	A	T	het	wt	het		QUAL=888;DP=245,379,614;AF=0.13,0.00,0.20;MQM=33;SAP=342;ABP=759;SAR=0;SAF=156	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*163A>T::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*163A>T::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*163A>T::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*163A>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057841	0.2559	0.3482,0.1917,0.4258,0.2200,0.2748	0,.	26706	77672	0.6160			6.28				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057086	16057086	G	T	het	het	het		QUAL=19906;DP=249,378,613;AF=0.85,0.51,0.79;MQM=37;SAP=74;ABP=517;SAR=360;SAF=531	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*170G>T::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*170G>T::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*170G>T::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*170G>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057844	0.5151	0.4074,0.6123,0.5051,0.5517,0.5641	10449,.	55380	71806	-1.4160			0.21				0.05		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057110	16057110	A	G	het	het	het		QUAL=19800;DP=196,403,645;AF=0.74,0.53,0.77;MQM=38;SAP=4;ABP=376;SAR=419;SAF=434	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*194A>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*194A>G::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*194A>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*194A>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057845	0.5067	0.4027,0.6005,0.4972,0.5416,0.5529	9210,.	56591	73041	-0.6030			1.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057173	16057173	T	G	hom	hom	hom		QUAL=32874;DP=174,360,659;AF=0.99,1.00,1.00;MQM=41;SAP=399;ABP=0;SAR=829;SAF=363	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*257T>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*257T>G::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*257T>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*257T>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs6660218	1.0000	1.0000,1.0000,1.0000,1.0000,1.0000	76104,.	2	2	0.3150			3.77				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057187	16057187	G	C	het	wt	het		QUAL=4440;DP=222,321,648;AF=0.19,0.00,0.36;MQM=41;SAP=38;ABP=262;SAR=170;SAF=104	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*271G>C::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*271G>C::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*271G>C::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*271G>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	402540 [benign DISEASE=not specified];			rs1057854	0.3286	0.4073,0.2586,0.4385,0.3021,0.2917	223,.	46374	95650	-3.2250			0.15	0.01		COSV65152876	0	24033266,23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057247	16057247	C	G	het	hom	het		QUAL=18401;DP=339,224,515;AF=0.55,1.00,0.53;MQM=58;SAP=737;ABP=13;SAR=581;SAF=101	CLCNKB	3'UTR	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*331C>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*331C>G::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*331C>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*331C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057857	0.6294	0.5853,0.6681,0.4937,0.6527,0.6012	19811,.	55386	55948	-0.3610			3.09	0.02		COSV65153970	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057359	16057359	A	G	het	wt	het	off-target	QUAL=706;DP=105,56,110;AF=0.38,0.00,0.17;MQM=38;SAP=131;ABP=98;SAR=59;SAF=0	CLCNKB,FAM131C	downstream_gene	CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs749928769	0.0271	0.0284,0.0345,0.0002,0.0272,0.0185	9,.	4101	147625	-0.5220			2.21						0	40	0 / 0					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057419	16057419	C	T	het	het	het	off-target	QUAL=1581;DP=38,24,50;AF=0.87,0.46,0.66;MQM=47;SAP=170;ABP=37;SAR=77;SAF=0	CLCNKB,FAM131C	downstream_gene	CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs10927896	0.3115	0.1600,0.3368,0.4857,0.3693,0.3546	1667,.	43091	102597	-2.0060			0.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057479	16057479	G	T	wt	het	wt	off-target	QUAL=46;DP=47,6,18;AF=0.00,0.67,0.00;MQM=54;SAP=12;ABP=4;SAR=4;SAF=0	CLCNKB,FAM131C	downstream_gene	CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs12144211	0.2066	0.2516,0.1277,0.0012,0.2147,0.0989	1960,.	26727	117697	1.4340			9.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057491	16057491	G	A	het	wt	het	off-target	QUAL=143;DP=35,5,13;AF=0.23,0.00,0.31;MQM=60;SAP=29;ABP=29;SAR=12;SAF=0	CLCNKB,FAM131C	downstream_gene	CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs6604912	0.3693	0.4304,0.3195,0.4683,0.3475,0.3810	1,.	55397	94629	1.0980			9.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057529	16057529	T	A	het	wt	het	off-target	QUAL=134;DP=24,3,3;AF=0.38,0.00,0.33;MQM=60;SAP=25;ABP=7;SAR=10;SAF=0	CLCNKB,FAM131C	downstream_gene	CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs6604913	0.3696	0.4308,0.3189,0.4691,0.3478,0.3819	1,.	55490	94666	-0.4280			4.37						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16986248	16986248	C	T	het	hom	het		QUAL=707;DP=17,19,25;AF=0.41,0.95,0.44;MQM=60;SAP=12;ABP=5;SAR=12;SAF=24	ATP13A2	missense,synonymous	ATP13A2:ENST00000341676.9:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128475 [benign DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,History of neurodevelopmental disorder,not specified,not provided];			rs3170740	0.4110	0.1985,0.4461,0.2762,0.5266,0.4339	14373,.	33576	89314	-2.7740	T(0.32), , 	B(0.00), , 	0.29	0.24		COSV58697923	0	25741868,18414213,19085912,22743658,31562340,30232368,28170284,32327693,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986662	16986662	G	A	het	hom	het	off-target	QUAL=9679;DP=84,216,293;AF=0.39,1.00,0.50;MQM=60;SAP=38;ABP=5;SAR=238;SAF=158	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron26/26:c.3103+143C>T::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron27/28:c.3236-30C>T::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	559000 [benign DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,not provided];			rs2076605	0.4175	0.2186,0.4468,0.2815,0.5271,0.4529	14617,.	34089	88347	2.1340			9.24			COSV58702203	0.01	19085912	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986750	16986761	CCCAGGGCTCCT	-	het	wt	het	off-target	QUAL=2063;DP=45,167,208;AF=0.27,0.00,0.50;MQM=60;SAP=12;ABP=7;SAR=47;SAF=69	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron26/26:c.3103+44_3103+55del::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron27/28:c.3235+44_3235+55del::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron27/28:c.3220+44_3220+55del::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1174788 [benign DISEASE=not specified,not provided];			rs143483351	0.2409	0.1564,0.3376,0.5608,0.2309,0.2459	4929,.	26724	115258	1.8490			4.15				0.01	33246661	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986848	16986848	G	A	het	hom	het		QUAL=10657;DP=90,199,282;AF=0.47,1.00,0.50;MQM=60;SAP=18;ABP=3;SAR=216;SAF=165	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128473 [benign DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,History of neurodevelopmental disorder,not specified,not provided];			rs9435659	0.4120	0.1942,0.4477,0.2824,0.5293,0.4525	14510,.	33570	89334	-0.3600			0.47			COSV58700662	0.02	25741868,18414213,19085912,22743658,30232368	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986959	16986959	G	A	het	wt	het		QUAL=2312;DP=59,138,178;AF=0.47,0.00,0.44;MQM=60;SAP=33;ABP=9;SAR=72;SAF=34	ATP13A2	splice_region&intron	ATP13A2:ENST00000341676.9:splice_region_variant&intron_variant:LOW:intron25/26:c.2952-3C>T::,ATP13A2:ENST00000326735.13:splice_region_variant&intron_variant:LOW:intron26/28:c.3084-3C>T::,ATP13A2:ENST00000452699.5:splice_region_variant&intron_variant:LOW:intron26/28:c.3069-3C>T::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128471 [benign DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,History of neurodevelopmental disorder,not specified,not provided];			rs7531163	0.2427	0.1654,0.3380,0.5577,0.2304,0.2436	4944,.	26893	114749	0.7470			8.06		9.29>9.90	COSV104399909	0	25741868,18414213,19085912	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16987159	16987159	C	T	het	hom	het		QUAL=10638;DP=65,245,281;AF=0.51,1.00,0.47;MQM=60;SAP=149;ABP=5;SAR=122;SAF=288	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128470 [benign DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,History of neurodevelopmental disorder,not specified,not provided];			rs761421	0.4178	0.2204,0.4471,0.2748,0.5271,0.4530	14645,.	34185	88451	-0.8540			0.19			COSV58699127	0.03	25741868,18414213,19085912,22743658,30232368,30034773	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16988207	16988207	C	T	het	wt	het		QUAL=11072;DP=278,493,583;AF=0.48,0.01,0.51;MQM=60;SAP=31;ABP=3;SAR=179;SAF=254	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon24/27:c.2658G>A:p.Ser886=:,ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon25/29:c.2790G>A:p.Ser930=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128468 [benign DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,History of neurodevelopmental disorder,not specified,not provided];			rs3738815	0.2117	0.1473,0.3050,0.5600,0.1876,0.2391	3993,.	24198	119838	-2.3080			0.37			COSV58700021	0.05	25741868,18414213,19085912,22285144,22743658,30232368,34021172	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16988447	16988447	G	A	het	hom	het		QUAL=14033;DP=294,260,322;AF=0.50,0.99,0.45;MQM=60;SAP=394;ABP=6;SAR=433;SAF=118	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:PF00702 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128466 [benign DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,History of neurodevelopmental disorder,not specified,not provided];			rs9435662	0.4108	0.1943,0.4450,0.2825,0.5274,0.4540	14422,.	33573	89507	-5.0290			3.79			COSV58700683	0	25741868,18414213,19085912,22743658,30232368	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16991570	16991570	T	C	het	wt	het	off-target	QUAL=827;DP=47,24,20;AF=0.55,0.00,0.50;MQM=60;SAP=81;ABP=4;SAR=0;SAF=36	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron20/26:c.2236+164A>G::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron20/28:c.2251+164A>G::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron20/28:c.2236+164A>G::		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1281617 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs2076604	0.2118	0.1465,0.3052,0.5657,0.1877,0.2396	4015,.	24158	119808	-1.0580			5.70				0.94	19085912	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16992516	16992516	G	A	het	hom	het		QUAL=6562;DP=78,128,151;AF=0.47,1.00,0.48;MQM=60;SAP=55;ABP=4;SAR=156;SAF=81	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:PF00702 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:PF00702 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:PF00702 [haloacid dehalogenase-like hydrolase]		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128465 [benign DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,History of neurodevelopmental disorder,not specified,not provided];			rs2076603	0.5477	0.4409,0.5404,0.2804,0.6352,0.4959	23512,.	36216	68750	-0.0780			7.24			COSV58700878	0.01	25741868,18414213,19085912,22743658,30232368,30595370,30034773,33335927	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16996703	16996703	A	T	het	n/a	het	off-target	QUAL=436;DP=33,1,7;AF=0.52,0.00,0.86;MQM=60;SAP=53;ABP=5;SAR=23;SAF=0	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron12/26:c.1181-207T>A::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron12/28:c.1196-207T>A::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron12/28:c.1181-207T>A::		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1270970 [benign DISEASE=not provided];			rs2076602	0.2114	0.1460,0.3043,0.5635,0.1876,0.2391	3997,.	24145	119895	0.1770			6.47				0	22285144	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16996871	16996871	-	G	het	wt	het	off-target	QUAL=657;DP=30,26,46;AF=0.30,0.00,0.52;MQM=60;SAP=66;ABP=6;SAR=1;SAF=32	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron12/26:c.1180+148dup::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron12/28:c.1195+148dup::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron12/28:c.1180+148dup::		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1245001 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs55682704	0.2148	0.1595,0.3016,0.5633,0.1877,0.2389	4050,.	24519	119257				0.25				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16996954	16996954	T	C	hom	hom	hom	off-target	QUAL=5615;DP=36,68,88;AF=0.97,1.00,1.00;MQM=60;SAP=343;ABP=0;SAR=9;SAF=182	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron12/26:c.1180+66A>G::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron12/28:c.1195+66A>G::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron12/28:c.1180+66A>G::		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1192485 [benign DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,not provided];		MIR3 (SINE/MIR)	rs9435736	0.8068	0.7461,0.8723,0.8461,0.8242,0.7361	49690,.	23262	29372	-1.1830			0.56				0	19085912,30232368	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17004773	17004773	C	T	wt	het	wt		QUAL=643;DP=133,74,121;AF=0.00,0.41,0.00;MQM=60;SAP=3;ABP=9;SAR=15;SAF=15	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter]		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	293803 [uncertain significance(replaced by megSAP based on classifications:1x2,1x3) DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78];			rs140631323	0.0001	0.0001,0.0001,0.0000,0.0002,0.0000	0,.	14	152166	-4.7190			0.12	0.01		COSV58702839	0		1	12	0 / 0					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17005181	17005181	A	G	het	het	het	off-target	QUAL=3459;DP=123,83,126;AF=0.40,0.49,0.44;MQM=60;SAP=53;ABP=13;SAR=102;SAF=44	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron3/26:c.289-109T>C::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron3/28:c.289-109T>C::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron3/28:c.289-109T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1270274 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs3738814	0.5179	0.6450,0.5117,0.7145,0.4285,0.5786	21041,.	36569	73217	-0.0320			2.38			COSV58699306	0	20189936,25429064,28448500,31217584,34021172,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	18871570	18871570	T	G	het	wt	het		QUAL=3442;DP=95,148,185;AF=0.53,0.00,0.47;MQM=60;SAP=9;ABP=3;SAR=78;SAF=59	ALDH4A1	3'UTR	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*262A>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1275A>C::	regulatory_region_variant:enhancer	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294333 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138333	0.2420	0.2157,0.2341,0.0350,0.2769,0.1593	4696,.	27365	115129	0.9220			12.39				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871606	18871606	C	G	het	wt	het		QUAL=3398;DP=96,144,166;AF=0.54,0.00,0.49;MQM=60;SAP=7;ABP=3;SAR=75;SAF=59	ALDH4A1	3'UTR	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*226G>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1239G>C::	regulatory_region_variant:enhancer	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294334 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138328	0.2349	0.2087,0.2291,0.0019,0.2729,0.1266	4485,.	26750	116340	0.1220			4.21			COSV51895732	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871647	18871647	T	C	het	wt	het		QUAL=3477;DP=123,139,146;AF=0.54,0.00,0.48;MQM=60;SAP=5;ABP=3;SAR=74;SAF=62	ALDH4A1	3'UTR	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*185A>G::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1198A>G::	regulatory_region_variant:enhancer	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294336 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs7366541	0.2420	0.2157,0.2338,0.0349,0.2770,0.1594	4701,.	27374	115184	-1.1350			1.41			COSV51895747	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871920	18871920	G	A	het	wt	het		QUAL=4287;DP=167,168,196;AF=0.47,0.00,0.49;MQM=60;SAP=26;ABP=4;SAR=66;SAF=109	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-130C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*925C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294341 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1140477	0.2516	0.2517,0.2375,0.0346,0.2759,0.1594	4959,.	28316	113706	0.5890			4.94				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871924	18871924	C	T	het	wt	het		QUAL=4287;DP=167,168,196;AF=0.47,0.00,0.49;MQM=60;SAP=26;ABP=4;SAR=66;SAF=109	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-134G>A::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*921G>A::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294342 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138269	0.2516	0.2515,0.2376,0.0344,0.2759,0.1593	4960,.	28309	113707	0.1370			5.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872082	18872082	A	G	hom	hom	hom		QUAL=29643;DP=366,238,311;AF=1.00,1.00,0.99;MQM=60;SAP=10;ABP=0;SAR=482;SAF=429	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-292T>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*763T>C::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294344 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138267	0.6588	0.5235,0.7637,0.7152,0.7010,0.7554	33624,.	32916	51874	-4.5340			0.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872133	18872133	G	A	het	wt	het		QUAL=6408;DP=291,203,262;AF=0.48,0.00,0.45;MQM=60;SAP=20;ABP=7;SAR=153;SAF=108	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-343C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*712C>T::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294346 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs14311	0.2509	0.2463,0.2384,0.0348,0.2762,0.1592	4985,.	28185	113947	-0.0090			1.70				0	12970910	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872143	18872143	G	A	het	hom	het		QUAL=12547;DP=239,205,258;AF=0.49,1.00,0.53;MQM=60;SAP=6;ABP=4;SAR=243;SAF=216	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-353C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*702C>T::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294347 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs3202002	0.3984	0.2442,0.5214,0.6800,0.4248,0.5964	13009,.	34573	91479	-0.2920			3.42				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872188	18872188	C	-	het	hom	het		QUAL=7778;DP=103,165,182;AF=0.49,0.99,0.53;MQM=60;SAP=6;ABP=3;SAR=165;SAF=144	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-398del::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*657del::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294349 [likely benign DISEASE=Hyperprolinemia];			rs11311839	0.4073	0.2495,0.5284,0.6855,0.4372,0.6024	13583,.	34763	90125	-3.2790			0.02				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872401	18872401	A	G	het	wt	het		QUAL=5039;DP=190,194,247;AF=0.48,0.00,0.45;MQM=60;SAP=10;ABP=8;SAR=114;SAF=89	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*41+403T>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*444T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294353 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs9117	0.1839	0.0854,0.1961,0.0019,0.2498,0.1081	3075,.	21832	124152	0.2290			4.35				0	12970910	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872727	18872727	C	T	het	hom	het		QUAL=20784;DP=213,404,487;AF=0.43,1.00,0.47;MQM=60;SAP=57;ABP=16;SAR=293;SAF=427	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*41+77G>A::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*118G>A::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294359 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs11740	0.3994	0.2461,0.5235,0.6733,0.4258,0.5936	13035,.	34563	91179	-0.7970			0.48			COSV51892981	0	18843385,12970910,24686056	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872979	18872979	T	A	het	hom	het	off-target	QUAL=12560;DP=148,227,285;AF=0.47,0.99,0.52;MQM=60;SAP=126;ABP=3;SAR=300;SAF=142	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1580-22A>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1580-22A>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1427-22A>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1400-22A>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188868 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs28700162	0.4001	0.2465,0.5238,0.6741,0.4267,0.5979	13110,.	34605	91183	0.0000			7.70			COSV51895558	0.05		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872993	18872993	A	G	het	wt	het	off-target	QUAL=4653;DP=104,201,254;AF=0.62,0.00,0.48;MQM=60;SAP=108;ABP=4;SAR=141;SAF=46	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1580-36T>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1580-36T>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1427-36T>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1400-36T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs35255325	0.1881	0.1000,0.1982,0.0017,0.2494,0.1089	3134,.	22350	123496	0.0900			5.74				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874401	18874401	C	T	het	wt	het	off-target	QUAL=2868;DP=115,112,143;AF=0.43,0.00,0.52;MQM=60;SAP=231;ABP=4;SAR=5;SAF=119	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1579+62G>A::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1579+62G>A::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1426+62G>A::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1399+62G>A::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs35657817	0.2862	0.3718,0.2553,0.0019,0.2766,0.1293	6711,.	30076	108474	-1.0310			0.33				0	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874414	18874414	G	C	het	hom	het	off-target	QUAL=6916;DP=104,121,166;AF=0.55,1.00,0.46;MQM=60;SAP=368;ABP=3;SAR=24;SAF=231	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1579+49C>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1579+49C>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1426+49C>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1399+49C>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188869 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs28529092	0.4623	0.4287,0.5549,0.6781,0.4421,0.6235	16498,.	37225	81665	3.1040			11.59			COSV51895606	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874690	18874690	G	C	hom	hom	hom	off-target	QUAL=9859;DP=98,111,133;AF=0.99,0.98,0.99;MQM=60;SAP=728;ABP=0;SAR=337;SAF=1	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron13/15:c.1461-109C>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron13/14:c.1461-109C>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron12/13:c.1308-109C>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron13/14:c.1281-109C>G::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs6665917	0.6459	0.5269,0.7491,0.7194,0.6807,0.7361	32222,.	33769	53845	-2.4860			0.14				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874717	18874717	-	G	hom	hom	hom	off-target	QUAL=6205;DP=61,89,90;AF=0.92,0.98,0.99;MQM=60;SAP=507;ABP=0;SAR=232;SAF=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron13/15:c.1461-137dup::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron13/14:c.1461-137dup::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron12/13:c.1308-137dup::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron13/14:c.1281-137dup::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188871 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];		MIRb (SINE/MIR)	rs35163726	0.6413	0.5289,0.7458,0.6765,0.6769,0.7036	31698,.	34074	54512				1.68				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18875462	18875462	A	G	hom	hom	hom		QUAL=18220;DP=311,131,136;AF=1.00,1.00,1.00;MQM=60;SAP=207;ABP=0;SAR=172;SAF=405	ALDH4A1	synonymous	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon13/16:c.1380T>C:p.Asp460=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon13/15:c.1380T>C:p.Asp460=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:synonymous_variant:LOW:exon12/14:c.1227T>C:p.Asp409=:,ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon13/15:c.1200T>C:p.Asp400=:PF00171 [Aldehyde dehydrogenase family]	regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294369 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not specified];			rs2230708	0.7145	0.6844,0.7918,0.7216,0.7155,0.7662	38866,.	30784	43356	-1.3090			0.29				0	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876276	18876276	T	C	hom	hom	hom	off-target	QUAL=4035;DP=48,30,54;AF=1.00,1.00,1.00;MQM=60;SAP=148;ABP=0;SAR=19;SAF=113	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron12/15:c.1338+39A>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron12/14:c.1338+39A>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1186-773A>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron12/14:c.1158+39A>G::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188872 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs7550822	0.9217	0.7783,0.9566,0.9998,0.9788,0.9813	65159,.	9867	11909	-0.0870			5.29				0	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876402	18876402	G	A	hom	het	hom		QUAL=7422;DP=132,72,96;AF=0.99,0.33,0.99;MQM=60;SAP=26;ABP=20;SAR=99;SAF=151	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1251C>T:p.Ala417=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1251C>T:p.Ala417=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+806C>T::,ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1071C>T:p.Ala357=:PF00171 [Aldehyde dehydrogenase family]		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294374 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not provided];			rs2230707	0.4774	0.4358,0.6054,0.6155,0.4661,0.5010	17651,.	37218	79394	-9.1790			1.01			COSV51891838	0.01	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876423	18876423	T	C	hom	hom	hom		QUAL=7586;DP=96,74,87;AF=1.00,0.97,0.99;MQM=60;SAP=4;ABP=0;SAR=123;SAF=131	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1230A>G:p.Ser410=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1230A>G:p.Ser410=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+785A>G::,ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1050A>G:p.Ser350=:PF00171 [Aldehyde dehydrogenase family]		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294375 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not specified,not provided];			rs7550938	0.6428	0.4856,0.7503,0.7218,0.6946,0.7476	31974,.	33395	54093	-6.0680			1.04			COSV51894187	0.03	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876432	18876432	T	C	hom	hom	hom		QUAL=6356;DP=65,73,87;AF=1.00,0.96,0.99;MQM=60;SAP=5;ABP=0;SAR=104;SAF=117	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1221A>G:p.Ala407=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1221A>G:p.Ala407=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+776A>G::,ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1041A>G:p.Ala347=:PF00171 [Aldehyde dehydrogenase family]		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294376 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not specified,not provided];			rs2230706	0.6422	0.4853,0.7500,0.7202,0.6936,0.7478	31934,.	33409	54203	0.1280			2.89			COSV51893163	0.02	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877503	18877503	C	G	hom	hom	hom		QUAL=7567;DP=84,56,107;AF=0.98,1.00,1.00;MQM=60;SAP=133;ABP=0;SAR=183;SAF=62	ALDH4A1	synonymous	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon10/16:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon10/15:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:synonymous_variant:LOW:exon10/14:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon10/15:c.870G>C:p.Ala290=:PF00171 [Aldehyde dehydrogenase family]		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294382 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs2230705	0.7099	0.7216,0.7177,0.4548,0.7195,0.5809	38609,.	30705	44113	1.5970			8.71			COSV51892136	0	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877660	18877660	G	A	het	hom	wt	off-target	QUAL=269;DP=14,8,20;AF=0.43,1.00,0.00;MQM=60;SAP=33;ABP=4;SAR=14;SAF=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.941-48C>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.941-48C>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.941-48C>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.761-48C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188873 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs6426813	0.7243	0.6996,0.8232,0.9556,0.6994,0.8562	40352,.	29360	41898	-0.8390			0.54				0	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877679	18877679	A	G	hom	het	hom	off-target	QUAL=900;DP=14,7,20;AF=0.93,0.43,1.00;MQM=60;SAP=81;ABP=3;SAR=36;SAF=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.941-67T>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.941-67T>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.941-67T>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.761-67T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188910 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs6426814	0.8212	0.8781,0.8413,0.8722,0.7901,0.7498	51430,.	21983	27179	-1.3820			0.86				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877815	18877815	G	A	het	n/a	het	off-target	QUAL=268;DP=13,0,6;AF=0.62,,0.67;MQM=60;SAP=29;ABP=6;SAR=12;SAF=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.941-203C>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.941-203C>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.941-203C>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.761-203C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			MIR3 (SINE/MIR)	rs41302007	0.3198	0.2076,0.2631,0.1739,0.3899,0.3254	8487,.	31630	103396	-0.4680			0.17				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18879178	18879178	T	G	het	het	hom	off-target	QUAL=4354;DP=81,96,76;AF=0.49,0.55,0.99;MQM=60;SAP=368;ABP=4;SAR=0;SAF=168	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.940+122A>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.940+122A>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.940+122A>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.760+122A>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs28497538	0.4270	0.4888,0.4669,0.3641,0.3837,0.4233	14310,.	36256	87046	-3.6300			0.05				0	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18881651	18881651	-	GGTTGCCT	hom	hom	hom	off-target	QUAL=672;DP=7,7,14;AF=1.00,1.00,1.00;MQM=60;SAP=64;ABP=0;SAR=0;SAF=28	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron8/15:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron8/14:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron8/13:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron8/14:c.686+48_686+49insAGGCAACC::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs112548638	0.9844	0.9459,0.9943,1.0000,0.9998,0.9996	73707,.	2254	2370				1.51				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18883049	18883049	A	G	hom	hom	hom	off-target	QUAL=11391;DP=84,156,144;AF=1.00,0.99,1.00;MQM=60;SAP=383;ABP=0;SAR=62;SAF=321	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron7/15:c.678+75T>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron7/14:c.678+75T>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron7/13:c.678+75T>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron7/14:c.498+75T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188911 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs6426611	0.9702	0.8963,0.9896,0.9998,0.9996,0.9994	71804,.	4085	4539	-1.8660			0.03				0	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18883524	18883524	G	A	het	wt	hom	off-target	QUAL=1100;DP=45,16,28;AF=0.40,0.00,1.00;MQM=60;SAP=94;ABP=7;SAR=45;SAF=1	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron5/15:c.454-96C>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron5/14:c.454-96C>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron5/13:c.454-96C>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron5/14:c.274-96C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs28508407	0.3047	0.4536,0.3409,0.2417,0.2199,0.2321	8031,.	30249	105703	-3.5190			0.02			COSV51893250	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18885436	18885436	A	C	wt	hom	wt	off-target;low_conf_region	QUAL=55;DP=4,7,5;AF=0.00,0.86,0.00;MQM=60;SAP=9;ABP=0;SAR=1;SAF=5	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron5/15:c.453+37T>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron5/14:c.453+37T>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron5/13:c.453+37T>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron5/14:c.273+37T>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			(CACCC)n (Simple_repeat)	rs752213358	0.2364	0.2566,0.2396,0.1924,0.2312,0.2503	0,.	12845	41481	-3.5210			0.04			COSV51892118	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18885441	18885441	G	C	n/a	het	wt	off-target;low_conf_region	QUAL=27;DP=2,9,6;AF=0.00,0.56,0.00;MQM=60;SAP=14;ABP=3;SAR=0;SAF=5	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron5/15:c.453+32C>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron5/14:c.453+32C>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron5/13:c.453+32C>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron5/14:c.273+32C>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			(CACCC)n (Simple_repeat)	rs188233802	0.2342	0.2654,0.2084,0.2267,0.2273,0.2658	0,.	9992	32668	-0.6210			0.57				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18889340	18889340	T	C	hom	hom	hom	off-target	QUAL=11008;DP=118,95,143;AF=1.00,1.00,1.00;MQM=60;SAP=175;ABP=0;SAR=94;SAF=262	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron3/15:c.249+22A>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron3/14:c.249+22A>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron3/13:c.249+22A>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron3/14:c.69+22A>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188912 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs941495	0.9689	0.9926,0.9706,0.9996,0.9543,0.9907	71460,.	4553	4729	-0.5210			2.91				0.03	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18890554	18890554	A	C	het	het	wt	off-target	QUAL=1359;DP=84,37,50;AF=0.49,0.43,0.00;MQM=59;SAP=118;ABP=4;SAR=1;SAF=56	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron1/15:c.63-449T>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron1/14:c.63-449T>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron1/13:c.63-449T>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron1/14:c.-119+140T>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			AluSz (SINE/Alu)							0.4610			3.99				0.02		0	0	0 / 0					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	21554325	21554325	-	ATAT	het	wt	het	off-target	QUAL=111;DP=24,9,13;AF=0.29,0.00,0.31;MQM=60;SAP=27;ABP=16;SAR=11;SAF=0	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron2/11:c.61+195_61+198dup::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron1/9:c.-54-6289_-54-6286dup::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron1/10:c.-104-6289_-104-6286dup::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron2/11:c.61+195_61+198dup::	regulatory_region_variant:enhancer	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1253752 [benign DISEASE=not provided];			rs61491376	0.6394	0.4404,0.6635,0.4644,0.7506,0.6777	31197,.	31017	52673				0.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21563013	21563013	C	T	wt	wt	het	off-target	QUAL=664;DP=31,37,63;AF=0.00,0.00,0.51;MQM=60;SAP=72;ABP=3;SAR=0;SAF=32	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron4/11:c.298-97C>T::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron2/9:c.67-97C>T::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron3/10:c.133-97C>T::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron4/11:c.298-97C>T::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1177624 [benign DISEASE=Infantile hypophosphatasia,Childhood hypophosphatasia,Adult hypophosphatasia,not provided];			rs1256336	0.2365	0.3124,0.1805,0.0129,0.2368,0.1057	4605,.	26714	116004	0.3480			3.29				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21563142	21563142	T	C	hom	hom	het		QUAL=4777;DP=29,90,125;AF=0.97,1.00,0.52;MQM=60;SAP=32;ABP=3;SAR=67;SAF=116	ALPL	synonymous	ALPL:ENST00000374840.8:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245 [Alkaline phosphatase],ALPL:ENST00000539907.5:synonymous_variant:LOW:exon3/10:c.99T>C:p.Ser33=:PF00245 [Alkaline phosphatase],ALPL:ENST00000540617.5:synonymous_variant:LOW:exon4/11:c.165T>C:p.Ser55=:PF00245 [Alkaline phosphatase],ALPL:ENST00000374832.5:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245 [Alkaline phosphatase]		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	197678 [benign DISEASE=Infantile hypophosphatasia,Hypophosphatasia,Childhood hypophosphatasia,Adult hypophosphatasia,not specified,not provided];			rs1780316	0.9260	0.8668,0.9526,0.9871,0.9439,0.9557	65340,.	10226	11268	-0.8670			4.19			COSV66379629	0	25972531,27507156,30283886,23823483,25147783,34213743	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21563893	21563893	G	A	hom	hom	het	off-target	QUAL=646;DP=16,6,5;AF=1.00,1.00,0.40;MQM=60;SAP=55;ABP=3;SAR=0;SAF=24	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron5/11:c.473-148G>A::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron3/9:c.242-148G>A::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron4/10:c.308-148G>A::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron5/11:c.473-148G>A::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1188974 [benign DISEASE=Childhood hypophosphatasia,not provided];			rs1256335	0.8011	0.7734,0.8502,0.9838,0.7886,0.8118	48637,.	23862	30072	-1.5660			0.09			COSV66379633	0	30583557,19744961,19888898,25972531,23823483,25760040,32230794	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21563971	21563971	A	G	hom	hom	hom	off-target	QUAL=2585;DP=19,31,51;AF=1.00,1.00,1.00;MQM=60;SAP=222;ABP=0;SAR=0;SAF=101	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron5/11:c.473-70A>G::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron3/9:c.242-70A>G::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron4/10:c.308-70A>G::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron5/11:c.473-70A>G::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1177630 [benign DISEASE=Infantile hypophosphatasia,Childhood hypophosphatasia,Adult hypophosphatasia,not provided];		(GGGA)n (Simple_repeat)	rs1767428	0.9867	0.9540,0.9941,0.9998,0.9997,0.9998	72672,.	1911	1991	-0.3600			1.78				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21568455	21568455	G	A	het	wt	het	off-target	QUAL=665;DP=35,18,23;AF=0.54,0.06,0.57;MQM=60;SAP=75;ABP=4;SAR=33;SAF=0	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron7/11:c.792+208G>A::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron5/9:c.561+208G>A::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron6/10:c.627+208G>A::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron7/11:c.792+208G>A::	regulatory_region_variant:enhancer	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1297879 [benign DISEASE=not provided];			rs35526713	0.0779	0.0546,0.0703,0.0266,0.0892,0.0695	475,.	10897	140197	0.5610			5.19				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21570432	21570432	C	T	het	wt	het	off-target	QUAL=6286;DP=187,243,304;AF=0.49,0.00,0.55;MQM=60;SAP=189;ABP=6;SAR=204;SAF=55	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron6/9:c.631+58C>T::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron7/10:c.697+58C>T::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron8/11:c.862+58C>T::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1177590 [benign DISEASE=Infantile hypophosphatasia,Childhood hypophosphatasia,Adult hypophosphatasia,not provided];			rs2275375	0.2608	0.3064,0.2936,0.4774,0.2000,0.3029	5477,.	28651	112235	-1.1040			0.36			COSV66376176	0	19500388,34213743	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21573927	21573927	A	G	hom	hom	het	off-target	QUAL=5640;DP=75,78,97;AF=1.00,1.00,0.53;MQM=60;SAP=446;ABP=4;SAR=204;SAF=0	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron9/11:c.997+128A>G::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron7/9:c.766+128A>G::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron8/10:c.832+128A>G::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron9/11:c.997+128A>G::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1236467 [benign DISEASE=not provided];			rs2275370	0.7635	0.7068,0.7924,0.8026,0.7832,0.7685	44408,.	27285	35957	-0.3860			4.29			COSV66376031	0	19888898,25972531,19931660	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21573966	21573966	A	C	het	het	wt	off-target	QUAL=1376;DP=66,49,63;AF=0.58,0.51,0.00;MQM=60;SAP=140;ABP=5;SAR=63;SAF=0	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron9/11:c.997+167A>C::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron7/9:c.766+167A>C::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron8/10:c.832+167A>C::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron9/11:c.997+167A>C::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1241664 [benign DISEASE=not provided];			rs35488260	0.2144	0.1262,0.1860,0.0002,0.2897,0.0821	3993,.	24636	119530	0.5160			8.80			COSV66376032	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21575615	21575615	C	T	wt	wt	het	off-target	QUAL=1091;DP=119,68,99;AF=0.00,0.00,0.57;MQM=60;SAP=125;ABP=7;SAR=0;SAF=56	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron9/11:c.998-118C>T::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron7/9:c.767-118C>T::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron8/10:c.833-118C>T::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron9/11:c.998-118C>T::	regulatory_region_variant:enhancer	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]				rs116835106	0.0085	0.0028,0.0054,0.0015,0.0127,0.0257	9,.	1274	150902	-2.5310			0.12				0.03		2	152	0 / 0					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21576457	21576457	C	A	wt	wt	het	off-target	QUAL=1844;DP=148,120,140;AF=0.01,0.00,0.54;MQM=60;SAP=69;ABP=5;SAR=14;SAF=62	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron10/11:c.1190-65C>A::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron8/9:c.959-65C>A::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron9/10:c.1025-65C>A::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron10/11:c.1190-65C>A::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1177605 [benign DISEASE=Infantile hypophosphatasia,Childhood hypophosphatasia,Adult hypophosphatasia,not provided];			rs1780329	0.2480	0.3503,0.2771,0.4688,0.1657,0.2581	5377,.	26861	114073	-0.8730			0.94			COSV66376181	0	25972531,17195227,18769922,25025693,29754330,31666285,23612078	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577713	21577713	C	T	wt	het	wt		QUAL=1739;DP=60,173,234;AF=0.00,0.46,0.00;MQM=60;SAP=12;ABP=6;SAR=31;SAF=49	ALPL	3'UTR	ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*65C>T::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*65C>T::,ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	295558 [benign DISEASE=Hypophosphatasia,not provided];			rs1697405	0.3554	0.2575,0.3815,0.3100,0.4090,0.4238	10025,.	33949	97951	1.5200			10.69			COSV66376405	0	27468225,31666285	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577770	21577770	C	-	het	het	wt		QUAL=20497;DP=180,240,280;AF=0.53,0.45,1.00;MQM=60;SAP=14;ABP=3;SAR=89;SAF=122	ALPL	3'UTR	ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*124del::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*124del::,ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	295560 [benign/likely benign DISEASE=Hypophosphatasia,not provided];			rs140511985	0.0458	0.0187,0.0388,0.0000,0.0681,0.0234	213,.	6536	145012	0.9820			11.71				0		8	41	0 / 0					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577774	21577774	A	G	hom	hom	hom		QUAL=20497;DP=180,240,280;AF=0.53,0.45,1.00;MQM=60;SAP=14;ABP=3;SAR=89;SAF=122	ALPL	3'UTR	ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*126A>G::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*126A>G::,ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	295561 [benign DISEASE=Hypophosphatasia,not provided];			rs1697406	0.8719	0.8519,0.8725,0.8120,0.8856,0.9308	57845,.	16890	19484	0.1730			14.65				0	27468225,28899360	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577881	21577881	A	C	wt	wt	het		QUAL=2232;DP=125,190,197;AF=0.00,0.00,0.46;MQM=60;SAP=18;ABP=5;SAR=58;SAF=33	ALPL	3'UTR	ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*233A>C::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*233A>C::,ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	295563 [benign DISEASE=Hypophosphatasia,not provided];			rs1772719	0.1869	0.1944,0.1426,0.0158,0.2020,0.2008	2714,.	23018	123728	0.5140			15.42				0	30583557,25972531,19931660,31959995,33574263	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21578514	21578514	G	A	wt	wt	het	off-target	QUAL=947;DP=148,53,84;AF=0.00,0.00,0.50;MQM=60;SAP=70;ABP=3;SAR=39;SAF=3	ALPL	downstream_gene	ALPL:ENST00000374840.8:downstream_gene_variant:MODIFIER::::,ALPL:ENST00000539907.5:downstream_gene_variant:MODIFIER::::,ALPL:ENST00000540617.5:downstream_gene_variant:MODIFIER::::,ALPL:ENST00000374832.5:downstream_gene_variant:MODIFIER::::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]				rs1772720	0.0812	0.1132,0.0500,0.0125,0.0737,0.0446	554,.	11227	139639	0.0150			4.82					30048462	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21822690	21822690	G	C	het	wt	hom		QUAL=1349;DP=23,27,42;AF=0.43,0.00,1.00;MQM=60;SAP=91;ABP=4;SAR=3;SAF=49	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*475G>C::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*218+257G>C::,HSPG2:ENST00000374695.8:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295685 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs1049644	0.2994	0.4065,0.2196,0.1668,0.2547,0.4036	7246,.	30857	106115	1.9690			10.28			COSV60827857	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823442	21823442	T	C	hom	hom	hom		QUAL=15077;DP=110,143,232;AF=1.00,1.00,1.00;MQM=60;SAP=244;ABP=0;SAR=126;SAF=358	LDLRAD2,HSPG2	3'UTR,intron,synonymous	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1227T>C::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-468T>C::,HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon97/97:c.13050A>G:p.Ser4350=:PF00054 [Laminin G domain]	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295695 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs897467	0.7916	0.7175,0.7668,0.8228,0.8251,0.8300	47809,.	24698	31672	-3.7920			0.96			COSV60827391	0.23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823625	21823625	C	T	wt	wt	het		QUAL=3357;DP=145,206,313;AF=0.00,0.00,0.44;MQM=60;SAP=11;ABP=12;SAR=81;SAF=58	LDLRAD2,HSPG2	3'UTR,intron,missense	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1410C>T::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-285C>T::,HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon96/97:c.12994G>A:p.Val4332Ile:PF00054 [Laminin G domain]	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295699 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs1138469	0.0503	0.0297,0.0387,0.0002,0.0598,0.0972	257,.	7136	144500	-2.5780	 , ,T(1.00)	 , ,B(0.00)	0.00	0.21		COSV60828274	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823627	21823627	C	T	het	wt	het		QUAL=5826;DP=151,208,317;AF=0.46,0.01,0.55;MQM=60;SAP=8;ABP=5;SAR=134;SAF=111	LDLRAD2,HSPG2	3'UTR,intron,missense	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1412C>T::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-283C>T::,HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon96/97:c.12992G>A:p.Ser4331Asn:PF00054 [Laminin G domain]	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295700 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs3736360	0.1529	0.0827,0.1310,0.1662,0.1760,0.2969	1950,.	19359	128821	0.0090	 , ,T(0.39)	 , ,B(0.00)	9.47	0.12		COSV60827612	0	20072119,18559102,33462484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823667	21823667	G	T	het	wt	het		QUAL=8041;DP=290,205,324;AF=0.48,0.01,0.55;MQM=60;SAP=4;ABP=5;SAR=166;SAF=156	LDLRAD2,HSPG2	3'UTR,intron,synonymous	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1452G>T::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-243G>T::,HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon96/97:c.12952C>A:p.Arg4318=:PF00054 [Laminin G domain]	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295701 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs3736358	0.1402	0.0372,0.1277,0.1671,0.1760,0.2968	1837,.	17638	130754	3.7350			10.61			COSV60828118,COSV60829904	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823764	21823764	C	T	het	hom	wt	off-target	QUAL=3653;DP=74,108,202;AF=0.51,0.99,0.00;MQM=60;SAP=116;ABP=3;SAR=116;SAF=29	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1549C>T::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-146C>T::,HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron95/96:c.12900-45G>A::	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1225015 [benign DISEASE=not provided];			rs3736357	0.3912	0.1402,0.4754,0.6449,0.4865,0.3326	13591,.	32255	92483	1.1280			8.82				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21828352	21828352	A	G	het	wt	hom		QUAL=1307;DP=43,37,32;AF=0.37,0.00,0.97;MQM=60;SAP=7;ABP=9;SAR=19;SAF=28	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon89/97:c.12312T>C:p.Asp4104=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295707 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2228347	0.2527	0.1363,0.2142,0.1660,0.3049,0.4810	5420,.	27565	113591	1.3570			5.83			COSV60827859	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21828494	21828494	G	A	het	wt	hom	off-target	QUAL=584;DP=18,14,15;AF=0.44,0.00,1.00;MQM=60;SAP=24;ABP=3;SAR=19;SAF=4	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron88/96:c.12238-68C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1267772 [benign DISEASE=not provided];			rs10917052	0.2417	0.1317,0.2027,0.1658,0.2883,0.4781	4924,.	26823	115075	-0.3470			1.34			COSV60827793	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21829230	21829230	T	C	hom	hom	hom	off-target	QUAL=2881;DP=41,17,33;AF=0.98,1.00,1.00;MQM=60;SAP=4;ABP=0;SAR=48;SAF=42	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron87/96:c.11993-151A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	439796 [benign DISEASE=not specified,not provided];		MIRb (SINE/MIR)	rs7518070	0.7724	0.7058,0.7474,0.8137,0.7986,0.8217	45520,.	26435	34619	-1.9710			0.32				0	27223085	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21829348	21829348	T	C	het	wt	het	off-target	QUAL=1232;DP=37,65,75;AF=0.54,0.00,0.52;MQM=60;SAP=106;ABP=4;SAR=3;SAF=56	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron87/96:c.11992+35A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	618168 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs12042189	0.1405	0.0369,0.1289,0.1663,0.1760,0.2955	1839,.	17699	130727	-0.9940			0.12			COSV60828432	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21829360	21829360	C	T	het	wt	het	off-target	QUAL=1401;DP=58,71,83;AF=0.36,0.00,0.54;MQM=60;SAP=129;ABP=4;SAR=2;SAF=64	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron87/96:c.11992+23G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	618169 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs12023794	0.1531	0.0842,0.1315,0.1705,0.1756,0.2873	1944,.	19395	128829	-1.2010			0.53			COSV60829275	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21831196	21831196	G	A	hom	hom	hom	off-target	QUAL=16192;DP=94,201,254;AF=1.00,1.00,1.00;MQM=60;SAP=24;ABP=0;SAR=238;SAF=311	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron84/96:c.11562+19C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1174648 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs3736355	0.7703	0.7009,0.7465,0.8119,0.7976,0.8139	45249,.	26569	34919	-2.8120			0.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21831627	21831627	G	T	het	wt	het	off-target	QUAL=2878;DP=81,101,142;AF=0.52,0.00,0.54;MQM=60;SAP=100;ABP=5;SAR=96;SAF=23	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron82/96:c.11352+25C>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1261831 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2270701	0.1466	0.0588,0.1299,0.1652,0.1756,0.3001	1894,.	18499	129759	-3.4990			0.00				0.1	21146954	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21831870	21831870	G	A	het	hom	wt	off-target	QUAL=68;DP=10,4,5;AF=0.20,1.00,0.00;MQM=60;SAP=16;ABP=11;SAR=6;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron81/96:c.11208-74C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1237413 [benign DISEASE=not provided];			rs4654771	0.3586	0.1017,0.3998,0.4414,0.4803,0.2749	11777,.	30882	97356	0.0080			0.91			COSV65932968	0.02	27223085	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833281	21833281	G	A	het	wt	het		QUAL=4176;DP=136,207,237;AF=0.43,0.00,0.50;MQM=60;SAP=105;ABP=5;SAR=43;SAF=134	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon80/97:c.11082C>T:p.Pro3694=:PF00054 [Laminin G domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295724 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229486	0.1006	0.1712,0.0680,0.0004,0.0805,0.1088	927,.	13452	136778	-3.3340			0.71				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833550	21833550	C	T	het	wt	het		QUAL=5290;DP=183,221,284;AF=0.43,0.00,0.49;MQM=60;SAP=170;ABP=8;SAR=173;SAF=44	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon79/97:c.10895G>A:p.Arg3632Gln:PF07679 [Immunoglobulin I-set domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295727 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229493	0.1008	0.1715,0.0678,0.0004,0.0805,0.1094	924,.	13460	136626	0.0570	T(0.54)	B(0.03)	11.56	0.05		COSV105928417	0.05	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833655	21833655	C	T	het	hom	wt	off-target	QUAL=5299;DP=102,131,183;AF=0.60,1.00,0.00;MQM=60;SAP=285;ABP=12;SAR=175;SAF=17	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron78/96:c.10831-41G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1223305 [benign DISEASE=not provided];			rs7547731	0.3909	0.1416,0.4746,0.6446,0.4862,0.3292	13557,.	32324	92632	-2.8300			0.11				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21835143	21835143	T	-	het	het	het	off-target	QUAL=162;DP=15,7,8;AF=0.40,0.29,0.50;MQM=60;SAP=29;ABP=6;SAR=12;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron76/96:c.10454-198del::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1227252 [benign DISEASE=not provided];		FAM (SINE/Alu)	rs11338283	0.1054	0.1748,0.0722,0.0006,0.0838,0.1129	906,.	13636	131186	-0.1600			0.58				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21835760	21835760	C	G	het	wt	het	off-target	QUAL=2653;DP=154,53,77;AF=0.50,0.00,0.49;MQM=51;SAP=244;ABP=3;SAR=114;SAF=1	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron75/96:c.10356-123G>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296079 [benign DISEASE=not provided];		AluSz (SINE/Alu)	rs71636991	0.1005	0.1707,0.0678,0.0004,0.0806,0.1094	920,.	13418	136604	-2.5810			0.14				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836660	21836660	A	C	het	hom	wt	off-target	QUAL=2039;DP=73,38,45;AF=0.58,1.00,0.00;MQM=60;SAP=177;ABP=7;SAR=0;SAF=80	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron75/96:c.10355+142T>G::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1245162 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs12567651	0.2907	0.0823,0.3405,0.3348,0.3902,0.2237	7722,.	28752	107820	0.0320			9.68				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836717	21836717	C	A	het	wt	het	off-target	QUAL=2161;DP=110,72,93;AF=0.58,0.00,0.40;MQM=60;SAP=222;ABP=3;SAR=0;SAF=101	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron75/96:c.10355+85G>T::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	810881 [benign DISEASE=not specified,not provided];			rs35423650	0.0405	0.0095,0.0342,0.0002,0.0586,0.1027	177,.	5809	146041	1.1510			4.66				0		1	49	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836897	21836897	G	A	het	wt	het		QUAL=5569;DP=180,226,353;AF=0.51,0.00,0.40;MQM=60;SAP=4;ABP=22;SAR=112;SAF=120	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon75/97:c.10260C>T:p.His3420=:PF07679 [Immunoglobulin I-set domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295741 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs35444472	0.1002	0.1701,0.0677,0.0006,0.0804,0.1094	920,.	13410	136914	2.2680			8.58			COSV65932770	0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836909	21836909	G	A	wt	wt	het		QUAL=5289;DP=180,223,347;AF=0.01,0.00,0.60;MQM=60;SAP=3;ABP=35;SAR=107;SAF=103	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon75/97:c.10248C>T:p.Ser3416=:PF07679 [Immunoglobulin I-set domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295743 [benign/likely benign DISEASE=Connective tissue disorder,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];	CS011537 [CLASS=DM? MUT=ALT PHEN="Dyssegmental dysplasia Silverman-Handmaker type" GENE=HSPG2];		rs41310390	0.0502	0.0298,0.0382,0.0002,0.0601,0.0924	257,.	7130	144516	-2.2060			3.36			COSV65933172	0.06		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21839408	21839408	A	G	het	wt	het		QUAL=2715;DP=82,39,87;AF=0.65,0.00,0.67;MQM=60;SAP=46;ABP=39;SAR=32;SAF=79	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon73/97:c.9852T>C:p.Ala3284=:PF07679 [Immunoglobulin I-set domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295750 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2291826	0.3351	0.5358,0.2361,0.1679,0.2594,0.3913	9706,.	31500	101022	-3.3420			1.09			COSV65933346	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21839703	21839703	C	T	het	wt	het	off-target	QUAL=2058;DP=78,58,69;AF=0.54,0.00,0.58;MQM=60;SAP=21;ABP=7;SAR=28;SAF=54	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron72/96:c.9709+119G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1266053 [benign DISEASE=not provided];			rs35570238	0.0979	0.1620,0.0663,0.0015,0.0803,0.1091	856,.	13165	137143	-0.5230			0.52				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841112	21841112	C	T	het	wt	het		QUAL=2082;DP=48,164,183;AF=0.46,0.00,0.42;MQM=60;SAP=94;ABP=15;SAR=17;SAF=81	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon71/97:c.9502G>A:p.Ala3168Thr:PF13927 [Immunoglobulin domain]	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295758 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2228349	0.0980	0.1624,0.0663,0.0004,0.0804,0.1094	859,.	13201	137253	0.9590	T(0.71)	B(0.01)	9.06	0.12			0.01	20072119,23049933	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841723	21841723	C	T	het	hom	wt	off-target	QUAL=6336;DP=79,181,231;AF=0.47,1.00,0.00;MQM=60;SAP=61;ABP=4;SAR=147;SAF=71	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron69/96:c.9194-50G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1231634 [benign DISEASE=not provided];			rs7556412	0.6158	0.5051,0.5927,0.8188,0.6564,0.6127	29274,.	34977	58347	-0.1040			1.72				0	21146954,23593148,31970092,30646882	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841783	21841783	G	T	het	wt	het	off-target	QUAL=3743;DP=139,115,148;AF=0.54,0.00,0.51;MQM=60;SAP=198;ABP=4;SAR=133;SAF=17	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron69/96:c.9194-110C>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1271902 [benign DISEASE=not provided];			rs34470509	0.0405	0.0095,0.0342,0.0002,0.0585,0.1034	177,.	5805	146015	-0.2560			4.34				0		2	52	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841817	21841817	A	G	het	wt	het	off-target	QUAL=4008;DP=181,97,132;AF=0.51,0.00,0.52;MQM=60;SAP=183;ABP=4;SAR=139;SAF=23	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron69/96:c.9194-144T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1226588 [benign DISEASE=not provided];			rs12043008	0.2621	0.3012,0.2020,0.1727,0.2500,0.3902	5270,.	29291	112119	-0.2220			1.59				0.06	30646882	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842308	21842308	T	C	het	wt	het		QUAL=1449;DP=62,76,87;AF=0.47,0.00,0.43;MQM=60;SAP=37;ABP=7;SAR=49;SAF=17	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon68/97:c.8983A>G:p.Ser2995Gly:PF13895 [Immunoglobulin domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295764 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229491	0.1025	0.1781,0.0682,0.0004,0.0804,0.1084	968,.	13664	136558	-0.1830	T(1.00)	B(0.00)	3.31	0.04			0.04	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842352	21842352	A	T	het	wt	het		QUAL=927;DP=42,44,56;AF=0.52,0.00,0.38;MQM=60;SAP=58;ABP=6;SAR=38;SAF=5	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon68/97:c.8939T>A:p.Leu2980His:PF13895 [Immunoglobulin domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295765 [benign DISEASE=Connective tissue disorder,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229489	0.0406	0.0095,0.0343,0.0002,0.0586,0.1034	177,.	5813	145935	3.3680	T(1.00)	B(0.00)	18.20	0.07			0.03	20452482,20072119	69	2444	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842489	21842489	T	C	het	wt	het	off-target	QUAL=628;DP=41,8,11;AF=0.51,0.00,0.64;MQM=60;SAP=3;ABP=4;SAR=14;SAF=14	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron67/96:c.8911-109A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296076 [benign DISEASE=not provided];			rs7528408	0.1001	0.1694,0.0665,0.0004,0.0805,0.1114	912,.	13394	136844	-0.1850			3.47				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842646	21842646	G	C	het	wt	het	off-target	QUAL=1605;DP=53,68,86;AF=0.36,0.00,0.58;MQM=60;SAP=120;ABP=3;SAR=4;SAF=65	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron67/96:c.8910+124C>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1256741 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs7536441	0.1000	0.1693,0.0659,0.0004,0.0806,0.1107	907,.	13387	136873	-0.1020			1.98				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842693	21842693	A	G	het	wt	het	off-target	QUAL=2885;DP=63,121,157;AF=0.51,0.00,0.59;MQM=60;SAP=239;ABP=11;SAR=4;SAF=120	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron67/96:c.8910+77T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1228779 [benign DISEASE=not provided];			rs75779078	0.0407	0.0098,0.0342,0.0002,0.0586,0.1053	179,.	5828	145792	-2.2780			0.11				0.01		3	49	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21844386	21844386	G	A	wt	wt	het	off-target	QUAL=2868;DP=82,180,236;AF=0.00,0.00,0.53;MQM=60;SAP=268;ABP=5;SAR=125;SAF=1	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron64/96:c.8465-87C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293477 [benign DISEASE=not provided];			rs75613822	0.0503	0.0306,0.0383,0.0002,0.0597,0.0915	253,.	7144	144540	0.5770			8.57				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21845965	21845965	T	C	hom	hom	hom	off-target	QUAL=2552;DP=12,37,42;AF=1.00,1.00,1.00;MQM=60;SAP=201;ABP=0;SAR=0;SAF=91	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron64/96:c.8464+143A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1245045 [benign DISEASE=not provided];			rs7355045	0.7754	0.7003,0.7095,0.8211,0.8145,0.8212	45976,.	25966	34152	-1.4080			0.84			COSV65970143	0.07	21146954,20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21846651	21846651	C	T	het	wt	het	off-target	QUAL=8159;DP=103,376,509;AF=0.52,0.00,0.54;MQM=60;SAP=220;ABP=12;SAR=257;SAF=75	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron62/96:c.8165-52G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1182109 [benign DISEASE=not provided];			rs34792235	0.0406	0.0095,0.0343,0.0002,0.0586,0.1050	180,.	5815	146015	-0.3120			1.46				0		50	1742	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847184	21847184	T	C	het	wt	het	off-target	QUAL=1033;DP=54,55,60;AF=0.43,0.00,0.47;MQM=60;SAP=114;ABP=6;SAR=0;SAF=51	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron62/96:c.8164+170A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296073 [benign DISEASE=not provided];		MER3 (DNA/hAT-Charlie)	rs12757119	0.0406	0.0095,0.0342,0.0002,0.0586,0.1051	180,.	5818	146016	-4.5280			0.06				0.02		4	37	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847243	21847243	C	T	het	wt	het	off-target	QUAL=2881;DP=134,101,125;AF=0.54,0.00,0.46;MQM=60;SAP=285;ABP=3;SAR=0;SAF=130	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron62/96:c.8164+111G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1250728 [benign DISEASE=not provided];			rs35921133	0.0407	0.0096,0.0344,0.0002,0.0587,0.1051	180,.	5826	146008	-0.5830			1.38				0		4	60	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847497	21847497	A	G	het	wt	het		QUAL=7221;DP=159,324,425;AF=0.54,0.00,0.49;MQM=60;SAP=37;ABP=3;SAR=181;SAF=113	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron61/96:c.8026-5T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295781 [benign DISEASE=Connective tissue disorder,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs35917892	0.0406	0.0095,0.0342,0.0002,0.0585,0.1049	179,.	5811	145957	-2.0680			0.39		4.39>3.72		0		73	2431	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847933	21847933	T	G	het	wt	hom	off-target	QUAL=11585;DP=181,310,323;AF=0.46,0.01,0.99;MQM=60;SAP=3;ABP=6;SAR=199;SAF=207	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron60/96:c.7873+25A>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1256801 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2290501	0.3695	0.5254,0.2676,0.1732,0.3115,0.4819	11153,.	33836	95784	-0.6650			5.02	0.03		COSV65971017	0	23593148,20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848025	21848025	G	T	het	wt	het		QUAL=7471;DP=271,358,363;AF=0.43,0.00,0.51;MQM=60;SAP=4;ABP=7;SAR=158;SAF=144	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon60/97:c.7806C>A:p.Val2602=:PF13927 [Immunoglobulin domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295785 [benign DISEASE=Connective tissue disorder,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs12737091	0.0405	0.0095,0.0342,0.0002,0.0585,0.1051	177,.	5812	146004	2.1420			13.41				0.98		71	2434	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848107	21848107	A	G	hom	hom	hom	off-target	QUAL=17523;DP=86,234,247;AF=1.00,1.00,1.00;MQM=60;SAP=163;ABP=0;SAR=385;SAF=181	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron59/96:c.7738-14T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295787 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs3767138	0.7773	0.7074,0.7094,0.8203,0.8144,0.8207	46175,.	25821	33859	0.2490			13.76		10.37>10.27	COSV65970146	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848603	21848603	T	C	het	wt	het	off-target	QUAL=1825;DP=58,56,86;AF=0.50,0.00,0.58;MQM=60;SAP=142;ABP=6;SAR=4;SAF=75	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron59/96:c.7737+40A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1236320 [benign DISEASE=not provided];			rs34726153	0.0408	0.0096,0.0344,0.0002,0.0591,0.1048	179,.	5848	145780	-1.0900			0.26				0		50	1755	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21849969	21849969	C	T	het	wt	het	off-target	QUAL=1969;DP=44,76,131;AF=0.48,0.00,0.52;MQM=60;SAP=163;ABP=3;SAR=4;SAF=85	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron57/96:c.7446+72G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296070 [benign DISEASE=not provided];		AluSg (SINE/Alu)	rs71636993	0.0406	0.0097,0.0343,0.0002,0.0585,0.1051	179,.	5817	146029	-2.0650			0.03				0		3	51	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21850276	21850276	C	T	het	wt	het	off-target	QUAL=2816;DP=35,155,200;AF=0.49,0.00,0.50;MQM=60;SAP=10;ABP=3;SAR=68;SAF=49	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron56/96:c.7295-84G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1222260 [benign DISEASE=not provided];			rs34719083	0.0406	0.0095,0.0342,0.0002,0.0586,0.1051	181,.	5812	146016	-1.4550			0.05				0		4	60	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21850626	21850626	A	G	het	hom	wt	off-target	QUAL=582;DP=9,19,29;AF=0.56,1.00,0.00;MQM=58;SAP=55;ABP=3;SAR=24;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron55/96:c.7159-128T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1267282 [benign DISEASE=not provided];			rs61777200	0.3650	0.1067,0.4078,0.4422,0.4839,0.2839	12161,.	31138	96482	-1.8450			0.12			COSV65968900	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21851385	21851385	A	G	het	wt	het	off-target	QUAL=1347;DP=76,60,64;AF=0.43,0.00,0.48;MQM=60;SAP=142;ABP=5;SAR=0;SAF=64	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron55/96:c.7158+161T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1247546 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs12750012	0.0406	0.0095,0.0343,0.0002,0.0585,0.1052	180,.	5814	146054	0.1220			6.09				0		3	43	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21851976	21851976	A	G	het	wt	het	off-target	QUAL=2489;DP=66,84,121;AF=0.61,0.02,0.53;MQM=60;SAP=7;ABP=8;SAR=46;SAF=60	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron53/96:c.6871-50T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1223987 [benign DISEASE=not provided];			rs34346159	0.0405	0.0095,0.0343,0.0002,0.0585,0.1051	180,.	5807	145959	0.4620			6.02				0.05		50	1748	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852498	21852498	C	T	het	wt	het	off-target	QUAL=2088;DP=71,62,78;AF=0.49,0.00,0.64;MQM=60;SAP=28;ABP=9;SAR=27;SAF=58	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron52/96:c.6724+202G>A::	regulatory_region_variant:enhancer,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296069 [benign DISEASE=not provided];			rs35337242	0.0406	0.0095,0.0343,0.0002,0.0586,0.1049	178,.	5814	145988	-1.6520			0.13				0		3	47	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852543	21852543	G	A	het	wt	het	off-target	QUAL=1500;DP=45,75,90;AF=0.38,0.00,0.56;MQM=60;SAP=75;ABP=3;SAR=10;SAF=57	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron52/96:c.6724+157C>T::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296067 [benign DISEASE=not provided];			rs35999331	0.0405	0.0095,0.0343,0.0004,0.0585,0.1051	177,.	5813	146057	0.1990			3.43				0.03		3	49	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852751	21852751	C	T	het	wt	het		QUAL=3486;DP=86,152,203;AF=0.43,0.00,0.51;MQM=60;SAP=20;ABP=3;SAR=87;SAF=54	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon52/97:c.6673G>A:p.Gly2225Ser:	regulatory_region_variant:enhancer,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295807 [benign DISEASE=Connective tissue disorder,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs35669711	0.0406	0.0096,0.0342,0.0002,0.0585,0.1052	176,.	5810	145722	0.0570	T(0.09)	B(0.07)	11.19	0.23			0.02		69	2431	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852958	21852958	C	T	het	wt	het		QUAL=5793;DP=76,272,434;AF=0.49,0.00,0.46;MQM=60;SAP=69;ABP=9;SAR=76;SAF=161	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon51/97:c.6552G>A:p.Thr2184=:PF13927 [Immunoglobulin domain]	regulatory_region_variant:enhancer,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295810 [benign DISEASE=Connective tissue disorder,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs34443576	0.0406	0.0097,0.0343,0.0002,0.0585,0.1046	179,.	5815	145957	-8.1810			1.04			COSV65974636	0.02		68	2428	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21853180	21853180	T	C	het	hom	wt	off-target	QUAL=4740;DP=54,146,193;AF=0.57,0.99,0.00;MQM=60;SAP=385;ABP=6;SAR=176;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron50/96:c.6440-110A>G::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1237465 [benign DISEASE=not provided];			rs12049614	0.3991	0.1488,0.4436,0.6387,0.5032,0.3340	14042,.	32565	91325	-0.3830			2.47			COSV65970151	0.07		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21854055	21854055	T	C	hom	hom	hom	off-target	QUAL=4025;DP=83,20,32;AF=1.00,1.00,1.00;MQM=60;SAP=296;ABP=0;SAR=0;SAF=135	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron50/96:c.6439+138A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293473 [benign DISEASE=not provided];			rs12117402	0.7291	0.6146,0.6724,0.6279,0.7951,0.7612	40950,.	28868	41150	-0.1030			3.79				0	27223085	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21854230	21854230	C	T	het	wt	het		QUAL=3095;DP=83,143,196;AF=0.47,0.00,0.51;MQM=60;SAP=35;ABP=3;SAR=47;SAF=92	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon50/97:c.6402G>A:p.Val2134=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	285614 [benign DISEASE=Connective tissue disorder,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs12742444	0.0404	0.0095,0.0341,0.0002,0.0583,0.1044	177,.	5788	146030	0.0570			2.62				0		69	2421	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21854829	21854829	A	G	het	wt	het	off-target	QUAL=1210;DP=44,63,74;AF=0.55,0.00,0.43;MQM=60;SAP=108;ABP=4;SAR=54;SAF=2	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron48/96:c.6133+19T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1242960 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs36080251	0.0407	0.0096,0.0343,0.0002,0.0587,0.1054	180,.	5821	145881	-1.1260			0.01				0		49	1747	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21855402	21855402	C	T	het	wt	het		QUAL=5591;DP=149,257,311;AF=0.48,0.00,0.53;MQM=60;SAP=116;ABP=4;SAR=63;SAF=174	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon47/97:c.5899G>A:p.Val1967Ile:PF07679 [Immunoglobulin I-set domain]	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295823 [benign DISEASE=Connective tissue disorder,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229475	0.0404	0.0095,0.0342,0.0002,0.0584,0.1040	178,.	5794	146024	1.9340	T(0.17)	D(1.00)	22.50	0.24			0.01	20072119	69	2424	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21856978	21856978	A	C	hom	hom	hom	off-target	QUAL=1037;DP=18,7,13;AF=1.00,1.00,1.00;MQM=60;SAP=77;ABP=0;SAR=1;SAF=37	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron44/96:c.5575+37T>G::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293461 [benign DISEASE=not provided];			rs12024579	0.7619	0.6660,0.7045,0.8185,0.8081,0.8039	44462,.	26810	36176	-0.9590			1.67				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21856983	21856983	A	G	het	wt	het	off-target	QUAL=103;DP=19,8,13;AF=0.16,0.00,0.54;MQM=60;SAP=25;ABP=13;SAR=0;SAF=10	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron44/96:c.5575+32T>C::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1285244 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs200354565	0.0502	0.0410,0.0391,0.0002,0.0597,0.1056	206,.	7228	144458	-3.0650			0.03				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21856984	21856984	G	T	het	wt	het	off-target	QUAL=103;DP=19,8,13;AF=0.16,0.00,0.54;MQM=60;SAP=25;ABP=13;SAR=0;SAF=10	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron44/96:c.5575+31C>A::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1285245 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs12757277	0.0502	0.0410,0.0391,0.0002,0.0597,0.1059	206,.	7229	144499	-2.1160			0.03				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21857246	21857246	A	G	hom	hom	het	off-target	QUAL=7807;DP=95,119,114;AF=1.00,1.00,0.48;MQM=60;SAP=67;ABP=3;SAR=90;SAF=179	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron43/96:c.5394+39T>C::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1220862 [benign DISEASE=not provided];			rs2305562	0.5001	0.4278,0.4799,0.4593,0.5481,0.3743	19217,.	37482	75896	1.6720			9.86			COSV65970004	0.01	21146954,20072119,27223085	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21859741	21859741	A	G	hom	hom	hom	off-target	QUAL=18212;DP=94,232,277;AF=1.00,1.00,1.00;MQM=60;SAP=600;ABP=0;SAR=505;SAF=98	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron41/96:c.5183-65T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293460 [benign DISEASE=not provided];			rs10917056	0.9415	0.8121,0.9766,0.9549,0.9980,0.9932	67917,.	7413	8905	-0.1920			2.36				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21862269	21862269	C	T	wt	wt	het	off-target	QUAL=840;DP=133,51,69;AF=0.00,0.00,0.54;MQM=60;SAP=83;ABP=4;SAR=37;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron37/96:c.4741-154G>A::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1239399 [benign DISEASE=not provided];		L1ME3G (LINE/L1)	rs74229164	0.1740	0.0714,0.1659,0.1171,0.2192,0.3241	2692,.	21077	125599	-1.9940			0.04				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21864333	21864333	-	C	wt	wt	het	off-target	QUAL=901;DP=59,74,80;AF=0.02,0.00,0.55;MQM=60;SAP=101;ABP=5;SAR=45;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron36/96:c.4627-121dup::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1231660 [benign DISEASE=not provided];			rs3217649	0.1785	0.0985,0.1651,0.1040,0.2154,0.3244	2697,.	21727	124793				0.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21864961	21864961	G	A	het	hom	wt		QUAL=7140;DP=119,208,347;AF=0.39,1.00,0.00;MQM=60;SAP=4;ABP=14;SAR=122;SAF=132	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon36/97:c.4508C>T:p.Ala1503Val:PF00052 [Laminin B (Domain IV)]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	291236 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs897471	0.7042	0.6130,0.7714,0.8863,0.7319,0.5675	38063,.	30958	44974	4.3150	T(0.06)	D(1.00)	22.80	0.15		COSV65969427	0.01	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21872462	21872462	G	A	wt	wt	het	off-target	QUAL=1649;DP=84,104,135;AF=0.00,0.00,0.52;MQM=60;SAP=130;ABP=3;SAR=67;SAF=3	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron32/96:c.4030-85C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1222152 [benign DISEASE=not provided];			rs2290497	0.0567	0.0404,0.0444,0.0258,0.0634,0.1240	267,.	8087	143505	0.1500			2.87				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21872588	21872588	A	T	hom	hom	hom	off-target	QUAL=5905;DP=52,80,80;AF=0.98,1.00,1.00;MQM=60;SAP=3;ABP=0;SAR=106;SAF=105	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron32/96:c.4029+32T>A::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1233017 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2501266	0.9830	0.9413,0.9941,0.9998,0.9995,0.9996	73569,.	2443	2593	-2.1080			0.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21872752	21872752	C	T	het	hom	wt		QUAL=3063;DP=44,79,76;AF=0.64,1.00,0.01;MQM=60;SAP=21;ABP=10;SAR=69;SAF=39	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon32/97:c.3897G>A:p.Val1299=:PF00053 [Laminin EGF domain]	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	285755 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs2229482	0.5075	0.2824,0.4559,0.4261,0.6280,0.5015	21449,.	34134	74768	0.2560			7.98			COSV65968754	0.04	28552196	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873328	21873328	G	A	het	hom	wt	off-target	QUAL=1489;DP=44,32,39;AF=0.48,1.00,0.00;MQM=60;SAP=6;ABP=3;SAR=31;SAF=22	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron30/96:c.3793+47C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1235752 [benign DISEASE=not provided];			rs2454290	0.7521	0.4861,0.8495,0.9742,0.8522,0.7340	45165,.	24004	37690	0.0950			1.96				0	21146954	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873489	21873489	G	A	het	wt	het	off-target	QUAL=285;DP=18,7,14;AF=0.50,0.00,0.36;MQM=60;SAP=19;ABP=4;SAR=12;SAF=2	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron29/96:c.3744-65C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	810883 [benign/likely benign DISEASE=not specified,not provided];			rs34855688	0.0355	0.0083,0.0313,0.0002,0.0502,0.1014	153,.	5101	146787	0.5720			4.88				0		40	1503	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873574	21873574	A	G	hom	hom	het	off-target	QUAL=584;DP=17,3,5;AF=1.00,1.00,0.40;MQM=59;SAP=42;ABP=3;SAR=21;SAF=1	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron29/96:c.3744-150T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1252344 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs2247741	0.5086	0.2255,0.4597,0.2059,0.6771,0.5466	22905,.	31514	74720	0.0600			6.33			COSV65975718	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873589	21873589	T	C	hom	n/a	hom	off-target	QUAL=446;DP=9,2,5;AF=1.00,1.00,1.00;MQM=60;SAP=30;ABP=0;SAR=15;SAF=1	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron29/96:c.3744-165A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1248137 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs2445136	0.9801	0.9317,0.9935,1.0000,0.9993,0.9981	73176,.	2809	3023	-1.7210			0.38				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21874342	21874342	C	G	hom	hom	hom	off-target	QUAL=10481;DP=58,108,171;AF=1.00,1.00,1.00;MQM=60;SAP=323;ABP=0;SAR=57;SAF=280	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron28/96:c.3656+64G>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293451 [benign DISEASE=not provided];			rs2445135	0.9823	0.9389,0.9937,1.0000,0.9995,0.9998	73476,.	2537	2701	-0.8630			0.79				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21875616	21875616	C	T	hom	hom	hom	off-target	QUAL=26105;DP=196,282,399;AF=0.98,1.00,1.00;MQM=60;SAP=461;ABP=0;SAR=222;SAF=651	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron25/96:c.3302+13G>A::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295864 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];		MIRb (SINE/MIR)	rs2501265	0.9493	0.8247,0.9807,1.0000,0.9989,0.9992	69043,.	6415	7713	-6.5350			0.00				0.14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21876766	21876766	A	G	wt	het	wt	off-target	QUAL=1698;DP=139,116,120;AF=0.00,0.60,0.00;MQM=60;SAP=155;ABP=14;SAR=70;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron21/96:c.2686-114T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1270927 [benign DISEASE=not provided];			rs2454295	0.5440	0.3318,0.4902,0.3689,0.6665,0.5818	24388,.	33937	69327	0.2950			5.20			COSV65972143	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21878013	21878013	C	T	het	het	het	off-target	QUAL=2051;DP=46,71,60;AF=0.52,0.44,0.55;MQM=60;SAP=194;ABP=3;SAR=0;SAF=88	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron21/96:c.2685+173G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1260883 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs747546	0.1448	0.2580,0.1250,0.0410,0.0960,0.1326	2018,.	17997	130115	-1.3340			0.25				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21878915	21878915	T	C	hom	hom	hom	off-target	QUAL=5300;DP=77,44,45;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0;SAR=81;SAF=85	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron18/96:c.2471+79A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293450 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs2454294	0.9775	0.9217,0.9929,1.0000,0.9995,0.9998	72820,.	3155	3427	-1.3790			1.30				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21878973	21878973	T	C	hom	hom	hom	off-target;low_conf_region	QUAL=3619;DP=35,49,36;AF=0.97,1.00,1.00;MQM=60;SAP=28;ABP=0;SAR=41;SAF=78	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron18/96:c.2471+21A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1263480 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2454293	0.9653	0.8799,0.9884,0.9985,0.9992,0.9990	71099,.	4693	5279	-0.5580			2.13			COSV65975893	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21879262	21879262	C	A	het	het	het	off-target	QUAL=602;DP=29,19,17;AF=0.45,0.68,0.35;MQM=60;SAP=72;ABP=3;SAR=32;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron17/96:c.2344-141G>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1180925 [benign DISEASE=not provided];		L3 (LINE/CR1)	rs55728940	0.0640	0.0462,0.0807,0.0404,0.0640,0.1214	343,.	9044	142370	0.8450			4.47				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880156	21880156	T	C	hom	hom	hom		QUAL=22020;DP=193,236,255;AF=1.00,1.00,1.00;MQM=60;SAP=41;ABP=0;SAR=287;SAF=397	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon17/97:c.2294A>G:p.Asn765Ser:PF00053 [Laminin EGF domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295881 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs989994	0.9402	0.7920,0.9783,0.9996,0.9993,0.9994	67938,.	7274	9102	0.8000	T(0.19)	B(0.02)	15.51	0.14			0.01	26648445,20072119,22257501	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880449	21880449	G	A	hom	hom	hom		QUAL=7816;DP=118,61,73;AF=1.00,1.00,1.00;MQM=60;SAP=115;ABP=0;SAR=183;SAF=69	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon16/97:c.2109C>T:p.Ala703=:PF00052 [Laminin B (Domain IV)]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295882 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs1874793	0.9403	0.7922,0.9783,0.9994,0.9993,0.9994	67904,.	7258	9086	1.5060			10.77			COSV65974984	0	34946941	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880572	21880572	G	A	het	wt	het	off-target	QUAL=807;DP=36,41,52;AF=0.33,0.00,0.48;MQM=60;SAP=8;ABP=8;SAR=14;SAF=23	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron15/96:c.1999-13C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295886 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs77828146	0.0113	0.0027,0.0069,0.0000,0.0160,0.0223	20,.	1675	150525	-1.8390			0.42		5.42>5.43		0.01		9	612	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880742	21880742	T	C	hom	hom	hom		QUAL=10972;DP=156,73,131;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0;SAR=151;SAF=209	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon15/97:c.1912A>G:p.Met638Val:PF00052 [Laminin B (Domain IV)]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295887 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs1874792	0.9777	0.9226,0.9929,0.9998,0.9994,0.9996	72826,.	3131	3395	1.1480	T(1.00)	B(0.00)	7.39	0.07			0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21881312	21881324	CCCAGGGTGGCAG	-	hom	hom	hom	off-target	QUAL=6197;DP=46,70,113;AF=1.00,1.00,1.00;MQM=60;SAP=151;ABP=0;SAR=52;SAF=177	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron14/96:c.1818+15_1818+27del::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1267614 [benign DISEASE=not provided];			rs60267433	0.9654	0.8796,0.9887,1.0000,0.9994,0.9994	71087,.	4667	5259	1.2990			4.37				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21881537	21881537	C	T	het	hom	het	off-target	QUAL=4582;DP=69,93,122;AF=0.45,1.00,0.43;MQM=60;SAP=225;ABP=10;SAR=155;SAF=21	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron13/96:c.1655-35G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	439797 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs921847	0.9316	0.7987,0.9717,1.0000,0.9833,0.9764	66533,.	8674	10408	-0.3390			1.18				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21884729	21884729	T	C	het	het	het	off-target	QUAL=6842;DP=81,244,301;AF=0.54,0.43,0.48;MQM=60;SAP=65;ABP=10;SAR=100;SAF=191	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron12/96:c.1507+38A>G::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1248089 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs4654994	0.9056	0.8520,0.9091,0.9602,0.9330,0.9001	62475,.	12818	14358	-1.0400			1.28				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21885632	21885632	C	A	het	het	het	off-target	QUAL=2024;DP=40,68,61;AF=0.63,0.57,0.48;MQM=60;SAP=205;ABP=7;SAR=93;SAF=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron9/96:c.1079-181G>T::	regulatory_region_variant:open_chromatin_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1238974 [benign DISEASE=not provided];			rs28653609	0.1383	0.2328,0.1216,0.0404,0.0980,0.1108	1766,.	17497	130985	-0.6070			0.39				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21887634	21887634	A	G	hom	het	hom		QUAL=12537;DP=116,181,213;AF=1.00,0.50,1.00;MQM=60;SAP=229;ABP=3;SAR=314;SAF=105	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon8/97:c.744T>C:p.Leu248=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295909 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229478	0.4490	0.6379,0.5095,0.6316,0.3364,0.3996	16869,.	34419	83635	-1.8380			0.99	0.16		COSV65929973	0.12	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21890615	21890615	G	A	hom	hom	hom		QUAL=26146;DP=229,276,333;AF=1.00,1.00,1.00;MQM=60;SAP=262;ABP=0;SAR=577;SAF=261	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon4/97:c.324C>T:p.Phe108=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295913 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2501260	0.9566	0.8493,0.9832,1.0000,0.9994,0.9998	69966,.	5594	6608	2.0910			13.31				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22452666	22452666	T	C	hom	hom	hom		QUAL=28795;DP=266,256,395;AF=1.00,1.00,1.00;MQM=60;SAP=596;ABP=0;SAR=208;SAF=708	ZBTB40	intron,5'UTR	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron1/17:c.-70+662T>C::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron1/15:c.-70+662T>C::,ZBTB40:ENST00000404138.5:5_prime_UTR_variant:MODIFIER:exon2/19:c.-350T>C::	regulatory_region_variant:promoter				MER58B (DNA/hAT-Charlie)	rs10737466	0.9776	0.9228,0.9914,1.0000,0.9995,0.9998	72832,.	3131	3405	-1.5700			1.63				0.05		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22489769	22489769	T	C	hom	het	hom	off-target	QUAL=11365;DP=158,115,173;AF=1.00,0.45,1.00;MQM=60;SAP=800;ABP=5;SAR=4;SAF=379	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron1/17:c.-69-111T>C::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron1/15:c.-69-111T>C::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron2/18:c.-69-111T>C::	regulatory_region_variant:enhancer					rs1267005	0.7218	0.8907,0.7852,0.8965,0.6153,0.7003	40863,.	27985	42291	0.8330			9.46			COSV65144913	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22491224	22491224	A	G	hom	het	hom	off-target	QUAL=2366;DP=67,4,8;AF=1.00,0.75,1.00;MQM=60;SAP=172;ABP=5;SAR=0;SAF=78	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron2/17:c.698-176A>G::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron2/15:c.698-176A>G::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron3/18:c.698-176A>G::	regulatory_region_variant:enhancer					rs12566074	0.2564	0.0705,0.2137,0.3189,0.3462,0.3769	6339,.	26310	113098	-1.7510			0.08			COSV65144915	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22506250	22506250	A	T	hom	het	hom		QUAL=15643;DP=214,167,209;AF=1.00,0.56,0.99;MQM=60;SAP=486;ABP=8;SAR=426;SAF=88	ZBTB40	splice_region&intron	ZBTB40:ENST00000375647.5:splice_region_variant&intron_variant:LOW:intron6/17:c.1360+9A>T::,ZBTB40:ENST00000374651.8:splice_region_variant&intron_variant:LOW:intron4/15:c.1024+9A>T::,ZBTB40:ENST00000404138.5:splice_region_variant&intron_variant:LOW:intron7/18:c.1360+9A>T::						rs209732	0.7216	0.8911,0.7851,0.8983,0.6148,0.6998	40836,.	27996	42308	0.9000			10.34			COSV65144922	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22509184	22509184	A	G	hom	het	hom		QUAL=24905;DP=339,273,308;AF=1.00,0.53,1.00;MQM=60;SAP=4;ABP=5;SAR=405;SAF=387	ZBTB40	missense	ZBTB40:ENST00000375647.5:missense_variant:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys:,ZBTB40:ENST00000374651.8:missense_variant:MODERATE:exon7/16:c.1448A>G:p.Tyr483Cys:,ZBTB40:ENST00000404138.5:missense_variant:MODERATE:exon10/19:c.1784A>G:p.Tyr595Cys:			1260804 [benign DISEASE=not provided];			rs209729	0.7878	0.9072,0.8372,0.8977,0.7149,0.7058	47731,.	24208	32240	0.2260	D(0.03),T(0.10),D(0.03)	B(0.00),B(0.00),B(0.00)	10.71	0.02		COSV65144925	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22511094	22511094	T	-	het	het	het	off-target	QUAL=2613;DP=98,31,33;AF=0.57,0.45,0.61;MQM=60;SAP=198;ABP=7;SAR=0;SAF=90	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron9/17:c.1834-69del::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron7/15:c.1498-69del::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron10/18:c.1834-69del::					(T)n (Simple_repeat)	rs34404742	0.2999	0.1100,0.2739,0.4836,0.3768,0.4190	6534,.	27969	95813	-0.0480			6.16				0.17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22511094	22511095	TT	-	het	wt	het	off-target	QUAL=2613;DP=98,31,33;AF=0.23,0.10,0.15;MQM=59;SAP=70;ABP=137;SAR=0;SAF=31	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron9/17:c.1834-70_1834-69del::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron7/15:c.1498-70_1498-69del::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron10/18:c.1834-70_1834-69del::					(T)n (Simple_repeat)	rs34404742	0.0015	0.0006,0.0010,0.0027,0.0014,0.0002	0,.	204	136732	-0.0480			6.07				0.29		1	42	0 / 0					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22511451	22511451	T	C	hom	het	hom	off-target	QUAL=5377;DP=90,42,72;AF=0.99,0.50,1.00;MQM=60;SAP=279;ABP=3;SAR=167;SAF=15	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron10/17:c.2002+104T>C::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron8/15:c.1666+104T>C::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron11/18:c.2002+104T>C::						rs2073168	0.3229	0.1934,0.2718,0.4596,0.3851,0.4171	8747,.	31577	102895	-0.7320			0.39			COSV65144929	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22520216	22520216	G	A	hom	hom	hom		QUAL=12185;DP=169,93,135;AF=1.00,1.00,1.00;MQM=60;SAP=109;ABP=0;SAR=268;SAF=129	ZBTB40	missense	ZBTB40:ENST00000375647.5:missense_variant:MODERATE:exon14/18:c.2989G>A:p.Val997Met:PF00096 [Zinc finger C2H2 type],ZBTB40:ENST00000374651.8:missense_variant:MODERATE:exon12/16:c.2653G>A:p.Val885Met:PF00096 [Zinc finger C2H2 type],ZBTB40:ENST00000404138.5:missense_variant:MODERATE:exon15/19:c.2989G>A:p.Val997Met:PF00096 [Zinc finger C2H2 type]						rs209720	0.9969	0.9989,0.9973,1.0000,0.9946,0.9996	75621,.	478	480	1.8680	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	16.30	0.17			0	18840274	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22521304	22521304	G	A	hom	het	hom	off-target	QUAL=3730;DP=120,31,17;AF=1.00,0.35,1.00;MQM=60;SAP=324;ABP=9;SAR=0;SAF=148	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron14/17:c.3049-192G>A::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron12/15:c.2713-192G>A::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron15/18:c.3049-192G>A::					MIRb (SINE/MIR)	rs12754103	0.2857	0.0912,0.2549,0.4577,0.3707,0.4140	7645,.	28148	108602	-0.9840			0.10			COSV65144938	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22522510	22522510	A	C	hom	het	hom	off-target	QUAL=15091;DP=171,196,254;AF=0.99,0.48,0.99;MQM=60;SAP=341;ABP=4;SAR=399;SAF=116	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron16/17:c.3298+47A>C::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron14/15:c.2962+47A>C::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron17/18:c.3298+47A>C::					MIR (SINE/MIR)	rs998978	0.3068	0.1603,0.2644,0.4576,0.3727,0.4150	8092,.	30420	105318	-6.2610			0.01			COSV65144854	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22526222	22526222	G	C	hom	het	hom		QUAL=10743;DP=165,108,140;AF=0.99,0.46,0.99;MQM=60;SAP=169;ABP=4;SAR=94;SAF=258	ZBTB40	synonymous	ZBTB40:ENST00000375647.5:synonymous_variant:LOW:exon18/18:c.3546G>C:p.Pro1182=:,ZBTB40:ENST00000374651.8:synonymous_variant:LOW:exon16/16:c.3210G>C:p.Pro1070=:,ZBTB40:ENST00000404138.5:synonymous_variant:LOW:exon19/19:c.3546G>C:p.Pro1182=:						rs881646	0.3064	0.1601,0.2645,0.4571,0.3723,0.4147	8078,.	30406	105412	-1.1450			0.27			COSV65144952	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22526648	22526648	G	A	hom	het	hom		QUAL=17240;DP=138,234,316;AF=1.00,0.50,1.00;MQM=60;SAP=18;ABP=3;SAR=316;SAF=254	ZBTB40	3'UTR	ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*252G>A::,ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*252G>A::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*252G>A::						rs2281354	0.2564	0.0697,0.2162,0.3192,0.3455,0.3758	6335,.	26300	113046	0.1690			1.44			COSV65144954	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22528701	22528701	-	T	het	het	het		QUAL=985;DP=34,32,39;AF=0.44,0.25,0.56;MQM=60;SAP=84;ABP=8;SAR=2;SAF=43	ZBTB40	3'UTR	ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2320dup::,ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2320dup::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2320dup::					AluJo (SINE/Alu)	rs35637563	0.3478	0.3058,0.2776,0.4460,0.3749,0.4116	8815,.	31844	92758				0.68				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22528701	22528701	-	TT	wt	wt	het		QUAL=985;DP=34,32,39;AF=0.06,0.00,0.18;MQM=59;SAP=23;ABP=93;SAR=0;SAF=9	ZBTB40	3'UTR	ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2319_*2320dup::,ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2319_*2320dup::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2319_*2320dup::					AluJo (SINE/Alu)	rs35637563	0.0016	0.0030,0.0018,0.0010,0.0011,0.0022	1,.	231	142133				0.65				0.01		0	17	0 / 0					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22530108	22530108	T	C	hom	het	hom		QUAL=18911;DP=222,216,281;AF=0.99,0.49,1.00;MQM=60;SAP=81;ABP=3;SAR=229;SAF=377	ZBTB40	3'UTR	ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3712T>C::,ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*3712T>C::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*3712T>C::	regulatory_region_variant:enhancer					rs1062663	0.3161	0.1883,0.2670,0.4574,0.3751,0.4162	8345,.	31180	103572	-2.4240			0.05			COSV65144958	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22638945	22638945	A	G	het	n/a	het		QUAL=333;DP=14,2,5;AF=0.64,1.00,0.60;MQM=60;SAP=13;ABP=6;SAR=11;SAF=3	C1QA	5'UTR,3'UTR,synonymous	C1QA:ENST00000695738.1:5_prime_UTR_variant:MODIFIER:exon2/2:c.-100A>G::,C1QA:ENST00000695739.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*270A>G::,C1QA:ENST00000695740.1:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000695741.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*563A>G::,C1QA:ENST00000695742.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*490A>G::,C1QA:ENST00000695743.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*820A>G::,C1QA:ENST00000695744.1:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000695745.1:5_prime_UTR_variant:MODIFIER:exon2/2:c.-100A>G::,C1QA:ENST00000695746.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*270A>G::,C1QA:ENST00000374642.8:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000402322.2:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000438241.2:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)]		120550_[GENE=C1QA_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]&120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1167796 [benign DISEASE=C1Q deficiency,not specified,not provided];			rs172378	0.5118	0.7324,0.5318,0.5899,0.3850,0.6068	21690,.	34402	74194	-0.7330			4.63	0.06		COSV65889459	0	25294155,19440201,19493541,20528885,25817358,20003265,20332777,21060334,25326229,26085599,26798662,29795138,31019999,26683148,22897949,25637052,32556499,22236909,33058021,29230368,35024943	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55), C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22639734	22639734	T	G	het	het	het	off-target	QUAL=7779;DP=141,222,257;AF=0.52,0.54,0.47;MQM=60;SAP=188;ABP=4;SAR=240;SAF=76	C1QA,C1QC	downstream_gene,upstream_gene	C1QA:ENST00000695738.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695739.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695740.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695741.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695742.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695743.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695744.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695745.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695746.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000374642.8:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000402322.2:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000438241.2:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000695749.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695750.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695751.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695752.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695753.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374640.9:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374639.7:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374637.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	120550_[GENE=C1QA_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]&120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]			AluSq2 (SINE/Alu)	rs10917274	0.3576	0.4266,0.4347,0.4496,0.2990,0.4546	10137,.	34034	97564	-2.9250			1.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55), C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22647804	22647804	C	A	wt	het	wt		QUAL=578;DP=125,66,94;AF=0.02,0.50,0.00;MQM=60;SAP=79;ABP=3;SAR=35;SAF=0	C1QC	3'UTR	C1QC:ENST00000695749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000695750.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*731C>A::,C1QC:ENST00000695751.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000695752.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*430C>A::,C1QC:ENST00000695753.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*21C>A::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000374637.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1221376 [benign DISEASE=not provided];			rs9434	0.5046	0.7983,0.4797,0.5734,0.3682,0.4266	22004,.	32351	74967	0.4160			3.88			COSV65889466	0.01	19440201,19493541,19503741,19753309,31019999	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22647887	22647903	CCACCAGATGGACTTCT	-	wt	het	wt		QUAL=68;DP=24,18,16;AF=0.00,0.50,0.00;MQM=60;SAP=23;ABP=3;SAR=9;SAF=0	C1QC	3'UTR	C1QC:ENST00000695749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:ENST00000695750.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*816_*832del::,C1QC:ENST00000695751.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:ENST00000695752.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*515_*531del::,C1QC:ENST00000695753.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*106_*122del::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]			L2d2 (LINE/L2)	rs60255495	0.3447	0.4063,0.3659,0.3314,0.3215,0.3236	9073,.	32936	97108	2.1680			6.21				0	20147302	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648041	22648041	T	-	het	wt	het		QUAL=1407;DP=48,39,71;AF=0.40,0.21,0.46;MQM=60;SAP=93;ABP=23;SAR=5;SAF=55	C1QC	3'UTR	C1QC:ENST00000695749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:ENST00000695750.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*983del::,C1QC:ENST00000695751.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:ENST00000695752.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*682del::,C1QC:ENST00000695753.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*273del::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]			L2d2 (LINE/L2)	rs10601144	0.0928	0.0901,0.0618,0.0794,0.0944,0.1999	591,.	11698	125920	0.1970			0.35				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648041	22648042	TT	-	wt	het	wt		QUAL=1407;DP=48,39,71;AF=0.13,0.26,0.10;MQM=60;SAP=45;ABP=175;SAR=1;SAF=22	C1QC	3'UTR	C1QC:ENST00000695749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:ENST00000695750.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*982_*983del::,C1QC:ENST00000695751.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:ENST00000695752.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*681_*682del::,C1QC:ENST00000695753.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*272_*273del::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1257095 [benign DISEASE=not provided];		L2d2 (LINE/L2)	rs10601144	0.5121	0.7931,0.4881,0.5841,0.3805,0.4339	20079,.	30895	67693	0.1970			0.35				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648073	22648073	T	G	het	wt	wt		QUAL=58;DP=46,46,61;AF=0.35,0.04,0.07;MQM=58;SAP=51;ABP=12;SAR=0;SAF=22	C1QC	3'UTR	C1QC:ENST00000695749.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:ENST00000695750.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1000T>G::,C1QC:ENST00000695751.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:ENST00000695752.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*699T>G::,C1QC:ENST00000695753.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*290T>G::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]				rs1003478565	0.0029	0.0031,0.0054,0.0026,0.0024,0.0027	0,.	383	131945	-0.6130			5.99				0		0	14	0 / 0					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648301	22648301	C	A	wt	het	wt	off-target	QUAL=97;DP=43,19,20;AF=0.00,0.37,0.00;MQM=60;SAP=18;ABP=6;SAR=7;SAF=0	C1QC,C1QB	downstream_gene,upstream_gene	C1QC:ENST00000695749.1:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000695750.1:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000695751.1:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000695752.1:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000695753.1:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000374640.9:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000374639.7:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000374637.1:downstream_gene_variant:MODIFIER::::,C1QB:ENST00000695754.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695755.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695756.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695757.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695758.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695759.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695760.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695761.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695762.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000509305.6:upstream_gene_variant:MODIFIER::::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]&120570_[GENE=C1QB_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]				rs294180	0.5078	0.7997,0.4809,0.5781,0.3724,0.4283	22262,.	32489	74663	-1.0350			0.07					20528885	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42), C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22653162	22653162	T	G	het	het	het	off-target	QUAL=528;DP=26,22,16;AF=0.62,0.41,0.31;MQM=60;SAP=68;ABP=4;SAR=0;SAF=30	C1QB	upstream_gene	C1QB:ENST00000695754.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695755.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695756.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695757.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695758.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695759.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695760.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695761.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695762.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000509305.6:upstream_gene_variant:MODIFIER::::		120570_[GENE=C1QB_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]				rs291990	0.5835	0.8406,0.5359,0.6479,0.4627,0.6103	27958,.	32717	63271	-1.0180			4.53			COSV59246057			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22653406	22653406	T	C	het	het	het	off-target	QUAL=825;DP=46,17,21;AF=0.41,0.59,0.48;MQM=60;SAP=88;ABP=4;SAR=39;SAF=0	C1QB	intron,5'UTR	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-24+38T>C::,C1QB:ENST00000695755.1:5_prime_UTR_variant:MODIFIER:exon1/3:c.-88T>C::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron1/3:c.-177+38T>C::,C1QB:ENST00000695757.1:5_prime_UTR_variant:MODIFIER:exon1/3:c.-44T>C::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::	regulatory_region_variant:promoter	120570_[GENE=C1QB_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]			MER5A (DNA/hAT-Charlie)	rs291989	0.5835	0.8406,0.5359,0.6490,0.4625,0.6100	27986,.	32724	63324	-0.6110			6.67				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22653494	22653494	C	A	het	het	het	off-target	QUAL=397;DP=23,6,16;AF=0.48,0.33,0.50;MQM=60;SAP=49;ABP=3;SAR=21;SAF=0	C1QB	intron	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-24+126C>A::,C1QB:ENST00000695755.1:intron_variant:MODIFIER:intron1/2:c.-24+24C>A::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron1/3:c.-177+126C>A::,C1QB:ENST00000695757.1:intron_variant:MODIFIER:intron1/2:c.-24+68C>A::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::	regulatory_region_variant:promoter	120570_[GENE=C1QB_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]				rs913243	0.4301	0.4596,0.4297,0.4375,0.4162,0.5145	14168,.	37028	86602	0.7930			6.53				0	21951915,29795138	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22659292	22659292	-	GATGGATG	wt	het	wt	off-target;low_conf_region	QUAL=583;DP=25,22,41;AF=0.36,0.00,0.59;MQM=60;SAP=18;ABP=9;SAR=0;SAF=7	C1QB	intron	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695755.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron2/3:c.-23-119_-23-112dup::,C1QB:ENST00000695757.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-23-119_-23-112dup::		120570_[GENE=C1QB_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1269706 [benign DISEASE=not provided];		(GGAT)n (Simple_repeat)	rs56917855	0.2189	0.2608,0.2387,0.0270,0.2200,0.1407	3414,.	21277	100281				2.96				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22659293	22659296	GATG	-	het	wt	het	off-target;low_conf_region	QUAL=583;DP=25,22,41;AF=0.36,0.00,0.59;MQM=59;SAP=75;ABP=3;SAR=0;SAF=33	C1QB	intron	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695755.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron2/3:c.-23-115_-23-112del::,C1QB:ENST00000695757.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::		120570_[GENE=C1QB_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1252299 [benign DISEASE=not provided];		(GGAT)n (Simple_repeat)	rs56917855	0.0838	0.0679,0.0608,0.0711,0.0911,0.1806	467,.	9851	117849	2.2220			2.66				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22659347	22659350	GATG	-	het	het	het	off-target;low_conf_region	QUAL=1101;DP=26,50,60;AF=0.38,0.46,0.43;MQM=60;SAP=71;ABP=8;SAR=8;SAF=51	C1QB	intron	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695755.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron2/3:c.-23-49_-23-46del::,C1QB:ENST00000695757.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::		120570_[GENE=C1QB_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]			(GGAT)n (Simple_repeat)	rs140338008	0.4811	0.5008,0.5752,0.6022,0.4534,0.4755	13948,.	35070	67918	0.5560			1.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22661465	22661465	A	G	hom	hom	hom		QUAL=38239;DP=411,347,456;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0;SAR=609;SAF=605	C1QB	3'UTR	C1QB:ENST00000695754.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695755.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695756.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*79A>G::,C1QB:ENST00000695757.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695758.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*405A>G::,C1QB:ENST00000695759.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*405A>G::,C1QB:ENST00000695760.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695761.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*405A>G::,C1QB:ENST00000695762.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000509305.6:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695763.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1004A>G::		120570_[GENE=C1QB_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1258616 [benign DISEASE=not provided];			rs10580	0.9841	0.9960,0.9897,1.0000,0.9760,0.9921	73653,.	2388	2424	-1.0460			4.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	23796496	23796496	C	T	het	het	wt	off-target;low_conf_region	QUAL=928;DP=80,48,54;AF=0.56,0.44,0.02;MQM=60;SAP=140;ABP=3;SAR=1;SAF=66	GALE	splice_region&intron	GALE:ENST00000617979.5:splice_region_variant&intron_variant:LOW:intron10/11:c.873+13G>A::,GALE:ENST00000374497.7:splice_region_variant&intron_variant:LOW:intron10/11:c.873+13G>A::		606953_[GENE=GALE_PHENOS=Galactose epimerase deficiency, 230350 (3), Autosomal recessive]	92889 [benign DISEASE=UDPglucose-4-epimerase deficiency,not specified,not provided];		G-rich (Low_complexity)	rs760941	0.6705	0.6209,0.6933,0.6531,0.6824,0.7649	19762,.	33021	35649	-0.7980			0.86			COSV100994767,COSV65720422,COSV65720626	0	25741868,24033266,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYPLA2 (inh=n/a oe_syn=1.05 oe_mis=0.60 oe_lof=0.07), GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91)
chr1	23801977	23801977	C	T	hom	het	hom		QUAL=30065;DP=362,347,431;AF=1.00,0.50,1.00;MQM=60;SAP=42;ABP=3;SAR=418;SAF=550	HMGCL	3'UTR	HMGCL:ENST00000374490.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*486G>A::,HMGCL:ENST00000436439.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*486G>A::	regulatory_region_variant:promoter	606953_[GENE=GALE_PHENOS=Galactose epimerase deficiency, 230350 (3), Autosomal recessive]&613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	296841 [benign DISEASE=UDPglucose-4-epimerase deficiency,Deficiency of hydroxymethylglutaryl-CoA lyase];			rs11714	0.9131	0.9288,0.8779,0.8309,0.9138,0.8732	63472,.	12028	13234	-0.9180			7.69				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91), HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23802636	23802636	A	G	het	wt	hom	off-target	QUAL=7922;DP=152,153,194;AF=0.51,0.00,0.99;MQM=60;SAP=349;ABP=3;SAR=238;SAF=31	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron8/8:c.877-72T>C::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron6/6:c.664-72T>C::		606953_[GENE=GALE_PHENOS=Galactose epimerase deficiency, 230350 (3), Autosomal recessive]&613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	1177625 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase];			rs2076343	0.2690	0.1374,0.2468,0.2641,0.3379,0.1567	6126,.	28661	111155	1.3650			11.77			COSV52526949	0.05		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91), HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23804204	23804204	G	A	het	het	wt	off-target	QUAL=1041;DP=73,29,25;AF=0.55,0.38,0.00;MQM=59;SAP=114;ABP=3;SAR=0;SAF=51	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron8/8:c.876+196C>T::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron6/6:c.663+196C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	606953_[GENE=GALE_PHENOS=Galactose epimerase deficiency, 230350 (3), Autosomal recessive]&613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]			FRAM (SINE/Alu)	rs551491388	0.0018	0.0006,0.0008,0.0000,0.0031,0.0015	1,.	264	151834	-0.5680			5.53				0		0	39	0 / 0					GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91), HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23807972	23807972	C	T	hom	het	hom	off-target	QUAL=3934;DP=87,36,38;AF=0.99,0.61,1.00;MQM=60;SAP=320;ABP=7;SAR=0;SAF=146	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron7/8:c.750+163G>A::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron5/6:c.537+163G>A::	regulatory_region_variant:enhancer	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	684182 [benign DISEASE=not provided];		L2c (LINE/L2)	rs719399	0.9230	0.9663,0.8874,0.7907,0.9144,0.8666	64898,.	10572	11706	-0.1450			1.46				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23808231	23808231	T	C	hom	het	hom		QUAL=21774;DP=292,224,287;AF=1.00,0.53,1.00;MQM=60;SAP=18;ABP=4;SAR=383;SAF=314	HMGCL	synonymous	HMGCL:ENST00000374490.8:synonymous_variant:LOW:exon7/9:c.654A>G:p.Leu218=:PF00682 [HMGL-like],HMGCL:ENST00000436439.6:synonymous_variant:LOW:exon5/7:c.441A>G:p.Leu147=:PF00682 [HMGL-like]	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	92602 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase,not specified];			rs719400	0.9230	0.9658,0.8874,0.7910,0.9146,0.8665	64879,.	10582	11712	1.2340			10.02	0.08			0.01	25741868,17847002,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23814521	23814521	C	T	het	wt	hom	off-target	QUAL=2282;DP=96,32,44;AF=0.54,0.00,0.98;MQM=52;SAP=209;ABP=4;SAR=95;SAF=0	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron4/8:c.349-183G>A::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron4/6:c.348+2154G>A::		613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	673763 [benign DISEASE=not provided];		AluSg (SINE/Alu)	rs11591205	0.2655	0.1322,0.2391,0.2605,0.3359,0.1530	5982,.	28356	111574	0.2740			1.63				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23817442	23817442	A	G	hom	het	hom	off-target	QUAL=12961;DP=186,116,181;AF=0.99,0.50,1.00;MQM=60;SAP=388;ABP=3;SAR=75;SAF=349	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron3/8:c.252+34T>C::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron3/6:c.252+34T>C::	regulatory_region_variant:enhancer	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	255488 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase,not specified,not provided];			rs2076344	0.9232	0.9659,0.8882,0.7914,0.9148,0.8665	64954,.	10565	11691	-1.1720			1.30				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23825506	23825506	C	A	het	het	hom	off-target	QUAL=1442;DP=24,34,34;AF=0.29,0.47,1.00;MQM=60;SAP=102;ABP=8;SAR=54;SAF=3	HMGCL	upstream_gene	HMGCL:ENST00000374490.8:upstream_gene_variant:MODIFIER::::,HMGCL:ENST00000436439.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	1177626 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase,not provided];			rs6697805	0.4050	0.3819,0.3856,0.4642,0.4213,0.2841	12241,.	36415	89485	-2.8170			0.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23845053	23845053	C	G	het	het	hom	off-target	QUAL=2963;DP=103,47,45;AF=0.50,0.60,0.98;MQM=60;SAP=272;ABP=4;SAR=0;SAF=124	FUCA1	downstream_gene	FUCA1:ENST00000374479.4:downstream_gene_variant:MODIFIER::::		612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]				rs4649119	0.3654	0.2273,0.3604,0.4751,0.4314,0.2880	10647,.	34137	96281	-0.2530			2.56					19442614	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23846275	23846275	-	T	wt	het	het	off-target	QUAL=96;DP=27,7,12;AF=0.11,0.29,0.50;MQM=58;SAP=27;ABP=30;SAR=11;SAF=0	FUCA1	intron	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron6/7:c.1161-103dup::		612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	1294438 [benign DISEASE=not provided];		AluSz6 (SINE/Alu)	rs11456086	0.3608	0.2222,0.3572,0.4697,0.4311,0.2823	9590,.	31741	90201				0.65				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23846275	23846275	C	T	het	wt	het	off-target	QUAL=96;DP=27,7,12;AF=0.19,0.14,0.25;MQM=51;SAP=23;ABP=40;SAR=9;SAF=0	FUCA1	intron	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron6/7:c.1161-102G>A::		612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]			AluSz6 (SINE/Alu)	rs1329117558	0.0001	0.0000,0.0000,0.0000,0.0000,0.0000	0,.	1	141191	-3.0710			0.08				0		0	1	0 / 0					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23854317	23854317	A	-	het	het	het	off-target	QUAL=589;DP=105,33,48;AF=0.12,0.61,0.15;MQM=59;SAP=66;ABP=134;SAR=3;SAF=37	FUCA1	intron	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron5/7:c.969+43del::		612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	1252223 [benign DISEASE=not provided];		(A)n (Simple_repeat)	rs55699941	0.0934	0.0541,0.1244,0.2183,0.1006,0.1530	644,.	11841	127421	2.7730			8.02			COSV65699151	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23854472	23854472	T	C	het	wt	hom		QUAL=9719;DP=256,209,202;AF=0.50,0.00,1.00;MQM=60;SAP=12;ABP=3;SAR=146;SAF=182	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon5/8:c.857A>G:p.Gln286Arg:PF01120 [Alpha-L-fucosidase]	regulatory_region_variant:CTCF_binding_site	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	691 [benign DISEASE=FU1/FU2 POLYMORPHISM,Fucosidosis,not provided];			rs13551	0.2684	0.1449,0.2385,0.2634,0.3352,0.1481	6032,.	28741	111233	0.6870	D(0.02)	B(0.00)	17.84	0.06		COSV65698861	0	7815431,17427030,8504303	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23854687	23854687	C	T	het	wt	hom	off-target	QUAL=2500;DP=134,42,27;AF=0.51,0.00,1.00;MQM=60;SAP=211;ABP=3;SAR=96;SAF=0	FUCA1	intron	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron4/7:c.769-127G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	683990 [benign DISEASE=not provided];		MER20 (DNA/hAT-Charlie)	rs12748109	0.2653	0.1344,0.2367,0.2629,0.3351,0.1475	5939,.	28411	111601	-0.3500			7.00			COSV65698864	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23865710	23865710	A	G	het	het	hom	off-target	QUAL=8589;DP=223,100,138;AF=0.53,0.55,0.99;MQM=60;SAP=650;ABP=7;SAR=307;SAF=3	FUCA1	intron	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron1/7:c.390-85T>C::	TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	683925 [benign DISEASE=not provided];			rs34902309	0.3760	0.2633,0.3683,0.4726,0.4315,0.2884	11090,.	34986	94858	0.9330			8.76			COSV65692469	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868258	23868258	G	C	wt	het	wt		QUAL=1393;DP=157,112,122;AF=0.00,0.54,0.01;MQM=60;SAP=48;ABP=5;SAR=49;SAF=13	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon1/8:c.29C>G:p.Pro10Arg:	regulatory_region_variant:promoter	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	193053 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070956	0.1069	0.1182,0.1275,0.2089,0.0959,0.1402	954,.	14353	135845	0.7020	T(0.16)	B(0.02)	11.56	0.09		COSV65692258	0	24033266,9039984,27346075,34425818,35055161	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868280	23868280	C	G	het	het	wt		QUAL=2473;DP=143,107,112;AF=0.45,0.45,0.00;MQM=60;SAP=155;ABP=8;SAR=101;SAF=12	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon1/8:c.7G>C:p.Ala3Pro:	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	296895 [benign/likely benign DISEASE=Fucosidosis,not provided];			rs61996282	0.0094	0.0023,0.0423,0.0000,0.0084,0.0159	21,.	1392	150718	-2.1530	D(0.02)	B(0.00)	6.24	0.07			0	25741868	3	256	0 / 0					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868283	23868283	G	A	wt	het	wt		QUAL=1196;DP=121,103,113;AF=0.00,0.52,0.01;MQM=60;SAP=63;ABP=4;SAR=47;SAF=8	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon1/8:c.4C>T:p.Arg2Trp:	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	193052 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070955	0.1069	0.1179,0.1275,0.2092,0.0960,0.1404	952,.	14345	135795	-0.7810	D(0.00)	B(0.00)	16.29	0.08		COSV65692243	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868298	23868298	A	G	wt	het	wt		QUAL=1137;DP=74,96,100;AF=0.00,0.52,0.01;MQM=60;SAP=55;ABP=3;SAR=43;SAF=8	FUCA1,CNR2	upstream_gene,downstream_gene	FUCA1:ENST00000374479.4:upstream_gene_variant:MODIFIER::::,CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	193051 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070954	0.1069	0.1180,0.1275,0.2093,0.0959,0.1406	953,.	14338	135722	0.1300			10.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868372	23868372	A	C	wt	het	wt		QUAL=417;DP=26,49,33;AF=0.00,0.43,0.03;MQM=60;SAP=51;ABP=5;SAR=22;SAF=0	FUCA1,CNR2	upstream_gene,downstream_gene	FUCA1:ENST00000374479.4:upstream_gene_variant:MODIFIER::::,CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	368872 [benign/likely benign DISEASE=Fucosidosis,not provided];			rs2070953	0.1070	0.1182,0.1277,0.2100,0.0960,0.1396	962,.	14351	135845	-0.5800			6.98						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868408	23868408	C	A	wt	het	wt	off-target	QUAL=322;DP=19,36,20;AF=0.00,0.47,0.00;MQM=60;SAP=40;ABP=3;SAR=17;SAF=0	FUCA1,CNR2	upstream_gene,downstream_gene	FUCA1:ENST00000374479.4:upstream_gene_variant:MODIFIER::::,CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	683915 [benign DISEASE=not provided];			rs2070952	0.1067	0.1184,0.1275,0.2095,0.0952,0.1407	961,.	14298	135846	-0.5740			5.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	25800934	25800934	G	A	hom	hom	het	off-target	QUAL=6944;DP=90,92,127;AF=1.00,1.00,0.56;MQM=60;SAP=518;ABP=7;SAR=4;SAF=249	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron1/12:c.184-109G>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron1/11:c.184-109G>A::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron1/11:c.184-109G>A::	regulatory_region_variant:promoter	606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	669827 [benign DISEASE=not provided];			rs6659086	0.6318	0.7795,0.6745,0.6488,0.5487,0.7330	31155,.	33495	55845	-0.9560			4.31			COSV62525010	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25804968	25804968	G	A	het	hom	wt	off-target	QUAL=2266;DP=115,34,34;AF=0.53,1.00,0.00;MQM=60;SAP=209;ABP=4;SAR=0;SAF=95	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron3/12:c.404-174G>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron2/11:c.302-174G>A::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron2/11:c.302-174G>A::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	669829 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs11247735	0.5084	0.4923,0.6291,0.6118,0.4825,0.6856	19881,.	37373	74585	-0.0180			3.28			COSV62524936	0.01	22615972,27186328,31027226,25330801,29793041	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25805163	25805163	G	A	hom	hom	het		QUAL=15894;DP=160,220,332;AF=1.00,1.00,0.52;MQM=60;SAP=261;ABP=4;SAR=148;SAF=404	SELENON	missense	SELENON:ENST00000361547.7:missense_variant:MODERATE:exon4/13:c.425G>A:p.Cys142Tyr:,SELENON:ENST00000374315.1:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:,SELENON:ENST00000354177.9:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	95963 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders,not provided];			rs7349185	0.7951	0.7811,0.8530,0.9345,0.7807,0.8871	48208,.	24310	31106	0.8690	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	13.21	0.04		COSV62525203	0	25741868,24033266,18414213,23757202,23800289,26673400,32817544	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25809961	25809961	A	C	hom	hom	het	off-target	QUAL=5793;DP=63,88,141;AF=1.00,1.00,0.46;MQM=60;SAP=472;ABP=5;SAR=216;SAF=0	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron7/12:c.1010+141A>C::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron6/11:c.908+141A>C::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron6/11:c.839+141A>C::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	669830 [benign DISEASE=not provided];			rs6686366	0.7680	0.6734,0.8403,0.9773,0.7823,0.8914	45241,.	26167	35245	0.0430			4.83				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25811645	25811645	C	A	hom	hom	het	off-target	QUAL=18745;DP=148,278,383;AF=1.00,1.00,0.53;MQM=60;SAP=42;ABP=6;SAR=367;SAF=261	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron8/12:c.1093-46C>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron7/11:c.991-46C>A::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron7/11:c.922-46C>A::	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	261271 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,not provided];			rs760598	0.6991	0.4691,0.8044,0.9655,0.7657,0.8859	38885,.	28477	45737	0.9110			4.70				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25811771	25811771	T	C	hom	hom	het		QUAL=24631;DP=211,353,488;AF=1.00,1.00,0.51;MQM=60;SAP=3;ABP=4;SAR=402;SAF=412	SELENON	synonymous	SELENON:ENST00000361547.7:synonymous_variant:LOW:exon9/13:c.1173T>C:p.Pro391=:,SELENON:ENST00000374315.1:synonymous_variant:LOW:exon8/12:c.1071T>C:p.Pro357=:,SELENON:ENST00000354177.9:synonymous_variant:LOW:exon8/12:c.1002T>C:p.Pro334=:	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	95956 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders,not provided];			rs760597	0.7494	0.6168,0.8277,0.9660,0.7812,0.8878	43465,.	27044	38112	0.3020			9.57			COSV62525913	0	25741868,24033266,18414213,23757202,23800289	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25811960	25811960	A	G	hom	hom	het	off-target	QUAL=7183;DP=59,127,193;AF=1.00,0.99,0.46;MQM=60;SAP=598;ABP=6;SAR=274;SAF=0	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1281+81A>G::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1179+81A>G::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1110+81A>G::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	669832 [benign DISEASE=not provided];			rs11247744	0.7495	0.6166,0.8278,0.9663,0.7812,0.8877	43459,.	27036	38084	0.0640			5.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812480	25812480	-	ACAT	het	het	n/a	off-target;low_conf_region	QUAL=578;DP=22,7,1;AF=0.68,0.57,1.00;MQM=60;SAP=20;ABP=16;SAR=0;SAF=8	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-206_1282-205insCATA::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-206_1180-205insCATA::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-206_1111-205insCATA::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	1271278 [benign DISEASE=not provided];		(CA)n (Simple_repeat)	rs57085889	0.8188	0.8557,0.8566,0.9756,0.7815,0.8892	50973,.	21925	27419				2.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812480	25812480	C	T	het	het	n/a	off-target;low_conf_region	QUAL=578;DP=22,7,1;AF=0.23,0.43,0.00;MQM=59;SAP=46;ABP=9;SAR=0;SAF=20	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-207C>T::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-207C>T::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-207C>T::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]			(CA)n (Simple_repeat)	rs116343724	0.0002	0.0001,0.0002,0.0000,0.0002,0.0002	1,.	26	151308	-2.7320			0.06				0		1784	3987	0 / 0					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812561	25812564	ACAA	-	n/a	hom	wt	off-target;low_conf_region	QUAL=180;DP=0,6,8;AF=,0.83,0.00;MQM=60;SAP=14;ABP=0;SAR=0;SAF=5	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-123_1282-120del::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-123_1180-120del::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-123_1111-120del::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]			(AC)n (Simple_repeat)	rs201110629	0.0172	0.0083,0.0156,0.0008,0.0230,0.0114	11,.	1694	97834	0.1230			0.85				0		2	218	0 / 0					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812564	25812564	-	AC	n/a	wt	hom	off-target;low_conf_region	QUAL=180;DP=0,6,8;AF=,0.83,0.00;MQM=60;SAP=10;ABP=0;SAR=0;SAF=3	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-82_1282-81dup::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-82_1180-81dup::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-82_1111-81dup::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	1233960 [benign DISEASE=not provided];		(AC)n (Simple_repeat)	rs59333545	0.1124	0.1137,0.0932,0.0275,0.1260,0.0965	844,.	12911	115285				2.66				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812646	25812646	C	T	hom	hom	het	off-target	QUAL=2973;DP=18,54,70;AF=1.00,1.00,0.54;MQM=60;SAP=79;ABP=4;SAR=24;SAF=86	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-41C>T::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-41C>T::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-41C>T::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	261274 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,not provided];			rs10902685	0.6585	0.2997,0.7926,0.9664,0.7799,0.8857	36507,.	25883	51299	-0.0280			3.13				0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812901	25812901	A	G	hom	hom	het	off-target	QUAL=2619;DP=34,40,56;AF=1.00,1.00,0.45;MQM=60;SAP=218;ABP=4;SAR=99;SAF=0	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron10/12:c.1387+109A>G::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron9/11:c.1285+109A>G::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron9/11:c.1216+109A>G::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	669834 [benign DISEASE=not provided];			rs3738451	0.7500	0.6187,0.8272,0.9656,0.7812,0.8873	43469,.	26993	37969	-1.6750			0.11				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812953	25812953	G	A	hom	hom	het	off-target	QUAL=1509;DP=20,25,25;AF=1.00,1.00,0.40;MQM=60;SAP=122;ABP=5;SAR=55;SAF=0	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron10/12:c.1387+161G>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron9/11:c.1285+161G>A::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron9/11:c.1216+161G>A::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	669835 [benign DISEASE=not provided];		MIRc (SINE/MIR)	rs10751726	0.6501	0.2988,0.7839,0.9659,0.7648,0.8850	35917,.	26883	53143	0.3650			9.25				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25814082	25814082	C	A	hom	hom	het		QUAL=22046;DP=216,321,438;AF=1.00,1.00,0.50;MQM=60;SAP=124;ABP=3;SAR=481;SAF=276	SELENON	missense	SELENON:ENST00000361547.7:missense_variant:MODERATE:exon12/13:c.1506C>A:p.Asn502Lys:,SELENON:ENST00000374315.1:missense_variant:MODERATE:exon11/12:c.1404C>A:p.Asn468Lys:,SELENON:ENST00000354177.9:missense_variant:MODERATE:exon11/12:c.1335C>A:p.Asn445Lys:	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	95959 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders,not provided];			rs2294228	0.6585	0.3013,0.7921,0.9659,0.7796,0.8865	36889,.	26305	51897	0.1400	T(0.12),T(0.14),T(0.10)	B(0.00),B(0.00),B(0.02)	13.69	0.09		COSV62525671	0.33	25741868,24033266,18414213,23757202,22615972,25332755,23800289,26673400	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25817213	25817213	-	TTTTG	hom	hom	het		QUAL=11752;DP=148,191,232;AF=0.97,1.00,0.43;MQM=59;SAP=211;ABP=13;SAR=115;SAF=319	SELENON	3'UTR	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1511_*1515dup::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1511_*1515dup::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]				rs3033477	0.7226	0.5258,0.8165,0.9660,0.7796,0.8872	40659,.	27525	41775				1.60				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817330	25817330	T	C	hom	hom	het		QUAL=16585;DP=247,179,269;AF=1.00,0.98,0.45;MQM=55;SAP=20;ABP=8;SAR=239;SAF=305	SELENON	3'UTR	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1612T>C::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1612T>C::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	297050 [benign DISEASE=SEPN1-Related Disorders];		AluSx (SINE/Alu)	rs3203750	0.7208	0.5172,0.8166,0.9663,0.7805,0.8878	40881,.	27687	42399	0.3080			2.99				0	27586304	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817440	25817440	T	C	hom	hom	het		QUAL=22311;DP=341,228,349;AF=1.00,1.00,0.45;MQM=54;SAP=99;ABP=11;SAR=273;SAF=452	SELENON	3'UTR	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1722T>C::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1722T>C::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	297053 [benign DISEASE=SEPN1-Related Disorders];		AluSx (SINE/Alu)	rs4659383	0.8102	0.8237,0.8501,0.9771,0.7825,0.8922	50114,.	22945	28863	-1.2160			0.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817947	25817947	C	-	hom	hom	het		QUAL=4521;DP=77,77,105;AF=0.99,1.00,0.61;MQM=60;SAP=269;ABP=14;SAR=190;SAF=27	SELENON	3'UTR	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2236del::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2236del::	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	297061 [uncertain significance DISEASE=SEPN1-Related Disorders];			rs371383269	0.7254	0.5280,0.8214,0.9662,0.7826,0.8871	41194,.	27583	41639	-0.8170			0.76				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	26177705	26177705	C	G	het	het	wt	off-target	QUAL=3174;DP=137,107,148;AF=0.61,0.48,0.00;MQM=60;SAP=285;ABP=8;SAR=133;SAF=1	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron1/20:c.52+106C>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron1/20:c.52+106C>G::	regulatory_region_variant:promoter				AluSx1 (SINE/Alu)	rs2783707	0.4104	0.5977,0.5014,0.6502,0.2872,0.4855	14603,.	33157	89599	-0.9920			1.62				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26180262	26180262	A	G	het	het	wt	off-target	QUAL=416;DP=49,5,6;AF=0.41,0.40,0.00;MQM=60;SAP=51;ABP=7;SAR=0;SAF=22	CNKSR1	intron,5'UTR	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron1/20:c.53-191A>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron1/20:c.53-191A>G::,CNKSR1:ENST00000531191.5:5_prime_UTR_variant:MODIFIER:exon1/20:c.-913A>G::					MER5A (DNA/hAT-Charlie)	rs1889737	0.2512	0.4543,0.3687,0.6386,0.0995,0.4005	7374,.	23436	113824	0.0920			4.56				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26180299	26180299	A	G	het	het	wt	off-target	QUAL=677;DP=59,16,18;AF=0.47,0.31,0.00;MQM=60;SAP=75;ABP=5;SAR=0;SAF=33	CNKSR1	intron,5'UTR	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron1/20:c.53-154A>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron1/20:c.53-154A>G::,CNKSR1:ENST00000531191.5:5_prime_UTR_variant:MODIFIER:exon1/20:c.-876A>G::					MIRb (SINE/MIR)	rs1889738	0.2510	0.4540,0.3684,0.6386,0.0996,0.4000	7351,.	23409	113719	0.8660			7.19				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26181096	26181096	A	G	het	n/a	n/a	off-target	QUAL=90;DP=4,1,0;AF=0.75,1.00,;MQM=60;SAP=12;ABP=5;SAR=4;SAF=0	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron3/20:c.392+200A>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron3/20:c.392+200A>G::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron2/19:c.-383+200A>G::					AluSz (SINE/Alu)	rs12044058	0.1457	0.0927,0.3220,0.6413,0.0971,0.3972	3022,.	16068	129670	-0.4060			1.22				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26181802	26181802	G	A	het	het	wt	off-target	QUAL=5043;DP=208,206,281;AF=0.50,0.51,0.00;MQM=60;SAP=293;ABP=3;SAR=21;SAF=188	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron2/19:c.-382-55G>A::	regulatory_region_variant:open_chromatin_region				MIRb (SINE/MIR)	rs3819033	0.1250	0.0271,0.3135,0.5999,0.0963,0.3964	2675,.	13651	133021	0.6040			7.55			COSV64163468	0	32450446,24560374	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26181989	26181989	T	C	het	het	wt	off-target	QUAL=5554;DP=211,243,318;AF=0.46,0.52,0.00;MQM=60;SAP=245;ABP=3;SAR=191;SAF=33	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron3/19:c.-298+48T>C::	regulatory_region_variant:open_chromatin_region					rs2275945	0.1643	0.1570,0.3281,0.6437,0.0972,0.3999	3415,.	18164	127090	0.3060			11.55				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26183948	26183948	G	A	het	het	hom	off-target;low_conf_region	QUAL=328;DP=12,3,8;AF=0.67,0.67,1.00;MQM=60;SAP=42;ABP=7;SAR=0;SAF=18	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron9/20:c.855+118G>A::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron9/20:c.876+118G>A::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron8/19:c.81+118G>A::						rs12733981	0.2275	0.0601,0.2292,0.2235,0.2995,0.1268	2623,.	12766	61168	-0.1120			2.21	0.05			0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26185209	26185209	A	G	hom	hom	hom	off-target	QUAL=20266;DP=160,212,265;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0;SAR=340;SAF=296	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron14/20:c.1308+23A>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron14/20:c.1329+23A>G::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron13/19:c.534+23A>G::						rs2783680	0.5905	0.4678,0.6990,0.9718,0.5887,0.8065	27499,.	34630	62158	-0.7820			0.29				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26185393	26185393	T	-	het	wt	het	off-target	QUAL=18;DP=15,9,14;AF=0.33,0.00,0.14;MQM=60;SAP=18;ABP=20;SAR=7;SAF=0	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron14/20:c.1308+223del::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron14/20:c.1329+223del::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron13/19:c.534+223del::					AluYj4 (SINE/Alu)	rs559527821	0.0031	0.0012,0.0033,0.0004,0.0032,0.0012	0,.	410	130240	-1.7500			0.08				0.01		0	11	0 / 0					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26187620	26187620	C	T	het	wt	het	off-target	QUAL=105;DP=29,10,21;AF=0.24,0.00,0.10;MQM=43;SAP=23;ABP=47;SAR=9;SAF=0	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron16/20:c.1454+138C>T::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron16/20:c.1475+138C>T::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron15/19:c.680+138C>T::					AluSg (SINE/Alu)	rs1385309412	0.0001	0.0000,0.0000,0.0000,0.0001,0.0000	0,.	1	119923	-1.7410			0.27				0		0	2	0 / 0					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00), CATSPER4 (inh=n/a oe_syn=0.99 oe_mis=0.94 oe_lof=0.77)
chr1	26187621	26187621	T	-	wt	het	wt	off-target	QUAL=105;DP=29,10,21;AF=0.21,0.50,0.14;MQM=51;SAP=33;ABP=40;SAR=14;SAF=0	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron16/20:c.1454+158del::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron16/20:c.1475+158del::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron15/19:c.680+158del::					AluSg (SINE/Alu)	rs35307485	0.2426	0.3181,0.3532,0.5942,0.1650,0.4653	3479,.	22084	90680	0.3030			0.81				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00), CATSPER4 (inh=n/a oe_syn=0.99 oe_mis=0.94 oe_lof=0.77)
chr1	26189039	26189045	CCAGACT	-	hom	hom	hom	off-target	QUAL=1613;DP=16,20,32;AF=1.00,0.95,1.00;MQM=60;SAP=132;ABP=0;SAR=65;SAF=2	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron20/20:c.1872+101_1872+107del::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron20/20:c.1893+101_1893+107del::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron19/19:c.1098+101_1098+107del::						rs11278474	0.9532	0.8390,0.9805,0.9994,0.9988,0.9992	69337,.	5973	7103	1.0370			5.72				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00), CATSPER4 (inh=n/a oe_syn=0.99 oe_mis=0.94 oe_lof=0.77)
chr1	26760698	26760698	T	A	het	het	wt	off-target	QUAL=486;DP=72,4,3;AF=0.43,0.50,0.00;MQM=59;SAP=75;ABP=6;SAR=0;SAF=33	ARID1A	intron	ARID1A:ENST00000430799.7:intron_variant:MODIFIER:intron4/19:c.772-158T>A::,ARID1A:ENST00000324856.13:intron_variant:MODIFIER:intron4/19:c.1921-158T>A::,ARID1A:ENST00000457599.6:intron_variant:MODIFIER:intron4/19:c.1921-158T>A::,ARID1A:ENST00000374152.7:intron_variant:MODIFIER:intron3/18:c.772-158T>A::		603024_[GENE=ARID1A_PHENOS=Coffin-Siris syndrome 2, 614607 (3), Autosomal dominant]	1261600 [benign DISEASE=not provided];			rs191253395	0.0813	0.0274,0.0745,0.0200,0.1153,0.0630	590,.	10840	135760	0.2220			0.45			COSV61381440	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	26780484	26780484	C	T	wt	wt	het		QUAL=3133;DP=158,190,236;AF=0.00,0.00,0.52;MQM=60;SAP=11;ABP=4;SAR=72;SAF=51	ARID1A	synonymous	ARID1A:ENST00000430799.7:synonymous_variant:LOW:exon20/20:c.5434C>T:p.Leu1812=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000324856.13:synonymous_variant:LOW:exon20/20:c.6586C>T:p.Leu2196=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000457599.6:synonymous_variant:LOW:exon20/20:c.5935C>T:p.Leu1979=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000374152.7:synonymous_variant:LOW:exon19/19:c.5437C>T:p.Leu1813=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa]		603024_[GENE=ARID1A_PHENOS=Coffin-Siris syndrome 2, 614607 (3), Autosomal dominant]	210262 [benign/likely benign DISEASE=Intellectual disability, autosomal dominant 14,not specified,not provided];			rs149633292	0.0044	0.0004,0.0006,0.0000,0.0043,0.0008	10,.	653	151541	0.6540			7.24	0.10		COSV61385556	0	25741868	1	188	0 / 0	2	"Prima Vista kein Anhalt fr Splice-Defekt; 160727 [2] ahwalds1 28.07.2016"			ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	26781160	26781160	A	-	het	het	het	low_conf_region	QUAL=626;DP=86,16,24;AF=0.24,0.25,0.29;MQM=60;SAP=4;ABP=69;SAR=14;SAF=18	ARID1A	3'UTR	ARID1A:ENST00000430799.7:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::,ARID1A:ENST00000324856.13:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::		603024_[GENE=ARID1A_PHENOS=Coffin-Siris syndrome 2, 614607 (3), Autosomal dominant]			(A)n (Simple_repeat)	rs71007893	0.0184	0.0244,0.0142,0.0098,0.0171,0.0067	10,.	2086	112576	0.0460			6.28				0		4	264	0 / 0					ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	27369520	27369520	C	T	hom	hom	hom	off-target	QUAL=26178;DP=313,256,312;AF=1.00,1.00,1.00;MQM=60;SAP=1916;ABP=0;SAR=881;SAF=0	FCN3	intron	FCN3:ENST00000270879.9:intron_variant:MODIFIER:intron7/7:c.659-43G>A::,FCN3:ENST00000354982.2:intron_variant:MODIFIER:intron6/6:c.626-43G>A::	regulatory_region_variant:CTCF_binding_site	604973_[GENE=FCN3_PHENOS=Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive]			MIRb (SINE/MIR)	rs10218730	0.9926	0.9738,0.9979,1.0000,1.0000,0.9998	75011,.	1104	1134	-0.5380			1.56				0.06		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58), FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	27372958	27372958	A	T	hom	hom	hom	off-target	QUAL=1541;DP=31,16,9;AF=1.00,1.00,1.00;MQM=60;SAP=125;ABP=0;SAR=0;SAF=56	FCN3	intron	FCN3:ENST00000270879.9:intron_variant:MODIFIER:intron5/7:c.393+178T>A::,FCN3:ENST00000354982.2:intron_variant:MODIFIER:intron4/6:c.360+178T>A::,FCN3:ENST00000699963.1:intron_variant:MODIFIER:intron5/6:c.393+178T>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	604973_[GENE=FCN3_PHENOS=Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive]	992482 [uncertain significance DISEASE=Rheumatic heart disease];			rs10794501	0.6946	0.5401,0.7645,0.9001,0.7394,0.7918	37450,.	30491	46339	-0.1530			3.10				0.01	22471352,19220833,33591573,33499929	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	32780201	32780201	C	G	het	het	het		QUAL=9592;DP=260,186,254;AF=0.54,0.61,0.46;MQM=60;SAP=65;ABP=8;SAR=237;SAF=134	YARS1	synonymous	YARS1:ENST00000373477.9:synonymous_variant:LOW:exon11/13:c.1218G>C:p.Leu406=:PF01588 [Putative tRNA binding domain],YARS1:ENST00000675785.2:synonymous_variant:LOW:exon10/12:c.1071G>C:p.Leu357=:PF01588 [Putative tRNA binding domain]		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297151 [benign DISEASE=Charcot-Marie-Tooth disease dominant intermediate C,not specified];			rs699005	0.1035	0.1005,0.1668,0.0017,0.1020,0.0592	905,.	13934	136328	3.9130			9.05				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32780839	32780839	T	C	het	het	wt	off-target	QUAL=1327;DP=98,35,50;AF=0.42,0.54,0.00;MQM=60;SAP=133;ABP=6;SAR=0;SAF=60	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron10/12:c.1140+209A>G::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron9/11:c.993+209A>G::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	1253354 [benign DISEASE=not provided];			rs2282293	0.1373	0.0341,0.1223,0.2101,0.1802,0.2294	1787,.	17319	131233	-0.2280			1.76			COSV65113845	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32782196	32782196	G	T	het	het	het	off-target	QUAL=1006;DP=40,30,23;AF=0.50,0.57,0.48;MQM=60;SAP=107;ABP=3;SAR=0;SAF=48	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron9/12:c.1042+208C>A::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron8/11:c.895+208C>A::	regulatory_region_variant:enhancer	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670891 [benign DISEASE=not provided];			rs699004	0.0791	0.0178,0.1557,0.0017,0.1011,0.0592	667,.	10689	139891	-0.2010			1.30				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32786499	32786521	CACATGCATGACTATTCCTAGCC	-	het	het	wt	off-target	QUAL=3595;DP=114,226,316;AF=0.48,0.50,0.00;MQM=60;SAP=148;ABP=3;SAR=137;SAF=31	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron7/12:c.821-74_821-52del::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron6/11:c.674-74_674-52del::		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	1175561 [benign DISEASE=not provided];		L2d (LINE/L2)	rs149745059	0.1370	0.0341,0.1216,0.2098,0.1796,0.2277	1779,.	17256	131172	1.7760			4.89				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32791044	32791044	G	C	het	het	het	off-target	QUAL=4785;DP=194,63,91;AF=0.57,0.52,0.57;MQM=60;SAP=429;ABP=15;SAR=0;SAF=196	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron6/12:c.684+118C>G::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron5/11:c.537+118C>G::		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670889 [benign DISEASE=not provided];			rs881393	0.1734	0.2626,0.2143,0.0021,0.1384,0.0671	2659,.	21023	125589	0.5200			4.34				0	27903959	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32791283	32791283	C	A	hom	hom	het	off-target	QUAL=16364;DP=243,164,263;AF=0.99,0.99,0.52;MQM=60;SAP=278;ABP=4;SAR=402;SAF=140	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron5/12:c.592-29G>T::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron4/11:c.445-29G>T::		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670888 [benign DISEASE=not provided];			rs1765223	0.3118	0.3001,0.3370,0.2123,0.3185,0.2969	7496,.	32348	104510	1.2110			7.15			COSV65113032	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32810823	32810823	G	A	hom	hom	hom	off-target	QUAL=21306;DP=291,158,212;AF=1.00,1.00,1.00;MQM=60;SAP=66;ABP=0;SAR=261;SAF=399	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron2/12:c.205-57C>T::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron1/11:c.58-57C>T::	regulatory_region_variant:enhancer	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670335 [benign DISEASE=not provided];			rs4951787	0.9874	0.9563,0.9955,1.0000,0.9998,1.0000	74171,.	1836	1920	-0.4320			0.48				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32817174	32817174	C	A	het	het	het	off-target	QUAL=3099;DP=120,71,103;AF=0.48,0.51,0.44;MQM=60;SAP=49;ABP=5;SAR=42;SAF=96	YARS1	splice_region&intron	YARS1:ENST00000373477.9:splice_region_variant&intron_variant:LOW:intron1/12:c.57+14G>T::,YARS1:ENST00000675785.2:splice_region_variant&intron_variant:LOW:intron1/11:c.57+14G>T::	regulatory_region_variant:promoter	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297163 [benign DISEASE=Charcot-Marie-Tooth disease dominant intermediate C,not specified];			rs72654020	0.1019	0.0949,0.1663,0.0017,0.1019,0.0583	890,.	13727	136639	-0.2670			5.06				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37), S100PBP (inh=n/a oe_syn=1.12 oe_mis=0.99 oe_lof=0.11)
chr1	32817927	32817927	G	A	het	n/a	n/a		QUAL=41;DP=7,0,1;AF=0.57,,0.00;MQM=60;SAP=12;ABP=3;SAR=4;SAF=0	YARS1,S100PBP	5'UTR,intron	YARS1:ENST00000675785.2:5_prime_UTR_variant:MODIFIER:exon1/12:c.-683C>T::,S100PBP:ENST00000373476.5:intron_variant:MODIFIER:intron1/6:c.-120+328G>A::,S100PBP:ENST00000373475.10:intron_variant:MODIFIER:intron1/6:c.-120+238G>A::	regulatory_region_variant:promoter	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297175 [benign DISEASE=Charcot-Marie-Tooth disease dominant intermediate C,not provided];			rs72654022	0.0793	0.0184,0.1561,0.0017,0.1010,0.0592	676,.	10724	140128	1.5060			14.83				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37), S100PBP (inh=n/a oe_syn=1.12 oe_mis=0.99 oe_lof=0.11)
chr1	33010464	33010464	G	A	het	het	wt		QUAL=864;DP=321,105,140;AF=0.22,0.13,0.07;MQM=34;SAP=4;ABP=337;SAR=50;SAF=45	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*365C>T::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2717C>T::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2717C>T::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs143947377	0.4970	0.4936,0.4980,0.4977,0.4984,0.4978	0,.	64367	65137	2.3890			18.09			COSV61470449			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010473	33010473	A	T	het	het	wt		QUAL=971;DP=341,110,148;AF=0.23,0.13,0.07;MQM=34;SAP=6;ABP=351;SAR=56;SAF=45	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*356T>A::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2708T>A::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2708T>A::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs199780633	0.4969	0.4937,0.4978,0.4979,0.4982,0.4970	0,.	64398	65206	0.7280			15.20			COSV61467968			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010489	33010489	T	C	het	het	wt		QUAL=1331;DP=390,112,146;AF=0.24,0.11,0.08;MQM=35;SAP=8;ABP=372;SAR=66;SAF=50	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*340A>G::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2692A>G::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2692A>G::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*340A>G::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs140167370	0.4968	0.4936,0.4980,0.4966,0.4980,0.4978	0,.	64433	65269	-2.4150			0.37			COSV61470454			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010542	33010542	G	A	het	het	het		QUAL=70;DP=256,84,107;AF=0.14,0.12,0.11;MQM=38;SAP=5;ABP=535;SAR=33;SAF=25	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*287C>T::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2639C>T::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2639C>T::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*287C>T::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs201412582	0.4968	0.4936,0.4980,0.4989,0.4980,0.4977	0,.	63975	64805	0.4830			8.62			COSV61467875			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010623	33010624	AC	-	het	het	het		QUAL=1717;DP=219,71,72;AF=0.28,0.27,0.33;MQM=46;SAP=3;ABP=142;SAR=51;SAF=54	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*205_*206del::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2557_*2558del::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2557_*2558del::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*205_*206del::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs67829320	0.4992	0.4980,0.4997,0.4998,0.4997,0.5000	0,.	74401	74629	-0.1030			4.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010638	33010638	T	C	het	het	het		QUAL=2686;DP=268,72,78;AF=0.31,0.32,0.36;MQM=47;SAP=8;ABP=117;SAR=59;SAF=76	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*191A>G::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2543A>G::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2543A>G::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*191A>G::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs74066438	0.4994	0.4985,0.4997,0.4998,0.4998,0.5000	0,.	75176	75358	0.0200			4.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010691	33010691	A	G	het	het	het		QUAL=4593;DP=269,136,117;AF=0.30,0.49,0.45;MQM=50;SAP=130;ABP=65;SAR=46;SAF=154	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*138T>C::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2490T>C::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2490T>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*138T>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs74066439	0.4995	0.4987,0.4998,0.5000,0.4998,0.5000	0,.	75861	76011	0.1500			6.12			COSV61466645			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010752	33010752	C	T	het	het	het		QUAL=2531;DP=231,155,143;AF=0.17,0.41,0.33;MQM=47;SAP=30;ABP=215;SAR=54;SAF=97	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*77G>A::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2429G>A::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2429G>A::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*77G>A::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs66599471	0.4992	0.4981,0.4995,0.4998,0.4997,0.4998	4,.	74888	75138	-0.2060			9.65			COSV61466298			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010784	33010784	C	G	het	het	het	low_conf_region	QUAL=1872;DP=232,141,136;AF=0.21,0.37,0.26;MQM=48;SAP=7;ABP=243;SAR=60;SAF=76	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*45G>C::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2397G>C::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2397G>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*45G>C::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*94G>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs76881767	0.4971	0.4938,0.4982,0.4981,0.4985,0.4986	0,.	67589	68379	0.0650			19.37			COSV61466684			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010786	33010786	C	T	het	het	het	low_conf_region	QUAL=1872;DP=232,141,136;AF=0.21,0.37,0.26;MQM=48;SAP=7;ABP=243;SAR=60;SAF=76	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*43G>A::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2395G>A::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2395G>A::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*43G>A::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*92G>A::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs201842558	0.4968	0.4931,0.4979,0.4976,0.4984,0.4974	0,.	65619	66475	0.0390			16.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010795	33010795	G	A	het	het	het	low_conf_region	QUAL=1786;DP=230,132,136;AF=0.20,0.35,0.23;MQM=48;SAP=5;ABP=276;SAR=57;SAF=67	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*34C>T::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2386C>T::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2386C>T::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*34C>T::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*83C>T::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs79824855	0.4951	0.4903,0.4967,0.4975,0.4971,0.4951	0,.	58215	59365	1.6360			22.60			COSV61466650			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010803	33010803	T	G	het	het	het	low_conf_region	QUAL=1366;DP=219,128,132;AF=0.20,0.32,0.23;MQM=48;SAP=5;ABP=284;SAR=52;SAF=63	AK2	3'UTR	AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*26A>C::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2378A>C::,AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2378A>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*26A>C::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*75A>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs76230073	0.4896	0.4809,0.4919,0.4921,0.4935,0.4904	0,.	48571	50645	1.7520			20.60			COSV61467923			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33013330	33013330	G	C	het	wt	wt	low_conf_region	QUAL=530;DP=662,475,594;AF=0.18,0.04,0.02;MQM=36;SAP=23;ABP=610;SAR=93;SAF=56	AK2	missense,3'UTR	AK2:ENST00000373449.7:missense_variant:MODERATE:exon6/7:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase],AK2:ENST00000672715.1:missense_variant:MODERATE:exon6/6:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase],AK2:ENST00000354858.11:missense_variant:MODERATE:exon5/5:c.445C>G:p.His149Asp:PF00406 [Adenylate kinase],AK2:ENST00000548033.5:missense_variant:MODERATE:exon5/6:c.445C>G:p.His149Asp:PF00406 [Adenylate kinase],AK2:ENST00000467905.5:missense_variant:MODERATE:exon6/8:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase],AK2:ENST00000480134.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*74C>G::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]	529737 [benign DISEASE=Reticular dysgenesis];			rs80324279	0.0031	0.0010,0.0018,0.0026,0.0051,0.0016	0,.	450	144648	9.9640	D(0.01),D(0.01),D(0.01),D(0.01),D(0.01), 	B(0.31),B(0.44),B(0.17),P(0.88),B(0.44), 	25.30	0.78		COSV61466144	0		0	743	0 / 0					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33013358	33013358	C	G	het	wt	wt	low_conf_region	QUAL=667;DP=634,421,555;AF=0.17,0.03,0.02;MQM=36;SAP=18;ABP=596;SAR=82;SAF=52	AK2	missense,3'UTR	AK2:ENST00000373449.7:missense_variant:MODERATE:exon6/7:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase],AK2:ENST00000672715.1:missense_variant:MODERATE:exon6/6:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase],AK2:ENST00000354858.11:missense_variant:MODERATE:exon5/5:c.417G>C:p.Lys139Asn:PF00406 [Adenylate kinase],AK2:ENST00000548033.5:missense_variant:MODERATE:exon5/6:c.417G>C:p.Lys139Asn:PF00406 [Adenylate kinase],AK2:ENST00000467905.5:missense_variant:MODERATE:exon6/8:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase],AK2:ENST00000480134.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*46G>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]	1599150 [benign DISEASE=Reticular dysgenesis];			rs72884305	0.0020	0.0006,0.0012,0.0018,0.0033,0.0014	0,.	280	143274	-0.3850	D(0.03),D(0.03),D(0.03),D(0.03),D(0.03), 	B(0.03),B(0.09),B(0.00),B(0.05),B(0.09), 	21.60	0.19		COSV61466156	0		0	25	0 / 0					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	34781247	34781247	-	C	wt	wt	het		QUAL=151;DP=8,10,14;AF=0.00,0.00,0.57;MQM=60;SAP=20;ABP=4;SAR=0;SAF=8	GJB3	5'UTR	GJB3:ENST00000373366.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-551dup::	regulatory_region_variant:promoter,TF_binding_site_variant	603324_[GENE=GJB3_PHENOS=Deafness, digenic, GJB2/GJB3, 220290 (3), Digenic dominant, Autosomal recessive; Deafness, autosomal recessive (3); Deafness, autosomal dominant 2B, 612644 (3), Autosomal dominant; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal recessive, Autosomal dominant; Deafness, autosomal dominant, with peripheral neuropathy (3)]				rs3831969	0.2563	0.4228,0.1551,0.1452,0.1994,0.0769	5890,.	27030	112632				8.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	34782639	34782639	G	C	wt	het	het	off-target	QUAL=477;DP=96,22,36;AF=0.00,0.36,0.50;MQM=60;SAP=59;ABP=4;SAR=26;SAF=0	GJB3	intron	GJB3:ENST00000373366.3:intron_variant:MODIFIER:intron1/1:c.-26+861G>C::,GJB3:ENST00000373362.3:intron_variant:MODIFIER:intron1/1:c.-26+197G>C::	regulatory_region_variant:promoter	603324_[GENE=GJB3_PHENOS=Deafness, digenic, GJB2/GJB3, 220290 (3), Digenic dominant, Autosomal recessive; Deafness, autosomal recessive (3); Deafness, autosomal dominant 2B, 612644 (3), Autosomal dominant; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal recessive, Autosomal dominant; Deafness, autosomal dominant, with peripheral neuropathy (3)]				rs9426014	0.2942	0.5288,0.1749,0.1432,0.2104,0.0921	8280,.	28103	107149	0.1660			6.28				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	34785628	34785628	G	A	wt	het	het		QUAL=9695;DP=261,357,376;AF=0.00,0.54,0.50;MQM=60;SAP=7;ABP=5;SAR=176;SAF=203	GJB3	3'UTR	GJB3:ENST00000373366.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJB3:ENST00000373362.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::	regulatory_region_variant:CTCF_binding_site	603324_[GENE=GJB3_PHENOS=Deafness, digenic, GJB2/GJB3, 220290 (3), Digenic dominant, Autosomal recessive; Deafness, autosomal recessive (3); Deafness, autosomal dominant 2B, 612644 (3), Autosomal dominant; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal recessive, Autosomal dominant; Deafness, autosomal dominant, with peripheral neuropathy (3)]	297196 [benign DISEASE=Erythrokeratodermia variabilis et progressiva 1,not provided];			rs476220	0.4781	0.6185,0.3871,0.1775,0.4412,0.2668	18250,.	36058	79204	-0.1210			2.32			COSV64904373	0	33126609	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	39026255	39026255	G	C	het	hom	het	off-target	QUAL=4562;DP=72,84,102;AF=0.46,1.00,0.50;MQM=60;SAP=165;ABP=3;SAR=28;SAF=140	NDUFS5	upstream_gene	NDUFS5:ENST00000372967.3:upstream_gene_variant:MODIFIER::::,NDUFS5:ENST00000372969.8:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant					rs1984600	0.7036	0.4950,0.6639,0.4204,0.8490,0.5002	39640,.	27435	44963	-0.2760			6.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39026408	39026408	G	T	het	hom	het		QUAL=4652;DP=91,91,111;AF=0.52,1.00,0.47;MQM=60;SAP=53;ABP=3;SAR=128;SAF=62	NDUFS5	splice_region&intron	NDUFS5:ENST00000372967.3:splice_region_variant&intron_variant:LOW:intron1/2:c.-3+10G>T::,NDUFS5:ENST00000372969.8:splice_region_variant&intron_variant:LOW:intron1/2:c.-3+6G>T::	regulatory_region_variant:promoter,TF_binding_site_variant					rs1122472	0.7015	0.4878,0.6635,0.4215,0.8490,0.5000	39510,.	27441	45299	-1.2850			5.35		6.53>7.92		0.74		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39028994	39028994	-	T	het	wt	wt	off-target;low_conf_region	QUAL=359;DP=113,47,68;AF=0.09,0.38,0.22;MQM=59;SAP=92;ABP=206;SAR=41;SAF=0	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+69dup::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+69dup::	regulatory_region_variant:CTCF_binding_site					rs35464164	0.6957	0.4817,0.6587,0.4205,0.8437,0.4998	35867,.	25994	42740				0.37				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39028994	39028994	C	T	wt	het	het	off-target;low_conf_region	QUAL=359;DP=113,47,68;AF=0.19,0.21,0.15;MQM=55;SAP=96;ABP=195;SAR=43;SAF=0	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+54C>T::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+54C>T::	regulatory_region_variant:CTCF_binding_site					rs372159643	0.0001	0.0001,0.0000,0.0000,0.0001,0.0000	0,.	9	140641	-1.1560			0.28				0		15	134	0 / 0					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39029015	39029015	G	A	het	hom	het	off-target;low_conf_region	QUAL=5932;DP=201,98,123;AF=0.43,1.00,0.43;MQM=58;SAP=511;ABP=16;SAR=237;SAF=1	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+75G>A::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+75G>A::					AluSq10 (SINE/Alu)	rs3768323	0.7040	0.4937,0.6649,0.4194,0.8494,0.5000	38539,.	26575	43591	0.6170			3.13				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39029088	39029088	G	A	het	hom	het	off-target	QUAL=2906;DP=121,43,65;AF=0.47,1.00,0.40;MQM=60;SAP=268;ABP=8;SAR=125;SAF=1	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+148G>A::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+148G>A::					AluSq10 (SINE/Alu)	rs3768322	0.7037	0.4944,0.6642,0.4196,0.8491,0.5013	39414,.	27250	44668	0.4830			4.37				0.05		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	40073404	40073404	C	T	hom	het	het		QUAL=18469;DP=389,207,252;AF=1.00,0.39,0.50;MQM=60;SAP=59;ABP=13;SAR=236;SAF=360	PPT1	3'UTR	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*657G>A::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*657G>A::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*788G>A::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*657G>A::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*657G>A::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297230 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs1126973	0.7017	0.6203,0.6966,0.6577,0.7415,0.6629	37586,.	31457	45321	0.4510			7.40				0	17145094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073531	40073531	-	TGAT	hom	het	het		QUAL=19323;DP=341,360,457;AF=0.99,0.44,0.47;MQM=60;SAP=62;ABP=16;SAR=286;SAF=425	PPT1	3'UTR	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*526_*529dup::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*526_*529dup::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*657_*660dup::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*526_*529dup::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*526_*529dup::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297233 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,Neuronal Ceroid-Lipofuscinosis, Recessive,not provided];			rs397730033	0.6608	0.4963,0.6614,0.6187,0.7386,0.6564	33891,.	32395	51415				4.99				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073556	40073556	G	C	hom	het	het		QUAL=29708;DP=534,423,540;AF=1.00,0.46,0.48;MQM=60;SAP=157;ABP=10;SAR=361;SAF=625	PPT1	3'UTR	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*505C>G::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*505C>G::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*636C>G::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*505C>G::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*505C>G::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297234 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs1126972	0.6974	0.6059,0.6957,0.6571,0.7412,0.6625	37183,.	31575	45969	-0.6230			3.29				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073776	40073776	A	C	hom	het	het		QUAL=39398;DP=859,416,464;AF=0.99,0.53,0.45;MQM=60;SAP=63;ABP=4;SAR=736;SAF=548	PPT1	3'UTR	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*285T>G::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*285T>G::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*416T>G::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*285T>G::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*285T>G::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297240 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs1126970	0.6976	0.6060,0.6953,0.6582,0.7415,0.6631	37211,.	31579	45957	1.3970			10.22				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073900	40073900	A	G	het	wt	het		QUAL=7482;DP=342,237,267;AF=0.46,0.00,0.48;MQM=60;SAP=88;ABP=10;SAR=194;SAF=89	PPT1	3'UTR	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*161T>C::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*161T>C::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*292T>C::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*161T>C::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*161T>C::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297242 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs11552578	0.1156	0.1656,0.0992,0.1546,0.0740,0.1989	1193,.	15194	134524	2.4760			15.49			COSV61222731	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40080292	40080292	T	G	hom	het	het	off-target	QUAL=11280;DP=282,124,144;AF=1.00,0.46,0.47;MQM=60;SAP=842;ABP=6;SAR=5;SAF=401	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron7/9:c.714+105A>C::,PPT1:ENST00000530076.6:intron_variant:MODIFIER:intron2/4:c.-31+105A>C::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron6/8:c.627+105A>C::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron6/8:c.624+105A>C::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron6/9:c.627+105A>C::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron6/7:c.627+105A>C::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron3/5:c.318+105A>C::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180456 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs3122428	0.7394	0.7115,0.7085,0.7449,0.7500,0.7580	41529,.	29264	39584	-0.6460			0.98			COSV65655125	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40080537	40080537	C	T	het	wt	het	off-target	QUAL=6263;DP=236,222,288;AF=0.49,0.00,0.49;MQM=60;SAP=192;ABP=4;SAR=202;SAF=53	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron6/9:c.624-50G>A::,PPT1:ENST00000530076.6:intron_variant:MODIFIER:intron1/4:c.-121-50G>A::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron5/8:c.537-50G>A::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron5/8:c.534-50G>A::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron5/9:c.537-50G>A::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron5/7:c.537-50G>A::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron2/5:c.228-50G>A::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180457 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs77623018	0.0593	0.0162,0.0681,0.1353,0.0557,0.1462	442,.	8128	142904	-2.3850			0.07			COSV65655090	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40089649	40089649	C	T	het	het	wt	off-target;low_conf_region	QUAL=1706;DP=92,63,89;AF=0.49,0.46,0.01;MQM=60;SAP=166;ABP=4;SAR=75;SAF=0	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron5/9:c.521-137G>A::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron4/8:c.434-137G>A::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron4/8:c.431-137G>A::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron4/9:c.434-137G>A::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron4/7:c.434-137G>A::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-137G>A::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	668044 [benign DISEASE=not provided];			rs3131651	0.5065	0.2970,0.5251,0.4497,0.6170,0.4661	21019,.	34898	74962	-2.7140			0.01			COSV65655885	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091250	40091250	T	C	hom	hom	hom	off-target	QUAL=15651;DP=134,173,190;AF=1.00,1.00,1.00;MQM=60;SAP=541;ABP=0;SAR=73;SAF=424	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron5/9:c.520+79A>G::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron4/8:c.433+79A>G::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron4/8:c.430+79A>G::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron4/9:c.433+79A>G::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron4/7:c.433+79A>G::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-1738A>G::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180458 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs3122439	0.9945	0.9803,0.9988,1.0000,1.0000,0.9998	75284,.	819	843	-0.2180			1.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091270	40091270	A	T	wt	het	wt	off-target	QUAL=2670;DP=152,207,216;AF=0.00,0.51,0.00;MQM=60;SAP=39;ABP=3;SAR=32;SAF=74	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron5/9:c.520+59T>A::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron4/8:c.433+59T>A::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron4/8:c.430+59T>A::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron4/9:c.433+59T>A::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron4/7:c.433+59T>A::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-1758T>A::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	670785 [benign DISEASE=not provided];			rs56654546	0.0958	0.0809,0.1388,0.1500,0.0930,0.1314	767,.	13007	137323	1.0410			4.78			COSV65655895	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091361	40091361	A	G	het	wt	het		QUAL=9444;DP=434,344,349;AF=0.44,0.00,0.48;MQM=60;SAP=3;ABP=13;SAR=185;SAF=176	PPT1	missense,intron	PPT1:ENST00000641471.1:missense_variant:MODERATE:exon5/10:c.488T>C:p.Ile163Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000642050.2:missense_variant:MODERATE:exon4/9:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000433473.8:missense_variant:MODERATE:exon4/9:c.398T>C:p.Ile133Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000641319.1:missense_variant:MODERATE:exon4/10:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000439754.6:missense_variant:MODERATE:exon4/8:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-1849T>C::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	130022 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,History of neurodevelopmental disorder,not specified,not provided];			rs1800205	0.0468	0.0096,0.0351,0.1228,0.0470,0.1269	303,.	6509	144973	0.6890	T(0.38),T(0.37),T(0.37),T(0.38),T(0.36), 	B(0.16),B(0.04),B(0.00),B(0.00),B(0.00), 	16.02	0.20		COSV65655693	0.01	25741868,19054571	4	144	0 / 0					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091984	40091984	G	A	hom	het	hom	off-target	QUAL=9460;DP=224,68,60;AF=1.00,0.49,1.00;MQM=60;SAP=615;ABP=3;SAR=9;SAF=308	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron4/9:c.449+61C>T::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron3/8:c.362+61C>T::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron3/8:c.359+61C>T::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron3/9:c.362+61C>T::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron3/7:c.362+61C>T::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-2472C>T::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	670733 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs6672053	0.6469	0.4926,0.6144,0.6734,0.7189,0.6716	32542,.	33202	53646	0.5120			2.53				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40092584	40092584	C	G	hom	hom	hom	off-target	QUAL=13665;DP=275,68,97;AF=1.00,1.00,1.00;MQM=60;SAP=958;ABP=0;SAR=440;SAF=0	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron2/9:c.212-77G>C::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron1/8:c.125-77G>C::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron1/8:c.125-80G>C::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron1/9:c.125-77G>C::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron1/7:c.125-77G>C::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-3072G>C::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180459 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];		L1MB5 (LINE/L1)	rs4481840	0.9950	0.9823,0.9989,1.0000,1.0000,0.9998	75368,.	739	759	0.2390			3.90				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40092673	40092673	T	A	hom	het	hom	off-target	QUAL=5065;DP=145,14,15;AF=1.00,0.43,1.00;MQM=60;SAP=363;ABP=4;SAR=166;SAF=0	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron2/9:c.212-166A>T::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron1/8:c.125-166A>T::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron1/8:c.125-169A>T::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron1/9:c.125-166A>T::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron1/7:c.125-166A>T::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-3161A>T::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	668040 [benign DISEASE=not provided];		L1MB5 (LINE/L1)	rs4492608	0.6483	0.4930,0.6154,0.6737,0.7211,0.6736	32541,.	33193	53305	-1.1650			1.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40097321	40097321	T	C	hom	hom	hom		QUAL=5693;DP=36,56,97;AF=1.00,1.00,1.00;MQM=60;SAP=24;ABP=0;SAR=116;SAF=73	PPT1	upstream_gene	PPT1:ENST00000641471.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000642050.2:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000433473.8:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641319.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000439754.6:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000449045.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297250 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs6600313	0.8441	0.7543,0.8329,0.8845,0.8879,0.8795	54447,.	19476	23718	-0.6120			8.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40097347	40097347	G	T	het	wt	het		QUAL=1551;DP=30,46,82;AF=0.60,0.02,0.54;MQM=60;SAP=7;ABP=6;SAR=37;SAF=26	PPT1	upstream_gene	PPT1:ENST00000641471.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000642050.2:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000433473.8:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641319.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000439754.6:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000449045.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297251 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs41301070	0.0865	0.1724,0.0388,0.0201,0.0449,0.1044	820,.	11518	139030	-0.5190			6.03				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40257946	40257946	G	A	wt	het	wt	off-target	QUAL=53;DP=32,11,30;AF=0.00,0.55,0.00;MQM=60;SAP=16;ABP=3;SAR=0;SAF=6	ZMPSTE24-DT	non_coding_transcript_exon	ZMPSTE24-DT:ENST00000567508.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.26C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	606480_[GENE=ZMPSTE24_PHENOS=Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive; Restrictive dermopathy 1, 275210 (3), Autosomal recessive]	140505 [benign DISEASE=not provided];			rs3765483	0.1034	0.1111,0.1351,0.1532,0.0893,0.1539	900,.	13927	136399	-0.1720			5.83					19680556,19645629	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24-DT (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	40270145	40270145	T	G	wt	het	wt	off-target	QUAL=327;DP=100,43,62;AF=0.00,0.40,0.00;MQM=60;SAP=4;ABP=7;SAR=10;SAF=7	ZMPSTE24	splice_region&intron	ZMPSTE24:ENST00000372759.4:splice_region_variant&intron_variant:LOW:intron5/9:c.627+18T>G::	regulatory_region_variant:open_chromatin_region	606480_[GENE=ZMPSTE24_PHENOS=Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive; Restrictive dermopathy 1, 275210 (3), Autosomal recessive]	140531 [benign DISEASE=not specified,not provided];			rs16827109	0.0902	0.0647,0.1355,0.1529,0.0884,0.1533	714,.	12290	138452	0.2410			7.05			COSV65638901	0	25741868,21108632,19680556,19645629	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	40271844	40271844	T	G	hom	hom	hom	off-target	QUAL=11360;DP=124,105,126;AF=1.00,1.00,1.00;MQM=60;SAP=395;ABP=0;SAR=51;SAF=304	ZMPSTE24	intron	ZMPSTE24:ENST00000372759.4:intron_variant:MODIFIER:intron5/9:c.628-50T>G::		606480_[GENE=ZMPSTE24_PHENOS=Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive; Restrictive dermopathy 1, 275210 (3), Autosomal recessive]	140535 [benign DISEASE=not specified,not provided];			rs6677717	0.9875	0.9983,0.9958,1.0000,0.9858,0.9897	74221,.	1845	1905	-0.2280			0.98				0	25741868,21108632,19680556,19645629	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	42733051	42733051	C	T	het	n/a	n/a	off-target	QUAL=185;DP=14,0,1;AF=0.64,,1.00;MQM=58;SAP=25;ABP=5;SAR=0;SAF=10	CLDN19	downstream_gene	CLDN19:ENST00000296387.6:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000539749.5:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000372539.3:downstream_gene_variant:MODIFIER::::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]			AluSg (SINE/Alu)	rs11210707	0.6347	0.6441,0.5889,0.6359,0.6355,0.7120	30220,.	34286	54510	-0.5640			1.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42733077	42733077	-	TC	het	n/a	het	off-target	QUAL=231;DP=25,1,3;AF=0.60,0.00,0.33;MQM=53;SAP=38;ABP=4;SAR=0;SAF=16	CLDN19	downstream_gene	CLDN19:ENST00000296387.6:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000539749.5:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000372539.3:downstream_gene_variant:MODIFIER::::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs200763067	0.0823	0.0510,0.0797,0.1652,0.0985,0.0535	400,.	10590	127084				0.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42733353	42733353	C	T	het	wt	het		QUAL=6657;DP=213,253,333;AF=0.51,0.00,0.51;MQM=59;SAP=153;ABP=4;SAR=70;SAF=209	CLDN19	3'UTR	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1733G>A::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2409G>A::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297316 [benign DISEASE=Renal hypomagnesemia 5 with ocular involvement];		AluSx1 (SINE/Alu)	rs112310775	0.1218	0.1325,0.1208,0.2059,0.1153,0.0684	1173,.	16174	133518	-0.2000			0.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42733444	42733444	A	G	het	wt	het		QUAL=10843;DP=405,354,441;AF=0.48,0.00,0.50;MQM=60;SAP=15;ABP=3;SAR=185;SAF=233	CLDN19	3'UTR	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1642T>C::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2318T>C::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297318 [benign DISEASE=Renal hypomagnesemia 5 with ocular involvement];			rs56345167	0.1894	0.2711,0.1701,0.2069,0.1555,0.1249	3000,.	22777	123205	1.0130			6.35						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42734855	42734855	T	C	het	het	het		QUAL=5019;DP=134,127,142;AF=0.49,0.43,0.51;MQM=60;SAP=4;ABP=5;SAR=92;SAF=101	CLDN19	3'UTR	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*231A>G::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*907A>G::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297335 [benign DISEASE=Renal hypomagnesemia 5 with ocular involvement,not provided];			rs912075	0.5839	0.5382,0.5981,0.6652,0.5963,0.6580	26092,.	36486	63186	-1.7400			0.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735184	42735184	G	A	het	het	het		QUAL=7187;DP=118,210,253;AF=0.52,0.55,0.47;MQM=60;SAP=148;ABP=3;SAR=77;SAF=217	CLDN19	intron,3'UTR	CLDN19:ENST00000296387.6:intron_variant:MODIFIER:intron4/4:c.627-50C>T::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*578C>T::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*684C>T::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	1276324 [benign DISEASE=not provided];			rs74885359	0.0941	0.0248,0.0732,0.0010,0.1380,0.0356	941,.	12423	137781	-1.0660			0.27				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735545	42735545	A	C	het	het	het		QUAL=10357;DP=184,284,353;AF=0.45,0.49,0.49;MQM=60;SAP=4;ABP=5;SAR=191;SAF=206	CLDN19	intron,3'UTR	CLDN19:ENST00000296387.6:intron_variant:MODIFIER:intron4/4:c.626+333T>G::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*217T>G::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*323T>G::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	1287286 [benign DISEASE=not provided];		L2b (LINE/L2)	rs12141833	0.5392	0.3863,0.5808,0.6655,0.5943,0.6570	22921,.	36055	69995	-1.3840			0.82				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735863	42735863	G	A	het	wt	het		QUAL=4084;DP=87,176,242;AF=0.45,0.01,0.56;MQM=60;SAP=257;ABP=5;SAR=159;SAF=16	CLDN19	splice_region&intron,missense,3'UTR	CLDN19:ENST00000296387.6:splice_region_variant&intron_variant:LOW:intron4/4:c.626+15C>T::,CLDN19:ENST00000539749.5:missense_variant:MODERATE:exon3/3:c.556C>T:p.Arg186Cys:,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*5C>T::	regulatory_region_variant:CTCF_binding_site	610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297339 [benign DISEASE=Renal hypomagnesemia 5 with ocular involvement,not provided];			rs4660658	0.1861	0.2367,0.2204,0.2318,0.1556,0.1267	2767,.	22749	123703	0.4830	 ,T(0.07), 	 ,B(0.00), 	0.26	0.12		COSV56418053	0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42746440	42746440	C	T	het	het	het		QUAL=9051;DP=296,180,206;AF=0.49,0.54,0.48;MQM=60;SAP=25;ABP=3;SAR=141;SAF=200	P3H1	3'UTR	P3H1:ENST00000397054.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*393G>A::,P3H1:ENST00000296388.10:3_prime_UTR_variant:MODIFIER:exon15/15:c.*257G>A::,P3H1:ENST00000236040.8:3_prime_UTR_variant:MODIFIER:exon14/14:c.*472G>A::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	873598 [benign DISEASE=Osteogenesis imperfecta type 8,Osteogenesis Imperfecta, Recessive,not provided];			rs6882	0.6422	0.5562,0.6523,0.7077,0.6754,0.7746	31658,.	34354	54414	0.2250			4.65				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42747198	42747198	A	T	het	wt	het		QUAL=2939;DP=109,74,126;AF=0.48,0.00,0.50;MQM=60;SAP=3;ABP=3;SAR=56;SAF=59	P3H1	intron,missense	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron14/14:c.2074+55T>A::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron14/14:c.2055+74T>A::,P3H1:ENST00000236040.8:missense_variant:MODERATE:exon14/14:c.2129T>A:p.Phe710Tyr:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674902 [benign DISEASE=not provided];			rs3738496	0.1111	0.0725,0.1655,0.2424,0.1149,0.0706	1062,.	14774	135232	0.2420	 , ,T(0.73)	 , ,B(0.03)	1.93	0.02		COSV52536380	0.03	27335225	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42747828	42747828	C	T	het	het	het	off-target	QUAL=5978;DP=176,135,219;AF=0.47,0.49,0.47;MQM=60;SAP=137;ABP=5;SAR=189;SAF=64	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron12/13:c.1839-30G>A::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674901 [benign DISEASE=Osteogenesis imperfecta type 8,not provided];			rs3738499	0.5342	0.3621,0.5790,0.6648,0.5955,0.6861	22679,.	35774	70732	-1.4520			0.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42747939	42747939	T	C	het	het	het	off-target	QUAL=3676;DP=163,53,94;AF=0.52,0.42,0.49;MQM=60;SAP=239;ABP=3;SAR=141;SAF=12	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron12/14:c.1839-141A>G::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron12/14:c.1839-141A>G::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron12/13:c.1839-141A>G::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	667664 [benign DISEASE=not provided];			rs7552138	0.7298	0.7548,0.7136,0.7146,0.7194,0.8389	40572,.	29715	41037	-1.0290			0.70				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42748126	42748126	A	G	het	wt	het	off-target	QUAL=678;DP=49,21,20;AF=0.37,0.00,0.65;MQM=60;SAP=3;ABP=5;SAR=15;SAF=16	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron12/14:c.1838+74T>C::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron12/14:c.1838+74T>C::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron12/13:c.1838+74T>C::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674900 [benign DISEASE=not provided];			rs3738500	0.1111	0.0709,0.1661,0.2461,0.1153,0.0710	1074,.	14750	135184	0.5450			4.70			COSV52532624	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42762196	42762196	G	A	het	het	het	off-target	QUAL=3050;DP=142,43,62;AF=0.51,0.51,0.65;MQM=60;SAP=294;ABP=7;SAR=0;SAF=134	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron2/14:c.618+127C>T::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron2/14:c.618+127C>T::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron2/13:c.618+127C>T::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	667661 [benign DISEASE=not provided];		AluJr4 (SINE/Alu)	rs2760070	0.7007	0.6582,0.7010,0.7085,0.7171,0.8315	37339,.	31595	45403	-0.4280			0.92			COSV52532167	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42762518	42762518	T	A	hom	hom	hom	off-target	QUAL=19167;DP=189,212,255;AF=1.00,1.00,1.00;MQM=60;SAP=533;ABP=0;SAR=528;SAF=128	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron1/13:c.466-43A>T::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674899 [benign DISEASE=not provided];			rs2816593	0.9882	0.9971,0.9951,0.9998,0.9839,0.9921	74272,.	1754	1798	-0.1310			2.13				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42767127	42767127	G	T	wt	het	wt	off-target	QUAL=350;DP=8,27,19;AF=0.00,0.67,0.00;MQM=60;SAP=42;ABP=10;SAR=18;SAF=0	P3H1,C1orf50	upstream_gene	P3H1:ENST00000397054.7:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000296388.10:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000236040.8:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000372525.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	1290909 [benign DISEASE=not provided];			rs11210712	0.1990	0.0925,0.2288,0.0141,0.2528,0.1809	3590,.	23057	121687	0.0180			6.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42767136	42767136	C	G	het	het	het	off-target	QUAL=604;DP=11,22,18;AF=0.73,0.64,0.56;MQM=60;SAP=72;ABP=10;SAR=32;SAF=0	P3H1,C1orf50	upstream_gene	P3H1:ENST00000397054.7:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000296388.10:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000236040.8:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000372525.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674898 [benign DISEASE=not provided];			rs3738504	0.5999	0.5890,0.6112,0.7046,0.5900,0.7538	27569,.	36083	60841	0.7320			10.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42926579	42926579	C	G	wt	het	wt		QUAL=2154;DP=293,227,266;AF=0.00,0.41,0.00;MQM=60;SAP=3;ABP=19;SAR=47;SAF=47	SLC2A1	3'UTR	SLC2A1:ENST00000426263.10:3_prime_UTR_variant:MODIFIER:exon10/10:c.*462G>C::,SLC2A1:ENST00000674765.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*228G>C::		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	297374 [benign DISEASE=Dystonia 9,Encephalopathy due to GLUT1 deficiency];			rs4658	0.3411	0.5905,0.3636,0.3130,0.2182,0.2659	10880,.	30080	100144	-0.3080			1.42				0	26358256,28698656,30062472,30545124,29307798,30564000,30531820,26980812,26944167,33522072	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42927574	42927574	-	GGTGAGAAAT	wt	het	het	off-target	QUAL=727;DP=177,99,77;AF=0.00,0.35,0.32;MQM=60;SAP=61;ABP=42;SAR=10;SAF=50	SLC2A1	intron	SLC2A1:ENST00000426263.10:intron_variant:MODIFIER:intron9/9:c.1278+30_1278+31insATTTCTCACC::,SLC2A1:ENST00000674765.1:intron_variant:MODIFIER:intron8/8:c.1030-718_1030-717insATTTCTCACC::		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	1222935 [benign DISEASE=not provided];			rs3831326	0.5698	0.7738,0.5931,0.4827,0.4715,0.6035	25919,.	34482	65176				1.66				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42929964	42929964	C	T	wt	het	wt		QUAL=1557;DP=118,160,234;AF=0.00,0.43,0.00;MQM=60;SAP=71;ABP=11;SAR=57;SAF=11	SLC2A1	synonymous	SLC2A1:ENST00000426263.10:synonymous_variant:LOW:exon5/10:c.588G>A:p.Pro196=:PF00083 [Sugar (and other) transporter],SLC2A1:ENST00000674765.1:synonymous_variant:LOW:exon5/9:c.588G>A:p.Pro196=:PF00083 [Sugar (and other) transporter]		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	95414 [benign DISEASE=Dystonia 9,Encephalopathy due to GLUT1 deficiency,History of neurodevelopmental disorder,GLUT1 deficiency syndrome 1, autosomal recessive,not specified,not provided];			rs2229682	0.1568	0.0459,0.2137,0.0754,0.2038,0.1739	2275,.	19277	128123	-5.4280			1.82			COSV65286860	0.13	25741868,18414213,23757202,23427181,18212354,21135204,20419766,26980812,33981732	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42930743	42930743	G	A	wt	het	wt		QUAL=2460;DP=253,154,166;AF=0.00,0.62,0.01;MQM=60;SAP=5;ABP=21;SAR=43;SAF=53	SLC2A1	synonymous	SLC2A1:ENST00000426263.10:synonymous_variant:LOW:exon4/10:c.399C>T:p.Cys133=:PF00083 [Sugar (and other) transporter],SLC2A1:ENST00000674765.1:synonymous_variant:LOW:exon4/9:c.399C>T:p.Cys133=:PF00083 [Sugar (and other) transporter]	regulatory_region_variant:CTCF_binding_site	138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	95411 [benign DISEASE=Dystonia 9,Encephalopathy due to GLUT1 deficiency,History of neurodevelopmental disorder,GLUT1 deficiency syndrome 1, autosomal recessive,not specified,not provided];			rs11537641	0.1704	0.0941,0.2204,0.0991,0.2005,0.1875	2436,.	21033	126147	-1.4980			4.27			COSV65287469	0.05	25741868,18414213,23757202,30353771,21135204	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42943295	42943295	G	A	het	het	wt		QUAL=7385;DP=293,350,487;AF=0.43,0.52,0.00;MQM=60;SAP=70;ABP=5;SAR=204;SAF=106	SLC2A1	synonymous	SLC2A1:ENST00000426263.10:synonymous_variant:LOW:exon2/10:c.45C>T:p.Ala15=:,SLC2A1:ENST00000674765.1:synonymous_variant:LOW:exon2/9:c.45C>T:p.Ala15=:		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	95413 [benign DISEASE=Dystonia 9,Encephalopathy due to GLUT1 deficiency,Hereditary cryohydrocytosis with reduced stomatin,Childhood onset GLUT1 deficiency syndrome 2,History of neurodevelopmental disorder,GLUT1 deficiency syndrome 1, autosomal recessive,not specified,not provided];			rs1385129	0.2193	0.1769,0.2864,0.2920,0.2164,0.2732	3829,.	25667	118655	-1.8290			7.23			COSV65287476	0	25741868,25512783,18414213,23757202,22707195,29867928,25701507,30353771,18212354,21135204,31222984,25381171,26944167,33522072,34488469,31965635,34708297	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42943508	42943508	G	T	wt	het	het	off-target	QUAL=1559;DP=87,61,88;AF=0.00,0.51,0.49;MQM=60;SAP=164;ABP=3;SAR=74;SAF=0	SLC2A1	intron	SLC2A1:ENST00000426263.10:intron_variant:MODIFIER:intron1/9:c.19-187C>A::,SLC2A1:ENST00000674765.1:intron_variant:MODIFIER:intron1/8:c.19-187C>A::		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	670109 [benign DISEASE=not provided];			rs12718444	0.1573	0.1087,0.1303,0.1683,0.1779,0.1851	1988,.	19927	128079	1.6540			12.75				0	30595370,34641739,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43346404	43346404	G	A	het	wt	het	off-target	QUAL=3908;DP=136,111,148;AF=0.59,0.01,0.53;MQM=60;SAP=225;ABP=12;SAR=16;SAF=144	MPL	intron	MPL:ENST00000372470.9:intron_variant:MODIFIER:intron6/11:c.981-41G>A::,MPL:ENST00000413998.7:intron_variant:MODIFIER:intron6/11:c.960-41G>A::	regulatory_region_variant:enhancer	159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Thrombocythemia 2, 601977 (3), Somatic mutation, Autosomal dominant; Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive]	259760 [benign DISEASE=not specified,not provided];			rs1760670	0.3123	0.2244,0.3666,0.0734,0.3731,0.1377	7921,.	31582	104452	0.5750			8.30			COSV65245058	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53)
chr1	43348662	43348662	G	A	het	n/a	wt	off-target	QUAL=140;DP=13,2,5;AF=0.54,0.50,0.00;MQM=60;SAP=20;ABP=3;SAR=0;SAF=8	MPL	intron	MPL:ENST00000372470.9:intron_variant:MODIFIER:intron8/11:c.1309-181G>A::,MPL:ENST00000413998.7:intron_variant:MODIFIER:intron8/11:c.1288-181G>A::	regulatory_region_variant:promoter	159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Thrombocythemia 2, 601977 (3), Somatic mutation, Autosomal dominant; Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive]				rs115813067	0.0242	0.0798,0.0094,0.0000,0.0013,0.0013	136,.	3406	148352	-0.8140			1.01				0		0	1	0 / 0					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53)
chr1	43349193	43349193	T	C	het	wt	het	off-target	QUAL=868;DP=50,33,40;AF=0.56,0.00,0.43;MQM=60;SAP=92;ABP=3;SAR=1;SAF=44	MPL	intron	MPL:ENST00000372470.9:intron_variant:MODIFIER:intron9/11:c.1469-70T>C::,MPL:ENST00000413998.7:intron_variant:MODIFIER:intron9/11:c.1448-70T>C::	regulatory_region_variant:promoter	159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Thrombocythemia 2, 601977 (3), Somatic mutation, Autosomal dominant; Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive]	1250463 [benign DISEASE=not provided];			rs839995	0.3010	0.1793,0.3618,0.0985,0.3737,0.1467	7547,.	30528	105970	-0.1820			9.21				0	23575445	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53)
chr1	43354522	43354522	G	A	wt	het	wt	off-target	QUAL=1541;DP=182,121,119;AF=0.00,0.51,0.01;MQM=60;SAP=55;ABP=3;SAR=51;SAF=12	MPL,CDC20-DT,CDC20	downstream_gene,upstream_gene	MPL:ENST00000372470.9:downstream_gene_variant:MODIFIER::::,MPL:ENST00000413998.7:downstream_gene_variant:MODIFIER::::,CDC20-DT:ENST00000424948.2:downstream_gene_variant:MODIFIER::::,CDC20:ENST00000310955.11:upstream_gene_variant:MODIFIER::::,CDC20:ENST00000372462.1:upstream_gene_variant:MODIFIER::::		159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Thrombocythemia 2, 601977 (3), Somatic mutation, Autosomal dominant; Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive]	1287360 [benign DISEASE=not provided];			rs79064184	0.0372	0.0081,0.0334,0.0004,0.0495,0.0769	152,.	5349	146519	0.0160			0.45						1	18	0 / 0					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53), CDC20-DT (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), CDC20 (inh=n/a oe_syn=0.86 oe_mis=0.70 oe_lof=0.54)
chr1	43792353	43792353	-	GT	het	het	wt	off-target	QUAL=1078;DP=83,48,48;AF=0.45,0.33,0.00;MQM=60;SAP=118;ABP=13;SAR=53;SAF=0	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron2/11:c.119-22536_119-22535dup::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron2/10:c.119-22536_119-22535dup::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron2/4:c.119-22536_119-22535dup::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron2/7:c.164-22536_164-22535dup::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron3/6:c.211+206_211+207dup::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron3/10:c.166+206_166+207dup::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron3/12:c.166+206_166+207dup::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron3/10:c.166+206_166+207dup::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron3/12:c.211+206_211+207dup::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron3/11:c.166+206_166+207dup::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron3/11:c.211+206_211+207dup::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron3/9:c.166+206_166+207dup::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron2/8:c.119-22536_119-22535dup::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron3/12:c.166+206_166+207dup::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron4/12:c.166+206_166+207dup::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron3/12:c.166+206_166+207dup::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron3/12:c.211+206_211+207dup::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron3/12:c.166+206_166+207dup::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron3/11:c.166+206_166+207dup::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron3/11:c.166+206_166+207dup::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron2/10:c.166+206_166+207dup::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron1/10:c.119-22536_119-22535dup::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron2/5:c.166+206_166+207dup::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron1/4:c.119-22536_119-22535dup::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron2/7:c.166+206_166+207dup::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron1/6:c.164-22536_164-22535dup::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron2/10:c.166+206_166+207dup::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron1/6:c.119-22536_119-22535dup::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron1/3:c.119-22536_119-22535dup::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron1/6:c.119-22536_119-22535dup::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron2/5:c.211+206_211+207dup::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron1/6:c.164-22536_164-22535dup::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1261624 [benign DISEASE=not provided];			rs34077566	0.3702	0.2504,0.3114,0.5927,0.4284,0.4332	11056,.	34073	95591				0.41				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43814709	43814709	A	T	hom	hom	hom	off-target	QUAL=10200;DP=135,99,110;AF=0.99,1.00,1.00;MQM=60;SAP=746;ABP=0;SAR=0;SAF=342	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron2/11:c.119-182A>T::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron2/10:c.119-182A>T::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron2/4:c.119-182A>T::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron2/7:c.164-182A>T::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron3/6:c.212-182A>T::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron3/10:c.167-182A>T::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron3/12:c.167-182A>T::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron3/10:c.167-182A>T::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron3/12:c.212-182A>T::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron3/11:c.167-182A>T::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron3/11:c.212-182A>T::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron3/9:c.167-182A>T::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron2/8:c.119-182A>T::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron3/12:c.167-182A>T::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron4/12:c.167-182A>T::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron3/12:c.167-182A>T::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron3/12:c.212-182A>T::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron3/12:c.167-182A>T::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron3/11:c.167-182A>T::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron3/11:c.167-182A>T::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron2/10:c.167-182A>T::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron1/10:c.119-182A>T::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron2/5:c.167-182A>T::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron1/4:c.119-182A>T::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron2/7:c.167-182A>T::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron1/6:c.164-182A>T::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron2/10:c.167-182A>T::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron1/6:c.119-182A>T::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron1/3:c.119-182A>T::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron1/6:c.119-182A>T::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron2/5:c.212-182A>T::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron1/6:c.164-182A>T::	regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1241211 [benign DISEASE=not provided];			rs37468	0.9047	0.9675,0.8315,0.9165,0.8963,0.7736	62520,.	12636	14496	1.0620			8.64				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43814753	43814753	T	G	het	het	wt	off-target	QUAL=4850;DP=236,131,162;AF=0.53,0.56,0.00;MQM=60;SAP=422;ABP=7;SAR=1;SAF=196	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron2/11:c.119-138T>G::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron2/10:c.119-138T>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron2/4:c.119-138T>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron2/7:c.164-138T>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron3/6:c.212-138T>G::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron3/10:c.167-138T>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron3/12:c.167-138T>G::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron3/10:c.167-138T>G::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron3/12:c.212-138T>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron3/11:c.167-138T>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron3/11:c.212-138T>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron3/9:c.167-138T>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron2/8:c.119-138T>G::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron3/12:c.167-138T>G::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron4/12:c.167-138T>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron3/12:c.167-138T>G::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron3/12:c.212-138T>G::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron3/12:c.167-138T>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron3/11:c.167-138T>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron3/11:c.167-138T>G::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron2/10:c.167-138T>G::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron1/10:c.119-138T>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron2/5:c.167-138T>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron1/4:c.119-138T>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron2/7:c.167-138T>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron1/6:c.164-138T>G::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron2/10:c.167-138T>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron1/6:c.119-138T>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron1/3:c.119-138T>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron1/6:c.119-138T>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron2/5:c.212-138T>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron1/6:c.164-138T>G::	regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1229033 [benign DISEASE=not provided];			rs3791064	0.3956	0.3301,0.3206,0.5890,0.4328,0.4360	12254,.	35608	91858	0.0160			4.05			COSV53515144	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43824858	43824858	A	G	het	het	hom		QUAL=7889;DP=267,116,112;AF=0.46,0.41,0.98;MQM=60;SAP=25;ABP=13;SAR=167;SAF=114	ST3GAL3	missense,intron	ST3GAL3:ENST00000372372.7:missense_variant:MODERATE:exon4/12:c.289A>G:p.Thr97Ala:,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron3/10:c.161+9925A>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron3/4:c.161+9925A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron3/7:c.206+9925A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron4/6:c.254+9925A>G::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron4/10:c.209+9925A>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000647237.1:missense_variant:MODERATE:exon5/11:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron4/12:c.254+9925A>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron4/11:c.254+9925A>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron4/9:c.209+9925A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron3/8:c.161+9925A>G::,ST3GAL3:ENST00000351035.8:missense_variant:MODERATE:exon5/13:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron5/12:c.209+9925A>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000262915.8:missense_variant:MODERATE:exon5/13:c.382A>G:p.Thr128Ala:,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000372368.7:missense_variant:MODERATE:exon4/11:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron2/10:c.161+9925A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron3/5:c.209+9925A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron2/4:c.161+9925A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron3/7:c.209+9925A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron2/6:c.206+9925A>G::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron3/10:c.209+9925A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron2/6:c.161+9925A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron2/3:c.161+9925A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron2/6:c.161+9925A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron3/5:c.254+9925A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron2/6:c.206+9925A>G::	regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	130378 [benign DISEASE=not specified,not provided];		MER5B (DNA/hAT-Charlie)	rs37458	0.3178	0.3162,0.2760,0.1409,0.3471,0.1374	7879,.	32554	103692	-0.1460	T(0.74), , , , , , ,T(0.72), , , , , ,T(0.70), , ,T(0.74), , , ,T(0.71), , , , , , , , , , , 	B(0.00), , , , , , ,B(0.00), , , , , ,B(0.00), , ,B(0.00), , , ,B(0.00), , , , , , , , , , , 	0.65	0.01		COSV53510755	0.13	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43899785	43899785	A	G	het	wt	het	off-target	QUAL=3725;DP=140,106,157;AF=0.49,0.00,0.56;MQM=60;SAP=219;ABP=5;SAR=141;SAF=16	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron9/11:c.858+58A>G::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron8/10:c.696+58A>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-30347A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.442+5308A>G::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron8/10:c.651+58A>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron9/12:c.744+58A>G::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.906+58A>G::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron9/12:c.789+58A>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron9/11:c.789+58A>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.744+58A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.696+58A>G::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron10/12:c.906+58A>G::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron10/12:c.744+58A>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron9/12:c.744+58A>G::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron10/12:c.951+58A>G::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron10/12:c.837+58A>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron9/10:c.906+58A>G::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron7/10:c.696+58A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.397+5308A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.349+5308A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.554+522A>G::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron8/10:c.744+58A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.509+522A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-30347A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.603+58A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.442+5308A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*22+496A>G::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1233138 [benign DISEASE=not provided];			rs783304	0.2372	0.4189,0.2427,0.2186,0.1416,0.2800	5422,.	25214	115932	-0.0920			1.77			COSV53512272	0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43899857	43899857	G	A	hom	hom	hom	off-target	QUAL=6575;DP=116,44,66;AF=1.00,0.98,1.00;MQM=60;SAP=492;ABP=0;SAR=225;SAF=0	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron9/11:c.858+130G>A::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron8/10:c.696+130G>A::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-30275G>A::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*22+568G>A::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.442+5380G>A::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron8/10:c.651+130G>A::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron9/12:c.744+130G>A::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.906+130G>A::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron9/12:c.789+130G>A::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron9/11:c.744+130G>A::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron9/11:c.789+130G>A::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.744+130G>A::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.696+130G>A::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron10/12:c.906+130G>A::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron10/12:c.744+130G>A::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron9/12:c.744+130G>A::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron10/12:c.951+130G>A::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron10/12:c.837+130G>A::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron9/11:c.744+130G>A::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron9/11:c.744+130G>A::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron9/10:c.906+130G>A::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron7/10:c.696+130G>A::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.397+5380G>A::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.349+5380G>A::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*22+568G>A::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.554+594G>A::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron8/10:c.744+130G>A::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.509+594G>A::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-30275G>A::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.603+130G>A::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.442+5380G>A::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*22+568G>A::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1275447 [benign DISEASE=not provided];			rs783303	0.8127	0.6444,0.8511,0.8352,0.8909,0.8150	51136,.	21259	28475	0.4930			3.85				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43920633	43920633	C	T	hom	hom	hom	off-target	QUAL=10311;DP=138,86,132;AF=0.99,0.99,0.99;MQM=60;SAP=4;ABP=0;SAR=184;SAF=169	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron10/11:c.1005+83C>T::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron9/10:c.843+83C>T::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9499C>T::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9499C>T::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9499C>T::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron9/10:c.798+83C>T::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron10/12:c.891+83C>T::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9499C>T::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron10/12:c.936+83C>T::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron10/11:c.891+83C>T::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron10/11:c.936+83C>T::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9499C>T::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9499C>T::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron11/12:c.1053+83C>T::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron11/12:c.891+83C>T::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron10/12:c.891+83C>T::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron11/12:c.1098+83C>T::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron11/12:c.984+83C>T::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron10/11:c.891+83C>T::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron10/11:c.891+83C>T::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+83C>T::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron8/10:c.843+83C>T::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9499C>T::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9499C>T::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9499C>T::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9499C>T::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron9/10:c.801+83C>T::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9499C>T::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9499C>T::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9499C>T::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9499C>T::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9499C>T::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1259769 [benign DISEASE=not provided];			rs3120802	0.7963	0.5065,0.8592,0.8414,0.9255,0.8709	50808,.	19319	30943	-0.3250			1.44			COSV53517032	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43920943	43920943	A	G	hom	hom	hom	off-target	QUAL=11971;DP=76,127,210;AF=0.99,0.98,1.00;MQM=60;SAP=228;ABP=0;SAR=308;SAF=102	ST3GAL3	splice_region&intron,intron	ST3GAL3:ENST00000372372.7:splice_region_variant&intron_variant:LOW:intron11/11:c.1152+15A>G::,ST3GAL3:ENST00000361400.9:splice_region_variant&intron_variant:LOW:intron10/10:c.990+15A>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9189A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9189A>G::,ST3GAL3:ENST00000372374.7:splice_region_variant&intron_variant:LOW:intron10/10:c.945+15A>G::,ST3GAL3:ENST00000643252.1:splice_region_variant&intron_variant:LOW:intron11/12:c.1038+15A>G::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9189A>G::,ST3GAL3:ENST00000642331.1:splice_region_variant&intron_variant:LOW:intron11/12:c.1083+15A>G::,ST3GAL3:ENST00000347631.8:splice_region_variant&intron_variant:LOW:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000361392.9:splice_region_variant&intron_variant:LOW:intron11/11:c.1083+15A>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9189A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9189A>G::,ST3GAL3:ENST00000351035.8:splice_region_variant&intron_variant:LOW:intron12/12:c.1200+15A>G::,ST3GAL3:ENST00000646971.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1038+15A>G::,ST3GAL3:ENST00000647148.1:splice_region_variant&intron_variant:LOW:intron11/12:c.1038+15A>G::,ST3GAL3:ENST00000262915.8:splice_region_variant&intron_variant:LOW:intron12/12:c.1245+15A>G::,ST3GAL3:ENST00000361746.9:splice_region_variant&intron_variant:LOW:intron12/12:c.1131+15A>G::,ST3GAL3:ENST00000645034.1:splice_region_variant&intron_variant:LOW:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000644195.1:splice_region_variant&intron_variant:LOW:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+393A>G::,ST3GAL3:ENST00000646686.1:splice_region_variant&intron_variant:LOW:intron9/10:c.990+15A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9189A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9189A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9189A>G::,ST3GAL3:ENST00000372369.5:splice_region_variant&intron_variant:LOW:intron10/10:c.948+15A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9189A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9189A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9189A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9189A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9189A>G::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	262909 [benign DISEASE=Intellectual disability, autosomal recessive 12,Developmental and epileptic encephalopathy, 15,Early infantile epileptic encephalopathy with suppression bursts,not specified];			rs3120803	0.8513	0.6990,0.8758,0.8493,0.9259,0.8721	55812,.	17670	22580	-1.2040			2.10				0.29	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43920970	43920970	G	C	het	wt	het	off-target	QUAL=3416;DP=85,95,157;AF=0.49,0.00,0.64;MQM=60;SAP=121;ABP=19;SAR=115;SAF=27	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron11/11:c.1152+42G>C::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron10/10:c.990+42G>C::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9162G>C::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9162G>C::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron10/10:c.945+42G>C::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron11/12:c.1038+42G>C::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9162G>C::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron11/12:c.1083+42G>C::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron11/11:c.1083+42G>C::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9162G>C::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9162G>C::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron12/12:c.1200+42G>C::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron12/12:c.1038+42G>C::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron11/12:c.1038+42G>C::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron12/12:c.1245+42G>C::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron12/12:c.1131+42G>C::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+420G>C::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron9/10:c.990+42G>C::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9162G>C::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9162G>C::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9162G>C::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron10/10:c.948+42G>C::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9162G>C::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9162G>C::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9162G>C::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9162G>C::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9162G>C::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1261387 [benign DISEASE=not provided];			rs3764833	0.0553	0.0818,0.0461,0.1300,0.0384,0.0441	288,.	7838	143684	1.2920			9.06			COSV53519387	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43921089	43921089	A	-	het	wt	het	off-target	QUAL=727;DP=23,18,44;AF=0.48,0.00,0.61;MQM=60;SAP=86;ABP=6;SAR=38;SAF=0	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron11/11:c.1152+162del::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron10/10:c.990+162del::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9042del::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9042del::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9042del::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron10/10:c.945+162del::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron11/12:c.1038+162del::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9042del::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron11/12:c.1083+162del::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron11/11:c.1038+162del::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron11/11:c.1083+162del::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9042del::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9042del::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron12/12:c.1200+162del::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron12/12:c.1038+162del::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron11/12:c.1038+162del::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron12/12:c.1245+162del::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron12/12:c.1131+162del::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron11/11:c.1038+162del::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron11/11:c.1038+162del::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+540del::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron9/10:c.990+162del::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9042del::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9042del::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9042del::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9042del::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron10/10:c.948+162del::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9042del::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9042del::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9042del::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9042del::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9042del::	regulatory_region_variant:CTCF_binding_site	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]				rs3835022	0.0401	0.0290,0.0418,0.1279,0.0382,0.0423	141,.	5815	145899	-0.2410			0.52				0.03		0	24	0 / 0					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43930114	43930114	C	T	het	hom	het	off-target	QUAL=10324;DP=170,184,258;AF=0.43,1.00,0.47;MQM=60;SAP=99;ABP=12;SAR=124;SAF=253	ST3GAL3	splice_region&intron	ST3GAL3:ENST00000372372.7:splice_region_variant&intron_variant:LOW:intron11/11:c.1153-18C>T::,ST3GAL3:ENST00000361400.9:splice_region_variant&intron_variant:LOW:intron10/10:c.991-18C>T::,ST3GAL3:ENST00000330208.6:splice_region_variant&intron_variant:LOW:intron4/4:c.255-18C>T::,ST3GAL3:ENST00000335430.10:splice_region_variant&intron_variant:LOW:intron7/7:c.*23-18C>T::,ST3GAL3:ENST00000545417.5:splice_region_variant&intron_variant:LOW:intron6/6:c.443-18C>T::,ST3GAL3:ENST00000372374.7:splice_region_variant&intron_variant:LOW:intron10/10:c.946-18C>T::,ST3GAL3:ENST00000643252.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1235-18C>T::,ST3GAL3:ENST00000647237.1:splice_region_variant&intron_variant:LOW:intron10/10:c.907-18C>T::,ST3GAL3:ENST00000642331.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1280-18C>T::,ST3GAL3:ENST00000347631.8:splice_region_variant&intron_variant:LOW:intron11/11:c.1039-18C>T::,ST3GAL3:ENST00000361392.9:splice_region_variant&intron_variant:LOW:intron11/11:c.1084-18C>T::,ST3GAL3:ENST00000353126.8:splice_region_variant&intron_variant:LOW:intron9/9:c.745-18C>T::,ST3GAL3:ENST00000642934.1:splice_region_variant&intron_variant:LOW:intron8/8:c.697-18C>T::,ST3GAL3:ENST00000351035.8:splice_region_variant&intron_variant:LOW:intron12/12:c.1201-18C>T::,ST3GAL3:ENST00000646971.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1039-18C>T::,ST3GAL3:ENST00000647148.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1166-18C>T::,ST3GAL3:ENST00000262915.8:splice_region_variant&intron_variant:LOW:intron12/12:c.1246-18C>T::,ST3GAL3:ENST00000361746.9:splice_region_variant&intron_variant:LOW:intron12/12:c.1132-18C>T::,ST3GAL3:ENST00000644195.1:splice_region_variant&intron_variant:LOW:intron11/11:c.1039-18C>T::,ST3GAL3:ENST00000372368.7:splice_region_variant&intron_variant:LOW:intron10/10:c.1054-18C>T::,ST3GAL3:ENST00000646686.1:splice_region_variant&intron_variant:LOW:intron10/10:c.1187-18C>T::,ST3GAL3:ENST00000372362.6:splice_region_variant&intron_variant:LOW:intron5/5:c.398-18C>T::,ST3GAL3:ENST00000531451.5:splice_region_variant&intron_variant:LOW:intron4/4:c.350-18C>T::,ST3GAL3:ENST00000372365.5:splice_region_variant&intron_variant:LOW:intron7/7:c.*23-18C>T::,ST3GAL3:ENST00000372367.5:splice_region_variant&intron_variant:LOW:intron6/6:c.555-18C>T::,ST3GAL3:ENST00000372369.5:splice_region_variant&intron_variant:LOW:intron10/10:c.949-18C>T::,ST3GAL3:ENST00000528371.5:splice_region_variant&intron_variant:LOW:intron6/6:c.510-18C>T::,ST3GAL3:ENST00000531816.1:splice_region_variant&intron_variant:LOW:intron3/3:c.255-18C>T::,ST3GAL3:ENST00000531993.6:splice_region_variant&intron_variant:LOW:intron6/6:c.604-18C>T::,ST3GAL3:ENST00000361812.9:splice_region_variant&intron_variant:LOW:intron5/5:c.443-18C>T::,ST3GAL3:ENST00000372366.6:splice_region_variant&intron_variant:LOW:intron6/6:c.*23-18C>T::	regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	262910 [benign DISEASE=Intellectual disability, autosomal recessive 12,Developmental and epileptic encephalopathy, 15,Early infantile epileptic encephalopathy with suppression bursts,not specified];			rs2108202	0.6000	0.2322,0.6297,0.6220,0.7829,0.6101	31729,.	27752	60796	0.2390			12.44	0.03	9.65>10.17	COSV53521961	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	43930524	43930524	A	G	het	wt	het		QUAL=3226;DP=153,75,118;AF=0.44,0.00,0.49;MQM=60;SAP=3;ABP=6;SAR=65;SAF=61	ST3GAL3	3'UTR	ST3GAL3:ENST00000372372.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000361400.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000330208.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*341A>G::,ST3GAL3:ENST00000335430.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*415A>G::,ST3GAL3:ENST00000545417.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::,ST3GAL3:ENST00000372374.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000643252.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000647237.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000642331.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000347631.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000361392.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000353126.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*303A>G::,ST3GAL3:ENST00000642934.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*303A>G::,ST3GAL3:ENST00000351035.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000646971.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000647148.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000262915.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000361746.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000644195.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000372368.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000646686.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*322A>G::,ST3GAL3:ENST00000361812.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*322A>G::,ST3GAL3:ENST00000372366.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*415A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]				rs12561948	0.0381	0.0212,0.0415,0.1299,0.0383,0.0436	135,.	5519	146343	1.8380			17.29				0.01		0	5	0 / 0					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	43930974	43930974	C	G	het	hom	het		QUAL=13487;DP=226,221,263;AF=0.49,1.00,0.54;MQM=60;SAP=10;ABP=4;SAR=217;SAF=256	ST3GAL3	3'UTR	ST3GAL3:ENST00000361400.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000330208.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*791C>G::,ST3GAL3:ENST00000335430.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*865C>G::,ST3GAL3:ENST00000545417.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::,ST3GAL3:ENST00000372374.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000643252.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000647237.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000642331.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000347631.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000361392.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000353126.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*753C>G::,ST3GAL3:ENST00000642934.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*753C>G::,ST3GAL3:ENST00000351035.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000646971.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000647148.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000262915.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000361746.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000644195.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000372368.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000646686.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*772C>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]				rs6801	0.6003	0.2320,0.6300,0.6225,0.7831,0.6109	31765,.	27751	60785	0.1650			2.26			COSV53521971	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	44819674	44819674	C	T	hom	n/a	n/a	off-target	QUAL=388;DP=17,2,2;AF=0.94,0.50,0.50;MQM=59;SAP=34;ABP=3;SAR=1;SAF=17	BTBD19,PTCH2,RNU5E-6P	downstream_gene	BTBD19:ENST00000450269.6:downstream_gene_variant:MODIFIER::::,PTCH2:ENST00000447098.6:downstream_gene_variant:MODIFIER::::,RNU5E-6P:ENST00000365574.1:downstream_gene_variant:MODIFIER::::,PTCH2:ENST00000372192.4:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]			AluSx (SINE/Alu)	rs72674049	0.2283	0.3926,0.2064,0.2028,0.1688,0.1566	4432,.	22924	107438	-1.3930			3.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BTBD19 (inh=n/a oe_syn=0.65 oe_mis=0.62 oe_lof=0.32), PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44819746	44819746	C	G	hom	het	het	off-target	QUAL=2466;DP=88,4,5;AF=1.00,0.50,0.40;MQM=60;SAP=194;ABP=3;SAR=1;SAF=91	BTBD19,PTCH2,RNU5E-6P	downstream_gene	BTBD19:ENST00000450269.6:downstream_gene_variant:MODIFIER::::,PTCH2:ENST00000447098.6:downstream_gene_variant:MODIFIER::::,RNU5E-6P:ENST00000365574.1:downstream_gene_variant:MODIFIER::::,PTCH2:ENST00000372192.4:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]			AluSx (SINE/Alu)	rs72674051	0.2031	0.3334,0.1895,0.1896,0.1580,0.1419	4048,.	20756	113188	-1.1880			0.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BTBD19 (inh=n/a oe_syn=0.65 oe_mis=0.62 oe_lof=0.32), PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44819862	44819862	A	C	wt	het	wt		QUAL=164;DP=127,26,28;AF=0.00,0.42,0.00;MQM=60;SAP=19;ABP=4;SAR=1;SAF=10	PTCH2	3'UTR	PTCH2:ENST00000447098.6:3_prime_UTR_variant:MODIFIER:exon23/23:c.*827T>G::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]				rs181782534	0.0116	0.0020,0.0080,0.0000,0.0146,0.0342	25,.	1714	150446	-0.4220			0.75						8	220	0 / 0					BTBD19 (inh=n/a oe_syn=0.65 oe_mis=0.62 oe_lof=0.32), PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44819976	44819976	C	T	hom	het	het		QUAL=20079;DP=512,168,176;AF=0.99,0.55,0.49;MQM=60;SAP=681;ABP=4;SAR=112;SAF=575	PTCH2,RNU5E-6P	3'UTR,non_coding_transcript_exon	PTCH2:ENST00000447098.6:3_prime_UTR_variant:MODIFIER:exon23/23:c.*713G>A::,RNU5E-6P:ENST00000365574.1:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.22G>A::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]			U5 (snRNA)	rs41269085	0.2278	0.3724,0.2069,0.2056,0.1693,0.1586	4638,.	25366	117448	-0.3300			0.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BTBD19 (inh=n/a oe_syn=0.65 oe_mis=0.62 oe_lof=0.32), PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44827194	44827194	G	A	hom	het	het		QUAL=9033;DP=164,147,208;AF=0.99,0.51,0.50;MQM=60;SAP=53;ABP=3;SAR=127;SAF=216	PTCH2	synonymous	PTCH2:ENST00000447098.6:synonymous_variant:LOW:exon16/23:c.2487C>T:p.Asp829=:,PTCH2:ENST00000372192.4:synonymous_variant:LOW:exon16/22:c.2487C>T:p.Asp829=:		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]	1166504 [benign DISEASE=Gorlin syndrome,not provided];			rs2295996	0.1438	0.0831,0.1746,0.2030,0.1673,0.1556	1775,.	18316	130248	0.4630			2.03			COSV64709782	0	23826113	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44827846	44827846	A	G	hom	het	het		QUAL=12971;DP=192,271,323;AF=0.99,0.48,0.48;MQM=60;SAP=466;ABP=5;SAR=79;SAF=398	PTCH2	synonymous	PTCH2:ENST00000447098.6:synonymous_variant:LOW:exon14/23:c.2055T>C:p.Ala685=:,PTCH2:ENST00000372192.4:synonymous_variant:LOW:exon14/22:c.2055T>C:p.Ala685=:		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]	1166505 [benign DISEASE=Gorlin syndrome,not provided];			rs7525308	0.4236	0.5891,0.4079,0.4871,0.3496,0.3446	14614,.	35202	87666	1.9440			11.23			COSV64709500	0	30591961,23826113,20371205	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44828484	44828484	T	C	hom	het	het	off-target	QUAL=21878;DP=234,517,682;AF=1.00,0.53,0.48;MQM=60;SAP=99;ABP=3;SAR=512;SAF=320	PTCH2	intron	PTCH2:ENST00000447098.6:intron_variant:MODIFIER:intron12/22:c.1590+22A>G::,PTCH2:ENST00000372192.4:intron_variant:MODIFIER:intron12/21:c.1590+22A>G::		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]	1327456 [benign DISEASE=Gorlin syndrome];			rs2273940	0.4221	0.5836,0.4071,0.4863,0.3498,0.3455	14452,.	35255	87847	-2.2410			0.07			COSV64709511	0.01	20371205	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44830239	44830239	-	TA	hom	het	het	off-target	QUAL=1909;DP=69,7,15;AF=0.97,0.57,0.40;MQM=60;SAP=170;ABP=3;SAR=77;SAF=0	PTCH2	intron	PTCH2:ENST00000447098.6:intron_variant:MODIFIER:intron6/22:c.814-210_814-209insTA::,PTCH2:ENST00000372192.4:intron_variant:MODIFIER:intron6/21:c.814-210_814-209insTA::		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]	1175624 [benign DISEASE=not provided];			rs5773854	0.6309	0.7401,0.6928,0.9733,0.5498,0.6714	31121,.	33438	55984				8.90				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44841834	44841834	G	A	hom	het	het	off-target	QUAL=7505;DP=80,183,212;AF=0.99,0.51,0.55;MQM=60;SAP=196;ABP=6;SAR=64;SAF=224	PTCH2	splice_region&intron	PTCH2:ENST00000447098.6:splice_region_variant&intron_variant:LOW:intron2/22:c.265+13C>T::,PTCH2:ENST00000372192.4:splice_region_variant&intron_variant:LOW:intron2/21:c.265+13C>T::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]	1327457 [benign DISEASE=Gorlin syndrome];			rs3795720	0.3499	0.3265,0.4331,0.4373,0.3474,0.3329	9477,.	34201	98769	1.5370			12.41			COSV64709520	0	20371205,34990798	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44842219	44842219	C	A	wt	wt	het	off-target	QUAL=140;DP=76,33,46;AF=0.00,0.03,0.30;MQM=60;SAP=36;ABP=18;SAR=15;SAF=0	PTCH2	intron	PTCH2:ENST00000447098.6:intron_variant:MODIFIER:intron1/22:c.73-180G>T::,PTCH2:ENST00000372192.4:intron_variant:MODIFIER:intron1/21:c.73-180G>T::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]				rs546830330	0.0010	0.0003,0.0005,0.0000,0.0018,0.0000	0,.	147	151951	-0.8320			0.53				0.06		0	23	0 / 0					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44857528	44857528	A	-	het	het	het	off-target;low_conf_region	QUAL=245;DP=64,47,44;AF=0.25,0.09,0.14;MQM=60;SAP=59;ABP=152;SAR=0;SAF=26	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron11/11:c.1306+176del::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron10/10:c.1203-6525del::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]			AluSp (SINE/Alu)	rs200709551	0.0013	0.0011,0.0010,0.0025,0.0011,0.0023	0,.	175	134703	1.1110			2.63				0		0	27	0 / 0					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44874610	44874610	C	T	hom	het	het		QUAL=20737;DP=402,252,314;AF=1.00,0.48,0.48;MQM=60;SAP=323;ABP=5;SAR=179;SAF=494	EIF2B3	intron,3'UTR	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron10/11:c.1202+68G>A::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron10/10:c.1202+68G>A::,EIF2B3:ENST00000372183.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*31G>A::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	1288223 [benign DISEASE=not provided];		HAL1 (LINE/L1)	rs9988451	0.4308	0.5899,0.4667,0.4452,0.3554,0.3437	14980,.	35457	86427	0.3200			4.60				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44875031	44875031	T	C	hom	het	het	off-target	QUAL=2941;DP=89,11,18;AF=1.00,0.55,0.61;MQM=60;SAP=233;ABP=5;SAR=106;SAF=0	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron9/11:c.1054-205A>G::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron9/10:c.1054-205A>G::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron9/9:c.1054-205A>G::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	1232545 [benign DISEASE=not provided];			rs263955	0.6798	0.9040,0.7080,0.9753,0.5527,0.6623	37145,.	28944	48634	0.0610			12.79				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44879774	44879774	T	A	hom	het	het	off-target	QUAL=4407;DP=102,44,64;AF=1.00,0.57,0.48;MQM=60;SAP=296;ABP=3;SAR=6;SAF=152	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron8/11:c.975+44A>T::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron8/10:c.975+44A>T::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron8/9:c.975+44A>T::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	261223 [benign DISEASE=not specified,not provided];			rs3738248	0.1502	0.1116,0.1489,0.1605,0.1734,0.1550	1830,.	19180	129218	0.2800			8.31			COSV64517062	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44897320	44897320	T	C	hom	het	het	off-target	QUAL=6694;DP=143,71,91;AF=1.00,0.52,0.57;MQM=60;SAP=243;ABP=6;SAR=36;SAF=196	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron6/11:c.656+35A>G::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron6/10:c.656+35A>G::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron6/9:c.656+35A>G::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	261222 [benign DISEASE=not specified,not provided];			rs263978	0.6783	0.9037,0.7086,0.9756,0.5497,0.6614	37076,.	28990	48908	-1.3970			1.06				0	25741868,15986317,18854859	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44897628	44897628	G	C	hom	het	het	off-target	QUAL=4450;DP=136,11,14;AF=1.00,0.82,0.57;MQM=60;SAP=335;ABP=10;SAR=153;SAF=0	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron5/11:c.567-184C>G::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron5/10:c.567-184C>G::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron5/9:c.567-184C>G::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	1258642 [benign DISEASE=not provided];			rs263979	0.2520	0.4497,0.1888,0.1689,0.1814,0.1588	5955,.	26274	113366	-0.0230			3.14				0	31642026	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44986555	44986555	G	C	hom	het	het		QUAL=6870;DP=126,107,187;AF=1.00,0.43,0.43;MQM=60;SAP=3;ABP=16;SAR=123;SAF=129	EIF2B3	5'UTR	EIF2B3:ENST00000360403.7:5_prime_UTR_variant:MODIFIER:exon1/12:c.-72C>G::,EIF2B3:ENST00000620860.4:5_prime_UTR_variant:MODIFIER:exon1/11:c.-72C>G::,EIF2B3:ENST00000372183.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-72C>G::	regulatory_region_variant:promoter	606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	297453 [benign DISEASE=Vanishing white matter disease];			rs489676	0.4788	0.6293,0.5152,0.4383,0.4151,0.3679	18278,.	36169	79181	-3.4960			1.33				0	15986317	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21), PPIAP35 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS17P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	45500031	45500031	G	T	wt	wt	het	off-target	QUAL=620;DP=33,29,51;AF=0.03,0.03,0.59;MQM=60;SAP=72;ABP=6;SAR=0;SAF=32	CCDC163	5'UTR	CCDC163:ENST00000629482.3:5_prime_UTR_variant:MODIFIER:exon1/5:c.-422C>A::	regulatory_region_variant:promoter,TF_binding_site_variant	609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]	684370 [benign DISEASE=not provided];			rs3748643	0.7375	0.8180,0.7998,0.9425,0.6666,0.7574	41753,.	28535	39871	0.6820			13.89					19573432,29302025	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDC163 (inh=n/a oe_syn=1.01 oe_mis=0.96 oe_lof=0.19), MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21)
chr1	45509417	45509417	T	-	het	het	het		QUAL=662;DP=86,111,119;AF=0.23,0.26,0.09;MQM=60;SAP=15;ABP=267;SAR=39;SAF=21	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*217del::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*132+85del::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	1208561 [likely benign DISEASE=not provided];		AluSg7 (SINE/Alu)	rs56934185	0.0366	0.0120,0.0235,0.0000,0.0450,0.0242	161,.	4351	122889	-2.0820			0.14				0		4	28	0 / 0					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45509494	45509494	A	G	wt	wt	het		QUAL=1064;DP=197,122,142;AF=0.01,0.00,0.38;MQM=60;SAP=46;ABP=21;SAR=44;SAF=11	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*279A>G::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*132+147A>G::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297502 [benign DISEASE=Cobalamin C disease,Disorders of Intracellular Cobalamin Metabolism,not provided];		AluSg7 (SINE/Alu)	rs9729395	0.2298	0.2144,0.2936,0.3206,0.2217,0.2466	3982,.	26021	113887	0.6060			3.67				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45509628	45509628	G	A	wt	het	wt		QUAL=2026;DP=182,134,192;AF=0.01,0.59,0.01;MQM=60;SAP=40;ABP=12;SAR=22;SAF=59	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*413G>A::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*132+281G>A::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297505 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSg7 (SINE/Alu)	rs12021717	0.1786	0.0985,0.1398,0.0570,0.2319,0.1580	2711,.	21536	124024	0.5480			2.18			COSV53113272	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510068	45510069	CT	-	wt	wt	het	low_conf_region	QUAL=1771;DP=238,174,185;AF=0.00,0.01,0.49;MQM=58;SAP=22;ABP=3;SAR=32;SAF=60	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*855_*856del::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*133-459_*133-458del::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297512 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSx4 (SINE/Alu)	rs398052965	0.6744	0.6083,0.7759,0.9098,0.6650,0.7512	33011,.	31711	47179	0.2820			0.79				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510077	45510077	A	-	het	het	het	low_conf_region	QUAL=968;DP=156,103,101;AF=0.19,0.24,0.17;MQM=59;SAP=3;ABP=284;SAR=34;SAF=38	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*877del::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*133-437del::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]			AluSx4 (SINE/Alu)	rs986671995	0.0722	0.2249,0.0302,0.0012,0.0038,0.0032	574,.	6328	96032	0.2270			0.74				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510475	45510475	G	A	wt	wt	het		QUAL=4633;DP=344,281,402;AF=0.00,0.00,0.49;MQM=60;SAP=11;ABP=3;SAR=113;SAF=86	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1260G>A::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*133-54G>A::	regulatory_region_variant:enhancer	609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297522 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluJr (SINE/Alu)	rs882803	0.6691	0.5944,0.7734,0.9109,0.6629,0.7485	34371,.	32837	50247	-3.1030			0.23				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510591	45510591	-	T	wt	wt	het		QUAL=3847;DP=316,259,317;AF=0.01,0.00,0.47;MQM=60;SAP=4;ABP=5;SAR=81;SAF=71	MMACHC	3'UTR	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1376_*1377insT::,MMACHC:ENST00000616135.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*195_*196insT::	regulatory_region_variant:enhancer	609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297525 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs5773883	0.6689	0.5945,0.7732,0.9108,0.6627,0.7480	34342,.	32888	50276				0.75			COSV53112744	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510915	45510915	A	G	wt	wt	het		QUAL=2435;DP=264,153,170;AF=0.00,0.00,0.56;MQM=60;SAP=5;ABP=8;SAR=52;SAF=43	MMACHC,PRDX1	3'UTR	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1700A>G::,MMACHC:ENST00000616135.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*519A>G::,PRDX1:ENST00000447184.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*414T>C::,PRDX1:ENST00000424390.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*414T>C::,PRDX1:ENST00000676549.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*414T>C::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297529 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs1044717	0.7376	0.8179,0.8002,0.9427,0.6668,0.7569	41804,.	28546	39892	-0.7710			1.16				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45694588	45694588	C	T	hom	het	hom	off-target	QUAL=10267;DP=133,119,145;AF=1.00,0.47,1.00;MQM=60;SAP=279;ABP=4;SAR=270;SAF=64	TMEM69,IPP	downstream_gene	TMEM69:ENST00000372025.5:downstream_gene_variant:MODIFIER::::,IPP:ENST00000396478.4:downstream_gene_variant:MODIFIER::::						rs6658700	0.2833	0.2409,0.3098,0.3456,0.2945,0.3647	6216,.	30600	108856	0.2500			9.06					15986317	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45698718	45698727	TTTTTTTTTT	-	hom	n/a	hom		QUAL=737;DP=21,1,5;AF=1.00,1.00,1.00;MQM=60;SAP=62;ABP=0;SAR=0;SAF=27	IPP	3'UTR	IPP:ENST00000396478.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1239_*1248del::					AluJb (SINE/Alu)	rs78627575	0.3196	0.2760,0.3668,0.3746,0.3189,0.3968	6150,.	29519	89047	0.7410			0.78				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45699174	45699174	A	T	hom	het	hom		QUAL=21052;DP=306,179,299;AF=0.99,0.47,1.00;MQM=60;SAP=747;ABP=4;SAR=586;SAF=101	IPP	3'UTR	IPP:ENST00000396478.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*792T>A::						rs10749856	0.2862	0.2409,0.3111,0.3650,0.2975,0.3683	6344,.	30799	108463	1.3890			7.00				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45700203	45700203	-	A	hom	het	hom	off-target;low_conf_region	QUAL=9574;DP=142,190,202;AF=0.86,0.41,0.88;MQM=60;SAP=190;ABP=18;SAR=278;SAF=98	IPP	splice_region&intron	IPP:ENST00000396478.4:splice_region_variant&intron_variant:LOW:intron8/8:c.1531-14dup::						rs550999501	0.2848	0.2273,0.3103,0.3671,0.2996,0.3716	6009,.	30262	106158				15.65				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45727474	45727474	-	TCCC	hom	het	hom	off-target;low_conf_region	QUAL=119;DP=7,6,5;AF=0.43,0.17,0.60;MQM=55;SAP=18;ABP=9;SAR=0;SAF=7	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron5/8:c.1048+153_1048+156dup::					(CCTT)n (Simple_repeat)	rs200134370	0.3083	0.3876,0.2945,0.3221,0.2766,0.3383	6628,.	30943	99177				0.59				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45729540	45729542	AAC	-	hom	het	hom	off-target	QUAL=3243;DP=87,18,20;AF=0.94,0.50,1.00;MQM=60;SAP=227;ABP=3;SAR=2;SAF=109	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron4/8:c.880+72_880+74del::	regulatory_region_variant:enhancer					rs139068713	0.2804	0.2347,0.3082,0.3278,0.2940,0.3636	6064,.	30457	109271	1.0420			6.62				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45729703	45729703	T	C	hom	het	hom		QUAL=10569;DP=230,60,65;AF=1.00,0.57,0.97;MQM=60;SAP=139;ABP=5;SAR=235;SAF=92	IPP	missense	IPP:ENST00000396478.4:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:	regulatory_region_variant:enhancer					rs28375469	0.2817	0.2352,0.3089,0.3426,0.2948,0.3650	6168,.	30492	109198	7.6030	T(0.22)	B(0.00)	22.40	0.19		COSV63431879	0	32327693,33777101	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45740727	45740727	G	A	hom	n/a	n/a	off-target	QUAL=475;DP=15,0,2;AF=1.00,,1.00;MQM=60;SAP=40;ABP=0;SAR=0;SAF=17	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron3/8:c.724+174C>T::						rs28647556	0.5356	0.5679,0.4882,0.3746,0.5380,0.5094	21827,.	37485	70355	0.1770			9.68				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45740868	45740868	A	G	hom	het	hom	off-target	QUAL=9799;DP=270,25,37;AF=1.00,0.68,1.00;MQM=60;SAP=704;ABP=10;SAR=0;SAF=323	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron3/8:c.724+33T>C::						rs28507722	0.2816	0.2350,0.3094,0.3431,0.2946,0.3645	6160,.	30508	109258	1.3640			8.30			COSV63433613	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46189486	46189486	T	C	hom	hom	hom		QUAL=12797;DP=140,141,131;AF=0.99,1.00,1.00;MQM=60;SAP=158;ABP=0;SAR=120;SAF=291	POMGNT1	missense,missense&splice_region	POMGNT1:ENST00000371984.8:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000371992.1:missense_variant&splice_region_variant:MODERATE:exon21/23:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000396420.8:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000686737.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000685444.1:missense_variant:MODERATE:exon20/21:c.1768A>G:p.Met590Val:,POMGNT1:ENST00000688608.1:missense_variant:MODERATE:exon20/21:c.1768A>G:p.Met590Val:,POMGNT1:ENST00000692369.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000687683.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000687149.1:missense_variant:MODERATE:exon20/21:c.1906A>G:p.Met636Val:	regulatory_region_variant:enhancer	606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	167524 [benign DISEASE=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3,Autosomal recessive limb-girdle muscular dystrophy type 2O,Retinitis pigmentosa 76,Muscle eye brain disease,not specified];			rs6659553	0.9482	0.8188,0.9822,1.0000,0.9994,0.9992	68933,.	6431	7889	5.8290		B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	22.50	0.33	2.63>0.43		0.19	24033266,17878207,25373335,28765568	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN1 (inh=AR oe_syn=1.16 oe_mis=0.87 oe_lof=0.79), POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46191979	46191979	T	C	hom	hom	het	off-target	QUAL=13271;DP=245,144,172;AF=0.99,0.99,0.46;MQM=60;SAP=1013;ABP=5;SAR=0;SAF=465	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron17/22:c.1539+119A>G::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron16/20:c.1440+119A>G::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron16/20:c.1440+119A>G::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron17/20:c.1539+119A>G::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	667975 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs7521880	0.3486	0.3487,0.3618,0.1592,0.3528,0.4334	9397,.	34180	98970	-0.1390			5.50			COSV64339342	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46192656	46192656	A	G	hom	hom	het	off-target	QUAL=27532;DP=424,294,377;AF=0.99,1.00,0.47;MQM=60;SAP=430;ABP=5;SAR=656;SAF=237	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron14/22:c.1212-66T>C::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron13/20:c.1113-66T>C::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron13/20:c.1113-66T>C::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron14/20:c.1212-66T>C::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	671038 [benign DISEASE=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Retinitis pigmentosa 76,not provided];			rs2292484	0.3481	0.3477,0.3615,0.1599,0.3524,0.4330	9309,.	34178	98870	0.2780			8.97			COSV64341376	0.08		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46192671	46192671	G	A	hom	hom	het	off-target	QUAL=26391;DP=426,275,360;AF=1.00,1.00,0.48;MQM=60;SAP=451;ABP=5;SAR=648;SAF=224	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron14/22:c.1212-81C>T::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron13/20:c.1113-81C>T::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron13/20:c.1113-81C>T::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron14/20:c.1212-81C>T::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	671037 [benign DISEASE=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Retinitis pigmentosa 76,not provided];			rs2292485	0.3479	0.3471,0.3618,0.1591,0.3524,0.4322	9291,.	34169	98857	0.1270			3.74			COSV64341379	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46193432	46193432	T	C	hom	hom	het	off-target	QUAL=40792;DP=348,624,797;AF=1.00,1.00,0.49;MQM=60;SAP=16;ABP=4;SAR=726;SAF=635	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron11/22:c.1027-44A>G::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron10/20:c.928-44A>G::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron10/20:c.928-44A>G::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron11/20:c.1027-44A>G::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	260869 [benign DISEASE=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3,Autosomal recessive limb-girdle muscular dystrophy type 2O,Retinitis pigmentosa 76,not specified,not provided];			rs7527668	0.3772	0.4456,0.3731,0.1596,0.3534,0.4343	11081,.	35149	94623	-0.3030			4.53			COSV64339664	0.12	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46193691	46193691	T	C	hom	hom	het	off-target	QUAL=23740;DP=296,318,329;AF=0.99,1.00,0.55;MQM=60;SAP=166;ABP=9;SAR=518;SAF=274	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron10/22:c.951-52A>G::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron9/20:c.852-52A>G::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron9/20:c.852-52A>G::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron10/20:c.951-52A>G::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	671035 [benign DISEASE=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Retinitis pigmentosa 76,not provided];			rs7527935	0.3487	0.3485,0.3621,0.1596,0.3528,0.4336	9408,.	34163	98953	-0.0180			1.62			COSV64339668	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46194623	46194623	T	C	hom	hom	het		QUAL=17580;DP=258,198,303;AF=1.00,0.99,0.45;MQM=60;SAP=111;ABP=11;SAR=380;SAF=209	POMGNT1	synonymous,intron	POMGNT1:ENST00000371984.8:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000371992.1:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,POMGNT1:ENST00000396420.8:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000686737.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron7/20:c.652+221A>G::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron7/20:c.652+221A>G::,POMGNT1:ENST00000692369.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000687683.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000687149.1:synonymous_variant:LOW:exon8/21:c.681A>G:p.Lys227=:	regulatory_region_variant:enhancer	606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	95761 [benign DISEASE=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3,Autosomal recessive limb-girdle muscular dystrophy type 2O,Retinitis pigmentosa 76,Muscle eye brain disease,not specified,Congenital Muscular Dystrophy, alpha-dystroglycan related,not provided];			rs2292487	0.3492	0.3496,0.3621,0.1593,0.3531,0.4337	9428,.	34204	98904	0.3970			10.11	0.05		COSV64339346	0.04	25741868,24033266,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	47250369	47250370	AA	-	het	het	wt		QUAL=5540;DP=253,174,174;AF=0.51,0.52,0.00;MQM=56;SAP=3;ABP=4;SAR=112;SAF=109	STIL	3'UTR	STIL:ENST00000360380.7:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:ENST00000371877.8:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::,STIL:ENST00000337817.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*766_*767del::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	297544 [benign DISEASE=Primary Microcephaly, Recessive];			rs75930208	0.4249	0.1690,0.4307,0.4475,0.5212,0.5497	15808,.	32905	87333	1.6070			3.64				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47251517	47251517	A	G	het	het	wt		QUAL=8543;DP=442,231,305;AF=0.51,0.40,0.01;MQM=60;SAP=38;ABP=7;SAR=124;SAF=196	STIL	synonymous	STIL:ENST00000360380.7:synonymous_variant:LOW:exon18/18:c.3483T>C:p.Pro1161=:,STIL:ENST00000371877.8:synonymous_variant:LOW:exon17/17:c.3486T>C:p.Pro1162=:,STIL:ENST00000337817.10:synonymous_variant:LOW:exon19/19:c.3345T>C:p.Pro1115=:,STIL:ENST00000396221.6:synonymous_variant:LOW:exon17/17:c.3432T>C:p.Pro1144=:,STIL:ENST00000682977.1:synonymous_variant:LOW:exon18/18:c.3345T>C:p.Pro1115=:,STIL:ENST00000447475.7:synonymous_variant:LOW:exon19/19:c.3291T>C:p.Pro1097=:		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	94095 [benign DISEASE=Microcephaly 7, primary, autosomal recessive,not specified,not provided];			rs2758735	0.4259	0.1706,0.4313,0.4473,0.5219,0.5494	15893,.	32953	87277	-0.8210			0.85				0	25741868,18414213,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47260415	47260415	T	C	het	het	het		QUAL=6427;DP=211,117,176;AF=0.51,0.47,0.47;MQM=60;SAP=76;ABP=4;SAR=77;SAF=168	STIL	missense	STIL:ENST00000360380.7:missense_variant:MODERATE:exon17/18:c.2951A>G:p.His984Arg:,STIL:ENST00000371877.8:missense_variant:MODERATE:exon16/17:c.2954A>G:p.His985Arg:,STIL:ENST00000337817.10:missense_variant:MODERATE:exon18/19:c.2813A>G:p.His938Arg:,STIL:ENST00000396221.6:missense_variant:MODERATE:exon16/17:c.2900A>G:p.His967Arg:,STIL:ENST00000682977.1:missense_variant:MODERATE:exon17/18:c.2813A>G:p.His938Arg:,STIL:ENST00000447475.7:missense_variant:MODERATE:exon18/19:c.2759A>G:p.His920Arg:		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	94094 [benign DISEASE=Microcephaly 7, primary, autosomal recessive,not specified,not provided];			rs13376679	0.2528	0.2017,0.2152,0.0254,0.3137,0.2084	5203,.	28020	113584	0.0110	T(0.53),T(0.53),T(0.52),T(0.58),T(0.52),T(0.58)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	1.81	0.03		COSV54551803	0	25741868,23757202,23772360	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47269608	47269608	T	C	het	n/a	n/a	off-target	QUAL=66;DP=5,0,0;AF=0.60,,;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron15/17:c.2474+27A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	160057 [benign DISEASE=not specified,not provided];			rs2742104	0.4259	0.1705,0.4318,0.4486,0.5219,0.5502	15882,.	32941	87211	-0.1460			1.27			COSV54550059	0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47272449	47272449	T	-	hom	hom	het	off-target	QUAL=235;DP=13,3,5;AF=0.85,0.67,0.20;MQM=60;SAP=33;ABP=7;SAR=14;SAF=0	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron13/17:c.2218-208del::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron12/16:c.2218-208del::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron14/18:c.2077-208del::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron12/16:c.2218-208del::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron13/17:c.2077-208del::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron14/18:c.2077-208del::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	1295564 [benign DISEASE=not provided];		AluJr (SINE/Alu)	rs60685133	0.5265	0.3446,0.5013,0.4683,0.6058,0.6703	20771,.	35204	69016	-0.3060			0.31				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47281321	47281321	G	A	het	het	het	off-target	QUAL=2697;DP=168,20,44;AF=0.50,0.45,0.41;MQM=60;SAP=244;ABP=4;SAR=111;SAF=0	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron12/17:c.1249-112C>T::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron11/16:c.1249-112C>T::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron13/18:c.1108-112C>T::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron11/16:c.1249-112C>T::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron12/17:c.1108-112C>T::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron13/18:c.1108-112C>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	1246005 [benign DISEASE=not provided];			rs11211505	0.2589	0.2220,0.2175,0.0252,0.3140,0.2083	5410,.	28490	112554	-0.5560			1.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47281418	47281418	T	C	het	hom	het	off-target	QUAL=870;DP=64,3,7;AF=0.47,1.00,0.57;MQM=60;SAP=83;ABP=3;SAR=37;SAF=0	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron12/17:c.1249-209A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron11/16:c.1249-209A>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron13/18:c.1108-209A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron11/16:c.1249-209A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron12/17:c.1108-209A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron13/18:c.1108-209A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	1182531 [benign DISEASE=not provided];		L2c (LINE/L2)	rs12145974	0.2589	0.2225,0.2173,0.0254,0.3139,0.2076	5414,.	28501	112595	0.3230			9.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47287733	47287733	G	A	het	het	wt	off-target	QUAL=2245;DP=162,53,84;AF=0.40,0.53,0.00;MQM=60;SAP=164;ABP=12;SAR=88;SAF=5	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron10/17:c.1024-73C>T::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron9/16:c.1024-73C>T::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron11/18:c.883-73C>T::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron9/16:c.1024-73C>T::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron10/17:c.883-73C>T::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron11/18:c.883-73C>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	673949 [benign DISEASE=not provided];			rs12125261	0.3828	0.0933,0.4084,0.2242,0.5107,0.4536	13917,.	30274	93684	0.7330			14.90			COSV54548877	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47299818	47299818	T	C	het	het	hom	off-target	QUAL=3886;DP=130,45,55;AF=0.45,0.67,1.00;MQM=60;SAP=316;ABP=3;SAR=0;SAF=144	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron7/17:c.701+87A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron6/16:c.701+87A>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron8/18:c.560+87A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron6/16:c.701+87A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron7/17:c.560+87A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron8/18:c.560+87A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	670465 [benign DISEASE=not provided];			rs9436838	0.5823	0.8401,0.5726,0.5812,0.4858,0.4549	27945,.	32618	63498	-0.3510			5.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47301469	47301469	C	A	het	het	hom	off-target	QUAL=3490;DP=173,26,43;AF=0.49,0.46,1.00;MQM=60;SAP=305;ABP=4;SAR=0;SAF=139	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron6/17:c.453+92G>T::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron5/16:c.453+92G>T::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron6/18:c.453+92G>T::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron5/16:c.453+92G>T::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron5/17:c.453+92G>T::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron6/18:c.453+92G>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	670581 [benign DISEASE=not provided];			rs6689687	0.5824	0.8401,0.5721,0.5844,0.4858,0.4554	27928,.	32602	63420	0.1760			2.52			COSV54552578	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47302242	47302242	G	A	het	het	hom		QUAL=13720;DP=245,185,258;AF=0.51,0.54,0.99;MQM=60;SAP=33;ABP=5;SAR=200;SAF=281	STIL	missense	STIL:ENST00000360380.7:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000371877.8:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000337817.10:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000396221.6:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000682977.1:missense_variant:MODERATE:exon4/18:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000447475.7:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus]		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	21354 [benign DISEASE=Microcephaly 7, primary, autosomal recessive,not specified,not provided];			rs3125630	0.5751	0.8317,0.5687,0.5529,0.4791,0.4502	27255,.	32820	64532	5.3540	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	18.91	0.17		COSV54548838	0	25741868,20301772,23772360	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47304769	47304769	A	C	het	het	hom	off-target	QUAL=3960;DP=70,63,77;AF=0.57,0.54,0.99;MQM=60;SAP=329;ABP=7;SAR=0;SAF=150	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron4/17:c.152+120T>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron3/16:c.152+120T>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron4/18:c.152+120T>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron3/16:c.152+120T>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron3/17:c.152+120T>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron4/18:c.152+120T>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	670580 [benign DISEASE=not provided];			rs3122615	0.5749	0.8312,0.5680,0.5516,0.4792,0.4506	27259,.	32858	64604	-0.1650			3.20				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47304794	47304794	T	C	wt	wt	het	off-target	QUAL=1416;DP=84,87,124;AF=0.00,0.00,0.49;MQM=60;SAP=96;ABP=3;SAR=5;SAF=56	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron4/17:c.152+95A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron3/16:c.152+95A>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron4/18:c.152+95A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron3/16:c.152+95A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron3/17:c.152+95A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron4/18:c.152+95A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	672536 [benign DISEASE=not provided];			rs3122616	0.2205	0.2848,0.3119,0.5268,0.1603,0.2394	4352,.	24790	118390	-0.1080			10.61			COSV54553648	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47305114	47305114	T	A	het	het	wt	off-target	QUAL=2183;DP=140,56,70;AF=0.45,0.55,0.00;MQM=60;SAP=207;ABP=4;SAR=94;SAF=0	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron3/17:c.45-118A>T::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron2/16:c.45-118A>T::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron3/18:c.45-118A>T::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron2/16:c.45-118A>T::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron2/17:c.45-118A>T::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron3/18:c.45-118A>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	670141 [benign DISEASE=not provided];			rs6692734	0.3822	0.0928,0.4091,0.2241,0.5095,0.4522	13916,.	30288	93934	-0.4510			0.37			COSV54552742	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47305134	47305134	T	C	het	het	het	off-target	QUAL=2371;DP=122,22,28;AF=0.55,0.59,0.61;MQM=60;SAP=214;ABP=9;SAR=97;SAF=0	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron3/17:c.45-138A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron2/16:c.45-138A>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron3/18:c.45-138A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron2/16:c.45-138A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron2/17:c.45-138A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron3/18:c.45-138A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	1293134 [benign DISEASE=not provided];			rs12129594	0.2551	0.2027,0.2179,0.0254,0.3171,0.2087	5302,.	28179	113255	-0.4610			1.20			COSV54549757	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	50600416	50600416	T	C	het	het	wt		QUAL=3511;DP=166,136,172;AF=0.43,0.48,0.00;MQM=60;SAP=78;ABP=9;SAR=34;SAF=103	FAF1	intron	FAF1:ENST00000396153.7:intron_variant:MODIFIER:intron8/18:c.745-4200A>G::					Charlie1a (DNA/hAT-Charlie)	rs6679854	0.2326	0.1788,0.2394,0.0033,0.2810,0.2406	4536,.	26275	116641	0.3190			4.52			COSV65639546	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAF1 (inh=n/a oe_syn=0.86 oe_mis=0.68 oe_lof=0.12)
chr1	52941734	52941734	-	A	wt	wt	het	off-target;low_conf_region	QUAL=471;DP=94,56,84;AF=0.29,0.13,0.10;MQM=59;SAP=19;ABP=352;SAR=4;SAF=16	SCP2	intron	SCP2:ENST00000371514.8:intron_variant:MODIFIER:intron1/15:c.70-47dup::,SCP2:ENST00000528311.5:intron_variant:MODIFIER:intron1/14:c.-116-6260dup::,SCP2:ENST00000371509.8:intron_variant:MODIFIER:intron1/14:c.70-47dup::,SCP2:ENST00000407246.6:intron_variant:MODIFIER:intron1/14:c.70-47dup::,SCP2:ENST00000371513.9:intron_variant:MODIFIER:intron1/10:c.70-47dup::		184755_[GENE=SCP2_PHENOS=?Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3), Autosomal recessive]	1197564 [likely benign DISEASE=not provided];		AluSg (SINE/Alu)	rs143386725	0.0142	0.0332,0.0121,0.0272,0.0035,0.0059	17,.	1655	116925				0.81				0		4	349	0 / 0					SCP2 (inh=AR oe_syn=0.97 oe_mis=0.79 oe_lof=0.49), H3P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	52941735	52941735	A	-	het	het	wt	off-target;low_conf_region	QUAL=471;DP=94,56,84;AF=0.07,0.04,0.13;MQM=58;SAP=50;ABP=212;SAR=6;SAF=36	SCP2	intron	SCP2:ENST00000371514.8:intron_variant:MODIFIER:intron1/15:c.70-47del::,SCP2:ENST00000528311.5:intron_variant:MODIFIER:intron1/14:c.-116-6260del::,SCP2:ENST00000371509.8:intron_variant:MODIFIER:intron1/14:c.70-47del::,SCP2:ENST00000407246.6:intron_variant:MODIFIER:intron1/14:c.70-47del::,SCP2:ENST00000371513.9:intron_variant:MODIFIER:intron1/10:c.70-47del::		184755_[GENE=SCP2_PHENOS=?Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3), Autosomal recessive]	801491 [benign DISEASE=Sterol carrier protein 2 deficiency,not provided];		AluSg (SINE/Alu)	rs143386725	0.0704	0.1129,0.0601,0.2209,0.0374,0.0754	296,.	7764	110264	0.0050			0.25				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SCP2 (inh=AR oe_syn=0.97 oe_mis=0.79 oe_lof=0.49), H3P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	53047765	53047765	T	C	wt	het	wt	off-target	QUAL=2249;DP=264,163,223;AF=0.00,0.55,0.00;MQM=60;SAP=119;ABP=6;SAR=10;SAF=79	SCP2	intron	SCP2:ENST00000371514.8:intron_variant:MODIFIER:intron14/15:c.1469-93T>C::,SCP2:ENST00000528311.5:intron_variant:MODIFIER:intron13/14:c.1226-93T>C::,SCP2:ENST00000371509.8:intron_variant:MODIFIER:intron13/14:c.1337-93T>C::,SCP2:ENST00000407246.6:intron_variant:MODIFIER:intron13/14:c.1397-93T>C::,SCP2:ENST00000430330.6:intron_variant:MODIFIER:intron3/4:c.248-93T>C::,SCP2:ENST00000408941.7:intron_variant:MODIFIER:intron2/3:c.127-93T>C::,SCP2:ENST00000435345.6:intron_variant:MODIFIER:intron3/4:c.257-93T>C::,SCP2:ENST00000488965.1:intron_variant:MODIFIER:intron2/2:c.127-93T>C::	regulatory_region_variant:enhancer	184755_[GENE=SCP2_PHENOS=?Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3), Autosomal recessive]	1290761 [benign DISEASE=not provided];			rs1288362	0.3361	0.1050,0.3391,0.2735,0.4482,0.2609	10336,.	30423	100939	-0.6460			2.69			COSV65260679	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SCP2 (inh=AR oe_syn=0.97 oe_mis=0.79 oe_lof=0.49)
chr1	53196294	53196294	G	A	het	wt	hom	off-target	QUAL=1471;DP=72,31,34;AF=0.40,0.00,0.97;MQM=60;SAP=129;ABP=9;SAR=1;SAF=61	CPT2	upstream_gene	CPT2:ENST00000636867.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000636891.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000637252.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000636935.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000635862.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000371486.4:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	1236333 [benign DISEASE=not provided];			rs10888776	0.4549	0.2772,0.4471,0.7229,0.5413,0.2732	17087,.	34937	82801	0.1590			9.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78)
chr1	53197151	53197151	C	A	het	wt	het	off-target	QUAL=1504;DP=11,61,106;AF=0.36,0.00,0.60;MQM=60;SAP=3;ABP=10;SAR=34;SAF=34	CPT2	intron	CPT2:ENST00000636867.1:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:ENST00000636891.1:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:ENST00000637252.1:intron_variant:MODIFIER:intron1/5:c.152+56C>A::,CPT2:ENST00000636935.1:intron_variant:MODIFIER:intron1/3:c.152+56C>A::,CPT2:ENST00000635862.1:intron_variant:MODIFIER:intron1/5:c.152+56C>A::,CPT2:ENST00000371486.4:intron_variant:MODIFIER:intron1/4:c.152+56C>A::	regulatory_region_variant:promoter	600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	1177631 [benign DISEASE=Carnitine palmitoyl transferase II deficiency, severe infantile form,Carnitine palmitoyl transferase II deficiency, neonatal form,not provided];			rs72673121	0.1450	0.0395,0.1483,0.0508,0.2153,0.0934	2092,.	17868	130030	-0.0020			7.72				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78)
chr1	53209860	53209860	T	C	wt	wt	het	off-target	QUAL=92;DP=116,15,24;AF=0.01,0.00,0.33;MQM=60;SAP=23;ABP=9;SAR=0;SAF=9	CPT2	intron	CPT2:ENST00000636867.1:intron_variant:MODIFIER:intron3/4:c.341-155T>C::,CPT2:ENST00000636891.1:intron_variant:MODIFIER:intron3/4:c.341-155T>C::,CPT2:ENST00000637252.1:intron_variant:MODIFIER:intron3/5:c.341-155T>C::,CPT2:ENST00000636935.1:intron_variant:MODIFIER:intron3/3:c.341-3404T>C::,CPT2:ENST00000635862.1:intron_variant:MODIFIER:intron3/5:c.341-155T>C::,CPT2:ENST00000371486.4:intron_variant:MODIFIER:intron3/4:c.341-155T>C::		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	680257 [benign DISEASE=Carnitine palmitoyl transferase II deficiency, severe infantile form,Carnitine palmitoyl transferase II deficiency, neonatal form,not provided];			rs12737375	0.2553	0.0928,0.2399,0.4607,0.3245,0.1660	6043,.	26733	113233	-0.7310			4.22			COSV53760513	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	53210776	53210776	G	A	het	wt	hom		QUAL=11219;DP=287,215,230;AF=0.53,0.00,1.00;MQM=60;SAP=57;ABP=6;SAR=241;SAF=143	CPT2	missense,intron	CPT2:ENST00000636867.1:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636891.1:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000637252.1:missense_variant:MODERATE:exon4/6:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636935.1:intron_variant:MODIFIER:intron3/3:c.341-2488G>A::,CPT2:ENST00000635862.1:missense_variant:MODERATE:exon4/6:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000371486.4:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase]		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	92429 [benign DISEASE=Carnitine palmitoyl transferase II deficiency, severe infantile form,Carnitine palmitoyl transferase II deficiency, neonatal form,Carnitine palmitoyltransferase II deficiency,not specified,not provided]; 30118 [risk factor DISEASE=Encephalopathy, acute, infection-induced, susceptibility to, 4];	CM139511 [CLASS=DP MUT=ALT PHEN="Infuenza infection-associated encephalopathy" GENE=CPT2];		rs1799821	0.4590	0.2892,0.4494,0.7225,0.5422,0.2729	17289,.	35129	82165	-0.0480	T(1.00),T(0.99),T(1.00), ,T(1.00),T(1.00)	B(0.03),B(0.01),B(0.01), ,B(0.01),B(0.00)	0.01	0.23		COSV53758728	0	15986317,23757202,15811315,18306170,20934285,21697855,22809552,26874509,26010953,26460316,33170162,27156515,25361188,34234772	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	53213557	53213557	A	G	het	wt	het		QUAL=6125;DP=267,177,238;AF=0.48,0.00,0.46;MQM=60;SAP=8;ABP=7;SAR=107;SAF=130	CPT2	missense,3'UTR	CPT2:ENST00000636867.1:missense_variant:MODERATE:exon5/5:c.1870A>G:p.Met624Val:,CPT2:ENST00000636891.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*192A>G::,CPT2:ENST00000637252.1:missense_variant:MODERATE:exon6/6:c.1975A>G:p.Met659Val:,CPT2:ENST00000636935.1:missense_variant:MODERATE:exon4/4:c.634A>G:p.Met212Val:,CPT2:ENST00000635862.1:missense_variant:MODERATE:exon6/6:c.1906A>G:p.Met636Val:,CPT2:ENST00000371486.4:missense_variant:MODERATE:exon5/5:c.1939A>G:p.Met647Val:		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	92433 [benign DISEASE=Carnitine palmitoyl transferase II deficiency, severe infantile form,Carnitine palmitoyl transferase II deficiency, neonatal form,Carnitine palmitoyltransferase II deficiency,not specified,not provided];	CM1720321 [CLASS=DM? MUT=ALT PHEN="Carnitine palmitoyltransferase 2 deficiency" GENE=CPT2];		rs1799822	0.1515	0.0513,0.1635,0.0817,0.2168,0.0948	2187,.	18683	129113	7.4310	D(0.01), ,D(0.01),D(0.02),D(0.01),D(0.01)	B(0.01), ,B(0.00),B(0.07),B(0.00),B(0.01)	22.80	0.29		COSV53759353	0.02	23757202,31201655,15647998,32778093,33170162,27156515,33031748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	53214206	53214206	T	C	wt	wt	het		QUAL=694;DP=104,48,47;AF=0.00,0.00,0.60;MQM=60;SAP=14;ABP=7;SAR=20;SAF=8	CZIB	3'UTR	CZIB:ENST00000294360.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*453A>G::		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	368876 [benign DISEASE=Carnitine palmitoyltransferase II deficiency];			rs1056438	0.2551	0.0927,0.2399,0.4619,0.3242,0.1673	6029,.	26732	113280	-0.2760			5.30				0	33457407	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	54849678	54849678	T	C	hom	hom	hom		QUAL=17140;DP=246,129,156;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0;SAR=286;SAF=245	DHCR24	3'UTR	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2555A>G::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2555A>G::	regulatory_region_variant:enhancer	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297612 [benign DISEASE=Desmosterolosis];			rs657688	0.9994	0.9982,0.9997,0.9998,1.0000,1.0000	76006,.	85	85	-0.6870			2.33				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54850268	54850268	G	T	het	wt	het		QUAL=10592;DP=445,318,385;AF=0.47,0.00,0.50;MQM=60;SAP=22;ABP=5;SAR=172;SAF=232	DHCR24	3'UTR	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1965C>A::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1965C>A::	regulatory_region_variant:enhancer	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297621 [benign DISEASE=Desmosterolosis];			rs11555500	0.0239	0.0071,0.0146,0.0004,0.0389,0.0050	75,.	3486	148562	0.8670			6.54				0		0	13	0 / 0					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54850409	54850409	A	C	hom	hom	hom		QUAL=25126;DP=318,190,256;AF=1.00,1.00,1.00;MQM=60;SAP=8;ABP=0;SAR=402;SAF=362	DHCR24	3'UTR	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1824T>G::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1824T>G::	regulatory_region_variant:enhancer	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297623 [benign DISEASE=Desmosterolosis];			rs654561	0.9895	0.9687,0.9969,0.9923,0.9997,0.9702	74529,.	1556	1604	-0.2930			3.19				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54854229	54854229	A	G	hom	hom	hom		QUAL=601;DP=7,3,9;AF=1.00,1.00,1.00;MQM=60;SAP=29;ABP=0;SAR=17;SAF=2	DHCR24	synonymous	DHCR24:ENST00000371269.9:synonymous_variant:LOW:exon7/9:c.1026T>C:p.Ile342=:,DHCR24:ENST00000535035.6:synonymous_variant:LOW:exon8/10:c.1062T>C:p.Ile354=:,DHCR24:ENST00000436604.2:synonymous_variant:LOW:exon7/10:c.1026T>C:p.Ile342=:		606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297654 [benign DISEASE=Desmosterolosis,not provided];			rs718265	0.6648	0.6171,0.6211,0.4113,0.6969,0.8034	33896,.	33113	50887	1.6670			9.77			COSV64875204	0	17510943,21901424,17579359,24489783,34680591	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54871277	54871277	C	G	hom	hom	hom	off-target	QUAL=7887;DP=58,101,112;AF=1.00,1.00,1.00;MQM=60;SAP=591;ABP=0;SAR=0;SAF=271	DHCR24	intron	DHCR24:ENST00000371269.9:intron_variant:MODIFIER:intron5/8:c.876+73G>C::,DHCR24:ENST00000535035.6:intron_variant:MODIFIER:intron5/9:c.876+73G>C::,DHCR24:ENST00000436604.2:intron_variant:MODIFIER:intron5/9:c.876+73G>C::		606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	1278679 [benign DISEASE=not provided];			rs608458	0.6173	0.5334,0.5548,0.3726,0.6714,0.7863	29724,.	34360	58164	-0.2220			1.26			COSV64874146	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54876242	54876242	T	G	hom	hom	hom	off-target	QUAL=5316;DP=106,28,43;AF=1.00,1.00,1.00;MQM=60;SAP=387;ABP=0;SAR=177;SAF=0	DHCR24	intron	DHCR24:ENST00000371269.9:intron_variant:MODIFIER:intron2/8:c.388-195A>C::,DHCR24:ENST00000535035.6:intron_variant:MODIFIER:intron2/9:c.388-195A>C::,DHCR24:ENST00000436604.2:intron_variant:MODIFIER:intron2/9:c.388-195A>C::		606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	1260254 [benign DISEASE=not provided];			rs638944	0.5111	0.3548,0.4488,0.4008,0.5824,0.6983	21053,.	35503	74239	-0.2660			0.61				0	15986317,17510943,21901424	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54998739	54998739	A	G	hom	hom	het	off-target	QUAL=629;DP=15,7,3;AF=1.00,1.00,0.67;MQM=60;SAP=55;ABP=4;SAR=0;SAF=24	BSND	upstream_gene	BSND:ENST00000651561.1:upstream_gene_variant:MODIFIER::::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	1224218 [benign DISEASE=not provided];			rs2500338	0.6332	0.3866,0.7028,0.3283,0.7779,0.6990	32761,.	30723	55743	0.4130			7.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	54998838	54998838	C	G	hom	hom	het	off-target	QUAL=4117;DP=75,55,62;AF=0.97,0.96,0.50;MQM=60;SAP=344;ABP=3;SAR=0;SAF=157	BSND	upstream_gene	BSND:ENST00000651561.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	1234155 [benign DISEASE=not provided];			rs2500339	0.6294	0.3855,0.6747,0.3126,0.7778,0.6991	32428,.	30808	56320	0.4310			16.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	54999070	54999070	T	C	hom	hom	het		QUAL=35366;DP=338,531,650;AF=0.99,1.00,0.48;MQM=60;SAP=532;ABP=5;SAR=322;SAF=858	BSND	5'UTR	BSND:ENST00000651561.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-117T>C::	regulatory_region_variant:open_chromatin_region	606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297673 [benign DISEASE=Bartter disease type 4a,not provided];			rs2500340	0.6697	0.5224,0.6884,0.3282,0.7787,0.7001	35224,.	31321	50203	-0.3600			1.25			COSV64870665	0	33462484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	54999117	54999117	C	G	hom	hom	het		QUAL=37486;DP=330,570,758;AF=0.99,1.00,0.48;MQM=60;SAP=206;ABP=5;SAR=460;SAF=804	BSND	5'UTR	BSND:ENST00000651561.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-70C>G::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297674 [benign DISEASE=Bartter disease type 4a,not provided];			rs2500341	0.6699	0.5226,0.6879,0.3361,0.7785,0.7002	35240,.	31320	50172	-1.0610			2.96			COSV64871304	0	19646679,31879347	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55007370	55007370	G	A	het	wt	hom	off-target	QUAL=219;DP=3,3,8;AF=0.67,0.00,1.00;MQM=60;SAP=25;ABP=4;SAR=10;SAF=0	BSND	intron	BSND:ENST00000651561.1:intron_variant:MODIFIER:intron3/3:c.548+98G>A::	regulatory_region_variant:enhancer	606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	1221679 [benign DISEASE=not provided];			rs6687801	0.4878	0.6216,0.3113,0.2154,0.4707,0.5176	18945,.	35909	77483	0.2380			4.89			COSV64870849	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55008652	55008652	A	C	het	wt	hom		QUAL=18393;DP=295,321,451;AF=0.56,0.01,1.00;MQM=60;SAP=164;ABP=11;SAR=415;SAF=201	BSND	3'UTR	BSND:ENST00000651561.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*24A>C::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297681 [benign DISEASE=Bartter disease type 4a,not provided];			rs6682884	0.4178	0.4921,0.2850,0.3054,0.4253,0.2878	13661,.	36103	88397	0.5590			3.81			COSV64871593	0	17652939	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55008803	55008803	C	G	het	wt	hom	off-target	QUAL=5156;DP=167,81,124;AF=0.43,0.00,1.00;MQM=60;SAP=426;ABP=11;SAR=195;SAF=0	BSND	3'UTR	BSND:ENST00000651561.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*175C>G::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	368877 [benign DISEASE=Bartter syndrome,not provided];			rs4339899	0.4543	0.5906,0.2970,0.3097,0.4303,0.4541	16440,.	36094	82854	-1.1140			0.18			COSV64871308	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	56874802	56874802	A	T	wt	wt	het	off-target	QUAL=410;DP=54,26,38;AF=0.00,0.00,0.50;MQM=60;SAP=44;ABP=3;SAR=0;SAF=19	C8A	intron	C8A:ENST00000695677.1:intron_variant:MODIFIER:intron2/10:c.172-147A>T::,C8A:ENST00000695678.1:intron_variant:MODIFIER:intron2/10:c.172-147A>T::,C8A:ENST00000695681.1:intron_variant:MODIFIER:intron2/10:c.172-147A>T::,C8A:ENST00000361249.4:intron_variant:MODIFIER:intron2/10:c.172-147A>T::		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]			L3 (LINE/CR1)	rs3738563	0.1008	0.0263,0.0643,0.1009,0.1501,0.0804	1000,.	13337	136773	-0.8510			0.61			COSV63486343	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56875054	56875054	C	A	het	hom	wt		QUAL=5788;DP=135,141,210;AF=0.43,0.99,0.00;MQM=60;SAP=7;ABP=9;SAR=108;SAF=90	C8A	missense	C8A:ENST00000695677.1:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:,C8A:ENST00000695678.1:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:,C8A:ENST00000695681.1:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:,C8A:ENST00000361249.4:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]	17039 [benign DISEASE=COMPLEMENT COMPONENT 8, ALPHA SUBUNIT, A/B POLYMORPHISM,not specified,not provided];			rs652785	0.3256	0.2102,0.2493,0.4605,0.3807,0.5029	8678,.	32107	102473	0.0330	T(0.67),T(0.68),T(0.71),T(0.67)	B(0.01),B(0.01),B(0.01),B(0.01)	6.82	0.10		COSV63484431	0.04	24033266,15986317,7649542,20029952,25798599	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56885772	56885772	G	A	het	wt	het	off-target	QUAL=1456;DP=128,13,20;AF=0.45,0.00,0.50;MQM=56;SAP=148;ABP=6;SAR=0;SAF=67	C8A	intron	C8A:ENST00000695677.1:intron_variant:MODIFIER:intron6/10:c.856-155G>A::,C8A:ENST00000695678.1:intron_variant:MODIFIER:intron6/10:c.856-155G>A::,C8A:ENST00000695681.1:intron_variant:MODIFIER:intron6/10:c.787-155G>A::,C8A:ENST00000361249.4:intron_variant:MODIFIER:intron6/10:c.856-155G>A::		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]			AluSc5 (SINE/Alu)	rs139789526	0.1223	0.0300,0.1436,0.0010,0.1765,0.0619	1504,.	15535	133109	-0.9510			1.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56906918	56906918	C	T	het	hom	het	off-target	QUAL=3366;DP=154,20,41;AF=0.60,1.00,0.59;MQM=60;SAP=298;ABP=18;SAR=136;SAF=0	C8A	intron	C8A:ENST00000695677.1:intron_variant:MODIFIER:intron8/10:c.1226+122C>T::,C8A:ENST00000695678.1:intron_variant:MODIFIER:intron8/10:c.1226+122C>T::,C8A:ENST00000695681.1:intron_variant:MODIFIER:intron8/10:c.1153+126C>T::,C8A:ENST00000361249.4:intron_variant:MODIFIER:intron8/10:c.1222+126C>T::		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]				rs619545	0.7844	0.9258,0.6695,0.9973,0.7142,0.8900	47640,.	23957	32783	0.2660			4.91				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56907828	56907830	AGA	-	wt	wt	het	off-target	QUAL=270;DP=85,49,56;AF=0.00,0.02,0.32;MQM=60;SAP=44;ABP=19;SAR=0;SAF=19	C8A	intron	C8A:ENST00000695677.1:intron_variant:MODIFIER:intron8/10:c.1227-125_1227-123del::,C8A:ENST00000695678.1:intron_variant:MODIFIER:intron8/10:c.1227-125_1227-123del::,C8A:ENST00000695681.1:intron_variant:MODIFIER:intron8/10:c.1154-121_1154-119del::,C8A:ENST00000361249.4:intron_variant:MODIFIER:intron8/10:c.1223-121_1223-119del::		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]				rs10562652	0.2211	0.1473,0.1716,0.0676,0.2891,0.1674	4093,.	25413	118339	-0.0990			0.46				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56912740	56912740	T	C	hom	hom	hom	off-target	QUAL=5243;DP=97,44,35;AF=1.00,1.00,1.00;MQM=60;SAP=385;ABP=0;SAR=176;SAF=0	C8A	intron	C8A:ENST00000695677.1:intron_variant:MODIFIER:intron10/10:c.1552+115T>C::,C8A:ENST00000695678.1:intron_variant:MODIFIER:intron10/10:c.1603+115T>C::,C8A:ENST00000695681.1:intron_variant:MODIFIER:intron10/10:c.1534+115T>C::,C8A:ENST00000361249.4:intron_variant:MODIFIER:intron10/10:c.1603+115T>C::		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]				rs623077	0.8883	0.9140,0.9013,0.9319,0.8595,0.9650	60133,.	14831	16995	-0.4330			3.04			COSV63483457	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56917685	56917685	C	T	wt	wt	het		QUAL=6231;DP=370,376,465;AF=0.00,0.00,0.53;MQM=60;SAP=4;ABP=6;SAR=118;SAF=129	C8A	missense	C8A:ENST00000695677.1:missense_variant:MODERATE:exon11/11:c.1673C>T:p.Pro558Leu:PF00090 [Thrombospondin type 1 domain],C8A:ENST00000695678.1:missense_variant:MODERATE:exon11/11:c.1724C>T:p.Pro575Leu:PF00090 [Thrombospondin type 1 domain],C8A:ENST00000695681.1:missense_variant:MODERATE:exon11/11:c.1655C>T:p.Pro552Leu:PF00090 [Thrombospondin type 1 domain],C8A:ENST00000361249.4:missense_variant:MODERATE:exon11/11:c.1724C>T:p.Pro575Leu:PF00090 [Thrombospondin type 1 domain]		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]	1166647 [benign DISEASE=not provided];			rs17300936	0.0868	0.0332,0.0562,0.0701,0.1264,0.0707	729,.	11748	138882	0.5720	T(0.48),T(0.48),T(0.47),T(0.48)	B(0.00),B(0.00),B(0.01),B(0.00)	14.20	0.02		COSV63486347	0	25798599	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56929091	56929098	GGCTAGAG	-	hom	hom	hom	off-target	QUAL=3025;DP=26,34,50;AF=1.00,1.00,1.00;MQM=60;SAP=242;ABP=0;SAR=0;SAF=110	C8B	downstream_gene	C8B:ENST00000371237.9:downstream_gene_variant:MODIFIER::::,C8B:ENST00000695842.1:downstream_gene_variant:MODIFIER::::,C8B:ENST00000696164.1:downstream_gene_variant:MODIFIER::::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs3040448	0.8292	0.7054,0.8856,0.9463,0.8638,0.8977	37937,.	14460	18602	0.2160			0.91						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929347	56929347	A	G	het	het	wt	low_conf_region	QUAL=14161;DP=536,529,781;AF=0.52,0.49,0.00;MQM=60;SAP=137;ABP=3;SAR=177;SAF=359	C8B	3'UTR	C8B:ENST00000371237.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*57T>C::,C8B:ENST00000695842.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*57T>C::,C8B:ENST00000696164.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs2795	0.3185	0.2188,0.3662,0.5184,0.3257,0.5133	8247,.	31928	103590	0.0380			4.66				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929578	56929578	T	C	hom	hom	hom	off-target	QUAL=25439;DP=273,249,294;AF=1.00,1.00,1.00;MQM=60;SAP=1172;ABP=0;SAR=738;SAF=76	C8B	splice_region&intron	C8B:ENST00000371237.9:splice_region_variant&intron_variant:LOW:intron11/11:c.1622-20A>G::,C8B:ENST00000695842.1:splice_region_variant&intron_variant:LOW:intron10/10:c.1493-20A>G::,C8B:ENST00000696164.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1622-20A>G::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]	1168190 [benign DISEASE=not specified,not provided];			rs605648	0.8506	0.7812,0.8925,0.9349,0.8589,0.9646	55308,.	18807	22731	-2.3430			0.13		8.84>8.35		0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929748	56929748	C	G	het	het	wt	off-target	QUAL=1347;DP=87,20,25;AF=0.56,0.50,0.00;MQM=60;SAP=131;ABP=5;SAR=59;SAF=0	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron11/11:c.1622-190G>C::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron10/10:c.1493-190G>C::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron12/12:c.1622-190G>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]			L2b (LINE/L2)	rs653804	0.3186	0.2189,0.3664,0.5194,0.3257,0.5154	8241,.	31889	103471	-0.2680			1.80				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929761	56929761	C	G	het	wt	het	off-target	QUAL=795;DP=87,17,14;AF=0.44,0.00,0.21;MQM=60;SAP=92;ABP=11;SAR=41;SAF=0	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron11/11:c.1622-203G>C::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron10/10:c.1493-203G>C::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron12/12:c.1622-203G>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]			L2b (LINE/L2)	rs2281598	0.1356	0.0558,0.2246,0.3387,0.1394,0.1647	1751,.	17099	131377	-3.3980			0.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56931628	56931628	G	A	het	het	wt	off-target	QUAL=2370;DP=201,28,30;AF=0.44,0.50,0.00;MQM=60;SAP=225;ABP=9;SAR=0;SAF=102	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron11/11:c.1621+182C>T::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron10/10:c.1492+182C>T::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron12/12:c.1621+182C>T::	regulatory_region_variant:enhancer,TF_binding_site_variant	120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs683824	0.3188	0.2192,0.3669,0.5202,0.3257,0.5135	8246,.	31923	103469	-0.9450			0.21				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56932065	56932065	G	C	het	het	wt	off-target	QUAL=2316;DP=141,54,65;AF=0.48,0.56,0.02;MQM=60;SAP=218;ABP=3;SAR=99;SAF=0	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron10/11:c.1553-187C>G::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron9/10:c.1424-187C>G::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron11/12:c.1553-187C>G::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs612563	0.3187	0.2191,0.3667,0.5194,0.3258,0.5139	8260,.	31902	103498	-0.2810			1.38			COSV64777108	0.15	29875488	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56940719	56940719	T	C	het	het	hom	off-target	QUAL=2125;DP=89,28,34;AF=0.45,0.46,1.00;MQM=60;SAP=192;ABP=5;SAR=0;SAF=87	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron9/11:c.1398+130A>G::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron8/10:c.1269+130A>G::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron10/12:c.1398+130A>G::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs6669836	0.4341	0.2980,0.4664,0.4080,0.5074,0.3426	14998,.	35902	85896	0.0150			3.31			COSV64777813	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56943656	56943656	A	G	wt	het	wt	off-target	QUAL=2747;DP=185,187,229;AF=0.00,0.58,0.00;MQM=60;SAP=52;ABP=14;SAR=30;SAF=80	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron8/11:c.1234+40T>C::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron7/10:c.1105+2165T>C::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron9/12:c.1234+40T>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs72670361	0.0308	0.0090,0.0294,0.0004,0.0480,0.0060	92,.	4495	147493	0.1450			1.11				0		35	1195	0 / 0					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56956811	56956811	C	T	hom	hom	hom		QUAL=26277;DP=295,249,267;AF=1.00,1.00,1.00;MQM=60;SAP=156;ABP=0;SAR=286;SAF=525	C8B	missense	C8B:ENST00000371237.9:missense_variant:MODERATE:exon3/12:c.349G>A:p.Gly117Arg:,C8B:ENST00000695842.1:missense_variant:MODERATE:exon3/11:c.349G>A:p.Gly117Arg:,C8B:ENST00000696164.1:missense_variant:MODERATE:exon4/13:c.349G>A:p.Gly117Arg:		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]	1169777 [benign DISEASE=not provided];			rs1013579	0.9788	0.9945,0.9728,0.9994,0.9680,0.9890	72908,.	3090	3220	0.9500	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	13.85	0.04			0.09	20438785,25798599,29875488,28240269,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	63402460	63402460	A	T	het	wt	wt	off-target	QUAL=104;DP=27,8,19;AF=0.37,0.00,0.05;MQM=49;SAP=27;ABP=7;SAR=11;SAF=0	ALG6	intron	ALG6:ENST00000263440.6:intron_variant:MODIFIER:intron4/14:c.257+117A>T::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]				rs541594476	0.0025	0.0015,0.0051,0.0013,0.0025,0.0036	0,.	184	74468	0.0120			5.04			COSV54767263	0		7	33	0 / 0					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63406210	63406210	A	G	het	het	hom	off-target	QUAL=7688;DP=237,85,105;AF=0.51,0.65,1.00;MQM=60;SAP=577;ABP=8;SAR=4;SAF=276	ALG6	intron	ALG6:ENST00000263440.6:intron_variant:MODIFIER:intron5/14:c.347-107A>G::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	1180566 [benign DISEASE=Congenital disorder of glycosylation type 1C,not provided];			rs1012872	0.3594	0.3644,0.4451,0.4850,0.3303,0.4705	10037,.	34490	97244	0.0500			6.30			COSV54765676	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63407200	63407200	A	G	het	het	hom	off-target	QUAL=7178;DP=241,93,101;AF=0.49,0.43,1.00;MQM=60;SAP=337;ABP=5;SAR=230;SAF=30	ALG6	intron	ALG6:ENST00000263440.6:intron_variant:MODIFIER:intron7/14:c.494+74A>G::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	1180568 [benign DISEASE=Congenital disorder of glycosylation type 1C,not provided];			rs6588028	0.5964	0.7908,0.6494,0.6760,0.4829,0.6423	28520,.	33502	61262	-0.5080			0.19				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63411459	63411459	G	T	het	het	hom	off-target	QUAL=1393;DP=59,12,13;AF=0.61,0.50,1.00;MQM=60;SAP=114;ABP=8;SAR=54;SAF=1	ALG6	intron	ALG6:ENST00000263440.6:intron_variant:MODIFIER:intron8/14:c.680+128G>T::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	1230601 [benign DISEASE=not provided];			rs12125868	0.3590	0.3627,0.4454,0.4859,0.3303,0.4712	10005,.	34493	97321	-0.1420			1.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63415679	63415680	TA	-	het	n/a	n/a	off-target	QUAL=83;DP=7,1,0;AF=0.71,0.00,;MQM=60;SAP=14;ABP=6;SAR=0;SAF=5	ALG6	intron	ALG6:ENST00000263440.6:intron_variant:MODIFIER:intron10/14:c.903-183_903-182del::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	1254388 [benign DISEASE=not provided];			rs10567757	0.3526	0.3392,0.4434,0.4843,0.3305,0.4715	9554,.	34150	97782	0.1750			0.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63415881	63415881	C	T	het	het	hom		QUAL=7295;DP=245,64,86;AF=0.56,0.44,1.00;MQM=60;SAP=252;ABP=7;SAR=41;SAF=211	ALG6	missense	ALG6:ENST00000263440.6:missense_variant:MODERATE:exon11/15:c.911C>T:p.Ser304Phe:PF03155 [ALG6 ALG8 glycosyltransferase family]		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	95531 [benign/likely benign DISEASE=Congenital disorder of glycosylation type 1C,not specified];			rs4630153	0.7573	0.8663,0.7654,0.8587,0.6845,0.8644	44156,.	26767	36879	0.6530	T(0.32)	B(0.00)	21.60	0.19		COSV54765155	0.25	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63437781	63437781	T	C	het	het	hom		QUAL=2157;DP=96,14,21;AF=0.54,0.57,1.00;MQM=60;SAP=84;ABP=5;SAR=68;SAF=13	ALG6	3'UTR	ALG6:ENST00000263440.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*761T>C::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	297858 [benign DISEASE=Congenital disorder of glycosylation type 1C];			rs3009572	0.6055	0.8196,0.6530,0.6747,0.4846,0.6448	29520,.	32690	59762	-0.1410			1.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39), ITGB3BP (inh=n/a oe_syn=1.01 oe_mis=0.85 oe_lof=0.85)
chr1	63438623	63438623	T	C	het	het	hom	off-target	QUAL=2346;DP=80,26,29;AF=0.54,0.46,1.00;MQM=60;SAP=109;ABP=3;SAR=74;SAF=10	ALG6,ITGB3BP	downstream_gene	ALG6:ENST00000263440.6:downstream_gene_variant:MODIFIER::::,ITGB3BP:ENST00000271002.15:downstream_gene_variant:MODIFIER::::,ITGB3BP:ENST00000371092.7:downstream_gene_variant:MODIFIER::::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]				rs3009573	0.7621	0.8736,0.7692,0.8587,0.6897,0.8654	44705,.	26417	36159	0.0920			2.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39), ITGB3BP (inh=n/a oe_syn=1.01 oe_mis=0.85 oe_lof=0.85)
chr1	67000108	67000108	G	A	het	wt	wt	low_conf_region	QUAL=287;DP=76,20,26;AF=0.37,0.05,0.00;MQM=60;SAP=66;ABP=14;SAR=29;SAF=0	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4232C>T::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			AluJr (SINE/Alu)	rs901342235	0.0013	0.0004,0.0012,0.0012,0.0013,0.0000	0,.	162	123622	-0.2800			0.83				0		2	26	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67000287	67000287	T	-	wt	wt	het		QUAL=218;DP=29,7,8;AF=0.21,0.29,0.00;MQM=60;SAP=4;ABP=40;SAR=2;SAF=4	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4053del::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			AluJr (SINE/Alu), (T)n (Simple_repeat)	rs377396719	0.0022	0.0003,0.0023,0.0013,0.0017,0.0010	0,.	306	136178	1.0070			1.14				0		0	61	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67000305	67000305	A	-	het	het	wt		QUAL=218;DP=29,7,8;AF=0.21,0.29,0.00;MQM=60;SAP=4;ABP=27;SAR=3;SAF=5	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035del::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs397861605	0.0102	0.0217,0.0043,0.0016,0.0063,0.0031	28,.	1406	141480	-2.0130			0.09			COSV105095829	0		6	93	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67000305	67000305	A	T	wt	het	wt		QUAL=218;DP=29,7,8;AF=0.21,0.29,0.00;MQM=60;SAP=6;ABP=47;SAR=5;SAF=2	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035T>A::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]				rs7540819	0.6460	0.8580,0.5619,0.5174,0.5974,0.4056	27960,.	27809	45893	-2.0130			0.36			COSV105095829	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67009294	67009294	C	T	hom	hom	hom	off-target	QUAL=1170;DP=33,3,5;AF=1.00,1.00,1.00;MQM=60;SAP=92;ABP=0;SAR=41;SAF=0	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron10/11:c.877-127G>A::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1246419 [benign DISEASE=not provided];		A-rich (Low_complexity)	rs2755271	0.5828	0.3338,0.7090,0.8380,0.6610,0.7652	27877,.	32761	63365	-0.8890			1.34				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021436	67021436	C	A	hom	hom	hom	off-target	QUAL=10850;DP=124,102,123;AF=1.00,1.00,1.00;MQM=60;SAP=427;ABP=0;SAR=44;SAF=305	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron9/11:c.797+99G>T::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1231615 [benign DISEASE=not provided];			rs2065002	0.5807	0.3261,0.7090,0.8368,0.6607,0.7725	27755,.	32595	63631	-1.7600			0.18			COSV52431286	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021692	67021697	CCAACA	-	het	het	het	off-target;low_conf_region	QUAL=1788;DP=22,28,34;AF=0.86,0.61,0.79;MQM=59;SAP=44;ABP=58;SAR=19;SAF=0	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-95_730-90del::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1269364 [benign DISEASE=not provided];		(ACACAG)n (Simple_repeat)	rs66809311	0.3310	0.1519,0.4167,0.3384,0.4056,0.4373	8684,.	27144	89952	0.2540			1.97				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021693	67021693	C	A	het	het	het	off-target;low_conf_region	QUAL=1788;DP=22,28,34;AF=0.86,0.61,0.79;MQM=60;SAP=79;ABP=49;SAR=55;SAF=8	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-91G>T::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1244705 [benign DISEASE=not provided];			rs61780038	0.3209	0.1666,0.4172,0.5861,0.3904,0.4860	2677,.	17586	48554	-0.4890			1.68			COSV52429637	0	30595370,32888493,29844566	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021694	67021694	A	G	het	het	het	off-target;low_conf_region	QUAL=1788;DP=22,28,34;AF=0.86,0.61,0.79;MQM=60;SAP=79;ABP=49;SAR=55;SAF=8	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-92T>C::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1276665 [benign DISEASE=not provided];			rs61780039	0.2486	0.1191,0.3167,0.5408,0.3180,0.3666	2683,.	17477	69031	0.1890			5.60			COSV52429647	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021706	67021706	G	C	het	het	het	off-target;low_conf_region	QUAL=1294;DP=36,25,30;AF=0.69,0.52,0.63;MQM=54;SAP=73;ABP=16;SAR=50;SAF=7	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-104C>G::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1273225 [benign DISEASE=not provided];		(ACACAG)n (Simple_repeat)	rs11576749	0.1369	0.1171,0.1668,0.3846,0.1368,0.1470	467,.	7981	56213	-0.6390			0.96			COSV52429658	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021712	67021712	G	C	hom	hom	hom	off-target;low_conf_region	QUAL=2052;DP=37,31,33;AF=0.73,0.81,0.73;MQM=53;SAP=113;ABP=0;SAR=69;SAF=7	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-110C>G::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			(ACACAG)n (Simple_repeat)	rs11576752	0.4233	0.2450,0.5022,0.6466,0.4741,0.5482	7901,.	27065	58413	-2.9340			0.27				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021718	67021718	G	C	hom	hom	hom	off-target	QUAL=2527;DP=52,27,33;AF=0.88,0.96,1.00;MQM=52;SAP=214;ABP=0;SAR=103;SAF=2	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-116C>G::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1234073 [benign DISEASE=not provided];		(ACACAG)n (Simple_repeat)	rs11576753	0.5303	0.2804,0.6575,0.7781,0.6155,0.6961	19411,.	29384	60412	-1.0760			0.40			COSV52430323	0	34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021724	67021724	G	C	hom	hom	hom	off-target	QUAL=2553;DP=58,26,29;AF=0.91,0.96,1.00;MQM=51;SAP=235;ABP=0;SAR=107;SAF=0	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-122C>G::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1246882 [benign DISEASE=not provided];		(ACACAG)n (Simple_repeat)	rs11208992	0.6505	0.4787,0.7343,0.8306,0.6864,0.7870	24453,.	28926	41826	0.2770			1.85				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67042051	67042051	T	A	hom	hom	hom	off-target	QUAL=6519;DP=101,45,68;AF=1.00,1.00,1.00;MQM=60;SAP=468;ABP=0;SAR=0;SAF=214	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.729+185A>T::	regulatory_region_variant:open_chromatin_region	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1233310 [benign DISEASE=not provided];			rs2815375	0.7485	0.6611,0.8407,0.8366,0.7743,0.8779	43001,.	27792	38230	-0.2340			1.93				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67042398	67042401	CACT	-	het	wt	het	off-target	QUAL=3780;DP=159,216,229;AF=0.48,0.01,0.47;MQM=60;SAP=264;ABP=6;SAR=167;SAF=18	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron7/11:c.637-73_637-70del::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1247932 [benign DISEASE=not provided];		(CA)n (Simple_repeat)	rs10543599	0.3162	0.0944,0.3916,0.5010,0.3878,0.5738	9214,.	29539	103737	1.5870			3.57				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67047220	67047220	G	T	hom	hom	hom	off-target	QUAL=12445;DP=171,106,112;AF=1.00,1.00,1.00;MQM=60;SAP=502;ABP=0;SAR=45;SAF=344	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron7/11:c.636+45C>A::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1234892 [benign DISEASE=Schneckenbecken dysplasia,not provided];			rs1024229	0.6902	0.7673,0.6751,0.6405,0.6621,0.7523	36445,.	31992	47068	-0.7010			3.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67047237	67047237	A	C	hom	hom	hom	off-target	QUAL=13908;DP=180,121,139;AF=0.99,1.00,1.00;MQM=60;SAP=475;ABP=0;SAR=65;SAF=374	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron7/11:c.636+28T>G::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1270736 [benign DISEASE=Schneckenbecken dysplasia,not provided];			rs1024230	0.6902	0.7670,0.6750,0.6405,0.6623,0.7517	36434,.	31984	47066	-0.2060			6.35				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67049626	67049626	C	T	hom	hom	hom	off-target	QUAL=6621;DP=156,24,32;AF=1.00,1.00,1.00;MQM=60;SAP=463;ABP=0;SAR=0;SAF=212	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron6/11:c.533+156G>A::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1287418 [benign DISEASE=not provided];			rs2755257	0.5319	0.3404,0.5813,0.6396,0.6072,0.6806	22716,.	35407	71131	-0.9060			0.11				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67050633	67050633	T	A	hom	hom	hom	off-target	QUAL=6908;DP=176,20,27;AF=0.99,1.00,1.00;MQM=60;SAP=485;ABP=0;SAR=222;SAF=0	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron4/11:c.393-129A>T::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1261093 [benign DISEASE=not provided];			rs2815383	0.5003	0.2272,0.5666,0.6347,0.6102,0.6758	21344,.	33359	75951	1.1760			4.93				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67051804	67051804	A	-	het	het	hom	off-target	QUAL=1136;DP=80,5,4;AF=0.55,0.20,1.00;MQM=60;SAP=109;ABP=4;SAR=0;SAF=49	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron4/11:c.392+208del::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1286317 [benign DISEASE=not provided];			rs34503429	0.6313	0.6847,0.5890,0.6429,0.6216,0.7454	30540,.	34674	55928	0.4550			5.43				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67052643	67052643	T	C	wt	wt	het	off-target	QUAL=497;DP=171,53,64;AF=0.00,0.00,0.41;MQM=60;SAP=59;ABP=8;SAR=0;SAF=26	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron3/11:c.324+128A>G::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]				rs183805701	0.0022	0.0008,0.0041,0.0000,0.0033,0.0000	0,.	332	151896	-0.6800			3.54				0		0	34	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054377	67054378	CA	-	het	het	hom		QUAL=470;DP=23,8,12;AF=0.39,0.50,1.00;MQM=60;SAP=57;ABP=5;SAR=25;SAF=0	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1250615 [benign DISEASE=not provided];			rs3840439	0.6253	0.6467,0.5894,0.6381,0.6319,0.7496	29928,.	35044	56862	0.1920			7.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054400	67054400	C	T	het	het	wt		QUAL=196;DP=11,6,7;AF=0.82,0.50,0.00;MQM=60;SAP=29;ABP=9;SAR=12;SAF=0	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1243207 [benign DISEASE=not provided];			rs3806321	0.1451	0.0833,0.2272,0.2721,0.1515,0.1455	1881,.	18297	130015	-0.6420			3.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054457	67054457	T	G	hom	n/a	hom	off-target	QUAL=245;DP=4,2,3;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0;SAR=9;SAF=0	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1282317 [benign DISEASE=not provided];			rs2025087	0.7612	0.8062,0.7574,0.8610,0.7412,0.8451	44244,.	27186	36284	-1.1250			4.56					34006833	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	75724531	75724531	G	A	hom	het	het		QUAL=2094;DP=15,71,99;AF=0.93,0.51,0.43;MQM=60;SAP=96;ABP=5;SAR=15;SAF=78	ACADM	5'UTR	ACADM:ENST00000680964.1:5_prime_UTR_variant:MODIFIER:exon1/12:c.-257G>A::,ACADM:ENST00000541113.6:5_prime_UTR_variant:MODIFIER:exon1/11:c.-257G>A::,ACADM:ENST00000680805.1:5_prime_UTR_variant:MODIFIER:exon1/11:c.-257G>A::	regulatory_region_variant:promoter	607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	298063 [benign/likely benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency,not provided];			rs17848068	0.2690	0.2615,0.2331,0.0249,0.2890,0.2166	5738,.	29404	111086	-2.2320			1.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75724883	75724883	C	T	hom	het	het	off-target	QUAL=348;DP=10,7,8;AF=0.90,0.57,0.38;MQM=60;SAP=38;ABP=3;SAR=16;SAF=0	ACADM	intron	ACADM:ENST00000680964.1:intron_variant:MODIFIER:intron1/11:c.30+66C>T::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron1/10:c.30+66C>T::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron1/10:c.30+66C>T::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron1/11:c.-250+66C>T::,ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron1/12:c.30+66C>T::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron1/11:c.30+66C>T::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron1/6:c.30+66C>T::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron1/11:c.30+66C>T::	regulatory_region_variant:promoter	607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	1292156 [benign DISEASE=not provided];			rs116034618	0.1151	0.0297,0.1276,0.0006,0.1612,0.0984	1325,.	14850	134486	-0.2630			6.37				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75728545	75728545	T	-	hom	hom	hom	off-target	QUAL=16886;DP=177,157,206;AF=1.00,1.00,1.00;MQM=60;SAP=415;ABP=0;SAR=430;SAF=110	ACADM	intron	ACADM:ENST00000680964.1:intron_variant:MODIFIER:intron2/11:c.118+60del::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron2/10:c.118+60del::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron2/10:c.118+60del::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron1/11:c.-249-3186del::,ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron2/12:c.118+60del::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron2/11:c.118+60del::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron1/6:c.30+3731del::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron2/11:c.130+60del::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	226050 [benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency,not provided];			rs796117827	1.0000	1.0000,1.0000,1.0000,1.0000,1.0000	76091,.	1	1	0.0000			0.47				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75728621	75728621	A	G	hom	hom	hom	off-target	QUAL=11363;DP=178,81,107;AF=1.00,1.00,1.00;MQM=60;SAP=798;ABP=0;SAR=366;SAF=0	ACADM	intron	ACADM:ENST00000680964.1:intron_variant:MODIFIER:intron2/11:c.118+133A>G::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron2/10:c.118+133A>G::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron2/10:c.118+133A>G::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron1/11:c.-249-3113A>G::,ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron2/12:c.118+133A>G::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron2/11:c.118+133A>G::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron1/6:c.30+3804A>G::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron2/11:c.130+133A>G::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	1261087 [benign DISEASE=not provided];			rs1146572	0.9269	0.9702,0.8583,0.7488,0.9332,0.9225	65572,.	9874	11130	-0.1760			2.40			COSV63720717	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75750752	75750752	T	-	het	het	het	off-target	QUAL=88;DP=29,3,5;AF=0.34,0.33,0.20;MQM=58;SAP=29;ABP=13;SAR=12;SAF=0	ACADM	splice_region&intron,intron	ACADM:ENST00000680964.1:splice_region_variant&intron_variant:LOW:intron10/11:c.946-4del::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron9/10:c.849+1207del::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron9/10:c.804+220del::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron10/11:c.687+220del::,ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron11/12:c.1044+220del::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron10/11:c.945+220del::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron5/6:c.507+220del::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron10/11:c.957+220del::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]			MIRb (SINE/MIR), AluSg (SINE/Alu)	rs745487585	0.0070	0.0173,0.0042,0.0021,0.0021,0.0007	5,.	966	138356	-1.4820			0.18				0.01		1	25	0 / 0					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75761039	75761039	A	C	het	wt	wt	off-target	QUAL=144;DP=31,5,4;AF=0.58,0.00,0.00;MQM=60;SAP=42;ABP=5;SAR=0;SAF=18	ACADM	intron	ACADM:ENST00000680964.1:intron_variant:MODIFIER:intron11/11:c.*39-83A>C::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron9/10:c.850-83A>C::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron9/10:c.805-83A>C::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron10/11:c.688-83A>C::,ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron11/12:c.1045-83A>C::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron10/11:c.946-83A>C::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron5/6:c.508-83A>C::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron10/11:c.958-83A>C::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]			AluJr (SINE/Alu)	rs74090743						-0.5470			0.83				0		0	0	0 / 0					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75763641	75763641	T	C	wt	het	het		QUAL=125;DP=31,6,10;AF=0.03,0.17,0.70;MQM=60;SAP=23;ABP=3;SAR=9;SAF=0	ACADM	3'UTR	ACADM:ENST00000681790.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::,ACADM:ENST00000370841.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	298081 [benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency];			rs1146587	0.6571	0.7071,0.6252,0.7231,0.6439,0.7060	32909,.	33993	52097	-1.2740			0.90				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	92474854	92474854	C	T	het	wt	het		QUAL=6067;DP=278,118,165;AF=0.54,0.00,0.49;MQM=60;SAP=86;ABP=4;SAR=68;SAF=162	GFI1	3'UTR	GFI1:ENST00000294702.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000370332.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000427103.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs41313373	0.0947	0.0231,0.1157,0.0198,0.1275,0.0890	886,.	12630	137630	2.7080			15.72				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92475800	92475800	A	G	wt	het	wt		QUAL=3115;DP=445,227,280;AF=0.00,0.52,0.00;MQM=60;SAP=3;ABP=4;SAR=62;SAF=58	GFI1	3'UTR	GFI1:ENST00000294702.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:ENST00000370332.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:ENST00000427103.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	1271213 [benign DISEASE=not provided];			rs4970714	0.7118	0.8038,0.7036,0.9450,0.6458,0.8500	39148,.	29839	43791	-2.9480			0.04			COSV54042587	0	20075157	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92478757	92478757	-	AGAGAG	wt	het	wt	low_conf_region	QUAL=5313;DP=60,99,154;AF=0.68,0.46,0.42;MQM=60;SAP=19;ABP=65;SAR=18;SAF=5	GFI1	splice_region&intron	GFI1:ENST00000294702.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:ENST00000370332.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:ENST00000427103.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	1170883 [benign DISEASE=Neutropenia, severe congenital, 2, autosomal dominant,not specified,not provided];			rs35896485	0.3228	0.1999,0.3877,0.5556,0.3538,0.5183	7898,.	28691	93347				7.21				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92478758	92478759	AG	-	wt	wt	het	low_conf_region	QUAL=5313;DP=60,99,154;AF=0.68,0.46,0.42;MQM=60;SAP=20;ABP=194;SAR=36;SAF=16	GFI1	splice_region&intron	GFI1:ENST00000294702.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:ENST00000370332.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:ENST00000427103.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	298182 [likely benign(replaced by megSAP based on classifications:3x1,2x3) DISEASE=Neutropenia, severe congenital, 2, autosomal dominant,Severe congenital neutropenia,not provided];		(AG)n (Simple_repeat)	rs35896485	0.1234	0.1135,0.1009,0.0302,0.1384,0.0420	1087,.	14857	120989	3.1660			7.48				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92478758	92478763	AGAGAG	-	hom	het	het	low_conf_region	QUAL=5313;DP=60,99,154;AF=0.00,0.01,0.33;MQM=60;SAP=127;ABP=12;SAR=122;SAF=29	GFI1	splice_region&intron	GFI1:ENST00000294702.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:ENST00000370332.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:ENST00000427103.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	298185 [benign DISEASE=Neutropenia, severe congenital, 2, autosomal dominant,Severe congenital neutropenia,not provided];		(AG)n (Simple_repeat)	rs35896485	0.1112	0.0621,0.1456,0.0251,0.1318,0.1107	941,.	13479	122769	3.1660			6.76				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92483141	92483141	C	T	het	wt	het	off-target	QUAL=532;DP=27,7,14;AF=0.59,0.00,0.57;MQM=60;SAP=4;ABP=6;SAR=14;SAF=10	GFI1	intron	GFI1:ENST00000294702.6:intron_variant:MODIFIER:intron2/6:c.116-95G>A::,GFI1:ENST00000370332.5:intron_variant:MODIFIER:intron2/6:c.116-95G>A::,GFI1:ENST00000427103.6:intron_variant:MODIFIER:intron2/6:c.116-95G>A::	regulatory_region_variant:promoter	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs530464819	0.0092	0.0016,0.0077,0.0000,0.0122,0.0062	13,.	1371	150825	-0.0260			8.68				0		0	136	0 / 0					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92483381	92483381	C	T	het	het	wt		QUAL=3343;DP=98,265,322;AF=0.47,0.46,0.00;MQM=60;SAP=106;ABP=8;SAR=39;SAF=128	GFI1	missense	GFI1:ENST00000294702.6:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000370332.5:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000427103.6:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:	regulatory_region_variant:promoter	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	259699 [benign DISEASE=Neutropenia, severe congenital, 2, autosomal dominant,not specified,not provided];			rs34631763	0.0404	0.0103,0.0430,0.0000,0.0592,0.0108	183,.	5785	146091	2.4960	T(0.53),T(0.53),T(0.53)	B(0.02),B(0.02),B(0.02)	16.72	0.06		COSV54042707	0.01	25741868,24033266,20075157,27080012,31013831,31649884,26447191,31508375	61	1748	0 / 0					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92486100	92486100	-	A	het	het	het	off-target	QUAL=2441;DP=91,67,106;AF=0.47,0.49,0.32;MQM=60;SAP=3;ABP=19;SAR=54;SAF=56	GFI1	intron	GFI1:ENST00000294702.6:intron_variant:MODIFIER:intron1/6:c.-100+625dup::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs112925059	0.1223	0.0507,0.1591,0.0266,0.1563,0.1175	1259,.	15392	128570				6.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92486661	92486661	A	-	hom	hom	hom	off-target	QUAL=1727;DP=24,19,19;AF=1.00,1.00,1.00;MQM=60;SAP=71;ABP=0;SAR=9;SAF=53	GFI1	intron	GFI1:ENST00000294702.6:intron_variant:MODIFIER:intron1/6:c.-100+65del::	regulatory_region_variant:promoter,TF_binding_site_variant	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs66635255	1.0000	1.0000,0.9999,1.0000,1.0000,1.0000	76061,.	2	2	-0.4670			12.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	97078196	97078196	G	A	het	het	het		QUAL=16071;DP=471,323,440;AF=0.48,0.50,0.48;MQM=60;SAP=234;ABP=5;SAR=174;SAF=427	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*780C>T::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100064 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs291593	0.2898	0.2278,0.2927,0.6077,0.2755,0.4682	6936,.	30116	107810	-1.0340			0.19				0	24944790,23960437,28481884,34449663,32235849,34442436	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97078208	97078208	C	T	het	het	het		QUAL=15538;DP=404,340,463;AF=0.49,0.50,0.47;MQM=60;SAP=145;ABP=5;SAR=195;SAF=391	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*768G>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100065 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs291592	0.4520	0.3170,0.5746,0.9706,0.4530,0.6152	16990,.	34597	83143	0.1450			2.72				0	23960437,28481884,32235849	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97078403	97078403	C	T	het	het	wt		QUAL=7022;DP=325,212,285;AF=0.52,0.44,0.00;MQM=60;SAP=214;ABP=3;SAR=212;SAF=52	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*573G>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100067 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs1042482	0.0625	0.0146,0.0448,0.1296,0.0790,0.1770	400,.	8707	142613	0.2650			2.97				0	24944790	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97079215	97079215	T	C	hom	hom	hom	off-target	QUAL=27762;DP=232,299,380;AF=0.99,1.00,1.00;MQM=60;SAP=1348;ABP=0;SAR=829;SAF=79	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron22/22:c.2908-69A>G::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1222833 [benign DISEASE=not provided];			rs290855	0.8023	0.7105,0.8681,0.9882,0.8133,0.8920	49271,.	23382	30036	0.5570			5.41				0	20587604	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97082275	97082275	G	A	hom	hom	hom	off-target	QUAL=15058;DP=185,126,164;AF=1.00,1.00,1.00;MQM=60;SAP=702;ABP=0;SAR=42;SAF=433	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron22/22:c.2907+55C>T::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1255090 [benign DISEASE=not provided];			rs290854	1.0000	1.0000,1.0000,1.0000,1.0000,1.0000	76061,.	3	3	0.2870			2.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97306391	97306391	C	A	wt	wt	het	off-target	QUAL=1499;DP=176,106,132;AF=0.00,0.00,0.46;MQM=60;SAP=69;ABP=5;SAR=52;SAF=9	DPYD,DPYD-AS1	intron,intron&non_coding_transcript	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron16/22:c.2059-94G>T::,DPYD-AS1:ENST00000422980.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.249+82C>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1270293 [benign DISEASE=not provided];			rs7556439	0.2422	0.0716,0.3916,0.3333,0.2888,0.3191	5483,.	25785	114991	-0.2720			8.84				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77), DPYD-AS1 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97450068	97450068	A	G	het	wt	het		QUAL=4784;DP=202,150,187;AF=0.45,0.00,0.52;MQM=60;SAP=177;ABP=4;SAR=33;SAF=156	DPYD	synonymous	DPYD:ENST00000370192.8:synonymous_variant:LOW:exon14/23:c.1896T>C:p.Phe632=:PF01180 [Dihydroorotate dehydrogenase]		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100088 [drug response DISEASE=capecitabine response - Toxicity,fluorouracil response - Toxicity,Dihydropyrimidine dehydrogenase deficiency,not specified,not provided];			rs17376848	0.0438	0.0216,0.0729,0.1237,0.0452,0.0391	195,.	6276	145466	0.2880			6.57			COSV100928729	0	25741868,16115930,18299612,19104657,19530960,20819423,21498394,24923815,25677447,26099996,26794347,29065426,17697348,21362212,23942539,19473056,30545124,14635116,25782327,14523039,16007086,23588312,27487151,31076604,25915935,28481884,33194059,33228198,33305610,34050721,34064668,34442436,33235483,25614737,33317085,34959317	2	101	0 / 0					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97515585	97515585	-	T	wt	wt	het	off-target	QUAL=18;DP=45,6,6;AF=0.00,0.00,0.50;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron13/22:c.1740+140_1740+141insA::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1225056 [benign DISEASE=not provided];			rs56080540	0.0835	0.0529,0.0549,0.0102,0.0992,0.1020	637,.	11407	139259				5.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97515686	97515686	T	C	hom	het	hom	off-target;low_conf_region	QUAL=8027;DP=188,44,54;AF=1.00,0.45,1.00;MQM=60;SAP=546;ABP=4;SAR=3;SAF=259	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron13/22:c.1740+40A>G::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100090 [benign DISEASE=not provided];			rs2811178	0.6178	0.6263,0.6538,0.7523,0.5857,0.6264	29076,.	35535	57971	-0.0810			0.88				0	23960437,34959317	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97516150	97516150	C	T	hom	het	hom	off-target	QUAL=2690;DP=89,3,6;AF=1.00,0.67,1.00;MQM=60;SAP=214;ABP=4;SAR=97;SAF=0	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron12/22:c.1525-209G>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1282683 [benign DISEASE=not provided];			rs1337752	0.6167	0.6208,0.6534,0.7523,0.5865,0.6232	28976,.	35525	58105	-0.0740			0.51				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97549850	97549850	A	T	het	het	wt	off-target	QUAL=1566;DP=97,21,28;AF=0.55,0.52,0.00;MQM=60;SAP=142;ABP=5;SAR=64;SAF=0	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron11/22:c.1340-106T>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100099 [benign DISEASE=not provided];			rs61789183	0.0864	0.0223,0.0768,0.0004,0.1280,0.0480	777,.	11588	139014	0.9650			6.49				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77), SEC63P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97679170	97679170	T	C	wt	wt	het		QUAL=586;DP=168,36,55;AF=0.01,0.00,0.47;MQM=60;SAP=4;ABP=3;SAR=12;SAF=15	DPYD	missense	DPYD:ENST00000370192.8:missense_variant:MODERATE:exon8/23:c.775A>G:p.Lys259Glu:PF07992 [Pyridine nucleotide-disulphide oxidoreductase]		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	235464 [benign(replaced by megSAP based on classifications:5x1,1x2,1x3) DISEASE=Dihydropyrimidine dehydrogenase deficiency,not specified,not provided];	CM033369 [CLASS=DM MUT=ALT PHEN="Dihydropyrimidine dehydrogenase deficiency" GENE=DPYD];		rs45589337	0.0051	0.0014,0.0036,0.0000,0.0075,0.0050	6,.	770	151364	3.8740	D(0.00)	B(0.14)	22.80	0.61		COSV99058634	0	25741868,18299612,24648345,26801900,14635116,24326041,19288105,32707991,33305610	1	390	0 / 0	1	"[3] Stephan Waldmller 18.11.2015 [n/a] comment imported from detected variant: HGMD: DM fr Dihydropyrimidine dehydrogenase deficiency, Literatur nicht berzeugend, VUS3, swal 151118 [1] ahbuchr1 26.09.2016 MAF>1%, homozygote in ExAC"			DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97719971	97719971	A	G	hom	hom	hom		QUAL=15798;DP=206,123,150;AF=1.00,1.00,1.00;MQM=60;SAP=12;ABP=0;SAR=262;SAF=217	DPYD	intron,3'UTR	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron5/22:c.483+1539T>C::,DPYD:ENST00000306031.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*917T>C::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]				rs2151562	0.9953	0.9831,0.9992,1.0000,1.0000,1.0000	75151,.	713	717	0.4060			5.55				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97720521	97720521	T	C	hom	hom	hom		QUAL=20031;DP=282,136,192;AF=1.00,1.00,1.00;MQM=60;SAP=211;ABP=0;SAR=184;SAF=426	DPYD	intron,3'UTR	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron5/22:c.483+989A>G::,DPYD:ENST00000306031.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*367A>G::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]				rs1333718	0.9953	0.9833,0.9991,1.0000,1.0000,1.0000	75164,.	707	711	0.7280			16.20				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97883329	97883329	A	G	wt	wt	het		QUAL=2645;DP=218,162,215;AF=0.00,0.00,0.48;MQM=60;SAP=8;ABP=4;SAR=60;SAF=44	DPYD	missense	DPYD:ENST00000370192.8:missense_variant:MODERATE:exon2/23:c.85T>C:p.Cys29Arg:,DPYD:ENST00000306031.5:missense_variant:MODERATE:exon2/6:c.85T>C:p.Cys29Arg:		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	435 [drug response DISEASE=capecitabine response - Toxicity,fluorouracil response - Toxicity,Dihydropyrimidine dehydrogenase deficiency,not specified,not provided];	CM970421 [CLASS=DFP MUT=ALT PHEN="Dihydropyrimidine dehydrogenase deficiency" GENE=DPYD];		rs1801265	0.2732	0.4032,0.2474,0.0722,0.2254,0.2476	6303,.	28901	110407	1.6470	T(0.52),T(0.41)	B(0.00),B(0.00)	18.87				0.04	24944790,29334895,31361092,11156223,17121937,18299612,19104657,19530960,20819423,21498394,23988873,24590654,24647007,24923815,25110414,25677447,26216193,26794347,29065426,29193749,25066213,29372689,18381459,26858644,17697348,30356105,19473056,9266349,9439663,20570913,21472143,26785747,28618970,28679691,29681089,23960437,14635116,23328581,23481061,26846104,27249515,27487151,24401318,24297552,26484159,23588107,29273807,28114309,29075194,30915274,31076604,24388031,28481884,29152729,32619063,23781135,30114658,32707991,21521029,33194059,33228198,33305610,34050721,34064668,30551678,20601926,32231042,34442436,33235483,34525956,33491253,34429635,33519226,32347657,33767731,33089968,25614737,34780066,34629888,34798807,33569925,34916829,34959317,34621706,34949935,34944636,29998006,17848752,27752409,24434920	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97988913	97988913	G	T	wt	wt	het		QUAL=707;DP=245,71,74;AF=0.00,0.00,0.42;MQM=60;SAP=9;ABP=7;SAR=11;SAF=20	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-9598C>A::,MIR137HG:ENST00000424528.2:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.1726C>A::						rs41285694	0.1171	0.0327,0.0912,0.0586,0.1630,0.1411	1418,.	14958	134108	0.4760			1.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97989572	97989572	A	-	het	het	het		QUAL=932;DP=84,17,28;AF=0.38,0.24,0.25;MQM=60;SAP=18;ABP=34;SAR=13;SAF=30	MIR137HG	intron&non_coding_transcript,splice_region&intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-10257del::,MIR137HG:ENST00000424528.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron4/4:n.1070-3del::	regulatory_region_variant:enhancer				AluSp (SINE/Alu)	rs543197080	0.0315	0.0943,0.0142,0.0081,0.0041,0.0032	149,.	3660	121810	-0.9170			0.30						1	152	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97990401	97990401	G	A	wt	wt	het		QUAL=1441;DP=174,115,145;AF=0.00,0.00,0.42;MQM=60;SAP=52;ABP=11;SAR=49;SAF=12	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-11086C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-832C>T::					L1PA13 (LINE/L1)	rs61785886	0.1172	0.0329,0.0912,0.0580,0.1629,0.1409	1417,.	14967	134141	-1.2530			1.12						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991087	97991087	G	A	wt	wt	het		QUAL=662;DP=144,45,76;AF=0.00,0.00,0.39;MQM=59;SAP=6;ABP=10;SAR=12;SAF=18	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-11772C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-1518C>T::					AluY (SINE/Alu)	rs61785887	0.0851	0.0225,0.0650,0.0575,0.1212,0.1071	753,.	11400	138750	-0.3250			1.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991175	97991175	C	T	wt	wt	het		QUAL=965;DP=214,57,114;AF=0.00,0.00,0.39;MQM=59;SAP=4;ABP=14;SAR=20;SAF=25	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-11860G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-1606G>A::					AluY (SINE/Alu)	rs61785888	0.1180	0.0336,0.0921,0.0567,0.1640,0.1396	1434,.	15039	133899	0.3960			4.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991351	97991351	C	A	wt	wt	het		QUAL=1314;DP=192,87,96;AF=0.00,0.00,0.53;MQM=60;SAP=18;ABP=4;SAR=16;SAF=35	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-12036G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-1782G>T::						rs4573558	0.1264	0.0629,0.0944,0.0558,0.1643,0.1398	1503,.	16211	132827	-1.2890			0.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991747	97991747	C	G	wt	wt	het		QUAL=2097;DP=278,105,175;AF=0.00,0.00,0.47;MQM=60;SAP=4;ABP=4;SAR=38;SAF=45	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-12432G>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-2178G>C::						rs2893376	0.1655	0.1935,0.1128,0.0565,0.1657,0.1511	2247,.	20656	126776	-1.0200			0.17					27338279	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991967	97991967	A	T	wt	wt	het		QUAL=1562;DP=205,63,125;AF=0.00,0.00,0.49;MQM=60;SAP=29;ABP=3;SAR=44;SAF=17	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-12652T>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-2398T>A::						rs2391873	0.1545	0.1558,0.1084,0.0564,0.1654,0.1507	1959,.	19563	128541	-0.1440			11.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97994504	97994504	A	C	het	wt	het		QUAL=2944;DP=159,63,88;AF=0.48,0.00,0.51;MQM=60;SAP=216;ABP=3;SAR=6;SAF=115	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-15189T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1069+412T>G::					AluSx (SINE/Alu)							-0.3580			2.70						0	3	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97994550	97994550	G	A	hom	hom	het		QUAL=9102;DP=166,85,125;AF=1.00,1.00,0.53;MQM=60;SAP=607;ABP=4;SAR=10;SAF=307	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-15235C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1069+366C>T::					AluSx (SINE/Alu)	rs9440288	0.8401	0.8262,0.8888,0.9417,0.8345,0.8483	53798,.	20123	24319	-1.3540			0.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995576	97995576	G	C	hom	hom	het		QUAL=22262;DP=266,282,366;AF=1.00,1.00,0.47;MQM=60;SAP=85;ABP=6;SAR=442;SAF=277	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16261C>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-576C>G::					L2a (LINE/L2)	rs9324380	0.9147	0.9770,0.9351,0.9426,0.8787,0.8925	63854,.	11459	12977	-4.7770			0.00					29942086,29326435	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995701	97995701	-	TTGT	hom	hom	het		QUAL=16425;DP=233,209,270;AF=0.99,1.00,0.44;MQM=60;SAP=49;ABP=11;SAR=334;SAF=225	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16387_141-16386insACAA::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-702_985-701insACAA::						rs10655213	0.8736	0.9372,0.9054,0.9424,0.8359,0.8598	58158,.	16198	19182				0.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995887	97995887	C	T	het	het	het		QUAL=4939;DP=163,96,103;AF=0.52,0.47,0.52;MQM=60;SAP=43;ABP=3;SAR=121;SAF=63	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16572G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-887G>A::						rs9662365	0.4913	0.4994,0.5192,0.4117,0.4906,0.3917	18442,.	37693	77217	-0.0280			14.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97996398	97996398	T	C	hom	hom	het		QUAL=5956;DP=150,26,33;AF=0.99,1.00,0.58;MQM=60;SAP=260;ABP=5;SAR=21;SAF=172	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-17083A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-1398A>G::						rs1938570	0.8676	0.9348,0.8993,0.9421,0.8254,0.8589	57259,.	17110	20094	-0.5300			0.32					23910899	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97997365	97997365	C	A	het	wt	het		QUAL=5225;DP=252,155,183;AF=0.50,0.00,0.48;MQM=60;SAP=70;ABP=3;SAR=147;SAF=66	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-18050G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-2365G>T::						rs146033831	0.0065	0.0007,0.0290,0.0632,0.0016,0.0044	27,.	934	150944	-0.1480			0.50						1	37	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97999972	97999972	G	A	hom	hom	het		QUAL=22731;DP=309,252,336;AF=1.00,1.00,0.50;MQM=60;SAP=336;ABP=3;SAR=197;SAF=531	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-20657C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-4972C>T::	regulatory_region_variant:enhancer					rs2154403	0.8819	0.9664,0.9076,0.9424,0.8360,0.8599	59505,.	15080	17954	0.9200			3.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98000284	98000284	G	A	het	het	wt		QUAL=5755;DP=282,224,308;AF=0.49,0.42,0.00;MQM=60;SAP=20;ABP=11;SAR=137;SAF=94	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-20969C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-5284C>T::					L2a (LINE/L2)	rs116319667	0.0095	0.0030,0.0059,0.0000,0.0162,0.0050	13,.	1413	150649	-0.3440			0.33						7	229	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98001230	98001230	T	C	wt	het	wt		QUAL=1949;DP=337,144,175;AF=0.01,0.51,0.00;MQM=60;SAP=3;ABP=3;SAR=37;SAF=38	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-21915A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-6230A>G::						rs12138817	0.2270	0.0766,0.3135,0.1256,0.3024,0.1366	4793,.	24915	117479	-0.8540			0.45					32184616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98002983	98002984	TA	-	hom	hom	het		QUAL=17172;DP=329,145,205;AF=0.98,1.00,0.54;MQM=60;SAP=241;ABP=6;SAR=416;SAF=164	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-23669_141-23668del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-7984_985-7983del::	regulatory_region_variant:enhancer					rs5776390	0.8727	0.9374,0.9070,0.9417,0.8352,0.8543	58049,.	16270	19308	0.0270			0.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98004131	98004131	A	-	het	wt	het		QUAL=6972;DP=211,245,312;AF=0.50,0.00,0.51;MQM=60;SAP=10;ABP=3;SAR=147;SAF=117	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-24816del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-9131del::						rs564190891	0.0022	0.0005,0.0140,0.0000,0.0011,0.0015	7,.	319	151759	2.0260			15.18						0	16	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98004495	98004495	-	AT	hom	hom	het		QUAL=23846;DP=516,128,229;AF=1.00,1.00,0.48;MQM=60;SAP=101;ABP=3;SAR=285;SAF=470	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-25181_141-25180insAT::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-9496_985-9495insAT::						rs10655252	0.8471	0.8469,0.8942,0.9422,0.8351,0.8549	54611,.	19363	23213				0.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98005049	98005049	A	G	hom	hom	het		QUAL=6773;DP=178,20,25;AF=1.00,1.00,0.44;MQM=60;SAP=228;ABP=4;SAR=31;SAF=178	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-25734T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-10049T>C::	regulatory_region_variant:enhancer					rs10747495	0.8818	0.9665,0.9088,0.9423,0.8356,0.8551	59481,.	15077	17973	0.6310			5.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98006231	98006231	C	A	wt	het	wt		QUAL=231;DP=278,55,89;AF=0.00,0.33,0.00;MQM=60;SAP=7;ABP=17;SAR=12;SAF=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-26916G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-11231G>T::					L1ME4a (LINE/L1)	rs55635742	0.0199	0.0049,0.0208,0.0002,0.0315,0.0025	40,.	2947	148899	-0.3040			0.54						8	386	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98006652	98006652	A	G	het	wt	het		QUAL=3000;DP=167,75,97;AF=0.46,0.00,0.41;MQM=60;SAP=54;ABP=11;SAR=32;SAF=84	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-27337T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-11652T>C::					(ATTAC)n (Simple_repeat)	rs78878051	0.0179	0.0141,0.0493,0.1726,0.0022,0.0484	129,.	2458	149210	1.1380			5.10						4	95	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98007323	98007323	C	T	hom	hom	het		QUAL=20990;DP=326,193,254;AF=1.00,1.00,0.56;MQM=60;SAP=16;ABP=11;SAR=361;SAF=299	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28008G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-12323G>A::	regulatory_region_variant:open_chromatin_region					rs1938564	0.8048	0.7025,0.8818,0.9423,0.8336,0.8439	49545,.	22909	29587	-0.2730			0.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98007402	98007402	T	A	hom	hom	het		QUAL=15845;DP=223,170,183;AF=1.00,1.00,0.55;MQM=60;SAP=23;ABP=6;SAR=280;SAF=213	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28087A>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-12402A>T::	regulatory_region_variant:open_chromatin_region					rs1938563	0.8809	0.9632,0.9086,0.9422,0.8355,0.8547	59197,.	15166	18058	0.4550			5.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98008160	98008160	T	A	hom	hom	het		QUAL=18851;DP=396,116,129;AF=1.00,1.00,0.55;MQM=60;SAP=185;ABP=6;SAR=181;SAF=402	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28845A>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-13160A>T::						rs1938562	0.8810	0.9633,0.9090,0.9421,0.8355,0.8551	59201,.	15155	18041	1.1500			6.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98009211	98009211	C	T	hom	hom	het		QUAL=15309;DP=290,116,162;AF=1.00,1.00,0.49;MQM=60;SAP=343;ABP=3;SAR=381;SAF=105	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-29896G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-14211G>A::						rs2391902	0.8116	0.7260,0.8837,0.9419,0.8338,0.8434	50263,.	22456	28550	0.3390			13.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98009966	98009966	T	C	hom	hom	het		QUAL=16449;DP=306,118,172;AF=1.00,1.00,0.52;MQM=60;SAP=172;ABP=4;SAR=157;SAF=357	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-30651A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-14966A>G::	regulatory_region_variant:enhancer					rs2154402	0.9145	0.9771,0.9359,0.9425,0.8783,0.8882	63715,.	11455	12991	0.7240			8.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98010357	98010357	G	A	hom	hom	het		QUAL=14289;DP=297,87,125;AF=1.00,1.00,0.55;MQM=60;SAP=8;ABP=6;SAR=210;SAF=243	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-31042C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-15357C>T::						rs9324381	0.8455	0.8444,0.8931,0.9421,0.8342,0.8451	54321,.	19540	23428	0.5390			3.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011162	98011162	G	A	hom	hom	het		QUAL=26059;DP=418,218,279;AF=1.00,1.00,0.59;MQM=60;SAP=3;ABP=25;SAR=399;SAF=403	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-31847C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16162C>T::						rs1938561	0.8818	0.9665,0.9088,0.9420,0.8356,0.8549	59488,.	15084	17968	0.2820			2.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011394	98011394	T	C	hom	hom	het		QUAL=25126;DP=338,267,328;AF=1.00,1.00,0.55;MQM=60;SAP=3;ABP=10;SAR=398;SAF=387	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32079A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16394A>G::					L2c (LINE/L2)	rs9440293	0.8805	0.9632,0.9087,0.9414,0.8350,0.8554	59131,.	15215	18115	-1.1320			0.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011402	98011402	C	T	hom	hom	het		QUAL=25405;DP=342,268,337;AF=1.00,1.00,0.55;MQM=60;SAP=6;ABP=9;SAR=414;SAF=380	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32087G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16402G>A::					L2c (LINE/L2)	rs9727941	0.8447	0.8438,0.8924,0.9415,0.8336,0.8444	54228,.	19603	23545	-0.2230			3.39						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011410	98011410	G	C	hom	hom	het		QUAL=25206;DP=342,265,340;AF=1.00,1.00,0.56;MQM=60;SAP=17;ABP=12;SAR=434;SAF=362	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32095C>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16410C>G::					L2c (LINE/L2)	rs9724773	0.8448	0.8441,0.8926,0.9411,0.8336,0.8442	54214,.	19606	23524	0.3430			3.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98012603	98012603	-	AC	het	hom	het		QUAL=11054;DP=251,118,167;AF=0.84,0.92,0.49;MQM=60;SAP=60;ABP=150;SAR=149;SAF=252	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-33290_141-33289dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-17605_985-17604dup::					MIRb (SINE/MIR)	rs112555829	0.7835	0.7548,0.8454,0.9268,0.7794,0.8099	45614,.	25048	32122				2.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98012988	98012988	A	T	hom	hom	het		QUAL=29785;DP=410,332,452;AF=1.00,1.00,0.48;MQM=60;SAP=179;ABP=5;SAR=619;SAF=340	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+33020T>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-17988T>A::					L2c (LINE/L2)	rs1938565	0.8818	0.9665,0.9088,0.9427,0.8356,0.8552	59509,.	15078	17972	0.1560			12.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98013425	98013425	C	T	hom	hom	het		QUAL=5322;DP=127,22,28;AF=1.00,1.00,0.43;MQM=60;SAP=13;ABP=4;SAR=94;SAF=67	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+32583G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-18425G>A::						rs1938566	0.8117	0.7259,0.8832,0.9421,0.8339,0.8434	50348,.	22491	28587	-1.1710			0.09					32203549	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014572	98014572	T	C	hom	hom	het		QUAL=22105;DP=405,193,218;AF=1.00,1.00,0.49;MQM=60;SAP=88;ABP=3;SAR=435;SAF=269	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31436A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19572A>G::					MER102b (DNA/hAT-Charlie)	rs1938567	0.8603	0.8917,0.9027,0.9401,0.8353,0.8547	56278,.	17832	21174	-0.9230			1.12					25434007	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014656	98014656	C	T	het	het	wt		QUAL=8052;DP=427,147,200;AF=0.54,0.50,0.01;MQM=60;SAP=23;ABP=7;SAR=179;SAF=126	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31352G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19656G>A::					MER102b (DNA/hAT-Charlie)	rs11165944	0.2957	0.1489,0.3500,0.5270,0.3392,0.4470	7354,.	29805	106045	-1.1420			0.43					34560273	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014760	98014760	A	-	het	het	het	low_conf_region	QUAL=645;DP=103,34,47;AF=0.12,0.18,0.34;MQM=60;SAP=3;ABP=162;SAR=18;SAF=16	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31248del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19760del::					A-rich (Low_complexity)	rs756636800	0.0134	0.0056,0.0111,0.0255,0.0142,0.0442	12,.	1422	106314	0.3190			1.28						1	245	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98016194	98016194	C	T	het	het	wt		QUAL=6616;DP=335,216,298;AF=0.46,0.47,0.01;MQM=60;SAP=22;ABP=10;SAR=152;SAF=105	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+29814G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-21194G>A::						rs6683447	0.2727	0.1228,0.3492,0.5671,0.3124,0.4046	6595,.	28257	110555	-0.8800			0.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017024	98017024	G	A	hom	hom	het		QUAL=14206;DP=266,104,171;AF=1.00,1.00,0.50;MQM=60;SAP=364;ABP=3;SAR=90;SAF=365	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28984C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22024C>T::					L1MB1 (LINE/L1)	rs2391903	0.9147	0.9772,0.9376,0.9406,0.8783,0.8885	63844,.	11446	12978	0.1620			3.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017137	98017137	A	G	hom	hom	het		QUAL=16875;DP=242,159,245;AF=1.00,1.00,0.54;MQM=60;SAP=3;ABP=6;SAR=268;SAF=265	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28871T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22137T>C::					L1MB1 (LINE/L1)	rs1892549	0.8552	0.8746,0.8984,0.9404,0.8352,0.8561	55762,.	18487	22021	-0.2100			2.95						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017272	98017272	A	G	hom	hom	het		QUAL=15794;DP=301,122,139;AF=1.00,1.00,0.44;MQM=60;SAP=53;ABP=8;SAR=294;SAF=189	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28736T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22272T>C::					L1MB1 (LINE/L1)	rs1892550	0.8553	0.8747,0.8986,0.9402,0.8353,0.8560	55794,.	18485	22011	-1.3240			0.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017405	98017405	C	T	hom	hom	het		QUAL=14102;DP=278,97,134;AF=1.00,0.99,0.45;MQM=60;SAP=90;ABP=6;SAR=283;SAF=151	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28603G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22405G>A::					L1MB1 (LINE/L1)	rs1892551	0.8554	0.8747,0.8986,0.9409,0.8353,0.8561	55797,.	18492	21988	0.8610			9.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017479	98017479	G	A	hom	hom	het		QUAL=9869;DP=216,54,75;AF=1.00,1.00,0.48;MQM=60;SAP=270;ABP=3;SAR=250;SAF=56	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28529C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22479C>T::						rs1892552	0.8554	0.8747,0.8986,0.9407,0.8354,0.8559	55783,.	18474	21986	-0.1480			0.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017594	98017594	A	G	hom	hom	het		QUAL=6154;DP=147,19,34;AF=1.00,1.00,0.62;MQM=60;SAP=4;ABP=7;SAR=89;SAF=98	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28414T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22594T>C::						rs2391904	0.8552	0.8745,0.8987,0.9402,0.8353,0.8560	55774,.	18481	22019	-0.2560			1.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017674	98017674	T	A	wt	het	wt		QUAL=148;DP=225,29,54;AF=0.00,0.41,0.00;MQM=60;SAP=6;ABP=5;SAR=4;SAF=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28334A>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22674A>T::						rs116414424	0.0265	0.0065,0.0266,0.0002,0.0412,0.0066	68,.	3897	148153	-1.0570			1.35						1	13	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017766	98017766	T	C	hom	hom	het		QUAL=6594;DP=154,33,49;AF=1.00,1.00,0.31;MQM=60;SAP=10;ABP=19;SAR=114;SAF=88	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28242A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22766A>G::						rs9324382	0.8537	0.8744,0.8972,0.9397,0.8336,0.8448	55543,.	18672	22240	0.5980			8.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018596	98018596	T	C	hom	hom	het		QUAL=7937;DP=166,53,91;AF=1.00,1.00,0.35;MQM=60;SAP=3;ABP=20;SAR=126;SAF=125	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27412A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23596A>G::						rs1938571	0.8049	0.7022,0.8835,0.9401,0.8336,0.8443	49686,.	22949	29649	-0.1250			1.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018735	98018735	G	A	hom	hom	het		QUAL=11189;DP=210,97,108;AF=1.00,1.00,0.36;MQM=60;SAP=11;ABP=21;SAR=191;SAF=155	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27273C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23735C>T::						rs4447033	0.8553	0.8747,0.8986,0.9400,0.8353,0.8563	55776,.	18478	22002	0.0700			1.21					27338279	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018918	98018918	T	C	hom	hom	het		QUAL=3396;DP=58,40,39;AF=1.00,1.00,0.36;MQM=57;SAP=64;ABP=10;SAR=84;SAF=28	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27090A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23918A>G::					AluSx1 (SINE/Alu)	rs1938572	0.8552	0.8747,0.8984,0.9397,0.8352,0.8560	55611,.	18448	21950	-2.1630			0.73						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019061	98019061	C	T	hom	hom	het		QUAL=3195;DP=79,12,27;AF=1.00,1.00,0.41;MQM=60;SAP=4;ABP=5;SAR=54;SAF=48	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26947G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24061G>A::					AluSx1 (SINE/Alu)	rs1938573	0.8564	0.8755,0.8997,0.9403,0.8359,0.8576	55598,.	18425	21737	-0.0450			0.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019398	98019398	G	T	hom	hom	het		QUAL=19114;DP=335,156,222;AF=1.00,1.00,0.47;MQM=60;SAP=9;ABP=5;SAR=278;SAF=317	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26610C>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24398C>A::						rs1938558	0.8553	0.8747,0.8987,0.9405,0.8352,0.8561	55812,.	18498	22020	1.1900			8.60						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019546	98019546	G	A	hom	hom	het		QUAL=13941;DP=250,126,154;AF=1.00,1.00,0.43;MQM=60;SAP=5;ABP=10;SAR=231;SAF=211	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26462C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24546C>T::					MIR (SINE/MIR)	rs1938559	0.8552	0.8746,0.8987,0.9401,0.8352,0.8558	55788,.	18497	22033	0.7920			6.77						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019636	98019636	C	T	hom	hom	het		QUAL=22291;DP=509,106,138;AF=1.00,1.00,0.43;MQM=60;SAP=50;ABP=8;SAR=398;SAF=277	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26372G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24636G>A::	regulatory_region_variant:open_chromatin_region				MIR (SINE/MIR)	rs1938560	0.8553	0.8746,0.8988,0.9405,0.8352,0.8562	55808,.	18479	22013	0.0020			2.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020017	98020017	C	T	hom	hom	het		QUAL=8872;DP=148,88,74;AF=1.00,1.00,0.64;MQM=60;SAP=378;ABP=15;SAR=252;SAF=31	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25991G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25017G>A::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant					rs9324383	0.8553	0.8746,0.8985,0.9405,0.8353,0.8561	55769,.	18481	22005	0.5110			3.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020142	98020142	-	TTT	het	n/a	n/a		QUAL=232;DP=20,2,2;AF=0.55,1.00,0.00;MQM=58;SAP=17;ABP=3;SAR=11;SAF=2	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25863_140+25865dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25145_985-25143dup::	regulatory_region_variant:open_chromatin_region					rs10637296	0.8121	0.7510,0.8789,0.9152,0.8265,0.8497	48238,.	21791	27361				1.99						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020371	98020371	T	C	hom	hom	het		QUAL=6998;DP=106,83,108;AF=1.00,0.99,0.44;MQM=58;SAP=356;ABP=6;SAR=20;SAF=216	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25637A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25371A>G::					AluSx1 (SINE/Alu)	rs9725319	0.8552	0.8746,0.8988,0.9404,0.8352,0.8555	55749,.	18482	22014	-1.8110			1.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020435	98020435	C	T	het	wt	het		QUAL=2544;DP=109,136,159;AF=0.38,0.00,0.45;MQM=60;SAP=55;ABP=19;SAR=30;SAF=82	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25573G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25435G>A::					AluSx1 (SINE/Alu)	rs74829086	0.0144	0.0141,0.0314,0.1347,0.0020,0.0459	89,.	2014	149854	-1.7430			0.12						4	84	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020606	98020606	T	C	hom	hom	het		QUAL=7541;DP=149,66,73;AF=1.00,1.00,0.36;MQM=60;SAP=219;ABP=16;SAR=198;SAF=43	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25402A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25402A>G::						rs4477335	0.8552	0.8747,0.8986,0.9401,0.8353,0.8561	55731,.	18468	21996	-0.2530			3.47						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020686	98020686	-	A	hom	hom	het		QUAL=4541;DP=130,19,24;AF=0.95,0.95,0.42;MQM=60;SAP=47;ABP=4;SAR=103;SAF=48	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25321dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25321dup::						rs61381274	0.8546	0.8732,0.8980,0.9403,0.8350,0.8558	55581,.	18522	22058				0.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020814	98020814	G	A	hom	hom	het		QUAL=4959;DP=101,32,41;AF=1.00,1.00,0.46;MQM=60;SAP=28;ABP=3;SAR=55;SAF=97	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25194C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25194C>T::						rs4480407	0.8738	0.9374,0.9084,0.9404,0.8356,0.8567	58306,.	16198	19182	0.4270			3.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021138	98021138	A	C	wt	het	wt		QUAL=1905;DP=497,160,183;AF=0.00,0.50,0.00;MQM=60;SAP=60;ABP=3;SAR=17;SAF=63	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24870T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24870T>G::						rs79792869	0.0266	0.0065,0.0267,0.0002,0.0413,0.0064	69,.	3904	148172	0.4270			2.77						1	13	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021524	98021524	A	G	wt	het	wt		QUAL=3008;DP=492,177,218;AF=0.00,0.62,0.00;MQM=60;SAP=26;ABP=26;SAR=72;SAF=38	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24484T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24484T>C::						rs77482155	0.0357	0.0080,0.0324,0.0004,0.0532,0.0223	123,.	5190	146746	2.9560			15.00						1	17	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021777	98021777	A	G	hom	hom	het		QUAL=20780;DP=273,220,282;AF=1.00,1.00,0.57;MQM=60;SAP=13;ABP=17;SAR=355;SAF=300	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24231T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24231T>C::						rs9659624	0.8551	0.8745,0.8986,0.9402,0.8351,0.8559	55733,.	18480	22022	0.7530			13.09					33686288	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021954	98021954	C	A	hom	hom	het		QUAL=20765;DP=389,161,203;AF=1.00,1.00,0.55;MQM=60;SAP=13;ABP=8;SAR=304;SAF=358	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24054G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24054G>T::						rs5005705	0.8538	0.8734,0.8972,0.9402,0.8342,0.8461	55521,.	18653	22211	-1.3150			0.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022010	98022010	C	T	hom	hom	het		QUAL=13857;DP=234,129,144;AF=1.00,0.99,0.53;MQM=60;SAP=48;ABP=5;SAR=267;SAF=172	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23998G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23998G>A::						rs9324384	0.8553	0.8745,0.8986,0.9404,0.8354,0.8563	55747,.	18486	21994	-0.6920			0.76						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022207	98022207	G	A	hom	hom	het		QUAL=18181;DP=308,165,181;AF=1.00,0.99,0.50;MQM=60;SAP=42;ABP=3;SAR=230;SAF=331	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23801C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23801C>T::						rs4634961	0.8554	0.8749,0.8987,0.9402,0.8354,0.8558	55740,.	18475	21963	-0.2480			1.66					24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022343	98022343	C	A	hom	hom	het		QUAL=19917;DP=273,232,262;AF=1.00,1.00,0.52;MQM=60;SAP=76;ABP=4;SAR=246;SAF=393	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23665G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23665G>T::						rs9324385	0.8553	0.8748,0.8985,0.9403,0.8353,0.8565	55747,.	18483	21989	0.0320			3.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022403	98022403	G	A	hom	hom	het		QUAL=26136;DP=377,265,327;AF=1.00,1.00,0.51;MQM=60;SAP=11;ABP=3;SAR=376;SAF=431	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23605C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23605C>T::						rs9324386	0.8553	0.8747,0.8985,0.9402,0.8354,0.8563	55772,.	18484	21992	-0.1830			0.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022474	98022474	G	A	hom	hom	het		QUAL=22613;DP=332,214,330;AF=1.00,1.00,0.50;MQM=60;SAP=106;ABP=3;SAR=446;SAF=263	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23534C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23534C>T::						rs9324387	0.8554	0.8747,0.8986,0.9401,0.8353,0.8567	55778,.	18487	21989	-0.0660			1.57					24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022599	98022599	G	A	hom	hom	het		QUAL=17798;DP=284,169,197;AF=1.00,1.00,0.46;MQM=60;SAP=3;ABP=5;SAR=267;SAF=277	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23409C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23409C>T::						rs9324388	0.8554	0.8749,0.8985,0.9404,0.8353,0.8564	55784,.	18475	21987	0.1320			7.83						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023307	98023307	A	G	hom	hom	het		QUAL=16788;DP=319,127,131;AF=1.00,1.00,0.64;MQM=60;SAP=433;ABP=26;SAR=427;SAF=103	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22701T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22701T>C::						rs9659996	0.8552	0.8746,0.8986,0.9399,0.8352,0.8561	55750,.	18484	22008	1.6210			12.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023339	98023339	C	T	hom	hom	het		QUAL=10349;DP=169,101,92;AF=1.00,1.00,0.58;MQM=60;SAP=129;ABP=8;SAR=230;SAF=93	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22669G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22669G>A::						rs9658841	0.8552	0.8746,0.8986,0.9399,0.8353,0.8558	55756,.	18488	22010	-0.3040			2.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023524	98023524	G	A	hom	hom	het		QUAL=7301;DP=173,26,38;AF=1.00,1.00,0.61;MQM=60;SAP=22;ABP=7;SAR=89;SAF=133	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22484C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22484C>T::						rs9661157	0.8553	0.8746,0.8990,0.9411,0.8353,0.8555	55701,.	18461	21965	-0.4100			0.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023721	98023721	-	TACTT	het	hom	het		QUAL=5495;DP=140,56,90;AF=0.86,0.96,0.36;MQM=60;SAP=5;ABP=55;SAR=109;SAF=97	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22286_140+22287insAAGTA::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22286_984+22287insAAGTA::						rs71071680	0.8548	0.8744,0.8982,0.9398,0.8348,0.8555	55491,.	18460	21992				12.72					34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023774	98023774	C	T	hom	hom	het		QUAL=9447;DP=219,52,81;AF=1.00,1.00,0.31;MQM=60;SAP=135;ABP=29;SAR=81;SAF=215	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22234G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22234G>A::						rs10747496	0.8554	0.8747,0.8988,0.9401,0.8353,0.8564	55648,.	18453	21941	0.3660			4.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023922	98023922	A	G	hom	hom	het		QUAL=19522;DP=400,125,163;AF=1.00,1.00,0.42;MQM=60;SAP=5;ABP=11;SAR=286;SAF=308	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22086T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22086T>C::						rs4584446	0.8552	0.8746,0.8985,0.9399,0.8353,0.8561	55703,.	18455	21983	-0.0180			2.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024179	98024179	T	C	hom	hom	het		QUAL=14470;DP=324,57,130;AF=1.00,1.00,0.51;MQM=60;SAP=355;ABP=3;SAR=89;SAF=358	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21829A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21829A>G::						rs2391905	0.8553	0.8746,0.8988,0.9401,0.8353,0.8556	55684,.	18457	21973	0.2110			6.28					24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024456	98024457	TT	-	hom	hom	het		QUAL=11091;DP=310,79,95;AF=0.90,0.92,0.54;MQM=60;SAP=141;ABP=4;SAR=282;SAF=122	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21551_140+21552del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21551_984+21552del::					L2a (LINE/L2)	rs55633609	0.8515	0.8649,0.8969,0.9385,0.8339,0.8549	53784,.	18659	22009	0.4400			0.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024609	98024609	C	T	hom	hom	het		QUAL=8595;DP=179,46,72;AF=1.00,1.00,0.44;MQM=60;SAP=9;ABP=5;SAR=115;SAF=142	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21399G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21399G>A::						rs4950117	0.8744	0.9393,0.9087,0.9403,0.8356,0.8561	58291,.	16090	19054	0.2330			3.05					24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024802	98024802	G	T	hom	hom	het		QUAL=16080;DP=259,154,169;AF=1.00,0.99,0.51;MQM=60;SAP=20;ABP=3;SAR=218;SAF=281	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21206C>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21206C>A::						rs4950118	0.8549	0.8747,0.8986,0.9401,0.8351,0.8561	55600,.	18493	22005	0.5410			16.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025080	98025080	T	C	hom	hom	het		QUAL=18252;DP=373,121,172;AF=0.99,1.00,0.48;MQM=60;SAP=150;ABP=3;SAR=386;SAF=189	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20928A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20928A>G::						rs10783082	0.8551	0.8745,0.8987,0.9400,0.8352,0.8568	55628,.	18440	21974	0.1160			14.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025214	98025214	-	TTAAGTAT	hom	hom	het		QUAL=13723;DP=233,153,151;AF=0.96,1.00,0.56;MQM=60;SAP=6;ABP=8;SAR=218;SAF=243	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20786_140+20793dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20786_984+20793dup::						rs5776392	0.8547	0.8742,0.8983,0.9400,0.8347,0.8557	55285,.	18404	21930				1.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025692	98025692	A	C	hom	hom	het		QUAL=18386;DP=338,140,192;AF=1.00,1.00,0.45;MQM=60;SAP=6;ABP=7;SAR=267;SAF=297	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20316T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20316T>G::					MIR3 (SINE/MIR)	rs4950119	0.8464	0.9153,0.8873,0.9396,0.8055,0.8095	54683,.	19001	23299	-0.6610			0.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025826	98025826	G	A	hom	hom	het		QUAL=14570;DP=269,105,175;AF=1.00,1.00,0.44;MQM=60;SAP=56;ABP=8;SAR=278;SAF=173	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20182C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20182C>T::					MIRb (SINE/MIR)	rs4950120	0.8553	0.8746,0.8988,0.9405,0.8351,0.8564	55570,.	18427	21923	0.1650			3.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025917	98025917	A	C	hom	hom	het		QUAL=17800;DP=354,116,173;AF=1.00,0.99,0.50;MQM=60;SAP=104;ABP=3;SAR=197;SAF=358	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20091T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20091T>G::					MIRb (SINE/MIR)	rs4245673	0.8551	0.8746,0.8988,0.9400,0.8352,0.8562	55635,.	18444	21978	0.9310			8.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98026176	98026176	T	C	hom	hom	het		QUAL=18398;DP=255,193,284;AF=1.00,1.00,0.49;MQM=60;SAP=126;ABP=3;SAR=384;SAF=202	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+19832A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+19832A>G::						rs1938568	0.8552	0.8747,0.8987,0.9400,0.8351,0.8561	55670,.	18464	21984	0.6240			13.98					24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98026906	98026906	C	T	hom	hom	het		QUAL=22556;DP=420,185,198;AF=1.00,0.99,0.46;MQM=60;SAP=58;ABP=5;SAR=281;SAF=413	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+19102G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+19102G>A::						rs9440393	0.8552	0.8748,0.8983,0.9400,0.8352,0.8558	55613,.	18446	21960	-0.8030			0.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027024	98027024	A	G	het	het	het		QUAL=13321;DP=470,260,283;AF=0.49,0.48,0.50;MQM=60;SAP=37;ABP=4;SAR=204;SAF=292	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18984T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18984T>C::						rs9440302	0.4874	0.4996,0.5042,0.3729,0.4906,0.3932	18108,.	37578	77622	0.5020			6.00					32184616,25217366	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027298	98027298	T	C	hom	hom	het		QUAL=16950;DP=356,95,113;AF=1.00,1.00,0.50;MQM=60;SAP=28;ABP=3;SAR=292;SAF=216	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18710A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18710A>G::						rs9324389	0.8552	0.8748,0.8988,0.9405,0.8352,0.8561	55628,.	18428	21950	-2.3170			0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027345	98027345	G	A	wt	het	wt		QUAL=1388;DP=320,92,90;AF=0.00,0.59,0.00;MQM=60;SAP=3;ABP=9;SAR=26;SAF=28	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18663C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18663C>T::						rs74700717	0.0199	0.0048,0.0208,0.0002,0.0315,0.0025	40,.	2937	148753	-1.2760			2.31						7	389	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027707	98027707	A	G	hom	hom	het		QUAL=13427;DP=217,123,187;AF=1.00,1.00,0.45;MQM=60;SAP=238;ABP=7;SAR=319;SAF=105	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18301T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18301T>C::	regulatory_region_variant:enhancer					rs1938569	0.8549	0.8745,0.8986,0.9401,0.8350,0.8535	55540,.	18445	21977	0.7930			5.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028229	98028229	G	A	hom	hom	het		QUAL=2323;DP=63,11,14;AF=0.98,1.00,0.36;MQM=60;SAP=90;ABP=5;SAR=11;SAF=67	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17779C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17779C>T::						rs2022864	0.8553	0.8745,0.8983,0.9402,0.8349,0.8561	55035,.	18261	21711	-0.7290			1.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028233	98028233	A	G	hom	hom	het		QUAL=2323;DP=63,11,14;AF=0.98,1.00,0.36;MQM=60;SAP=90;ABP=5;SAR=11;SAF=67	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17775T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17775T>C::						rs2022865	0.8551	0.8743,0.8980,0.9402,0.8348,0.8558	55020,.	18280	21754	-0.0130			7.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028629	98028629	G	A	hom	hom	het		QUAL=12920;DP=215,104,153;AF=1.00,0.99,0.55;MQM=60;SAP=60;ABP=6;SAR=252;SAF=149	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17379C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17379C>T::						rs10875124	0.8549	0.8741,0.8983,0.9402,0.8351,0.8560	55334,.	18394	21898	0.8880			5.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028644	98028644	A	C	hom	hom	het		QUAL=12382;DP=217,97,140;AF=1.00,0.99,0.53;MQM=60;SAP=77;ABP=4;SAR=251;SAF=136	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17364T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17364T>G::						rs10875125	0.8548	0.8740,0.8983,0.9401,0.8350,0.8557	55305,.	18395	21913	0.2010			1.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028832	98028832	-	A	hom	hom	het		QUAL=7913;DP=174,48,82;AF=0.98,1.00,0.44;MQM=60;SAP=120;ABP=6;SAR=69;SAF=186	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17175dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17175dup::						rs11404556	0.8552	0.8745,0.8987,0.9407,0.8354,0.8561	55486,.	18400	21904				8.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98029050	98029050	A	G	hom	hom	het		QUAL=14517;DP=242,132,151;AF=1.00,1.00,0.44;MQM=60;SAP=17;ABP=8;SAR=247;SAF=193	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+16958T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+16958T>C::						rs1198574	0.8553	0.8746,0.8989,0.9400,0.8355,0.8563	55488,.	18376	21886	0.7640			18.63					32184616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98029957	98029957	T	C	hom	hom	het		QUAL=10068;DP=153,96,129;AF=1.00,1.00,0.54;MQM=60;SAP=99;ABP=5;SAR=100;SAF=219	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+16051A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+16051A>G::						rs1198573	0.8552	0.8749,0.8980,0.9404,0.8351,0.8557	55357,.	18377	21865	3.3360			16.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98030956	98030956	T	-	het	het	wt		QUAL=4251;DP=222,105,144;AF=0.51,0.60,0.03;MQM=60;SAP=190;ABP=7;SAR=153;SAF=28	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+15052del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+15052del::						rs377025796	0.0104	0.0051,0.0038,0.0610,0.0122,0.0052	25,.	1485	145883	0.9970			1.85						1	155	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031620	98031620	A	C	hom	hom	het		QUAL=6039;DP=157,15,15;AF=1.00,1.00,0.67;MQM=60;SAP=6;ABP=7;SAR=99;SAF=83	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14388T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14388T>G::						rs1198572	0.8268	0.8525,0.8757,0.9396,0.8043,0.7985	51934,.	21206	26208	-0.4610			6.05					33686288	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031799	98031799	A	G	het	het	wt		QUAL=777;DP=53,13,9;AF=0.51,0.62,0.00;MQM=59;SAP=30;ABP=4;SAR=28;SAF=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14209T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14209T>C::						rs188465986	0.0082	0.0023,0.0037,0.0000,0.0132,0.0051	7,.	1070	131300	0.2980			4.16						0	162	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031807	98031807	T	C	het	wt	wt	low_conf_region	QUAL=40;DP=21,9,6;AF=0.00,0.44,0.00;MQM=51;SAP=12;ABP=20;SAR=4;SAF=0	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14201A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14201A>G::					(AC)n (Simple_repeat)	rs796242776	0.0007	0.0004,0.0005,0.0009,0.0009,0.0007	0,.	88	133546	-0.6360			2.76						4	305	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031808	98031811	ACAC	-	wt	het	wt	low_conf_region	QUAL=40;DP=21,9,6;AF=0.00,0.44,0.00;MQM=60;SAP=12;ABP=3;SAR=4;SAF=0	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14197_140+14200del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14197_984+14200del::					(AC)n (Simple_repeat)	rs34012276	0.0445	0.0487,0.0414,0.0067,0.0472,0.0414	109,.	5732	127704	0.3460			1.56						4	7	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98032116	98032116	A	G	hom	hom	het		QUAL=4984;DP=120,21,35;AF=1.00,1.00,0.37;MQM=60;SAP=89;ABP=8;SAR=38;SAF=116	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+13892T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+13892T>C::						rs1198571	0.8552	0.8747,0.8985,0.9405,0.8352,0.8560	55539,.	18398	21928	0.3560			3.24						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98032783	98032783	C	T	wt	het	wt		QUAL=2115;DP=592,195,248;AF=0.00,0.47,0.00;MQM=60;SAP=11;ABP=5;SAR=37;SAF=55	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+13225G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+13225G>A::						rs17371457	0.1802	0.0478,0.2749,0.0845,0.2445,0.1160	3158,.	20985	124223	-0.5830			1.43					32184616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98033342	98033342	C	A	hom	hom	het		QUAL=23989;DP=422,189,268;AF=1.00,1.00,0.47;MQM=60;SAP=210;ABP=5;SAR=501;SAF=236	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+12666G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+12666G>T::						rs1782815	0.8538	0.8745,0.8971,0.9400,0.8339,0.8452	55465,.	18600	22176	0.3820			2.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034034	98034034	A	-	het	wt	het	low_conf_region	QUAL=1635;DP=86,30,36;AF=0.58,0.00,0.53;MQM=58;SAP=67;ABP=8;SAR=57;SAF=12	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11974del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11974del::	regulatory_region_variant:enhancer				(AGAA)n (Simple_repeat)	rs143336786	0.0379	0.0884,0.0526,0.1307,0.0042,0.0669	100,.	2216	61386	0.1540			0.40						0	8	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034095	98034095	G	A	het	het	het	low_conf_region	QUAL=1393;DP=67,17,14;AF=0.52,0.65,0.50;MQM=54;SAP=6;ABP=4;SAR=31;SAF=22	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11913C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11913C>T::	regulatory_region_variant:enhancer				(AGAA)n (Simple_repeat)	rs1782814	0.2223	0.2121,0.2664,0.2841,0.2225,0.2146	2369,.	12402	59964	-0.5910			0.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034107	98034107	-	AAAG	hom	hom	het	low_conf_region	QUAL=1400;DP=41,10,7;AF=0.93,0.90,0.29;MQM=59;SAP=3;ABP=6;SAR=26;SAF=23	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11897_140+11900dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11897_984+11900dup::	regulatory_region_variant:enhancer				(AGAA)n (Simple_repeat)	rs780129382	0.3190	0.2956,0.4211,0.3066,0.3202,0.2755	4122,.	13390	46188				1.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034287	98034287	T	C	hom	hom	het		QUAL=10082;DP=168,94,158;AF=0.99,1.00,0.46;MQM=60;SAP=116;ABP=5;SAR=101;SAF=233	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11721A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11721A>G::	regulatory_region_variant:enhancer					rs1782813	0.8682	0.9183,0.9071,0.9399,0.8352,0.8567	57430,.	16896	20006	-0.3410			3.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034489	98034489	G	C	het	het	wt		QUAL=6863;DP=388,132,168;AF=0.50,0.45,0.01;MQM=60;SAP=20;ABP=4;SAR=105;SAF=150	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11519C>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11519C>G::	regulatory_region_variant:enhancer				UCON1 (Unknown)	rs7554283	0.2730	0.1211,0.3486,0.5671,0.3131,0.4044	6620,.	28203	110375	1.4970			14.87					32184616,34560273	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98035455	98035455	T	C	het	het	wt		QUAL=7037;DP=316,202,249;AF=0.48,0.53,0.00;MQM=60;SAP=30;ABP=3;SAR=159;SAF=102	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+10553A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+10553A>G::	regulatory_region_variant:enhancer					rs4950101	0.2385	0.1109,0.2377,0.5115,0.2804,0.3585	5010,.	26146	115508	1.6180			9.30					24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036428	98036428	T	C	hom	hom	het		QUAL=13803;DP=275,84,106;AF=0.99,1.00,0.59;MQM=60;SAP=4;ABP=11;SAR=204;SAF=216	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9580A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9580A>G::						rs1702294	0.8211	0.8326,0.8739,0.9397,0.8041,0.7995	51425,.	21875	27181	-0.0800			1.44					26836412,30035013,31995602,31268507,28072415,30518757,28117840,29635364,27072377,30618607,29442441,30038276,31409837,27620842,25056061,31835028,30285260,31522868,32152294,34625583,34159505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036603	98036603	G	C	hom	hom	het		QUAL=29063;DP=321,361,438;AF=1.00,1.00,0.51;MQM=60;SAP=58;ABP=4;SAR=377;SAF=529	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9405C>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9405C>G::					Tigger3a (DNA/TcMar-Tigger)	rs1702293	0.9146	0.9772,0.9374,0.9407,0.8782,0.8886	63761,.	11438	12978	-2.6840			0.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036784	98036784	G	A	hom	hom	het		QUAL=18814;DP=240,231,243;AF=1.00,1.00,0.48;MQM=60;SAP=15;ABP=4;SAR=322;SAF=264	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9224C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9224C>T::					Tigger3a (DNA/TcMar-Tigger)	rs1782810	0.7830	0.6982,0.8647,0.9396,0.8039,0.7979	46957,.	24951	32935	-0.0240			1.79					23871474,28540026	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036854	98036854	A	C	hom	hom	het		QUAL=21528;DP=275,249,295;AF=1.00,1.00,0.51;MQM=60;SAP=63;ABP=3;SAR=269;SAF=406	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9154T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9154T>G::					Tigger3a (DNA/TcMar-Tigger)	rs1782811	0.8819	0.9666,0.9103,0.9400,0.8356,0.8563	59450,.	15046	17940	-2.7810			0.54						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98037038	98037038	A	C	hom	hom	het		QUAL=18013;DP=241,208,270;AF=1.00,1.00,0.49;MQM=60;SAP=283;ABP=3;SAR=428;SAF=154	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+8970T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+8970T>G::						rs1628294	0.9146	0.9771,0.9373,0.9409,0.8783,0.8887	63749,.	11424	12966	-0.4600			2.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98037378	98037378	G	T	hom	hom	het		QUAL=10749;DP=212,74,108;AF=1.00,1.00,0.38;MQM=60;SAP=25;ABP=17;SAR=135;SAF=192	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+8630C>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+8630C>A::				CR159174 [CLASS=DP MUT=ALT PHEN="Schizophrenia increased risk" GENE=MIR137HG];		rs1625579	0.7827	0.6970,0.8647,0.9397,0.8040,0.7991	46893,.	24961	32961	-0.3280			0.73					27895608,24174267,23637625,28798405,25921703,22910404,21926974,22078159,22850735,22883350,22982201,23459466,23507081,23776546,23786914,23871474,23910899,24132022,24275578,24339136,24361663,24391914,24625753,24718684,24820543,25044277,25154622,25241074,25395183,26123324,26429811,26836412,27028512,27095331,27096222,27481827,28234206,28958479,29042896,29118371,29599094,30026708,30035013,30122962,30610940,31586698,32127940,32184616,29858046,25311363,23637704,26609515,28812221,25250332,22614287,27525637,29657307,27650867,25200985,24468824,25844328,29529357,28117840,24566148,29893792,27396304,26005852,31361772,29635364,27072377,25217366,30566479,30618607,23453885,25941532,24160291,25884492,28217082,29442441,27196537,25387707,31354550,23595788,29665782,31409837,24866554,26925706,24653674,25434007,27244233,24403877,24556472,27733313,27620842,24342994,31522868,33967611,28659691,32406920,23375658,32910167,25084801,32920385,27706734,33708240,32566292,23284144,29033781,22547958,25958205,23805071,34566604,33939221,3234811	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98040554	98040554	A	-	het	het	het		QUAL=822;DP=200,100,133;AF=0.22,0.13,0.17;MQM=60;SAP=6;ABP=388;SAR=34;SAF=44	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+5454del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+5454del::						rs528539462	0.0068	0.0051,0.0084,0.0019,0.0062,0.0000	0,.	709	103553	-1.7360			0.04						0	126	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98041060	98041060	-	TTCATTCA	het	wt	het		QUAL=2641;DP=82,19,37;AF=0.41,0.37,0.03;MQM=60;SAP=3;ABP=4;SAR=26;SAF=29	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+4940_140+4947dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+4940_984+4947dup::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.4380_4387dup::						rs35835879	0.1484	0.2319,0.1401,0.0916,0.1228,0.0513	1942,.	18469	128277				0.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98041060	98041060	-	TTCATTCATTCA	het	het	wt		QUAL=2641;DP=82,19,37;AF=0.41,0.37,0.03;MQM=57;SAP=4;ABP=49;SAR=19;SAF=23	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+4936_140+4947dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+4936_984+4947dup::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.4376_4387dup::						rs35835879	0.5572	0.5885,0.5362,0.6923,0.5306,0.6083	23580,.	36759	66689				0.12						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98041060	98041060	-	TTCATTCATTCATTCA	wt	het	wt		QUAL=2641;DP=82,19,37;AF=0.41,0.37,0.03;MQM=60;SAP=6;ABP=6;SAR=8;SAF=4	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+4932_140+4947dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+4932_984+4947dup::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.4372_4387dup::						rs35835879	0.1196	0.0598,0.1851,0.1474,0.1377,0.1320	1300,.	15418	132682				0.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042140	98042140	A	G	hom	hom	het		QUAL=6052;DP=154,15,35;AF=0.99,1.00,0.43;MQM=60;SAP=3;ABP=5;SAR=90;SAF=93	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3868T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3868T>C::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.3308T>C::						rs4292998	0.7943	0.7376,0.8688,0.9395,0.8041,0.7978	48245,.	24230	31256	-0.1470			5.88					30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042162	98042162	C	A	hom	hom	het		QUAL=7219;DP=183,18,38;AF=1.00,1.00,0.45;MQM=60;SAP=4;ABP=4;SAR=114;SAF=104	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3846G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3846G>T::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.3286G>T::						rs4411173	0.8682	0.9183,0.9069,0.9402,0.8353,0.8557	57565,.	16928	20046	0.5130			6.74					29500382	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042702	98042702	C	T	hom	hom	het		QUAL=39548;DP=576,411,500;AF=1.00,1.00,0.52;MQM=60;SAP=244;ABP=5;SAR=437;SAF=809	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3306G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3306G>A::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.2746G>A::	regulatory_region_variant:enhancer					rs2802535	0.7925	0.7306,0.8686,0.9392,0.8041,0.7998	47936,.	24375	31481	-0.7900			0.61					24566148,26005852,29635364,29033781	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042932	98042932	G	A	het	wt	het		QUAL=8629;DP=419,173,196;AF=0.50,0.00,0.56;MQM=60;SAP=191;ABP=5;SAR=242;SAF=76	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3076C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3076C>T::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.2516C>T::						rs78924727	0.0143	0.0135,0.0313,0.1345,0.0019,0.0469	90,.	1992	149938	-0.2050			1.03						4	83	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98046571	98046571	G	T	hom	hom	het		QUAL=32945;DP=409,411,496;AF=1.00,1.00,0.48;MQM=60;SAP=12;ABP=6;SAR=495;SAF=560	MIR137HG	non_coding_transcript_exon	MIR137HG:ENST00000424528.2:non_coding_transcript_exon_variant:MODIFIER:exon2/5:n.543C>A::	regulatory_region_variant:promoter					rs2660304	0.8267	0.8521,0.8763,0.9398,0.8041,0.7996	52012,.	21293	26273	1.2640			18.18					24885463,27004216,28803920,26429811,31059093,24566148,29893792,26005852,27913161,31361772,29635364,30618607,29442441,31409837,25434007,27620842,29483656,26198764,33686288,33479212,31522868,33708240,29033781,33343624,33794697	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98047588	98047588	T	A	hom	hom	het		QUAL=13200;DP=231,116,132;AF=1.00,1.00,0.53;MQM=60;SAP=11;ABP=4;SAR=228;SAF=189	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.487-961A>T::						rs2660303	0.9137	0.9745,0.9374,0.9407,0.8780,0.8884	63646,.	11563	13111	-0.2680			0.48					27004216	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048120	98048120	-	CA	wt	wt	het	low_conf_region	QUAL=916;DP=18,17,77;AF=0.00,0.00,0.53;MQM=60;SAP=9;ABP=4;SAR=15;SAF=26	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1256_486+1257dup::	regulatory_region_variant:promoter					rs1553269771	0.0059	0.0027,0.0038,0.0021,0.0085,0.0136	8,.	743	127455				2.81						29	75	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048120	98048120	-	CGCA	het	hom	wt	low_conf_region	QUAL=916;DP=18,17,77;AF=0.00,0.00,0.53;MQM=54;SAP=11;ABP=27;SAR=1;SAF=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1257_486+1258insTGCG::	regulatory_region_variant:promoter					rs150117500	0.0229	0.0509,0.0112,0.0005,0.0083,0.0014	97,.	2742	125280				2.72						0	2	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048156	98048156	-	CACACACACC	het	hom	wt		QUAL=916;DP=18,17,77;AF=0.00,0.00,0.53;MQM=54;SAP=11;ABP=27;SAR=1;SAF=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1221_486+1222insGGTGTGTGTG::	regulatory_region_variant:promoter				(CA)n (Simple_repeat)	rs750747213	0.0375	0.0111,0.0362,0.0014,0.0552,0.0323	149,.	5330	144670				5.84						0	1	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048289	98048289	G	A	hom	hom	het		QUAL=13245;DP=147,183,260;AF=1.00,0.99,0.47;MQM=60;SAP=46;ABP=5;SAR=178;SAF=273	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1089C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant					rs61786696	0.9146	0.9772,0.9373,0.9411,0.8782,0.8889	63862,.	11454	12992	0.0740			8.09					27004216	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048403	98048403	A	G	hom	hom	het		QUAL=18181;DP=248,207,277;AF=1.00,1.00,0.50;MQM=60;SAP=17;ABP=3;SAR=327;SAF=265	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+975T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant					rs61786697	0.9147	0.9774,0.9374,0.9405,0.8782,0.8894	63808,.	11434	12974	2.6530			20.00					27004216,33841080,32152294	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98049034	98049034	-	CT	wt	wt	het		QUAL=617;DP=159,97,106;AF=0.13,0.13,0.11;MQM=60;SAP=22;ABP=296;SAR=28;SAF=10	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+342_486+343dup::	regulatory_region_variant:promoter					rs143725104	0.0129	0.0073,0.0092,0.0047,0.0168,0.0138	20,.	1802	141548				13.44						5	216	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98049035	98049036	CT	-	het	het	wt		QUAL=617;DP=159,97,106;AF=0.02,0.00,0.33;MQM=60;SAP=5;ABP=447;SAR=19;SAF=26	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+342_486+343del::	regulatory_region_variant:promoter				(CT)n (Simple_repeat)	rs143725104	0.0105	0.0327,0.0035,0.0014,0.0019,0.0016	27,.	1445	141235	2.0910			16.18						0	85	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	99851033	99851033	A	G	wt	het	wt		QUAL=1816;DP=310,107,144;AF=0.00,0.64,0.01;MQM=60;SAP=3;ABP=23;SAR=35;SAF=36	AGL	5'UTR,splice_acceptor	AGL:ENST00000361915.8:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000294724.8:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000370163.7:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000370165.7:splice_acceptor_variant:HIGH:intron1/33:c.-8-2A>G:p.?:	regulatory_region_variant:promoter	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	195096 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2307130	0.4188	0.2633,0.4344,0.5452,0.4903,0.5429	14073,.	35501	88329	0.3570			15.29		3.27>-4.68	COSV54056176	0.24	25741868,16400609	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99851209	99851209	C	T	het	hom	het	off-target	QUAL=3350;DP=145,41,43;AF=0.46,1.00,0.44;MQM=60;SAP=214;ABP=6;SAR=119;SAF=8	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron2/33:c.82+85C>T::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron2/33:c.82+85C>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron2/33:c.82+85C>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron2/33:c.82+85C>T::	regulatory_region_variant:promoter	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	676091 [benign DISEASE=not provided];			rs663848	0.7586	0.9133,0.7147,0.6980,0.6960,0.7611	44447,.	26460	36708	-0.2350			3.85				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99852537	99852537	T	-	het	het	het	off-target	QUAL=263;DP=11,6,13;AF=0.45,0.17,0.54;MQM=58;SAP=31;ABP=4;SAR=0;SAF=13	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron2/33:c.82+1432del::	regulatory_region_variant:promoter	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]			AluJo (SINE/Alu)	rs58176899	0.0006	0.0004,0.0007,0.0003,0.0004,0.0026	1,.	72	118726	-0.2510			4.91				0.05		16	76	0 / 0					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99861470	99861470	C	T	het	het	het		QUAL=12734;DP=435,201,300;AF=0.53,0.48,0.46;MQM=60;SAP=4;ABP=3;SAR=226;SAF=238	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron1/32:c.35-33C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256750 [benign DISEASE=Glycogen storage disease type III,not specified];			rs2307129	0.2354	0.3901,0.1876,0.1190,0.1698,0.1949	5048,.	25665	116131	-1.0140			2.03			COSV54053030	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99864333	99864333	G	C	het	hom	het	off-target	QUAL=2585;DP=97,33,50;AF=0.54,1.00,0.38;MQM=60;SAP=220;ABP=3;SAR=1;SAF=103	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron3/32:c.413-53G>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	676092 [benign DISEASE=not provided];			rs535461	0.7310	0.8656,0.6943,0.6975,0.6778,0.7572	41149,.	28773	40869	-0.0880			2.44				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99864681	99864681	A	G	het	hom	het	off-target	QUAL=5004;DP=144,80,91;AF=0.47,1.00,0.49;MQM=60;SAP=422;ABP=4;SAR=193;SAF=0	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron5/33:c.664+92A>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron5/33:c.664+92A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron5/33:c.664+92A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron5/33:c.664+92A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron4/32:c.616+92A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	676094 [benign DISEASE=not provided];		A-rich (Low_complexity)	rs538389	0.7585	0.9128,0.7153,0.6972,0.6962,0.7607	44439,.	26442	36726	-0.8040			2.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99864739	99864739	T	C	het	hom	het	off-target	QUAL=2557;DP=122,29,36;AF=0.45,1.00,0.53;MQM=60;SAP=227;ABP=4;SAR=103;SAF=0	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron5/33:c.664+150T>C::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron5/33:c.664+150T>C::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron5/33:c.664+150T>C::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron5/33:c.664+150T>C::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron4/32:c.616+150T>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	677943 [benign DISEASE=not provided];			rs539157	0.7592	0.9152,0.7156,0.6975,0.6962,0.7606	44522,.	26361	36613	-1.6830			0.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99870232	99870232	A	G	het	het	het	off-target	QUAL=1107;DP=71,12,11;AF=0.56,0.25,0.73;MQM=60;SAP=114;ABP=4;SAR=0;SAF=51	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron5/33:c.665-168A>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron5/33:c.665-168A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron5/33:c.665-168A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron5/33:c.665-168A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron4/32:c.617-168A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	679283 [benign DISEASE=not provided];			rs67875069	0.2354	0.3902,0.1871,0.1193,0.1698,0.1943	5054,.	25666	116214	0.0710			3.08				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99870327	99870327	A	G	wt	het	wt	off-target	QUAL=762;DP=144,61,59;AF=0.00,0.57,0.02;MQM=60;SAP=81;ABP=6;SAR=0;SAF=36	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron5/33:c.665-73A>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron5/33:c.665-73A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron5/33:c.665-73A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron5/33:c.665-73A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron4/32:c.617-73A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1294321 [benign DISEASE=not provided];			rs903126	0.3827	0.1978,0.4105,0.4923,0.4674,0.4711	12142,.	33818	93730	2.5420			11.59				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99870805	99870805	C	T	het	hom	het		QUAL=8603;DP=340,98,117;AF=0.42,1.00,0.51;MQM=60;SAP=24;ABP=14;SAR=124;SAF=178	AGL	synonymous	AGL:ENST00000361915.8:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000294724.8:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370163.7:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370165.7:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370161.6:synonymous_variant:LOW:exon6/33:c.846C>T:p.Leu282=:PF14701 [Glycogen debranching enzyme glucanotransferase domain]		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	198432 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2230306	0.7588	0.9129,0.7161,0.6976,0.6963,0.7614	44424,.	26407	36643	1.0390			11.31				0.12	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99874669	99874669	G	A	het	hom	het	off-target	QUAL=11542;DP=218,169,229;AF=0.49,1.00,0.54;MQM=60;SAP=148;ABP=4;SAR=118;SAF=281	AGL	splice_region&intron	AGL:ENST00000361915.8:splice_region_variant&intron_variant:LOW:intron7/33:c.959-18G>A::,AGL:ENST00000294724.8:splice_region_variant&intron_variant:LOW:intron7/33:c.959-18G>A::,AGL:ENST00000370163.7:splice_region_variant&intron_variant:LOW:intron7/33:c.959-18G>A::,AGL:ENST00000370165.7:splice_region_variant&intron_variant:LOW:intron7/33:c.959-18G>A::,AGL:ENST00000370161.6:splice_region_variant&intron_variant:LOW:intron6/32:c.911-18G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256751 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs634880	0.7341	0.8415,0.6866,0.7206,0.6937,0.7379	41276,.	28812	40332	-0.9060			5.56		10.97>11.37	COSV54049593	0.02	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99876671	99876671	C	T	wt	het	wt	off-target	QUAL=938;DP=82,67,75;AF=0.00,0.57,0.00;MQM=60;SAP=54;ABP=6;SAR=34;SAF=4	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron11/33:c.1423+74C>T::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron11/33:c.1423+74C>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron11/33:c.1423+74C>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron11/33:c.1423+74C>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron10/32:c.1375+74C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1294319 [benign DISEASE=not provided];			rs3736295	0.5157	0.4250,0.5656,0.6738,0.5470,0.5983	20626,.	37032	73520	-0.6710			4.51			COSV54049212	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99877517	99877517	T	A	wt	het	wt	off-target	QUAL=38;DP=48,7,11;AF=0.00,0.57,0.00;MQM=60;SAP=12;ABP=3;SAR=0;SAF=4	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron11/33:c.1424-124T>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron11/33:c.1424-124T>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron11/33:c.1424-124T>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron11/33:c.1424-124T>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron10/32:c.1376-124T>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1294317 [benign DISEASE=not provided];			rs2291637	0.4896	0.3765,0.5454,0.6751,0.5314,0.5935	18819,.	36744	77544	-0.7600			4.83			COSV54049668	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99877597	99877597	A	G	wt	het	wt	off-target	QUAL=302;DP=175,22,41;AF=0.00,0.68,0.00;MQM=60;SAP=21;ABP=9;SAR=2;SAF=13	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron10/32:c.1376-44A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256722 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2291638	0.2969	0.0932,0.3241,0.4599,0.3929,0.3095	8120,.	28880	106856	-0.5580			8.44			COSV54049682	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99879853	99879853	C	G	wt	het	wt	off-target	QUAL=818;DP=154,71,106;AF=0.00,0.49,0.00;MQM=60;SAP=36;ABP=3;SAR=6;SAF=29	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron12/33:c.1612-70C>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron12/33:c.1612-70C>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron12/33:c.1612-70C>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron12/33:c.1612-70C>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron11/32:c.1564-70C>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1294318 [benign DISEASE=not provided];		(TTTC)n (Simple_repeat)	rs2392077	0.4898	0.3769,0.5451,0.6749,0.5315,0.5938	18796,.	36753	77455	0.7610			5.25			COSV54049704	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99881185	99881185	T	C	wt	het	wt		QUAL=2719;DP=287,209,284;AF=0.00,0.51,0.00;MQM=60;SAP=4;ABP=3;SAR=57;SAF=51	AGL	splice_region&intron	AGL:ENST00000361915.8:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000294724.8:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000370163.7:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000370165.7:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000370161.6:splice_region_variant&intron_variant:LOW:intron14/32:c.1953+8T>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256725 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs3736296	0.5158	0.4252,0.5646,0.6749,0.5470,0.5993	20631,.	37021	73497	2.0820			12.88			COSV54049713	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99884827	99884827	G	A	wt	het	wt	off-target	QUAL=630;DP=159,80,91;AF=0.00,0.41,0.00;MQM=60;SAP=75;ABP=8;SAR=33;SAF=0	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron20/33:c.2681+124G>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron20/33:c.2681+124G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron20/33:c.2681+124G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron20/33:c.2681+124G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron19/32:c.2633+124G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1235676 [benign DISEASE=not provided];		MER5A1 (DNA/hAT-Charlie)	rs2234707	0.5158	0.4249,0.5652,0.6755,0.5471,0.5983	20652,.	37050	73554	-0.0350			7.68			COSV54049748	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99888119	99888119	G	A	het	hom	het	off-target	QUAL=12234;DP=173,206,264;AF=0.53,1.00,0.47;MQM=60;SAP=104;ABP=3;SAR=281;SAF=141	AGL	splice_region&intron	AGL:ENST00000361915.8:splice_region_variant&intron_variant:LOW:intron21/33:c.2812+11G>A::,AGL:ENST00000294724.8:splice_region_variant&intron_variant:LOW:intron21/33:c.2812+11G>A::,AGL:ENST00000370163.7:splice_region_variant&intron_variant:LOW:intron21/33:c.2812+11G>A::,AGL:ENST00000370165.7:splice_region_variant&intron_variant:LOW:intron21/33:c.2812+11G>A::,AGL:ENST00000370161.6:splice_region_variant&intron_variant:LOW:intron20/32:c.2764+11G>A::	regulatory_region_variant:open_chromatin_region	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256730 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs555929	0.6622	0.5817,0.6948,0.6997,0.6934,0.7449	33501,.	33511	51265	-0.2370			0.59			COSV54049809	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99891485	99891485	A	G	wt	het	wt	off-target	QUAL=603;DP=192,61,81;AF=0.00,0.43,0.00;MQM=60;SAP=4;ABP=6;SAR=11;SAF=15	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron22/33:c.2950-121A>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron22/33:c.2950-121A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron22/33:c.2950-121A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron22/33:c.2950-121A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron21/32:c.2902-121A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1269708 [benign DISEASE=not provided];			rs2035960	0.5153	0.4238,0.5651,0.6747,0.5469,0.5984	20593,.	37009	73553	-0.5230			0.36			COSV54052442	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99891585	99891585	T	A	wt	het	wt	off-target	QUAL=1409;DP=198,121,186;AF=0.00,0.47,0.00;MQM=60;SAP=35;ABP=4;SAR=14;SAF=43	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron21/32:c.2902-21T>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256733 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2035961	0.4893	0.3756,0.5451,0.6745,0.5315,0.5935	18763,.	36706	77476	0.0910			5.65			COSV54051217	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99892547	99892547	C	T	het	het	het		QUAL=8382;DP=251,182,223;AF=0.49,0.47,0.51;MQM=60;SAP=8;ABP=4;SAR=174;SAF=146	AGL	missense	AGL:ENST00000361915.8:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000294724.8:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370163.7:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370165.7:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370161.6:missense_variant:MODERATE:exon23/33:c.3151C>T:p.Pro1051Ser:		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256734 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs3753494	0.1363	0.1202,0.1268,0.0262,0.1464,0.1495	1507,.	17690	131210	7.2800	D(0.04),D(0.04),D(0.04),D(0.04),D(0.03)	B(0.10),B(0.10),B(0.10),B(0.10),B(0.05)	22.20	0.30			0.11	25741868,25803781	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99892644	99892644	G	A	het	hom	het	off-target	QUAL=5719;DP=136,88,117;AF=0.46,1.00,0.49;MQM=60;SAP=296;ABP=5;SAR=187;SAF=20	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron23/32:c.3211+37G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256735 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs594249	0.6627	0.5821,0.6950,0.7009,0.6935,0.7486	33579,.	33515	51251	-1.8710			0.01			COSV54049828	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99900890	99900890	G	T	het	wt	wt	off-target;low_conf_region	QUAL=1522;DP=81,49,51;AF=0.28,0.78,0.43;MQM=58;SAP=66;ABP=108;SAR=29;SAF=0	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron25/32:c.3540+29G>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1204532 [likely benign DISEASE=not provided];		(T)n (Simple_repeat)	rs201885902	0.0013	0.0023,0.0017,0.0008,0.0006,0.0002	0,.	182	142146	0.6720			2.62				0.02		20	649	0 / 0	2	"[2] auto-classification 22.09.2017  "			AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99900891	99900892	TT	-	het	hom	het	off-target;low_conf_region	QUAL=1522;DP=81,49,51;AF=0.27,0.06,0.08;MQM=60;SAP=183;ABP=32;SAR=83;SAF=0	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron25/32:c.3540+43_3540+44del::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1220869 [benign DISEASE=not provided];		(T)n (Simple_repeat)	rs35956186	0.5254	0.4296,0.5078,0.4992,0.5864,0.4762	19107,.	36535	67533	2.0190			1.96				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99910892	99910892	G	A	wt	het	wt	off-target	QUAL=2103;DP=103,176,266;AF=0.00,0.49,0.00;MQM=60;SAP=9;ABP=3;SAR=51;SAF=36	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron27/32:c.3788+45G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256744 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2274570	0.4649	0.3719,0.5090,0.5693,0.5093,0.3765	16702,.	36933	80963	-0.2940			0.37			COSV54050212	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99910900	99910900	T	A	wt	het	wt	off-target	QUAL=2114;DP=106,173,261;AF=0.00,0.50,0.00;MQM=60;SAP=14;ABP=3;SAR=54;SAF=33	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron27/32:c.3788+53T>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1224847 [benign DISEASE=not provided];			rs1541041	0.4647	0.3719,0.5090,0.5684,0.5091,0.3771	16706,.	36943	81041	-0.3640			1.85			COSV54050222	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99912233	99912233	C	T	het	het	het	off-target	QUAL=1026;DP=47,13,25;AF=0.43,0.77,0.60;MQM=60;SAP=101;ABP=4;SAR=0;SAF=45	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron28/33:c.3837-172C>T::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron28/33:c.3837-172C>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron28/33:c.3837-172C>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron28/33:c.3837-172C>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron27/32:c.3789-172C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	680039 [benign DISEASE=not provided];			rs3818568	0.1362	0.1200,0.1279,0.0264,0.1465,0.1358	1504,.	17667	131109	0.0880			1.31				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99915553	99915553	-	T	het	het	het	off-target;low_conf_region	QUAL=986;DP=66,35,37;AF=0.39,0.37,0.41;MQM=60;SAP=74;ABP=17;SAR=48;SAF=6	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron31/33:c.4259+80dup::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron31/33:c.4259+80dup::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron31/33:c.4259+80dup::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron31/33:c.4259+80dup::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron30/32:c.4211+80dup::	regulatory_region_variant:enhancer	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1292307 [benign DISEASE=not provided];			rs11438303	0.4340	0.2506,0.4871,0.5717,0.5212,0.3881	14663,.	34203	82841				1.26				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99916313	99916313	G	A	wt	het	wt	off-target	QUAL=170;DP=120,46,63;AF=0.00,0.28,0.00;MQM=60;SAP=31;ABP=22;SAR=0;SAF=13	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron31/33:c.4260-97G>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron31/33:c.4260-97G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron31/33:c.4260-97G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron31/33:c.4260-97G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron30/32:c.4212-97G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1294320 [benign DISEASE=not provided];			rs2296885	0.3913	0.2553,0.4627,0.5566,0.4492,0.3286	12390,.	34596	92362	0.5240			4.82			COSV54050263	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99921923	99921923	G	T	wt	het	wt		QUAL=1097;DP=305,85,95;AF=0.00,0.52,0.00;MQM=60;SAP=4;ABP=3;SAR=25;SAF=20	AGL	3'UTR	AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*272G>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291351 [benign DISEASE=Glycogen storage disease type III,not provided];			rs1804808	0.3249	0.1200,0.4250,0.5563,0.4040,0.3156	9469,.	30260	102210	0.1500			2.81			COSV54050326,COSV54053994	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99922383	99922383	C	T	het	hom	het		QUAL=4274;DP=173,41,53;AF=0.49,1.00,0.45;MQM=60;SAP=14;ABP=4;SAR=61;SAF=88	AGL	3'UTR	AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*732C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291359 [benign DISEASE=Glycogen storage disease type III];			rs3766600	0.6176	0.5374,0.6432,0.6334,0.6583,0.5169	29017,.	35358	57836	0.8200			4.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99922679	99922679	C	T	wt	het	wt		QUAL=258;DP=191,42,61;AF=0.01,0.38,0.00;MQM=60;SAP=6;ABP=8;SAR=6;SAF=11	AGL	3'UTR	AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1028C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291363 [benign DISEASE=Glycogen storage disease type III];			rs3766601	0.4734	0.3976,0.5123,0.5720,0.5109,0.3774	17318,.	37085	79781	0.9610			4.49			COSV54050336	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99922947	99922947	A	C	wt	het	wt		QUAL=895;DP=221,61,69;AF=0.00,0.57,0.00;MQM=60;SAP=3;ABP=6;SAR=19;SAF=17	AGL	3'UTR	AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1296A>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291368 [benign DISEASE=Glycogen storage disease type III];			rs1804809	0.3799	0.2167,0.4593,0.5554,0.4488,0.3274	11969,.	33724	94108	0.0970			2.97			COSV54050348	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99923192	99923192	T	C	wt	het	wt		QUAL=1707;DP=266,123,168;AF=0.00,0.54,0.01;MQM=60;SAP=3;ABP=4;SAR=32;SAF=35	AGL	3'UTR	AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1541T>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291369 [benign DISEASE=Glycogen storage disease type III];			rs3766603	0.4047	0.3036,0.4670,0.5564,0.4489,0.3276	12947,.	35543	90365	-1.4380			0.29			COSV54050357	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100187173	100187173	G	A	wt	het	wt		QUAL=315;DP=111,37,41;AF=0.00,0.43,0.02;MQM=60;SAP=32;ABP=4;SAR=1;SAF=16	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*9082C>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291375 [benign DISEASE=Maple syrup urine disease,not provided];			rs72728160	0.1172	0.0317,0.1180,0.0008,0.1760,0.0319	1396,.	15030	134192	0.3260			3.52				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100187701	100187701	T	-	het	het	het		QUAL=159;DP=18,6,10;AF=0.33,0.33,0.30;MQM=59;SAP=8;ABP=12;SAR=3;SAF=8	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*8554del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1195364 [likely benign DISEASE=not provided];		AluJb (SINE/Alu)	rs886044938	0.0092	0.0050,0.0117,0.0021,0.0108,0.0119	5,.	1136	122938	-1.4950			0.14				0		2	208	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189352	100189352	A	-	het	wt	n/a		QUAL=1057;DP=42,8,1;AF=0.38,0.38,0.00;MQM=58;SAP=26;ABP=3;SAR=3;SAF=18	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903del::	regulatory_region_variant:enhancer	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291391 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Maple syrup urine disease,not provided];		AluSz (SINE/Alu)	rs71709231	0.8271	0.7126,0.8833,0.9574,0.8572,0.9238	49179,.	20233	24799	0.4640			3.74				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189352	100189353	AA	-	wt	het	n/a		QUAL=1057;DP=42,8,1;AF=0.48,0.00,1.00;MQM=55;SAP=13;ABP=53;SAR=1;SAF=7	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902_*6903del::	regulatory_region_variant:enhancer	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1200821 [likely benign DISEASE=not provided];		AluSz (SINE/Alu)	rs71709231	0.0072	0.0041,0.0070,0.0069,0.0066,0.0026	3,.	1024	142166	0.4640			3.95				0		1	65	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189352	100189352	A	T	het	het	n/a		QUAL=1057;DP=42,8,1;AF=0.38,0.38,0.00;MQM=59;SAP=4;ABP=9;SAR=8;SAF=11	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903T>A::	regulatory_region_variant:enhancer	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291392 [benign DISEASE=Maple syrup urine disease,not provided];		AluSz (SINE/Alu)	rs10783125	0.5469	0.5743,0.5227,0.5132,0.5156,0.5166	1720,.	15700	15860	0.4640			7.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189353	100189353	A	T	het	wt	n/a		QUAL=1057;DP=42,8,1;AF=0.38,0.38,0.00;MQM=58;SAP=26;ABP=3;SAR=3;SAF=18	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902T>A::	regulatory_region_variant:enhancer	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	875221 [uncertain significance DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs200943386	0.8051	0.6807,0.8678,0.9380,0.8397,0.8909	45023,.	22251	27179	0.4640			7.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189354	100189354	A	T	wt	het	n/a		QUAL=1057;DP=42,8,1;AF=0.38,0.38,0.00;MQM=55;SAP=13;ABP=53;SAR=1;SAF=7	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6901T>A::	regulatory_region_variant:enhancer	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291393 [uncertain significance DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs200062717	0.0074	0.0041,0.0078,0.0070,0.0069,0.0027	3,.	1050	140914	0.4640			7.53				0		0	66	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190027	100190027	T	A	hom	hom	hom		QUAL=4322;DP=104,15,13;AF=1.00,1.00,1.00;MQM=60;SAP=16;ABP=0;SAR=80;SAF=52	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6228A>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291395 [benign DISEASE=Maple syrup urine disease,not provided];		MER3 (DNA/hAT-Charlie)	rs4281338	0.7567	0.4764,0.8542,0.9515,0.8499,0.8833	45899,.	23284	36996	-0.7220			0.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190140	100190141	AA	-	het	wt	het		QUAL=3494;DP=180,57,89;AF=0.49,0.02,0.65;MQM=60;SAP=194;ABP=8;SAR=17;SAF=131	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6114_*6115del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291396 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Maple syrup urine disease,not provided];		MLT1J2 (LTR/ERVL-MaLR)	rs3081711	0.1790	0.0452,0.1632,0.1495,0.2465,0.1862	3079,.	21060	124836	0.4950			0.56				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190709	100190709	C	T	hom	hom	hom		QUAL=13994;DP=174,105,140;AF=0.99,1.00,1.00;MQM=60;SAP=30;ABP=0;SAR=173;SAF=245	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5546G>A::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291404 [benign DISEASE=Maple syrup urine disease,not provided];			rs11166412	0.7916	0.5644,0.8757,0.9522,0.8653,0.8994	49079,.	22067	31647	-0.7530			0.12				0	17998437	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190938	100190938	A	G	wt	het	wt		QUAL=1899;DP=403,187,261;AF=0.00,0.43,0.00;MQM=60;SAP=3;ABP=10;SAR=42;SAF=40	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5317T>C::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291406 [benign DISEASE=Maple syrup urine disease,not provided];			rs11166413	0.3056	0.0920,0.3747,0.2590,0.4035,0.3158	8651,.	29150	105578	0.6970			8.55			COSV64497182	0	32450446	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100191105	100191105	T	C	hom	hom	hom		QUAL=24023;DP=361,156,207;AF=1.00,1.00,1.00;MQM=60;SAP=65;ABP=0;SAR=433;SAF=289	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5150A>G::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291407 [benign DISEASE=Maple syrup urine disease,not provided];			rs6701655	0.7590	0.4790,0.8565,0.9523,0.8519,0.8971	46145,.	23087	36631	0.1090			2.52				0	31234531	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100191748	100191773	ATACACACACACACACACACACACAC	-	het	wt	het		QUAL=1931;DP=28,26,51;AF=0.43,0.88,0.39;MQM=58;SAP=3;ABP=4;SAR=19;SAF=18	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4482_*4507del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1228726 [benign DISEASE=not provided];		(AC)n (Simple_repeat)	rs1418854977	0.0429	0.0256,0.0331,0.0559,0.0491,0.0556	241,.	5799	140077	0.6740			0.29				0		4	9	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100191748	100191775	ATACACACACACACACACACACACACAC	-	het	hom	het		QUAL=1931;DP=28,26,51;AF=0.36,0.00,0.53;MQM=59;SAP=5;ABP=9;SAR=31;SAF=24	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4480_*4507del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1251386 [benign DISEASE=not provided];		(AC)n (Simple_repeat)	rs140341302	0.6814	0.5155,0.7664,0.8330,0.7301,0.7804	34782,.	30103	46595	0.6740			0.28				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100193022	100193022	G	A	hom	hom	hom		QUAL=34953;DP=339,320,473;AF=0.99,1.00,1.00;MQM=60;SAP=4;ABP=0;SAR=574;SAF=555	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3233C>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291424 [benign DISEASE=Maple syrup urine disease,not provided];			rs2784174	0.7592	0.4793,0.8565,0.9520,0.8519,0.8966	46156,.	23090	36612	0.1950			1.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), RPL23AP90 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100196535	100196536	TG	-	hom	hom	hom	off-target	QUAL=4125;DP=89,26,29;AF=1.00,0.96,1.00;MQM=60;SAP=314;ABP=0;SAR=143;SAF=0	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron10/10:c.1282-114_1282-113del::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron11/11:c.1408-114_1408-113del::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron11/11:c.739-114_739-113del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]				rs5776501	0.9896	0.9633,0.9975,1.0000,0.9999,0.9998	74248,.	1518	1570	0.0000			0.68				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), RPL23AP90 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100206073	100206073	A	-	het	hom	het	off-target	QUAL=92;DP=10,3,4;AF=0.40,0.33,0.25;MQM=57;SAP=16;ABP=5;SAR=0;SAF=6	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron10/10:c.1281+157del::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron11/11:c.1407+157del::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron11/11:c.738+157del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1241624 [benign DISEASE=not provided];		L1PA7 (LINE/L1)	rs35150096	0.4009	0.2477,0.4542,0.2849,0.4736,0.3729	9341,.	31345	74763	-0.0320			0.46				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100206310	100206310	T	A	wt	het	wt	low_conf_region	QUAL=295;DP=244,77,112;AF=0.00,0.25,0.00;MQM=60;SAP=3;ABP=46;SAR=9;SAF=11	DBT	splice_region&intron	DBT:ENST00000370132.8:splice_region_variant&intron_variant:LOW:intron9/10:c.1210-9A>T::,DBT:ENST00000681617.1:splice_region_variant&intron_variant:LOW:intron10/11:c.1336-9A>T::,DBT:ENST00000681780.1:splice_region_variant&intron_variant:LOW:intron10/11:c.667-9A>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	93987 [benign DISEASE=Maple syrup urine disease,not specified];			rs34229137	0.3134	0.1280,0.3848,0.2536,0.3919,0.3347	7976,.	29850	100356	0.7320			1.51		6.05>7.40	COSV64494912,COSV64495481	0.02	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100206504	100206504	T	C	hom	hom	hom		QUAL=29048;DP=343,245,303;AF=1.00,1.00,1.00;MQM=60;SAP=9;ABP=0;SAR=469;SAF=421	DBT	missense	DBT:ENST00000370132.8:missense_variant:MODERATE:exon9/11:c.1150A>G:p.Ser384Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)],DBT:ENST00000681617.1:missense_variant:MODERATE:exon10/12:c.1276A>G:p.Ser426Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)],DBT:ENST00000681780.1:missense_variant:MODERATE:exon10/12:c.607A>G:p.Ser203Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)]		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	128885 [benign DISEASE=Maple syrup urine disease,not specified,not provided];			rs12021720	0.8762	0.7652,0.9170,0.9666,0.9110,0.9531	58703,.	15816	18828	1.9390	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	12.46	0.12			0.01	30409984,29334895,21827660,9621512,30541556,23112750,22437669,32583022	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100215037	100215037	-	T	het	het	het	off-target;low_conf_region	QUAL=1313;DP=96,25,24;AF=0.55,0.48,0.42;MQM=60;SAP=125;ABP=3;SAR=70;SAF=5	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron6/10:c.773-55dup::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron6/11:c.773-55dup::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron7/11:c.230-55dup::,DBT:ENST00000370131.3:intron_variant:MODIFIER:intron6/7:c.773-55dup::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1291007 [benign DISEASE=not provided];			rs11431894	0.7788	0.5871,0.8484,0.9386,0.8414,0.8913	44764,.	23283	32037				0.95				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), BRI3P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100218933	100218934	GG	-	hom	hom	hom	off-target	QUAL=1523;DP=49,6,15;AF=0.88,1.00,1.00;MQM=60;SAP=142;ABP=0;SAR=64;SAF=0	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron4/10:c.434-187_434-186del::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron4/11:c.434-187_434-186del::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron5/11:c.-110-187_-110-186del::,DBT:ENST00000370131.3:intron_variant:MODIFIER:intron4/7:c.434-187_434-186del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1293954 [benign DISEASE=not provided];			rs55792733	0.8100	0.6105,0.8799,0.9522,0.8682,0.9080	48877,.	21101	27889	0.1350			1.00				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100230629	100230629	-	A	hom	hom	het	off-target;low_conf_region	QUAL=878;DP=33,4,12;AF=0.73,0.75,0.58;MQM=59;SAP=77;ABP=4;SAR=0;SAF=34	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron4/10:c.433+103dup::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron4/11:c.433+103dup::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron5/11:c.-111+103dup::,DBT:ENST00000370131.3:intron_variant:MODIFIER:intron4/7:c.433+103dup::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1291008 [benign DISEASE=not provided];		A-rich (Low_complexity)	rs11394110	0.8160	0.5742,0.8892,0.9615,0.9011,0.9470	48755,.	19030	26274				0.70				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100249898	100249898	G	A	hom	hom	hom	off-target	QUAL=12961;DP=46,191,275;AF=1.00,0.99,1.00;MQM=60;SAP=182;ABP=0;SAR=358;SAF=153	DBT	upstream_gene	DBT:ENST00000370132.8:upstream_gene_variant:MODIFIER::::,DBT:ENST00000681617.1:upstream_gene_variant:MODIFIER::::,DBT:ENST00000681780.1:upstream_gene_variant:MODIFIER::::,DBT:ENST00000370131.3:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1263587 [benign DISEASE=not provided];			rs3806235	0.7239	0.3906,0.8274,0.9414,0.8447,0.8380	43135,.	23715	41953	-1.2050			0.49					29740478	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), RTCA-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	109228441	109228441	T	C	hom	hom	hom		QUAL=21691;DP=237,204,230;AF=1.00,1.00,1.00;MQM=60;SAP=24;ABP=0;SAR=376;SAF=295	SARS1	splice_region&intron	SARS1:ENST00000234677.7:splice_region_variant&intron_variant:LOW:intron3/10:c.288+9T>C::,SARS1:ENST00000369923.4:splice_region_variant&intron_variant:LOW:intron3/11:c.288+9T>C::	regulatory_region_variant:enhancer	607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]	1327978 [benign DISEASE=Neurodevelopmental disorder with microcephaly, ataxia, and seizures];			rs683182	0.7031	0.4746,0.7826,0.8939,0.7915,0.6667	39240,.	28373	45129	-0.6230			1.81			COSV52320213	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109229259	109229259	G	T	hom	hom	hom	off-target	QUAL=4794;DP=114,23,26;AF=0.99,1.00,1.00;MQM=60;SAP=355;ABP=0;SAR=0;SAF=162	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron3/10:c.289-155G>T::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron3/11:c.289-155G>T::	regulatory_region_variant:enhancer	607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]				rs657511	0.9897	0.9646,0.9946,1.0000,0.9999,0.9998	74557,.	1520	1572	1.0760			5.33				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109231083	109231083	A	T	n/a	n/a	hom	off-target;low_conf_region	QUAL=116;DP=2,1,4;AF=1.00,0.00,1.00;MQM=60;SAP=16;ABP=0;SAR=6;SAF=0	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron5/10:c.591+62A>T::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron5/11:c.591+62A>T::	regulatory_region_variant:enhancer	607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]				rs66909315	0.0009	0.0027,0.0008,0.0010,0.0001,0.0002	0,.	121	137153	0.3750			2.40				0		71	648	0 / 0					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109235615	109235615	C	T	het	hom	wt	off-target	QUAL=492;DP=40,3,6;AF=0.50,1.00,0.00;MQM=60;SAP=24;ABP=3;SAR=19;SAF=4	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron7/10:c.969+184C>T::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron7/11:c.969+184C>T::		607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]			MIR (SINE/MIR)	rs4268379	0.3944	0.1458,0.4757,0.4597,0.4939,0.4334	13728,.	32403	91921	0.1580			4.36			COSV52320249	0	26487741	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109235955	109235955	T	C	hom	hom	hom	off-target	QUAL=18717;DP=176,160,262;AF=1.00,1.00,1.00;MQM=60;SAP=443;ABP=0;SAR=125;SAF=473	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron7/10:c.970-22T>C::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron7/11:c.970-22T>C::		607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]	1327979 [benign DISEASE=Neurodevelopmental disorder with microcephaly, ataxia, and seizures];			rs658092	0.7099	0.4983,0.7861,0.8939,0.7916,0.6673	39725,.	28416	44078	0.7830			9.53			COSV52320257	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	110167097	110167097	T	C	het	het	hom		QUAL=19106;DP=263,330,391;AF=0.46,0.00,1.00;MQM=60;SAP=76;ABP=202;SAR=129;SAF=51	SLC6A17,SLC6A17-AS1	synonymous,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon2/12:c.168T>C:p.Asp56=:,SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.522A>G::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.507A>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]	1333111 [benign DISEASE=Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome];			rs7527375	0.4958	0.4996,0.3924,0.2230,0.5340,0.3569	18666,.	36772	75374	-5.6260			0.64			COSV58991969	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110167098	110167098	G	A	het	wt	hom		QUAL=19106;DP=263,330,391;AF=0.46,0.00,1.00;MQM=60;SAP=231;ABP=7;SAR=372;SAF=140	SLC6A17,SLC6A17-AS1	missense,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:missense_variant:MODERATE:exon2/12:c.169G>A:p.Ala57Thr:,SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.521C>T::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.506C>T::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]	1333112 [benign DISEASE=Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome];			rs12737742	0.3358	0.0966,0.2981,0.2216,0.4598,0.3359	10397,.	29608	99698	0.6810	T(0.47), , 	B(0.05), , 	13.12	0.08		COSV58993671	0.01	29259604	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110167112	110167112	G	A	wt	het	wt		QUAL=4215;DP=251,312,375;AF=0.00,0.55,0.00;MQM=60;SAP=104;ABP=9;SAR=130;SAF=41	SLC6A17,SLC6A17-AS1	synonymous,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon2/12:c.183G>A:p.Pro61=:PF00209 [Sodium neurotransmitter symporter family],SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.507C>T::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.492C>T::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs41281364	0.0584	0.0537,0.0552,0.0006,0.0720,0.0151	279,.	8279	142411	-3.5070			3.74			COSV58997789	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110173788	110173798	TGAATGGAGCG	-	het	wt	hom	off-target	QUAL=1715;DP=52,54,45;AF=0.50,0.02,1.00;MQM=60;SAP=159;ABP=3;SAR=0;SAF=72	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron3/11:c.445-171_445-161del::	regulatory_region_variant:open_chromatin_region	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			Tigger15a (DNA/TcMar-Tigger)	rs67632953	0.3877	0.3012,0.3153,0.2213,0.4528,0.3359	11813,.	35161	92859	0.5050			7.02				0.06		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110173889	110173889	C	T	het	wt	hom	off-target	QUAL=7005;DP=102,207,195;AF=0.52,0.00,1.00;MQM=60;SAP=437;ABP=3;SAR=13;SAF=236	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron3/11:c.445-84C>T::	regulatory_region_variant:open_chromatin_region	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs12747833	0.3340	0.1018,0.3112,0.2588,0.4531,0.3349	10301,.	30163	101241	-0.2780			1.72			COSV58993259	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110176467	110176467	A	G	hom	hom	hom	off-target	QUAL=1953;DP=20,23,24;AF=1.00,1.00,1.00;MQM=60;SAP=148;ABP=0;SAR=0;SAF=67	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron5/11:c.754-162A>G::	regulatory_region_variant:enhancer,TF_binding_site_variant	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs589540	0.9436	0.9808,0.9525,0.9860,0.9157,0.9727	67792,.	7942	8586	-2.1500			0.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110192415	110192415	T	G	het	hom	het	off-target	QUAL=3973;DP=53,77,75;AF=0.49,1.00,0.53;MQM=60;SAP=88;ABP=3;SAR=34;SAF=109	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron7/11:c.1107-91T>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603583	0.6313	0.7318,0.5511,0.3480,0.6317,0.4385	30933,.	33981	55971	-1.1330			0.22				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110195674	110195674	G	A	het	het	het		QUAL=16462;DP=306,383,543;AF=0.50,0.54,0.53;MQM=60;SAP=48;ABP=9;SAR=265;SAF=380	SLC6A17	synonymous	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon10/12:c.1581G>A:p.Ser527=:PF00209 [Sodium neurotransmitter symporter family]	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784140	0.3679	0.1092,0.3919,0.2992,0.4965,0.3975	12538,.	30838	96070	-2.0460			6.89			COSV58991975,COSV58995492	0.16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110197242	110197242	A	G	het	het	het	off-target	QUAL=479;DP=14,11,17;AF=0.57,0.45,0.53;MQM=60;SAP=51;ABP=3;SAR=0;SAF=22	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron10/11:c.1653-195A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2761442	0.3913	0.1726,0.4053,0.3009,0.5056,0.4058	13318,.	32834	92514	0.4440			8.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110197651	110197651	G	T	het	het	het	off-target	QUAL=4715;DP=246,57,72;AF=0.54,0.40,0.58;MQM=60;SAP=372;ABP=5;SAR=190;SAF=7	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron11/11:c.1815+52G>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603581	0.3905	0.1908,0.4006,0.3000,0.4954,0.4009	13008,.	33323	92627	-0.2150			2.45				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110197784	110197784	C	T	het	het	het	off-target	QUAL=1159;DP=73,23,26;AF=0.48,0.30,0.38;MQM=60;SAP=23;ABP=9;SAR=37;SAF=15	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron11/11:c.1815+185C>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			MIRb (SINE/MIR)	rs2761443	0.3817	0.1601,0.3955,0.2999,0.4957,0.4005	12774,.	32499	94045	-0.7820			4.50				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198066	110198066	C	T	het	het	het	off-target	QUAL=8883;DP=177,255,329;AF=0.47,0.50,0.47;MQM=60;SAP=138;ABP=5;SAR=108;SAF=259	SLC6A17	splice_region&intron	SLC6A17:ENST00000331565.5:splice_region_variant&intron_variant:LOW:intron11/11:c.1816-10C>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2761445	0.3973	0.1934,0.4073,0.3015,0.5057,0.4048	13475,.	33361	91511	-0.7130			4.71		0.77>0.84	COSV58993252	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198459	110198459	C	G	het	het	wt		QUAL=2436;DP=136,119,157;AF=0.50,0.34,0.01;MQM=60;SAP=29;ABP=15;SAR=37;SAF=73	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*15C>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2761446	0.0347	0.0078,0.0209,0.0006,0.0530,0.0306	145,.	4985	146903	1.2140			4.22			COSV58992447	0		68	1616	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198464	110198464	C	T	wt	het	wt		QUAL=1787;DP=135,140,207;AF=0.00,0.54,0.00;MQM=60;SAP=4;ABP=5;SAR=34;SAF=41	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20C>T::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs41306175	0.0843	0.0825,0.0733,0.0039,0.1030,0.0174	569,.	11687	139299	-2.6300			0.06			COSV58995363	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198727	110198727	G	T	het	hom	het		QUAL=17097;DP=357,269,331;AF=0.47,1.00,0.57;MQM=60;SAP=4;ABP=5;SAR=305;SAF=319	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*283G>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603580	0.6379	0.7862,0.5427,0.3443,0.6191,0.4398	31868,.	33260	55072	-0.3460			0.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198961	110198961	C	G	het	hom	het		QUAL=10090;DP=171,176,215;AF=0.39,1.00,0.53;MQM=60;SAP=4;ABP=7;SAR=171;SAF=185	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*517C>G::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784141	0.6381	0.7865,0.5436,0.3451,0.6191,0.4401	31876,.	33240	55008	-1.1710			0.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199463	110199463	T	C	het	hom	het		QUAL=27438;DP=292,502,680;AF=0.44,1.00,0.49;MQM=60;SAP=23;ABP=8;SAR=529;SAF=435	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1019T>C::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603579	0.6395	0.7881,0.5464,0.3474,0.6205,0.4395	32025,.	33182	54816	0.6570			7.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199880	110199880	A	G	het	het	het	low_conf_region	QUAL=1558;DP=167,84,101;AF=0.32,0.25,0.26;MQM=59;SAP=156;ABP=146;SAR=92;SAF=8	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1436A>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			(GATG)n (Simple_repeat)	rs2361044	0.4032	0.1390,0.4260,0.3421,0.5099,0.4224	9505,.	26810	67814	-0.1920			5.40			COSV58997534	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199993	110199993	A	G	het	het	het		QUAL=2566;DP=123,70,108;AF=0.42,0.34,0.44;MQM=60;SAP=205;ABP=25;SAR=8;SAF=115	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1549A>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			GA-rich (Low_complexity)	rs12133992	0.3558	0.0998,0.3733,0.2835,0.4918,0.3670	11522,.	28249	92869	0.3660			3.70				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110200370	110200370	T	G	het	het	het		QUAL=7293;DP=173,180,266;AF=0.51,0.53,0.45;MQM=60;SAP=4;ABP=3;SAR=145;SAF=159	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1926T>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784142	0.3856	0.1704,0.4026,0.3020,0.4966,0.3886	12839,.	32618	92898	0.3880			8.85				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110200966	110200966	G	C	het	wt	het		QUAL=8420;DP=164,388,476;AF=0.53,0.00,0.52;MQM=60;SAP=12;ABP=6;SAR=186;SAF=149	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2522G>C::	regulatory_region_variant:enhancer	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs151008748	0.0201	0.0045,0.0238,0.0000,0.0241,0.0042	61,.	2933	148965	-0.6850			6.89				0		1	11	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110201213	110201213	G	A	wt	het	wt		QUAL=2274;DP=218,164,183;AF=0.00,0.54,0.00;MQM=60;SAP=6;ABP=6;SAR=50;SAF=39	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2769G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs12138403	0.0841	0.0822,0.0731,0.0037,0.1028,0.0178	565,.	11661	139323	0.1650			2.36				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110201559	110201559	C	T	wt	het	wt		QUAL=1082;DP=101,96,123;AF=0.01,0.46,0.00;MQM=60;SAP=3;ABP=4;SAR=24;SAF=21	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3115C>T::	regulatory_region_variant:enhancer	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs62621393	0.0841	0.0822,0.0732,0.0037,0.1029,0.0178	568,.	11661	139309	-4.2660			0.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110202252	110202252	G	A	wt	wt	het	off-target	QUAL=1733;DP=60,110,162;AF=0.00,0.00,0.46;MQM=60;SAP=20;ABP=6;SAR=49;SAF=25	SLC6A17	downstream_gene	SLC6A17:ENST00000331565.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs45445195	0.0216	0.0065,0.0412,0.0004,0.0306,0.0044	59,.	3166	148896	-0.7690			0.43						0	9	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110202393	110202393	T	G	het	hom	het	off-target	QUAL=2873;DP=148,30,41;AF=0.45,1.00,0.54;MQM=60;SAP=259;ABP=5;SAR=118;SAF=0	SLC6A17	downstream_gene	SLC6A17:ENST00000331565.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs545849	0.8523	0.9339,0.8601,0.8420,0.8116,0.8951	55483,.	18559	22439	0.2120			3.92						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	114705129	114705129	A	-	wt	het	wt		QUAL=990;DP=203,75,113;AF=0.00,0.59,0.01;MQM=60;SAP=6;ABP=8;SAR=27;SAF=19	NRAS	3'UTR	NRAS:ENST00000369535.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2965del::		164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]	291946 [likely benign DISEASE=Noonan syndrome];			rs61652108	0.2028	0.1319,0.1315,0.0228,0.2522,0.2344	3575,.	23651	121059	-0.3060			0.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19)
chr1	114707222	114707222	G	A	wt	het	wt		QUAL=1561;DP=407,125,196;AF=0.00,0.51,0.01;MQM=60;SAP=27;ABP=3;SAR=19;SAF=46	NRAS	3'UTR	NRAS:ENST00000369535.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*872C>T::		164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]	291967 [benign DISEASE=Noonan syndrome 6];			rs14804	0.2028	0.1323,0.1316,0.0225,0.2522,0.2343	3569,.	23687	121159	0.3720			8.30			COSV65733786	0	33390813,34828284	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19)
chr1	114714048	114714048	G	A	het	wt	hom	off-target	QUAL=2275;DP=68,33,52;AF=0.51,0.03,1.00;MQM=60;SAP=194;ABP=3;SAR=88;SAF=0	NRAS	intron	NRAS:ENST00000369535.5:intron_variant:MODIFIER:intron2/6:c.112-70C>T::		164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]	1231751 [benign DISEASE=not provided];			rs969273	0.7631	0.9344,0.8226,0.9983,0.6406,0.8326	45811,.	24351	36011	0.3140			2.70			COSV99794035	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19), CSDE1 (inh=n/a oe_syn=0.96 oe_mis=0.55 oe_lof=0.05)
chr1	114716780	114716780	C	T	het	wt	het		QUAL=3750;DP=185,111,128;AF=0.61,0.00,0.38;MQM=60;SAP=188;ABP=4;SAR=139;SAF=22	NRAS,CSDE1	upstream_gene,downstream_gene	NRAS:ENST00000369535.5:upstream_gene_variant:MODIFIER::::,CSDE1:ENST00000339438.10:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689989.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689217.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000438362.7:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000688211.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000358528.9:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000692719.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000610726.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689732.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000693467.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686235.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000684913.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686025.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686781.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000687759.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000692672.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000529046.6:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686667.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689885.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000691032.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000692044.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000690207.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000261443.9:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000530886.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000369530.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000534699.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]										2.4560			21.10				0		0	2	0 / 0					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19), CSDE1 (inh=n/a oe_syn=0.96 oe_mis=0.55 oe_lof=0.05)
chr1	115029744	115029744	A	G	het	hom	het	off-target	QUAL=8194;DP=163,122,179;AF=0.48,1.00,0.48;MQM=60;SAP=183;ABP=4;SAR=66;SAF=220	TSHB	upstream_gene	TSHB:ENST00000256592.3:upstream_gene_variant:MODIFIER::::		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]				rs1321108	0.4225	0.2902,0.4043,0.4979,0.4997,0.3878	14276,.	35489	87553	1.2730			14.76					24366283,23344678,26180634,27362444,25506236	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115033402	115033402	A	G	hom	hom	hom		QUAL=17936;DP=259,135,149;AF=1.00,1.00,1.00;MQM=60;SAP=58;ABP=0;SAR=213;SAF=330	TSHB	missense	TSHB:ENST00000256592.3:missense_variant:MODERATE:exon2/3:c.40A>G:p.Thr14Ala:		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]	256640 [benign DISEASE=Congenital hypothyroidism,Secondary hypothyroidism,not specified,not provided];			rs10776792	0.9766	0.9940,0.9865,1.0000,0.9663,0.9648	72526,.	3454	3564	0.2070	T(0.63)	B(0.00)	3.81	0.05			0.04	25741868,28515030,31242667	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115033790	115033790	T	A	het	wt	het	off-target	QUAL=1532;DP=105,8,11;AF=0.55,0.00,0.36;MQM=60;SAP=27;ABP=4;SAR=18;SAF=44	TSHB	intron	TSHB:ENST00000256592.3:intron_variant:MODIFIER:intron2/2:c.163-183T>A::		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]				rs17477369	0.0484	0.0187,0.0528,0.0131,0.0660,0.0499	204,.	6947	144675	-0.0780			1.74				0		4	7	0 / 0					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115033861	115033861	C	G	het	hom	het	off-target	QUAL=2888;DP=216,25,30;AF=0.37,1.00,0.53;MQM=60;SAP=240;ABP=29;SAR=3;SAF=118	TSHB	intron	TSHB:ENST00000256592.3:intron_variant:MODIFIER:intron2/2:c.163-112C>G::		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]	1268415 [benign DISEASE=not provided];			rs28566771	0.4647	0.4363,0.4192,0.4988,0.5004,0.3886	16620,.	37266	81232	-0.5090			2.36			COSV56655935	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115286692	115286692	G	A	hom	het	hom		QUAL=20215;DP=183,276,388;AF=0.99,0.51,0.99;MQM=60;SAP=140;ABP=3;SAR=248;SAF=459	NGF-AS1,NGF	intron&non_coding_transcript,missense,5'UTR	NGF-AS1:ENST00000425449.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.207+3452G>A::,NGF:ENST00000676038.2:missense_variant:MODERATE:exon4/4:c.104C>T:p.Ala35Val:,NGF:ENST00000369512.3:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF:ENST00000680116.1:missense_variant:MODERATE:exon4/4:c.104C>T:p.Ala35Val:,NGF:ENST00000681124.1:5_prime_UTR_variant:MODIFIER:exon3/3:c.-368C>T::,NGF:ENST00000675637.2:missense_variant:MODERATE:exon2/2:c.104C>T:p.Ala35Val:,NGF:ENST00000679806.1:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF:ENST00000680540.1:missense_variant:MODERATE:exon1/1:c.104C>T:p.Ala35Val:,NGF:ENST00000680752.1:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:		162030_[GENE=NGF_PHENOS=Neuropathy, hereditary sensory and autonomic, type V, 608654 (3), Autosomal recessive]	291993 [benign DISEASE=Congenital sensory neuropathy with selective loss of small myelinated fibers,not specified,not provided];			rs6330	0.3557	0.1916,0.3578,0.1620,0.4554,0.2212	10904,.	32263	97937	1.7880	 ,D(0.04),D(0.04),D(0.04), ,D(0.04),D(0.04),D(0.04),D(0.04)	 ,B(0.00),B(0.00),B(0.00), ,B(0.00),B(0.00),B(0.00),B(0.00)	22.80	0.10		COSV65687373	0	21294249,21358750,19063739,17192954,17212826,18520591,18763222,22330829,23195334,23772677,23964269,25162994,26989097,27486327,28413930,29499660,30214536,30981636,28507530,30283335,28751869,26215504,30983028,26675984,22832952,23388219,23565345,27196537,29453651,19038326,18179783,26579581,31996124,33170162,32599917,32894097,31577263,22301435,35040003,35088019	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NGF-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NGF (inh=AR oe_syn=1.17 oe_mis=0.80 oe_lof=0.00)
chr1	115338434	115338434	G	A	hom	het	hom	off-target	QUAL=2524;DP=23,38,51;AF=1.00,0.50,1.00;MQM=60;SAP=205;ABP=3;SAR=93;SAF=0	NGF-AS1,NGF	intron&non_coding_transcript,intron,5'UTR	NGF-AS1:ENST00000425449.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.208-27236G>A::,NGF:ENST00000679806.1:intron_variant:MODIFIER:intron1/2:c.-137+174C>T::,NGF:ENST00000680752.1:5_prime_UTR_variant:MODIFIER:exon1/3:c.-206C>T::	regulatory_region_variant:promoter	162030_[GENE=NGF_PHENOS=Neuropathy, hereditary sensory and autonomic, type V, 608654 (3), Autosomal recessive]	667672 [benign DISEASE=not provided];			rs11102930	0.5450	0.3550,0.5212,0.4274,0.6487,0.5127	23887,.	34981	69087	0.2770			7.60					19063739,27486327,21178826,22468730,30418350,19038326,31996124,33066277	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NGF-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NGF (inh=AR oe_syn=1.17 oe_mis=0.80 oe_lof=0.00)
chr1	119421632	119421632	T	C	het	wt	het	off-target	QUAL=1721;DP=97,54,56;AF=0.45,0.00,0.57;MQM=60;SAP=168;ABP=3;SAR=0;SAF=76	HSD3B2	intron	HSD3B2:ENST00000543831.5:intron_variant:MODIFIER:intron3/3:c.308-177T>C::,HSD3B2:ENST00000369416.4:intron_variant:MODIFIER:intron3/3:c.308-177T>C::		613890_[GENE=HSD3B2_PHENOS=Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive]	1243214 [benign DISEASE=not provided];			rs58154933	0.2460	0.5224,0.2105,0.2517,0.1124,0.2558	6948,.	23225	113787	-1.0750			0.54				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	119422896	119422896	C	T	het	wt	het		QUAL=10751;DP=464,297,355;AF=0.54,0.00,0.41;MQM=60;SAP=11;ABP=5;SAR=216;SAF=179	HSD3B2	3'UTR	HSD3B2:ENST00000543831.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::,HSD3B2:ENST00000369416.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::		613890_[GENE=HSD3B2_PHENOS=Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive]	292274 [benign DISEASE=3 beta-Hydroxysteroid dehydrogenase deficiency,not provided];			rs1819698	0.2430	0.5098,0.2097,0.2535,0.1123,0.2572	6732,.	23476	115062	0.6820			4.06				0	21708280,28652652,19197249,20660004,22638611,25114582,23284679,19168589,25600087,27814623,23593537,19230916	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	119422941	119422941	C	G	het	wt	het		QUAL=10544;DP=434,291,354;AF=0.54,0.00,0.42;MQM=60;SAP=5;ABP=5;SAR=201;SAF=181	HSD3B2	3'UTR	HSD3B2:ENST00000543831.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::,HSD3B2:ENST00000369416.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::		613890_[GENE=HSD3B2_PHENOS=Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive]	292275 [benign DISEASE=3 beta-Hydroxysteroid dehydrogenase deficiency];			rs1361530	0.1919	0.3410,0.1887,0.2517,0.1072,0.2549	3633,.	21932	122972	-0.6320			0.57				0	21708280,28652652,23284679,19168589	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	146017351	146017351	A	G	wt	wt	het	off-target	QUAL=1691;DP=194,129,135;AF=0.00,0.00,0.53;MQM=60;SAP=159;ABP=4;SAR=0;SAF=72	HJV	downstream_gene	HJV:ENST00000475797.1:downstream_gene_variant:MODIFIER::::,HJV:ENST00000497365.5:downstream_gene_variant:MODIFIER::::,HJV:ENST00000336751.11:downstream_gene_variant:MODIFIER::::,HJV:ENST00000357836.5:downstream_gene_variant:MODIFIER::::,HJV:ENST00000636675.1:downstream_gene_variant:MODIFIER::::,HJV:ENST00000634927.1:downstream_gene_variant:MODIFIER::::		608374_[GENE=HJV_PHENOS=Hemochromatosis, type 2A, 602390 (3), Autosomal recessive]			L2d (LINE/L2)	rs7551245	0.1476	0.3469,0.1686,0.1786,0.0411,0.1294	3023,.	16406	129638	0.0910			1.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HJV (inh=AR oe_syn=0.94 oe_mis=1.03 oe_lof=0.44)
chr1	147756396	147756396	G	A	wt	het	wt		QUAL=1649;DP=350,145,217;AF=0.00,0.46,0.00;MQM=60;SAP=15;ABP=5;SAR=24;SAF=43	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1404290876	0.0001	0.0000,0.0000,0.0000,0.0001,0.0000	0,.	6	152120	0.5250			3.18				0		0	3	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147756741	147756741	C	T	het	het	wt		QUAL=6287;DP=265,195,300;AF=0.51,0.55,0.00;MQM=60;SAP=5;ABP=6;SAR=128;SAF=114	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs11240121	0.3140	0.4772,0.3685,0.4707,0.2082,0.3915	8585,.	30492	104126	-0.2490			1.23				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757166	147757166	A	G	wt	wt	het		QUAL=2009;DP=214,134,161;AF=0.00,0.00,0.50;MQM=60;SAP=54;ABP=3;SAR=19;SAF=63	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1043806	0.1914	0.1709,0.1576,0.0899,0.2261,0.0680	2906,.	23275	122917	1.5780			10.62					21076161,23134779,17412882	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757430	147757430	G	A	het	het	wt		QUAL=7609;DP=351,316,383;AF=0.43,0.48,0.00;MQM=60;SAP=40;ABP=14;SAR=116;SAF=188	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1043802	0.2579	0.3634,0.3053,0.2554,0.1931,0.3603	5551,.	28073	112747	0.3330			4.57				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757496	147757520	GGGCATTTGCCAGAGGTACATACCA	-	het	het	het	low_conf_region	QUAL=10324;DP=250,333,408;AF=0.54,0.51,0.44;MQM=60;SAP=3;ABP=5;SAR=238;SAF=244	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs11267274	0.4875	0.5841,0.5280,0.5988,0.4318,0.4513	18185,.	37258	77394	0.2250			2.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757554	147757554	G	A	wt	wt	het		QUAL=5574;DP=432,380,483;AF=0.00,0.00,0.45;MQM=60;SAP=3;ABP=15;SAR=107;SAF=111	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::	regulatory_region_variant:enhancer,TF_binding_site_variant	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]	292441 [likely benign DISEASE=Familial atrial fibrillation];			rs36005900	0.1431	0.0386,0.1299,0.0008,0.2169,0.0330	2113,.	17493	130061	0.6610			6.97				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147758109	147758109	C	T	wt	wt	het		QUAL=2632;DP=318,191,231;AF=0.00,0.01,0.45;MQM=60;SAP=37;ABP=7;SAR=33;SAF=74	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1692141	0.1774	0.1217,0.1533,0.0903,0.2259,0.0678	2590,.	21775	125029	-0.5590			4.27					23134779,22713807,17412882,25893100	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147760380	147760380	A	G	het	het	wt	off-target	QUAL=2367;DP=146,79,129;AF=0.51,0.38,0.00;MQM=60;SAP=220;ABP=6;SAR=1;SAF=103	GJA5	intron	GJA5:ENST00000579774.3:intron_variant:MODIFIER:intron1/1:c.-34+119T>C::,GJA5:ENST00000621517.1:intron_variant:MODIFIER:intron1/1:c.-33-1109T>C::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]			L2c (LINE/L2)	rs12136839	0.0334	0.0111,0.0231,0.0002,0.0566,0.0073	127,.	4801	146105	-1.2540			0.27				0	25893100	0	0	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147760538	147760538	G	A	wt	het	wt		QUAL=3088;DP=307,250,365;AF=0.00,0.52,0.00;MQM=60;SAP=5;ABP=4;SAR=70;SAF=60	GJA5	5'UTR,intron	GJA5:ENST00000579774.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-73C>T::,GJA5:ENST00000621517.1:intron_variant:MODIFIER:intron1/1:c.-33-1267C>T::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]			L2c (LINE/L2)	rs191717313	0.0021	0.0006,0.0019,0.0000,0.0036,0.0010	0,.	316	151834	-0.0050			7.22				0.12		0	56	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147760632	147760632	T	C	het	het	het	off-target	QUAL=8401;DP=197,169,236;AF=0.49,0.56,0.58;MQM=60;SAP=257;ABP=14;SAR=262;SAF=66	GJA5	intron	GJA5:ENST00000621517.1:intron_variant:MODIFIER:intron1/1:c.-33-1361A>G::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]		CR112614 [CLASS=DFP MUT=ALT PHEN="Atrial fibrillation association with" GENE=GJA5];	L2c (LINE/L2)	rs10465885	0.4568	0.3867,0.5357,0.5494,0.4774,0.4618	15874,.	37633	82519	-0.3630			1.03					21076161,23134779,23040431,27826129,31270966,22690879,28496873,24065925,26516624,29915175,28775688,30061737,29504899,25893100,33350184,25200600	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	150799227	150799227	T	C	hom	hom	hom		QUAL=34915;DP=350,341,363;AF=1.00,1.00,1.00;MQM=60;SAP=16;ABP=0;SAR=487;SAF=567	CTSK	synonymous,intron	CTSK:ENST00000678337.1:synonymous_variant:LOW:exon6/7:c.867A>G:p.Ala289=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676716.1:synonymous_variant:LOW:exon5/6:c.708A>G:p.Ala236=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676966.1:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease],CTSK:ENST00000443913.2:synonymous_variant:LOW:exon7/8:c.1008A>G:p.Ala336=:PF00112 [Papain family cysteine protease],CTSK:ENST00000271651.8:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676751.1:intron_variant:MODIFIER:intron6/6:c.784+317A>G::,CTSK:ENST00000676970.1:synonymous_variant:LOW:exon7/8:c.843A>G:p.Ala281=:PF00112 [Papain family cysteine protease],CTSK:ENST00000677887.1:synonymous_variant:LOW:exon8/9:c.873A>G:p.Ala291=:PF00112 [Papain family cysteine protease],CTSK:ENST00000679260.1:synonymous_variant:LOW:exon6/7:c.612A>G:p.Ala204=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676824.1:synonymous_variant:LOW:exon8/9:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease]		601105_[GENE=CTSK_PHENOS=Pycnodysostosis, 265800 (3), Autosomal recessive]	1166561 [benign DISEASE=Pyknodysostosis,not provided];			rs10788796	0.9762	0.9246,0.9865,0.9911,0.9989,0.9766	72569,.	3402	3630	-7.3880			1.90				0.05		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTSK (inh=AR oe_syn=0.89 oe_mis=0.79 oe_lof=0.55), UBE2D3P3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	150807005	150807005	T	C	het	wt	wt	off-target	QUAL=175;DP=81,16,11;AF=0.28,0.00,0.00;MQM=46;SAP=53;ABP=36;SAR=23;SAF=0	CTSK	5'UTR,intron	CTSK:ENST00000678337.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-164A>G::,CTSK:ENST00000676966.1:intron_variant:MODIFIER:intron1/7:c.-2+125A>G::,CTSK:ENST00000443913.2:intron_variant:MODIFIER:intron1/7:c.177-199A>G::,CTSK:ENST00000271651.8:intron_variant:MODIFIER:intron1/7:c.-1-199A>G::,CTSK:ENST00000676751.1:intron_variant:MODIFIER:intron1/6:c.-1-199A>G::,CTSK:ENST00000676970.1:intron_variant:MODIFIER:intron1/7:c.-1-199A>G::,CTSK:ENST00000677887.1:intron_variant:MODIFIER:intron2/8:c.42-199A>G::,CTSK:ENST00000679260.1:intron_variant:MODIFIER:intron1/6:c.-1-199A>G::,CTSK:ENST00000676824.1:intron_variant:MODIFIER:intron2/8:c.-1-199A>G::	regulatory_region_variant:promoter	601105_[GENE=CTSK_PHENOS=Pycnodysostosis, 265800 (3), Autosomal recessive]			(TC)n (Simple_repeat)	rs10648774	0.0025	0.0003,0.0004,0.0004,0.0021,0.0005	2,.	349	138529	-2.2240			3.16				0		5	615	0 / 0					CTSK (inh=AR oe_syn=0.89 oe_mis=0.79 oe_lof=0.55), ARNT (inh=n/a oe_syn=0.95 oe_mis=0.70 oe_lof=0.15)
chr1	150808106	150808106	T	C	het	het	wt	off-target	QUAL=1550;DP=102,33,43;AF=0.46,0.61,0.00;MQM=60;SAP=148;ABP=3;SAR=0;SAF=67	CTSK	intron	CTSK:ENST00000271651.8:intron_variant:MODIFIER:intron1/7:c.-2+108A>G::,CTSK:ENST00000676751.1:intron_variant:MODIFIER:intron1/6:c.-2+108A>G::,CTSK:ENST00000676970.1:intron_variant:MODIFIER:intron1/7:c.-2+108A>G::,CTSK:ENST00000677887.1:intron_variant:MODIFIER:intron1/8:c.-53+108A>G::,CTSK:ENST00000679260.1:intron_variant:MODIFIER:intron1/6:c.-2+108A>G::,CTSK:ENST00000676824.1:intron_variant:MODIFIER:intron2/8:c.-2+108A>G::	regulatory_region_variant:promoter	601105_[GENE=CTSK_PHENOS=Pycnodysostosis, 265800 (3), Autosomal recessive]				rs4379678	0.0739	0.0141,0.0662,0.1828,0.0937,0.1031	582,.	10086	140942	-0.7520			8.02				0	18366646,32117071,22844403,20628624,22674224	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTSK (inh=AR oe_syn=0.89 oe_mis=0.79 oe_lof=0.55), ARNT (inh=n/a oe_syn=0.95 oe_mis=0.70 oe_lof=0.15), RNU6-1309P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	151341298	151341298	A	G	het	hom	wt		QUAL=6590;DP=285,90,138;AF=0.49,1.00,0.01;MQM=60;SAP=37;ABP=3;SAR=145;SAF=85	RFX5	3'UTR	RFX5:ENST00000290524.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:ENST00000452671.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	292600 [benign DISEASE=MHC class II deficiency];			rs7552906	0.6292	0.6229,0.6062,0.6436,0.6514,0.6233	30201,.	35155	56321	0.2160			5.21				0	31922974	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151341903	151341903	T	C	het	hom	het		QUAL=8308;DP=199,113,157;AF=0.56,1.00,0.47;MQM=60;SAP=416;ABP=4;SAR=268;SAF=30	RFX5	3'UTR	RFX5:ENST00000290524.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:ENST00000452671.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:ENST00000368870.6:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::	regulatory_region_variant:enhancer	601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	292605 [benign DISEASE=MHC class II deficiency];		MLT1K (LTR/ERVL-MaLR)	rs1752387	0.7836	0.8391,0.7742,0.6981,0.7776,0.7222	46919,.	25212	32872	-1.7860			1.28			COSV51841510	0	31922974	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151342811	151342811	G	C	het	het	wt		QUAL=3185;DP=118,137,186;AF=0.49,0.51,0.00;MQM=60;SAP=14;ABP=3;SAR=77;SAF=51	RFX5	missense	RFX5:ENST00000290524.8:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain],RFX5:ENST00000452671.7:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain],RFX5:ENST00000368870.6:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain]		601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	292612 [benign DISEASE=MHC class II deficiency,not specified,not provided];			rs2233854	0.1133	0.0304,0.1128,0.0014,0.1707,0.0867	1332,.	14570	134848	1.7820	D(0.00),D(0.00),D(0.00)	B(0.11),B(0.11),B(0.11)	20.80	0.03		COSV51839208	0.01	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76), RFX5-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	151343685	151343685	G	A	hom	hom	hom		QUAL=13278;DP=188,94,132;AF=1.00,1.00,1.00;MQM=60;SAP=35;ABP=0;SAR=168;SAF=246	RFX5	synonymous	RFX5:ENST00000290524.8:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000452671.7:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000368870.6:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:		601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	403373 [benign DISEASE=MHC class II deficiency,not specified];			rs1752386	0.9788	0.9252,0.9939,1.0000,0.9998,0.9996	72963,.	2965	3231	0.0830			6.86				0.03	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76), RFX5-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152302209	152302209	T	A	hom	hom	hom		QUAL=8567;DP=95,63,107;AF=1.00,1.00,1.00;MQM=60;SAP=180;ABP=0;SAR=59;SAF=206	FLG-AS1,FLG	intron&non_coding_transcript,3'UTR	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-30374T>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-30374T>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+376T>A::,FLG:ENST00000368799.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*491A>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs1933061	0.9980	0.9994,0.9990,1.0000,0.9963,0.9994	75809,.	304	304	-2.4350			0.05				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303673	152303673	C	T	het	het	het		QUAL=43645;DP=466,1277,1871;AF=0.49,0.50,0.51;MQM=59;SAP=52;ABP=3;SAR=803;SAF=1004	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28910C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28910C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+1840C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.11213G>A:p.Arg3738His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs77422831	0.1571	0.0342,0.3262,0.5678,0.1355,0.3768	3119,.	17606	127972	-2.0090	 , , ,T(0.43)	 , , ,B(0.07)	0.41	0.02		COSV64245538	0	27678121	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303901	152303901	C	G	wt	het	het		QUAL=10141;DP=502,1476,2042;AF=0.05,0.19,0.31;MQM=28;SAP=456;ABP=1783;SAR=247;SAF=689	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28682C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28682C>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2068C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10985G>C:p.Ser3662Thr:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1206244 [benign DISEASE=not specified,not provided];			rs75235053	0.0225	0.0030,0.0549,0.1004,0.0197,0.0830	0,.	2960	128916	-0.4810	 , , ,D(0.01)	 , , ,P(0.76)	14.34	0.03		COSV64238890	0	29281699,34484176	0	4111	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303983	152303983	C	T	wt	het	het		QUAL=17475;DP=424,1550,2203;AF=0.09,0.22,0.39;MQM=31;SAP=491;ABP=1094;SAR=878;SAF=352	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28600C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28600C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2150C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10903G>A:p.Asp3635Asn:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1246453 [benign DISEASE=not provided];			rs75448155	0.0356	0.0050,0.0868,0.1539,0.0321,0.1185	0,.	4627	125523	1.6980	 , , ,D(0.00)	 , , ,D(0.97)	22.20	0.10		COSV64238118	0	34484176	0	194	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304107	152304107	C	G	het	het	het	low_conf_region	QUAL=11150;DP=352,899,632;AF=0.15,0.19,0.69;MQM=33;SAP=49;ABP=363;SAR=390;SAF=272	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28476C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28476C>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2274C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10779G>C:p.Glu3593Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1274774 [benign DISEASE=not provided];			rs12083389	0.1826	0.3565,0.2008,0.3753,0.0826,0.2179	2272,.	17836	100178	0.0220	 , , ,T(1.00)	 , , ,B(0.01)	0.24	0.04		COSV64240501	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304122	152304122	G	A	wt	het	hom	low_conf_region	QUAL=11614;DP=387,808,429;AF=0.07,0.21,0.98;MQM=31;SAP=140;ABP=607;SAR=406;SAF=209	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28461G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28461G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2289G>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10764C>T:p.His3588=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1274484 [benign DISEASE=not provided];			rs12742178	0.0890	0.0682,0.1558,0.3675,0.0737,0.1977	712,.	9196	108730	-2.4390			0.12			COSV64237396	0	34484176	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304150	152304150	G	C	het	het	hom	low_conf_region	QUAL=6363;DP=445,754,313;AF=0.12,0.15,0.98;MQM=33;SAP=240;ABP=1339;SAR=352;SAF=124	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28433G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28433G>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2317G>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10736C>G:p.Thr3579Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1225072 [benign DISEASE=not provided];			rs3126075	0.2207	0.5080,0.2238,0.4077,0.0749,0.2092	5466,.	15324	92720	-4.9740	 , , ,T(0.57)	 , , ,B(0.00)	0.00	0.01		COSV64238703	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304195	152304195	C	T	wt	het	het	low_conf_region	QUAL=1743;DP=609,884,484;AF=0.10,0.13,0.26;MQM=45;SAP=277;ABP=1243;SAR=53;SAF=248	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28388C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28388C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2362C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10691G>A:p.Arg3564His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1263753 [benign DISEASE=not provided];			rs7518080	0.0589	0.1197,0.0848,0.2276,0.0251,0.0884	1,.	6288	100524	-0.4320	 , , ,T(1.00)	 , , ,B(0.00)	0.21	0.01		COSV64235950	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304223	152304223	A	G	het	het	het	low_conf_region	QUAL=7750;DP=517,893,547;AF=0.25,0.14,0.55;MQM=36;SAP=808;ABP=795;SAR=505;SAF=51	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28360A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28360A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2390A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10663T>C:p.Trp3555Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1265104 [benign DISEASE=not provided];			rs12728605	0.1377	0.2879,0.1686,0.3310,0.0533,0.1826	24,.	16253	102113	-0.2880	 , , ,T(0.58)	 , , ,B(0.12)	1.06	0.01		COSV64235956	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304296	152304296	C	A	het	het	het	low_conf_region	QUAL=32012;DP=411,1141,670;AF=0.45,0.44,0.86;MQM=57;SAP=60;ABP=99;SAR=543;SAF=725	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28287C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28287C>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2463C>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10590G>T:p.Arg3530Ser:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1237029 [benign DISEASE=not provided];			rs72697000	0.1458	0.0330,0.3002,0.5066,0.1306,0.3489	2021,.	17794	127888	-1.4330	 , , ,T(0.73)	 , , ,D(1.00)	6.17	0.06		COSV64247197	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304395	152304395	A	G	het	het	hom	low_conf_region	QUAL=38505;DP=531,1125,642;AF=0.41,0.47,0.99;MQM=59;SAP=8;ABP=36;SAR=665;SAF=720	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28188A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28188A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2562A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10491T>C:p.Asp3497=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1231010 [benign DISEASE=not provided];			rs3126066	0.2861	0.4726,0.3772,0.6067,0.1391,0.4073	8359,.	26244	107212	-1.9970			0.22			COSV64245547,COSV64251897	0	29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304413	152304413	A	G	het	het	hom	low_conf_region	QUAL=37803;DP=529,1141,633;AF=0.40,0.46,0.99;MQM=59;SAP=12;ABP=49;SAR=646;SAF=721	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28170A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28170A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2580A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10473T>C:p.Asn3491=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1272130 [benign DISEASE=not provided];			rs3126067	0.3537	0.6995,0.4074,0.6120,0.1415,0.4093	14148,.	24670	96764	-2.0410			0.23			COSV64247205	0	29281699,32315356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304579	152304579	C	G	het	het	het	low_conf_region	QUAL=26788;DP=484,851,546;AF=0.38,0.46,0.89;MQM=54;SAP=36;ABP=65;SAR=591;SAF=465	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28004C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28004C>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2746C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10307G>C:p.Gly3436Ala:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs2065955	0.3460	0.6923,0.4008,0.5984,0.1386,0.3905	13368,.	24748	97300	-0.7110	 , , ,T(0.08)	 , , ,P(0.75)	11.40	0.03		COSV64245550	0	29281699,29774148,27535066	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304692	152304692	A	G	het	het	hom		QUAL=45471;DP=527,1061,910;AF=0.47,0.45,0.99;MQM=51;SAP=250;ABP=26;SAR=601;SAF=1032	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27891A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27891A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2859A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10194T>C:p.Ser3398=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs3091276	0.3026	0.5096,0.3890,0.6163,0.1449,0.4214	9175,.	26245	102759	-1.2340			0.95			COSV64246356	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304833	152304833	G	A	wt	wt	het		QUAL=25932;DP=619,1360,2025;AF=0.00,0.00,0.51;MQM=54;SAP=3;ABP=6;SAR=524;SAF=514	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27750G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27750G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3000G>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10053C>T:p.Asp3351=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs34687484	0.0036	0.0010,0.0029,0.0002,0.0054,0.0059	3,.	534	151388	-4.7750			0.07				0		5	248	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304869	152304869	C	T	het	het	het	low_conf_region	QUAL=47271;DP=573,1337,1985;AF=0.45,0.48,0.48;MQM=59;SAP=4;ABP=26;SAR=911;SAF=936	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27714C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27714C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3036C>T::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10017G>A:p.Gln3339=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs2065956	0.1566	0.0340,0.3262,0.5666,0.1354,0.3784	3146,.	17459	127937	-0.3080			0.30			COSV64237848	0	29281699,21163515,19733298,24831437,29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304920	152304920	T	C	het	het	hom	low_conf_region	QUAL=80827;DP=521,1283,1870;AF=0.45,0.49,0.99;MQM=59;SAP=47;ABP=10;SAR=1477;SAF=1243	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27663T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27663T>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3087T>C::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9966A>G:p.Gln3322=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302748 [benign DISEASE=not provided];			rs6681433	0.2009	0.1283,0.3576,0.5910,0.1594,0.4401	4067,.	22282	121018	-1.1510			0.19			COSV64251428	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305078	152305078	G	A	wt	wt	het		QUAL=19203;DP=503,1192,1542;AF=0.00,0.00,0.49;MQM=60;SAP=27;ABP=5;SAR=422;SAF=330	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27505G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27505G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3245G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.9808C>T:p.Arg3270Cys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs35621145	0.0179	0.0042,0.0196,0.0248,0.0233,0.0592	54,.	2603	149035	-0.2850	 , , ,D(0.04)	 , , ,P(0.84)	16.54	0.11		COSV64237541	0		25	943	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305241	152305241	C	A	het	het	hom	low_conf_region	QUAL=41729;DP=296,897,1119;AF=0.35,0.35,1.00;MQM=48;SAP=289;ABP=232;SAR=991;SAF=542	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27342C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27342C>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3408C>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9645G>T:p.Val3215=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1246798 [benign DISEASE=not provided];			rs9436066	0.2994	0.4717,0.3875,0.6509,0.1597,0.4398	8533,.	27741	104837	-4.7800			0.06			COSV64238716	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305346	152305346	T	C	het	wt	hom	low_conf_region	QUAL=8024;DP=322,656,340;AF=0.18,0.00,0.98;MQM=38;SAP=850;ABP=289;SAR=390;SAF=0	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27237T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27237T>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3513T>C::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9540A>G:p.Ser3180=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1174667 [benign DISEASE=not specified,not provided];			rs3126069	0.1576	0.0767,0.3010,0.5366,0.1336,0.3566	2574,.	16557	115991	-4.2200			0.79			COSV64242448,COSV64251192	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305350	152305350	A	C	het	wt	hom	low_conf_region	QUAL=8024;DP=322,656,340;AF=0.18,0.00,0.98;MQM=38;SAP=850;ABP=289;SAR=390;SAF=0	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27233A>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27233A>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3517A>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.9536T>G:p.Val3179Gly:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1175078 [benign DISEASE=not specified,not provided];			rs2065957	0.2652	0.4483,0.3423,0.5749,0.1351,0.3657	6657,.	23041	100727	-1.7610	 , , ,T(1.00)	 , , ,B(0.00)	0.25	0.03		COSV64246955	0	29281699,34833463	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305958	152305958	T	G	het	het	wt	low_conf_region	QUAL=2702;DP=443,489,551;AF=0.23,0.24,0.00;MQM=39;SAP=487;ABP=558;SAR=0;SAF=223	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26625T>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26625T>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4125T>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8928A>C:p.Glu2976Asp:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1175150 [benign DISEASE=not specified,not provided];			rs61816760	0.3726	0.3878,0.3316,0.1205,0.3909,0.3117	607,.	39412	68406	-1.9480	 , , ,T(0.54)	 , , ,B(0.25)	0.04	0.02		COSV64235961	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306008	152306008	C	T	wt	wt	het		QUAL=3359;DP=437,702,878;AF=0.00,0.00,0.25;MQM=39;SAP=485;ABP=469;SAR=0;SAF=222	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26575C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26575C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4175C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8878G>A:p.Gly2960Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1205931 [benign DISEASE=not specified,not provided];			rs61690342	0.0348	0.0999,0.0227,0.0188,0.0185,0.0448	4,.	4620	128396	-2.2770	 , , ,T(0.29)	 , , ,B(0.00)	0.24	0.04			0		1	945	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306079	152306079	T	C	het	het	het		QUAL=26888;DP=442,1310,1612;AF=0.25,0.25,0.50;MQM=46;SAP=834;ABP=480;SAR=280;SAF=972	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26504T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26504T>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4246T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8807A>G:p.Asp2936Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1242222 [benign DISEASE=not provided];			rs80221306	0.1586	0.1019,0.2692,0.4126,0.1291,0.3114	5,.	21103	112011	-0.3070	 , , ,T(0.38)	 , , ,B(0.01)	7.29	0.02		COSV64237772	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306213	152306213	C	A	het	het	hom		QUAL=149780;DP=692,2559,3381;AF=0.55,0.55,1.00;MQM=50;SAP=65;ABP=87;SAR=2397;SAF=2782	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26370C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26370C>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4380C>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.8673G>T:p.Val2891=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1222401 [benign DISEASE=not provided];			rs57672167	0.2310	0.2299,0.3741,0.6023,0.1593,0.4365	5985,.	20434	107850	-4.9140			0.19			COSV64247949	0	34833463	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306338	152306338	C	T	wt	het	het	low_conf_region	QUAL=21671;DP=1099,2993,4213;AF=0.09,0.18,0.25;MQM=39;SAP=184;ABP=4853;SAR=661;SAF=1037	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26245C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26245C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4505C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8548G>A:p.Gly2850Ser:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1260709 [benign DISEASE=not provided];			rs2184952	0.0322	0.0297,0.0674,0.1914,0.0173,0.0955	0,.	3563	107117	-0.3030	 , , ,T(0.85)	 , , ,B(0.12)	1.83	0.02		COSV64238707	0		0	207	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306380	152306380	T	G	het	het	het		QUAL=16088;DP=851,2690,3957;AF=0.22,0.21,0.18;MQM=51;SAP=3;ABP=6147;SAR=729;SAF=717	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26203T>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26203T>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4547T>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8506A>C:p.Ser2836Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1246169 [benign DISEASE=not provided];			rs11582087	0.1192	0.0346,0.2379,0.3985,0.1001,0.2637	0,.	15921	117599	-0.6650	 , , ,D(0.04)	 , , ,B(0.09)	13.19	0.03		COSV64235994	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306543	152306543	G	A	het	het	het		QUAL=8471;DP=998,2435,4113;AF=0.15,0.19,0.17;MQM=35;SAP=11;ABP=7088;SAR=680;SAF=612	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26040G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26040G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4710G>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.8343C>T:p.Asp2781=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1178454 [benign DISEASE=not provided];			rs57670307	0.0968	0.0247,0.2125,0.3786,0.0830,0.2382	0,.	12963	121019	-3.2420			0.77			COSV64241227,COSV64246502	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307253	152307253	C	T	het	het	hom		QUAL=71302;DP=588,1193,1542;AF=0.47,0.52,0.99;MQM=59;SAP=3;ABP=4;SAR=1211;SAF=1222	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25330C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25330C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5420C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7633G>A:p.Gly2545Arg:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302747 [benign DISEASE=not provided];			rs3126072	0.3095	0.5155,0.3957,0.6237,0.1603,0.4440	9449,.	27134	102714	-1.6190	 , , ,T(0.45)	 , , ,B(0.00)	1.64	0.02		COSV64248815	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307365	152307365	G	C	het	het	hom		QUAL=72640;DP=476,1191,1577;AF=0.49,0.51,1.00;MQM=59;SAP=29;ABP=4;SAR=1126;SAF=1295	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25218G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25218G>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5532G>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7521C>G:p.His2507Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302746 [benign DISEASE=not provided];			rs3126074	0.3011	0.4755,0.3921,0.6211,0.1604,0.4441	8618,.	28172	105402	-5.2830	 , , ,T(1.00)	 , , ,B(0.00)	0.00	0.02		COSV100910597	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307444	152307444	A	G	het	het	hom		QUAL=75444;DP=456,1213,1666;AF=0.50,0.53,1.00;MQM=59;SAP=23;ABP=7;SAR=1186;SAF=1338	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25139A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25139A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5611A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7442T>C:p.Leu2481Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302745 [benign DISEASE=not provided];			rs55650366	0.2028	0.1338,0.3587,0.5962,0.1594,0.4373	4056,.	22438	120068	-1.1930	 , , ,T(1.00)	 , , ,B(0.00)	0.03	0.01		COSV64245556	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307488	152307488	C	T	wt	wt	het		QUAL=22736;DP=627,1226,1675;AF=0.00,0.00,0.52;MQM=60;SAP=23;ABP=10;SAR=393;SAF=483	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25095C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25095C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5655C>T::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.7398G>A:p.Pro2466=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1265210 [benign DISEASE=not provided];			rs71625199	0.0176	0.0036,0.0196,0.0237,0.0233,0.0579	47,.	2576	148776	-9.3410			0.11			COSV64236421	0	29281699,32325630	18	951	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307556	152307556	T	C	het	het	hom		QUAL=82483;DP=548,1329,1841;AF=0.47,0.51,1.00;MQM=58;SAP=87;ABP=3;SAR=1222;SAF=1549	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25027T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25027T>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5723T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7330A>G:p.Lys2444Glu:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1222131 [benign DISEASE=not provided];			rs71625200	0.2028	0.1340,0.3584,0.5967,0.1593,0.4363	4069,.	22510	120486	-1.0410	 , , ,T(1.00)	 , , ,B(0.00)	1.36	0.03		COSV64248823	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307694	152307694	C	G	het	het	hom		QUAL=56696;DP=464,1162,1440;AF=0.45,0.44,0.97;MQM=47;SAP=536;ABP=53;SAR=1416;SAF=696	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24889C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24889C>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5861C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7192G>C:p.Glu2398Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1239802 [benign DISEASE=not provided];			rs71625201	0.1795	0.1242,0.3047,0.4799,0.1490,0.3675	1665,.	23326	121884	-1.6180	 , , ,T(0.37)	 , , ,B(0.01)	0.20	0.02		COSV64237400	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307789	152307789	C	G	het	het	het		QUAL=34967;DP=503,1100,1084;AF=0.38,0.31,0.86;MQM=38;SAP=537;ABP=54;SAR=1035;SAF=434	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24794C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24794C>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5956C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7097G>C:p.Ser2366Thr:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1265666 [benign DISEASE=not provided];			rs71625202	0.1475	0.0363,0.2805,0.4365,0.1442,0.3333	414,.	21156	127046	-0.1640	 , , ,D(0.01)	 , , ,D(0.97)	14.30	0.09		COSV64236000	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307871	152307871	C	T	het	het	het	low_conf_region	QUAL=29872;DP=487,1151,1013;AF=0.34,0.29,0.79;MQM=37;SAP=262;ABP=5;SAR=454;SAF=848	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24712C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24712C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6038C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7015G>A:p.Asp2339Asn:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs139476473	0.1517	0.0364,0.2953,0.4615,0.1457,0.3504	1049,.	20538	126556	1.6960	 , , ,D(0.02)	 , , ,D(0.94)	22.80	0.14		COSV64236201	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307896	152307896	G	A	het	het	hom		QUAL=40990;DP=507,1116,1041;AF=0.48,0.34,0.99;MQM=36;SAP=1192;ABP=187;SAR=353;SAF=1306	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24687G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24687G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6063G>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6990C>T:p.His2330=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1179883 [benign DISEASE=not provided];			rs6664985	0.3001	0.4790,0.3877,0.6171,0.1591,0.4377	8554,.	27935	105053	-5.0360			0.07			COSV64242880	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307995	152307995	C	G	het	het	het	low_conf_region	QUAL=9792;DP=667,1350,1875;AF=0.23,0.14,0.29;MQM=37;SAP=139;ABP=2459;SAR=567;SAF=330	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24588C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24588C>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6162C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6891G>C:p.Glu2297Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1286180 [benign DISEASE=not provided];			rs78179835	0.1224	0.1406,0.2076,0.3652,0.0746,0.2563	102,.	14442	105024	-1.2630	 , , ,T(1.00)	 , , ,B(0.00)	0.00	0.03		COSV64236496	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308209	152308209	C	A	wt	wt	het	low_conf_region	QUAL=1916;DP=404,1243,1788;AF=0.03,0.06,0.15;MQM=55;SAP=127;ABP=1895;SAR=109;SAF=253	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24374C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24374C>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6376C>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6677G>T:p.Gly2226Val:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs544807449	0.0018	0.0086,0.0005,0.0012,0.0001,0.0012	0,.	173	96461	-0.0090	 , , ,T(0.07)	 , , ,B(0.37)	9.62	0.17		COSV64242592,COSV64251050	0		0	211	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308211	152308211	C	T	wt	wt	het	low_conf_region	QUAL=1916;DP=404,1243,1788;AF=0.03,0.06,0.15;MQM=55;SAP=127;ABP=1895;SAR=109;SAF=253	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24372C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24372C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6378C>T::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6675G>A:p.Val2225=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1244717 [benign DISEASE=not provided];			rs564482396	0.0021	0.0101,0.0006,0.0013,0.0001,0.0013	0,.	194	93928	-0.8000			0.36			COSV64243287,COSV64244530	0		0	212	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308212	152308212	A	G	wt	wt	het	low_conf_region	QUAL=1916;DP=404,1243,1788;AF=0.03,0.06,0.15;MQM=55;SAP=127;ABP=1895;SAR=109;SAF=253	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24371A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24371A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6379A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6674T>C:p.Val2225Ala:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1255099 [benign DISEASE=not provided];			rs116918835	0.0021	0.0106,0.0006,0.0014,0.0001,0.0013	0,.	197	92835	-1.7780	 , , ,T(0.52)	 , , ,B(0.00)	0.36	0.04		COSV64243288	0		0	212	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308215	152308215	A	T	wt	wt	het	low_conf_region	QUAL=1916;DP=404,1243,1788;AF=0.03,0.06,0.15;MQM=55;SAP=127;ABP=1895;SAR=109;SAF=253	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24368A>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24368A>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6382A>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6671T>A:p.Leu2224Gln:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1235186 [benign DISEASE=not provided];			rs117945779	0.0071	0.0360,0.0029,0.0014,0.0003,0.0014	0,.	648	90562	-1.5680	 , , ,T(0.99)	 , , ,B(0.00)	1.12	0.03		COSV64235963	0		0	218	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308260	152308260	T	C	het	het	het		QUAL=23848;DP=788,1503,2391;AF=0.31,0.18,0.33;MQM=55;SAP=72;ABP=1994;SAR=551;SAF=754	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24323T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24323T>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6427T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6626A>G:p.His2209Arg:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1287967 [benign DISEASE=not provided];			rs66977240	0.1843	0.3067,0.2482,0.3974,0.0968,0.2837	0,.	23242	102886	-1.7600	 , , ,T(0.75)	 , , ,B(0.00)	0.00	0.01		COSV64235967	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308283	152308283	A	G	het	het	het		QUAL=36254;DP=855,1557,2674;AF=0.34,0.23,0.40;MQM=54;SAP=96;ABP=1154;SAR=725;SAF=997	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24300A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24300A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6450A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6603T>C:p.Asp2201=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1182765 [benign DISEASE=not provided];			rs2338554	0.2420	0.4181,0.2864,0.4173,0.1250,0.3137	2529,.	29172	107224	-1.1410			0.51			COSV64236535	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308306	152308306	A	G	het	het	hom		QUAL=131893;DP=886,1655,2790;AF=0.65,0.63,1.00;MQM=57;SAP=49;ABP=428;SAR=2050;SAF=2356	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24277A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24277A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6473A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6580T>C:p.Tyr2194His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1244740 [benign DISEASE=not provided];			rs2184953	0.3696	0.7013,0.4220,0.6327,0.1626,0.4529	14547,.	26803	95339	-5.5540	 , , ,T(0.34)	 , , ,B(0.00)	0.14	0.01		COSV64235971	0	29281699,28487959,18434257,27206134,24831437,29774148,32315356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308312	152308312	T	G	het	het	het		QUAL=71680;DP=890,1660,2827;AF=0.31,0.27,0.73;MQM=55;SAP=110;ABP=18;SAR=1207;SAF=1577	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24271T>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24271T>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6479T>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6574A>C:p.Lys2192Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1239242 [benign DISEASE=not provided];			rs66954353	0.2345	0.3528,0.3029,0.4252,0.1413,0.3336	51,.	34160	111858	-0.3510	 , , ,T(1.00)	 , , ,B(0.00)	0.66	0.02		COSV64236338	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308388	152308388	A	G	het	het	hom		QUAL=112027;DP=509,1512,2563;AF=0.61,0.66,1.00;MQM=55;SAP=3;ABP=378;SAR=1931;SAF=1931	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24195A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24195A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6518A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6498T>C:p.Ser2166=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1223320 [benign DISEASE=not provided];			rs2184954	0.3044	0.4806,0.3936,0.6312,0.1611,0.4507	8796,.	28321	104897	-3.3990			0.94			COSV100910603	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308424	152308424	T	G	het	het	het		QUAL=32395;DP=702,1473,2391;AF=0.31,0.30,0.36;MQM=51;SAP=7;ABP=1059;SAR=743;SAF=795	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24159T>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24159T>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6482T>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6462A>C:p.Gln2154His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1174419 [benign DISEASE=not provided];			rs74129452	0.2268	0.3533,0.2958,0.4219,0.1269,0.3181	0,.	32860	112046	-4.1840	 , , ,T(1.00)	 , , ,B(0.00)	0.01	0.11		COSV64235975	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308531	152308531	A	G	het	het	het		QUAL=32683;DP=834,1597,2398;AF=0.29,0.31,0.32;MQM=59;SAP=54;ABP=1478;SAR=660;SAF=849	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24052A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24052A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6375A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6355T>C:p.Tyr2119His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1221916 [benign DISEASE=not provided];			rs7512553	0.2288	0.3588,0.2990,0.4223,0.1261,0.3098	0,.	34101	114975	-0.1890	 , , ,T(1.00)	 , , ,B(0.00)	2.22	0.04		COSV64247222	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308532	152308532	A	G	het	het	het		QUAL=32683;DP=834,1597,2398;AF=0.29,0.31,0.32;MQM=59;SAP=54;ABP=1478;SAR=660;SAF=849	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24051A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24051A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6374A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6354T>C:p.His2118=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1179898 [benign DISEASE=not provided];			rs7512554	0.2286	0.3584,0.2984,0.4226,0.1259,0.3087	0,.	34116	115152	-2.6100			0.38			COSV64247223	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308563	152308563	G	A	het	het	het		QUAL=33540;DP=940,1648,2393;AF=0.30,0.32,0.31;MQM=60;SAP=26;ABP=1487;SAR=720;SAF=848	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24020G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24020G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6343G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6323C>T:p.Ala2108Val:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1179724 [benign DISEASE=not provided];			rs7522925	0.2282	0.3592,0.2981,0.4217,0.1253,0.3046	0,.	34194	115662	-3.2620	 , , ,T(0.06)	 , , ,B(0.02)	0.04	0.07		COSV64245563	0	29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308752	152308752	C	G	het	het	het		QUAL=38189;DP=738,1968,2612;AF=0.25,0.35,0.33;MQM=53;SAP=26;ABP=1397;SAR=800;SAF=935	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23831C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23831C>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6154C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6134G>C:p.Ser2045Thr:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1266034 [benign DISEASE=not provided];			rs7546186	0.2233	0.3461,0.2953,0.4181,0.1241,0.3035	0,.	33363	116073	1.0670	 , , ,T(0.09)	 , , ,P(0.72)	15.34	0.09		COSV64238126	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308814	152308814	A	G	het	het	het		QUAL=35392;DP=658,1993,2597;AF=0.22,0.34,0.33;MQM=51;SAP=15;ABP=1494;SAR=885;SAF=790	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23769A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23769A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6092A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6072T>C:p.His2024=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1263645 [benign DISEASE=not provided];			rs80353812	0.2251	0.3553,0.2959,0.4189,0.1233,0.3030	0,.	33452	115158	-6.8100			0.14			COSV64245566	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308828	152308828	A	C	het	het	het		QUAL=36883;DP=666,1969,2608;AF=0.26,0.34,0.34;MQM=51;SAP=32;ABP=1376;SAR=931;SAF=780	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23755A>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23755A>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6078A>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6058T>G:p.Ser2020Ala:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1266162 [benign DISEASE=not provided];			rs7512857	0.2189	0.3332,0.2938,0.4203,0.1233,0.3026	0,.	32559	116177	0.0140	 , , ,T(0.18)	 , , ,D(0.93)	10.79	0.03		COSV64245569	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308841	152308841	G	T	wt	wt	het		QUAL=21012;DP=793,2032,2642;AF=0.00,0.00,0.34;MQM=60;SAP=20;ABP=594;SAR=491;SAF=408	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23742G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23742G>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6065G>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6045C>A:p.Asp2015Glu:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1251416 [benign DISEASE=not provided];			rs71626704	0.0176	0.0037,0.0192,0.0243,0.0232,0.0582	47,.	2584	149470	-0.1350	 , , ,T(0.20)	 , , ,B(0.23)	2.51	0.05			0	29281699,32325630	17	951	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309003	152309003	G	T	het	het	hom		QUAL=106329;DP=888,1621,1993;AF=0.60,0.68,1.00;MQM=56;SAP=144;ABP=486;SAR=2049;SAF=1564	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23580G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23580G>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5903G>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5883C>A:p.His1961Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1278608 [benign DISEASE=not provided];			rs3126079	0.3684	0.7004,0.4209,0.6307,0.1622,0.4471	14548,.	26818	95850	-7.0030	 , , ,T(0.81)	 , , ,B(0.00)	0.00	0.02		COSV64242281	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309047	152309047	A	C	het	het	het		QUAL=20251;DP=816,1554,1835;AF=0.19,0.30,0.30;MQM=49;SAP=188;ABP=1818;SAR=740;SAF=425	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23536A>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23536A>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5859A>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5839T>G:p.Trp1947Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1270895 [benign DISEASE=not specified,not provided];			rs80059102	0.2160	0.3425,0.2885,0.4179,0.1187,0.2971	0,.	31205	113269	-1.9190	 , , ,T(0.31)	 , , ,B(0.00)	2.79	0.01		COSV100912331,COSV64235980	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309058	152309058	A	T	het	het	het		QUAL=17143;DP=761,1514,1781;AF=0.18,0.28,0.28;MQM=48;SAP=241;ABP=2035;SAR=697;SAF=357	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23525A>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23525A>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5848A>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5828T>A:p.Leu1943His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1205946 [benign/likely benign DISEASE=not specified,not provided];			rs113544881	0.2002	0.3005,0.2798,0.4143,0.1148,0.2912	1,.	28162	112544	-2.1680	 , , ,T(1.00)	 , , ,B(0.00)	0.06	0.05		COSV64235983	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309214	152309214	C	T	het	het	het		QUAL=41084;DP=540,1169,1371;AF=0.47,0.51,0.53;MQM=59;SAP=4;ABP=6;SAR=775;SAF=800	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23369C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23369C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5692C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5672G>A:p.Arg1891Gln:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1247656 [benign DISEASE=not provided];			rs12407748	0.1566	0.0341,0.3265,0.5663,0.1356,0.3744	3092,.	17513	127639	-2.7720	 , , ,T(0.46)	 , , ,B(0.17)	0.01	0.05		COSV64235683	0	29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309215	152309215	G	A	wt	wt	het		QUAL=16228;DP=558,1171,1371;AF=0.00,0.00,0.47;MQM=60;SAP=7;ABP=16;SAR=306;SAF=340	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23368G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23368G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5691G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5671C>T:p.Arg1891Trp:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs36006086	0.0179	0.0043,0.0197,0.0251,0.0233,0.0588	48,.	2620	148856	-1.2590	 , , ,D(0.01)	 , , ,D(0.98)	18.13	0.04		COSV64237885,COSV64241834	0		18	951	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309269	152309269	G	T	wt	wt	het		QUAL=16358;DP=630,1185,1419;AF=0.00,0.00,0.45;MQM=60;SAP=10;ABP=33;SAR=299;SAF=344	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23314G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23314G>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5637G>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5617C>A:p.Gln1873Lys:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1235678 [benign DISEASE=not provided];			rs62623409	0.0179	0.0042,0.0196,0.0255,0.0233,0.0593	50,.	2619	149073	2.7110	 , , ,T(0.09)	 , , ,B(0.04)	11.52	0.04		COSV64237889	0	29281699,32325630	19	949	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309472	152309472	G	A	het	het	het		QUAL=37609;DP=455,1118,1941;AF=0.48,0.51,0.39;MQM=58;SAP=12;ABP=110;SAR=814;SAF=735	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23111G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23111G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5434G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5414C>T:p.Ala1805Val:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1248526 [benign DISEASE=not provided];			rs12405241	0.1568	0.0342,0.3259,0.5677,0.1355,0.3746	3081,.	17510	127330	-5.8650	 , , ,T(0.20)	 , , ,D(0.96)	0.15	0.10		COSV64247244	0	33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309616	152309616	T	C	wt	wt	het		QUAL=2595;DP=521,1243,1981;AF=0.00,0.00,0.17;MQM=52;SAP=3;ABP=1910;SAR=169;SAF=164	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22967T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22967T>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5290T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5270A>G:p.Glu1757Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs778942937	0.0038	0.0006,0.0044,0.0058,0.0049,0.0147	0,.	569	147627	0.5620	 , , ,T(0.11)	 , , ,B(0.08)	15.12	0.03		COSV64244851	0		0	44	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309791	152309791	G	A	het	het	het		QUAL=36454;DP=420,1225,1518;AF=0.48,0.47,0.48;MQM=60;SAP=11;ABP=16;SAR=795;SAF=719	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22792G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22792G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5115G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5095C>T:p.Arg1699Cys:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs12405278	0.1570	0.0341,0.3262,0.5702,0.1355,0.3766	3128,.	17559	127861	-0.0710	 , , ,D(0.02)	 , , ,D(0.91)	19.54	0.05		COSV64245576	0	22209813	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309835	152309835	C	T	het	het	het		QUAL=39271;DP=513,1234,1507;AF=0.46,0.48,0.51;MQM=60;SAP=28;ABP=6;SAR=864;SAF=729	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22748C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22748C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5071C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5051G>A:p.Arg1684His:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs12407807	0.1665	0.0667,0.3289,0.5702,0.1357,0.3758	3222,.	18836	126568	-4.5020	 , , ,T(0.55)	 , , ,D(0.97)	2.50	0.07		COSV64247251	0	33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310046	152310046	C	T	wt	het	wt		QUAL=11248;DP=553,1012,1246;AF=0.00,0.48,0.00;MQM=60;SAP=11;ABP=6;SAR=223;SAF=264	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22537C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22537C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4860C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4840G>A:p.Ala1614Thr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]										-1.3830	 , , ,T(0.20)	 , , ,B(0.16)	3.62	0.03		COSV64246735	0		0	1	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310318	152310318	G	A	wt	wt	het		QUAL=16949;DP=442,1154,1462;AF=0.00,0.00,0.48;MQM=60;SAP=3;ABP=7;SAR=351;SAF=355	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22265G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22265G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4588G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4568C>T:p.Thr1523Ile:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1293919 [benign DISEASE=not provided];			rs12750081	0.0179	0.0042,0.0197,0.0246,0.0233,0.0589	50,.	2612	149214	-0.5980	 , , ,D(0.04)	 , , ,B(0.04)	7.59	0.01		COSV64247535	0		19	948	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310434	152310434	G	C	wt	wt	het		QUAL=18572;DP=490,1078,1491;AF=0.00,0.00,0.49;MQM=60;SAP=11;ABP=4;SAR=341;SAF=393	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22149G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22149G>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4472G>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4452C>G:p.Asp1484Glu:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1278160 [benign DISEASE=not provided];			rs71626706	0.0178	0.0038,0.0197,0.0248,0.0233,0.0589	50,.	2593	148765	-4.7510	 , , ,T(1.00)	 , , ,B(0.00)	0.00	0.05		COSV64250380	0	29281699	19	951	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310441	152310441	G	T	het	het	het		QUAL=38082;DP=478,1070,1522;AF=0.49,0.50,0.50;MQM=59;SAP=13;ABP=3;SAR=806;SAF=722	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22142G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22142G>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4465G>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4445C>A:p.Ser1482Tyr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1277512 [benign DISEASE=not provided];			rs11204978	0.1563	0.0340,0.3257,0.5668,0.1353,0.3728	3082,.	17505	127733	0.0040	 , , ,D(0.00)	 , , ,B(0.34)	12.42	0.06		COSV64247255	0	29281699,29774148,33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310476	152310476	A	G	wt	wt	het		QUAL=19714;DP=548,1142,1570;AF=0.00,0.00,0.49;MQM=60;SAP=15;ABP=5;SAR=351;SAF=417	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22107A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22107A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4430A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.4410T>C:p.His1470=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1241427 [benign DISEASE=not provided];			rs12732920	0.0178	0.0038,0.0196,0.0254,0.0233,0.0602	48,.	2603	148881	-7.1290			0.15				0		19	949	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310577	152310577	G	A	wt	wt	het		QUAL=20704;DP=588,1195,1684;AF=0.00,0.00,0.49;MQM=60;SAP=3;ABP=5;SAR=415;SAF=410	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22006G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22006G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4329G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4309C>T:p.Arg1437Cys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	916211 [likely benign DISEASE=not provided];			rs12750571	0.0048	0.0012,0.0061,0.0002,0.0070,0.0064	4,.	717	151249	0.4170	 , , ,D(0.01)	 , , ,P(0.64)	22.40	0.04		COSV105827350	0		4	391	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310760	152310760	T	C	het	het	hom		QUAL=76306;DP=531,1305,1681;AF=0.49,0.49,1.00;MQM=55;SAP=6;ABP=6;SAR=1316;SAF=1252	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21823T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21823T>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4146T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4126A>G:p.Arg1376Gly:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1178727 [benign DISEASE=not provided];			rs11581433	0.2023	0.1328,0.3577,0.5965,0.1592,0.4366	4077,.	22549	121045	-3.1550	 , , ,T(1.00)	 , , ,B(0.00)	0.00	0.01		COSV64246547	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310807	152310807	C	T	het	het	het		QUAL=40127;DP=523,1245,1653;AF=0.49,0.50,0.49;MQM=54;SAP=15;ABP=5;SAR=890;SAF=793	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21776C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21776C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4099C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4079G>A:p.Arg1360His:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1253040 [benign DISEASE=not provided];			rs11586631	0.1573	0.0346,0.3257,0.5699,0.1355,0.3760	3117,.	17592	127692	-3.9920	 , , ,T(0.83)	 , , ,B(0.05)	0.02	0.02		COSV64245581	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311386	152311386	G	C	het	het	hom		QUAL=65048;DP=545,1105,1462;AF=0.48,0.50,1.00;MQM=54;SAP=4;ABP=4;SAR=1151;SAF=1120	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21197G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21197G>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3520G>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.3500C>G:p.Ala1167Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1298018 [benign DISEASE=not provided];			rs58001094	0.3655	0.6978,0.4179,0.6236,0.1617,0.4437	14267,.	26645	95809	-2.4700	 , , ,T(1.00)	 , , ,B(0.01)	0.03	0.05		COSV64238211	0	29281699,32315356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311499	152311499	A	G	het	het	hom		QUAL=75643;DP=587,1206,1698;AF=0.51,0.50,1.00;MQM=52;SAP=14;ABP=4;SAR=1242;SAF=1357	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21084A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21084A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3407A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.3387T>C:p.Ser1129=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1245184 [benign DISEASE=not provided];			rs66831674	0.3011	0.4754,0.3912,0.6210,0.1603,0.4434	8653,.	28269	105779	-2.6140			0.53			COSV64248837	0	29281699,34224231	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311901	152311901	G	A	het	wt	het		QUAL=30466;DP=613,1314,1577;AF=0.53,0.02,0.54;MQM=56;SAP=3;ABP=30;SAR=606;SAF=596	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20682G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20682G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3005G>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2985C>T:p.His995=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs373872833	0.0001	0.0001,0.0008,0.0000,0.0000,0.0000	0,.	15	149535	-1.2540			0.12			COSV64236179	0		0	4	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311948	152311948	G	C	wt	wt	het		QUAL=21818;DP=730,1324,1653;AF=0.02,0.04,0.51;MQM=55;SAP=85;ABP=5;SAR=363;SAF=549	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20635G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20635G>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2958G>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2938C>G:p.His980Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	402869 [benign DISEASE=not specified,not provided];			rs12756586	0.0251	0.0261,0.0231,0.0288,0.0240,0.0709	52,.	3345	134223	-3.1850	 , , ,T(1.00)	 , , ,B(0.00)	0.00	0.02		COSV64236115	0	24033266,29281699	19	998	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312002	152312002	A	G	wt	wt	het	low_conf_region	QUAL=622;DP=539,1303,1789;AF=0.01,0.07,0.13;MQM=39;SAP=112;ABP=2096;SAR=101;SAF=230	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20581A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20581A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2904A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2884T>C:p.Trp962Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1200762 [likely benign DISEASE=not specified,not provided];			rs199888588	0.0222	0.0803,0.0155,0.0184,0.0030,0.0280	0,.	2695	118737	-1.9140	 , , ,T(0.91)	 , , ,B(0.00)	0.11	0.02		COSV64239582	0		0	310	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312021	152312021	A	G	wt	wt	het	low_conf_region	QUAL=2110;DP=517,1341,1947;AF=0.02,0.07,0.16;MQM=40;SAP=12;ABP=2015;SAR=181;SAF=223	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20562A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20562A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2885A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2865T>C:p.His955=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs144437056	0.0325	0.1205,0.0215,0.0280,0.0043,0.0297	0,.	3836	114286	-5.4140			0.18			COSV64248679	0		0	57	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312029	152312029	C	G	wt	wt	het		QUAL=2717;DP=545,1373,2009;AF=0.02,0.07,0.16;MQM=41;SAP=5;ABP=1993;SAR=208;SAF=226	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20554C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20554C>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2877C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2857G>C:p.Glu953Gln:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1206179 [benign DISEASE=not specified,not provided];			rs201137357	0.0468	0.1720,0.0295,0.0257,0.0046,0.0310	55,.	5530	114898	-0.1500	 , , ,T(0.10)	 , , ,P(0.89)	12.90	0.06		COSV64235720	0		0	66	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312065	152312065	G	A	wt	wt	het		QUAL=5;DP=529,1437,2146;AF=0.00,0.00,0.13;MQM=45;SAP=7;ABP=2613;SAR=146;SAF=125	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20518G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20518G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2841G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2821C>T:p.Arg941Cys:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs138002269	0.0014	0.0003,0.0012,0.0004,0.0019,0.0061	0,.	212	149164	-0.4950	 , , ,D(0.01)	 , , ,D(0.96)	18.67	0.05		COSV64245372,COSV64246254	0		0	650	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312100	152312100	C	A	wt	wt	het		QUAL=1884;DP=584,1429,2116;AF=0.03,0.05,0.15;MQM=43;SAP=110;ABP=2300;SAR=269;SAF=129	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20483C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20483C>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2806C>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2786G>T:p.Gly929Val:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1206107 [likely benign DISEASE=not provided];			rs143382793	0.0141	0.0600,0.0066,0.0047,0.0014,0.0086	0,.	1725	120833	-0.6740	 , , ,D(0.04)	 , , ,P(0.85)	15.32	0.03		COSV64242745	0		0	862	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312121	152312121	A	C	wt	wt	het		QUAL=220;DP=519,1423,2109;AF=0.02,0.04,0.12;MQM=43;SAP=117;ABP=2583;SAR=232;SAF=100	FLG-AS1,FLG	intron&non_coding_transcript,missense	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20462A>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20462A>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2785A>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2765T>G:p.Ile922Ser:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs201928359	0.0088	0.0383,0.0033,0.0017,0.0008,0.0045	0,.	1088	122926	-1.6050	 , , ,T(1.00)	 , , ,B(0.00)	2.17	0.02		COSV64236204	0		0	297	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312378	152312378	A	G	het	het	hom		QUAL=57578;DP=484,875,1247;AF=0.49,0.51,0.99;MQM=59;SAP=23;ABP=3;SAR=1028;SAF=894	FLG-AS1,FLG	intron&non_coding_transcript,synonymous	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20205A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20205A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2528A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2508T>C:p.Asp836=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1230019 [benign DISEASE=not provided];			rs3120653	0.3105	0.5076,0.3975,0.6217,0.1611,0.4415	9079,.	28150	102852	-2.3270			0.35			COSV104425295,COSV64244277	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312623	152312623	C	T	het	het	hom		QUAL=86295;DP=491,1419,1884;AF=0.51,0.50,1.00;MQM=60;SAP=24;ABP=3;SAR=1334;SAF=1501	FLG-AS1,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19960C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19960C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2283C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2263G>A:p.Glu755Lys:,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.48C>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	377878 [benign DISEASE=not specified];			rs74129461	0.1857	0.0773,0.3496,0.5887,0.1590,0.4333	3756,.	20635	123423	-0.4630	 , , ,D(0.03), 	 , , ,B(0.22), 	12.23	0.03		COSV64248843	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312705	152312705	G	T	wt	wt	het		QUAL=22886;DP=475,1377,1844;AF=0.00,0.00,0.48;MQM=60;SAP=31;ABP=7;SAR=501;SAF=393	FLG-AS1,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19878G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19878G>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2201G>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2181C>A:p.His727Gln:PF03516 [Filaggrin],FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.130G>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs7512779	0.0179	0.0042,0.0196,0.0248,0.0233,0.0590	51,.	2615	149239	-4.9160	 , , ,T(0.07), 	 , , ,B(0.15), 	0.00	0.01			0		19	949	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313454	152313454	G	A	het	het	hom		QUAL=70473;DP=524,1174,1569;AF=0.51,0.49,0.99;MQM=60;SAP=10;ABP=3;SAR=1161;SAF=1248	FLG-AS1,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19129G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19129G>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1452G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1432C>T:p.Pro478Ser:,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.879G>A::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	666623 [benign DISEASE=not specified,not provided];	CM084968 [CLASS=DP MUT=ALT PHEN="Psoriasis increased risk association with" GENE=FLG];		rs11584340	0.2034	0.1381,0.3576,0.5921,0.1590,0.4353	4065,.	22639	120535	-1.8060	 , , ,T(1.00), 	 , , ,B(0.03), 	0.00	0.04		COSV64239594	0	29281699,28866311,18193244,29774148,24521637,32325630	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313526	152313526	T	C	het	het	hom		QUAL=68625;DP=461,1149,1578;AF=0.48,0.49,0.99;MQM=60;SAP=6;ABP=5;SAR=1146;SAF=1204	FLG-AS1,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19057T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19057T>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1380T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1360A>G:p.Thr454Ala:,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.951T>C::,FLG-AS1:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.68T>C::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	666624 [benign DISEASE=not specified,not provided];	CM1611993 [CLASS=R MUT=ALT PHEN="Ichthyosis vulgaris" GENE=FLG];		rs2011331	0.3025	0.4784,0.3936,0.6241,0.1602,0.4441	8757,.	28312	105664	-1.3090	 , , ,T(1.00), , 	 , , ,B(0.01), , 	0.74	0.08		COSV64245598	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313556	152313556	C	T	het	het	het		QUAL=40828;DP=564,1210,1562;AF=0.48,0.50,0.46;MQM=60;SAP=5;ABP=17;SAR=815;SAF=779	FLG-AS1,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19027C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19027C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1350C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1330G>A:p.Gly444Arg:,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.981C>T::,FLG-AS1:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.98C>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1249558 [benign DISEASE=not provided];			rs11588170	0.1567	0.0340,0.3261,0.5668,0.1355,0.3757	3090,.	17551	127743	-0.3500	 , , ,T(0.18), , 	 , , ,P(0.82), , 	14.31	0.04		COSV64247273	0	29281699,33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313650	152313650	A	G	het	het	wt		QUAL=20668;DP=461,1206,1514;AF=0.50,0.50,0.00;MQM=60;SAP=4;ABP=3;SAR=425;SAF=405	FLG-AS1,FLG	intron&non_coding_transcript,synonymous,non_coding_transcript_exon	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-18933A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-18933A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1256A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.1236T>C:p.Arg412=:PF03516 [Filaggrin],FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.1075A>G::,FLG-AS1:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.192A>G::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1259919 [benign DISEASE=not specified,not provided];			rs11582620	0.0914	0.0214,0.0786,0.1004,0.1235,0.1984	914,.	12006	137552	-4.6310			0.81			COSV64236548	0	29281699,21163515,27206134,19733298,29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313891	152313891	C	A	het	het	hom		QUAL=59514;DP=569,910,1279;AF=0.51,0.50,1.00;MQM=60;SAP=142;ABP=3;SAR=1190;SAF=830	FLG-AS1,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-18692C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-18692C>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1015C>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.995G>T:p.Gly332Val:,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.1316C>A::,FLG-AS1:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.433C>A::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs41267154	0.2009	0.1285,0.3565,0.5933,0.1590,0.4353	4024,.	22448	121326	-0.4760	 , , ,D(0.04), , 	 , , ,D(1.00), , 	14.12	0.02		COSV64246426	0	29281699,34224231,33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152314866	152314866	T	-	het	het	hom	off-target;low_conf_region	QUAL=1882;DP=96,16,39;AF=0.46,0.44,0.92;MQM=60;SAP=192;ABP=5;SAR=87;SAF=0	FLG-AS1,FLG	intron&non_coding_transcript,intron,non_coding_transcript_exon	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-17706del::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-17706del::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-29del::,FLG:ENST00000368799.2:intron_variant:MODIFIER:intron2/2:c.139-119del::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon2/5:n.1717del::,FLG-AS1:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon2/7:n.834del::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1288712 [benign DISEASE=not provided];			rs34224823	0.1953	0.0447,0.3628,0.6073,0.1842,0.4444	4020,.	20513	117623	-0.2050			0.57				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152325041	152325041	A	G	het	het	hom	off-target	QUAL=3603;DP=143,26,47;AF=0.51,0.62,1.00;MQM=60;SAP=298;ABP=4;SAR=0;SAF=136	FLG-AS1,FLG	intron&non_coding_transcript,intron	FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-7542A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-7542A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.515-7542A>G::,FLG:ENST00000368799.2:intron_variant:MODIFIER:intron1/2:c.-22+148T>C::,FLG-AS1:ENST00000665223.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/4:n.1798-7542A>G::,FLG-AS1:ENST00000392688.7:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/6:n.915-7542A>G::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs12407553	0.2022	0.1328,0.3575,0.5961,0.1590,0.4355	4061,.	22559	121027	0.1790			5.10				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	154156196	154156196	G	A	wt	het	wt		QUAL=797;DP=183,86,125;AF=0.01,0.45,0.00;MQM=60;SAP=7;ABP=5;SAR=16;SAF=25	TPM3	3'UTR	TPM3:ENST00000611659.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1443C>T::,TPM3:ENST00000368533.8:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]			AluSq2 (SINE/Alu)	rs4540651	0.6116	0.7412,0.6669,0.8944,0.5074,0.6639	29444,.	34008	59006	0.0330			1.28						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NUP210L (inh=n/a oe_syn=0.95 oe_mis=0.76 oe_lof=0.27), TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154156789	154156789	A	G	wt	het	wt		QUAL=132;DP=105,11,19;AF=0.00,0.73,0.00;MQM=60;SAP=7;ABP=8;SAR=6;SAF=2	TPM3	3'UTR	TPM3:ENST00000611659.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*850T>C::,TPM3:ENST00000368533.8:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:ENST00000330188.13:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]				rs1051370	0.3058	0.1413,0.4531,0.4407,0.3407,0.3723	8025,.	30453	105547	-0.3650			9.61					18957677,20022891,23196875,24388127,26981122,27805284,18957674,33173933	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NUP210L (inh=n/a oe_syn=0.95 oe_mis=0.76 oe_lof=0.27), TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154162081	154162081	A	C	wt	het	wt		QUAL=1949;DP=461,217,366;AF=0.00,0.44,0.00;MQM=60;SAP=22;ABP=10;SAR=63;SAF=34	TPM3	intron,3'UTR	TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.602-4360T>G::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.744-4360T>G::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.776-4360T>G::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.395-4360T>G::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*5856T>G::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]	292625 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];			rs3196889	0.3024	0.1394,0.4525,0.4404,0.3365,0.3710	7823,.	30283	105979	0.3690			5.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154165752	154165752	G	A	wt	het	wt		QUAL=640;DP=198,37,56;AF=0.01,0.76,0.00;MQM=60;SAP=36;ABP=24;SAR=4;SAF=25	TPM3	intron,3'UTR	TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+4648C>T::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+3553C>T::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+4648C>T::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2185C>T::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]	292666 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];		AluSq2 (SINE/Alu)	rs10908723	0.3196	0.1510,0.4847,0.4498,0.3432,0.3806	7583,.	29370	94818	-0.0240			2.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154165790	154165790	A	-	het	het	het		QUAL=1014;DP=145,27,40;AF=0.21,0.22,0.30;MQM=59;SAP=68;ABP=141;SAR=5;SAF=43	TPM3	intron,3'UTR	TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+4610del::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+3515del::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+4610del::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2147del::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]	292667 [likely benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];		AluSq2 (SINE/Alu)	rs68185418	0.2384	0.3377,0.1652,0.4191,0.1822,0.2054	1418,.	16735	62523	-0.4990			0.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154166689	154166689	-	T	wt	het	wt		QUAL=117;DP=183,36,38;AF=0.12,0.00,0.08;MQM=60;SAP=8;ABP=350;SAR=11;SAF=5	TPM3	intron,3'UTR	TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+3710dup::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+2615dup::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+3710dup::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247dup::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]	292677 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];			rs72189266	0.4314	0.4383,0.5627,0.5107,0.3926,0.5280	13897,.	35940	83994				6.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154166690	154166690	T	-	het	wt	wt		QUAL=117;DP=183,36,38;AF=0.03,0.31,0.00;MQM=60;SAP=23;ABP=232;SAR=20;SAF=5	TPM3	intron,3'UTR	TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+3710del::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+2615del::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+3710del::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+3710del::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247del::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]			AluSx1 (SINE/Alu)	rs72189266	0.0004	0.0001,0.0005,0.0000,0.0004,0.0002	0,.	57	147745	0.8190			5.50						0	11	0 / 0					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154166905	154166905	A	C	wt	het	wt		QUAL=552;DP=147,61,71;AF=0.00,0.44,0.01;MQM=60;SAP=18;ABP=5;SAR=7;SAF=21	TPM3	intron,3'UTR	TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+3495T>G::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+2400T>G::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+3495T>G::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1032T>G::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]	292682 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];		AluSx1 (SINE/Alu)	rs6673171	0.3035	0.1423,0.4532,0.4404,0.3365,0.3732	7855,.	30375	105761	0.7390			4.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154169432	154169432	A	G	wt	het	wt	off-target	QUAL=3050;DP=183,250,303;AF=0.00,0.50,0.00;MQM=60;SAP=50;ABP=3;SAR=88;SAF=36	TPM3	intron	TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+968T>C::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+968T>C::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000651641.1:intron_variant:MODIFIER:intron8/9:c.776-49T>C::,TPM3:ENST00000368530.7:intron_variant:MODIFIER:intron8/9:c.776-49T>C::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]	262627 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy 1,not specified,not provided];			rs4845364	0.6275	0.8045,0.6793,0.8809,0.5033,0.6658	31338,.	32644	56596	1.1000			18.83				0.01	25741868,32317632	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154272666	154272666	T	G	wt	wt	het		QUAL=2989;DP=377,166,244;AF=0.00,0.02,0.50;MQM=60;SAP=3;ABP=3;SAR=66;SAF=61	HAX1	5'UTR	HAX1:ENST00000696932.1:5_prime_UTR_variant:MODIFIER:exon2/8:c.-58T>G::,HAX1:ENST00000457918.6:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000696938.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000483970.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000696941.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-113T>G::,HAX1:ENST00000328703.12:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000697830.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-63T>G::,HAX1:ENST00000697592.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-142T>G::	regulatory_region_variant:promoter	605998_[GENE=HAX1_PHENOS=Neutropenia, severe congenital 3, autosomal recessive, 610738 (3), Autosomal recessive]	292700 [benign DISEASE=Kostmann syndrome,not provided];			rs11265425	0.2172	0.0524,0.1618,0.4432,0.2852,0.1789	4607,.	23808	119030	-2.1040			2.40			COSV55171217	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UBAP2L (inh=n/a oe_syn=1.01 oe_mis=0.62 oe_lof=0.03), HAX1 (inh=AR oe_syn=0.87 oe_mis=0.97 oe_lof=0.85)
chr1	154576245	154576245	T	C	hom	hom	het		QUAL=9000;DP=115,126,108;AF=0.98,1.00,0.52;MQM=60;SAP=12;ABP=3;SAR=165;SAF=130	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::,CHRNB2:ENST00000637900.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]				rs2072660	0.7061	0.5629,0.7587,0.7354,0.7677,0.8014	38418,.	30466	44666	-2.5390			0.27				0	21467728,17373692,18593715,15154117,17503330,18534558,18571741,19259974,19760673,20854418,25036316,21606948,16314871,20736995,22180580,23691092,24667010,25640319,25778907,23350800,24486638,26301171,24057800,24569419,25774163,25259584,23264444,28054193,19698703,19665479,19854014,33217458	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154576404	154576404	G	A	wt	wt	het		QUAL=1186;DP=76,62,106;AF=0.00,0.02,0.48;MQM=60;SAP=3;ABP=3;SAR=25;SAF=27	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::,CHRNB2:ENST00000637900.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]				rs2072661	0.2534	0.2805,0.2337,0.2810,0.2378,0.1997	4804,.	28896	113476	0.5620			5.30				0	22992668,21808284,25819021,18593715,18165968,15154117,17503330,18534558,19859904,20854418,25036316,21606948,20736995,22180580,23691092,24667010,25778907,19238175,19482438,19755656,20981002,22103610,22290489,23249876,23943838,29196725,18618000,24065931,23350800,24486638,26301171,22002450,24569419,24428733,23824835,34413872	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154576994	154576994	T	C	wt	wt	het		QUAL=3420;DP=299,241,299;AF=0.00,0.00,0.45;MQM=60;SAP=16;ABP=10;SAR=53;SAF=81	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1062T>C::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]&146920_[GENE=ADAR_PHENOS=Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive]				rs12130403	0.2979	0.2858,0.2787,0.2910,0.3073,0.2307	6706,.	31846	106678	-0.0680			6.02				0.05	31832568	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	154578468	154578469	AG	-	wt	wt	het		QUAL=3336;DP=271,211,267;AF=0.00,0.00,0.49;MQM=60;SAP=23;ABP=3;SAR=83;SAF=48	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2538_*2539del::	regulatory_region_variant:enhancer	118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]&146920_[GENE=ADAR_PHENOS=Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive]				rs3841062	0.2699	0.2778,0.2165,0.2919,0.2706,0.2142	5508,.	29993	110911	0.4920			1.36				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	154579534	154579534	C	G	het	het	wt		QUAL=8445;DP=296,338,412;AF=0.55,0.48,0.00;MQM=60;SAP=3;ABP=4;SAR=162;SAF=164	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3602C>G::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]&146920_[GENE=ADAR_PHENOS=Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive]				rs1049998302	0.0001	0.0000,0.0000,0.0000,0.0001,0.0000	0,.	2	152176	-0.4080			1.19				0		0	3	0 / 0					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	155234893	155234893	A	G	wt	het	wt		QUAL=74;DP=52,18,27;AF=0.00,0.56,0.00;MQM=27;SAP=25;ABP=3;SAR=0;SAF=10	GBA1	3'UTR	GBA1:ENST00000368373.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*102T>C::,GBA1:ENST00000327247.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*102T>C::,GBA1:ENST00000427500.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*102T>C::,GBA1:ENST00000428024.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*102T>C::		606463_[GENE=GBA1_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]				rs368275143	0.0194	0.0653,0.0153,0.0020,0.0072,0.0141	14,.	235	13287	1.0560			6.97				0		6	84	0 / 0					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA1 (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155234903	155234903	C	T	wt	het	wt		QUAL=123;DP=49,24,31;AF=0.00,0.58,0.00;MQM=28;SAP=33;ABP=4;SAR=0;SAF=14	GBA1	3'UTR	GBA1:ENST00000368373.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*92G>A::,GBA1:ENST00000327247.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*92G>A::,GBA1:ENST00000427500.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*92G>A::,GBA1:ENST00000428024.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*92G>A::		606463_[GENE=GBA1_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]				rs708606	0.0071	0.0047,0.0097,0.0035,0.0082,0.0146	1,.	127	18171	0.5230			6.12			COSV59168994	0	31077260	8	57	0 / 0					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA1 (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155235878	155235878	G	T	hom	hom	hom	off-target;low_conf_region	QUAL=21497;DP=144,252,338;AF=0.98,1.00,1.00;MQM=56;SAP=755;ABP=0;SAR=617;SAF=114	GBA1	intron	GBA1:ENST00000368373.8:intron_variant:MODIFIER:intron8/10:c.1225-34C>A::,GBA1:ENST00000327247.9:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA1:ENST00000427500.7:intron_variant:MODIFIER:intron7/9:c.1078-34C>A::,GBA1:ENST00000428024.3:intron_variant:MODIFIER:intron7/9:c.964-34C>A::	regulatory_region_variant:enhancer	606463_[GENE=GBA1_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]	256871 [benign DISEASE=Gaucher disease type I,Gaucher disease perinatal lethal,Gaucher disease,not specified,not provided];			rs3115534	0.9531	0.8407,0.9828,0.9996,0.9980,0.9985	68942,.	5961	7075	0.1160			1.83				0.04	25741868,23418865	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA1 (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155237596	155237596	A	T	het	het	wt	off-target	QUAL=4084;DP=191,140,174;AF=0.52,0.54,0.00;MQM=53;SAP=333;ABP=5;SAR=169;SAF=6	GBA1	splice_region&intron	GBA1:ENST00000368373.8:splice_region_variant&intron_variant:LOW:intron6/10:c.762-18T>A::,GBA1:ENST00000327247.9:splice_region_variant&intron_variant:LOW:intron7/11:c.762-18T>A::,GBA1:ENST00000427500.7:splice_region_variant&intron_variant:LOW:intron5/9:c.615-18T>A::,GBA1:ENST00000428024.3:splice_region_variant&intron_variant:LOW:intron5/9:c.501-18T>A::		606463_[GENE=GBA1_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]	198756 [benign DISEASE=not specified,not provided];			rs140335079	0.0086	0.0027,0.0122,0.0002,0.0133,0.0025	6,.	1300	150916	0.7750			7.07		10.84>7.92		0.03	25741868,32714263,34380910	5	597	0 / 0					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA1 (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155238856	155238856	T	C	hom	hom	hom	off-target	QUAL=3492;DP=46,35,46;AF=1.00,1.00,1.00;MQM=51;SAP=270;ABP=0;SAR=126;SAF=1	GBA1	intron	GBA1:ENST00000368373.8:intron_variant:MODIFIER:intron4/10:c.455-206A>G::,GBA1:ENST00000327247.9:intron_variant:MODIFIER:intron5/11:c.455-206A>G::,GBA1:ENST00000427500.7:intron_variant:MODIFIER:intron3/9:c.308-206A>G::,GBA1:ENST00000428024.3:intron_variant:MODIFIER:intron3/9:c.194-206A>G::		606463_[GENE=GBA1_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]				rs7416991	0.5693	0.3038,0.6338,0.2957,0.7026,0.6419	27027,.	32389	65397	0.3340			4.30				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA1 (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155752715	155752715	C	G	hom	hom	het	off-target	QUAL=890;DP=31,3,3;AF=1.00,1.00,0.67;MQM=48;SAP=81;ABP=4;SAR=36;SAF=0	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron29/31:c.5843-125G>C::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron29/31:c.5843-125G>C::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron29/31:c.5843-128G>C::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron29/31:c.5843-128G>C::					AluJr (SINE/Alu)	rs12134456	0.2570	0.0594,0.2210,0.0041,0.3773,0.2038	6621,.	25799	112881	-0.3730			0.77				0.01	31152163,31578528,32888493,31676860	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSTO2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155754524	155754524	G	T	het	het	wt	off-target;low_conf_region	QUAL=212;DP=59,47,81;AF=0.41,0.11,0.04;MQM=50;SAP=72;ABP=50;SAR=32;SAF=0	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::					AluSg (SINE/Alu)	rs200722936	0.0004	0.0002,0.0006,0.0006,0.0005,0.0012	0,.	43	98949	0.1270			1.70			COSV55185833	0		1	14	0 / 0					MSTO2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155767594	155767594	C	T	hom	hom	hom	off-target	QUAL=8270;DP=38,118,156;AF=1.00,1.00,1.00;MQM=45;SAP=151;ABP=0;SAR=229;SAF=83	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::						rs849712	0.9365	0.7780,0.9761,1.0000,0.9995,0.9990	67305,.	7491	9633	-0.1340			3.66				0.12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155767635	155767638	ACAC	-	hom	hom	hom	off-target	QUAL=5147;DP=49,79,106;AF=0.86,0.86,0.90;MQM=52;SAP=448;ABP=0;SAR=205;SAF=0	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron19/31:c.2647-97_2647-94del::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron19/31:c.2647-97_2647-94del::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron19/31:c.2647-97_2647-94del::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron19/31:c.2647-97_2647-94del::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron19/20:c.2647-97_2647-94del::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron19/20:c.2647-97_2647-94del::					(AC)n (Simple_repeat)	rs3831996	0.5190	0.2811,0.5814,0.2911,0.6395,0.5875	21767,.	34052	71918	0.5100			1.23				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155776550	155776550	T	-	hom	hom	hom	off-target;low_conf_region	QUAL=7100;DP=134,60,115;AF=0.84,0.97,0.89;MQM=60;SAP=262;ABP=0;SAR=226;SAF=46	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron15/31:c.2092-69del::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron15/31:c.2092-69del::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron15/31:c.2092-69del::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron15/31:c.2092-69del::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron15/20:c.2092-69del::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron15/20:c.2092-69del::					AluJr (SINE/Alu)	rs60525991	0.8616	0.6435,0.9323,0.9986,0.9485,0.9602	56485,.	15099	20581	0.4820			1.56				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155783885	155783885	A	G	hom	hom	hom	off-target	QUAL=10385;DP=159,76,107;AF=1.00,1.00,1.00;MQM=59;SAP=720;ABP=0;SAR=3;SAF=339	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron14/31:c.1892+101T>C::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron14/31:c.1892+101T>C::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron14/31:c.1892+101T>C::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron14/31:c.1892+101T>C::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron14/20:c.1892+101T>C::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron14/20:c.1892+101T>C::						rs822019	0.8352	0.5451,0.9234,0.9990,0.9511,0.9379	55500,.	16000	25064	-0.8600			1.94				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155785306	155785306	G	A	hom	hom	hom	off-target	QUAL=25676;DP=234,248,305;AF=1.00,1.00,1.00;MQM=60;SAP=188;ABP=0;SAR=264;SAF=523	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::						rs822021	0.9363	0.7776,0.9761,1.0000,0.9995,0.9990	67377,.	7548	9682	-1.0920			5.37				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155785448	155785448	T	C	hom	hom	hom	off-target	QUAL=20678;DP=154,229,266;AF=1.00,1.00,1.00;MQM=60;SAP=290;ABP=0;SAR=471;SAF=178	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron12/31:c.1748-74A>G::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron12/31:c.1748-74A>G::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron12/31:c.1748-74A>G::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron12/31:c.1748-74A>G::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron12/20:c.1748-74A>G::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron12/20:c.1748-74A>G::					L3b (LINE/CR1)	rs822022	0.8636	0.6415,0.9349,0.9992,0.9513,0.9613	58205,.	14934	20754	-0.4910			8.87				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155804783	155804783	-	A	het	wt	wt	off-target;low_conf_region	QUAL=6;DP=29,5,6;AF=0.14,0.00,0.00;MQM=60;SAP=12;ABP=36;SAR=0;SAF=4	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron11/31:c.1645+165dup::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron11/31:c.1645+165dup::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron11/31:c.1645+165dup::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron11/31:c.1645+165dup::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron11/20:c.1645+165dup::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron11/20:c.1645+165dup::					AluJr (SINE/Alu)	rs780720104	0.0048	0.0121,0.0019,0.0013,0.0016,0.0010	2,.	630	130816				2.31				0		0	17	0 / 0					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155804808	155804808	T	C	hom	hom	hom	off-target	QUAL=3049;DP=50,30,32;AF=1.00,1.00,1.00;MQM=60;SAP=246;ABP=0;SAR=0;SAF=112	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron11/31:c.1645+141A>G::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron11/31:c.1645+141A>G::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron11/31:c.1645+141A>G::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron11/31:c.1645+141A>G::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron11/20:c.1645+141A>G::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron11/20:c.1645+141A>G::						rs822016	0.8696	0.6610,0.9370,0.9998,0.9515,0.9622	58681,.	14569	19787	0.4160			6.38				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155813972	155813972	C	T	hom	hom	hom	off-target	QUAL=2702;DP=63,14,10;AF=1.00,1.00,1.00;MQM=60;SAP=151;ABP=0;SAR=82;SAF=5	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron9/31:c.1282-168G>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron9/31:c.1282-168G>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron9/31:c.1282-168G>A::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron9/31:c.1282-168G>A::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron9/20:c.1282-168G>A::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron9/20:c.1282-168G>A::						rs822012	0.8360	0.5481,0.9237,0.9990,0.9509,0.9384	55575,.	16021	24955	-0.1590			6.85				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155814581	155814581	G	A	hom	hom	hom	off-target	QUAL=9023;DP=153,75,96;AF=1.00,1.00,1.00;MQM=60;SAP=707;ABP=0;SAR=324;SAF=0	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron8/31:c.1162-132C>T::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron8/31:c.1162-132C>T::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron8/31:c.1162-132C>T::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron8/31:c.1162-132C>T::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron8/20:c.1162-132C>T::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron8/20:c.1162-132C>T::					AluSx (SINE/Alu)	rs822013	0.9364	0.7779,0.9759,1.0000,0.9995,0.9990	67335,.	7541	9655	-1.4210			0.68				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155815788	155815791	AACT	-	hom	hom	hom	off-target	QUAL=22150;DP=249,210,270;AF=1.00,1.00,1.00;MQM=60;SAP=212;ABP=0;SAR=232;SAF=497	GON4L	splice_region&intron	GON4L:ENST00000368331.6:splice_region_variant&intron_variant:LOW:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000615926.4:splice_region_variant&intron_variant:LOW:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000437809.5:splice_region_variant&intron_variant:LOW:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000271883.9:splice_region_variant&intron_variant:LOW:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000361040.9:splice_region_variant&intron_variant:LOW:intron8/20:c.1161+14_1161+17del::,GON4L:ENST00000622608.2:splice_region_variant&intron_variant:LOW:intron8/20:c.1161+14_1161+17del::						rs148569012	0.8634	0.6406,0.9352,0.9994,0.9512,0.9613	57983,.	14913	20703	-0.2520			6.23				0.19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155815986	155815986	A	-	het	wt	het	off-target	QUAL=95;DP=257,79,103;AF=0.12,0.08,0.11;MQM=60;SAP=81;ABP=469;SAR=44;SAF=3	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron7/31:c.1066-86del::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron7/31:c.1066-86del::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron7/31:c.1066-86del::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron7/31:c.1066-86del::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron7/20:c.1066-86del::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron7/20:c.1066-86del::						rs913306261	0.0019	0.0038,0.0026,0.0011,0.0009,0.0011	0,.	264	135698	0.3180			7.39				0		0	18	0 / 0					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155853180	155853180	C	T	hom	hom	hom	off-target	QUAL=1645;DP=31,10,16;AF=1.00,1.00,1.00;MQM=60;SAP=127;ABP=0;SAR=0;SAF=57	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron2/31:c.505+96G>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron2/31:c.505+96G>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron2/31:c.505+96G>A::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron2/31:c.505+96G>A::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron2/20:c.505+96G>A::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron2/20:c.505+96G>A::	regulatory_region_variant:enhancer					rs822490	0.5332	0.2817,0.5910,0.2948,0.6633,0.5970	23771,.	33509	70945	-1.2110			0.42			COSV55201923	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155853211	155853211	T	C	hom	hom	hom	off-target	QUAL=3144;DP=61,26,21;AF=1.00,1.00,1.00;MQM=60;SAP=238;ABP=0;SAR=0;SAF=108	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron2/31:c.505+65A>G::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron2/31:c.505+65A>G::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron2/31:c.505+65A>G::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron2/31:c.505+65A>G::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron2/20:c.505+65A>G::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron2/20:c.505+65A>G::						rs822491	0.9997	0.9992,0.9995,1.0000,1.0000,1.0000	76070,.	44	44	-0.0960			4.46				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	156054582	156054582	A	G	hom	n/a	n/a	off-target	QUAL=105;DP=3,0,2;AF=1.00,,0.50;MQM=60;SAP=12;ABP=3;SAR=0;SAF=4	UBQLN4,LAMTOR2	upstream_gene	UBQLN4:ENST00000368309.4:upstream_gene_variant:MODIFIER::::,LAMTOR2:ENST00000368305.9:upstream_gene_variant:MODIFIER::::,LAMTOR2:ENST00000368304.9:upstream_gene_variant:MODIFIER::::,LAMTOR2:ENST00000368302.3:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	610389_[GENE=LAMTOR2_PHENOS=Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3), Autosomal recessive]	1233192 [benign DISEASE=not provided];			rs3754293	0.4429	0.1829,0.5555,0.1595,0.5621,0.5642	17366,.	32586	84670	1.6360			17.34					31709530	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UBQLN4 (inh=n/a oe_syn=0.86 oe_mis=0.56 oe_lof=0.12), LAMTOR2 (inh=AR oe_syn=1.11 oe_mis=0.57 oe_lof=0.30)
chr1	156055305	156055305	C	T	wt	het	wt		QUAL=1260;DP=86,108,167;AF=0.00,0.51,0.00;MQM=60;SAP=12;ABP=3;SAR=20;SAF=35	LAMTOR2	synonymous	LAMTOR2:ENST00000368305.9:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain],LAMTOR2:ENST00000368304.9:synonymous_variant:LOW:exon2/3:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain],LAMTOR2:ENST00000368302.3:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain]	regulatory_region_variant:promoter	610389_[GENE=LAMTOR2_PHENOS=Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3), Autosomal recessive]	1165734 [benign DISEASE=not provided];			rs7541	0.1180	0.0523,0.1206,0.0014,0.1603,0.0749	1270,.	15402	134156	-0.9160			8.58			COSV64145997	0	23341997	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UBQLN4 (inh=n/a oe_syn=0.86 oe_mis=0.56 oe_lof=0.12), LAMTOR2 (inh=AR oe_syn=1.11 oe_mis=0.57 oe_lof=0.30)
chr1	156130443	156130443	-	G	wt	het	wt	off-target	QUAL=9;DP=22,13,21;AF=0.00,0.31,0.00;MQM=60;SAP=12;ABP=7;SAR=0;SAF=4	LMNA	intron	LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron4/12:c.357-171dup::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron3/12:c.357-171dup::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron2/12:c.357-171dup::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron2/11:c.357-171dup::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron2/12:c.357-171dup::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron2/11:c.357-171dup::,LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron2/12:c.357-171dup::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron1/9:c.357-171dup::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron1/11:c.357-171dup::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron1/11:c.357-171dup::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron1/12:c.21-171dup::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron2/10:c.114-171dup::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron2/12:c.60-171dup::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	1243267 [benign DISEASE=not provided];			rs113265975	0.0820	0.1742,0.0567,0.0006,0.0479,0.0517	806,.	10794	138874				17.46				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156130948	156130948	T	C	wt	het	wt	off-target	QUAL=111;DP=44,16,18;AF=0.02,0.44,0.00;MQM=60;SAP=20;ABP=4;SAR=8;SAF=0	LMNA	intron	LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron5/12:c.513+175T>C::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron4/12:c.513+175T>C::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron3/12:c.513+175T>C::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron3/11:c.513+175T>C::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron3/12:c.513+175T>C::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron3/11:c.513+175T>C::,LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron3/12:c.513+175T>C::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron2/9:c.513+175T>C::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron2/11:c.513+175T>C::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron2/11:c.513+175T>C::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron2/12:c.177+175T>C::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron3/10:c.270+175T>C::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron3/12:c.216+175T>C::	regulatory_region_variant:CTCF_binding_site	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	672782 [benign DISEASE=not provided];			rs577492	0.2114	0.5664,0.1039,0.0227,0.0712,0.1301	7090,.	17954	119878	-0.7020			1.45				0	17327437	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156134206	156134206	A	C	wt	het	wt	off-target	QUAL=537;DP=52,48,47;AF=0.02,0.54,0.00;MQM=60;SAP=62;ABP=4;SAR=0;SAF=27	LMNA	intron	LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron5/12:c.514-197A>C::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron4/12:c.514-197A>C::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron3/12:c.514-197A>C::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron3/11:c.514-197A>C::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron3/12:c.514-197A>C::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron3/11:c.514-197A>C::,LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron3/12:c.514-197A>C::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron2/9:c.514-197A>C::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron2/11:c.514-197A>C::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron2/11:c.514-197A>C::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron2/12:c.178-197A>C::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron3/10:c.271-197A>C::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron3/12:c.217-197A>C::	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	672783 [benign DISEASE=not provided];			rs569025	0.2295	0.6288,0.1095,0.0227,0.0715,0.1311	8673,.	17486	116976	-0.9490			1.93				0.01	34107879	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156135237	156135237	T	C	wt	het	wt		QUAL=341;DP=91,36,54;AF=0.01,0.47,0.00;MQM=60;SAP=20;ABP=3;SAR=15;SAF=3	LMNA	synonymous	LMNA:ENST00000368301.6:synonymous_variant:LOW:exon8/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000676385.2:synonymous_variant:LOW:exon7/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000675939.1:synonymous_variant:LOW:exon6/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000675667.1:synonymous_variant:LOW:exon6/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000683032.1:synonymous_variant:LOW:exon6/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000682650.1:synonymous_variant:LOW:exon6/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000361308.9:synonymous_variant:LOW:exon6/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000677389.1:synonymous_variant:LOW:exon5/10:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000368300.9:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000368299.7:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000448611.6:synonymous_variant:LOW:exon5/13:c.525T>C:p.Ala175=:PF00038 [Intermediate filament protein],LMNA:ENST00000368297.5:synonymous_variant:LOW:exon6/11:c.618T>C:p.Ala206=:PF00038 [Intermediate filament protein],LMNA:ENST00000473598.6:synonymous_variant:LOW:exon6/13:c.564T>C:p.Ala188=:PF00038 [Intermediate filament protein]	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	48088 [benign DISEASE=Cardiomyopathy,Dilated cardiomyopathy 1A,Familial partial lipodystrophy, Dunnigan type,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Charcot-Marie-Tooth disease type 2B1,Congenital muscular dystrophy due to LMNA mutation,Charcot-Marie-Tooth disease,Emery-Dreifuss muscular dystrophy,Charcot-Marie-Tooth disease type 2,Benign scapuloperoneal muscular dystrophy with cardiomyopathy,Lethal tight skin contracture syndrome,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,not provided];	CM217020 [CLASS=DM? MUT=ALT PHEN="Cardiomyopathy dilated modifier of" GENE=LMNA];		rs538089	0.1760	0.4421,0.0930,0.0227,0.0709,0.1291	4475,.	17838	125380	-7.5680			5.54				0	25741868,24033266,15637659,20127487,28785654,18344805,23861362,23757202,29104234,27896052,22419169,32698886	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156135818	156135818	G	T	wt	het	wt	off-target	QUAL=904;DP=42,71,77;AF=0.00,0.61,0.00;MQM=60;SAP=96;ABP=10;SAR=0;SAF=43	LMNA	intron	LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron8/12:c.937-83G>T::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron7/12:c.937-83G>T::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron6/12:c.937-83G>T::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron6/11:c.937-83G>T::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron6/12:c.937-83G>T::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron6/11:c.937-83G>T::,LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron6/12:c.937-83G>T::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron5/9:c.937-83G>T::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron5/11:c.937-83G>T::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron5/11:c.937-83G>T::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron5/12:c.601-83G>T::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron6/10:c.694-83G>T::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron6/12:c.640-83G>T::	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]				rs646840	0.1756	0.4417,0.0933,0.0228,0.0707,0.1282	4431,.	17801	125207	0.2890			6.13				0.01	28785654	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156136137	156136137	G	A	wt	het	wt	off-target	QUAL=3073;DP=90,261,311;AF=0.01,0.49,0.00;MQM=60;SAP=14;ABP=3;SAR=77;SAF=52	LMNA	splice_region&intron	LMNA:ENST00000368301.6:splice_region_variant&intron_variant:LOW:intron9/12:c.1157+16G>A::,LMNA:ENST00000676385.2:splice_region_variant&intron_variant:LOW:intron8/12:c.1157+16G>A::,LMNA:ENST00000675939.1:splice_region_variant&intron_variant:LOW:intron7/12:c.1157+16G>A::,LMNA:ENST00000675667.1:splice_region_variant&intron_variant:LOW:intron7/11:c.1157+16G>A::,LMNA:ENST00000683032.1:splice_region_variant&intron_variant:LOW:intron7/12:c.1157+16G>A::,LMNA:ENST00000682650.1:splice_region_variant&intron_variant:LOW:intron7/11:c.1157+16G>A::,LMNA:ENST00000361308.9:splice_region_variant&intron_variant:LOW:intron7/12:c.1157+16G>A::,LMNA:ENST00000677389.1:splice_region_variant&intron_variant:LOW:intron6/9:c.1157+16G>A::,LMNA:ENST00000368300.9:splice_region_variant&intron_variant:LOW:intron6/11:c.1157+16G>A::,LMNA:ENST00000368299.7:splice_region_variant&intron_variant:LOW:intron6/11:c.1157+16G>A::,LMNA:ENST00000448611.6:splice_region_variant&intron_variant:LOW:intron6/12:c.821+16G>A::,LMNA:ENST00000368297.5:splice_region_variant&intron_variant:LOW:intron7/10:c.914+16G>A::,LMNA:ENST00000473598.6:splice_region_variant&intron_variant:LOW:intron7/12:c.860+16G>A::	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	36474 [benign/likely benign DISEASE=Primary dilated cardiomyopathy,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease type 2,not specified,not provided];			rs534807	0.1757	0.4434,0.0933,0.0225,0.0701,0.1238	4477,.	17759	125349	0.5750			3.25				0	25741868,24033266,28785654,18344805,23757202,27896052,22419169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156136394	156136394	T	C	wt	het	wt		QUAL=1107;DP=46,108,140;AF=0.00,0.46,0.00;MQM=60;SAP=14;ABP=4;SAR=33;SAF=17	LMNA	synonymous	LMNA:ENST00000368301.6:synonymous_variant:LOW:exon10/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000676385.2:synonymous_variant:LOW:exon9/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000675939.1:synonymous_variant:LOW:exon8/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000675667.1:synonymous_variant:LOW:exon8/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000683032.1:synonymous_variant:LOW:exon8/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000682650.1:synonymous_variant:LOW:exon8/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000361308.9:synonymous_variant:LOW:exon8/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000677389.1:synonymous_variant:LOW:exon7/10:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368300.9:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368299.7:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000448611.6:synonymous_variant:LOW:exon7/13:c.1002T>C:p.Asp334=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368297.5:synonymous_variant:LOW:exon8/11:c.1095T>C:p.Asp365=:PF00932 [Lamin Tail Domain],LMNA:ENST00000473598.6:synonymous_variant:LOW:exon8/13:c.1041T>C:p.Asp347=:PF00932 [Lamin Tail Domain]	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	48037 [benign DISEASE=Cardiomyopathy,Dilated cardiomyopathy 1A,Familial partial lipodystrophy, Dunnigan type,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Charcot-Marie-Tooth disease type 2B1,Congenital muscular dystrophy due to LMNA mutation,Charcot-Marie-Tooth disease,Emery-Dreifuss muscular dystrophy,Charcot-Marie-Tooth disease type 2,Benign scapuloperoneal muscular dystrophy with cardiomyopathy,Lethal tight skin contracture syndrome,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,not provided];			rs505058	0.2268	0.6194,0.1092,0.0228,0.0709,0.1352	8429,.	17626	117582	-0.5110			5.62			COSV61542738	0	25741868,24033266,17327460,17994215,20127487,28785654,18344805,23861362,23757202,18780302,18830724,18848371,20574532,20594621,21537449,21903150,23164068,29596498,21132329,30781626,29104234,30595370,27896052,22419169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156136578	156136578	G	A	wt	het	wt	off-target	QUAL=105;DP=40,18,26;AF=0.00,0.39,0.04;MQM=60;SAP=13;ABP=5;SAR=7;SAF=1	LMNA	intron	LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron10/12:c.1380+142G>A::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron9/12:c.1380+142G>A::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron8/12:c.1380+142G>A::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron8/11:c.1380+142G>A::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron8/12:c.1380+142G>A::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron8/11:c.1380+142G>A::,LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron8/12:c.1380+142G>A::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron7/9:c.1380+142G>A::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron7/11:c.1380+142G>A::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron7/11:c.1380+142G>A::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron7/12:c.1044+142G>A::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron8/10:c.1137+142G>A::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron8/12:c.1083+142G>A::	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	672784 [benign DISEASE=not provided];		MIRc (SINE/MIR)	rs476000	0.2241	0.6128,0.1081,0.0227,0.0702,0.1293	8237,.	17599	117941	-2.8530			0.15				0.05	22419169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156137072	156137072	C	T	wt	het	wt	off-target	QUAL=2815;DP=183,239,371;AF=0.00,0.53,0.00;MQM=60;SAP=33;ABP=5;SAR=85;SAF=43	LMNA	intron	LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron11/12:c.1489-41C>T::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron10/12:c.1489-41C>T::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron9/12:c.1489-41C>T::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron9/11:c.1489-41C>T::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron9/12:c.1489-41C>T::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron9/11:c.1489-41C>T::,LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron9/12:c.1489-41C>T::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron8/9:c.1489-41C>T::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron8/12:c.1153-41C>T::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron9/10:c.1246-41C>T::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron9/12:c.1192-41C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	66834 [benign DISEASE=not specified,not provided];			rs553016	0.1672	0.4126,0.0904,0.0228,0.0703,0.1272	3896,.	17618	126548	0.3860			6.84			COSV61542554	0.01	25741868,15637659,16262891,18344805,27896052	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156137743	156137743	C	T	het	wt	het		QUAL=6933;DP=148,261,349;AF=0.61,0.00,0.55;MQM=60;SAP=26;ABP=21;SAR=113;SAF=168	LMNA	synonymous,intron,splice_region&synonymous	LMNA:ENST00000368301.6:synonymous_variant:LOW:exon13/13:c.1698C>T:p.His566=:,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron11/12:c.1608+511C>T::,LMNA:ENST00000675939.1:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:,LMNA:ENST00000675667.1:splice_region_variant&synonymous_variant:LOW:exon11/12:c.1698C>T:p.His566=:,LMNA:ENST00000683032.1:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron10/11:c.1608+511C>T::,LMNA:ENST00000361308.9:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:,LMNA:ENST00000677389.1:synonymous_variant:LOW:exon10/10:c.1698C>T:p.His566=:,LMNA:ENST00000368300.9:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000368299.7:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000448611.6:splice_region_variant&synonymous_variant:LOW:exon10/13:c.1362C>T:p.His454=:,LMNA:ENST00000368297.5:synonymous_variant:LOW:exon11/11:c.1455C>T:p.His485=:,LMNA:ENST00000473598.6:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1401C>T:p.His467=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	48048 [benign DISEASE=Cardiomyopathy,Dilated cardiomyopathy 1A,Familial partial lipodystrophy, Dunnigan type,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Charcot-Marie-Tooth disease type 2B1,Congenital muscular dystrophy due to LMNA mutation,Charcot-Marie-Tooth disease,Emery-Dreifuss muscular dystrophy,Charcot-Marie-Tooth disease type 2,Benign scapuloperoneal muscular dystrophy with cardiomyopathy,Lethal tight skin contracture syndrome,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,not provided];	CM003892 [CLASS=DP MUT=ALT PHEN="Metabolic syndrome association with" GENE=LMNA];		rs4641	0.2128	0.0934,0.2823,0.2525,0.2611,0.3038	4003,.	24349	119727	-1.6030			8.23		9.30>7.83	COSV61541921	0	25741868,24033266,15637659,16262891,17327437,17327460,17327461,17994215,19841875,20127487,20501691,21108632,22303384,22340368,24244950,26365620,26379929,26602028,27182706,28785654,25649378,21980471,27409638,25151201,23090008,24019745,27896052,23800289,26634508,24831476,32698886,33953703,34021172	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156139185	156139185	G	C	wt	het	wt		QUAL=36;DP=68,7,15;AF=0.00,0.57,0.00;MQM=60;SAP=5;ABP=3;SAR=1;SAF=3	LMNA	3'UTR,intron	LMNA:ENST00000675939.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::,LMNA:ENST00000675667.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*206G>C::,LMNA:ENST00000683032.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::,LMNA:ENST00000682650.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000361308.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::,LMNA:ENST00000368300.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000368299.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron12/12:c.1655+83G>C::,LMNA:ENST00000473598.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::	regulatory_region_variant:enhancer	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	66756 [benign DISEASE=not specified,not provided];			rs7339	0.1697	0.4214,0.0905,0.0227,0.0704,0.1267	4048,.	17640	125952	-0.0620			2.75			COSV61542559	0	16262891,28785654,18344805	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156139303	156139303	-	A	wt	het	wt		QUAL=51;DP=57,33,51;AF=0.02,0.24,0.04;MQM=60;SAP=8;ABP=22;SAR=3;SAF=8	LMNA	3'UTR,intron	LMNA:ENST00000368300.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:ENST00000368299.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron12/12:c.1655+215dup::		150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	1267964 [benign DISEASE=not provided];			rs200317083	0.1338	0.3007,0.0861,0.0033,0.0704,0.0614	1718,.	13777	111481				13.27				0	32888494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156815564	156815564	T	C	hom	hom	hom	off-target	QUAL=4462;DP=71,44,39;AF=1.00,1.00,1.00;MQM=60;SAP=337;ABP=0;SAR=0;SAF=154	SH2D2A	intron	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.70-343A>G::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.124-343A>G::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.124-343A>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667736 [benign DISEASE=not provided];			rs2150906	0.8551	0.6781,0.8625,0.9363,0.9417,0.8963	56484,.	16957	22009	-1.7110			0.21			COSV63885495,COSV63885550	0.06	30738251	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156815825	156815825	G	A	hom	hom	hom		QUAL=22395;DP=196,210,298;AF=1.00,1.00,1.00;MQM=60;SAP=54;ABP=0;SAR=416;SAF=288	SH2D2A,NTRK1	intron,5'UTR	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.69+181C>T::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,NTRK1:ENST00000392302.7:5_prime_UTR_variant:MODIFIER:exon1/17:c.-77G>A::,NTRK1:ENST00000674537.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-217G>A::	regulatory_region_variant:promoter	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	380853 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not specified];			rs1800601	0.6352	0.5053,0.6952,0.8193,0.6766,0.6463	31197,.	34046	55384	-1.8390			0.22			COSV63884607	0.04	20219210,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156815971	156815971	G	-	hom	hom	hom	off-target	QUAL=7316;DP=91,81,98;AF=1.00,1.00,1.00;MQM=60;SAP=589;ABP=0;SAR=270;SAF=0	SH2D2A,NTRK1	intron	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.69+35del::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.123+35del::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.123+35del::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron1/16:c.-64+133del::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron1/17:c.-204+133del::	regulatory_region_variant:promoter	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1225268 [benign DISEASE=not provided];			rs11325907	0.5644	0.3365,0.6460,0.8183,0.6424,0.6459	25680,.	34062	65942	0.2390			2.35				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156815979	156815979	A	G	hom	hom	hom	off-target	QUAL=7528;DP=84,78,102;AF=1.00,1.00,1.00;MQM=60;SAP=576;ABP=0;SAR=264;SAF=0	SH2D2A,NTRK1	intron	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.69+27T>C::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.123+27T>C::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.123+27T>C::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron1/16:c.-64+141A>G::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron1/17:c.-204+141A>G::	regulatory_region_variant:promoter	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667767 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not provided];			rs7546838	0.5983	0.4552,0.6585,0.8177,0.6425,0.6467	27774,.	34990	60782	-1.3060			1.14			COSV63884348	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156815987	156815987	G	A	hom	hom	hom	off-target	QUAL=6012;DP=85,74,87;AF=0.98,1.00,1.00;MQM=60;SAP=533;ABP=0;SAR=244;SAF=0	SH2D2A,NTRK1	splice_region&intron,intron	SH2D2A:ENST00000368198.7:splice_region_variant&intron_variant:LOW:intron2/8:c.69+19C>T::,SH2D2A:ENST00000368199.8:splice_region_variant&intron_variant:LOW:intron2/8:c.123+19C>T::,SH2D2A:ENST00000392306.2:splice_region_variant&intron_variant:LOW:intron2/8:c.123+19C>T::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron1/16:c.-64+149G>A::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron1/17:c.-204+149G>A::	regulatory_region_variant:promoter	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667768 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not provided];			rs1800600	0.6546	0.5745,0.6998,0.8180,0.6766,0.6534	32670,.	33714	52256	-0.7970			0.37				0	18554728	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156868349	156868349	T	C	hom	hom	hom	off-target	QUAL=3464;DP=58,32,29;AF=1.00,1.00,1.00;MQM=60;SAP=220;ABP=0;SAR=114;SAF=5	NTRK1	intron	NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron6/16:c.412+100T>C::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron7/17:c.412+100T>C::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron5/15:c.574+100T>C::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron5/16:c.574+100T>C::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron5/15:c.574+100T>C::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667738 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not provided];			rs1800879	0.6296	0.6382,0.6460,0.9499,0.6036,0.7328	30567,.	34534	56290	-4.5820			0.02				0	18077166,16373086	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156871467	156871467	A	C	hom	hom	hom	off-target	QUAL=4942;DP=75,42,53;AF=1.00,1.00,1.00;MQM=60;SAP=372;ABP=0;SAR=0;SAF=170	NTRK1	intron	NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron7/16:c.556-156A>C::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron8/17:c.556-156A>C::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron6/15:c.718-156A>C::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron6/16:c.718-156A>C::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron6/15:c.718-156A>C::	regulatory_region_variant:enhancer	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667741 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not provided];			rs2644614	0.9798	0.9300,0.9926,1.0000,0.9995,0.9996	73129,.	2838	3076	-0.5680			1.42				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156875700	156875700	-	GT	wt	wt	het	off-target;low_conf_region	QUAL=932;DP=16,39,44;AF=0.06,0.56,0.00;MQM=60;SAP=15;ABP=82;SAR=12;SAF=3	NTRK1	intron	NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron12/16:c.1321+69_1321+70dup::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron13/17:c.1321+69_1321+70dup::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70dup::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70dup::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70dup::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1291502 [benign DISEASE=not provided];			rs56185968	0.0960	0.2513,0.0546,0.0390,0.0322,0.0509	1280,.	11098	128600				1.16				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156875700	156875700	-	GTGT	wt	wt	het	off-target;low_conf_region	QUAL=932;DP=16,39,44;AF=0.06,0.56,0.00;MQM=60;SAP=24;ABP=3;SAR=19;SAF=4	NTRK1	intron	NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron12/16:c.1321+67_1321+70dup::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron13/17:c.1321+67_1321+70dup::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron11/15:c.1483+67_1483+70dup::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron12/16:c.1501+67_1501+70dup::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+67_1483+70dup::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1236121 [benign DISEASE=not provided];			rs56185968	0.5038	0.3119,0.5285,0.0608,0.6280,0.3190	19739,.	32345	70749				1.11				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156875701	156875702	GT	-	wt	het	wt	off-target;low_conf_region	QUAL=932;DP=16,39,44;AF=0.06,0.03,0.30;MQM=60;SAP=24;ABP=4;SAR=19;SAF=4	NTRK1	intron	NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron12/16:c.1321+69_1321+70del::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron13/17:c.1321+69_1321+70del::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70del::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70del::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70del::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1291500 [benign DISEASE=not provided];		(GT)n (Simple_repeat)	rs56185968	0.1423	0.1645,0.1581,0.3693,0.1082,0.1775	1561,.	17177	122379	0.3490			0.83				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156876441	156876441	G	A	het	hom	wt		QUAL=6437;DP=146,147,146;AF=0.51,1.00,0.00;MQM=60;SAP=50;ABP=3;SAR=76;SAF=145	NTRK1	synonymous	NTRK1:ENST00000392302.7:synonymous_variant:LOW:exon14/17:c.1494G>A:p.Gln498=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000674537.1:synonymous_variant:LOW:exon15/18:c.1494G>A:p.Gln498=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000368196.7:synonymous_variant:LOW:exon13/16:c.1656G>A:p.Gln552=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000524377.7:synonymous_variant:LOW:exon14/17:c.1674G>A:p.Gln558=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000358660.3:synonymous_variant:LOW:exon13/16:c.1665G>A:p.Gln555=:PF07714 [Protein tyrosine and serine/threonine kinase]	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	292889 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not specified,not provided];			rs6334	0.2009	0.1386,0.2262,0.3462,0.2179,0.2399	3221,.	24110	121520	0.2210			8.92			COSV62323674	0	23195334,21178826,29054434,30283335,20003389,29453651,16373086,33004033,31577263	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156879002	156879002	C	T	het	wt	hom	off-target	QUAL=654;DP=24,15,19;AF=0.42,0.00,0.95;MQM=60;SAP=64;ABP=4;SAR=0;SAF=28	NTRK1	intron	NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron14/16:c.1626-120C>T::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron15/17:c.1626-120C>T::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron13/15:c.1788-120C>T::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron14/16:c.1806-120C>T::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron13/15:c.1797-120C>T::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667763 [benign DISEASE=not provided];			rs2768756	0.5213	0.1742,0.5551,0.0491,0.7238,0.3709	25601,.	28014	72738	-0.1740			3.70			COSV62329334	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156879016	156879016	T	C	het	het	hom	off-target	QUAL=933;DP=27,17,22;AF=0.41,0.41,1.00;MQM=60;SAP=90;ABP=6;SAR=0;SAF=40	NTRK1	intron	NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron14/16:c.1626-106T>C::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron15/17:c.1626-106T>C::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron13/15:c.1788-106T>C::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron14/16:c.1806-106T>C::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron13/15:c.1797-106T>C::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667764 [benign DISEASE=not provided];			rs2768757	0.7956	0.6803,0.7905,0.3894,0.8915,0.5560	49400,.	22092	31056	-1.5260			0.13			COSV62328512	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156879203	156879203	C	T	het	wt	hom		QUAL=3877;DP=48,104,128;AF=0.33,0.01,0.97;MQM=60;SAP=11;ABP=15;SAR=59;SAF=82	NTRK1	synonymous	NTRK1:ENST00000392302.7:synonymous_variant:LOW:exon15/17:c.1707C>T:p.Ala569=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000674537.1:synonymous_variant:LOW:exon16/18:c.1707C>T:p.Ala569=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000368196.7:synonymous_variant:LOW:exon14/16:c.1869C>T:p.Ala623=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000524377.7:synonymous_variant:LOW:exon15/17:c.1887C>T:p.Ala629=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000358660.3:synonymous_variant:LOW:exon14/16:c.1878C>T:p.Ala626=:PF07714 [Protein tyrosine and serine/threonine kinase]		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	138564 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not specified];			rs6337	0.5331	0.2143,0.5586,0.0503,0.7240,0.3707	25959,.	29030	70892	-3.9860			1.64			COSV62325231	0.04	26384852,20003389,16373086,33986442	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156880312	156880312	G	C	het	het	hom	off-target	QUAL=1424;DP=19,25,29;AF=0.58,0.56,1.00;MQM=60;SAP=120;ABP=5;SAR=54;SAF=0	NTRK1	intron	NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron16/16:c.2025+155G>C::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron17/17:c.2025+155G>C::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron15/15:c.2187+155G>C::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron16/16:c.2205+155G>C::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron15/15:c.2196+155G>C::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667765 [benign DISEASE=not provided];			rs2274499	0.8280	0.6719,0.8382,0.4740,0.9327,0.6858	53395,.	18751	26085	0.0000			2.51				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156880320	156880320	T	G	het	het	hom	off-target	QUAL=1478;DP=17,26,31;AF=0.65,0.54,1.00;MQM=60;SAP=125;ABP=5;SAR=56;SAF=0	NTRK1	intron	NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron16/16:c.2025+163T>G::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron17/17:c.2025+163T>G::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron15/15:c.2187+163T>G::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron16/16:c.2205+163T>G::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron15/15:c.2196+163T>G::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667766 [benign DISEASE=not provided];			rs2274500	0.8282	0.6719,0.8385,0.4731,0.9332,0.6858	53434,.	18723	26061	-3.5770			0.10				0.04	29029385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156881249	156881249	T	G	hom	n/a	n/a	off-target	QUAL=244;DP=6,1,2;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0;SAR=0;SAF=9	NTRK1	intron	NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron16/16:c.2026-208T>G::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron17/17:c.2026-208T>G::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron15/15:c.2188-208T>G::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron16/16:c.2206-208T>G::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron15/15:c.2197-208T>G::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	670556 [benign DISEASE=not provided];			rs2768758	0.9797	0.9287,0.9936,1.0000,0.9999,0.9998	73136,.	2823	3087	-0.4380			3.40				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	160039331	160039331	A	C	het	het	wt		QUAL=3042;DP=172,68,80;AF=0.50,0.46,0.00;MQM=60;SAP=7;ABP=3;SAR=51;SAF=66	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1171T>G::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2715T>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2062T>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2062T>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2062T>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293090 [benign DISEASE=Autosomal recessive nonsyndromic hearing loss 4,EAST syndrome,not provided];			rs1053074	0.4563	0.6135,0.4433,0.3345,0.3984,0.4692	16600,.	35475	81821	1.6730			8.27			COSV63635370	0	16451705,25874548,32021205,19864112,17660461	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039353	160039353	G	C	hom	hom	hom		QUAL=8538;DP=143,59,69;AF=1.00,0.97,1.00;MQM=60;SAP=24;ABP=0;SAR=109;SAF=160	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1149C>G::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2693C>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2040C>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2040C>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2040C>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293091 [benign DISEASE=Autosomal recessive nonsyndromic hearing loss 4,EAST syndrome,not provided];			rs2486254	0.9977	0.9920,0.9988,1.0000,0.9999,1.0000	74911,.	350	354	0.1670			3.99				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039374	160039375	AC	-	wt	wt	het		QUAL=1024;DP=15,37,41;AF=0.33,0.46,0.07;MQM=60;SAP=6;ABP=16;SAR=12;SAF=7	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1127_587+1128del::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2671_487+2672del::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2018_*2019del::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2018_*2019del::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2018_*2019del::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293094 [uncertain significance(replaced by megSAP based on classifications:1x1,3x3) DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed,not provided];		(AC)n (Simple_repeat)	rs56656397	0.1202	0.0846,0.1176,0.0572,0.1436,0.1039	987,.	14167	118131	0.6770			0.96				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039374	160039377	ACAC	-	wt	het	wt		QUAL=1024;DP=15,37,41;AF=0.33,0.46,0.07;MQM=60;SAP=6;ABP=39;SAR=8;SAF=13	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1125_587+1128del::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2669_487+2672del::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2016_*2019del::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2016_*2019del::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2016_*2019del::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293095 [benign/likely benign DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed,not provided];		(AC)n (Simple_repeat)	rs56656397	0.1668	0.1768,0.2380,0.1774,0.1489,0.1091	1898,.	18601	111851	0.6770			5.44				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039374	160039379	ACACAC	-	het	het	wt		QUAL=1024;DP=15,37,41;AF=0.33,0.46,0.07;MQM=60;SAP=5;ABP=46;SAR=15;SAF=10	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1123_587+1128del::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2667_487+2672del::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2014_*2019del::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2014_*2019del::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2014_*2019del::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293097 [uncertain significance(replaced by megSAP based on classifications:1x1,3x3) DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed,not provided];		(AC)n (Simple_repeat)	rs56656397	0.0898	0.1277,0.0632,0.0635,0.0807,0.0725	549,.	10978	122382	0.6770			5.31				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039629	160039629	A	C	hom	hom	hom		QUAL=31991;DP=368,263,345;AF=1.00,1.00,1.00;MQM=60;SAP=37;ABP=0;SAR=426;SAF=550	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+873T>G::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2417T>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1764T>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1764T>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1764T>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293102 [benign DISEASE=Autosomal recessive nonsyndromic hearing loss 4,EAST syndrome,not provided];			rs2486253	0.8189	0.8179,0.8263,0.9609,0.8053,0.8230	51070,.	22339	27535	0.2820			7.94			COSV105294526	0	25008907,32021205,33187755	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160040361	160040361	C	T	wt	het	wt		QUAL=2265;DP=332,195,282;AF=0.00,0.50,0.00;MQM=60;SAP=6;ABP=3;SAR=54;SAF=43	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+141G>A::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+1685G>A::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1032G>A::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1032G>A::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1032G>A::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	874513 [benign/likely benign DISEASE=Autosomal recessive nonsyndromic hearing loss 4,EAST syndrome];			rs17375748	0.0447	0.0116,0.0356,0.0006,0.0683,0.0232	208,.	6388	145408	0.2860			1.55				0	28520217,33096746,33462668	2	33	0 / 0					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160042703	160042703	G	A	wt	het	het	off-target	QUAL=1668;DP=87,65,94;AF=0.00,0.42,0.54;MQM=60;SAP=172;ABP=3;SAR=78;SAF=0	KCNJ10	intron	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron1/3:c.1-171C>T::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron1/2:c.1-171C>T::,KCNJ10:ENST00000644903.1:intron_variant:MODIFIER:intron1/1:c.1-171C>T::,KCNJ10:ENST00000638728.1:intron_variant:MODIFIER:intron2/2:c.1-171C>T::,KCNJ10:ENST00000638868.1:intron_variant:MODIFIER:intron2/2:c.1-171C>T::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	682044 [benign DISEASE=not provided];		AluSx (SINE/Alu)	rs3120973	0.2382	0.0623,0.2391,0.3240,0.3155,0.2302	5339,.	25536	115794	-1.1120			0.25				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160069869	160069869	G	A	wt	het	wt	off-target	QUAL=161;DP=17,27,39;AF=0.00,0.37,0.00;MQM=60;SAP=25;ABP=7;SAR=0;SAF=10	KCNJ10	intron	KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron1/3:c.-1+153C>T::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron1/2:c.-1+153C>T::,KCNJ10:ENST00000644903.1:intron_variant:MODIFIER:intron1/1:c.-1+153C>T::,KCNJ10:ENST00000638728.1:intron_variant:MODIFIER:intron1/2:c.-67+153C>T::	regulatory_region_variant:promoter	602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	1253634 [benign DISEASE=not provided];			rs2820585	0.2185	0.0563,0.2157,0.2256,0.2966,0.1945	4528,.	24172	118842	-0.1510			4.76				0	32021205,19864112,33096746	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160276695	160276695	C	T	het	het	n/a	off-target	QUAL=246;DP=30,4,0;AF=0.40,0.25,;MQM=60;SAP=31;ABP=7;SAR=0;SAF=13	PEX19	downstream_gene	PEX19:ENST00000368072.10:downstream_gene_variant:MODIFIER::::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]				rs1557524	0.4550	0.3501,0.4760,0.3446,0.5040,0.6096	16108,.	36875	82747	0.2290			2.95				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	160277200	160277200	T	-	het	het	het		QUAL=1365;DP=292,136,193;AF=0.18,0.22,0.17;MQM=60;SAP=3;ABP=538;SAR=57;SAF=58	PEX19	3'UTR	PEX19:ENST00000368072.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2351del::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]			Charlie10 (DNA/hAT-Charlie)	rs751979135	0.0011	0.0006,0.0006,0.0004,0.0009,0.0004	0,.	164	144762	-0.5870			0.23				0.01		0	6	0 / 0					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	160277395	160277395	G	C	het	wt	hom		QUAL=10190;DP=282,165,217;AF=0.44,0.01,1.00;MQM=60;SAP=12;ABP=13;SAR=190;SAF=152	PEX19	3'UTR	PEX19:ENST00000368072.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2156C>G::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]	293196 [benign DISEASE=Peroxisome biogenesis disorder 12A (Zellweger)];		Charlie10 (DNA/hAT-Charlie)	rs10594	0.4553	0.3503,0.4767,0.3458,0.5040,0.6103	16142,.	36891	82771	0.4650			3.34			COSV63619513	0.18	20819849,16451705,19001172,25284319	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	160282002	160282002	A	G	het	wt	hom	off-target	QUAL=6879;DP=209,91,148;AF=0.44,0.00,1.00;MQM=60;SAP=298;ABP=9;SAR=30;SAF=211	PEX19	intron	PEX19:ENST00000368072.10:intron_variant:MODIFIER:intron5/7:c.594+37T>C::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]	1227462 [benign DISEASE=Peroxisome biogenesis disorder 12A (Zellweger),not provided];			rs2795067	0.6435	0.8627,0.5760,0.4658,0.5564,0.7055	32988,.	31799	54179	-1.4240			0.16			COSV63619299	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	161167557	161167557	C	T	het	wt	wt	off-target;low_conf_region	QUAL=269;DP=45,35,49;AF=0.51,0.03,0.08;MQM=47;SAP=64;ABP=3;SAR=28;SAF=0	PPOX	intron	PPOX:ENST00000352210.9:intron_variant:MODIFIER:intron4/12:c.338+71C>T::,PPOX:ENST00000367999.9:intron_variant:MODIFIER:intron4/12:c.338+71C>T::,PPOX:ENST00000544598.5:intron_variant:MODIFIER:intron3/5:c.222+323C>T::,PPOX:ENST00000535223.5:intron_variant:MODIFIER:intron2/3:c.87+623C>T::,PPOX:ENST00000462866.5:intron_variant:MODIFIER:intron1/3:c.87+623C>T::	regulatory_region_variant:promoter	600923_[GENE=PPOX_PHENOS=Porphyria variegata, 176200 (3), Autosomal dominant]			AluSx4 (SINE/Alu)	rs141054760	0.0045	0.0048,0.0048,0.0029,0.0046,0.0053	0,.	331	73585	-0.5660			1.01			COSV57087179	0.02		48	49	0 / 0					USP21 (inh=n/a oe_syn=0.95 oe_mis=0.69 oe_lof=0.31), PPOX (inh=AD oe_syn=1.05 oe_mis=0.83 oe_lof=0.30), B4GALT3 (inh=n/a oe_syn=0.94 oe_mis=0.74 oe_lof=0.34)
chr1	161170329	161170329	A	C	het	het	het	off-target;low_conf_region	QUAL=840;DP=29,42,69;AF=0.31,0.69,0.64;MQM=54;SAP=181;ABP=12;SAR=0;SAF=82	PPOX	intron	PPOX:ENST00000352210.9:intron_variant:MODIFIER:intron9/12:c.988-80A>C::,PPOX:ENST00000367999.9:intron_variant:MODIFIER:intron9/12:c.988-80A>C::,PPOX:ENST00000544598.5:intron_variant:MODIFIER:intron3/5:c.223-291A>C::,PPOX:ENST00000535223.5:intron_variant:MODIFIER:intron2/3:c.88-291A>C::,PPOX:ENST00000462866.5:intron_variant:MODIFIER:intron1/3:c.88-291A>C::		600923_[GENE=PPOX_PHENOS=Porphyria variegata, 176200 (3), Autosomal dominant]				rs944809134	0.2472	0.2218,0.1301,0.2007,0.3273,0.2238	0,.	10692	32562	-5.2820			0.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USP21 (inh=n/a oe_syn=0.95 oe_mis=0.69 oe_lof=0.31), PPOX (inh=AD oe_syn=1.05 oe_mis=0.83 oe_lof=0.30), B4GALT3 (inh=n/a oe_syn=0.94 oe_mis=0.74 oe_lof=0.34)
chr1	161170337	161170337	A	C	wt	het	het	off-target	QUAL=198;DP=22,38,58;AF=0.09,0.26,0.28;MQM=57;SAP=64;ABP=47;SAR=0;SAF=28	PPOX	intron	PPOX:ENST00000352210.9:intron_variant:MODIFIER:intron9/12:c.988-72A>C::,PPOX:ENST00000367999.9:intron_variant:MODIFIER:intron9/12:c.988-72A>C::,PPOX:ENST00000544598.5:intron_variant:MODIFIER:intron3/5:c.223-283A>C::,PPOX:ENST00000535223.5:intron_variant:MODIFIER:intron2/3:c.88-283A>C::,PPOX:ENST00000462866.5:intron_variant:MODIFIER:intron1/3:c.88-283A>C::		600923_[GENE=PPOX_PHENOS=Porphyria variegata, 176200 (3), Autosomal dominant]				rs1174445197	0.0203	0.0292,0.0082,0.0118,0.0243,0.0067	0,.	100	4838	-2.4180			0.17				0		0	1	0 / 0					USP21 (inh=n/a oe_syn=0.95 oe_mis=0.69 oe_lof=0.31), PPOX (inh=AD oe_syn=1.05 oe_mis=0.83 oe_lof=0.30), B4GALT3 (inh=n/a oe_syn=0.94 oe_mis=0.74 oe_lof=0.34)
chr1	161170488	161170488	A	-	het	wt	het		QUAL=6439;DP=229,326,376;AF=0.46,0.00,0.46;MQM=60;SAP=80;ABP=12;SAR=89;SAF=188	PPOX	frameshift,intron	PPOX:ENST00000352210.9:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593 [Flavin containing amine oxidoreductase],PPOX:ENST00000367999.9:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593 [Flavin containing amine oxidoreductase],PPOX:ENST00000544598.5:intron_variant:MODIFIER:intron3/5:c.223-132del::,PPOX:ENST00000535223.5:intron_variant:MODIFIER:intron2/3:c.88-132del::,PPOX:ENST00000462866.5:intron_variant:MODIFIER:intron1/3:c.88-132del::		600923_[GENE=PPOX_PHENOS=Porphyria variegata, 176200 (3), Autosomal dominant]										7.2260							0.12		0	2	0 / 0					USP21 (inh=n/a oe_syn=0.95 oe_mis=0.69 oe_lof=0.31), PPOX (inh=AD oe_syn=1.05 oe_mis=0.83 oe_lof=0.30), B4GALT3 (inh=n/a oe_syn=0.94 oe_mis=0.74 oe_lof=0.34)
chr1	161206347	161206347	A	G	wt	wt	het	off-target	QUAL=1224;DP=116,71,91;AF=0.00,0.00,0.58;MQM=60;SAP=110;ABP=8;SAR=1;SAF=52	NDUFS2	intron	NDUFS2:ENST00000677550.1:intron_variant:MODIFIER:intron3/13:c.203-60A>G::,NDUFS2:ENST00000676600.1:intron_variant:MODIFIER:intron3/14:c.203-60A>G::,NDUFS2:ENST00000678507.1:intron_variant:MODIFIER:intron3/14:c.203-60A>G::,NDUFS2:ENST00000677579.1:intron_variant:MODIFIER:intron3/14:c.203-60A>G::,NDUFS2:ENST00000677231.1:intron_variant:MODIFIER:intron3/12:c.203-60A>G::,NDUFS2:ENST00000678911.1:intron_variant:MODIFIER:intron3/13:c.203-60A>G::,NDUFS2:ENST00000677846.1:intron_variant:MODIFIER:intron3/15:c.203-60A>G::,NDUFS2:ENST00000679176.1:intron_variant:MODIFIER:intron3/13:c.203-60A>G::,NDUFS2:ENST00000367993.7:intron_variant:MODIFIER:intron3/14:c.203-60A>G::,NDUFS2:ENST00000392179.5:intron_variant:MODIFIER:intron2/12:c.203-60A>G::,NDUFS2:ENST00000678511.1:intron_variant:MODIFIER:intron3/14:c.203-60A>G::,NDUFS2:ENST00000677453.1:intron_variant:MODIFIER:intron2/14:c.203-60A>G::,NDUFS2:ENST00000678783.1:intron_variant:MODIFIER:intron2/12:c.203-60A>G::,NDUFS2:ENST00000676972.1:intron_variant:MODIFIER:intron2/13:c.203-60A>G::		602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	1229436 [benign DISEASE=not provided];			rs4656993	0.6097	0.6095,0.6759,0.8913,0.5702,0.7465	28598,.	35460	59308	0.2820			5.74				0	23637325,26053550,20406964	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34)
chr1	161212171	161212171	A	-	wt	het	wt	off-target	QUAL=39;DP=21,13,23;AF=0.05,0.31,0.04;MQM=60;SAP=16;ABP=7;SAR=0;SAF=6	NDUFS2	intron	NDUFS2:ENST00000677550.1:intron_variant:MODIFIER:intron10/13:c.987-168del::,NDUFS2:ENST00000676600.1:intron_variant:MODIFIER:intron10/14:c.987-168del::,NDUFS2:ENST00000678507.1:intron_variant:MODIFIER:intron10/14:c.987-168del::,NDUFS2:ENST00000677579.1:intron_variant:MODIFIER:intron10/14:c.987-168del::,NDUFS2:ENST00000677231.1:intron_variant:MODIFIER:intron9/12:c.909-168del::,NDUFS2:ENST00000678911.1:intron_variant:MODIFIER:intron9/13:c.909-168del::,NDUFS2:ENST00000677846.1:intron_variant:MODIFIER:intron10/15:c.987-168del::,NDUFS2:ENST00000679176.1:intron_variant:MODIFIER:intron10/13:c.987-168del::,NDUFS2:ENST00000367993.7:intron_variant:MODIFIER:intron10/14:c.987-168del::,NDUFS2:ENST00000392179.5:intron_variant:MODIFIER:intron9/12:c.987-168del::,NDUFS2:ENST00000678511.1:intron_variant:MODIFIER:intron10/14:c.987-168del::,NDUFS2:ENST00000677453.1:intron_variant:MODIFIER:intron9/14:c.987-168del::,NDUFS2:ENST00000678783.1:intron_variant:MODIFIER:intron8/12:c.912-168del::,NDUFS2:ENST00000676972.1:intron_variant:MODIFIER:intron9/13:c.987-168del::		602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]				rs79986323	0.0011	0.0005,0.0008,0.0021,0.0011,0.0000	0,.	154	136776	0.9320			5.78				0		0	10	0 / 0					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214269	161214269	-	TG	wt	wt	het		QUAL=1662;DP=228,160,212;AF=0.19,0.08,0.13;MQM=60;SAP=69;ABP=729;SAR=62;SAF=14	NDUFS2	3'UTR	NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359dup::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359dup::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107dup::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*106_*107dup::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359dup::,NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359dup::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*106_*107dup::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107dup::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	293284 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Mitochondrial complex I deficiency,not provided];			rs10629771	0.2807	0.3793,0.2735,0.4673,0.2202,0.3199	5962,.	29248	105488				1.48				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214269	161214269	-	TGTG	wt	het	wt		QUAL=1662;DP=228,160,212;AF=0.19,0.08,0.13;MQM=60;SAP=42;ABP=454;SAR=38;SAF=9	NDUFS2	3'UTR	NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*356_*359dup::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*356_*359dup::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*104_*107dup::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*104_*107dup::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*356_*359dup::,NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*356_*359dup::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*104_*107dup::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*104_*107dup::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	1253405 [benign DISEASE=not provided];			rs10629771	0.1292	0.0836,0.1266,0.0305,0.1564,0.1061	1280,.	16401	127849				1.43				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214270	161214271	TG	-	het	wt	wt		QUAL=1662;DP=228,160,212;AF=0.02,0.08,0.27;MQM=60;SAP=92;ABP=691;SAR=70;SAF=12	NDUFS2	3'UTR	NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359del::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359del::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107del::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*106_*107del::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359del::,NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359del::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*106_*107del::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107del::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	293286 [uncertain significance DISEASE=Mitochondrial complex I deficiency];		(TG)n (Simple_repeat)	rs10629771	0.0013	0.0013,0.0003,0.0004,0.0009,0.0087	0,.	194	146494	0.3460			2.26				0		1	38	0 / 0					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214307	161214307	A	G	wt	wt	het		QUAL=2153;DP=361,186,251;AF=0.00,0.00,0.39;MQM=60;SAP=112;ABP=29;SAR=84;SAF=14	NDUFS2	3'UTR	NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*366A>G::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*366A>G::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*114A>G::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*114A>G::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*366A>G::,NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*366A>G::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*114A>G::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*114A>G::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	293289 [benign DISEASE=Mitochondrial complex I deficiency, nuclear type 1,not provided];			rs1136224	0.1418	0.0443,0.1924,0.3014,0.1556,0.2952	1776,.	16859	123515	-0.8360			1.40				0	18682780,22545919,30782949,26053550,32450446	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161304858	161304858	G	C	wt	het	het		QUAL=71;DP=35,28,33;AF=0.00,0.29,0.30;MQM=60;SAP=42;ABP=25;SAR=0;SAF=18	MPZ	3'UTR	MPZ:ENST00000533357.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1018C>G::,MPZ:ENST00000672602.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*826C>G::,MPZ:ENST00000491222.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1018C>G::,MPZ:ENST00000672287.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1018C>G::	regulatory_region_variant:promoter	159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]				rs185093979	0.2822	0.2122,0.1774,0.2416,0.3751,0.2747	1,.	20069	51057	-0.5840			0.46				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	161305115	161305115	T	C	wt	het	wt		QUAL=172;DP=68,29,18;AF=0.00,0.38,0.00;MQM=60;SAP=3;ABP=7;SAR=6;SAF=5	MPZ	3'UTR	MPZ:ENST00000533357.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*761A>G::,MPZ:ENST00000672602.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*569A>G::,MPZ:ENST00000491222.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*761A>G::,MPZ:ENST00000672287.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*761A>G::	regulatory_region_variant:promoter	159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]	293304 [benign DISEASE=Charcot-Marie-Tooth disease type 1B,Roussy-Levy syndrome,Charcot-Marie-Tooth disease type 4E,Charcot-Marie-Tooth disease dominant intermediate D,Neuropathy, congenital hypomyelinating, 2,not provided];			rs16832786	0.1292	0.2207,0.0842,0.0413,0.1042,0.1483	1547,.	16520	132212	-1.1360			2.00				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	161306644	161306644	A	G	hom	hom	hom	off-target	QUAL=12504;DP=180,88,126;AF=1.00,1.00,1.00;MQM=60;SAP=32;ABP=0;SAR=161;SAF=233	MPZ	intron	MPZ:ENST00000533357.5:intron_variant:MODIFIER:intron3/5:c.448+64T>C::,MPZ:ENST00000672602.2:intron_variant:MODIFIER:intron3/5:c.448+64T>C::,MPZ:ENST00000491222.5:intron_variant:MODIFIER:intron2/4:c.-141+64T>C::,MPZ:ENST00000672287.2:intron_variant:MODIFIER:intron2/4:c.-141+64T>C::,MPZ:ENST00000526189.3:intron_variant:MODIFIER:intron3/5:c.367+145T>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]	683189 [benign DISEASE=not provided];			rs6674383	1.0000	1.0000,1.0000,1.0000,1.0000,1.0000	76078,.	0	0	-1.2910			0.63				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	161307006	161307006	G	A	het	wt	wt	off-target	QUAL=73;DP=77,15,15;AF=0.31,0.00,0.07;MQM=51;SAP=57;ABP=27;SAR=25;SAF=0	MPZ	intron	MPZ:ENST00000533357.5:intron_variant:MODIFIER:intron2/5:c.235-85C>T::,MPZ:ENST00000672602.2:intron_variant:MODIFIER:intron2/5:c.235-85C>T::,MPZ:ENST00000491222.5:intron_variant:MODIFIER:intron1/4:c.-354-85C>T::,MPZ:ENST00000672287.2:intron_variant:MODIFIER:intron1/4:c.-354-85C>T::,MPZ:ENST00000526189.3:intron_variant:MODIFIER:intron2/5:c.235-85C>T::	regulatory_region_variant:promoter	159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]			(A)n (Simple_repeat)	rs76800398	0.0147	0.0107,0.0127,0.0102,0.0180,0.0029	0,.	115	7685	0.8930			2.50				0		0	0	0 / 0					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	161309728	161309728	T	C	wt	het	n/a	off-target	QUAL=41;DP=8,4,1;AF=0.00,0.75,0.00;MQM=60;SAP=10;ABP=5;SAR=0;SAF=3	MPZ	intron	MPZ:ENST00000533357.5:intron_variant:MODIFIER:intron1/5:c.67+111A>G::,MPZ:ENST00000672602.2:intron_variant:MODIFIER:intron1/5:c.67+111A>G::,MPZ:ENST00000526189.3:intron_variant:MODIFIER:intron1/5:c.67+111A>G::		159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]&602413_[GENE=SDHC_PHENOS=Paragangliomas 3, 605373 (3), Autosomal dominant; Paraganglioma and gastric stromal sarcoma, 606864 (3); Gastrointestinal stromal tumor, 606764 (3), Isolated cases, Autosomal dominant]	667646 [benign DISEASE=not provided];			rs11579939	0.0792	0.0516,0.0669,0.0033,0.1066,0.1000	560,.	10867	139401	0.0980			13.94				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25), SDHC (inh=AD oe_syn=1.04 oe_mis=0.76 oe_lof=0.67)
chr1	167430497	167430497	A	C	het	het	wt	off-target	QUAL=1877;DP=120,40,51;AF=0.52,0.48,0.00;MQM=60;SAP=179;ABP=3;SAR=0;SAF=81	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2527T>G::	regulatory_region_variant:enhancer,TF_binding_site_variant	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs870875	0.3681	0.3008,0.4694,0.4300,0.3606,0.4548	10608,.	34779	96107	-0.7870			0.38					25569266,23936387	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430524	167430524	T	G	hom	hom	hom	off-target	QUAL=6793;DP=113,53,65;AF=1.00,1.00,1.00;MQM=60;SAP=505;ABP=0;SAR=0;SAF=231	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2500A>C::	regulatory_region_variant:enhancer	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs870876	0.8605	0.7964,0.8877,0.7662,0.8853,0.9075	56559,.	17813	21227	-1.5450			1.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430631	167430631	-	AG	hom	hom	hom		QUAL=15215;DP=189,147,177;AF=0.99,0.99,0.99;MQM=60;SAP=781;ABP=0;SAR=41;SAF=468	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2391_429+2392dup::	regulatory_region_variant:enhancer	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs5778549	0.9877	0.9583,0.9927,0.9998,0.9998,0.9994	74289,.	1791	1873				0.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430725	167430725	T	C	hom	hom	hom		QUAL=39572;DP=382,380,464;AF=1.00,1.00,1.00;MQM=60;SAP=331;ABP=0;SAR=398;SAF=828	CD247	intron,3'UTR	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2299A>G::,CD247:ENST00000392122.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:ENST00000700155.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*956A>G::,CD247:ENST00000470379.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*956A>G::,CD247:ENST00000700156.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700157.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700158.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:ENST00000362089.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:ENST00000700106.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:ENST00000700165.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700134.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700107.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:ENST00000700159.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700160.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:ENST00000700108.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:ENST00000700109.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::	regulatory_region_variant:enhancer	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs947480	0.9877	0.9584,0.9927,1.0000,0.9998,0.9994	74309,.	1788	1868	-1.3400			1.51				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430837	167430837	T	A	hom	hom	hom		QUAL=44558;DP=402,433,558;AF=1.00,1.00,1.00;MQM=60;SAP=15;ABP=0;SAR=739;SAF=653	CD247	intron,3'UTR	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2187A>T::,CD247:ENST00000392122.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:ENST00000700155.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*844A>T::,CD247:ENST00000470379.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*844A>T::,CD247:ENST00000700156.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700157.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700158.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:ENST00000362089.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:ENST00000700106.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:ENST00000700165.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700134.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700107.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:ENST00000700159.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700160.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:ENST00000700108.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:ENST00000700109.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::	regulatory_region_variant:enhancer,TF_binding_site_variant	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs1052231	0.8188	0.7591,0.8600,0.7646,0.8364,0.8685	51196,.	22197	27575	-0.1800			2.97				0	25569266,18178846,30064597,19422667,23861880,34233083,33902375	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167434267	167434267	A	G	hom	hom	hom	off-target	QUAL=3729;DP=88,20,22;AF=1.00,1.00,1.00;MQM=60;SAP=285;ABP=0;SAR=130;SAF=0	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron5/7:c.337-191T>C::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron5/7:c.334-191T>C::,CD247:ENST00000700155.1:intron_variant:MODIFIER:intron3/4:c.52-191T>C::,CD247:ENST00000470379.2:intron_variant:MODIFIER:intron3/5:c.49-191T>C::,CD247:ENST00000700156.1:intron_variant:MODIFIER:intron4/6:c.49-191T>C::,CD247:ENST00000700157.1:intron_variant:MODIFIER:intron4/6:c.178-191T>C::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron5/7:c.49-191T>C::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron5/7:c.337-191T>C::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron6/8:c.361-191T>C::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron5/6:c.337-191T>C::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron4/6:c.253-191T>C::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron6/8:c.358-191T>C::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron5/6:c.334-191T>C::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron6/8:c.49-191T>C::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron6/8:c.49-191T>C::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron6/8:c.52-191T>C::,CD247:ENST00000476733.6:intron_variant:MODIFIER:intron3/5:c.52-191T>C::		186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1259945 [benign DISEASE=not provided];			rs952962	0.8629	0.8032,0.8901,0.7668,0.8858,0.9086	56763,.	17673	20853	-1.3100			0.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167438449	167438449	T	C	hom	hom	hom	off-target	QUAL=11097;DP=160,104,111;AF=1.00,1.00,1.00;MQM=60;SAP=817;ABP=0;SAR=0;SAF=375	CD247	intron,missense	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron4/7:c.300+121A>G::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron4/7:c.300+121A>G::,CD247:ENST00000700155.1:intron_variant:MODIFIER:intron2/4:c.15+121A>G::,CD247:ENST00000470379.2:intron_variant:MODIFIER:intron2/5:c.15+121A>G::,CD247:ENST00000700156.1:intron_variant:MODIFIER:intron3/6:c.15+121A>G::,CD247:ENST00000700157.1:intron_variant:MODIFIER:intron3/6:c.144+121A>G::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron4/7:c.15+121A>G::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron4/7:c.300+121A>G::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron5/8:c.324+121A>G::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron4/6:c.300+121A>G::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron4/6:c.252+169A>G::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron5/8:c.324+121A>G::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron4/6:c.300+121A>G::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron5/8:c.15+121A>G::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron5/8:c.15+121A>G::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron5/8:c.15+121A>G::,CD247:ENST00000476733.6:intron_variant:MODIFIER:intron2/5:c.15+121A>G::,CD247:ENST00000700161.1:missense_variant:MODERATE:exon2/2:c.136A>G:p.Arg46Gly:,CD247:ENST00000700142.1:missense_variant:MODERATE:exon4/4:c.421A>G:p.Arg141Gly:		186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1192703 [benign DISEASE=Immunodeficiency 25,not provided];			rs2462553	0.8655	0.8076,0.8913,0.7743,0.8881,0.9082	57110,.	17375	20443	-2.3710			0.12				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167438836	167438836	C	A	hom	hom	hom	off-target	QUAL=6321;DP=116,39,56;AF=1.00,1.00,1.00;MQM=60;SAP=419;ABP=0;SAR=206;SAF=5	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron3/7:c.220-186G>T::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron3/7:c.220-186G>T::,CD247:ENST00000700155.1:intron_variant:MODIFIER:intron1/4:c.-66-186G>T::,CD247:ENST00000470379.2:intron_variant:MODIFIER:intron1/5:c.-66-186G>T::,CD247:ENST00000700156.1:intron_variant:MODIFIER:intron2/6:c.-66-186G>T::,CD247:ENST00000700157.1:intron_variant:MODIFIER:intron2/6:c.64-186G>T::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron3/7:c.-66-186G>T::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron3/7:c.220-186G>T::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron4/8:c.244-186G>T::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron3/6:c.220-186G>T::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron3/6:c.220-186G>T::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron4/8:c.244-186G>T::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron3/6:c.220-186G>T::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron4/8:c.-66-186G>T::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron4/8:c.-66-186G>T::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron4/8:c.-66-186G>T::,CD247:ENST00000476733.6:intron_variant:MODIFIER:intron1/5:c.-66-186G>T::,CD247:ENST00000700161.1:intron_variant:MODIFIER:intron1/1:c.-66-186G>T::,CD247:ENST00000700142.1:intron_variant:MODIFIER:intron3/3:c.220-186G>T::		186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1258083 [benign DISEASE=not provided];			rs2258497	0.8601	0.8226,0.8790,0.7755,0.8731,0.8915	56310,.	18103	21271	-1.1210			0.32			COSV62979487	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167439433	167439433	C	T	het	het	hom	off-target	QUAL=11562;DP=76,218,288;AF=0.54,0.49,0.99;MQM=60;SAP=166;ABP=3;SAR=306;SAF=126	CD247	intron,5'UTR	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:ENST00000700155.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-156G>A::,CD247:ENST00000470379.2:5_prime_UTR_variant:MODIFIER:exon1/6:c.-156G>A::,CD247:ENST00000700156.1:intron_variant:MODIFIER:intron1/6:c.-123-33G>A::,CD247:ENST00000700157.1:intron_variant:MODIFIER:intron1/6:c.7-33G>A::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron2/7:c.-123-33G>A::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron3/8:c.187-33G>A::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron2/6:c.163-33G>A::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron2/6:c.163-33G>A::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron3/8:c.187-33G>A::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron2/6:c.163-33G>A::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron3/8:c.-123-33G>A::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron3/8:c.-123-33G>A::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron3/8:c.-123-33G>A::,CD247:ENST00000476733.6:5_prime_UTR_variant:MODIFIER:exon1/6:c.-156G>A::,CD247:ENST00000700161.1:5_prime_UTR_variant:MODIFIER:exon1/2:c.-156G>A::,CD247:ENST00000700142.1:intron_variant:MODIFIER:intron2/3:c.163-33G>A::	regulatory_region_variant:promoter	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1179252 [benign DISEASE=not provided];			rs840016	0.2827	0.0879,0.3062,0.1048,0.4032,0.2919	7499,.	28012	109122	0.5350			10.89			COSV62980812	0	20453842,20933377,22294642,22355377,26119816,33344378	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167440943	167440943	C	T	wt	wt	het	off-target	QUAL=1159;DP=114,78,109;AF=0.00,0.00,0.50;MQM=60;SAP=122;ABP=3;SAR=55;SAF=0	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron1/7:c.59-176G>A::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron1/7:c.59-176G>A::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron1/7:c.-227-176G>A::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron1/7:c.59-176G>A::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron2/8:c.83-176G>A::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron1/6:c.59-176G>A::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron1/6:c.59-176G>A::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron2/8:c.83-176G>A::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron1/6:c.59-176G>A::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron2/8:c.-227-176G>A::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron2/8:c.-227-176G>A::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron2/8:c.-227-176G>A::,CD247:ENST00000700142.1:intron_variant:MODIFIER:intron1/3:c.59-176G>A::		186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs75534980	0.0132	0.0025,0.0141,0.0000,0.0196,0.0029	33,.	1942	150194	0.2630			3.51				0.02		4	236	0 / 0					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167518349	167518349	C	G	het	het	wt	off-target	QUAL=1448;DP=49,67,87;AF=0.53,0.55,0.00;MQM=60;SAP=115;ABP=5;SAR=3;SAF=60	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron1/8:c.-64+59G>C::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron1/6:c.58+59G>C::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron1/6:c.58+59G>C::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron1/8:c.-64+59G>C::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron1/6:c.58+59G>C::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron1/8:c.-327+59G>C::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron1/8:c.-537+59G>C::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron1/8:c.-537+59G>C::,CD247:ENST00000700142.1:intron_variant:MODIFIER:intron1/3:c.58+59G>C::	regulatory_region_variant:promoter	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1237879 [benign DISEASE=not provided];		(CCACTC)n (Simple_repeat)	rs35864197	0.1429	0.0756,0.1295,0.0179,0.1884,0.2394	1771,.	18179	130325	0.8050			6.53				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39), AKR1D1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	173825449	173825449	C	T	wt	wt	het	off-target	QUAL=200;DP=37,23,34;AF=0.00,0.04,0.41;MQM=60;SAP=36;ABP=5;SAR=15;SAF=0	DARS2	intron	DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron1/13:c.127+93C>T::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron1/15:c.127+93C>T::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron1/14:c.127+93C>T::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron1/16:c.127+93C>T::,DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron1/15:c.127+93C>T::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron1/13:c.127+93C>T::	regulatory_region_variant:promoter	610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]				rs146050880	0.0309	0.0135,0.0264,0.0047,0.0414,0.0346	83,.	4260	138840	-1.6540			2.12			COSV53408650	0		0	24	0 / 0					CENPL (inh=n/a oe_syn=0.92 oe_mis=0.84 oe_lof=0.30), DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173826666	173826666	T	-	het	het	het	off-target;low_conf_region	QUAL=777;DP=119,21,45;AF=0.22,0.33,0.22;MQM=60;SAP=96;ABP=118;SAR=0;SAF=43	DARS2	splice_region&intron	DARS2:ENST00000648960.1:splice_region_variant&intron_variant:LOW:intron1/13:c.128-5del::,DARS2:ENST00000648807.1:splice_region_variant&intron_variant:LOW:intron1/15:c.128-5del::,DARS2:ENST00000649067.1:splice_region_variant&intron_variant:LOW:intron1/14:c.128-5del::,DARS2:ENST00000649689.2:splice_region_variant&intron_variant:LOW:intron1/16:c.128-5del::,DARS2:ENST00000647645.1:splice_region_variant&intron_variant:LOW:intron1/15:c.128-5del::,DARS2:ENST00000648458.1:splice_region_variant&intron_variant:LOW:intron1/13:c.128-5del::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]	559192 [benign DISEASE=not provided];		(T)n (Simple_repeat)	rs746151025	0.0114	0.0055,0.0124,0.0214,0.0131,0.0078	4,.	1456	127406	0.0210			1.78				0.04		0	144	0 / 0					CENPL (inh=n/a oe_syn=0.92 oe_mis=0.84 oe_lof=0.30), DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173838019	173838019	C	T	wt	wt	het	off-target	QUAL=644;DP=85,49,57;AF=0.00,0.00,0.51;MQM=60;SAP=66;ABP=3;SAR=0;SAF=29	DARS2	intron	DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron8/13:c.771-171C>T::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron8/15:c.771-171C>T::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron8/14:c.771-171C>T::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron8/16:c.771-171C>T::,DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron8/15:c.771-171C>T::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron8/13:c.771-171C>T::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]	683703 [benign DISEASE=not provided];		AluSg (SINE/Alu)	rs3791021	0.1875	0.3953,0.1227,0.3188,0.0921,0.1044	4119,.	20262	123490	-1.5910			0.42				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173845120	173845120	T	C	wt	wt	het	off-target	QUAL=408;DP=120,33,41;AF=0.00,0.00,0.49;MQM=60;SAP=46;ABP=3;SAR=0;SAF=20	DARS2	intron	DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron11/13:c.1129-109T>C::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron11/15:c.1129-109T>C::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron11/14:c.1129-109T>C::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron11/16:c.1129-109T>C::,DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron11/15:c.1128+4147T>C::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron11/13:c.1129-109T>C::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]	671620 [benign DISEASE=not provided];			rs77124001	0.0824	0.0394,0.0755,0.3152,0.0889,0.1004	744,.	11037	139569	-0.1400			2.41			COSV53406344	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173850284	173850284	A	-	het	het	het	off-target;low_conf_region	QUAL=443;DP=66,19,29;AF=0.23,0.26,0.24;MQM=60;SAP=62;ABP=72;SAR=0;SAF=27	DARS2	intron	DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron12/13:c.1191+5007del::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron12/15:c.1192-3051del::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron12/14:c.1192-3051del::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron12/16:c.1192-29del::,DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron11/15:c.1129-29del::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron12/13:c.1192-29del::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]				rs199872112	0.0013	0.0012,0.0008,0.0010,0.0014,0.0017	0,.	153	115811	-2.2710			0.11				0		0	104	0 / 0					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173850606	173850606	T	-	het	het	het	off-target	QUAL=201;DP=48,18,25;AF=0.27,0.28,0.16;MQM=59;SAP=51;ABP=56;SAR=22;SAF=0	DARS2	intron	DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron12/13:c.1191+5330del::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron12/15:c.1192-2728del::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron12/14:c.1192-2728del::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron13/16:c.1344+142del::,DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron12/15:c.1281+142del::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron13/13:c.1344+142del::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]	1201456 [likely benign DISEASE=not provided];		AluSx (SINE/Alu)	rs66665709	0.0041	0.0006,0.0041,0.0023,0.0036,0.0020	0,.	578	141250	2.0850			5.40				0		1	19	0 / 0					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	179550354	179550354	G	A	hom	hom	hom	off-target	QUAL=694;DP=16,5,3;AF=1.00,1.00,1.00;MQM=60;SAP=55;ABP=0;SAR=0;SAF=24	AXDND1	intron	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-4158G>A::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-4158G>A::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]				rs3767840	0.6142	0.6037,0.6386,0.4693,0.6251,0.5914	28791,.	35662	58576	0.0230			5.93				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179550503	179550506	TTTC	-	wt	wt	het	off-target	QUAL=485;DP=124,52,58;AF=0.00,0.00,0.41;MQM=60;SAP=55;ABP=7;SAR=0;SAF=24	AXDND1	intron	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-4006_*1207-4003del::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-4006_3032-4003del::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]				rs147171656	0.2023	0.0693,0.2028,0.0493,0.2723,0.1926	3759,.	23206	121150	0.8130			9.71				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179550745	179550745	T	C	hom	hom	hom		QUAL=27861;DP=267,272,327;AF=1.00,1.00,1.00;MQM=60;SAP=214;ABP=0;SAR=578;SAF=288	AXDND1,NPHS2	intron,3'UTR	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3767T>C::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3767T>C::,NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*428A>G::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*428A>G::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224486 [benign DISEASE=Nephrotic syndrome, type 2];			rs1060775	0.9045	0.8419,0.9358,0.9639,0.9297,0.8777	62357,.	12792	14520	0.2640			3.71				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179550915	179550915	T	C	het	hom	wt		QUAL=7961;DP=328,121,177;AF=0.45,1.00,0.00;MQM=60;SAP=42;ABP=9;SAR=100;SAF=170	AXDND1,NPHS2	intron,3'UTR	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3597T>C::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3597T>C::,NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*258A>G::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*258A>G::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224485 [benign DISEASE=Nephrotic syndrome, type 2,not provided];			rs2274622	0.2418	0.1273,0.3025,0.3559,0.2811,0.3507	4892,.	26967	115233	0.2590			6.33				0	17942957	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551016	179551016	C	T	hom	hom	hom		QUAL=24187;DP=285,194,263;AF=1.00,1.00,0.99;MQM=60;SAP=29;ABP=0;SAR=323;SAF=417	AXDND1,NPHS2	intron,3'UTR	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3496C>T::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3496C>T::,NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*157G>A::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*157G>A::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224483 [benign DISEASE=Nephrotic syndrome, type 2,not provided];			rs1410590	0.9072	0.8516,0.9366,0.9636,0.9297,0.8780	62758,.	12506	14114	-1.5440			0.37				0	23269701,17236131	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551119	179551119	C	G	hom	hom	hom		QUAL=22283;DP=391,131,174;AF=0.99,0.99,0.99;MQM=60;SAP=195;ABP=0;SAR=469;SAF=222	AXDND1,NPHS2	intron,3'UTR	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3393C>G::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3393C>G::,NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*54G>C::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*54G>C::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	293845 [benign DISEASE=Nephrotic syndrome, type 2,not provided];			rs1410591	0.6147	0.6039,0.6383,0.4681,0.6265,0.5911	28851,.	35685	58533	0.9520			5.38			COSV62634863	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551371	179551371	G	A	hom	hom	hom		QUAL=20877;DP=349,128,184;AF=0.99,0.99,1.00;MQM=60;SAP=27;ABP=0;SAR=286;SAF=371	AXDND1,NPHS2	intron,synonymous	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3141G>A::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3141G>A::,NPHS2:ENST00000367615.9:synonymous_variant:LOW:exon8/8:c.954C>T:p.Ala318=:,NPHS2:ENST00000367616.4:synonymous_variant:LOW:exon7/7:c.750C>T:p.Ala250=:	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260432 [benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, type 2,not specified,not provided];			rs1410592	0.6140	0.6039,0.6382,0.4677,0.6252,0.5912	28786,.	35685	58617	-0.5620			2.36			COSV62634578	0	25741868,20947785,31754646,24070238	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179552549	179552549	T	C	het	wt	het	off-target	QUAL=3037;DP=147,83,124;AF=0.44,0.00,0.47;MQM=60;SAP=156;ABP=8;SAR=15;SAF=108	AXDND1,NPHS2	intron	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-1963T>C::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-1963T>C::,NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron7/7:c.873+54A>G::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron6/6:c.669+54A>G::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1227202 [benign DISEASE=not provided];			rs11808359	0.0468	0.0116,0.0328,0.0000,0.0700,0.0264	265,.	6582	144998	-0.1000			4.38				0		73	1903	0 / 0					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179552596	179552596	T	C	wt	het	wt		QUAL=1100;DP=137,113,196;AF=0.01,0.44,0.00;MQM=60;SAP=18;ABP=6;SAR=16;SAF=35	AXDND1,NPHS2	intron,splice_region&intron	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-1916T>C::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-1916T>C::,NPHS2:ENST00000367615.9:splice_region_variant&intron_variant:LOW:intron7/7:c.873+7A>G::,NPHS2:ENST00000367616.4:splice_region_variant&intron_variant:LOW:intron6/6:c.669+7A>G::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260430 [benign/likely benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, type 2,not specified,not provided];			rs115778946	0.0297	0.0073,0.0343,0.0004,0.0478,0.0087	97,.	4326	147484	-0.3160			1.92				0.06	25741868	71	2006	0 / 0					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179552797	179552797	G	T	hom	hom	het	off-target	QUAL=8380;DP=156,83,103;AF=1.00,1.00,0.46;MQM=60;SAP=508;ABP=5;SAR=272;SAF=14	AXDND1,NPHS2	intron	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-1715G>T::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-1715G>T::,NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron6/7:c.795-116C>A::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron5/6:c.591-116C>A::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1289362 [benign DISEASE=not provided];			rs2274626	0.4165	0.5525,0.4368,0.4318,0.3521,0.3976	13856,.	35588	88674	-0.3310			2.27				0	17903305,17942957,17236131	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179559782	179559782	G	A	wt	wt	het	off-target	QUAL=2053;DP=167,134,157;AF=0.00,0.00,0.53;MQM=60;SAP=12;ABP=4;SAR=51;SAF=32	NPHS2	intron	NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron3/7:c.452-21C>T::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron3/6:c.452-21C>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1180466 [benign DISEASE=Nephrotic syndrome, type 2,not provided];			rs12401708	0.2023	0.0696,0.2025,0.0484,0.2719,0.1935	3794,.	23157	121243	0.0840			2.16				0	20947785,26820844	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179559807	179559807	G	A	wt	wt	het	off-target	QUAL=1838;DP=145,114,138;AF=0.00,0.00,0.54;MQM=60;SAP=21;ABP=5;SAR=50;SAF=25	NPHS2	intron	NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron3/7:c.452-46C>T::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron3/6:c.452-46C>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1180467 [benign DISEASE=Nephrotic syndrome, type 2,not provided];			rs12401711	0.2025	0.0698,0.2024,0.0488,0.2721,0.1936	3795,.	23177	121203	-0.3660			1.72			COSV62635112	0	26820844	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179559905	179559905	G	A	het	wt	het	off-target	QUAL=1366;DP=75,39,52;AF=0.48,0.00,0.46;MQM=60;SAP=133;ABP=4;SAR=60;SAF=0	NPHS2	intron	NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron3/7:c.452-144C>T::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron3/6:c.452-144C>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1232335 [benign DISEASE=not provided];		MER94 (DNA/hAT-Blackjack)	rs41267604	0.0519	0.0309,0.0343,0.0000,0.0696,0.0264	272,.	7339	144165	-0.0400			3.52				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179575763	179575763	T	C	n/a	hom	hom		QUAL=442;DP=1,3,13;AF=1.00,1.00,1.00;MQM=60;SAP=4;ABP=0;SAR=7;SAF=10	NPHS2	synonymous	NPHS2:ENST00000367615.9:synonymous_variant:LOW:exon1/8:c.102A>G:p.Gly34=:,NPHS2:ENST00000367616.4:synonymous_variant:LOW:exon1/7:c.102A>G:p.Gly34=:		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260424 [benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, type 2,not specified,not provided];			rs1079292	0.9474	0.8439,0.9755,0.9775,0.9928,0.9406	68551,.	6873	7987	-0.4120			2.12			COSV62634486	0	25741868,20947785,31754646	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	179575915	179575915	C	A	n/a	wt	het		QUAL=196;DP=1,9,18;AF=0.00,0.00,0.61;MQM=60;SAP=3;ABP=5;SAR=6;SAF=5	NPHS2	5'UTR	NPHS2:ENST00000367615.9:5_prime_UTR_variant:MODIFIER:exon1/8:c.-51G>T::,NPHS2:ENST00000367616.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-51G>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	225144 [benign DISEASE=Nephrotic syndrome, type 2,not specified,not provided]; 225143 [pathogenic DISEASE=Nephrotic syndrome, type 2];	CR068160 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=NPHS2];		rs12406197	0.2367	0.1599,0.2685,0.1133,0.2725,0.2079	4502,.	26994	116076	-1.1430			4.19			COSV62635817	0	20947785,16900088,31754646	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	179575980	179575980	G	A	n/a	hom	wt	off-target	QUAL=67;DP=1,4,7;AF=1.00,1.00,0.00;MQM=60;SAP=14;ABP=0;SAR=5;SAF=0	NPHS2,RNU5F-2P	upstream_gene	NPHS2:ENST00000367615.9:upstream_gene_variant:MODIFIER::::,NPHS2:ENST00000367616.4:upstream_gene_variant:MODIFIER::::,RNU5F-2P:ENST00000516066.1:upstream_gene_variant:MODIFIER::::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1165811 [benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, type 2,not provided];	CR068161 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=NPHS2];		rs1079291	0.2331	0.0957,0.2978,0.3644,0.2813,0.3585	4745,.	25907	116435	-4.5670			0.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	180230249	180230249	-	AG	het	hom	wt	off-target	QUAL=207;DP=30,8,9;AF=0.37,1.00,0.00;MQM=60;SAP=44;ABP=8;SAR=0;SAF=19	LHX4	upstream_gene	LHX4:ENST00000263726.4:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]			G-rich (Low_complexity)	rs138033992	0.4142	0.4547,0.3369,0.1708,0.4343,0.3836	13157,.	35628	87604				18.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180248115	180248115	C	T	het	hom	wt	off-target	QUAL=2245;DP=99,38,50;AF=0.49,1.00,0.00;MQM=60;SAP=192;ABP=3;SAR=0;SAF=87	LHX4	intron	LHX4:ENST00000263726.4:intron_variant:MODIFIER:intron1/5:c.77-170C>T::	regulatory_region_variant:enhancer	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	1269459 [benign DISEASE=not provided];		MER91A (DNA/hAT-Tip100)	rs4652490	0.1834	0.2019,0.1344,0.1588,0.1967,0.0821	2695,.	22499	124203	-0.3180			0.75				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180248656	180248656	C	T	het	hom	wt	off-target	QUAL=718;DP=53,12,24;AF=0.47,0.92,0.00;MQM=60;SAP=81;ABP=3;SAR=36;SAF=0	LHX4	intron	LHX4:ENST00000263726.4:intron_variant:MODIFIER:intron2/5:c.248+200C>T::		602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	1285896 [benign DISEASE=not provided];			rs3911334	0.1833	0.2019,0.1341,0.1580,0.1967,0.0821	2690,.	22503	124243	-3.2990			0.11				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180266593	180266593	C	T	het	wt	het		QUAL=1863;DP=74,91,107;AF=0.51,0.00,0.42;MQM=60;SAP=88;ABP=6;SAR=70;SAF=13	LHX4	splice_region&synonymous	LHX4:ENST00000263726.4:splice_region_variant&synonymous_variant:LOW:exon3/6:c.450C>T:p.Asn150=:	regulatory_region_variant:enhancer	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	262223 [benign DISEASE=Short stature-pituitary and cerebellar defects-small sella turcica syndrome,not specified,not provided];			rs16855642	0.0389	0.1032,0.0183,0.0146,0.0112,0.0178	261,.	5396	146194	-0.7690			8.34		9.89>9.26		0	25741868	10	607	0 / 0					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180271375	180271375	T	C	het	het	wt		QUAL=1647;DP=67,77,115;AF=0.52,0.47,0.00;MQM=60;SAP=76;ABP=3;SAR=11;SAF=60	LHX4,ACBD6	splice_region&intron,3'UTR	LHX4:ENST00000263726.4:splice_region_variant&intron_variant:LOW:intron3/5:c.452-5T>C::,ACBD6:ENST00000642319.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1850A>G::	regulatory_region_variant:enhancer	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	293866 [benign DISEASE=Short stature-pituitary and cerebellar defects-small sella turcica syndrome,not provided];			rs2764449	0.0575	0.0149,0.0454,0.0181,0.0786,0.0717	357,.	8038	143352	1.0550			8.63		10.03>9.20	COSV55378051	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180271617	180271617	C	T	het	het	het	off-target	QUAL=2226;DP=69,45,63;AF=0.55,0.49,0.51;MQM=60;SAP=67;ABP=4;SAR=72;SAF=20	LHX4,ACBD6	intron,3'UTR	LHX4:ENST00000263726.4:intron_variant:MODIFIER:intron4/5:c.606+83C>T::,ACBD6:ENST00000642319.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1608G>A::	regulatory_region_variant:enhancer,TF_binding_site_variant	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	1266198 [benign DISEASE=not provided];			rs3845397	0.3999	0.1687,0.3311,0.5635,0.4993,0.5914	14049,.	32521	90973	-3.5160			0.05			COSV55372623	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180274389	180274389	A	G	het	het	het		QUAL=7700;DP=210,155,203;AF=0.48,0.48,0.57;MQM=60;SAP=6;ABP=4;SAR=155;SAF=136	LHX4,ACBD6	missense,intron	LHX4:ENST00000263726.4:missense_variant:MODERATE:exon6/6:c.983A>G:p.Asn328Ser:,ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron10/13:c.*936+262T>C::		602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	262225 [benign DISEASE=Short stature-pituitary and cerebellar defects-small sella turcica syndrome,not specified,not provided];			rs7536561	0.4197	0.1880,0.3446,0.5931,0.5184,0.6076	15297,.	33139	88125	2.5250	T(1.00), 	B(0.00), 	13.78	0.26		COSV55374116	0	25741868,25938945,23199197,29998616,34868058	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180288557	180288557	A	C	hom	hom	hom	off-target	QUAL=19073;DP=249,155,202;AF=1.00,1.00,1.00;MQM=60;SAP=827;ABP=0;SAR=542;SAF=63	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron7/13:c.695-40T>G::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron7/7:c.695-40T>G::	regulatory_region_variant:enhancer					rs2254465	0.9499	0.9608,0.9429,0.9884,0.9444,0.9116	68664,.	7144	7628	-3.9170			0.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180314524	180314524	T	C	hom	hom	hom	off-target	QUAL=4532;DP=84,32,36;AF=1.00,1.00,1.00;MQM=58;SAP=333;ABP=0;SAR=0;SAF=152	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron7/13:c.694+168A>G::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron7/7:c.694+168A>G::					AluSx1 (SINE/Alu)	rs2764433	0.9564	0.9830,0.9460,0.9883,0.9447,0.9117	69688,.	6202	6634	-2.3750			0.19				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180397348	180397348	G	C	het	het	hom	off-target	QUAL=1638;DP=59,17,27;AF=0.53,0.35,1.00;MQM=60;SAP=133;ABP=3;SAR=1;SAF=63	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron6/13:c.663+168C>G::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron6/7:c.663+168C>G::	regulatory_region_variant:enhancer,TF_binding_site_variant				L1MB5 (LINE/L1)	rs10798759	0.5499	0.3980,0.5163,0.5651,0.6236,0.6678	23793,.	35916	68342	-0.2870			0.48				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180413647	180413647	T	A	het	het	hom	off-target	QUAL=940;DP=76,7,7;AF=0.39,0.57,1.00;MQM=60;SAP=92;ABP=9;SAR=41;SAF=0	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron4/13:c.468-176A>T::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron4/7:c.468-176A>T::						rs4421553	0.4867	0.1871,0.4867,0.5635,0.6203,0.6597	20797,.	32315	77955	-0.5460			0.49				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180501931	180501931	C	T	het	n/a	n/a	off-target	QUAL=60;DP=6,1,0;AF=0.67,1.00,;MQM=60;SAP=14;ABP=4;SAR=0;SAF=5	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron1/13:c.222+114G>A::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron1/7:c.222+114G>A::	regulatory_region_variant:promoter				(A)n (Simple_repeat)	rs61811621	0.0208	0.0055,0.0159,0.0000,0.0258,0.0059	55,.	3020	147242	-1.3100			2.37				0		1	8	0 / 0					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	183186093	183186093	C	A	wt	het	wt		QUAL=2642;DP=173,249,306;AF=0.00,0.49,0.01;MQM=60;SAP=59;ABP=3;SAR=34;SAF=91	LAMC2	upstream_gene	LAMC2:ENST00000493293.5:upstream_gene_variant:MODIFIER::::,LAMC2:ENST00000264144.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	293975 [benign DISEASE=Junctional epidermolysis bullosa,not provided];			rs2276544	0.1395	0.0649,0.1919,0.3152,0.1598,0.1962	1751,.	17696	130766	0.1400			13.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186170	183186170	G	A	het	wt	hom		QUAL=19348;DP=265,354,500;AF=0.54,0.00,1.00;MQM=60;SAP=65;ABP=7;SAR=254;SAF=389	LAMC2	upstream_gene	LAMC2:ENST00000493293.5:upstream_gene_variant:MODIFIER::::,LAMC2:ENST00000264144.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	293977 [benign DISEASE=Junctional epidermolysis bullosa,not provided];			rs2276543	0.2732	0.1957,0.3148,0.3809,0.2789,0.3379	5955,.	29601	110453	3.4730			21.50					29875488,30072576,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186264	183186264	A	G	wt	het	wt		QUAL=3317;DP=364,283,397;AF=0.00,0.48,0.00;MQM=60;SAP=3;ABP=4;SAR=71;SAF=66	LAMC2	5'UTR	LAMC2:ENST00000493293.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-89A>G::,LAMC2:ENST00000264144.5:5_prime_UTR_variant:MODIFIER:exon1/23:c.-89A>G::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	293979 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not provided];			rs2276542	0.1811	0.2158,0.2041,0.3306,0.1581,0.1998	2655,.	22236	124534	1.7150			17.56			COSV51459231			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186347	183186347	C	A	wt	wt	het		QUAL=791;DP=26,68,90;AF=0.00,0.00,0.47;MQM=60;SAP=28;ABP=4;SAR=10;SAF=32	LAMC2	5'UTR	LAMC2:ENST00000493293.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-6C>A::,LAMC2:ENST00000264144.5:5_prime_UTR_variant:MODIFIER:exon1/23:c.-6C>A::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	293983 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not provided];			rs684527	0.2565	0.1012,0.2946,0.4276,0.2949,0.3435	5789,.	27397	112971	0.4330			18.61				0	30048462,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186565	183186565	C	A	het	wt	hom	off-target	QUAL=864;DP=66,16,13;AF=0.45,0.00,1.00;MQM=60;SAP=96;ABP=4;SAR=43;SAF=0	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.79+134C>A::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.79+134C>A::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1250223 [benign DISEASE=not provided];			rs6678888	0.3167	0.2414,0.3350,0.4635,0.3167,0.3807	7112,.	31062	97704	0.9110			8.75				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186581	183186581	T	-	het	het	hom	off-target	QUAL=723;DP=58,13,7;AF=0.43,0.46,1.00;MQM=60;SAP=86;ABP=5;SAR=38;SAF=0	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.79+150del::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.79+150del::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1178172 [benign DISEASE=not provided];			rs60707856	0.5595	0.6888,0.5684,0.7262,0.4751,0.5602	24518,.	35809	66801	0.6650			6.26			COSV51452174,COSV51455144	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186582	183186582	C	A	het	het	hom	off-target	QUAL=723;DP=58,13,7;AF=0.43,0.46,1.00;MQM=60;SAP=86;ABP=5;SAR=38;SAF=0	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.79+151C>A::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.79+151C>A::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1253775 [benign DISEASE=not provided];			rs61418038	0.5595	0.6888,0.5684,0.7261,0.4751,0.5606	24521,.	35812	66804	0.0720			7.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183207835	183207835	-	T	het	het	het	off-target;low_conf_region	QUAL=1124;DP=55,54,46;AF=0.13,0.39,0.28;MQM=60;SAP=84;ABP=78;SAR=1;SAF=40	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.80-31dup::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.80-31dup::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1224645 [benign DISEASE=not provided];			rs10668798	0.1747	0.1972,0.1658,0.2532,0.1582,0.2268	2244,.	19899	115183				7.18			COSV51458071	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183207835	183207835	-	TT	wt	wt	het	off-target;low_conf_region	QUAL=1124;DP=55,54,46;AF=0.11,0.06,0.39;MQM=60;SAP=62;ABP=146;SAR=0;SAF=27	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.80-32_80-31dup::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.80-32_80-31dup::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1229395 [benign DISEASE=not provided];			rs10668798	0.3407	0.2980,0.3682,0.3783,0.3495,0.2778	8267,.	30995	91997				6.90			COSV51458071	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183208083	183208083	A	G	het	wt	hom	off-target	QUAL=9050;DP=136,212,242;AF=0.47,0.00,1.00;MQM=60;SAP=220;ABP=4;SAR=241;SAF=66	LAMC2	splice_region&intron	LAMC2:ENST00000493293.5:splice_region_variant&intron_variant:LOW:intron2/21:c.268+14A>G::,LAMC2:ENST00000264144.5:splice_region_variant&intron_variant:LOW:intron2/22:c.268+14A>G::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	259785 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];		GA-rich (Low_complexity)	rs647347	0.4585	0.4673,0.4802,0.5517,0.4288,0.5083	16114,.	37313	82133	-1.3710			0.14			COSV51456075,COSV51458451	0.07	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183208147	183208147	G	C	wt	het	wt	off-target	QUAL=1691;DP=162,125,131;AF=0.00,0.56,0.00;MQM=60;SAP=155;ABP=7;SAR=70;SAF=0	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron2/21:c.268+78G>C::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron2/22:c.268+78G>C::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]			GA-rich (Low_complexity)							-0.5790			0.17				0		0	0	0 / 0					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183215293	183215293	C	T	wt	het	wt	off-target	QUAL=871;DP=98,60,84;AF=0.00,0.62,0.01;MQM=60;SAP=86;ABP=10;SAR=0;SAF=38	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron2/21:c.269-160C>T::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron2/22:c.269-160C>T::	regulatory_region_variant:open_chromatin_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1287887 [benign DISEASE=not provided];			rs2274982	0.1039	0.0355,0.1285,0.1870,0.1286,0.0841	956,.	13898	136314	0.2380			1.86				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183215389	183215389	C	T	wt	het	wt	off-target	QUAL=1451;DP=312,134,220;AF=0.00,0.48,0.00;MQM=60;SAP=90;ABP=4;SAR=7;SAF=58	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron2/21:c.269-64C>T::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron2/22:c.269-64C>T::	regulatory_region_variant:open_chromatin_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1245200 [benign DISEASE=not provided];			rs2274981	0.2564	0.3871,0.2893,0.3516,0.1776,0.3106	5767,.	27420	112948	0.1440			4.48			COSV51453590	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183215481	183215481	C	T	wt	het	wt		QUAL=2930;DP=271,244,345;AF=0.00,0.48,0.01;MQM=60;SAP=3;ABP=4;SAR=57;SAF=62	LAMC2	synonymous	LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon3/22:c.297C>T:p.Ser99=:PF00053 [Laminin EGF domain],LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon3/23:c.297C>T:p.Ser99=:PF00053 [Laminin EGF domain]	regulatory_region_variant:open_chromatin_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	259787 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs2274980	0.2562	0.3866,0.2895,0.3505,0.1775,0.3100	5744,.	27419	112937	-0.4250			9.04			COSV51453066	0	25741868,25363238	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183215713	183215713	T	G	wt	het	wt	off-target	QUAL=542;DP=175,48,87;AF=0.00,0.56,0.01;MQM=60;SAP=64;ABP=5;SAR=28;SAF=0	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron3/21:c.404+125T>G::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron3/22:c.404+125T>G::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1227354 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs875794	0.2984	0.5300,0.3086,0.3524,0.1786,0.3120	8629,.	28099	106627	-1.3930			0.24			COSV51459573	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183218359	183218359	T	C	wt	het	wt	off-target	QUAL=3569;DP=342,295,465;AF=0.00,0.48,0.00;MQM=60;SAP=8;ABP=4;SAR=63;SAF=81	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron3/21:c.405-31T>C::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron3/22:c.405-31T>C::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1180478 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,not provided];			rs10911285	0.2563	0.3865,0.2895,0.3504,0.1775,0.3107	5750,.	27447	113033	-1.1210			6.51			COSV51453509	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183218468	183218468	C	T	wt	het	wt		QUAL=3073;DP=195,249,323;AF=0.00,0.50,0.00;MQM=60;SAP=28;ABP=3;SAR=82;SAF=44	LAMC2	synonymous	LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon4/22:c.483C>T:p.Val161=:PF00053 [Laminin EGF domain],LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon4/23:c.483C>T:p.Val161=:PF00053 [Laminin EGF domain]	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	259789 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs1129723	0.2563	0.3867,0.2895,0.3494,0.1776,0.3106	5756,.	27447	113035	0.7460			12.32			COSV51453519	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183222009	183222009	C	T	wt	het	wt	off-target	QUAL=1103;DP=138,108,153;AF=0.00,0.45,0.00;MQM=60;SAP=78;ABP=5;SAR=4;SAF=45	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron5/21:c.641-80C>T::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron5/22:c.641-80C>T::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1180479 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,not provided];			rs2296307	0.2575	0.3901,0.2899,0.3534,0.1778,0.3102	5817,.	27473	112765	-0.0870			1.74			COSV51453597	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183223169	183223169	T	G	wt	het	wt		QUAL=2777;DP=226,207,280;AF=0.00,0.53,0.00;MQM=60;SAP=14;ABP=5;SAR=44;SAF=68	LAMC2	synonymous	LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon7/22:c.798T>G:p.Gly266=:PF00052 [Laminin B (Domain IV)],LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon7/23:c.798T>G:p.Gly266=:PF00052 [Laminin B (Domain IV)]		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	259790 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs1047980	0.2931	0.5112,0.3081,0.3521,0.1787,0.3120	8160,.	28216	107412	-0.3900			10.35			COSV51453536	0.02	25741868,31151762	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183223361	183223361	A	G	wt	het	wt	off-target	QUAL=2028;DP=216,137,173;AF=0.00,0.59,0.00;MQM=60;SAP=123;ABP=13;SAR=74;SAF=7	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron7/21:c.953+37A>G::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron7/22:c.953+37A>G::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1268335 [benign DISEASE=not provided];			rs3738824	0.1269	0.1147,0.1377,0.1878,0.1291,0.0852	1242,.	16826	132814	0.4220			5.28			COSV51456347	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183225484	183225484	A	G	wt	het	wt	off-target	QUAL=483;DP=111,53,61;AF=0.01,0.45,0.00;MQM=60;SAP=57;ABP=4;SAR=0;SAF=25	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron7/21:c.954-124A>G::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron7/22:c.954-124A>G::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1277223 [benign DISEASE=not provided];			rs2021956	0.2571	0.3891,0.2898,0.3523,0.1776,0.3109	5797,.	27467	112877	-0.2240			1.15			COSV51455315	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183232835	183232835	G	C	wt	het	wt		QUAL=907;DP=128,109,163;AF=0.00,0.39,0.00;MQM=60;SAP=28;ABP=15;SAR=32;SAF=10	LAMC2	missense	LAMC2:ENST00000493293.5:missense_variant:MODERATE:exon14/22:c.2198G>C:p.Ser733Thr:,LAMC2:ENST00000264144.5:missense_variant:MODERATE:exon14/23:c.2198G>C:p.Ser733Thr:		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	259784 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs2296303	0.1609	0.2314,0.1530,0.1898,0.1296,0.0856	2136,.	20179	127555	1.3040	D(0.05),D(0.05)	B(0.17),B(0.13)	13.16	0.07		COSV51456358	0.04	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183236345	183236345	C	T	wt	het	wt	off-target	QUAL=534;DP=70,47,82;AF=0.00,0.55,0.01;MQM=57;SAP=62;ABP=4;SAR=0;SAF=27	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron16/21:c.2457-115C>T::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron16/22:c.2457-115C>T::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1278594 [benign DISEASE=not provided];		AluJb (SINE/Alu)	rs3738823	0.1593	0.2295,0.1532,0.1894,0.1292,0.0824	2054,.	19568	124954	-1.7180			0.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183236389	183236389	A	-	het	het	wt	off-target;low_conf_region	QUAL=2484;DP=61,27,64;AF=0.51,0.44,0.50;MQM=59;SAP=8;ABP=164;SAR=8;SAF=15	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron16/21:c.2457-54del::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron16/22:c.2457-54del::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1235485 [benign DISEASE=not provided];		AluJb (SINE/Alu)	rs34154823	0.2973	0.4963,0.3060,0.4908,0.1922,0.3596	6215,.	24421	87113	-0.0480			0.73				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183236389	183236390	AA	-	het	het	het	off-target;low_conf_region	QUAL=2484;DP=61,27,64;AF=0.13,0.30,0.11;MQM=59;SAP=97;ABP=3;SAR=9;SAF=66	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron16/21:c.2457-55_2457-54del::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron16/22:c.2457-55_2457-54del::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1278088 [benign DISEASE=not provided];		AluJb (SINE/Alu)	rs34154823	0.3943	0.2607,0.3897,0.4306,0.4434,0.3339	9358,.	30181	75107	0.3020			1.50				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183236389	183236391	AAA	-	wt	wt	het	off-target;low_conf_region	QUAL=2484;DP=61,27,64;AF=0.07,0.04,0.31;MQM=60;SAP=28;ABP=152;SAR=4;SAF=21	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron16/21:c.2457-56_2457-54del::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron16/22:c.2457-56_2457-54del::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]			AluJb (SINE/Alu)	rs34154823	0.0014	0.0004,0.0018,0.0005,0.0011,0.0000	0,.	173	123955	0.3020			1.88				0		3	66	0 / 0					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183237438	183237438	G	A	wt	het	wt		QUAL=3682;DP=364,276,404;AF=0.00,0.51,0.00;MQM=60;SAP=27;ABP=3;SAR=91;SAF=51	LAMC2	synonymous	LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon18/22:c.2688G>A:p.Gln896=:,LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon18/23:c.2688G>A:p.Gln896=:	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	259786 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs1047981	0.2922	0.5082,0.3064,0.3515,0.1788,0.3117	8099,.	28220	107584	-0.3600			0.17			COSV51453550	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183238468	183238468	T	C	wt	het	wt	off-target	QUAL=1090;DP=197,82,112;AF=0.00,0.56,0.00;MQM=60;SAP=45;ABP=6;SAR=38;SAF=8	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron19/21:c.2869+47T>C::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron19/22:c.2869+47T>C::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]				rs1925043	0.2989	0.5311,0.3085,0.3522,0.1790,0.3122	8644,.	28132	106542	-1.2890			0.62			COSV51453562	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183239707	183239707	T	G	wt	het	wt	off-target	QUAL=124;DP=89,11,26;AF=0.00,0.73,0.00;MQM=60;SAP=20;ABP=8;SAR=8;SAF=0	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron20/21:c.3069+144T>G::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron20/22:c.3069+144T>G::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1183236 [benign DISEASE=not provided];			rs648809	0.1413	0.1839,0.1459,0.1983,0.1205,0.0885	1586,.	18315	130589	-0.9030			0.30			COSV51455053	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183239951	183239951	C	A	wt	het	wt	off-target	QUAL=727;DP=204,76,104;AF=0.00,0.49,0.00;MQM=60;SAP=83;ABP=3;SAR=0;SAF=37	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron20/21:c.3070-89C>A::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron20/22:c.3070-89C>A::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1179728 [benign DISEASE=not provided];			rs2477436	0.2767	0.4815,0.2965,0.3519,0.1678,0.3164	7311,.	27405	109857	0.1650			6.94			COSV51453621	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183241246	183241246	A	-	het	het	wt	low_conf_region	QUAL=143;DP=18,9,4;AF=0.28,0.67,0.00;MQM=60;SAP=5;ABP=5;SAR=7;SAF=4	LAMC2	3'UTR,intron	LAMC2:ENST00000493293.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*862del::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron22/22:c.3328+870del::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs11318188	0.1926	0.1572,0.2649,0.3583,0.1851,0.2311	1395,.	17578	85392	0.4720			0.78				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183243036	183243036	C	A	wt	het	wt	off-target	QUAL=657;DP=129,61,55;AF=0.01,0.52,0.00;MQM=60;SAP=75;ABP=3;SAR=0;SAF=33	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron22/22:c.3329-111C>A::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1276996 [benign DISEASE=not provided];			rs3768594	0.2419	0.3574,0.2819,0.3751,0.1673,0.3111	5090,.	26558	115144	0.8030			4.28			COSV51457662	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183243413	183243413	T	G	wt	het	wt		QUAL=2485;DP=214,174,247;AF=0.00,0.56,0.00;MQM=60;SAP=9;ABP=8;SAR=41;SAF=57	LAMC2	3'UTR	LAMC2:ENST00000264144.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*13T>G::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	294025 [benign DISEASE=Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa];			rs3768593	0.2421	0.3579,0.2823,0.3752,0.1676,0.3103	5110,.	26584	115198	0.2590			7.28			COSV51452226	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183244275	183244275	G	T	wt	het	wt		QUAL=2295;DP=275,178,200;AF=0.00,0.49,0.01;MQM=60;SAP=3;ABP=3;SAR=44;SAF=46	LAMC2	3'UTR	LAMC2:ENST00000264144.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*875G>T::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	294036 [benign DISEASE=Junctional epidermolysis bullosa];			rs10797863	0.0988	0.0376,0.1265,0.1963,0.1195,0.0855	861,.	13288	136976	-0.1160			0.43				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183244798	183244798	C	T	wt	wt	het		QUAL=4919;DP=472,284,395;AF=0.00,0.00,0.47;MQM=60;SAP=3;ABP=6;SAR=94;SAF=92	LAMC2	3'UTR	LAMC2:ENST00000264144.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*1398C>T::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	294053 [uncertain significance DISEASE=Junctional epidermolysis bullosa];			rs564740740	0.0023	0.0007,0.0008,0.0000,0.0037,0.0021	0,.	349	151837	0.4890			4.86			COSV51452086	0		0	65	0 / 0					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183555720	183555720	C	A	hom	hom	hom		QUAL=43677;DP=452,380,543;AF=1.00,0.99,0.99;MQM=60;SAP=109;ABP=0;SAR=555;SAF=814	NCF2	3'UTR	NCF2:ENST00000367535.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*398G>T::,NCF2:ENST00000413720.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:ENST00000418089.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*398G>T::,NCF2:ENST00000367536.5:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::,NCF2:ENST00000697351.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:ENST00000697330.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	294066 [benign DISEASE=Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2];			rs796860	0.9016	0.9375,0.8946,0.9981,0.8773,0.9475	61925,.	13237	14955	-2.0460			1.14				0	24163247,30567305	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMG7 (inh=n/a oe_syn=0.96 oe_mis=0.75 oe_lof=0.12), NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183556317	183556317	T	G	hom	hom	hom	off-target	QUAL=17381;DP=259,135,168;AF=1.00,1.00,0.99;MQM=60;SAP=770;ABP=0;SAR=503;SAF=58	NCF2	intron	NCF2:ENST00000367535.8:intron_variant:MODIFIER:intron14/14:c.1469-87A>C::,NCF2:ENST00000413720.5:intron_variant:MODIFIER:intron13/13:c.1334-87A>C::,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron12/12:c.1226-87A>C::,NCF2:ENST00000367536.5:intron_variant:MODIFIER:intron15/15:c.1469-87A>C::,NCF2:ENST00000697351.1:intron_variant:MODIFIER:intron13/13:c.1361-87A>C::,NCF2:ENST00000697330.1:intron_variant:MODIFIER:intron15/15:c.1469-87A>C::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	1226524 [benign DISEASE=not provided];			rs699244	0.8936	0.9068,0.8932,0.9981,0.8786,0.9476	60816,.	14276	16178	0.3840			3.06			COSV61633935	0	17897462	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMG7 (inh=n/a oe_syn=0.96 oe_mis=0.75 oe_lof=0.12), NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183565800	183565800	C	T	hom	hom	het	off-target	QUAL=13707;DP=147,193,253;AF=1.00,1.00,0.51;MQM=60;SAP=61;ABP=3;SAR=290;SAF=178	NCF2	intron	NCF2:ENST00000367535.8:intron_variant:MODIFIER:intron9/14:c.925-21G>A::,NCF2:ENST00000413720.5:intron_variant:MODIFIER:intron8/13:c.790-21G>A::,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron7/12:c.682-21G>A::,NCF2:ENST00000367536.5:intron_variant:MODIFIER:intron10/15:c.925-21G>A::,NCF2:ENST00000697351.1:intron_variant:MODIFIER:intron8/13:c.817-21G>A::,NCF2:ENST00000697330.1:intron_variant:MODIFIER:intron10/15:c.925-21G>A::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	1235081 [benign DISEASE=Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2,not provided];			rs2296164	0.4552	0.3605,0.5597,0.6145,0.4739,0.4699	16095,.	36866	82666	-2.9130			0.01			COSV62315476	0	25416100,24163247,30567305,24239855	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183573252	183573252	T	C	hom	hom	het		QUAL=18366;DP=257,192,266;AF=0.98,1.00,0.55;MQM=60;SAP=6;ABP=8;SAR=281;SAF=309	NCF2	missense,intron	NCF2:ENST00000367535.8:missense_variant:MODERATE:exon5/15:c.542A>G:p.Lys181Arg:,NCF2:ENST00000413720.5:missense_variant:MODERATE:exon4/14:c.407A>G:p.Lys136Arg:,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron3/12:c.367-2413A>G::,NCF2:ENST00000367536.5:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:,NCF2:ENST00000697351.1:intron_variant:MODIFIER:intron4/13:c.501+1235A>G::,NCF2:ENST00000697330.1:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:	regulatory_region_variant:enhancer	608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	256116 [benign DISEASE=Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2,not specified,not provided];			rs2274064	0.4574	0.3649,0.5605,0.6194,0.4730,0.5127	16259,.	36951	82419	0.6150	T(0.81),T(0.88), ,T(0.81), ,T(0.81)	B(0.00),B(0.00), ,B(0.00), ,B(0.00)	16.25	0.08		COSV62314890	0	25741868,24033266,16608528,23821607,25416100,24163247,24239855,28926565,24159917	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183587156	183587156	A	G	het	wt	het	off-target	QUAL=832;DP=74,24,26;AF=0.39,0.00,0.42;MQM=60;SAP=90;ABP=12;SAR=40;SAF=0	NCF2	intron	NCF2:ENST00000367535.8:intron_variant:MODIFIER:intron1/14:c.175-179T>C::,NCF2:ENST00000413720.5:intron_variant:MODIFIER:intron1/13:c.175-179T>C::,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron1/12:c.175-179T>C::,NCF2:ENST00000367536.5:intron_variant:MODIFIER:intron2/15:c.175-179T>C::,NCF2:ENST00000697351.1:intron_variant:MODIFIER:intron1/13:c.175-179T>C::,NCF2:ENST00000697330.1:intron_variant:MODIFIER:intron2/15:c.175-179T>C::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	1287540 [benign DISEASE=not provided];			rs789192	0.4933	0.6750,0.4736,0.1670,0.4387,0.3226	19723,.	35515	76991	0.2970			3.84			COSV62315307	0	30567305	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	196651787	196651787	C	T	het	wt	het	off-target	QUAL=4158;DP=301,48,61;AF=0.49,0.04,0.52;MQM=60;SAP=396;ABP=3;SAR=0;SAF=181	CFH	5'UTR	CFH:ENST00000359637.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-331C>T::	regulatory_region_variant:promoter	134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1249325 [benign DISEASE=not provided];	CR033844 [CLASS=DP MUT=ALT PHEN="Haemolytic uraemic syndrome association with" GENE=CFH];		rs3753394	0.2280	0.0746,0.2772,0.5275,0.2868,0.2775	5008,.	24617	117303	-0.3120			4.41					18483746,19861685,26559391,31118930,27805046,22253485,30696427,22035603,26152901,17167412,19026761,18421087,20161815,15870199,18316707,18515590,19187823,20132989,21784901,22509112,23687431,23919682,24365176,24558588,25205864,26296146,27252648,29844195,30225264,30300269,31815877,31925659,21067572,21111031,31525397,19162324,23966370,26852301,30073298,31883521,22622361,22223611,23431077,20595690,22153652,27500215,19373492,19878229,25735482,23441108,24722444,23028341,31428128,30046676,22246034,29929468,24904082,24272913,23747994,17517971,18371543,15163532,19854291,20850857,20304497,33976403,33387109,34150810,33920896,32923941,34502390,33224962,33643312,24201651,32954088,33456587,20523265,35052395	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196672844	196672845	GA	-	het	het	het	off-target	QUAL=18;DP=82,15,14;AF=0.11,0.20,0.36;MQM=60;SAP=32;ABP=119;SAR=1;SAF=16	CFH	intron	CFH:ENST00000359637.3:intron_variant:MODIFIER:intron1/8:c.59-114_59-113del::,CFH:ENST00000695968.1:intron_variant:MODIFIER:intron1/7:c.59-114_59-113del::,CFH:ENST00000695969.1:intron_variant:MODIFIER:intron1/16:c.59-114_59-113del::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron1/20:c.59-114_59-113del::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron1/21:c.59-114_59-113del::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron1/20:c.59-114_59-113del::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron2/22:c.-131-114_-131-113del::,CFH:ENST00000695978.1:intron_variant:MODIFIER:intron1/10:c.59-114_59-113del::,CFH:ENST00000695979.1:intron_variant:MODIFIER:intron1/9:c.59-114_59-113del::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron1/22:c.59-114_59-113del::,CFH:ENST00000696023.1:intron_variant:MODIFIER:intron1/9:c.59-114_59-113del::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron1/21:c.59-114_59-113del::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron1/21:c.59-114_59-113del::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron1/21:c.59-114_59-113del::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron1/9:c.59-114_59-113del::,CFH:ENST00000696030.1:intron_variant:MODIFIER:intron1/9:c.59-114_59-113del::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron1/21:c.59-114_59-113del::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron1/9:c.59-114_59-113del::,CFH:ENST00000695987.1:intron_variant:MODIFIER:intron1/9:c.-131-114_-131-113del::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]			(GA)n (Simple_repeat)	rs55759441	0.0132	0.0447,0.0067,0.0002,0.0004,0.0000	43,.	1890	148130	0.5060			0.73				0		1	18	0 / 0					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196672942	196672942	C	T	wt	het	wt	off-target	QUAL=324;DP=121,48,74;AF=0.00,0.38,0.00;MQM=60;SAP=15;ABP=10;SAR=4;SAF=14	CFH	intron	CFH:ENST00000359637.3:intron_variant:MODIFIER:intron1/8:c.59-36C>T::,CFH:ENST00000695968.1:intron_variant:MODIFIER:intron1/7:c.59-36C>T::,CFH:ENST00000695969.1:intron_variant:MODIFIER:intron1/16:c.59-36C>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron1/20:c.59-36C>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron1/20:c.59-36C>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron2/22:c.-131-36C>T::,CFH:ENST00000695978.1:intron_variant:MODIFIER:intron1/10:c.59-36C>T::,CFH:ENST00000695979.1:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron1/22:c.59-36C>T::,CFH:ENST00000696023.1:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:ENST00000696030.1:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:ENST00000695987.1:intron_variant:MODIFIER:intron1/9:c.-131-36C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1209735 [benign DISEASE=Basal laminar drusen,Hemolytic uremic syndrome, atypical, susceptibility to, 1,Factor H deficiency,Age related macular degeneration 4,not provided];			rs551397	0.3977	0.7175,0.3888,0.4243,0.2339,0.3270	15215,.	29929	91431	-0.1450			1.01			COSV62776788	0	17314151,24453474,22618592,24692129,18421087,20161815,23289807,30179527,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196673103	196673103	G	A	wt	het	wt		QUAL=924;DP=231,83,139;AF=0.00,0.48,0.00;MQM=60;SAP=5;ABP=3;SAR=23;SAF=17	CFH	missense,5'UTR	CFH:ENST00000359637.3:missense_variant:MODERATE:exon2/9:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695968.1:missense_variant:MODERATE:exon2/8:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695969.1:missense_variant:MODERATE:exon2/17:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695970.1:missense_variant:MODERATE:exon2/21:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695971.1:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695974.1:missense_variant:MODERATE:exon2/21:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:5_prime_UTR_variant:MODIFIER:exon3/23:c.-6G>A::,CFH:ENST00000695978.1:missense_variant:MODERATE:exon2/11:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695979.1:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695981.1:missense_variant:MODERATE:exon2/23:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696023.1:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696030.1:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695987.1:5_prime_UTR_variant:MODIFIER:exon2/10:c.-6G>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	16550 [benign DISEASE=Basal laminar drusen,Hemolytic uremic syndrome, atypical, susceptibility to, 1,Factor H deficiency,Age related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided];			rs800292	0.3968	0.7159,0.3882,0.4231,0.2338,0.3259	15151,.	29949	91577	1.6040	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00), ,T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),D(0.04),T(1.00),T(1.00),T(1.00), 	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00), ,B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00), 	7.64	0.14		COSV62776782	0.08	18162041,25537509,19961953,18541031,29700787,27730450,19861685,20203157,26559391,31118930,16080115,17314151,30696427,18043728,19796758,22035603,22059990,26152901,27239600,24453474,21637784,23873044,25132797,29312345,17167412,19026761,19958499,20181037,20961462,22618592,25276841,25883802,22936692,23577725,19825847,20157618,23620142,24069533,18787502,24692129,18421087,20161815,23289807,17591627,20157352,8072530,15870199,16299065,17022693,17877809,17947292,17962488,18316707,18515590,19187823,19259132,19823576,19933189,20132989,20538655,20581873,20678803,20689796,21394116,21397333,21555552,21609242,21784901,21811649,21850184,21856016,21896867,21899915,21909106,22019782,22046503,22065918,22065928,22174912,22509112,22534080,22536038,22558131,22666427,22714898,22876110,23103884,23111182,23233260,23289808,23687431,23864767,23919682,24120328,24365176,24393350,24403817,24520367,24558588,24675670,24860613,24865190,24865191,24906858,25205864,25277308,25388911,25558172,25612476,25732348,25771815,25792034,26171855,26217379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196673839	196673839	-	TT	wt	het	wt	off-target	QUAL=947;DP=98,110,131;AF=0.00,0.39,0.00;MQM=60;SAP=5;ABP=14;SAR=18;SAF=25	CFH	splice_region&intron,intron	CFH:ENST00000359637.3:splice_region_variant&intron_variant:LOW:intron2/8:c.245-10_245-9dup::,CFH:ENST00000695968.1:intron_variant:MODIFIER:intron2/7:c.244+684_244+685dup::,CFH:ENST00000695969.1:splice_region_variant&intron_variant:LOW:intron2/16:c.245-10_245-9dup::,CFH:ENST00000695970.1:splice_region_variant&intron_variant:LOW:intron2/20:c.245-10_245-9dup::,CFH:ENST00000695971.1:splice_region_variant&intron_variant:LOW:intron2/21:c.245-10_245-9dup::,CFH:ENST00000695974.1:splice_region_variant&intron_variant:LOW:intron2/20:c.245-10_245-9dup::,CFH:ENST00000695976.1:splice_region_variant&intron_variant:LOW:intron3/22:c.56-10_56-9dup::,CFH:ENST00000695978.1:splice_region_variant&intron_variant:LOW:intron2/10:c.245-10_245-9dup::,CFH:ENST00000695979.1:splice_region_variant&intron_variant:LOW:intron2/9:c.245-10_245-9dup::,CFH:ENST00000695981.1:splice_region_variant&intron_variant:LOW:intron2/22:c.245-10_245-9dup::,CFH:ENST00000696023.1:splice_region_variant&intron_variant:LOW:intron2/9:c.245-10_245-9dup::,CFH:ENST00000696027.1:splice_region_variant&intron_variant:LOW:intron2/21:c.245-10_245-9dup::,CFH:ENST00000696028.1:splice_region_variant&intron_variant:LOW:intron2/21:c.245-10_245-9dup::,CFH:ENST00000696029.1:splice_region_variant&intron_variant:LOW:intron2/21:c.245-10_245-9dup::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+684_244+685dup::,CFH:ENST00000696030.1:splice_region_variant&intron_variant:LOW:intron2/9:c.245-10_245-9dup::,CFH:ENST00000367429.9:splice_region_variant&intron_variant:LOW:intron2/21:c.245-10_245-9dup::,CFH:ENST00000630130.2:splice_region_variant&intron_variant:LOW:intron2/9:c.245-10_245-9dup::,CFH:ENST00000695987.1:splice_region_variant&intron_variant:LOW:intron2/9:c.56-10_56-9dup::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1166414 [benign DISEASE=not specified,not provided];	CI063658 [CLASS=DM MUT=ALT PHEN="Membranoproliferative glomerulonephritis" GENE=CFH];		rs35507625	0.2426	0.1874,0.3134,0.4961,0.2277,0.3280	4684,.	27266	114360				1.21				0.02	19796758,27239600	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196685194	196685194	A	C	het	het	het		QUAL=9406;DP=284,209,266;AF=0.49,0.48,0.48;MQM=60;SAP=61;ABP=5;SAR=232;SAF=133	CFH	synonymous,intron	CFH:ENST00000359637.3:synonymous_variant:LOW:exon6/9:c.729A>C:p.Ala243=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695968.1:synonymous_variant:LOW:exon5/8:c.738A>C:p.Ala246=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695969.1:synonymous_variant:LOW:exon7/17:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695970.1:synonymous_variant:LOW:exon7/21:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695971.1:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:,CFH:ENST00000695974.1:synonymous_variant:LOW:exon7/21:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:synonymous_variant:LOW:exon8/23:c.732A>C:p.Ala244=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695978.1:synonymous_variant:LOW:exon7/11:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695979.1:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:,CFH:ENST00000695981.1:synonymous_variant:LOW:exon7/23:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696023.1:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+12031A>C::,CFH:ENST00000696030.1:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695987.1:synonymous_variant:LOW:exon7/10:c.732A>C:p.Ala244=:PF00084 [Sushi repeat (SCR repeat)]		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294488 [benign DISEASE=Basal laminar drusen,Hemolytic uremic syndrome, atypical, susceptibility to, 1,Factor H deficiency,Age related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided];			rs1061147	0.6297	0.5784,0.7293,0.9474,0.6176,0.7202	30581,.	34356	56166	-0.1750			6.10			COSV62778986	0	17314151,18043728,19796758,27239600,24453474,21637784,24586071,17167412,19026761,16936733,15870199,16299065,22558131,28011711,20339564,27068115,31031394,28729648,29854987,25756647,29706360,27239594,23326517,29606303,28293111,15163532,30571950,33102952,31919107,33920896,24634144,33564431,30389424,32179765	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196689367	196689367	G	T	het	het	het	off-target;low_conf_region	QUAL=1495;DP=93,15,17;AF=0.55,0.53,0.18;MQM=60;SAP=138;ABP=3;SAR=0;SAF=62	CFH	intron	CFH:ENST00000359637.3:intron_variant:MODIFIER:intron6/8:c.773-53G>T::,CFH:ENST00000695968.1:intron_variant:MODIFIER:intron5/7:c.782-53G>T::,CFH:ENST00000695969.1:intron_variant:MODIFIER:intron7/16:c.965-53G>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron7/20:c.965-53G>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron7/21:c.965-74G>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron7/20:c.965-53G>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron8/22:c.776-53G>T::,CFH:ENST00000695978.1:intron_variant:MODIFIER:intron7/10:c.965-53G>T::,CFH:ENST00000695979.1:intron_variant:MODIFIER:intron7/9:c.965-74G>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron7/22:c.965-53G>T::,CFH:ENST00000696023.1:intron_variant:MODIFIER:intron7/9:c.965-53G>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+16204G>T::,CFH:ENST00000696030.1:intron_variant:MODIFIER:intron7/9:c.965-128G>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron7/9:c.965-53G>T::,CFH:ENST00000695987.1:intron_variant:MODIFIER:intron7/9:c.776-53G>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1276326 [benign DISEASE=not provided];			rs482934	0.6916	0.7857,0.7594,0.9480,0.6194,0.7205	37045,.	30974	46850	-0.1410			1.48			COSV62776949	0	19796758,24453474	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196689775	196689775	G	A	het	het	het	off-target	QUAL=1074;DP=71,17,13;AF=0.49,0.29,0.54;MQM=60;SAP=105;ABP=4;SAR=47;SAF=0	CFH	intron	CFH:ENST00000359637.3:intron_variant:MODIFIER:intron7/8:c.967+161G>A::,CFH:ENST00000695968.1:intron_variant:MODIFIER:intron6/7:c.976+161G>A::,CFH:ENST00000695969.1:intron_variant:MODIFIER:intron8/16:c.1159+161G>A::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron8/20:c.1159+161G>A::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron8/21:c.1138+161G>A::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron8/20:c.1159+161G>A::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron9/22:c.970+161G>A::,CFH:ENST00000695978.1:intron_variant:MODIFIER:intron8/10:c.1159+161G>A::,CFH:ENST00000695979.1:intron_variant:MODIFIER:intron8/9:c.1138+161G>A::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron8/22:c.1159+161G>A::,CFH:ENST00000696023.1:intron_variant:MODIFIER:intron8/9:c.1159+161G>A::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron8/21:c.1159+161G>A::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron8/21:c.1159+161G>A::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron8/21:c.1159+161G>A::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+16612G>A::,CFH:ENST00000696030.1:intron_variant:MODIFIER:intron8/9:c.1084+161G>A::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron8/21:c.1159+161G>A::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron8/9:c.1159+161G>A::,CFH:ENST00000695987.1:intron_variant:MODIFIER:intron8/9:c.970+161G>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1289573 [benign DISEASE=not provided];			rs12029785	0.6451	0.6292,0.7372,0.9483,0.6184,0.7202	32007,.	33854	53844	-0.2900			0.27				0	24453474	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196690107	196690107	C	T	het	het	het		QUAL=5483;DP=190,104,108;AF=0.57,0.41,0.49;MQM=57;SAP=134;ABP=3;SAR=47;SAF=158	CFH	missense,intron	CFH:ENST00000359637.3:missense_variant:MODERATE:exon8/9:c.1012C>T:p.His338Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695968.1:missense_variant:MODERATE:exon7/8:c.1021C>T:p.His341Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695969.1:missense_variant:MODERATE:exon9/17:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695970.1:missense_variant:MODERATE:exon9/21:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695971.1:missense_variant:MODERATE:exon9/22:c.1183C>T:p.His395Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695974.1:missense_variant:MODERATE:exon9/21:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:missense_variant:MODERATE:exon10/23:c.1015C>T:p.His339Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695978.1:missense_variant:MODERATE:exon9/11:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695979.1:missense_variant:MODERATE:exon9/10:c.1183C>T:p.His395Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695981.1:missense_variant:MODERATE:exon9/23:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696023.1:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+16944C>T::,CFH:ENST00000696030.1:missense_variant:MODERATE:exon9/10:c.1129C>T:p.His377Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695987.1:missense_variant:MODERATE:exon9/10:c.1015C>T:p.His339Tyr:PF00084 [Sushi repeat (SCR repeat)]		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294490 [benign(replaced by megSAP based on classifications:10x1,1x3) DISEASE=Basal laminar drusen,Hemolytic uremic syndrome, atypical, susceptibility to, 1,Factor H deficiency,Age related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided];			rs1061170	0.6446	0.6290,0.7374,0.9484,0.6178,0.7192	31967,.	33902	53948	-8.3310	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00), ,T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.01),B(0.00),B(0.01),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00), ,B(0.00),B(0.00),B(0.00),B(0.00)	0.00	0.09		COSV62776341	0.01	18248681,16519819,16723442,17697822,18162041,19076828,19692124,18541031,29334895,29700787,23820649,19861685,20203157,23251215,26559391,31118930,27306948,16080115,17314151,22022419,22253485,30696427,24498017,18043728,19796758,22035603,22059990,26152901,27239600,24453474,21637784,22969267,23873044,25132797,24586071,25786237,15761122,17167412,17917691,19026761,19958499,20961462,21072178,22259222,22618592,24526414,25276841,25883802,22936692,26681391,16936733,21807600,23523162,23577725,19825847,26493033,20157618,22694956,23620142,20378180,24692129,23289807,32034129,32100327,20385826,22155603,29579787,26490493,17591627,20157352,23112570,15870199,16299065,17022693,17877809,17962488,18316707,18515590,19187823,19259132,19823576,20132989,20581873,20678803,20689796,21394116,21555552,21609242,21784901,21811649,21850184,21856016,22019782,22046503,22174912,22509112,22536038,22558131,22666427,23103884,23111182,23289808,23687431,23919682,24120328,24403817,24558588,24675670,24860613,25205864,25558172,25612476,25792034,2617185	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196701627	196701627	C	T	het	het	het	off-target	QUAL=3757;DP=161,62,88;AF=0.52,0.45,0.56;MQM=58;SAP=353;ABP=4;SAR=161;SAF=0	CFH	intron,3'UTR	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron9/16:c.1336+11388C>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron9/20:c.1336+11388C>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron9/21:c.1315+11388C>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron9/20:c.1336+11388C>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron10/22:c.1147+11388C>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron9/22:c.1336+11388C>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron9/21:c.1336+11388C>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron9/21:c.1336+11388C>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron9/21:c.1336+11388C>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-26719C>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron9/21:c.1336+11388C>T::,CFH:ENST00000695987.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*296C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]			LTR26 (LTR/ERV1)	rs4658046	0.6475	0.6402,0.7394,0.9473,0.6172,0.7187	32287,.	33754	53526	-1.8450			0.44				0	24453474,16936733,32843070,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196701709	196701709	A	G	het	het	het	off-target	QUAL=1478;DP=89,14,18;AF=0.52,0.57,0.50;MQM=60;SAP=140;ABP=3;SAR=63;SAF=0	CFH	intron,3'UTR	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron9/16:c.1336+11470A>G::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron9/20:c.1336+11470A>G::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron9/21:c.1315+11470A>G::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron9/20:c.1336+11470A>G::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron10/22:c.1147+11470A>G::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron9/22:c.1336+11470A>G::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron9/21:c.1336+11470A>G::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron9/21:c.1336+11470A>G::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron9/21:c.1336+11470A>G::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-26637A>G::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron9/21:c.1336+11470A>G::,CFH:ENST00000695987.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*378A>G::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]				rs10754199	0.6476	0.6400,0.7397,0.9477,0.6173,0.7186	32284,.	33729	53489	-0.5760			3.62				0	16936733,20385819,29875488	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196713817	196713817	G	A	het	het	het		QUAL=8591;DP=262,192,257;AF=0.42,0.49,0.48;MQM=60;SAP=100;ABP=13;SAR=103;SAF=224	CFH	synonymous,intron	CFH:ENST00000695969.1:synonymous_variant:LOW:exon10/17:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695970.1:synonymous_variant:LOW:exon10/21:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695971.1:synonymous_variant:LOW:exon10/22:c.1398G>A:p.Ala466=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695974.1:synonymous_variant:LOW:exon10/21:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:synonymous_variant:LOW:exon11/23:c.1230G>A:p.Ala410=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695981.1:synonymous_variant:LOW:exon10/23:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-14529G>A::,CFH:ENST00000367429.9:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)]		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294491 [benign DISEASE=Basal laminar drusen,Hemolytic uremic syndrome, atypical, susceptibility to, 1,Factor H deficiency,Age related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided];	CM062504 [CLASS=DP MUT=ALT PHEN="Membranoproliferative glomerulonephritis association" GENE=CFH];		rs2274700	0.4394	0.4650,0.4845,0.4436,0.4080,0.5585	14776,.	37072	85016	0.4850			1.75			COSV66406791	0.01	29700787,22022419,18043728,19796758,22035603,27239600,24453474,21637784,23873044,26838040,17917691,22618592,22936692,26681391,16936733,21807600,23523162,19825847,24692129,18421087,20161815,30179527,15870199,16299065,17962488,20132989,20678803,22046503,22558131,23687431,24860613,25612476,25771815,27778189,27832277,30225264,22905135,20339564,16612335,17327825,18081690,20843825,21402993,22324898,22699975,22848687,24289920,28358029,26852301,19692168,27625572,31819893,29875488,29376001,29142592,23441108,19025119,29854987,29033536,29263899,24391822,26634245,15163532,18596911,21882633,23582991,33564431,34502390,32578437,32610483,32328755,32179765,20523265	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196715438	196715438	C	T	het	wt	het	off-target	QUAL=1362;DP=95,16,18;AF=0.57,0.00,0.22;MQM=60;SAP=129;ABP=3;SAR=0;SAF=58	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron10/16:c.1520-155C>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron10/20:c.1520-155C>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron10/21:c.1499-155C>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron10/20:c.1520-155C>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron11/22:c.1331-155C>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron10/22:c.1520-155C>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron10/21:c.1520-155C>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron10/21:c.1520-155C>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron10/21:c.1520-155C>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-12908C>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron10/21:c.1520-155C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]				rs535465835	0.0001	0.0001,0.0000,0.0000,0.0001,0.0000	0,.	11	151981	-2.4820			0.01				0		0	0	0 / 0					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196715444	196715444	C	T	het	wt	het	off-target	QUAL=1426;DP=100,18,22;AF=0.54,0.00,0.27;MQM=60;SAP=133;ABP=3;SAR=0;SAF=60	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron10/16:c.1520-149C>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron10/20:c.1520-149C>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron10/21:c.1499-149C>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron10/20:c.1520-149C>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron11/22:c.1331-149C>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron10/22:c.1520-149C>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron10/21:c.1520-149C>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron10/21:c.1520-149C>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron10/21:c.1520-149C>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-12902C>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron10/21:c.1520-149C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1265873 [benign DISEASE=not provided];			rs6664877	0.1972	0.2683,0.1530,0.0552,0.1750,0.3196	3298,.	23357	121919	-1.1770			0.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196715445	196715445	A	G	het	wt	het	off-target	QUAL=1426;DP=100,18,22;AF=0.54,0.00,0.27;MQM=60;SAP=133;ABP=3;SAR=0;SAF=60	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron10/16:c.1520-148A>G::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron10/20:c.1520-148A>G::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron10/21:c.1499-148A>G::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron10/20:c.1520-148A>G::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron11/22:c.1331-148A>G::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron10/22:c.1520-148A>G::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron10/21:c.1520-148A>G::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron10/21:c.1520-148A>G::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron10/21:c.1520-148A>G::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-12901A>G::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron10/21:c.1520-148A>G::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1290753 [benign DISEASE=not provided];			rs6677460	0.2320	0.3508,0.1676,0.0550,0.1953,0.3264	4767,.	25716	116710	0.0970			2.16				0	32321835	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196715495	196715495	G	T	het	het	het	off-target	QUAL=2530;DP=137,44,62;AF=0.43,0.55,0.42;MQM=60;SAP=240;ABP=9;SAR=0;SAF=109	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron10/16:c.1520-98G>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron10/20:c.1520-98G>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron10/21:c.1499-98G>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron10/20:c.1520-98G>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron11/22:c.1331-98G>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron10/22:c.1520-98G>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron10/21:c.1520-98G>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron10/21:c.1520-98G>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron10/21:c.1520-98G>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-12851G>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron10/21:c.1520-98G>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1258057 [benign DISEASE=not provided];			rs203674	0.6555	0.7355,0.7410,0.9474,0.5790,0.7119	33388,.	32783	52327	-0.9460			0.29				0	18541031,21197116,18043728,19796758,22035603,22059990,26152901,27239600,15870199,30073298,28729648,19878229,25735482,24272913	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196736796	196736796	C	A	het	het	het	off-target;low_conf_region	QUAL=139;DP=16,4,13;AF=0.25,0.50,0.38;MQM=60;SAP=19;ABP=11;SAR=1;SAF=10	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron15/16:c.2414-28C>A::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron15/20:c.2414-28C>A::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron15/21:c.2393-28C>A::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron14/20:c.2237-28C>A::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron16/22:c.2225-28C>A::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron15/22:c.2414-28C>A::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron15/21:c.2408-28C>A::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron3/9:c.422-28C>A::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1274202 [benign DISEASE=not provided];		(TTAATT)n (Simple_repeat)	rs375046	0.6730	0.7965,0.7473,0.9425,0.5778,0.7201	35062,.	31009	49135	-1.3850			0.85				0.05	24453474,22834933	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196740686	196740686	G	T	het	wt	het		QUAL=6993;DP=283,187,216;AF=0.53,0.00,0.51;MQM=60;SAP=40;ABP=5;SAR=97;SAF=164	CFH	intron,missense	CFH:ENST00000695970.1:intron_variant:MODIFIER:intron17/20:c.2783-1189G>T::,CFH:ENST00000695971.1:missense_variant:MODERATE:exon18/22:c.2829G>T:p.Gln943His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695974.1:missense_variant:MODERATE:exon17/21:c.2673G>T:p.Gln891His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:missense_variant:MODERATE:exon19/23:c.2661G>T:p.Gln887His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695981.1:missense_variant:MODERATE:exon18/23:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:missense_variant:MODERATE:exon18/22:c.2844G>T:p.Gln948His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:missense_variant:MODERATE:exon6/10:c.858G>T:p.Gln286His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)]		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294510 [likely benign(replaced by megSAP based on classifications:2x1,5x2,1x3) DISEASE=Basal laminar drusen,Hemolytic uremic syndrome, atypical, susceptibility to, 1,Age related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not specified,not provided];	CM034428 [CLASS=DM? MUT=ALT PHEN="Haemolytic uraemic syndrome" GENE=CFH];		rs149474608	0.0040	0.0011,0.0039,0.0000,0.0061,0.0002	0,.	607	151421	-0.6000	 ,D(0.04),D(0.04),D(0.04),D(0.04),D(0.04),D(0.03),D(0.04),D(0.03),D(0.04)	 ,B(0.00),B(0.02),B(0.00),B(0.00),B(0.00),B(0.02),B(0.00),B(0.01),D(0.99)	16.35	0.32		COSV99054698	0	14583443,27007659,28056875,25814826,30377230,29148534,28752844,32641076	1	219	0 / 0	2	"[2] Ute Grasshoff 30.01.2015 [n/a] comment imported from detected variant: conflicting evidence"			CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196741786	196741786	T	C	het	wt	het	off-target	QUAL=2996;DP=122,69,87;AF=0.59,0.01,0.55;MQM=60;SAP=266;ABP=13;SAR=0;SAF=121	CFH	intron	CFH:ENST00000695970.1:intron_variant:MODIFIER:intron17/20:c.2783-89T>C::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron18/21:c.2936-89T>C::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron17/20:c.2780-89T>C::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron19/22:c.2768-89T>C::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron18/22:c.2957-89T>C::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron18/21:c.2951-89T>C::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron18/21:c.2885-89T>C::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron18/21:c.2957-95T>C::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron6/9:c.965-89T>C::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron18/21:c.2957-89T>C::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1228859 [benign DISEASE=not provided];			rs16840522	0.2263	0.3314,0.1682,0.0546,0.1948,0.3244	4491,.	25437	117689	0.6700			7.56			COSV66408666	0	17314151,24453474,23873044,32321835,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196743447	196743447	T	C	wt	het	wt		QUAL=305;DP=179,132,120;AF=0.00,0.23,0.00;MQM=45;SAP=70;ABP=84;SAR=0;SAF=31	CFH	splice_region&intron	CFH:ENST00000695970.1:splice_region_variant&intron_variant:LOW:intron18/20:c.2960-5T>C::,CFH:ENST00000695971.1:splice_region_variant&intron_variant:LOW:intron19/21:c.3113-5T>C::,CFH:ENST00000695974.1:splice_region_variant&intron_variant:LOW:intron18/20:c.2957-5T>C::,CFH:ENST00000695976.1:splice_region_variant&intron_variant:LOW:intron20/22:c.2945-5T>C::,CFH:ENST00000695981.1:splice_region_variant&intron_variant:LOW:intron19/22:c.3134-5T>C::,CFH:ENST00000696027.1:splice_region_variant&intron_variant:LOW:intron19/21:c.3128-5T>C::,CFH:ENST00000696028.1:splice_region_variant&intron_variant:LOW:intron19/21:c.3062-5T>C::,CFH:ENST00000696029.1:splice_region_variant&intron_variant:LOW:intron19/21:c.3128-5T>C::,CFH:ENST00000695984.1:splice_region_variant&intron_variant:LOW:intron7/9:c.1142-5T>C::,CFH:ENST00000367429.9:splice_region_variant&intron_variant:LOW:intron19/21:c.3134-5T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	875337 [uncertain significance DISEASE=Basal laminar drusen,Hemolytic uremic syndrome, atypical, susceptibility to, 1,Age related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not specified,not provided];			rs513699	0.0292	0.0297,0.0482,0.0476,0.0251,0.0249	0,.	3010	99962	3.0890			9.48		9.26>8.55	COSV66406795	0.04	26559391,29148534	0	6339	0 / 0					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196743456	196743456	C	T	wt	het	wt		QUAL=512;DP=192,149,135;AF=0.00,0.26,0.00;MQM=47;SAP=57;ABP=76;SAR=4;SAF=35	CFH	synonymous	CFH:ENST00000695970.1:synonymous_variant:LOW:exon19/21:c.2964C>T:p.Thr988=:,CFH:ENST00000695971.1:synonymous_variant:LOW:exon20/22:c.3117C>T:p.Thr1039=:,CFH:ENST00000695974.1:synonymous_variant:LOW:exon19/21:c.2961C>T:p.Thr987=:,CFH:ENST00000695976.1:synonymous_variant:LOW:exon21/23:c.2949C>T:p.Thr983=:,CFH:ENST00000695981.1:synonymous_variant:LOW:exon20/23:c.3138C>T:p.Thr1046=:,CFH:ENST00000696027.1:synonymous_variant:LOW:exon20/22:c.3132C>T:p.Thr1044=:,CFH:ENST00000696028.1:synonymous_variant:LOW:exon20/22:c.3066C>T:p.Thr1022=:,CFH:ENST00000696029.1:synonymous_variant:LOW:exon20/22:c.3132C>T:p.Thr1044=:,CFH:ENST00000695984.1:synonymous_variant:LOW:exon8/10:c.1146C>T:p.Thr382=:,CFH:ENST00000367429.9:synonymous_variant:LOW:exon20/22:c.3138C>T:p.Thr1046=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294519 [benign DISEASE=Basal laminar drusen,Hemolytic uremic syndrome, atypical, susceptibility to, 1,Age related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not specified];			rs61822181	0.0552	0.0525,0.0845,0.0951,0.0506,0.0464	0,.	5432	92896	-0.2980			2.55			COSV66406800	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196746205	196746205	G	A	het	wt	het	off-target	QUAL=1062;DP=72,10,12;AF=0.58,0.00,0.50;MQM=51;SAP=107;ABP=7;SAR=48;SAF=0	CFH	intron	CFH:ENST00000695970.1:intron_variant:MODIFIER:intron20/20:c.3319+206G>A::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron21/21:c.3472+206G>A::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron20/20:c.3316+206G>A::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron22/22:c.3304+206G>A::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron21/22:c.3493+206G>A::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron21/21:c.3487+206G>A::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron21/21:c.3421+206G>A::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron21/21:c.3487+206G>A::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron9/9:c.1501+206G>A::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron21/21:c.3493+206G>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]			AluY (SINE/Alu)	rs34231058	0.0364	0.0073,0.0292,0.0430,0.0465,0.1022	170,.	5187	146489	0.5070			2.17				0.03		0	45	0 / 0					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	197084011	197084011	T	C	het	het	het	off-target	QUAL=1224;DP=89,7,9;AF=0.51,0.43,0.44;MQM=60;SAP=116;ABP=3;SAR=0;SAF=52	ASPM	downstream_gene	ASPM:ENST00000367409.9:downstream_gene_variant:MODIFIER::::,ASPM:ENST00000680265.1:downstream_gene_variant:MODIFIER::::,ASPM:ENST00000294732.11:downstream_gene_variant:MODIFIER::::,ASPM:ENST00000680710.1:downstream_gene_variant:MODIFIER::::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1252618 [benign DISEASE=not provided];			rs1332660	0.1762	0.0444,0.3331,0.6941,0.1619,0.3092	3852,.	19080	125230	-0.1650			6.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197084243	197084243	G	A	hom	hom	hom		QUAL=19004;DP=240,138,197;AF=1.00,1.00,1.00;MQM=60;SAP=66;ABP=0;SAR=223;SAF=352	ASPM	3'UTR	ASPM:ENST00000367409.9:3_prime_UTR_variant:MODIFIER:exon28/28:c.*81C>T::,ASPM:ENST00000680265.1:3_prime_UTR_variant:MODIFIER:exon29/29:c.*81C>T::,ASPM:ENST00000294732.11:3_prime_UTR_variant:MODIFIER:exon27/27:c.*81C>T::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	294591 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not provided];			rs12677	0.7844	0.4518,0.8713,0.9992,0.9102,0.8981	49972,.	19223	32749	3.0170			4.41				0	18541031	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197084432	197084432	A	-	het	het	het	low_conf_region	QUAL=420;DP=97,26,41;AF=0.21,0.12,0.29;MQM=59;SAP=48;ABP=120;SAR=31;SAF=4	ASPM	splice_region&intron	ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron27/27:c.10332-6del::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron28/28:c.10554-6del::,ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron26/26:c.5577-6del::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron27/27:c.10308-6del::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1204775 [likely benign DISEASE=not provided];			rs200839523	0.0035	0.0048,0.0034,0.0014,0.0018,0.0009	2,.	496	142552	-0.4390			0.01				0.01		0	15	0 / 0					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197086652	197086652	T	C	hom	hom	hom	off-target	QUAL=4305;DP=80,28,32;AF=1.00,1.00,1.00;MQM=60;SAP=307;ABP=0;SAR=0;SAF=140	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron27/27:c.10331+151A>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron28/28:c.10553+151A>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron26/26:c.5576+151A>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron27/27:c.10307+151A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678055 [benign DISEASE=not provided];			rs10733087	0.7840	0.4507,0.8712,0.9992,0.9103,0.8980	49998,.	19231	32857	-0.6590			1.16				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197086795	197086795	T	C	hom	hom	hom		QUAL=13633;DP=168,108,137;AF=1.00,1.00,1.00;MQM=60;SAP=199;ABP=0;SAR=110;SAF=303	ASPM	splice_region&intron	ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron27/27:c.10331+8A>G::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron28/28:c.10553+8A>G::,ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron26/26:c.5576+8A>G::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron27/27:c.10307+8A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	157775 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not specified,not provided];			rs10754213	0.7841	0.4511,0.8714,0.9992,0.9104,0.8977	49988,.	19226	32816	-0.0560			1.86				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197090748	197090748	G	A	hom	hom	hom	off-target	QUAL=5522;DP=95,41,53;AF=0.99,1.00,1.00;MQM=60;SAP=411;ABP=0;SAR=0;SAF=188	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron23/27:c.9636+102C>T::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron24/28:c.9858+102C>T::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron22/26:c.4881+102C>T::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron23/27:c.9612+102C>T::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673924 [benign DISEASE=not provided];			rs4915315	0.7703	0.4059,0.8652,0.9787,0.9099,0.8980	48974,.	19084	34902	-2.4770			0.03				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197090762	197090762	A	G	hom	hom	hom	off-target	QUAL=6262;DP=99,47,65;AF=1.00,1.00,1.00;MQM=60;SAP=461;ABP=0;SAR=0;SAF=211	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron23/27:c.9636+88T>C::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron24/28:c.9858+88T>C::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron22/26:c.4881+88T>C::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron23/27:c.9612+88T>C::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673923 [benign DISEASE=not provided];			rs10754214	0.7627	0.3795,0.8633,0.9787,0.9098,0.8974	48486,.	18913	36051	0.7910			5.73				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197090798	197090798	A	G	hom	hom	hom	off-target	QUAL=8873;DP=104,80,101;AF=1.00,1.00,1.00;MQM=60;SAP=483;ABP=0;SAR=17;SAF=268	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron23/27:c.9636+52T>C::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron24/28:c.9858+52T>C::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron22/26:c.4881+52T>C::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron23/27:c.9612+52T>C::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673922 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not provided];			rs4915316	0.7625	0.3789,0.8632,0.9787,0.9098,0.8975	48460,.	18909	36079	1.5570			5.16				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197091229	197091230	TG	-	hom	n/a	n/a	off-target	QUAL=1269;DP=62,2,1;AF=0.82,0.50,1.00;MQM=60;SAP=118;ABP=0;SAR=53;SAF=0	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron22/27:c.9445-189_9445-188del::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron23/28:c.9667-189_9667-188del::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron21/26:c.4690-189_4690-188del::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron22/27:c.9421-189_9421-188del::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1274698 [benign DISEASE=not provided];		(TG)n (Simple_repeat)	rs35277950	0.7832	0.4530,0.8703,0.9990,0.9082,0.8970	49331,.	19335	32667	0.3770			0.60				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101391	197101391	C	G	wt	het	wt		QUAL=1189;DP=299,97,129;AF=0.00,0.49,0.00;MQM=60;SAP=12;ABP=3;SAR=17;SAF=31	ASPM	missense,intron	ASPM:ENST00000367409.9:missense_variant:MODERATE:exon18/28:c.7860G>C:p.Gln2620His:,ASPM:ENST00000680265.1:missense_variant:MODERATE:exon18/29:c.7860G>C:p.Gln2620His:,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5227G>C::,ASPM:ENST00000680710.1:missense_variant:MODERATE:exon18/28:c.7860G>C:p.Gln2620His:	regulatory_region_variant:enhancer	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21609 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not specified,not provided];			rs12138336	0.0487	0.0140,0.0448,0.0008,0.0732,0.0288	237,.	6911	144317	-0.9070	T(0.10),T(0.08), ,T(0.12)	B(0.03),B(0.05), ,B(0.00)	2.86	0.08		COSV54130527	0	25741868,18414213,20301772,16631353	3	99	0 / 0					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101646	197101646	C	T	het	het	het		QUAL=8718;DP=227,189,246;AF=0.55,0.46,0.49;MQM=60;SAP=13;ABP=3;SAR=185;SAF=146	ASPM	synonymous,intron	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif],ASPM:ENST00000680265.1:synonymous_variant:LOW:exon18/29:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif],ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5482G>A::,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif]	regulatory_region_variant:enhancer	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21603 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not specified,not provided];			rs10922162	0.1755	0.0420,0.3336,0.6955,0.1620,0.3052	3827,.	18942	124952	0.1710			1.00			COSV54139486	0	25741868,18414213,20301772,21297427,15355437,23381943	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101685	197101685	T	C	hom	hom	hom		QUAL=19698;DP=237,155,197;AF=1.00,1.00,1.00;MQM=60;SAP=35;ABP=0;SAR=341;SAF=248	ASPM	synonymous,intron	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon18/29:c.7566A>G:p.Leu2522=:,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5521A>G::,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:	regulatory_region_variant:enhancer	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21602 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not specified,not provided];			rs1412640	0.8119	0.5470,0.8835,0.9992,0.9105,0.8982	52003,.	19083	28509	-0.3560			1.00				0	25741868,20301772	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101771	197101771	A	G	hom	hom	hom		QUAL=23179;DP=318,167,205;AF=1.00,1.00,1.00;MQM=60;SAP=17;ABP=0;SAR=312;SAF=378	ASPM	missense,intron	ASPM:ENST00000367409.9:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:,ASPM:ENST00000680265.1:missense_variant:MODERATE:exon18/29:c.7480T>C:p.Tyr2494His:,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5607T>C::,ASPM:ENST00000680710.1:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:	regulatory_region_variant:enhancer	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21599 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not specified,not provided];			rs964201	0.9967	0.9992,0.9979,0.9998,0.9942,0.9977	75383,.	507	507	3.0690	T(1.00),T(1.00), ,T(1.00)	B(0.00),B(0.00), ,B(0.01)	15.59	0.19			0	25741868,18414213,20301772,25480035,16141009	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197122407	197122407	A	T	hom	hom	hom		QUAL=24410;DP=311,201,250;AF=1.00,1.00,1.00;MQM=60;SAP=141;ABP=0;SAR=271;SAF=491	ASPM	synonymous	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000680265.1:synonymous_variant:LOW:exon14/29:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000294732.11:synonymous_variant:LOW:exon14/27:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000680710.1:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain]		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21578 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not specified,not provided];			rs4915337	0.7840	0.4510,0.8714,0.9988,0.9101,0.8979	49965,.	19236	32836	-0.2950			7.32				0.01	25741868,18541031,20301772,16631353	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197123968	197123968	A	T	hom	hom	n/a	off-target	QUAL=3002;DP=89,5,2;AF=1.00,1.00,1.00;MQM=60;SAP=211;ABP=0;SAR=0;SAF=96	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron13/27:c.3390+142T>A::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron13/28:c.3390+142T>A::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron13/26:c.3390+142T>A::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron13/27:c.3390+142T>A::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	670423 [benign DISEASE=not provided];			rs6685259	0.8908	0.8192,0.9166,0.9992,0.9116,0.8999	60497,.	14464	16612	-2.2250			0.02				0	34260948	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197124702	197124702	T	C	hom	n/a	hom	off-target	QUAL=598;DP=17,0,3;AF=1.00,,1.00;MQM=59;SAP=46;ABP=0;SAR=0;SAF=20	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron12/27:c.3168+168A>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron12/28:c.3168+168A>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron12/26:c.3168+168A>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron12/27:c.3168+168A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1227779 [benign DISEASE=not provided];		(AT)n (Simple_repeat)	rs4915338	0.7600	0.3778,0.8609,0.9793,0.9051,0.8951	47870,.	19040	36244	0.9350			5.43				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197124900	197124900	C	T	het	het	het		QUAL=9389;DP=392,152,183;AF=0.50,0.48,0.48;MQM=60;SAP=298;ABP=4;SAR=68;SAF=288	ASPM	synonymous	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon12/29:c.3138G>A:p.Arg1046=:,ASPM:ENST00000294732.11:synonymous_variant:LOW:exon12/27:c.3138G>A:p.Arg1046=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21573 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not specified,not provided];			rs6676084	0.2568	0.1590,0.2532,0.1264,0.3106,0.2969	5398,.	28171	112803	-1.3250			0.48			COSV54127589,COSV54135932	0.03	25741868,18414213,20301772,21297427	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197128343	197128343	-	A	het	het	het	off-target	QUAL=803;DP=53,8,5;AF=0.47,0.75,0.60;MQM=59;SAP=77;ABP=3;SAR=0;SAF=34	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron10/27:c.2936+146dup::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron10/28:c.2936+146dup::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron10/26:c.2936+146dup::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron10/27:c.2936+146dup::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1242265 [benign DISEASE=not provided];			rs200280533	0.6863	0.3870,0.7955,0.9514,0.7705,0.8213	34339,.	25961	43259				1.23				0.05		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197129013	197129013	G	C	hom	hom	hom	off-target	QUAL=5988;DP=143,18,31;AF=1.00,1.00,1.00;MQM=60;SAP=420;ABP=0;SAR=0;SAF=192	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron9/27:c.2760+174C>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron9/28:c.2760+174C>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron9/26:c.2760+174C>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron9/27:c.2760+174C>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678053 [benign DISEASE=not provided];			rs6695300	0.8651	0.7323,0.9007,0.9992,0.9111,0.8999	57378,.	16691	20499	-1.2280			0.31				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197132491	197132491	T	C	hom	hom	hom	off-target	QUAL=4757;DP=72,41,42;AF=0.99,1.00,1.00;MQM=60;SAP=337;ABP=0;SAR=154;SAF=0	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron6/27:c.2420-139A>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron6/28:c.2420-139A>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron6/26:c.2420-139A>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron6/27:c.2420-139A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678052 [benign DISEASE=not provided];			rs3737111	0.4571	0.2843,0.5947,0.8225,0.4736,0.6074	17213,.	34940	82404	-0.8560			1.42				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197133615	197133615	A	G	het	het	het	off-target	QUAL=3220;DP=142,70,73;AF=0.49,0.40,0.45;MQM=60;SAP=228;ABP=8;SAR=123;SAF=7	ASPM	splice_region&intron	ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron5/27:c.2174-20T>C::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron5/28:c.2174-20T>C::,ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron5/26:c.2174-20T>C::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron5/27:c.2174-20T>C::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95887 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not specified,not provided];			rs4915344	0.1764	0.0444,0.3334,0.6948,0.1619,0.3102	3862,.	19095	125223	0.8830			16.16		6.91>6.50	COSV54132578	0.18	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197133709	197133709	A	C	hom	hom	hom	off-target	QUAL=4097;DP=97,16,22;AF=1.00,1.00,1.00;MQM=60;SAP=296;ABP=0;SAR=135;SAF=0	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron5/27:c.2174-114T>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron5/28:c.2174-114T>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron5/26:c.2174-114T>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron5/27:c.2174-114T>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678051 [benign DISEASE=not provided];			rs4915345	0.8123	0.5475,0.8835,0.9992,0.9103,0.8983	52118,.	19146	28516	-0.7650			0.63				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197135020	197135020	A	-	hom	hom	hom	off-target	QUAL=4884;DP=98,25,39;AF=0.99,0.96,0.97;MQM=60;SAP=314;ABP=0;SAR=4;SAF=155	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron5/27:c.2173+76del::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron5/28:c.2173+76del::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron5/26:c.2173+76del::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron5/27:c.2173+76del::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673908 [benign DISEASE=not provided];			rs35659894	0.7625	0.3791,0.8629,0.9787,0.9097,0.8974	48507,.	18935	36119	0.2300			0.79				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197139563	197139563	C	T	hom	n/a	hom	off-target	QUAL=1669;DP=44,0,10;AF=1.00,,1.00;MQM=60;SAP=120;ABP=0;SAR=0;SAF=54	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron4/27:c.2026+204G>A::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron4/28:c.2026+204G>A::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron4/26:c.2026+204G>A::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron4/27:c.2026+204G>A::	regulatory_region_variant:enhancer	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678050 [benign DISEASE=not provided];		L1MA4 (LINE/L1)	rs10737687	0.7625	0.3789,0.8630,0.9788,0.9097,0.8975	48512,.	18935	36117	0.3670			4.02				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197139816	197139816	A	G	het	het	wt		QUAL=4128;DP=256,109,143;AF=0.42,0.44,0.00;MQM=60;SAP=27;ABP=21;SAR=57;SAF=98	ASPM	synonymous	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon4/29:c.1977T>C:p.Ile659=:,ASPM:ENST00000294732.11:synonymous_variant:LOW:exon4/27:c.1977T>C:p.Ile659=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21561 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not specified,not provided];			rs17550662	0.0410	0.0090,0.0310,0.0000,0.0636,0.0110	178,.	5880	145940	2.0950			6.35				0.2	18414213,20301772,21297427	76	2313	0 / 0					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197139912	197139912	C	T	hom	hom	hom	off-target	QUAL=12561;DP=234,65,88;AF=1.00,1.00,1.00;MQM=60;SAP=452;ABP=0;SAR=335;SAF=52	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron3/28:c.1922-41G>A::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron3/26:c.1922-41G>A::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	157788 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not specified,not provided];			rs1332663	0.7842	0.4513,0.8715,0.9992,0.9101,0.8981	50010,.	19234	32822	-0.9920			5.70			COSV54136485	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197143403	197143403	G	A	hom	hom	hom		QUAL=7450;DP=111,61,52;AF=1.00,0.98,1.00;MQM=60;SAP=10;ABP=0;SAR=125;SAF=98	ASPM	synonymous	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon3/29:c.849C>T:p.Ser283=:,ASPM:ENST00000294732.11:synonymous_variant:LOW:exon3/27:c.849C>T:p.Ser283=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:	regulatory_region_variant:promoter	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95890 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not specified,not provided];			rs6677082	0.7627	0.3793,0.8632,0.9788,0.9097,0.8974	48487,.	18925	36061	0.2230			2.02				0	25741868,18541031,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197143943	197143943	G	A	hom	hom	hom	off-target	QUAL=4412;DP=107,14,21;AF=1.00,1.00,1.00;MQM=60;SAP=311;ABP=0;SAR=142;SAF=0	ASPM	splice_region&intron	ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron2/27:c.441+14C>T::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron2/28:c.441+14C>T::,ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron2/26:c.441+14C>T::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron2/27:c.441+14C>T::	regulatory_region_variant:promoter	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95888 [benign/likely benign DISEASE=Microcephaly 5, primary, autosomal recessive,not specified,not provided];			rs1571964	0.7628	0.3795,0.8632,0.9790,0.9096,0.8978	48485,.	18932	36040	0.1980			4.14				0	25741868,18414213,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	198638824	198638824	T	A	wt	wt	het	off-target	QUAL=80;DP=29,11,22;AF=0.00,0.00,0.32;MQM=60;SAP=18;ABP=9;SAR=0;SAF=7	PTPRC	upstream_gene	PTPRC:ENST00000348564.11:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000442510.8:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000697631.1:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000697632.1:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000367364.5:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000413409.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]				rs2274364	0.0370	0.0086,0.0836,0.1361,0.0317,0.0949	186,.	5247	146253	1.0410			7.16						0	0	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198638868	198638868	G	A	wt	wt	het	off-target	QUAL=447;DP=53,42,68;AF=0.00,0.00,0.37;MQM=60;SAP=57;ABP=13;SAR=0;SAF=25	PTPRC	upstream_gene	PTPRC:ENST00000348564.11:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000442510.8:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000697631.1:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000697632.1:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000367364.5:upstream_gene_variant:MODIFIER::::,PTPRC:ENST00000413409.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]				rs2274365	0.0696	0.1194,0.0991,0.1360,0.0326,0.0949	537,.	9506	141384	-0.5080			0.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198692539	198692539	G	A	het	het	wt		QUAL=808;DP=56,7,5;AF=0.46,0.86,0.00;MQM=60;SAP=10;ABP=3;SAR=11;SAF=21	PTPRC	intron,3'UTR	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron3/29:c.100+166G>A::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron3/32:c.100+166G>A::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron3/30:c.100+166G>A::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron2/28:c.-456+166G>A::,PTPRC:ENST00000367364.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*155G>A::,PTPRC:ENST00000413409.6:intron_variant:MODIFIER:intron3/3:c.100+166G>A::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]				rs115067628	0.0098	0.0023,0.0047,0.0002,0.0155,0.0083	17,.	1459	150195	-0.7680			0.15				0		2	185	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198696566	198696568	ATG	-	wt	wt	het	off-target	QUAL=611;DP=93,47,55;AF=0.00,0.00,0.51;MQM=60;SAP=64;ABP=3;SAR=0;SAF=28	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron3/29:c.100+4193_100+4195del::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron3/32:c.101-146_101-144del::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron3/30:c.101-146_101-144del::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron2/28:c.-456+4193_-456+4195del::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]			(TA)n (Simple_repeat)	rs1050669320	0.0001	0.0001,0.0001,0.0000,0.0000,0.0000	0,.	3	152191	0.0580			0.56				0		0	0	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198696788	198696788	C	G	wt	het	wt		QUAL=3192;DP=449,205,293;AF=0.00,0.58,0.00;MQM=60;SAP=8;ABP=15;SAR=68;SAF=52	PTPRC	intron,synonymous	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron3/29:c.100+4415C>G::,PTPRC:ENST00000442510.8:synonymous_variant:LOW:exon4/33:c.177C>G:p.Pro59=:,PTPRC:ENST00000697631.1:synonymous_variant:LOW:exon4/31:c.177C>G:p.Pro59=:,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron2/28:c.-456+4415C>G::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	378444 [benign/likely benign DISEASE=PTPRC POLYMORPHISM,Immunodeficiency 104,not specified,not provided];	CS952043 [CLASS=DFP MUT=ALT PHEN="Defective splicing" GENE=PTPRC];		rs17612648	0.0083	0.0026,0.0073,0.0002,0.0138,0.0071	8,.	1252	150872	0.5270			3.33			COSV100723197	0	25147926,16400609,19898481,20158892,18634151,19879912,22095823,22524693,28759630,30332657,31572362,21067564,19111528,32888494,31824477,21507955,15372250,7621884,11528386,11548742,11841494,11101853,12373647,16505159	3	564	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198697103	198697103	A	G	wt	wt	het	off-target	QUAL=20;DP=51,5,4;AF=0.00,0.00,0.75;MQM=60;SAP=10;ABP=5;SAR=3;SAF=0	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron3/29:c.100+4730A>G::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron4/32:c.298+194A>G::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron4/30:c.298+194A>G::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron2/28:c.-456+4730A>G::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1250478 [benign DISEASE=not provided];			rs2296618	0.2023	0.3606,0.1856,0.1233,0.1387,0.1696	3981,.	22769	121207	1.2130			9.34				0	31361310,31959851,27863252,30595370,31015401,32888494,34103634,34469753,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198708291	198708291	T	A	wt	wt	het	off-target	QUAL=521;DP=105,37,45;AF=0.00,0.00,0.51;MQM=60;SAP=24;ABP=3;SAR=19;SAF=4	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron7/29:c.550+30T>A::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron10/32:c.1033+30T>A::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron8/30:c.748+30T>A::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron6/28:c.-6+30T>A::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1271164 [benign DISEASE=not provided];			rs2274368	0.0537	0.0726,0.0913,0.1422,0.0314,0.0911	282,.	7606	143898	-0.3250			0.39				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198709964	198709964	G	A	het	wt	het	off-target	QUAL=1019;DP=73,8,13;AF=0.47,0.00,0.54;MQM=60;SAP=92;ABP=3;SAR=41;SAF=0	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron8/29:c.688+140G>A::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron11/32:c.1171+140G>A::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron9/30:c.886+140G>A::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron7/28:c.133+140G>A::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1288182 [benign DISEASE=not provided];		L1M4 (LINE/L1)	rs10753834	0.0843	0.0231,0.0942,0.0004,0.1233,0.0093	754,.	11300	139090	-0.2870			2.51				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198709964	198709964	G	T	wt	wt	het	off-target	QUAL=1019;DP=73,8,13;AF=0.00,0.00,0.46;MQM=60;SAP=16;ABP=3;SAR=6;SAF=0	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron8/29:c.688+140G>T::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron11/32:c.1171+140G>T::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron9/30:c.886+140G>T::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron7/28:c.133+140G>T::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1232658 [benign DISEASE=not provided];		L1M4 (LINE/L1)	rs10753834	0.4052	0.5916,0.4366,0.3903,0.3080,0.3822	13680,.	34174	90326	-0.2870			2.04				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198732160	198732160	T	C	hom	hom	het	off-target	QUAL=2962;DP=73,17,19;AF=1.00,1.00,0.63;MQM=60;SAP=225;ABP=6;SAR=0;SAF=102	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron15/29:c.1492-140T>C::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron18/32:c.1975-140T>C::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron16/30:c.1690-140T>C::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron14/28:c.937-140T>C::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1280542 [benign DISEASE=not provided];			rs1932433	0.6066	0.6546,0.5556,0.3520,0.6275,0.4267	28229,.	35409	59573	-0.9970			0.40				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198748089	198748089	-	T	het	het	het	off-target;low_conf_region	QUAL=700;DP=50,16,33;AF=0.30,0.56,0.24;MQM=60;SAP=42;ABP=30;SAR=4;SAF=28	PTPRC	splice_region&intron	PTPRC:ENST00000348564.11:splice_region_variant&intron_variant:LOW:intron23/29:c.2365-4dup::,PTPRC:ENST00000442510.8:splice_region_variant&intron_variant:LOW:intron26/32:c.2848-4dup::,PTPRC:ENST00000697631.1:splice_region_variant&intron_variant:LOW:intron24/30:c.2563-4dup::,PTPRC:ENST00000697632.1:splice_region_variant&intron_variant:LOW:intron22/28:c.1810-4dup::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs57296163	0.2590	0.0930,0.2271,0.1183,0.3688,0.1608	5361,.	24396	100450				0.22				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198749603	198749603	A	G	het	wt	het	off-target	QUAL=3828;DP=213,80,109;AF=0.47,0.00,0.50;MQM=60;SAP=298;ABP=4;SAR=150;SAF=5	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron25/29:c.2589+54A>G::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron28/32:c.3072+54A>G::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron26/30:c.2787+54A>G::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron24/28:c.2034+54A>G::	regulatory_region_variant:open_chromatin_region	151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]				rs549239314	0.0010	0.0005,0.0003,0.0000,0.0017,0.0000	0,.	150	151734	-0.6400			0.07				0		0	45	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198754594	198754594	-	TAAG	hom	n/a	het	off-target	QUAL=1809;DP=66,2,6;AF=0.94,1.00,0.33;MQM=60;SAP=146;ABP=4;SAR=66;SAF=0	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron29/29:c.3162+192_3162+195dup::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron32/32:c.3645+192_3645+195dup::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron30/30:c.3360+192_3360+195dup::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron28/28:c.2607+192_2607+195dup::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1286830 [benign DISEASE=not provided];			rs34412391	0.2507	0.1064,0.2201,0.0911,0.3535,0.1399	5669,.	26544	113202				1.41				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	201039454	201039454	-	G	hom	het	het	off-target	QUAL=1995;DP=46,29,54;AF=0.91,0.52,0.50;MQM=60;SAP=185;ABP=3;SAR=0;SAF=84	CACNA1S	downstream_gene	CACNA1S:ENST00000362061.4:downstream_gene_variant:MODIFIER::::,CACNA1S:ENST00000681874.1:downstream_gene_variant:MODIFIER::::,CACNA1S:ENST00000367338.7:downstream_gene_variant:MODIFIER::::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]				rs35360610	0.5501	0.7856,0.4309,0.4175,0.4791,0.3254	24814,.	33943	68347				0.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201040158	201040158	C	T	wt	wt	het	off-target	QUAL=332;DP=104,32,33;AF=0.00,0.00,0.48;MQM=60;SAP=23;ABP=3;SAR=2;SAF=14	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron43/43:c.5370+73G>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron42/42:c.5310+73G>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron42/42:c.5313+73G>A::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]				rs1034542271	0.0001	0.0000,0.0000,0.0000,0.0001,0.0000	0,.	1	152209	-0.1020			2.36				0		0	0	0 / 0					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201040428	201040428	A	G	hom	het	het	off-target	QUAL=5964;DP=131,63,83;AF=0.99,0.52,0.48;MQM=60;SAP=125;ABP=3;SAR=155;SAF=48	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron42/43:c.5227-54T>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron41/42:c.5167-54T>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron41/42:c.5170-54T>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678243 [benign DISEASE=Hypokalemic periodic paralysis, type 1,not provided];			rs1546416	0.3581	0.4153,0.2937,0.2978,0.3533,0.2610	9989,.	34460	97588	-0.3470			0.78			COSV62945146	0.03	19825159,32765863	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201040769	201040769	T	C	hom	hom	hom	off-target	QUAL=3848;DP=54,30,46;AF=1.00,1.00,1.00;MQM=60;SAP=121;ABP=0;SAR=107;SAF=23	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron41/43:c.5135-56A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron40/42:c.5075-56A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron40/42:c.5078-56A>G::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678241 [benign DISEASE=Hypokalemic periodic paralysis, type 1,not provided];			rs6427875	0.9933	0.9975,0.9912,1.0000,0.9896,0.9948	75086,.	1002	1020	-4.2510			0.00				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201041734	201041734	T	C	hom	het	het	off-target	QUAL=3698;DP=62,92,107;AF=1.00,0.49,0.44;MQM=60;SAP=337;ABP=5;SAR=154;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron40/43:c.5049-145A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron39/42:c.4989-145A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron39/42:c.4992-145A>G::	regulatory_region_variant:CTCF_binding_site	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678239 [benign DISEASE=not provided];			rs6675915	0.5527	0.7934,0.4314,0.4264,0.4792,0.3275	25121,.	33779	68011	-0.0780			3.75			COSV62945328	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201043469	201043469	G	A	hom	wt	hom		QUAL=365;DP=10,3,4;AF=1.00,0.00,1.00;MQM=60;SAP=25;ABP=0;SAR=13;SAF=1	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon40/44:c.4860C>T:p.Pro1620=:,CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon39/43:c.4800C>T:p.Pro1600=:,CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon39/43:c.4803C>T:p.Pro1601=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254841 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis, type 1,not specified];			rs41267497	0.1045	0.0296,0.0901,0.0004,0.1619,0.0218	1167,.	13549	136047	-1.2030			0.12				0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201044208	201044208	T	C	hom	het	het	off-target	QUAL=6224;DP=75,129,186;AF=0.99,0.53,0.58;MQM=60;SAP=546;ABP=12;SAR=0;SAF=250	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron39/43:c.4797+120A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron38/42:c.4737+120A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron38/42:c.4740+120A>G::	regulatory_region_variant:CTCF_binding_site	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678237 [benign DISEASE=not provided];			rs2297906	0.5514	0.7882,0.4314,0.4252,0.4796,0.3270	24889,.	33867	68043	-0.2290			2.61				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201047168	201047168	G	A	wt	wt	het		QUAL=3275;DP=343,183,245;AF=0.00,0.00,0.52;MQM=60;SAP=14;ABP=4;SAR=51;SAF=76	CACNA1S	missense	CACNA1S:ENST00000362061.4:missense_variant:MODERATE:exon38/44:c.4615C>T:p.Arg1539Cys:,CACNA1S:ENST00000681874.1:missense_variant:MODERATE:exon37/43:c.4555C>T:p.Arg1519Cys:,CACNA1S:ENST00000367338.7:missense_variant:MODERATE:exon37/43:c.4558C>T:p.Arg1520Cys:		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	197021 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis, type 1,not specified,not provided];			rs3850625	0.0905	0.0215,0.0809,0.0360,0.1204,0.1930	823,.	12123	138313	7.7080	D(0.01),D(0.01),D(0.01)	B(0.30),B(0.09),B(0.30)	26.80	0.28		COSV62938023	0.01	25741868,23139751,19825159,26831199,24029420,28452372,30604766,31440704,31152163,31511532,31015462,33097823,30595370,33547301,25658027,31851124,33790942,34429635,34798807,34949935,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201050977	201050977	A	G	wt	het	het		QUAL=6114;DP=131,211,276;AF=0.01,0.53,0.49;MQM=60;SAP=98;ABP=3;SAR=72;SAF=176	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061.4:splice_region_variant&intron_variant:LOW:intron33/43:c.4113+7T>C::,CACNA1S:ENST00000681874.1:splice_region_variant&intron_variant:LOW:intron32/42:c.4053+7T>C::,CACNA1S:ENST00000367338.7:splice_region_variant&intron_variant:LOW:intron32/42:c.4056+7T>C::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	199680 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis, type 1,not specified,not provided];			rs6702590	0.7786	0.9288,0.8019,0.9940,0.6658,0.8757	47206,.	23958	33666	-0.1500			3.11				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201051232	201051232	G	A	hom	het	het	off-target	QUAL=6100;DP=121,114,140;AF=0.97,0.40,0.52;MQM=60;SAP=515;ABP=5;SAR=236;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron32/43:c.3954-89C>T::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron31/42:c.3894-89C>T::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron31/42:c.3897-89C>T::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	680202 [benign DISEASE=not provided];			rs12138260	0.1051	0.0291,0.0898,0.0004,0.1631,0.0217	1186,.	13615	136121	-1.2270			1.53				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201054308	201054308	C	T	wt	het	het	off-target	QUAL=363;DP=54,23,29;AF=0.00,0.48,0.38;MQM=60;SAP=51;ABP=6;SAR=0;SAF=22	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron29/43:c.3666+197G>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron28/42:c.3606+197G>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron28/42:c.3610-721G>A::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1238693 [benign DISEASE=not provided];			rs3818873	0.5322	0.3765,0.6450,0.8560,0.5384,0.8134	22798,.	35279	71083	-0.0660			3.98				0	32765863	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201054723	201054723	C	G	wt	het	het	off-target;low_conf_region	QUAL=61;DP=12,8,10;AF=0.00,0.50,0.60;MQM=59;SAP=25;ABP=3;SAR=10;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron28/43:c.3610-162G>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron27/42:c.3550-162G>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron28/42:c.3610-1136G>C::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]				rs529174581	0.1014	0.1430,0.0838,0.0438,0.0951,0.1216	0,.	571	5059	-1.5300			0.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201054728	201054728	T	G	wt	het	het	off-target	QUAL=66;DP=12,5,6;AF=0.00,0.80,0.83;MQM=58;SAP=23;ABP=13;SAR=9;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron28/43:c.3610-167A>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron27/42:c.3550-167A>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron28/42:c.3610-1141A>C::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	680271 [likely benign DISEASE=not provided];			rs988057279	0.0816	0.0890,0.0762,0.0671,0.0835,0.0969	0,.	889	10005	-2.7920			0.06				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201054732	201054732	T	G	wt	het	het	off-target	QUAL=66;DP=12,5,6;AF=0.00,0.80,0.83;MQM=58;SAP=23;ABP=13;SAR=9;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron28/43:c.3610-171A>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron27/42:c.3550-171A>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron28/42:c.3610-1145A>C::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]				rs913779535	0.1227	0.1228,0.0835,0.1205,0.1404,0.1272	0,.	2195	15693	-2.0630			2.81				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201062179	201062179	A	C	wt	het	het	off-target	QUAL=3316;DP=76,121,170;AF=0.00,0.40,0.53;MQM=60;SAP=193;ABP=5;SAR=124;SAF=14	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron23/43:c.2907-89T>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron22/42:c.2847-89T>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron23/42:c.2907-89T>G::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1192645 [benign DISEASE=Hypokalemic periodic paralysis, type 1,not provided];			rs2297903	0.5167	0.4823,0.6050,0.7606,0.4906,0.7006	20657,.	37057	73315	-1.5020			7.75				0.21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201069559	201069559	A	G	het	wt	het		QUAL=8030;DP=214,341,426;AF=0.47,0.00,0.51;MQM=60;SAP=19;ABP=3;SAR=183;SAF=135	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon18/44:c.2403T>C:p.Phe801=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:,CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:PF00520 [Ion transport protein]	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254814 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis, type 1,not specified,not provided];			rs7415038	0.4211	0.5259,0.3364,0.0016,0.4483,0.1700	14602,.	34746	87922	4.8560			12.17			COSV62939654	0.01	25741868,19825159,20681998	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201073349	201073351	CTG	-	het	wt	hom	off-target	QUAL=1310;DP=65,25,20;AF=0.66,0.00,1.00;MQM=60;SAP=140;ABP=18;SAR=0;SAF=63	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron15/43:c.2157+198_2157+200del::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron15/42:c.2157+198_2157+200del::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron15/42:c.2157+198_2157+200del::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678223 [benign DISEASE=not provided];			rs71138316	0.7059	0.4989,0.7269,0.9601,0.7753,0.8979	39104,.	28732	44558	0.2530			4.38				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201073490	201073490	G	A	het	wt	hom	off-target	QUAL=4972;DP=80,101,140;AF=0.49,0.00,1.00;MQM=60;SAP=127;ABP=3;SAR=39;SAF=140	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron15/43:c.2157+59C>T::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron15/42:c.2157+59C>T::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron15/42:c.2157+59C>T::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678298 [benign DISEASE=Hypokalemic periodic paralysis, type 1,not provided];			rs9333652	0.4396	0.3453,0.4761,0.9591,0.4016,0.7636	16095,.	34542	85068	0.1200			1.76				0	19825159	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201074718	201074719	CT	-	het	wt	het	off-target	QUAL=2514;DP=97,57,85;AF=0.49,0.00,0.88;MQM=60;SAP=270;ABP=52;SAR=123;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron13/43:c.1949-99_1949-98del::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron13/42:c.1949-99_1949-98del::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron13/42:c.1949-99_1949-98del::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678222 [benign DISEASE=Hypokalemic periodic paralysis, type 1,not provided];			rs66932448	0.7200	0.5472,0.7325,0.9601,0.7759,0.8980	40291,.	28681	42499	-0.2410			0.99				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201075620	201075620	A	G	het	wt	hom		QUAL=10528;DP=149,258,278;AF=0.52,0.00,1.00;MQM=60;SAP=25;ABP=4;SAR=208;SAF=148	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061.4:splice_region_variant&intron_variant:LOW:intron12/43:c.1828-5T>C::,CACNA1S:ENST00000681874.1:splice_region_variant&intron_variant:LOW:intron12/42:c.1828-5T>C::,CACNA1S:ENST00000367338.7:splice_region_variant&intron_variant:LOW:intron12/42:c.1828-5T>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254804 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis, type 1,not specified,not provided];			rs1998721	0.7208	0.5497,0.7329,0.9607,0.7760,0.8981	40463,.	28673	42455	-0.5120			0.14		11.27>10.69		0	25741868,27182706,32765863	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201076897	201076897	G	T	het	wt	het	off-target	QUAL=4279;DP=79,275,331;AF=0.48,0.01,0.52;MQM=60;SAP=313;ABP=4;SAR=19;SAF=193	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron12/43:c.1827+23C>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron12/42:c.1827+23C>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron12/42:c.1827+23C>A::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1293266 [benign DISEASE=not provided];		L2c (LINE/L2)	rs7549030	0.0679	0.0784,0.0490,0.0002,0.0705,0.0253	411,.	9510	141812	-0.1210			1.74				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077251	201077251	T	G	het	wt	hom	off-target	QUAL=5680;DP=70,129,172;AF=0.41,0.00,1.00;MQM=60;SAP=439;ABP=7;SAR=201;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron11/43:c.1620-124A>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron11/42:c.1620-124A>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron11/42:c.1620-124A>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678221 [benign DISEASE=not provided];			rs925060	0.7138	0.5686,0.6747,0.8157,0.7815,0.8684	39318,.	29650	43418	0.2580			4.14				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077260	201077260	A	G	het	wt	hom	off-target	QUAL=5147;DP=76,107,150;AF=0.46,0.00,1.00;MQM=60;SAP=405;ABP=4;SAR=185;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron11/43:c.1620-133T>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron11/42:c.1620-133T>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron11/42:c.1620-133T>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678220 [benign DISEASE=not provided];			rs6672094	0.8043	0.7947,0.7766,0.9594,0.7980,0.9091	49206,.	23618	29690	-4.3810			0.04				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077934	201077934	G	A	hom	hom	het		QUAL=15001;DP=139,260,266;AF=0.99,1.00,0.48;MQM=60;SAP=126;ABP=4;SAR=176;SAF=348	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon11/44:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein]		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254801 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis, type 1,not specified];	CM023570 [CLASS=DP MUT=ALT PHEN="Hypokalaemic periodic paralysis association with" GENE=CACNA1S];		rs4915476	0.2250	0.2593,0.2484,0.0402,0.2210,0.1005	4045,.	26128	117868	4.9060			9.80			COSV62944479	0	25741868,26648445,11940049	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077947	201077947	A	G	hom	hom	het		QUAL=17369;DP=184,267,286;AF=0.99,1.00,0.50;MQM=60;SAP=117;ABP=3;SAR=208;SAF=384	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon11/44:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein]		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254800 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis, type 1,not specified,not provided];			rs4915477	0.6848	0.8932,0.6517,0.2343,0.6507,0.2952	37747,.	28592	47920	-1.1500			3.40			COSV62938741	0	25741868,26648445,18325191	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201083071	201083071	T	C	hom	hom	het	off-target	QUAL=14784;DP=202,181,258;AF=1.00,0.99,0.50;MQM=60;SAP=1021;ABP=3;SAR=10;SAF=498	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron10/43:c.1393+91A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron10/42:c.1393+91A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron10/42:c.1393+91A>G::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678296 [benign DISEASE=not provided];			rs3767511	0.2226	0.2607,0.2270,0.0335,0.2207,0.1053	3960,.	25918	118192	-0.0180			6.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201083512	201083512	G	A	het	het	hom	off-target	QUAL=3414;DP=90,47,65;AF=0.43,0.57,1.00;MQM=60;SAP=287;ABP=3;SAR=131;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron9/43:c.1233-190C>T::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron9/42:c.1233-190C>T::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron9/42:c.1233-190C>T::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678219 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs4915478	0.6330	0.7323,0.6884,0.9975,0.5172,0.8211	31630,.	32918	55764	-1.0690			0.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201085069	201085069	G	T	wt	het	wt	off-target	QUAL=923;DP=82,88,113;AF=0.00,0.50,0.00;MQM=60;SAP=19;ABP=3;SAR=13;SAF=31	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron8/43:c.1151-38C>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron8/42:c.1151-38C>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron8/42:c.1151-38C>A::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678295 [benign DISEASE=not provided];			rs41267505	0.1565	0.1424,0.2207,0.0337,0.1633,0.0763	2027,.	19736	128238	-0.0120			0.41			COSV62945385	0	32572223	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201089564	201089564	T	C	hom	het	hom	off-target	QUAL=10825;DP=156,143,166;AF=1.00,0.50,1.00;MQM=60;SAP=848;ABP=3;SAR=392;SAF=1	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron5/43:c.695-101A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron5/42:c.695-101A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron5/42:c.695-101A>G::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678218 [benign DISEASE=not provided];			rs2296384	0.5839	0.5907,0.5150,0.3844,0.6239,0.5139	26217,.	36302	63242	-0.0040			2.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201091737	201091737	G	A	wt	wt	het		QUAL=2468;DP=165,158,185;AF=0.01,0.00,0.54;MQM=60;SAP=6;ABP=5;SAR=56;SAF=44	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon5/44:c.597C>T:p.Ile199=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon5/43:c.597C>T:p.Ile199=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon5/43:c.597C>T:p.Ile199=:PF00520 [Ion transport protein]	regulatory_region_variant:CTCF_binding_site	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254852 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis, type 1,not specified,not provided];			rs2296383	0.3282	0.1091,0.3489,0.3659,0.4329,0.4368	9768,.	30358	102112	-0.7110			8.08			COSV62936330	0.01	25741868,19825159,32765863,32825595	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201110404	201110404	C	T	het	wt	het	off-target	QUAL=3249;DP=123,133,188;AF=0.46,0.00,0.50;MQM=60;SAP=329;ABP=4;SAR=150;SAF=0	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron1/43:c.153-135G>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron1/42:c.153-135G>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron1/42:c.153-135G>A::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1298108 [benign DISEASE=not provided];			rs111530734	0.0205	0.0056,0.0165,0.0000,0.0248,0.0029	60,.	3001	149071	-0.8410			0.45				0.01	31211845	0	9	0 / 0					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39), ASCL5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209614868	209614868	T	C	hom	het	het		QUAL=5677;DP=152,41,72;AF=0.99,0.59,0.46;MQM=60;SAP=455;ABP=3;SAR=0;SAF=208	CAMK1G,LAMB3	downstream_gene	CAMK1G:ENST00000361322.3:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000651530.1:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000009105.5:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000356082.9:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000391911.5:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000367030.7:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	368859 [benign DISEASE=Junctional epidermolysis bullosa];			rs926387	0.7480	0.9218,0.7570,0.7558,0.6590,0.7009	43642,.	26417	38297	-1.4470			0.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209615169	209615169	G	A	het	wt	het		QUAL=5466;DP=185,240,262;AF=0.53,0.00,0.46;MQM=60;SAP=108;ABP=3;SAR=161;SAF=58	LAMB3	3'UTR	LAMB3:ENST00000356082.9:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:ENST00000391911.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*102C>T::,LAMB3:ENST00000367030.7:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	295059 [benign DISEASE=Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not provided];	CR1010233 [CLASS=DP MUT=ALT PHEN="Cervical cancer increased risk association with" GENE=LAMB3];		rs2566	0.2740	0.2475,0.3510,0.3462,0.2735,0.2703	5818,.	30008	110364	1.1420			8.92			COSV50521190	0	20163849,21627860,21692980,23554684,23614619,28584635,23320911,29963045,25337271,25132800,25363238	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209618217	209618217	C	T	het	wt	het	off-target	QUAL=3186;DP=183,66,63;AF=0.58,0.02,0.37;MQM=60;SAP=186;ABP=5;SAR=118;SAF=13	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron19/22:c.2910-169G>A::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron18/21:c.2910-169G>A::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron19/22:c.2910-169G>A::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1286389 [benign DISEASE=not provided];			rs2076220	0.2907	0.3064,0.3563,0.3449,0.2737,0.2710	6516,.	31162	107816	-0.0670			1.13				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209618270	209618270	G	A	het	wt	het	off-target	QUAL=2528;DP=172,37,45;AF=0.48,0.00,0.40;MQM=60;SAP=16;ABP=5;SAR=63;SAF=38	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron19/22:c.2909+182C>T::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron18/21:c.2909+182C>T::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron19/22:c.2909+182C>T::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1276454 [benign DISEASE=not provided];			rs2076221	0.3470	0.5003,0.3784,0.3430,0.2745,0.2719	9927,.	32871	99219	-0.2600			0.19			COSV50524219	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209618670	209618670	-	C	hom	hom	hom	off-target	QUAL=12635;DP=161,131,180;AF=0.94,0.94,0.98;MQM=60;SAP=697;ABP=0;SAR=416;SAF=36	LAMB3	splice_region&intron	LAMB3:ENST00000356082.9:splice_region_variant&intron_variant:LOW:intron18/22:c.2702-12dup::,LAMB3:ENST00000391911.5:splice_region_variant&intron_variant:LOW:intron17/21:c.2702-12dup::,LAMB3:ENST00000367030.7:splice_region_variant&intron_variant:LOW:intron18/22:c.2702-12dup::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255590 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs397807887	0.9565	0.9877,0.9750,0.9998,0.9318,0.9899	69717,.	6171	6617				12.76				0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209622922	209622922	G	A	het	wt	het	off-target	QUAL=779;DP=56,12,14;AF=0.55,0.00,0.36;MQM=60;SAP=7;ABP=3;SAR=14;SAF=22	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron17/22:c.2556+60C>T::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron16/21:c.2556+60C>T::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron17/22:c.2556+60C>T::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1180485 [benign DISEASE=Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,not provided];			rs3737913	0.2746	0.2468,0.3529,0.3513,0.2744,0.2687	5840,.	30027	110185	-4.6550			0.00			COSV61915383	0	25368101	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209625908	209625908	A	G	het	hom	het		QUAL=21487;DP=299,382,547;AF=0.41,1.00,0.50;MQM=60;SAP=292;ABP=10;SAR=550;SAF=228	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon13/22:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain]	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255587 [benign DISEASE=Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs2179402	0.7488	0.7711,0.7514,0.8235,0.7270,0.7403	42675,.	28549	38217	-0.9660			1.56			COSV61918520	0.02	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209627765	209627765	C	T	het	hom	het	off-target	QUAL=3429;DP=196,24,24;AF=0.53,1.00,0.54;MQM=60;SAP=184;ABP=4;SAR=124;SAF=16	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron11/22:c.1289-186G>A::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron10/21:c.1289-186G>A::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron11/22:c.1289-186G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1180469 [benign DISEASE=Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,not provided];			rs61822212	0.1721	0.0429,0.1267,0.0164,0.2485,0.1402	3048,.	20078	125944	-1.1520			0.35				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209630750	209630750	G	A	hom	hom	hom	off-target	QUAL=12072;DP=112,124,157;AF=1.00,1.00,1.00;MQM=60;SAP=153;ABP=0;SAR=279;SAF=114	LAMB3	splice_region&intron	LAMB3:ENST00000356082.9:splice_region_variant&intron_variant:LOW:intron8/22:c.823-15C>T::,LAMB3:ENST00000391911.5:splice_region_variant&intron_variant:LOW:intron7/21:c.823-15C>T::,LAMB3:ENST00000367030.7:splice_region_variant&intron_variant:LOW:intron8/22:c.823-15C>T::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255598 [benign DISEASE=Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs4844863	0.8414	0.8288,0.8295,0.8273,0.8457,0.8004	53847,.	20115	24093	-1.8920			1.56		8.37>7.66	COSV61919103	0.01	25741868,25363238	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209634627	209634627	G	A	hom	hom	hom		QUAL=5400;DP=34,58,91;AF=1.00,1.00,1.00;MQM=60;SAP=81;ABP=0;SAR=132;SAF=51	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon5/22:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)]	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255596 [benign DISEASE=Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs1130667	0.3101	0.1395,0.2663,0.2410,0.3970,0.3248	8286,.	30464	104660	-4.0090			0.33			COSV61916410	0.02	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209638541	209638541	T	G	hom	hom	hom		QUAL=19054;DP=255,137,210;AF=1.00,1.00,1.00;MQM=60;SAP=68;ABP=0;SAR=234;SAF=368	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon3/22:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)]	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255592 [benign DISEASE=Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs2076356	0.5597	0.4198,0.5028,0.2760,0.6504,0.4822	25022,.	34984	66904	-0.8890			5.33			COSV61915034	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209638718	209638718	T	C	hom	hom	hom	off-target	QUAL=8272;DP=105,68,103;AF=1.00,1.00,1.00;MQM=60;SAP=543;ABP=0;SAR=269;SAF=7	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron3/22:c.184-70A>G::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron2/21:c.184-70A>G::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron3/22:c.184-70A>G::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1180480 [benign DISEASE=Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,not provided];			rs2076357	0.5862	0.3863,0.6158,0.6343,0.6778,0.6755	27353,.	34303	62827	-0.6750			4.59			COSV61915925	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209651362	209651362	A	T	hom	hom	hom	off-target	QUAL=9345;DP=169,80,84;AF=0.99,1.00,1.00;MQM=60;SAP=724;ABP=0;SAR=332;SAF=0	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::	regulatory_region_variant:promoter	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1252656 [benign DISEASE=not provided];			rs10779510	0.8772	0.7999,0.9064,0.9992,0.8914,0.9483	58763,.	15921	18677	-0.3030			3.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209652041	209652041	T	C	hom	hom	hom	off-target	QUAL=4096;DP=73,31,35;AF=1.00,1.00,1.00;MQM=60;SAP=305;ABP=0;SAR=0;SAF=139	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron1/22:c.-38+328A>G::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron1/22:c.-38+208A>G::	regulatory_region_variant:promoter	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1285919 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs10863778	0.8445	0.8046,0.8600,0.6983,0.8665,0.7896	54282,.	19721	23619	0.3640			5.56				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209652603	209652603	C	G	hom	hom	hom	off-target	QUAL=2543;DP=46,17,25;AF=0.98,1.00,1.00;MQM=60;SAP=192;ABP=0;SAR=87;SAF=0	LAMB3	upstream_gene	LAMB3:ENST00000356082.9:upstream_gene_variant:MODIFIER::::,LAMB3:ENST00000391911.5:upstream_gene_variant:MODIFIER::::,LAMB3:ENST00000367030.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1242415 [benign DISEASE=not provided];			rs7519942	0.9254	0.9214,0.9275,0.9992,0.9162,0.9557	65137,.	10516	11354	-0.5090			0.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209786269	209786269	G	T	het	wt	het		QUAL=6852;DP=337,125,185;AF=0.53,0.00,0.50;MQM=58;SAP=12;ABP=4;SAR=152;SAF=118	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2151C>A::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2151C>A::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295175 [benign DISEASE=Van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs1044516	0.2288	0.2664,0.3278,0.5502,0.1729,0.3113	4638,.	25498	117204	-0.3060			0.98				0.02	20652317,31495697,30410503,31122291,25663376,27033726,33195260	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209786527	209786527	G	A	hom	hom	hom		QUAL=19090;DP=313,125,150;AF=1.00,0.99,0.99;MQM=57;SAP=4;ABP=0;SAR=285;SAF=300	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1893C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1893C>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295178 [benign DISEASE=Van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs680331	0.8087	0.8473,0.8267,0.8060,0.7917,0.7799	49753,.	23355	29055	-0.0200			1.32				0	21319277,23248214	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209786742	209786742	A	-	wt	wt	het		QUAL=1633;DP=253,130,118;AF=0.00,0.00,0.53;MQM=60;SAP=3;ABP=4;SAR=32;SAF=31	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1678del::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1678del::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295181 [benign DISEASE=Van der Woude syndrome 1,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs141112353	0.1927	0.1959,0.1888,0.0908,0.1981,0.1201	2876,.	23547	122761	0.4050			0.86				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209786807	209786807	T	A	wt	wt	het		QUAL=1217;DP=263,101,104;AF=0.00,0.00,0.48;MQM=60;SAP=9;ABP=3;SAR=19;SAF=31	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1613A>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1613A>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]				rs1195550606						-0.6430			0.75				0		0	1	0 / 0					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787091	209787091	G	A	het	wt	het		QUAL=6312;DP=254,200,249;AF=0.46,0.00,0.51;MQM=60;SAP=56;ABP=4;SAR=83;SAF=160	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1329C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1329C>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295184 [benign DISEASE=Van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];		AluJo (SINE/Alu)	rs2235372	0.2258	0.2695,0.3278,0.4723,0.1725,0.3098	4426,.	25436	117562	-1.0050			1.31			COSV50551228	0	23121717	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787577	209787577	A	C	het	hom	wt		QUAL=2820;DP=123,44,124;AF=0.47,1.00,0.00;MQM=60;SAP=13;ABP=4;SAR=62;SAF=40	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*843T>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*843T>G::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295189 [benign DISEASE=Van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs599021	0.3629	0.2611,0.3016,0.2410,0.4326,0.3532	10686,.	33703	96675	0.2660			4.92				0	18278815,17438386,20652317,19388848	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787580	209787580	T	C	het	wt	het		QUAL=3153;DP=129,44,123;AF=0.54,0.00,0.45;MQM=60;SAP=35;ABP=3;SAR=84;SAF=41	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*840A>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*840A>G::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295190 [benign DISEASE=Van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs742214	0.2246	0.2665,0.3267,0.4724,0.1724,0.3090	4383,.	25341	117721	-0.9660			0.99				0	30410503	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787678	209787678	T	A	het	wt	het		QUAL=2226;DP=97,51,81;AF=0.51,0.02,0.49;MQM=60;SAP=19;ABP=3;SAR=32;SAF=58	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*742A>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*742A>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295193 [benign DISEASE=Van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs742215	0.2306	0.2863,0.3289,0.4740,0.1725,0.3102	4595,.	25625	116195	0.9740			10.13			COSV54213600	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787969	209787969	T	C	het	wt	het		QUAL=6617;DP=266,188,239;AF=0.52,0.01,0.47;MQM=60;SAP=3;ABP=3;SAR=128;SAF=122	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*451A>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*451A>G::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295199 [benign DISEASE=Van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs17317411	0.1074	0.0300,0.1145,0.0403,0.1516,0.1868	1158,.	13998	135614	0.3090			13.74			COSV54213602	0	20652317,28593555,23121717,30689861	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209788009	209788009	G	A	wt	wt	het		QUAL=2560;DP=332,163,207;AF=0.00,0.00,0.47;MQM=60;SAP=4;ABP=4;SAR=52;SAF=46	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*411C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*411C>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295200 [benign DISEASE=Van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];		MIR3 (SINE/MIR)	rs187379424	0.0047	0.0009,0.0007,0.0000,0.0064,0.0006	4,.	710	151342	1.8520			10.32				0		0	72	0 / 0					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209790458	209790458	G	A	het	wt	het	off-target	QUAL=3830;DP=194,88,127;AF=0.52,0.00,0.52;MQM=60;SAP=363;ABP=4;SAR=0;SAF=166	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron7/8:c.1060+37C>T::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron5/6:c.775+37C>T::	regulatory_region_variant:enhancer	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	1291060 [benign DISEASE=not provided];			rs2235373	0.2156	0.2347,0.3231,0.4713,0.1724,0.3081	4031,.	24733	119293	-0.8660			0.88			COSV65418889	0	18278815,17438386,20652317,19388848,25592222,19444471,28593555,33137956	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209792242	209792242	G	C	het	wt	hom	off-target	QUAL=10466;DP=195,213,261;AF=0.46,0.00,1.00;MQM=60;SAP=256;ABP=6;SAR=74;SAF=276	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron6/8:c.667+27C>G::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron4/6:c.382+27C>G::	regulatory_region_variant:enhancer	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259926 [benign DISEASE=Autosomal dominant popliteal pterygium syndrome,not specified,not provided];			rs2235375	0.3674	0.2881,0.4937,0.5656,0.3703,0.4317	10636,.	34569	96133	0.0730			2.36			COSV65418892	0	25741868,17318851,18278815,17438386,20215007,15558496,25853057,23940636,19734457,28712851,20631690,33195260,25489771,32533457	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209795339	209795339	C	A	het	wt	hom		QUAL=18555;DP=339,325,459;AF=0.45,0.00,1.00;MQM=60;SAP=7;ABP=10;SAR=289;SAF=323	IRF6	synonymous	IRF6:ENST00000367021.8:synonymous_variant:LOW:exon5/9:c.459G>T:p.Ser153=:,IRF6:ENST00000542854.5:synonymous_variant:LOW:exon3/7:c.174G>T:p.Ser58=:	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259925 [benign DISEASE=Van der Woude syndrome 1,Autosomal dominant popliteal pterygium syndrome,Orofacial cleft 6, susceptibility to,Popliteal pterygium syndrome,Van der Woude syndrome,not specified,not provided];			rs2013162	0.3652	0.2799,0.4945,0.5666,0.3702,0.4299	10523,.	34453	96473	-1.7160			0.79			COSV65418898	0.01	25741868,20403199,29065370,18278815,20436469,18978678,27511269,17438386,20652317,19521098,19937600,21319277,23029012,31448957,18209213,29211286,21859832,21204206,15558496,25853057,23940636,16096995,19734457,22440537,31156544,17616516,28593555,25663376,29291710,18452891,33195260,27706679,33406080,25489771,35075162	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209795573	209795573	G	A	het	wt	het	off-target	QUAL=2854;DP=161,67,80;AF=0.50,0.00,0.53;MQM=60;SAP=270;ABP=3;SAR=123;SAF=0	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron4/8:c.380-155C>T::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron2/6:c.95-155C>T::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	1291056 [benign DISEASE=not provided];			rs17015224	0.1701	0.2251,0.1422,0.0647,0.1590,0.2142	2375,.	21099	126119	-0.1270			1.23			COSV65418901	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209796557	209796557	G	C	het	wt	hom		QUAL=4842;DP=209,51,86;AF=0.47,0.02,0.99;MQM=60;SAP=346;ABP=4;SAR=178;SAF=7	IRF6	splice_region&intron	IRF6:ENST00000367021.8:splice_region_variant&intron_variant:LOW:intron3/8:c.175-5C>G::,IRF6:ENST00000542854.5:splice_region_variant&intron_variant:LOW:intron1/6:c.-111-5C>G::	regulatory_region_variant:open_chromatin_region,regulatory_region_variant:CTCF_binding_site	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259923 [benign DISEASE=Van der Woude syndrome 1,Autosomal dominant popliteal pterygium syndrome,Orofacial cleft 6, susceptibility to,Popliteal pterygium syndrome,Van der Woude syndrome,not specified,not provided];			rs7552506	0.3199	0.2718,0.3134,0.1558,0.3569,0.3340	7901,.	32663	103027	1.3340			13.91		9.65>6.86	COSV65419346	0.02	25741868,20652317,19937600,18209213,17551329,28593555,33195260,32108996,25489771	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209796634	209796634	A	C	het	n/a	het	off-target;low_conf_region	QUAL=61;DP=9,1,9;AF=0.44,0.00,0.11;MQM=48;SAP=14;ABP=11;SAR=5;SAF=0	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron3/8:c.175-82T>G::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron1/6:c.-111-82T>G::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]			(AC)n (Simple_repeat)	rs113569623	0.0001	0.0001,0.0001,0.0000,0.0001,0.0000	0,.	8	136804	0.1100			2.89			COSV65418639	0		12	1128	0 / 0					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209796635	209796636	AC	-	wt	n/a	het	off-target;low_conf_region	QUAL=61;DP=9,1,9;AF=0.44,0.00,0.11;MQM=60;SAP=12;ABP=3;SAR=4;SAF=0	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron3/8:c.175-84_175-83del::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron1/6:c.-111-84_-111-83del::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	1179706 [benign DISEASE=not provided];		(AC)n (Simple_repeat)	rs3028134	0.1456	0.1013,0.1362,0.0959,0.1686,0.1304	1406,.	17083	116723	1.6150			8.22				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209796751	209796751	C	G	het	n/a	n/a	off-target	QUAL=449;DP=48,2,1;AF=0.52,0.00,0.00;MQM=60;SAP=57;ABP=3;SAR=25;SAF=0	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron3/8:c.175-199G>C::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron1/6:c.-111-199G>C::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	1285878 [benign DISEASE=not provided];			rs17015226	0.1700	0.2251,0.1422,0.0645,0.1590,0.2144	2373,.	21058	125976	0.0710			3.88			COSV65418904	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209802041	209802041	A	G	het	hom	wt		QUAL=11934;DP=284,263,350;AF=0.49,1.00,0.00;MQM=60;SAP=57;ABP=3;SAR=251;SAF=151	IRF6	splice_region&5'UTR,intron	IRF6:ENST00000367021.8:splice_region_variant&5_prime_UTR_variant:LOW:exon2/9:c.-73T>C::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron1/6:c.-112+3906T>C::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295214 [benign DISEASE=Van der Woude syndrome 1,Orofacial cleft 6, susceptibility to,not specified,not provided];			rs861019	0.4329	0.5053,0.3301,0.2406,0.4331,0.3500	14686,.	36369	86125	-0.2070			2.01		10.77>11.03	COSV65419778	0	17318851,18278815,17438386,20652317,19388848,23029012,31495697,16160700,18209213,19561605,21834040,29211286,28593555,18452891,33195260,33406080	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806173	209806173	T	A	wt	wt	het		QUAL=1266;DP=34,94,126;AF=0.00,0.00,0.54;MQM=60;SAP=71;ABP=5;SAR=57;SAF=11	IRF6	5'UTR	IRF6:ENST00000542854.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-338A>T::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295219 [benign DISEASE=Van der Woude syndrome 1,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs12403006	0.1588	0.0444,0.1775,0.0916,0.2131,0.1302	2392,.	19356	127908	-0.0070			6.99			COSV65419508		28593555	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806184	209806184	A	T	wt	wt	het		QUAL=1207;DP=25,83,117;AF=0.00,0.00,0.53;MQM=60;SAP=98;ABP=4;SAR=57;SAF=5	IRF6	upstream_gene	IRF6:ENST00000367021.8:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	368864 [benign DISEASE=Van der Woude syndrome 1,Orofacial cleft 6, susceptibility to,Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];	CR173661 [CLASS=R MUT=ALT PHEN="Orofacial clefting" GENE=IRF6];		rs34743335	0.1589	0.0444,0.1776,0.0914,0.2132,0.1307	2397,.	19353	127779	0.0190			16.03					27369588,28593555,28361103,33195260	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806268	209806268	C	G	het	wt	hom	off-target	QUAL=1915;DP=36,43,53;AF=0.61,0.00,1.00;MQM=60;SAP=166;ABP=7;SAR=75;SAF=0	IRF6	upstream_gene	IRF6:ENST00000367021.8:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]				rs7545538	0.4030	0.2862,0.5146,0.5677,0.4279,0.4744	12826,.	35626	90762	0.9250			9.94					25592222	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806290	209806290	C	T	het	wt	hom	off-target	QUAL=1631;DP=41,32,39;AF=0.66,0.00,1.00;MQM=60;SAP=146;ABP=12;SAR=66;SAF=0	IRF6	upstream_gene	IRF6:ENST00000367021.8:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]				rs7545542	0.3748	0.2801,0.5006,0.5669,0.3853,0.4400	11103,.	34779	95065	0.5000			8.22					33817668	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	215622731	215622732	AA	-	hom	n/a	n/a	off-target	QUAL=509;DP=18,0,2;AF=0.94,,1.00;MQM=60;SAP=44;ABP=0;SAR=0;SAF=19	KCTD3,USH2A	downstream_gene	KCTD3:ENST00000259154.9:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000307340.8:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000674083.1:downstream_gene_variant:MODIFIER::::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs34483623	0.9832	0.9437,0.9930,0.9981,0.9991,0.9983	73341,.	2505	2553	-1.3290			0.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215622854	215622854	-	TTATT	het	het	wt	off-target	QUAL=649;DP=95,18,34;AF=0.35,0.22,0.00;MQM=60;SAP=83;ABP=32;SAR=0;SAF=37	KCTD3,USH2A	downstream_gene	KCTD3:ENST00000259154.9:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000307340.8:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000674083.1:downstream_gene_variant:MODIFIER::::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs75551431	0.2360	0.1000,0.2461,0.4349,0.2787,0.5135	4938,.	25925	115885				1.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215623008	215623008	T	G	het	wt	hom		QUAL=13548;DP=353,178,266;AF=0.52,0.00,1.00;MQM=60;SAP=224;ABP=4;SAR=118;SAF=332	USH2A	3'UTR	USH2A:ENST00000307340.8:3_prime_UTR_variant:MODIFIER:exon72/72:c.*2773A>C::,USH2A:ENST00000674083.1:3_prime_UTR_variant:MODIFIER:exon73/73:c.*2773A>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs6667509	0.1045	0.1154,0.0973,0.0571,0.1024,0.1282	856,.	14176	136146	2.2060			5.40				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215624672	215624672	G	A	hom	hom	hom		QUAL=33458;DP=445,226,327;AF=1.00,1.00,1.00;MQM=60;SAP=39;ABP=0;SAR=435;SAF=563	USH2A	3'UTR	USH2A:ENST00000307340.8:3_prime_UTR_variant:MODIFIER:exon72/72:c.*1109C>T::,USH2A:ENST00000674083.1:3_prime_UTR_variant:MODIFIER:exon73/73:c.*1109C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs2797255	0.9908	0.9681,0.9967,1.0000,0.9998,1.0000	74692,.	1339	1405	-0.3060			0.14				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215634665	215634665	G	A	het	het	wt		QUAL=3678;DP=174,136,193;AF=0.48,0.50,0.00;MQM=60;SAP=189;ABP=3;SAR=133;SAF=19	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon70/72:c.15091C>T:p.Arg5031Trp:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon70/73:c.15091C>T:p.Arg5031Trp:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48455 [benign/likely benign DISEASE=Usher syndrome type 2A,Retinitis pigmentosa 39,not specified,not provided];	CM165975 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa" GENE=USH2A];		rs56038610	0.0133	0.0032,0.0033,0.0000,0.0174,0.0098	24,.	1982	150118	3.1780	D(0.02),D(0.02)	B(0.15),B(0.30)	16.64	0.09		COSV99048303	0.01	24033266,21569298,18273898,26927203	8	655	0 / 0	1	"[3] auto-classification 14.09.2017 [1] harmuth 08.05.2018"			USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215640844	215640844	C	A	het	wt	het	off-target	QUAL=92;DP=25,15,9;AF=0.24,0.13,0.22;MQM=55;SAP=25;ABP=40;SAR=10;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron67/71:c.14792-110G>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron67/72:c.14792-110G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]			(AACAA)n (Simple_repeat)	rs78797010	0.0018	0.0013,0.0012,0.0011,0.0022,0.0013	0,.	186	102880	-3.5250			0.02				0		1	14	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215640845	215640845	A	-	het	het	wt	off-target	QUAL=92;DP=25,15,9;AF=0.24,0.40,0.22;MQM=60;SAP=33;ABP=23;SAR=14;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron67/71:c.14792-111del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron67/72:c.14792-111del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1231816 [benign DISEASE=not provided];		(AACAA)n (Simple_repeat)	rs56212994	0.7560	0.5788,0.8377,0.8395,0.8182,0.8105	28548,.	21050	25226	-0.0150			0.47				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215674720	215674720	C	T	het	het	wt		QUAL=8189;DP=377,246,314;AF=0.51,0.50,0.01;MQM=60;SAP=28;ABP=3;SAR=189;SAF=129	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.13191G>A:p.Glu4397=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.13191G>A:p.Glu4397=:PF00041 [Fibronectin type III domain]		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48413 [benign DISEASE=Usher syndrome type 2A,not specified,not provided];			rs2009923	0.1587	0.0561,0.1627,0.3507,0.1849,0.2909	2361,.	19397	127887	0.2990			0.97			COSV56336645	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215675245	215675245	T	C	wt	het	wt		QUAL=3267;DP=276,245,319;AF=0.00,0.51,0.00;MQM=60;SAP=12;ABP=3;SAR=74;SAF=51	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.12666A>G:p.Thr4222=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.12666A>G:p.Thr4222=:PF00041 [Fibronectin type III domain]		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48403 [benign DISEASE=Usher syndrome type 2A,not specified,not provided];			rs2797234	0.3390	0.2196,0.4162,0.3052,0.3907,0.2991	9406,.	32729	100521	-0.4260			0.69			COSV56342646	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215675299	215675299	T	C	het	het	hom		QUAL=20675;DP=383,280,374;AF=0.47,0.50,0.99;MQM=60;SAP=40;ABP=4;SAR=292;SAF=401	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.12612A>G:p.Thr4204=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.12612A>G:p.Thr4204=:PF00041 [Fibronectin type III domain]		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	177993 [benign DISEASE=Usher syndrome type 2A,not specified,not provided];			rs2797235	0.7480	0.6348,0.7988,0.6452,0.8131,0.6797	43036,.	27640	38318	0.1010			0.59			COSV56342874	0	24033266,21686329,20145675	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215675702	215675702	C	G	het	het	wt	off-target	QUAL=5318;DP=282,151,199;AF=0.48,0.50,0.01;MQM=60;SAP=360;ABP=3;SAR=200;SAF=13	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron62/71:c.12295-86G>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron62/72:c.12295-86G>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1290576 [benign DISEASE=not provided];			rs4443864	0.1963	0.1217,0.1902,0.3566,0.2122,0.3361	3263,.	23318	122174	-1.2320			0.46			COSV56377492	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680015	215680015	G	A	het	wt	het	off-target	QUAL=975;DP=76,5,15;AF=0.47,0.00,0.47;MQM=60;SAP=96;ABP=4;SAR=0;SAF=43	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron62/71:c.12294+134C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron62/72:c.12294+134C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1236125 [benign DISEASE=not provided];			rs10864183	0.2049	0.1271,0.2500,0.3897,0.2149,0.5112	3718,.	23734	120922	1.0170			15.75			COSV56344121	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680407	215680407	T	-	het	het	het	off-target	QUAL=3605;DP=149,53,68;AF=0.52,0.62,0.85;MQM=60;SAP=320;ABP=40;SAR=163;SAF=6	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron61/71:c.12067-31del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron61/72:c.12067-31del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1225305 [benign DISEASE=Usher syndrome type 2A,Retinitis pigmentosa 39,not provided];			rs5780842	0.8933	0.7622,0.9434,0.9941,0.9427,0.9204	58941,.	13199	15659	1.7360			0.52				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680493	215680493	A	G	het	wt	het	off-target	QUAL=2010;DP=117,24,34;AF=0.55,0.00,0.59;MQM=60;SAP=185;ABP=7;SAR=84;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron61/71:c.12067-117T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron61/72:c.12067-117T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1247988 [benign DISEASE=not provided];			rs12140451	0.1925	0.1242,0.1942,0.2921,0.2117,0.4858	3158,.	22856	122374	-0.4630			0.43			COSV56344126	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680558	215680558	G	C	het	wt	het	off-target	QUAL=1144;DP=81,5,9;AF=0.54,0.00,0.67;MQM=60;SAP=112;ABP=5;SAR=50;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron61/71:c.12067-182C>G::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron61/72:c.12067-182C>G::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1174446 [benign DISEASE=not provided];			rs4375237	0.2602	0.3144,0.2699,0.3908,0.2161,0.5229	5539,.	28356	112122	-0.3540			0.45			COSV56344135	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215728150	215728150	C	T	hom	het	hom		QUAL=39513;DP=410,542,641;AF=0.99,0.42,0.99;MQM=60;SAP=125;ABP=34;SAR=501;SAF=768	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon61/72:c.11946G>A:p.Leu3982=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon61/73:c.11946G>A:p.Leu3982=:PF00041 [Fibronectin type III domain]		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48387 [benign DISEASE=Usher syndrome type 2A,not specified,not provided];			rs2820718	0.1684	0.1688,0.1126,0.0039,0.1856,0.1358	2287,.	21016	126404	0.7290			4.65				0	25741868,24033266,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215741409	215741409	G	T	het	het	wt		QUAL=5393;DP=207,192,253;AF=0.53,0.52,0.00;MQM=60;SAP=65;ABP=5;SAR=66;SAF=143	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon60/72:c.11677C>A:p.Pro3893Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon60/73:c.11677C>A:p.Pro3893Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48380 [benign/likely benign DISEASE=Usher syndrome type 2A,not specified,not provided];	CM165987 [CLASS=DM? MUT=ALT PHEN="Usher syndrome 2" GENE=USH2A];		rs41303285	0.0129	0.0034,0.0033,0.0002,0.0195,0.0127	19,.	1916	150028	6.1100	D(0.03),D(0.03)	D(0.98),D(1.00)	24.80	0.34		COSV99048391	0.01	24033266,25133751,20507924,21569298,22004887,18273898,17405132,20145675,29216386,25999674,26927203	13	735	0 / 0	3	"[3] auto-classification 14.09.2017"		"DVD: Benign; gnomAD: 59 homo cases; ClinVar: Class1 (all 6 entries)"	USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215743079	215743079	C	T	hom	het	hom	off-target	QUAL=4799;DP=95,38,51;AF=1.00,0.45,1.00;MQM=60;SAP=357;ABP=4;SAR=0;SAF=163	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron59/71:c.11548+98G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron59/72:c.11548+98G>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1290577 [benign DISEASE=not provided];			rs2797223	0.1500	0.1231,0.1086,0.0050,0.1722,0.1122	1866,.	19029	128999	1.8500			13.46				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215758586	215758586	T	A	wt	wt	het		QUAL=2193;DP=223,176,196;AF=0.00,0.00,0.46;MQM=60;SAP=42;ABP=6;SAR=25;SAF=65	USH2A	splice_region&intron	USH2A:ENST00000307340.8:splice_region_variant&intron_variant:LOW:intron58/71:c.11389+9A>T::,USH2A:ENST00000674083.1:splice_region_variant&intron_variant:LOW:intron58/72:c.11389+9A>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48372 [benign DISEASE=Usher syndrome type 2A,not specified,not provided];			rs12095085	0.1232	0.1352,0.0990,0.0010,0.1314,0.0452	1271,.	16185	133265	0.4490			5.50				0.02	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215759461	215759461	C	T	hom	n/a	n/a	off-target	QUAL=1652;DP=56,2,2;AF=1.00,0.50,0.50;MQM=60;SAP=129;ABP=3;SAR=0;SAF=58	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron57/71:c.11231+199G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron57/72:c.11231+199G>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1259820 [benign DISEASE=not provided];			rs55908750	0.0416	0.0474,0.0203,0.0054,0.0426,0.0642	147,.	6008	145380	-1.6560			0.13				0		2	1	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215759615	215759615	G	A	wt	het	wt	off-target	QUAL=1056;DP=203,82,122;AF=0.00,0.55,0.00;MQM=60;SAP=76;ABP=5;SAR=3;SAF=42	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron57/71:c.11231+45C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron57/72:c.11231+45C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177014 [benign/likely benign DISEASE=Usher syndrome type 2A,not provided];			rs17025373	0.0703	0.0147,0.1413,0.3552,0.0652,0.0976	739,.	9213	141369	-1.3310			0.20			COSV56338606	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215782390	215782390	-	AA	hom	het	het	off-target	QUAL=1546;DP=51,6,9;AF=0.98,0.50,0.67;MQM=60;SAP=131;ABP=4;SAR=59;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron53/71:c.10586-196_10586-195dup::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron53/72:c.10586-196_10586-195dup::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1222339 [benign DISEASE=not provided];			rs35071811	0.3622	0.4513,0.3276,0.2815,0.3280,0.3441	10266,.	34407	96765				2.16				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215782595	215782595	T	G	hom	het	het	off-target	QUAL=991;DP=27,10,11;AF=0.96,0.40,0.55;MQM=60;SAP=65;ABP=3;SAR=2;SAF=34	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron53/71:c.10585+143A>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron53/72:c.10585+143A>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	678884 [benign DISEASE=Usher syndrome type 2A,not provided];			rs6665799	0.3627	0.4525,0.3279,0.2837,0.3282,0.3444	10326,.	34462	96844	-0.6860			0.38				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215782962	215782962	A	G	hom	hom	hom	off-target	QUAL=3921;DP=79,22,27;AF=0.99,1.00,1.00;MQM=60;SAP=262;ABP=0;SAR=125;SAF=2	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron52/71:c.10388-27T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron52/72:c.10388-27T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177015 [benign DISEASE=Usher syndrome type 2A,not provided];			rs7518466	0.5906	0.7212,0.5831,0.6335,0.5249,0.4919	27103,.	35480	62166	-0.8160			0.04				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215786825	215786825	T	G	hom	hom	hom		QUAL=26925;DP=220,286,366;AF=1.00,1.00,1.00;MQM=60;SAP=226;ABP=0;SAR=585;SAF=286	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon52/72:c.10232A>C:p.Glu3411Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon52/73:c.10232A>C:p.Glu3411Ala:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48344 [benign DISEASE=Usher syndrome type 2A,not specified,not provided];			rs10864198	0.5798	0.6834,0.5793,0.6333,0.5249,0.4928	25934,.	36153	63793	2.9590	T(1.00),T(1.00)	B(0.00),B(0.00)	11.04	0.09		COSV56336661	0.02	25741868,24033266,23757202,21686329,20145675,18665195,29986705,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215790032	215790032	G	A	wt	wt	het	off-target	QUAL=1532;DP=129,110,128;AF=0.00,0.00,0.50;MQM=60;SAP=109;ABP=3;SAR=4;SAF=60	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron51/71:c.10182+27C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron51/72:c.10182+27C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1290575 [benign DISEASE=not provided];			rs11120629	0.1279	0.1502,0.1020,0.0008,0.1312,0.0466	1381,.	16574	131822	0.0070			3.33			COSV56371467	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215813880	215813880	T	C	wt	wt	het		QUAL=3234;DP=271,169,280;AF=0.00,0.00,0.46;MQM=60;SAP=22;ABP=6;SAR=82;SAF=48	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon49/72:c.9595A>G:p.Asn3199Asp:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon49/73:c.9595A>G:p.Asn3199Asp:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48631 [benign DISEASE=Usher syndrome type 2A,not specified,not provided];			rs4129843	0.0557	0.0785,0.0619,0.1517,0.0421,0.0767	299,.	7864	143596	0.1950	T(1.00),T(1.00)	B(0.00),B(0.00)	0.54	0.04		COSV56343447	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215838019	215838019	T	C	wt	wt	het		QUAL=3248;DP=340,238,263;AF=0.00,0.00,0.49;MQM=60;SAP=5;ABP=3;SAR=58;SAF=70	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon47/72:c.9343A>G:p.Thr3115Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon47/73:c.9343A>G:p.Thr3115Ala:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48623 [benign DISEASE=Usher syndrome type 2A,not specified,not provided];			rs56032526	0.0361	0.0101,0.0540,0.1522,0.0421,0.0769	169,.	5154	146686	0.0680	T(1.00),T(1.00)	B(0.00),B(0.00)	0.79	0.14		COSV56343459	0	25741868,24033266,18273898	14	510	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215846085	215846085	A	-	wt	wt	het	off-target	QUAL=404;DP=124,42,44;AF=0.02,0.00,0.50;MQM=60;SAP=55;ABP=3;SAR=24;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron44/71:c.8846-52del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron44/72:c.8846-52del::	regulatory_region_variant:enhancer	608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1256903 [benign DISEASE=not provided];			rs77889398	0.0368	0.0103,0.0549,0.1539,0.0428,0.0774	173,.	5152	143776	0.0850			0.15			COSV56391224	0.09		2	18	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215877638	215877638	C	T	wt	wt	het	off-target	QUAL=809;DP=109,49,56;AF=0.00,0.00,0.63;MQM=60;SAP=79;ABP=11;SAR=0;SAF=35	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron43/71:c.8681+120G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron43/72:c.8681+120G>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	761707 [benign DISEASE=not provided];			rs56301415	0.0495	0.0588,0.0632,0.1403,0.0411,0.0757	220,.	7088	144532	0.4900			15.31				0		0	27	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215877783	215877783	G	A	wt	wt	het		QUAL=2907;DP=195,198,215;AF=0.00,0.00,0.52;MQM=60;SAP=12;ABP=4;SAR=45;SAF=67	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon43/72:c.8656C>T:p.Leu2886Phe:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon43/73:c.8656C>T:p.Leu2886Phe:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48607 [benign/likely benign DISEASE=Usher syndrome type 2A,not specified,not provided];	CM1413302 [CLASS=R MUT=ALT PHEN="Hearing loss" GENE=USH2A];		rs41277200	0.0496	0.0588,0.0632,0.1422,0.0411,0.0758	222,.	7088	144464	6.8370	T(1.00),T(1.00)	B(0.00),B(0.00)	18.56	0.14		COSV56343477	0.01	25741868,24033266,18273898,17085681	2	111	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215877945	215877945	A	G	wt	het	het	off-target	QUAL=3326;DP=231,136,138;AF=0.00,0.45,0.54;MQM=60;SAP=167;ABP=3;SAR=118;SAF=17	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron42/71:c.8559-65T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron42/72:c.8559-65T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177604 [benign DISEASE=Usher syndrome type 2A,not provided];			rs7518358	0.2433	0.3395,0.2125,0.4374,0.1945,0.3718	4941,.	27092	114980	0.8390			16.11			COSV56431732	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215878039	215878039	G	T	wt	wt	het	off-target	QUAL=530;DP=91,32,39;AF=0.00,0.00,0.64;MQM=60;SAP=57;ABP=10;SAR=25;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron42/71:c.8559-159C>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron42/72:c.8559-159C>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs79952600	0.0399	0.0250,0.0586,0.1416,0.0411,0.0761	163,.	5650	143908	-0.1970			0.06				0		0	11	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215879207	215879207	A	G	wt	het	het	off-target	QUAL=1417;DP=187,80,71;AF=0.00,0.50,0.39;MQM=60;SAP=151;ABP=6;SAR=68;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron41/71:c.8224-109T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron41/72:c.8224-109T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1180911 [benign DISEASE=not provided];			rs6669557	0.1755	0.1889,0.1750,0.3301,0.1692,0.2263	2404,.	21866	125362	0.6750			7.35			COSV56388299	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215993112	215993112	T	G	het	het	wt		QUAL=2819;DP=125,94,98;AF=0.48,0.57,0.00;MQM=60;SAP=11;ABP=4;SAR=67;SAF=47	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon35/72:c.6713A>C:p.Glu2238Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon35/73:c.6713A>C:p.Glu2238Ala:	regulatory_region_variant:CTCF_binding_site	608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48568 [benign/likely benign DISEASE=Usher syndrome type 2A,not specified,not provided];	CM140482 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa autosomal recessive" GENE=USH2A];		rs41277212	0.0192	0.0057,0.0136,0.0004,0.0272,0.0131	47,.	2833	149243	4.8150	D(0.00),D(0.00)	P(0.91),D(0.99)	25.00	0.27		COSV56370381	0	24033266,18273898,17085681,29343940	23	977	0 / 0	3	"[3] auto-classification 14.09.2017"		"DVD: Benign"	USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215998787	215998787	T	-	het	wt	het	off-target	QUAL=13;DP=83,74,86;AF=0.08,0.03,0.14;MQM=60;SAP=49;ABP=224;SAR=0;SAF=21	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron34/71:c.6657+100del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron34/72:c.6657+100del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1235862 [benign DISEASE=not provided];			rs140899702	0.0409	0.1370,0.0141,0.0002,0.0017,0.0020	336,.	5100	135496	0.3260			0.83			COSV56388325	0		0	7	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215999038	215999038	A	G	hom	hom	hom		QUAL=18994;DP=180,188,228;AF=0.99,1.00,1.00;MQM=60;SAP=432;ABP=0;SAR=469;SAF=126	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon34/72:c.6506T>C:p.Ile2169Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon34/73:c.6506T>C:p.Ile2169Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48562 [benign DISEASE=Usher syndrome type 2A,not specified,not provided];			rs10864219	0.5097	0.4297,0.5576,0.8422,0.5018,0.6120	20294,.	36736	74396	2.3650	T(0.12),T(0.12)	B(0.02),B(0.08)	17.40	0.11		COSV56370398	0.04	25741868,24033266,21686329,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215999243	215999243	G	A	hom	hom	hom	off-target	QUAL=2233;DP=62,5,6;AF=1.00,1.00,1.00;MQM=60;SAP=162;ABP=0;SAR=73;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron33/71:c.6486-185C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron33/72:c.6486-185C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1267088 [benign DISEASE=not provided];			rs1436780	0.9459	0.9431,0.9420,0.9998,0.9430,0.9544	68102,.	7725	8225	0.3710			6.83				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216046439	216046439	A	G	het	het	hom		QUAL=8822;DP=201,124,147;AF=0.49,0.51,1.00;MQM=60;SAP=328;ABP=3;SAR=47;SAF=262	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon32/72:c.6317T>C:p.Ile2106Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon32/73:c.6317T>C:p.Ile2106Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	167815 [benign DISEASE=Usher syndrome type 2A,not specified,not provided];			rs6657250	0.6674	0.7652,0.5062,0.4447,0.6757,0.5006	34516,.	32185	50453	1.2600	T(1.00),T(1.00)	B(0.00),B(0.00)	9.86	0.13		COSV56342913	0.05	24033266,21686329,18665195,31817543,29283788	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216048379	216048379	C	T	hom	hom	het	off-target	QUAL=8812;DP=149,78,141;AF=1.00,1.00,0.53;MQM=60;SAP=659;ABP=4;SAR=0;SAF=302	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron31/71:c.6163+155G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron31/72:c.6163+155G>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1297779 [benign DISEASE=not provided];			rs10864227	0.3701	0.1794,0.2969,0.4880,0.4600,0.3729	11713,.	32753	95615	3.5030			18.59			COSV56436962	0	29283788	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216072799	216072799	G	C	wt	het	wt	off-target	QUAL=1539;DP=233,152,194;AF=0.00,0.43,0.00;MQM=60;SAP=85;ABP=9;SAR=8;SAF=58	USH2A,USH2A-AS2	intron,intron&non_coding_transcript,non_coding_transcript_exon	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron29/71:c.5857+90C>G::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron29/72:c.5857+90C>G::,USH2A-AS2:ENST00000446411.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.136+199G>C::,USH2A-AS2:ENST00000430890.5:non_coding_transcript_exon_variant:MODIFIER:exon1/3:n.71G>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs183556728	0.0023	0.0005,0.0035,0.0000,0.0037,0.0002	2,.	341	151797	-1.0490			0.12				0		0	175	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS2 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216073334	216073334	G	-	het	het	het	off-target	QUAL=5119;DP=174,98,132;AF=0.51,0.53,0.55;MQM=60;SAP=423;ABP=6;SAR=208;SAF=5	USH2A,USH2A-AS2	intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron27/71:c.5573-34del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron27/72:c.5573-34del::,USH2A-AS2:ENST00000446411.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.136+736del::,USH2A-AS2:ENST00000430890.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.78+530del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1243806 [benign DISEASE=Usher syndrome type 2A,Retinitis pigmentosa 39,not provided];			rs35944387	0.7229	0.7439,0.7618,0.9427,0.6928,0.7833	39926,.	29804	42040	0.8790			13.09				0.01	21686329	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS2 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216084852	216084852	G	T	het	het	het		QUAL=6000;DP=155,133,176;AF=0.49,0.51,0.51;MQM=60;SAP=170;ABP=3;SAR=184;SAF=50	USH2A,USH2A-AS2	synonymous,intron&non_coding_transcript	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon25/72:c.5013C>A:p.Gly1671=:PF02210 [Laminin G domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon25/73:c.5013C>A:p.Gly1671=:PF02210 [Laminin G domain],USH2A-AS2:ENST00000446411.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.266-1870G>T::,USH2A-AS2:ENST00000430890.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.208-1870G>T::,USH2A-AS2:ENST00000442606.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.207-1870G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48527 [benign DISEASE=Usher syndrome type 2A,not specified,not provided];			rs56110889	0.1624	0.1938,0.1352,0.0006,0.1799,0.0584	2189,.	20293	127253	0.1710			8.24			COSV56425186	0.01	25741868,24033266,23757202,17085681	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS2 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216174110	216174110	C	A	het	het	wt		QUAL=3548;DP=218,108,121;AF=0.41,0.45,0.00;MQM=60;SAP=3;ABP=18;SAR=68;SAF=71	USH2A	intron,3'UTR	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron21/71:c.4627+1142G>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron21/72:c.4627+1142G>T::,USH2A:ENST00000366942.3:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1128G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	295405 [benign DISEASE=Retinitis pigmentosa,Usher syndrome type 2A];			rs401269	0.2034	0.1636,0.2038,0.2184,0.2345,0.2210	3220,.	24450	120948	-0.1820			4.30				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216174214	216174214	A	G	het	het	wt		QUAL=3712;DP=224,56,55;AF=0.48,0.54,0.00;MQM=60;SAP=78;ABP=3;SAR=103;SAF=34	USH2A	intron,3'UTR	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron21/71:c.4627+1038T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron21/72:c.4627+1038T>C::,USH2A:ENST00000366942.3:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1024T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	295407 [benign DISEASE=Retinitis pigmentosa,Usher syndrome type 2A];			rs439940	0.2042	0.1663,0.2040,0.2202,0.2346,0.2214	3243,.	24564	120978	0.8240			7.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216175422	216175422	C	T	het	het	hom		QUAL=29624;DP=479,455,509;AF=0.53,0.49,1.00;MQM=60;SAP=151;ABP=4;SAR=622;SAF=363	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon21/72:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon21/73:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000366942.3:missense_variant:MODERATE:exon21/21:c.4457G>A:p.Arg1486Lys:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	177992 [benign DISEASE=Usher syndrome type 2A,not specified,not provided];			rs1805049	0.6291	0.5770,0.6613,0.7624,0.6226,0.7088	30303,.	34966	56360	-1.5240	T(0.56),T(0.57),T(0.30)	B(0.03),B(0.05),B(0.03)	6.63	0.02		COSV56346078	0.29	24033266,21686329,20145675,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216190498	216190498	-	T	het	het	het	off-target	QUAL=165;DP=51,16,17;AF=0.27,0.19,0.12;MQM=60;SAP=44;ABP=58;SAR=19;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron19/71:c.4252-132dup::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron19/72:c.4252-132dup::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron19/20:c.4252-132dup::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs746805392	0.0200	0.0090,0.0270,0.1705,0.0126,0.0151	91,.	2595	136171				0.05				0		1	116	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216196766	216196766	C	T	het	het	wt	off-target	QUAL=3479;DP=188,93,127;AF=0.51,0.51,0.00;MQM=60;SAP=278;ABP=3;SAR=138;SAF=4	USH2A,USH2A-AS1	intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron18/71:c.4082-44G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron18/72:c.4082-44G>A::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron18/20:c.4082-44G>A::,USH2A-AS1:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+841C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177619 [benign DISEASE=Usher syndrome type 2A,not provided];			rs447102	0.1776	0.0715,0.1971,0.2202,0.2348,0.2198	2763,.	21449	124947	-1.2300			0.01			COSV56445389	0	18665195	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216196788	216196788	T	G	hom	hom	hom	off-target	QUAL=10430;DP=172,71,95;AF=0.99,1.00,1.00;MQM=60;SAP=709;ABP=0;SAR=334;SAF=3	USH2A,USH2A-AS1	intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron18/71:c.4082-66A>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron18/72:c.4082-66A>C::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron18/20:c.4082-66A>C::,USH2A-AS1:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+863T>G::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177620 [benign DISEASE=Usher syndrome type 2A,not provided];			rs386851	0.9053	0.9750,0.9000,0.9818,0.8665,0.9329	62565,.	12564	14402	0.0510			2.24				0	18665195	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216198592	216198592	A	C	het	het	wt		QUAL=4100;DP=223,82,90;AF=0.54,0.55,0.00;MQM=60;SAP=336;ABP=7;SAR=162;SAF=3	USH2A,USH2A-AS1	splice_region&intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:splice_region_variant&intron_variant:LOW:intron17/71:c.3812-8T>G::,USH2A:ENST00000674083.1:splice_region_variant&intron_variant:LOW:intron17/72:c.3812-8T>G::,USH2A:ENST00000366942.3:splice_region_variant&intron_variant:LOW:intron17/20:c.3812-8T>G::,USH2A-AS1:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+2667A>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48508 [benign DISEASE=Retinitis pigmentosa,Usher syndrome type 2A,not specified,not provided];			rs646094	0.2046	0.1635,0.2088,0.2202,0.2357,0.2212	3257,.	24576	120886	2.6310			8.66		9.73>8.94		0.14	25741868,24033266,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216217352	216217352	C	T	het	het	hom	off-target	QUAL=7335;DP=178,110,125;AF=0.48,0.52,1.00;MQM=60;SAP=358;ABP=3;SAR=29;SAF=238	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron15/71:c.3157+35G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron15/72:c.3157+35G>A::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron15/20:c.3157+35G>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177621 [benign DISEASE=Usher syndrome type 2A,not provided];		L3b (LINE/CR1)	rs1324330	0.5591	0.3423,0.6319,0.7603,0.6194,0.6920	25206,.	34456	66924	0.1690			2.32			COSV56329695	0.03	20145675,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216232288	216232288	T	A	het	het	wt	off-target	QUAL=1160;DP=86,7,11;AF=0.53,0.43,0.00;MQM=60;SAP=109;ABP=4;SAR=49;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron13/71:c.2810-152A>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron13/72:c.2810-152A>T::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron13/20:c.2810-152A>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs533694105	0.0018	0.0006,0.0011,0.0000,0.0031,0.0006	0,.	278	151966	-0.2400			0.75				0		0	51	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216289580	216289580	C	A	het	wt	het	off-target	QUAL=1412;DP=93,35,34;AF=0.44,0.00,0.53;MQM=60;SAP=131;ABP=4;SAR=59;SAF=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron10/71:c.1841-170G>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron10/72:c.1841-170G>T::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron10/20:c.1841-170G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1216713 [likely benign DISEASE=not provided];			rs114284380	0.0133	0.0021,0.0082,0.0000,0.0183,0.0029	21,.	1981	150121	3.4400			18.53				0		5	174	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216418661	216418661	T	C	hom	hom	hom		QUAL=18986;DP=160,189,255;AF=1.00,0.99,1.00;MQM=60;SAP=131;ABP=0;SAR=395;SAF=207	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon3/72:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon3/73:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily],USH2A:ENST00000366942.3:synonymous_variant:LOW:exon3/21:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily]		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48528 [benign DISEASE=Retinitis pigmentosa,Usher syndrome type 2A,not specified,not provided];			rs4253963	0.6173	0.5014,0.6566,0.8326,0.6508,0.6231	29431,.	34781	58049	-0.5650			0.35				0.03	25741868,24033266,22876132,21686329,18665195,31817543,29283788,32313182	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216421964	216421964	C	T	hom	hom	hom		QUAL=33057;DP=294,279,443;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0;SAR=502;SAF=513	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon2/72:c.373G>A:p.Ala125Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon2/73:c.373G>A:p.Ala125Thr:,USH2A:ENST00000366942.3:missense_variant:MODERATE:exon2/21:c.373G>A:p.Ala125Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48507 [benign DISEASE=Retinitis pigmentosa,Usher syndrome type 2A,not specified,not provided];			rs10779261	0.7323	0.7555,0.7225,0.8325,0.7083,0.7604	40838,.	29559	40667	0.3580	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	4.92	0.08			0	25741868,24033266,21686329,20145675,18665195,30419932,31817543,29283788,32313182,33829662	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	220150107	220150107	T	-	het	het	het		QUAL=1404;DP=143,38,46;AF=0.27,0.37,0.26;MQM=60;SAP=13;ABP=93;SAR=24;SAF=41	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*1144del::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295627 [uncertain significance DISEASE=Warburg micro syndrome,Martsolf syndrome];		FLAM_C (SINE/Alu)	rs11316594	0.4708	0.6212,0.4804,0.6891,0.3863,0.4469	14619,.	33260	70264	-2.8380			0.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220150452	220150452	T	-	het	het	het		QUAL=699;DP=53,14,21;AF=0.30,0.43,0.29;MQM=60;SAP=41;ABP=28;SAR=3;SAF=25	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*799del::,RAB3GAP2:ENST00000691661.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*799del::,RAB3GAP2:ENST00000691862.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*799del::,RAB3GAP2:ENST00000690315.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*799del::,RAB3GAP2:ENST00000692972.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*799del::,RAB3GAP2:ENST00000687647.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*799del::,RAB3GAP2:ENST00000686381.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*799del::,RAB3GAP2:ENST00000687065.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*799del::,RAB3GAP2:ENST00000692813.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*799del::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs35147354	0.1647	0.3170,0.1314,0.2453,0.0903,0.1101	2069,.	16481	104543	-0.1300			3.64				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220150452	220150453	TT	-	het	wt	wt		QUAL=699;DP=53,14,21;AF=0.25,0.21,0.14;MQM=60;SAP=12;ABP=65;SAR=5;SAF=14	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*798_*799del::,RAB3GAP2:ENST00000691661.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*798_*799del::,RAB3GAP2:ENST00000691862.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*798_*799del::,RAB3GAP2:ENST00000690315.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*798_*799del::,RAB3GAP2:ENST00000692972.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*798_*799del::,RAB3GAP2:ENST00000687647.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*798_*799del::,RAB3GAP2:ENST00000686381.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*798_*799del::,RAB3GAP2:ENST00000687065.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*798_*799del::,RAB3GAP2:ENST00000692813.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*798_*799del::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs35147354	0.0015	0.0028,0.0016,0.0007,0.0009,0.0013	0,.	188	124964	-0.1300			3.62				0		0	62	0 / 0					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220150847	220150847	A	G	het	wt	het		QUAL=9846;DP=414,217,267;AF=0.55,0.00,0.53;MQM=60;SAP=283;ABP=13;SAR=293;SAF=75	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::,RAB3GAP2:ENST00000691661.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::,RAB3GAP2:ENST00000691862.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*404T>C::,RAB3GAP2:ENST00000690315.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*404T>C::,RAB3GAP2:ENST00000692972.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*404T>C::,RAB3GAP2:ENST00000687647.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::,RAB3GAP2:ENST00000686381.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*404T>C::,RAB3GAP2:ENST00000687065.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*404T>C::,RAB3GAP2:ENST00000692813.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*404T>C::,RAB3GAP2:ENST00000685664.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*708T>C::,RAB3GAP2:ENST00000690824.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295635 [benign DISEASE=Warburg micro syndrome 2,Martsolf syndrome];			rs1059140	0.0717	0.0172,0.0602,0.0623,0.0983,0.1428	520,.	9860	141232	0.2210			6.90				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157330	220157330	C	T	het	wt	het		QUAL=9501;DP=416,209,288;AF=0.55,0.00,0.48;MQM=60;SAP=266;ABP=5;SAR=78;SAF=289	RAB3GAP2	synonymous	RAB3GAP2:ENST00000358951.7:synonymous_variant:LOW:exon31/35:c.3495G>A:p.Leu1165=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000691661.1:synonymous_variant:LOW:exon31/35:c.3507G>A:p.Leu1169=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000691862.1:synonymous_variant:LOW:exon30/34:c.3393G>A:p.Leu1131=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000690315.1:synonymous_variant:LOW:exon30/34:c.3396G>A:p.Leu1132=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000692972.1:synonymous_variant:LOW:exon32/36:c.3570G>A:p.Leu1190=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000687647.1:synonymous_variant:LOW:exon31/35:c.3231G>A:p.Leu1077=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000686381.1:synonymous_variant:LOW:exon32/36:c.3231G>A:p.Leu1077=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000687065.1:synonymous_variant:LOW:exon32/36:c.3231G>A:p.Leu1077=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000692813.1:synonymous_variant:LOW:exon30/34:c.3459G>A:p.Leu1153=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000685664.1:synonymous_variant:LOW:exon31/34:c.3495G>A:p.Leu1165=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000690824.1:synonymous_variant:LOW:exon31/35:c.3495G>A:p.Leu1165=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus]		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	130080 [benign DISEASE=Warburg micro syndrome 2,Martsolf syndrome,not specified];			rs11547779	0.0710	0.0172,0.0596,0.0627,0.0979,0.1286	510,.	9769	141097	-0.5860			5.52			COSV62784001	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157863	220157863	C	G	het	wt	het		QUAL=6490;DP=291,182,248;AF=0.45,0.00,0.46;MQM=60;SAP=3;ABP=11;SAR=124;SAF=123	RAB3GAP2	missense	RAB3GAP2:ENST00000358951.7:missense_variant:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000691661.1:missense_variant:MODERATE:exon30/35:c.3287G>C:p.Ser1096Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000691862.1:missense_variant:MODERATE:exon29/34:c.3173G>C:p.Ser1058Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000690315.1:missense_variant:MODERATE:exon29/34:c.3176G>C:p.Ser1059Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000692972.1:missense_variant:MODERATE:exon31/36:c.3350G>C:p.Ser1117Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000687647.1:missense_variant:MODERATE:exon30/35:c.3011G>C:p.Ser1004Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000686381.1:missense_variant:MODERATE:exon31/36:c.3011G>C:p.Ser1004Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000687065.1:missense_variant:MODERATE:exon31/36:c.3011G>C:p.Ser1004Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000692813.1:missense_variant:MODERATE:exon29/34:c.3239G>C:p.Ser1080Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000685664.1:missense_variant:MODERATE:exon30/34:c.3275G>C:p.Ser1092Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000690824.1:missense_variant:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus]		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	130079 [benign DISEASE=Warburg micro syndrome 2,Martsolf syndrome,not specified];			rs2289189	0.0708	0.0172,0.0586,0.0618,0.0977,0.1288	507,.	9756	141356	7.3560	D(0.05),T(0.05),T(0.06),T(0.06),D(0.05),D(0.05),D(0.05),D(0.05),T(0.06),T(0.22),T(0.06)	P(0.86),P(0.77),P(0.77),P(0.82),P(0.77),P(0.86),P(0.86),P(0.86),P(0.67),P(0.77),P(0.77)	25.70	0.18		COSV62784008	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157956	220157956	C	G	het	wt	het	off-target	QUAL=4154;DP=168,143,161;AF=0.46,0.00,0.53;MQM=60;SAP=173;ABP=3;SAR=138;SAF=25	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron29/34:c.3262-80G>C::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron29/34:c.3274-80G>C::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron28/33:c.3160-80G>C::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron28/33:c.3163-80G>C::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron30/35:c.3337-80G>C::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron29/34:c.2998-80G>C::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron30/35:c.2998-80G>C::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron30/35:c.2998-80G>C::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron28/33:c.3226-80G>C::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron29/33:c.3262-80G>C::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron29/34:c.3262-80G>C::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1293227 [benign DISEASE=not provided];			rs3767655	0.0708	0.0172,0.0586,0.0620,0.0978,0.1284	509,.	9760	141380	-1.0190			0.21				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157977	220157977	T	G	wt	het	wt	off-target	QUAL=1552;DP=133,108,133;AF=0.00,0.56,0.00;MQM=60;SAP=45;ABP=6;SAR=47;SAF=13	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron29/34:c.3262-101A>C::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron29/34:c.3274-101A>C::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron28/33:c.3160-101A>C::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron28/33:c.3163-101A>C::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron30/35:c.3337-101A>C::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron29/34:c.2998-101A>C::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron30/35:c.2998-101A>C::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron30/35:c.2998-101A>C::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron28/33:c.3226-101A>C::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron29/33:c.3262-101A>C::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron29/34:c.3262-101A>C::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1228713 [benign DISEASE=not provided];			rs3767654	0.1484	0.0373,0.2223,0.1347,0.1907,0.1609	2143,.	18288	129536	0.2030			3.17			COSV62782794,COSV62783440	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220159210	220159210	C	T	het	het	het	off-target	QUAL=2778;DP=114,53,64;AF=0.52,0.43,0.55;MQM=60;SAP=257;ABP=3;SAR=0;SAF=117	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron29/34:c.3261+176G>A::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron29/34:c.3273+176G>A::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron28/33:c.3159+176G>A::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron28/33:c.3162+176G>A::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron30/35:c.3336+176G>A::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron29/34:c.2997+176G>A::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron30/35:c.2997+176G>A::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron30/35:c.2997+176G>A::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron28/33:c.3226-1334G>A::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron29/33:c.3261+176G>A::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron29/34:c.3261+176G>A::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1257064 [benign DISEASE=not provided];			rs2789792	0.4824	0.6787,0.4849,0.7100,0.3733,0.4491	19270,.	34682	78566	-5.6310			0.04				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220159534	220159534	G	A	het	het	het	off-target	QUAL=2079;DP=106,25,38;AF=0.53,0.52,0.42;MQM=60;SAP=171;ABP=3;SAR=83;SAF=2	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron28/34:c.3226-113C>T::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron28/34:c.3238-113C>T::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron27/33:c.3124-113C>T::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron27/33:c.3127-113C>T::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron29/35:c.3301-113C>T::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron28/34:c.2962-113C>T::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron29/35:c.2962-113C>T::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron29/35:c.2962-113C>T::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron28/33:c.3226-1658C>T::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron28/33:c.3226-113C>T::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron28/34:c.3226-113C>T::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1258027 [benign DISEASE=not provided];			rs2808026	0.4823	0.6782,0.4853,0.7098,0.3733,0.4482	19273,.	34716	78636	0.3150			5.54				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220162088	220162088	A	G	wt	het	wt	off-target	QUAL=580;DP=134,60,61;AF=0.00,0.45,0.00;MQM=60;SAP=46;ABP=4;SAR=2;SAF=25	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron28/34:c.3225+110T>C::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron28/34:c.3237+110T>C::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron27/33:c.3123+110T>C::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron27/33:c.3126+110T>C::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron29/35:c.3300+110T>C::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron28/34:c.2961+110T>C::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron29/35:c.2961+110T>C::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron29/35:c.2961+110T>C::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron28/33:c.3225+110T>C::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron28/33:c.3225+110T>C::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron28/34:c.3225+110T>C::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	668611 [benign DISEASE=not provided];			rs2164790	0.2785	0.3512,0.3132,0.4039,0.2290,0.2371	6234,.	29849	109641	-1.5740			0.14				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220162424	220162428	ATTTC	-	wt	wt	het	off-target	QUAL=181;DP=51,22,27;AF=0.00,0.00,0.41;MQM=60;SAP=27;ABP=5;SAR=11;SAF=0	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron27/34:c.3155-160_3155-156del::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron27/34:c.3167-160_3167-156del::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron26/33:c.3053-160_3053-156del::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron26/33:c.3056-160_3056-156del::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron28/35:c.3230-160_3230-156del::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron27/34:c.2891-160_2891-156del::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron28/35:c.2891-160_2891-156del::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron28/35:c.2891-160_2891-156del::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron27/33:c.3155-160_3155-156del::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron27/33:c.3155-160_3155-156del::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron27/34:c.3155-160_3155-156del::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]				rs779116294	0.0007	0.0000,0.0000,0.0000,0.0010,0.0000	0,.	110	152078	0.0260			0.35				0		0	21	0 / 0					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220172230	220172230	A	C	het	wt	het	off-target	QUAL=1258;DP=102,17,15;AF=0.47,0.00,0.47;MQM=60;SAP=122;ABP=4;SAR=55;SAF=0	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron22/34:c.2417-181T>G::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron22/34:c.2429-181T>G::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron21/33:c.2315-181T>G::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron21/33:c.2318-181T>G::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron23/35:c.2492-181T>G::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron22/34:c.2153-181T>G::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron23/35:c.2153-181T>G::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron23/35:c.2153-181T>G::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron22/33:c.2417-181T>G::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron22/33:c.2417-181T>G::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron22/34:c.2417-181T>G::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1263789 [benign DISEASE=not provided];			rs73098558	0.1296	0.1297,0.1037,0.0993,0.1353,0.1899	1373,.	16973	132405	-1.8110			0.14				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220172536	220172536	A	G	het	wt	het	off-target	QUAL=3641;DP=159,64,111;AF=0.54,0.00,0.56;MQM=60;SAP=282;ABP=8;SAR=5;SAF=143	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron22/34:c.2416+101T>C::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron22/34:c.2428+101T>C::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron21/33:c.2314+101T>C::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron21/33:c.2317+101T>C::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron23/35:c.2491+101T>C::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron22/34:c.2152+101T>C::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron23/35:c.2152+101T>C::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron23/35:c.2152+101T>C::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron22/33:c.2416+101T>C::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron22/33:c.2416+101T>C::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron22/34:c.2416+101T>C::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1178138 [benign DISEASE=not provided];			rs41303055	0.0714	0.0172,0.0593,0.0626,0.0977,0.1456	527,.	9806	141258	-0.2050			2.52				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220182092	220182092	T	-	het	het	het	off-target	QUAL=382;DP=38,5,7;AF=0.39,0.20,0.43;MQM=60;SAP=44;ABP=9;SAR=0;SAF=19	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron21/34:c.2310+165del::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron21/34:c.2322+165del::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron20/33:c.2208+165del::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron20/33:c.2211+165del::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron22/35:c.2385+165del::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron21/34:c.2046+165del::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron22/35:c.2046+165del::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron22/35:c.2046+165del::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron21/33:c.2310+165del::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron21/33:c.2310+165del::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron21/34:c.2310+165del::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1231942 [benign DISEASE=not provided];			rs11343960	0.4804	0.6785,0.4819,0.7095,0.3721,0.4202	19006,.	34587	78525	0.3420			0.42				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220193155	220193155	T	A	het	wt	het	off-target	QUAL=1862;DP=115,64,60;AF=0.45,0.00,0.45;MQM=60;SAP=166;ABP=7;SAR=1;SAF=78	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron13/34:c.1270+85A>T::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron13/34:c.1282+85A>T::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron12/33:c.1168+85A>T::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron12/33:c.1171+85A>T::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron14/35:c.1345+85A>T::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron13/34:c.1006+85A>T::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron14/35:c.1006+85A>T::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron14/35:c.1006+85A>T::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron13/33:c.1270+85A>T::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron13/33:c.1270+85A>T::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron13/34:c.1270+85A>T::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1293232 [benign DISEASE=not provided];			rs78010602	0.0693	0.0167,0.0562,0.0641,0.0966,0.1010	480,.	9579	141631	0.1860			5.30				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220196404	220196404	A	-	wt	het	wt		QUAL=829;DP=165,91,94;AF=0.05,0.48,0.01;MQM=60;SAP=88;ABP=3;SAR=50;SAF=4	RAB3GAP2	splice_region&intron	RAB3GAP2:ENST00000358951.7:splice_region_variant&intron_variant:LOW:intron9/34:c.812-6del::,RAB3GAP2:ENST00000691661.1:splice_region_variant&intron_variant:LOW:intron9/34:c.824-6del::,RAB3GAP2:ENST00000691862.1:splice_region_variant&intron_variant:LOW:intron8/33:c.710-6del::,RAB3GAP2:ENST00000690315.1:splice_region_variant&intron_variant:LOW:intron8/33:c.713-6del::,RAB3GAP2:ENST00000692972.1:splice_region_variant&intron_variant:LOW:intron10/35:c.887-6del::,RAB3GAP2:ENST00000687647.1:splice_region_variant&intron_variant:LOW:intron9/34:c.548-6del::,RAB3GAP2:ENST00000686381.1:splice_region_variant&intron_variant:LOW:intron10/35:c.548-6del::,RAB3GAP2:ENST00000687065.1:splice_region_variant&intron_variant:LOW:intron10/35:c.548-6del::,RAB3GAP2:ENST00000692813.1:splice_region_variant&intron_variant:LOW:intron9/33:c.812-6del::,RAB3GAP2:ENST00000685664.1:splice_region_variant&intron_variant:LOW:intron9/33:c.812-6del::,RAB3GAP2:ENST00000690824.1:splice_region_variant&intron_variant:LOW:intron9/34:c.812-6del::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295665 [benign DISEASE=Warburg micro syndrome 2,Warburg micro syndrome,Martsolf syndrome,not provided];			rs35396665	0.2647	0.2572,0.3217,0.3901,0.2485,0.2439	5003,.	28498	106966	-0.0030			1.96				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19), MIR664A (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), SNORA36B (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	220206161	220206161	G	C	het	het	het	off-target	QUAL=1032;DP=71,13,14;AF=0.51,0.46,0.29;MQM=60;SAP=103;ABP=4;SAR=46;SAF=0	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron7/34:c.613-155C>G::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron7/34:c.625-155C>G::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron6/33:c.511-155C>G::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron7/33:c.613-155C>G::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron7/35:c.613-155C>G::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron7/34:c.349-155C>G::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron8/35:c.349-155C>G::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron8/35:c.349-155C>G::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron7/33:c.613-155C>G::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron7/33:c.613-155C>G::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron7/34:c.613-155C>G::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron7/9:c.613-155C>G::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1243694 [benign DISEASE=not provided];			rs4142940	0.4572	0.6847,0.4510,0.4528,0.3524,0.3729	17608,.	34207	82439	-1.4300			3.15			COSV52966966	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19), SNX2P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	220213730	220213730	-	T	hom	n/a	het	off-target;low_conf_region	QUAL=467;DP=23,1,6;AF=0.83,0.00,0.67;MQM=60;SAP=53;ABP=4;SAR=0;SAF=23	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron3/34:c.304+125dup::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron3/34:c.316+125dup::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron3/33:c.304+125dup::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron3/33:c.304+125dup::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron3/35:c.304+125dup::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron3/34:c.40+125dup::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron4/35:c.40+125dup::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron4/35:c.40+125dup::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron3/33:c.304+125dup::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron3/33:c.304+125dup::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron3/34:c.304+125dup::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron3/9:c.304+125dup::	regulatory_region_variant:enhancer	609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]			G-rich (Low_complexity)	rs370682557	0.1136	0.0348,0.0824,0.0977,0.1380,0.1991	701,.	6185	59193				0.27				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220213735	220213735	G	A	het	wt	het	off-target;low_conf_region	QUAL=438;DP=25,3,6;AF=0.88,0.00,0.67;MQM=60;SAP=59;ABP=34;SAR=0;SAF=26	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron3/34:c.304+121C>T::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron3/34:c.316+121C>T::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron3/33:c.304+121C>T::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron3/33:c.304+121C>T::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron3/35:c.304+121C>T::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron3/34:c.40+121C>T::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron4/35:c.40+121C>T::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron4/35:c.40+121C>T::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron3/33:c.304+121C>T::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron3/33:c.304+121C>T::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron3/34:c.304+121C>T::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron3/9:c.304+121C>T::	regulatory_region_variant:enhancer	609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1251110 [benign DISEASE=not provided];		G-rich (Low_complexity)	rs138212227	0.0757	0.0185,0.0529,0.0252,0.1049,0.1434	667,.	6932	100972	0.0340			0.90			COSV52967437	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220213741	220213741	G	A	het	wt	het	off-target;low_conf_region	QUAL=678;DP=37,4,9;AF=0.86,0.00,0.78;MQM=60;SAP=88;ABP=51;SAR=0;SAF=39	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron3/34:c.304+115C>T::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron3/34:c.316+115C>T::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron3/33:c.304+115C>T::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron3/33:c.304+115C>T::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron3/35:c.304+115C>T::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron3/34:c.40+115C>T::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron4/35:c.40+115C>T::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron4/35:c.40+115C>T::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron3/33:c.304+115C>T::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron3/33:c.304+115C>T::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron3/34:c.304+115C>T::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron3/9:c.304+115C>T::	regulatory_region_variant:enhancer	609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1248119 [benign DISEASE=not provided];		G-rich (Low_complexity)	rs147804604	0.0843	0.0241,0.0569,0.0827,0.1081,0.1629	641,.	7621	96653	-1.4020			0.19			COSV52967451	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220232949	220232949	A	G	het	het	het	off-target	QUAL=4351;DP=138,94,130;AF=0.45,0.51,0.52;MQM=60;SAP=207;ABP=3;SAR=153;SAF=24	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron1/34:c.116-86T>C::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron1/34:c.116-86T>C::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron1/33:c.116-86T>C::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron1/33:c.116-86T>C::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron1/35:c.116-86T>C::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron1/34:c.-149-86T>C::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron2/35:c.-149-86T>C::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron2/35:c.-149-86T>C::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron1/33:c.116-86T>C::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron1/33:c.116-86T>C::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron1/34:c.116-86T>C::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron1/9:c.116-86T>C::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	673980 [benign DISEASE=not provided];		X10b_DNA (DNA/TcMar-Tigger)	rs10863538	0.4581	0.7088,0.4504,0.4497,0.3412,0.3823	18000,.	33553	82289	0.5120			3.15			COSV52966274	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220272146	220272146	C	T	het	wt	het	off-target	QUAL=668;DP=22,34,67;AF=0.50,0.00,0.51;MQM=60;SAP=101;ABP=3;SAR=0;SAF=45	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron1/34:c.115+77G>A::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron1/34:c.115+77G>A::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron1/33:c.115+77G>A::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron1/33:c.115+77G>A::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron1/35:c.115+77G>A::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron1/34:c.-150+210G>A::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron2/35:c.-150+77G>A::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron2/35:c.-150+77G>A::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron1/33:c.115+77G>A::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron1/33:c.115+77G>A::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron1/34:c.115+77G>A::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron1/9:c.115+77G>A::	regulatory_region_variant:promoter	609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1293230 [benign DISEASE=not provided];			rs2292418	0.0686	0.0168,0.0546,0.0716,0.0947,0.1202	471,.	9427	140827	-2.0140			5.33			COSV52967126	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19), AURKAP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	222928597	222928597	A	C	het	het	het	off-target	QUAL=5401;DP=179,136,156;AF=0.42,0.47,0.50;MQM=60;SAP=264;ABP=9;SAR=190;SAF=28	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron2/8:c.-18+27A>C::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron2/8:c.-17-14210A>C::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron1/7:c.-18+27A>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs35491159	0.3181	0.3070,0.2327,0.0539,0.3581,0.2492	8061,.	32228	103652	-0.0850			5.90				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222942767	222942767	C	T	het	het	het	off-target	QUAL=3237;DP=101,91,104;AF=0.48,0.51,0.48;MQM=60;SAP=316;ABP=3;SAR=0;SAF=144	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron1/7:c.-17-40C>T::			1247665 [benign DISEASE=not provided];			rs75109669	0.1771	0.1957,0.1331,0.0019,0.1962,0.0750	2527,.	21846	124978	-0.0570			8.58				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41), NDUFB1P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	222982872	222982872	C	T	hom	hom	hom	off-target	QUAL=2098;DP=40,10,18;AF=1.00,1.00,1.00;MQM=60;SAP=151;ABP=0;SAR=0;SAF=68	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron3/8:c.510-208C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron3/8:c.510-208C>T::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron2/7:c.510-208C>T::			1182516 [benign DISEASE=not provided];			rs2926160	0.9781	0.9270,0.9888,1.0000,0.9992,0.9994	72794,.	3107	3337	-3.2720			0.03				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222982938	222982938	-	TT	wt	wt	het	off-target	QUAL=183;DP=105,32,41;AF=0.00,0.00,0.29;MQM=60;SAP=29;ABP=18;SAR=0;SAF=12	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron3/8:c.510-132_510-131dup::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron3/8:c.510-132_510-131dup::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron2/7:c.510-132_510-131dup::			1242292 [benign DISEASE=not provided];			rs10626845	0.2827	0.2522,0.3090,0.2121,0.2844,0.3395	5839,.	30101	106023				0.27				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222983040	222983040	C	T	hom	hom	hom	off-target	QUAL=17389;DP=272,113,154;AF=1.00,1.00,1.00;MQM=60;SAP=477;ABP=0;SAR=98;SAF=441	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron2/7:c.510-40C>T::			1250961 [benign DISEASE=not provided];			rs2926159	0.9997	0.9991,0.9999,1.0000,1.0000,1.0000	75769,.	39	39	1.0190			10.88				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222983311	222983311	C	T	het	het	het	off-target	QUAL=2016;DP=125,28,33;AF=0.49,0.43,0.55;MQM=60;SAP=201;ABP=3;SAR=91;SAF=0	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron4/8:c.539+202C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron4/8:c.539+202C>T::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron3/7:c.539+202C>T::			1238426 [benign DISEASE=not provided];			rs4388710	0.3415	0.1898,0.3921,0.4287,0.4063,0.3255	9528,.	32761	99915	-0.5440			0.47			COSV52666631	0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222994871	222994871	T	C	wt	wt	het	off-target	QUAL=1100;DP=181,56,93;AF=0.00,0.00,0.48;MQM=60;SAP=7;ABP=3;SAR=18;SAF=27	DISP1	splice_region&intron	DISP1:ENST00000675850.1:splice_region_variant&intron_variant:LOW:intron7/8:c.890-14T>C::,DISP1:ENST00000675961.1:splice_region_variant&intron_variant:LOW:intron7/8:c.890-14T>C::,DISP1:ENST00000284476.7:splice_region_variant&intron_variant:LOW:intron6/7:c.890-14T>C::	regulatory_region_variant:enhancer		262132 [benign DISEASE=not specified,not provided];			rs2609359	0.3510	0.4358,0.3373,0.2958,0.2992,0.4475	9713,.	33854	98528	0.0770			8.15		10.87>9.80	COSV52656379	0.01	25741868,19184110	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223002278	223002278	G	A	het	wt	het	off-target	QUAL=4159;DP=192,118,138;AF=0.52,0.00,0.52;MQM=60;SAP=377;ABP=4;SAR=0;SAF=172	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron8/8:c.988-107G>A::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron8/8:c.988-107G>A::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron7/7:c.988-107G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer					rs190562655	0.0027	0.0010,0.0028,0.0000,0.0038,0.0012	1,.	414	151690	-0.9070			0.18				0		0	34	0 / 0					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223004232	223004232	A	G	wt	wt	het		QUAL=5304;DP=505,262,406;AF=0.00,0.00,0.50;MQM=60;SAP=28;ABP=3;SAR=78;SAF=127	DISP1	synonymous	DISP1:ENST00000675850.1:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:ENST00000675961.1:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:ENST00000284476.7:synonymous_variant:LOW:exon8/8:c.2835A>G:p.Lys945=:			262128 [benign DISEASE=not specified,not provided];			rs2609355	0.2656	0.1840,0.2819,0.2237,0.2979,0.2988	5579,.	29190	111554	-0.5890			3.67			COSV52659190	0	25741868,19184110	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223005219	223005219	A	C	hom	hom	het		QUAL=20467;DP=190,288,371;AF=1.00,1.00,0.53;MQM=60;SAP=3;ABP=6;SAR=335;SAF=340	DISP1	synonymous	DISP1:ENST00000675850.1:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:ENST00000675961.1:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:ENST00000284476.7:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:			262131 [benign DISEASE=not specified,not provided];			rs9441941	0.5347	0.4509,0.5495,0.4942,0.5816,0.4712	21985,.	37268	70692	-0.9000			1.93			COSV52656581	0	25741868,22952568,19184110	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	225401771	225401771	C	T	het	wt	het		QUAL=8397;DP=322,266,352;AF=0.50,0.00,0.44;MQM=60;SAP=9;ABP=8;SAR=173;SAF=144	LBR	3'UTR	LBR:ENST00000272163.9:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:ENST00000338179.6:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	295917 [benign DISEASE=Greenberg dysplasia];			rs7406	0.2527	0.5120,0.1432,0.0423,0.1593,0.3054	6962,.	24479	113573	0.7850			9.24				0	25079360,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a oe_syn=0.79 oe_mis=0.80 oe_lof=1.07), LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225403048	225403048	G	C	het	wt	het		QUAL=4482;DP=310,46,55;AF=0.47,0.00,0.51;MQM=60;SAP=150;ABP=4;SAR=33;SAF=142	LBR	3'UTR	LBR:ENST00000272163.9:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:ENST00000338179.6:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	295928 [benign DISEASE=Greenberg dysplasia,not provided];			rs11551874	0.0917	0.0358,0.0703,0.0410,0.1202,0.2584	844,.	12258	138074	0.6960			2.76				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a oe_syn=0.79 oe_mis=0.80 oe_lof=1.07), LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225410144	225410144	A	G	het	hom	het	off-target	QUAL=6229;DP=179,78,95;AF=0.58,1.00,0.62;MQM=60;SAP=526;ABP=24;SAR=0;SAF=241	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron10/13:c.1314+147T>C::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron10/13:c.1314+147T>C::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1225790 [benign DISEASE=not provided];			rs1011319	0.7419	0.4693,0.8558,0.9574,0.8405,0.6981	44131,.	24500	39224	-5.9380			0.02				0.01	26489030,28286461	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225410607	225410607	A	C	het	hom	het	off-target	QUAL=2971;DP=102,32,64;AF=0.54,1.00,0.52;MQM=60;SAP=264;ABP=4;SAR=120;SAF=0	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron9/13:c.1189-191T>G::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron9/13:c.1189-191T>G::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1224301 [benign DISEASE=not provided];		L1MC4a (LINE/L1)	rs1538930	0.5854	0.3327,0.7155,0.8521,0.6687,0.4932	27999,.	32922	62972	0.0910			2.94				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225411153	225411153	G	A	het	wt	het	off-target	QUAL=844;DP=63,11,10;AF=0.54,0.00,0.40;MQM=60;SAP=86;ABP=3;SAR=0;SAF=38	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron9/13:c.1188+184C>T::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron9/13:c.1188+184C>T::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1239470 [benign DISEASE=not provided];			rs17557867	0.0876	0.0223,0.0685,0.0408,0.1200,0.2536	812,.	11694	138758	-2.5190			0.02				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225412650	225412650	A	-	het	het	het	low_conf_region	QUAL=185;DP=88,28,35;AF=0.20,0.11,0.17;MQM=59;SAP=62;ABP=138;SAR=27;SAF=0	LBR	splice_region&intron	LBR:ENST00000272163.9:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::,LBR:ENST00000338179.6:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	439855 [benign/likely benign DISEASE=not specified,not provided];			rs78306811	0.0091	0.0185,0.0050,0.0019,0.0044,0.0098	5,.	1209	132231	-0.0670			2.55				0		0	96	0 / 0					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225415401	225415401	C	T	het	hom	het	off-target;low_conf_region	QUAL=7198;DP=218,104,142;AF=0.42,1.00,0.46;MQM=60;SAP=183;ABP=16;SAR=204;SAF=57	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron6/13:c.838-69G>A::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron6/13:c.838-69G>A::	regulatory_region_variant:CTCF_binding_site	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1263342 [benign DISEASE=not provided];		(AT)n (Simple_repeat)	rs6702433	0.7295	0.4273,0.8496,0.9573,0.8400,0.6935	43234,.	24391	41101	-0.1800			0.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225419442	225419442	C	T	het	hom	het		QUAL=1842;DP=75,20,47;AF=0.40,1.00,0.45;MQM=60;SAP=45;ABP=10;SAR=54;SAF=17	LBR	missense	LBR:ENST00000272163.9:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:ENST00000338179.6:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258619 [benign DISEASE=Pelger-Huet anomaly,Greenberg dysplasia,Reynolds syndrome,not specified,not provided];			rs2230419	0.7296	0.4277,0.8494,0.9567,0.8398,0.6984	43266,.	24388	41110	-0.1670	T(0.41),T(0.41)	B(0.01),B(0.01)	0.00	0.17		COSV55291160	0.01	25741868,24033266,26489030,28286461	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225422182	225422182	A	G	het	hom	het		QUAL=2336;DP=123,15,17;AF=0.57,1.00,0.59;MQM=60;SAP=7;ABP=9;SAR=41;SAF=54	LBR	synonymous	LBR:ENST00000272163.9:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:ENST00000338179.6:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:	regulatory_region_variant:promoter	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258617 [benign DISEASE=Pelger-Huet anomaly,Greenberg dysplasia,Reynolds syndrome,not specified,not provided];			rs1056608	0.6841	0.3936,0.8180,0.8924,0.7915,0.6497	38101,.	27720	48000	-0.7860			2.29				0.01	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225423959	225423959	C	T	het	het	hom		QUAL=17163;DP=364,210,283;AF=0.53,0.49,1.00;MQM=60;SAP=13;ABP=4;SAR=264;SAF=315	LBR	synonymous	LBR:ENST00000272163.9:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465 [Lamin-B receptor of TUDOR domain],LBR:ENST00000338179.6:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465 [Lamin-B receptor of TUDOR domain]		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258616 [benign DISEASE=Pelger-Huet anomaly,Greenberg dysplasia,Reynolds syndrome,not specified,not provided];			rs1056607	0.7115	0.6386,0.7742,0.7602,0.7371,0.5079	38809,.	30508	43838	-3.1000			1.22			COSV55289527	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225424143	225424143	C	T	wt	het	het	off-target;low_conf_region	QUAL=2274;DP=183,83,110;AF=0.00,0.43,0.52;MQM=60;SAP=114;ABP=4;SAR=81;SAF=12	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	810884 [benign DISEASE=not specified,not provided];			rs1340867	0.6202	0.5923,0.7122,0.7605,0.6226,0.3846	29478,.	35252	57694	-1.5450			0.31				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225427864	225427864	G	C	het	het	hom	off-target	QUAL=252;DP=5,4,7;AF=0.60,0.50,1.00;MQM=60;SAP=29;ABP=3;SAR=0;SAF=12	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron1/13:c.-15+90C>G::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron1/13:c.-15+842C>G::	regulatory_region_variant:promoter	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1247977 [benign DISEASE=not provided];			rs4653636	0.7419	0.6424,0.8017,0.7816,0.7823,0.5606	42220,.	28146	39172	-0.2910			6.29				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225428676	225428676	G	C	het	het	wt	off-target	QUAL=4190;DP=197,179,249;AF=0.55,0.50,0.00;MQM=60;SAP=305;ABP=5;SAR=16;SAF=182	LBR	intron	LBR:ENST00000338179.6:intron_variant:MODIFIER:intron1/13:c.-15+30C>G::	regulatory_region_variant:promoter	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]				rs75691342	0.0776	0.0516,0.0611,0.0398,0.0916,0.2295	565,.	10677	140267	-0.4380			4.82						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	226360483	226360483	A	-	het	het	het	off-target	QUAL=221;DP=45,15,13;AF=0.16,0.40,0.31;MQM=60;SAP=40;ABP=48;SAR=0;SAF=17	PARP1	downstream_gene	PARP1:ENST00000366794.10:downstream_gene_variant:MODIFIER::::,PARP1:ENST00000677203.1:downstream_gene_variant:MODIFIER::::						rs111264055	0.0013	0.0018,0.0013,0.0018,0.0009,0.0004	0,.	181	142641	-0.1470			0.15						0	2	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226360853	226360853	A	G	wt	het	wt		QUAL=860;DP=168,77,97;AF=0.01,0.49,0.00;MQM=60;SAP=38;ABP=3;SAR=32;SAF=7	PARP1	3'UTR	PARP1:ENST00000366794.10:3_prime_UTR_variant:MODIFIER:exon23/23:c.*607T>C::,PARP1:ENST00000677203.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*607T>C::				CR122378 [CLASS=DP MUT=ALT PHEN="Bladder cancer increased risk association with" GENE=PARP1];		rs8679	0.1659	0.0610,0.1790,0.0595,0.2280,0.2480	2639,.	19952	126876	-0.5110			1.46				0	31637880,23614619,21976407,25114582,21767974,22166496,25003827,27746584,29048575,31413734,29937070,26630397,28646528,29156695,28537887,26261599,25139788,22964086,24616890,17560163,34530710,33391423,33791158,32780923,33112558,33147530	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226361797	226361797	G	A	wt	het	wt	off-target	QUAL=723;DP=145,57,93;AF=0.00,0.56,0.00;MQM=60;SAP=56;ABP=5;SAR=2;SAF=30	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron22/22:c.2963+172C>T::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron21/21:c.2834+172C>T::						rs2271347	0.1647	0.0609,0.1773,0.0596,0.2263,0.2462	2600,.	19833	126951	-0.6350			0.62				0.02	27746584,19925161,27099827,29683114,23370117,30260276,29799308,35005347	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226362185	226362185	T	-	het	het	het	off-target	QUAL=30;DP=100,55,78;AF=0.13,0.20,0.19;MQM=60;SAP=88;ABP=227;SAR=39;SAF=0	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron21/22:c.2849-102del::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron20/21:c.2720-102del::					AluSx (SINE/Alu)	rs368063214	0.0024	0.0021,0.0017,0.0010,0.0021,0.0011	0,.	333	140645	0.9620			1.53				0		0	17	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226363223	226363223	G	C	het	hom	het	off-target	QUAL=5158;DP=103,71,107;AF=0.43,1.00,0.62;MQM=60;SAP=162;ABP=4;SAR=148;SAF=33	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron20/22:c.2787-63C>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron19/21:c.2658-63C>G::						rs747657	0.5776	0.4567,0.5435,0.1943,0.6709,0.6256	26426,.	34916	64186	-0.6160			0.35			COSV64690496	0.02	20981448,17560163,32341527	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226363759	226363759	T	C	het	hom	het	off-target	QUAL=1813;DP=69,25,22;AF=0.58,1.00,0.36;MQM=60;SAP=162;ABP=4;SAR=0;SAF=73	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron20/22:c.2786+184A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron19/21:c.2657+184A>G::	regulatory_region_variant:enhancer				MLT1O (LTR/ERVL-MaLR)	rs752309	0.8100	0.8463,0.6884,0.5321,0.8404,0.8035	50367,.	22409	28893	-0.2500			3.31			COSV64689687	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226363828	226363828	C	G	het	hom	het	off-target	QUAL=4015;DP=143,51,75;AF=0.52,1.00,0.44;MQM=60;SAP=340;ABP=3;SAR=1;SAF=158	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron20/22:c.2786+115G>C::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron19/21:c.2657+115G>C::	regulatory_region_variant:enhancer					rs752307	0.8211	0.8698,0.6919,0.5704,0.8405,0.8872	51758,.	21336	27210	-0.7920			0.61			COSV64689696,COSV64692544	0	19249341,20522537,17560163,29403010,33284833,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226365341	226365341	C	T	wt	wt	het	off-target	QUAL=306;DP=85,35,35;AF=0.00,0.00,0.46;MQM=60;SAP=38;ABP=4;SAR=16;SAF=0	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron18/22:c.2506-187G>A::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron17/21:c.2377-187G>A::	regulatory_region_variant:enhancer					rs3219140	0.0363	0.0286,0.0241,0.0000,0.0453,0.0062	107,.	5309	146675	-0.2990			0.77				0		4	32	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226365784	226365784	A	C	het	n/a	het	off-target;low_conf_region	QUAL=292;DP=37,2,7;AF=0.41,0.00,0.29;MQM=57;SAP=40;ABP=8;SAR=0;SAF=17	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron18/22:c.2505+170T>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron17/21:c.2376+170T>G::	regulatory_region_variant:open_chromatin_region				AluSx (SINE/Alu)	rs118165556	0.8014	0.8303,0.6819,0.5319,0.8337,0.8181	47274,.	22814	29086	-0.7340			1.00				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226365785	226365785	C	A	het	n/a	het	off-target;low_conf_region	QUAL=292;DP=37,2,7;AF=0.41,0.00,0.29;MQM=57;SAP=40;ABP=8;SAR=0;SAF=17	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron18/22:c.2505+169G>T::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron17/21:c.2376+169G>T::	regulatory_region_variant:open_chromatin_region				AluSx (SINE/Alu)	rs146042055	0.8155	0.8498,0.6890,0.5710,0.8409,0.8874	49527,.	21534	27286	-0.8190			0.36				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226365789	226365789	C	A	het	n/a	het	off-target;low_conf_region	QUAL=292;DP=37,2,7;AF=0.41,0.00,0.29;MQM=57;SAP=40;ABP=8;SAR=0;SAF=17	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron18/22:c.2505+165G>T::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron17/21:c.2376+165G>T::	regulatory_region_variant:open_chromatin_region				AluSx (SINE/Alu)	rs34917861	0.8129	0.8490,0.6863,0.5700,0.8378,0.8866	48928,.	21774	27528	-0.8680			0.29				0	32888493	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226365793	226365793	-	A	het	n/a	het	off-target;low_conf_region	QUAL=103;DP=19,2,8;AF=0.42,0.00,0.13;MQM=60;SAP=23;ABP=10;SAR=0;SAF=9	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron18/22:c.2505+160dup::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron17/21:c.2376+160dup::	regulatory_region_variant:open_chromatin_region				AluSx (SINE/Alu)	rs11378196	0.8176	0.8694,0.6886,0.5701,0.8351,0.8849	49403,.	21300	26792				0.43				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226366233	226366233	A	C	het	hom	het	off-target	QUAL=1721;DP=67,20,37;AF=0.48,1.00,0.54;MQM=60;SAP=159;ABP=3;SAR=72;SAF=0	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron17/22:c.2407-181T>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron16/21:c.2278-181T>G::	regulatory_region_variant:open_chromatin_region				MIR3 (SINE/MIR)	rs2271349	0.8166	0.8693,0.6910,0.5318,0.8405,0.8035	51215,.	21672	27864	-1.2250			0.39				0.25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226367601	226367601	A	G	het	wt	het		QUAL=5930;DP=196,218,300;AF=0.49,0.00,0.47;MQM=60;SAP=64;ABP=5;SAR=160;SAF=78	PARP1	missense	PARP1:ENST00000366794.10:missense_variant:MODERATE:exon17/23:c.2285T>C:p.Val762Ala:PF02877 [Poly(ADP-ribose) polymerase regulatory domain],PARP1:ENST00000677203.1:missense_variant:MODERATE:exon16/22:c.2156T>C:p.Val719Ala:PF02877 [Poly(ADP-ribose) polymerase regulatory domain]			1261945 [benign DISEASE=not provided];	CM042761 [CLASS=DFP MUT=ALT PHEN="Prostate cancer susceptibility association with" GENE=PARP1];		rs1136410	0.1573	0.0539,0.3020,0.4289,0.1593,0.1122	2589,.	18737	128135	8.9420	D(0.02),D(0.01)	P(0.68),B(0.15)	27.40	0.18		COSV64689246	0	21976407,21767974,31413734,30337837,25111588,23139751,19249341,26648684,18191955,17267408,21989229,31288058,32103589,21606320,16465622,16857995,17203305,17220334,18701435,19109789,19124499,19318434,19822020,20150366,20211558,20353610,20486200,20559012,21037106,21129811,21385363,21420246,21700777,21810555,22127734,22687647,22740911,22792228,22850545,22969958,23608917,23633189,23644255,23720673,24172093,24203816,24340057,24500421,25106941,25179837,25231222,25493225,25911198,26921778,27055523,27099827,27285066,27323894,27415837,27588484,27840165,27866211,28765340,28956850,29399184,29484706,29662639,30183716,31489712,31584889,31609976,31762827,31983162,28206966,22430443,25178586,31374908,28749454,29937070,29577582,31415677,22868256,25837821,29156789,31171785,27105872,26316174,27959887,25356504,24392019,27209488,27052028,28423490,26261599,25374063,26388025,22591901,29184509,23755158,27081507,27324896,31921313,28599464,24853559,25139788,26019482,27895737,23857046,23537197,24489833,20725763,17214964,17560163,2011383	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226367647	226367647	G	A	wt	het	wt	off-target	QUAL=2128;DP=205,175,243;AF=0.00,0.49,0.00;MQM=60;SAP=37;ABP=3;SAR=62;SAF=25	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron16/22:c.2278-39C>T::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron15/21:c.2149-39C>T::						rs3219123	0.0403	0.0097,0.0407,0.0002,0.0595,0.0462	198,.	5733	146027	0.4890			3.05				0	31134135,21767974,20158304,21537398,17560163	69	2146	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226368393	226368393	T	C	hom	hom	hom	off-target	QUAL=2783;DP=24,20,46;AF=1.00,1.00,1.00;MQM=60;SAP=128;ABP=0;SAR=81;SAF=9	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron15/22:c.2155-72A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron14/21:c.2026-72A>G::						rs1805400	0.9850	0.9472,0.9951,1.0000,0.9999,0.9998	73894,.	2135	2289	-0.5630			6.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226374060	226374060	G	C	het	hom	het	off-target	QUAL=2784;DP=111,33,46;AF=0.51,1.00,0.43;MQM=60;SAP=242;ABP=3;SAR=0;SAF=110	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron14/22:c.2070+166C>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron13/21:c.1941+3048C>G::						rs2377312	0.8038	0.8241,0.6875,0.5328,0.8403,0.8032	49568,.	23045	29833	0.0570			2.36			COSV64690890	0	33284833	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226376990	226376990	T	C	het	hom	het	off-target	QUAL=2955;DP=133,38,36;AF=0.50,1.00,0.33;MQM=60;SAP=255;ABP=5;SAR=0;SAF=116	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron13/22:c.1941+118A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron13/21:c.1941+118A>G::					L1M4 (LINE/L1)	rs3219090	0.5764	0.4519,0.5429,0.1935,0.6713,0.6266	26306,.	34875	64309	1.3350			10.08			COSV64689321	0.01	21976407,21983785,19925161,27099827,30824778,25077817,24535833,23393188,24906573,26998216,27221533,28759004,29641532,24642353,24980573,25837821,28667740,29753029,25307738,27993549,25380778,26342156,29890168,23580930,23537197,32341527,32856602,30190865,29799308,31568773,32226509,33383480,27644669,35045882,35005347,34898573	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226379025	226379025	A	C	het	hom	het	off-target	QUAL=6544;DP=155,104,131;AF=0.54,0.99,0.47;MQM=60;SAP=544;ABP=3;SAR=0;SAF=249	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron12/22:c.1745+117T>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron12/21:c.1745+117T>G::						rs907190	0.8038	0.8242,0.6874,0.5330,0.8403,0.8030	49546,.	23028	29808	-1.0680			3.41			COSV64689201	0.01	33284833	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226379471	226379471	A	C	het	het	wt	off-target	QUAL=4406;DP=228,147,213;AF=0.49,0.46,0.00;MQM=60;SAP=31;ABP=5;SAR=65;SAF=113	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron11/22:c.1612+102T>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron11/21:c.1612+102T>G::						rs2271345	0.1321	0.0962,0.1113,0.0313,0.1555,0.2049	1456,.	17172	131952	-1.7420			0.12			COSV64689740	0	17560163	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226380964	226380964	T	C	het	het	wt	off-target	QUAL=3187;DP=144,157,190;AF=0.48,0.45,0.01;MQM=60;SAP=290;ABP=7;SAR=2;SAF=138	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron9/22:c.1300+104A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron9/21:c.1300+104A>G::						rs1805410	0.1323	0.0962,0.1114,0.0316,0.1558,0.2066	1465,.	17183	131945	-0.1450			3.59			COSV64689744	0	21976407,21767974,21668397,20574454,22701660,23921907,27758874,23872737,17560163	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226383139	226383139	T	C	het	hom	het		QUAL=4875;DP=92,72,92;AF=0.58,1.00,0.51;MQM=60;SAP=35;ABP=6;SAR=111;SAF=61	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon8/23:c.1056A>G:p.Lys352=:,PARP1:ENST00000677203.1:synonymous_variant:LOW:exon8/22:c.1056A>G:p.Lys352=:						rs1805415	0.8276	0.8926,0.6932,0.5710,0.8408,0.8883	52662,.	20600	26226	-0.1010			8.59			COSV64689254	0.03	19249341,17267408,27153553,17560163,20113831,33284833	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226385663	226385663	A	G	het	wt	het		QUAL=4736;DP=157,208,247;AF=0.54,0.00,0.45;MQM=60;SAP=152;ABP=4;SAR=156;SAF=40	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon7/23:c.852T>C:p.Ala284=:PF08063 [PADR1 (NUC008) domain],PARP1:ENST00000677203.1:synonymous_variant:LOW:exon7/22:c.852T>C:p.Ala284=:PF08063 [PADR1 (NUC008) domain]				CM071915 [CLASS=DP MUT=ALT PHEN="Colorectal adenoma association with" GENE=PARP1];		rs1805414	0.4243	0.5425,0.4582,0.8063,0.3315,0.3806	14726,.	35019	87471	-2.5750			0.42			COSV64689261	0	18805967,21767974,27746584,29662639,30183716,31609976,31762827,19604089,21695249,17560163,20113831,33284833,23803078,32352035	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226388569	226388569	A	G	het	wt	het	off-target	QUAL=3410;DP=171,83,100;AF=0.59,0.00,0.46;MQM=60;SAP=314;ABP=7;SAR=1;SAF=146	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron5/22:c.717+87T>C::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron5/21:c.717+87T>C::						rs2255403	0.1895	0.1527,0.3101,0.4676,0.1596,0.1968	3228,.	22379	123293	2.3010			9.54			COSV64687805	0	20522537,17560163,34477880	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226390346	226390346	G	T	het	wt	het	off-target;low_conf_region	QUAL=1256;DP=67,66,93;AF=0.31,0.00,0.47;MQM=60;SAP=112;ABP=15;SAR=4;SAF=61	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron4/22:c.617+64C>A::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron4/21:c.617+64C>A::						rs1805411	0.1721	0.1066,0.3066,0.4284,0.1591,0.1126	2801,.	20554	125836	-0.1320			1.52			COSV64688261	0	21487324,33284833	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226390398	226390398	T	C	hom	het	hom	off-target	QUAL=8987;DP=90,121,162;AF=1.00,0.55,0.99;MQM=60;SAP=435;ABP=5;SAR=33;SAF=284	PARP1	splice_region&intron	PARP1:ENST00000366794.10:splice_region_variant&intron_variant:LOW:intron4/22:c.617+12A>G::,PARP1:ENST00000677203.1:splice_region_variant&intron_variant:LOW:intron4/21:c.617+12A>G::						rs1805403	0.8340	0.9383,0.8227,0.9401,0.7725,0.7529	53408,.	19974	25232	-5.7450			0.01				0	27746584,19657367	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226392088	226392102	ACGTTGAGCTAGCAC	-	het	wt	het	off-target	QUAL=1404;DP=101,44,52;AF=0.43,0.00,0.54;MQM=60;SAP=157;ABP=5;SAR=0;SAF=71	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron3/22:c.402+97_402+111del::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron3/21:c.402+97_402+111del::						rs201956818	0.0148	0.0027,0.0101,0.0002,0.0188,0.0010	31,.	2191	149987	3.0680			6.55				0		2	210	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226402008	226402008	C	T	het	wt	het	off-target	QUAL=1636;DP=134,17,31;AF=0.44,0.00,0.48;MQM=60;SAP=164;ABP=7;SAR=0;SAF=74	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron2/22:c.286+206G>A::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron2/21:c.286+206G>A::						rs2666428	0.4422	0.6125,0.4619,0.8061,0.3293,0.3771	16327,.	34516	84720	-0.5930			6.43			COSV104680319	0	21976407,31413734,29937070,33391423,33791158,32780923	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226402257	226402257	G	A	het	wt	het		QUAL=9316;DP=297,299,469;AF=0.46,0.00,0.48;MQM=60;SAP=6;ABP=7;SAR=171;SAF=194	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon2/23:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region],PARP1:ENST00000677203.1:synonymous_variant:LOW:exon2/22:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region]						rs1805404	0.1790	0.1305,0.3090,0.4293,0.1593,0.1127	2944,.	21335	124861	3.1620			11.98			COSV64687027	0	17267408,20486200,30183716,31609976,27462201,31415677,20113831,32888493,33284833,23576132	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226407946	226407946	C	G	het	wt	het		QUAL=2211;DP=42,138,146;AF=0.52,0.00,0.50;MQM=60;SAP=3;ABP=3;SAR=47;SAF=48	PARP1	5'UTR	PARP1:ENST00000366794.10:5_prime_UTR_variant:MODIFIER:exon1/23:c.-17G>C::,PARP1:ENST00000677203.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-17G>C::	regulatory_region_variant:promoter,TF_binding_site_variant					rs907187	0.1614	0.0539,0.3036,0.4301,0.1631,0.1135	2724,.	19075	127461	0.9510			12.41			COSV64687065	0	21767974,17267408,21989229,31288058,32103589,26261599,17560163,20113831	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226961502	226961502	G	A	wt	het	wt		QUAL=294;DP=72,31,35;AF=0.00,0.48,0.00;MQM=60;SAP=4;ABP=3;SAR=9;SAF=6	COQ8A	splice_region&intron,synonymous	COQ8A:ENST00000366778.5:splice_region_variant&intron_variant:LOW:intron1/14:c.-34-6G>A::,COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128273 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,Autosomal recessive cerebellar ataxia,not specified,not provided];			rs11549708	0.1605	0.0514,0.1236,0.0010,0.2414,0.0753	2570,.	19281	127743	-3.5600			3.92		-0.47>-4.84	COSV64658484	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226964961	226964961	C	T	wt	het	wt	off-target	QUAL=926;DP=82,67,85;AF=0.01,0.63,0.00;MQM=60;SAP=80;ABP=12;SAR=2;SAF=41	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron2/14:c.22-39C>T::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron2/14:c.178-39C>T::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]				rs759581953	0.0001	0.0000,0.0000,0.0000,0.0001,0.0000	0,.	2	152224	-1.1540			0.06				0		0	3	0 / 0					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226977534	226977534	C	T	het	wt	het	off-target	QUAL=433;DP=18,31,24;AF=0.50,0.00,0.50;MQM=60;SAP=3;ABP=3;SAR=11;SAF=10	COQ8A	splice_region&intron	COQ8A:ENST00000366778.5:splice_region_variant&intron_variant:LOW:intron5/14:c.574+11C>T::,COQ8A:ENST00000366777.4:splice_region_variant&intron_variant:LOW:intron5/14:c.730+11C>T::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]				rs759489004	0.0001	0.0000,0.0000,0.0000,0.0000,0.0000	0,.	1	152147	0.7940			6.46				0		0	3	0 / 0					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226977661	226977661	C	G	wt	wt	het	off-target	QUAL=106;DP=14,16,13;AF=0.00,0.00,0.46;MQM=60;SAP=16;ABP=3;SAR=6;SAF=0	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron5/14:c.574+138C>G::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron5/14:c.730+138C>G::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]				rs544460523	0.0030	0.0009,0.0011,0.0000,0.0050,0.0019	2,.	446	151700	-0.2140			1.21				0		0	55	0 / 0					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226982597	226982597	A	G	het	hom	wt	off-target	QUAL=4736;DP=57,139,189;AF=0.61,0.99,0.00;MQM=60;SAP=158;ABP=9;SAR=31;SAF=142	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron6/14:c.698-81A>G::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron6/14:c.854-81A>G::		606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671530 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not provided];			rs2297412	0.4409	0.4715,0.3964,0.2085,0.4671,0.2323	15029,.	36788	84760	-2.7470			0.16				0	27863252,33356394	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226982842	226982842	C	G	het	het	wt	off-target	QUAL=3779;DP=114,177,294;AF=0.61,0.47,0.01;MQM=60;SAP=90;ABP=4;SAR=117;SAF=38	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron7/14:c.784-52C>G::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron7/14:c.940-52C>G::		606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671531 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not provided];			rs2297413	0.2028	0.1310,0.2339,0.3127,0.2304,0.1545	3383,.	24082	121244	0.6420			2.96			COSV64657732	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226983509	226983509	G	A	het	wt	hom	off-target	QUAL=5893;DP=84,143,175;AF=0.49,0.00,0.99;MQM=60;SAP=204;ABP=3;SAR=37;SAF=178	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron8/14:c.925-43G>A::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671619 [benign DISEASE=not provided];			rs12739480	0.1060	0.0359,0.0616,0.0506,0.1430,0.2072	1139,.	13844	135926	-0.4310			0.57			COSV64659018	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226983884	226983884	T	-	het	hom	wt	off-target	QUAL=1937;DP=103,40,77;AF=0.44,1.00,0.00;MQM=60;SAP=69;ABP=7;SAR=68;SAF=17	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1100+32del::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1256+32del::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1183738 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not provided];			rs3215919	0.3693	0.2928,0.3260,0.1381,0.4430,0.1997	10965,.	34216	95890	-0.8150			0.16				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984035	226984035	-	T	wt	het	wt	off-target	QUAL=2156;DP=65,57,41;AF=0.63,0.53,0.00;MQM=60;SAP=4;ABP=3;SAR=12;SAF=15	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-59_1101-58insT::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1294314 [benign DISEASE=not provided];			rs149374145	0.1614	0.0530,0.1236,0.0006,0.2397,0.0710	2411,.	18625	121807				3.95				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984036	226984036	G	T	het	het	wt	off-target	QUAL=2156;DP=65,57,41;AF=0.63,0.53,0.00;MQM=60;SAP=54;ABP=10;SAR=15;SAF=56	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-58G>T::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1291028 [benign DISEASE=not provided];			rs1574184	0.2469	0.2692,0.2342,0.2409,0.2430,0.1634	4060,.	26254	104872	1.7960			4.23			COSV64656763	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984037	226984037	G	T	wt	het	wt	off-target	QUAL=2156;DP=65,57,41;AF=0.63,0.53,0.00;MQM=60;SAP=4;ABP=3;SAR=12;SAF=15	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-57G>T::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1262417 [benign DISEASE=not provided];			rs377335668	0.1554	0.0499,0.1208,0.0034,0.2357,0.0695	2351,.	18470	125934	0.2130			0.99				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984038	226984038	G	T	het	het	wt	off-target	QUAL=2156;DP=65,57,41;AF=0.63,0.53,0.00;MQM=60;SAP=54;ABP=10;SAR=15;SAF=56	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-56G>T::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1188901 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not provided];			rs1574185	0.2348	0.2401,0.2194,0.2354,0.2409,0.1599	3739,.	25551	107637	-0.1650			0.81				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984257	226984257	G	C	wt	het	wt	off-target	QUAL=1013;DP=114,75,107;AF=0.00,0.53,0.00;MQM=60;SAP=4;ABP=4;SAR=22;SAF=18	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron11/14:c.1242+22G>C::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1247645 [benign DISEASE=not provided];			rs7530213	0.2505	0.1591,0.2402,0.0960,0.3202,0.1282	5196,.	27711	113999	0.7580			6.30			COSV64657987	0.32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984589	226984589	C	T	het	hom	wt		QUAL=15686;DP=331,380,506;AF=0.47,0.98,0.00;MQM=60;SAP=6;ABP=5;SAR=252;SAF=278	COQ8A	synonymous	COQ8A:ENST00000366778.5:synonymous_variant:LOW:exon12/15:c.1284C>T:p.Phe428=:PF03109 [ABC1 atypical kinase-like domain],COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:PF03109 [ABC1 atypical kinase-like domain]	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128274 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not specified,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs12593	0.3501	0.2032,0.3193,0.1730,0.4539,0.1986	10345,.	32521	98771	-0.2170			4.88			COSV64656797	0	31816047,34127677	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226985202	226985202	G	A	het	hom	wt	off-target	QUAL=8133;DP=101,230,303;AF=0.60,0.98,0.00;MQM=60;SAP=98;ABP=12;SAR=87;SAF=199	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron13/14:c.1417-52G>A::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	676090 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not provided];			rs2297415	0.3780	0.2887,0.3341,0.1668,0.4606,0.1997	11508,.	34414	94486	-2.2820			1.16			COSV62011699,COSV62017351	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226985234	226985234	C	G	het	hom	wt	off-target	QUAL=9709;DP=115,265,340;AF=0.62,1.00,0.00;MQM=60;SAP=18;ABP=17;SAR=144;SAF=192	COQ8A	splice_region&intron	COQ8A:ENST00000366778.5:splice_region_variant&intron_variant:LOW:intron13/14:c.1417-20C>G::,COQ8A:ENST00000366777.4:splice_region_variant&intron_variant:LOW:intron13/14:c.1573-20C>G::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	518313 [benign/likely benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not specified,not provided];			rs2297416	0.3737	0.2725,0.3343,0.1669,0.4608,0.1999	11314,.	34149	95149	0.0300			3.50		12.28>10.93	COSV62011473	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986421	226986421	C	G	wt	het	wt	off-target	QUAL=940;DP=87,73,139;AF=0.00,0.56,0.00;MQM=60;SAP=6;ABP=5;SAR=17;SAF=24	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron14/14:c.1504-32C>G::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671534 [benign DISEASE=not provided];			rs41303131	0.1979	0.0935,0.1451,0.0048,0.2844,0.1144	3668,.	22710	121816	-1.9210			0.17			COSV62005838	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986444	226986444	T	C	het	hom	wt		QUAL=4063;DP=103,89,168;AF=0.53,1.00,0.00;MQM=60;SAP=50;ABP=4;SAR=44;SAF=100	COQ8A	splice_region&intron	COQ8A:ENST00000366778.5:splice_region_variant&intron_variant:LOW:intron14/14:c.1504-9T>C::,COQ8A:ENST00000366777.4:splice_region_variant&intron_variant:LOW:intron14/14:c.1660-9T>C::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296024 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,Autosomal recessive cerebellar ataxia,not specified,not provided];			rs7552783	0.4430	0.4163,0.3722,0.2134,0.5033,0.2637	15302,.	36558	84446	-3.6360			5.40		11.51>10.71	COSV62011703,COSV62011928	0	26503814,32439900	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986509	226986509	T	C	het	hom	wt		QUAL=5374;DP=162,118,185;AF=0.45,1.00,0.00;MQM=60;SAP=3;ABP=6;SAR=98;SAF=93	COQ8A	synonymous	COQ8A:ENST00000366778.5:synonymous_variant:LOW:exon15/15:c.1560T>C:p.Ser520=:,COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128275 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,Autosomal recessive cerebellar ataxia,not specified,not provided];			rs3738725	0.4134	0.3151,0.3557,0.2174,0.5033,0.2622	13639,.	35310	88830	-5.5320			0.04			COSV62011476	0.18	32888494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987122	226987122	-	T	het	hom	wt		QUAL=13740;DP=246,373,474;AF=0.46,1.00,0.00;MQM=60;SAP=75;ABP=7;SAR=179;SAF=306	COQ8A	3'UTR	COQ8A:ENST00000366778.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:ENST00000366777.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::		606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296038 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type];			rs11420839	0.4035	0.2941,0.3513,0.1696,0.5004,0.2416	13225,.	34851	90637				1.76				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987544	226987544	-	T	het	hom	wt		QUAL=7958;DP=163,221,329;AF=0.45,0.96,0.00;MQM=60;SAP=26;ABP=6;SAR=171;SAF=116	COQ8A,CDC42BPA	downstream_gene	COQ8A:ENST00000366778.5:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366777.4:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296050 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs3215920	0.3726	0.1862,0.3403,0.1681,0.5012,0.2408	12089,.	32416	95286				1.93				0	34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987552	226987552	C	T	het	hom	wt		QUAL=8644;DP=165,214,324;AF=0.48,1.00,0.00;MQM=60;SAP=45;ABP=4;SAR=184;SAF=109	COQ8A,CDC42BPA	downstream_gene	COQ8A:ENST00000366778.5:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366777.4:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	368867 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs10495274	0.5257	0.3804,0.4832,0.3437,0.6349,0.3946	22087,.	35663	72025	-0.9260			0.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987666	226987666	G	T	het	hom	wt	off-target	QUAL=3399;DP=119,75,136;AF=0.49,1.00,0.00;MQM=60;SAP=292;ABP=3;SAR=133;SAF=0	COQ8A,CDC42BPA	downstream_gene	COQ8A:ENST00000366778.5:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366777.4:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1250369 [benign DISEASE=not provided];			rs6426558	0.4031	0.2834,0.3506,0.2162,0.5019,0.2618	13205,.	34872	90734	-0.4880			0.39					27863252,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	228159235	228159235	G	A	het	wt	het		QUAL=2189;DP=43,92,130;AF=0.53,0.00,0.54;MQM=60;SAP=25;ABP=5;SAR=62;SAF=31	GJC2	3'UTR	GJC2:ENST00000366714.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*157G>A::		608803_[GENE=GJC2_PHENOS=Lymphatic malformation 3, 613480 (3), Autosomal dominant; ?Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive]	1265470 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Hereditary spastic paraplegia,not provided];			rs45491398	0.0576	0.0160,0.0406,0.0008,0.0906,0.0223	366,.	8039	143449	-1.8580			0.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54), IBA57-DT (inh=n/a oe_syn=1.01 oe_mis=1.00 oe_lof=n/a)
chr1	228159651	228159651	A	G	hom	hom	hom		QUAL=1506;DP=30,8,13;AF=1.00,1.00,1.00;MQM=60;SAP=105;ABP=0;SAR=1;SAF=50	GJC2	3'UTR	GJC2:ENST00000366714.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*573A>G::		608803_[GENE=GJC2_PHENOS=Lymphatic malformation 3, 613480 (3), Autosomal dominant; ?Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive]				rs6668719	0.8480	0.6453,0.8862,0.7607,0.9472,0.9246	55985,.	16902	23106	0.0710			4.20				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54), IBA57-DT (inh=n/a oe_syn=1.01 oe_mis=1.00 oe_lof=n/a)
chr1	228424743	228424743	A	G	het	het	hom	off-target	QUAL=3092;DP=104,51,46;AF=0.47,0.55,1.00;MQM=60;SAP=270;ABP=3;SAR=0;SAF=123	H3-4	downstream_gene	H3-4:ENST00000366696.2:downstream_gene_variant:MODIFIER::::						rs1188473	0.8982	0.9456,0.9458,0.6745,0.8920,0.8538	61589,.	13421	15491	-0.2750			0.95						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228425137	228425137	G	T	het	het	hom		QUAL=18667;DP=288,285,384;AF=0.51,0.46,1.00;MQM=60;SAP=428;ABP=4;SAR=511;SAF=151	H3-4	synonymous	H3-4:ENST00000366696.2:synonymous_variant:LOW:exon1/1:c.189C>A:p.Ile63=:PF00125 [Core histone H2A/H2B/H3/H4]	regulatory_region_variant:CTCF_binding_site					rs2230656	0.7372	0.4073,0.8655,0.6629,0.8864,0.8469	44714,.	22742	39988	2.0500			8.50			COSV64210568	0.06	30066433,29405169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228425191	228425191	G	A	wt	wt	het		QUAL=2236;DP=186,211,259;AF=0.00,0.00,0.47;MQM=60;SAP=158;ABP=5;SAR=107;SAF=14	H3-4	synonymous	H3-4:ENST00000366696.2:synonymous_variant:LOW:exon1/1:c.135C>T:p.Gly45=:PF00125 [Core histone H2A/H2B/H3/H4]	regulatory_region_variant:CTCF_binding_site					rs56336130	0.0631	0.0162,0.0585,0.0206,0.0919,0.0937	417,.	8772	142644	0.1770			6.19			COSV64210887	0.67	29405169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228425351	228425351	T	C	het	het	hom	off-target	QUAL=1615;DP=58,34,30;AF=0.40,0.41,1.00;MQM=60;SAP=148;ABP=11;SAR=67;SAF=0	H3-4	5'UTR	H3-4:ENST00000366696.2:5_prime_UTR_variant:MODIFIER:exon1/1:c.-26A>G::						rs1188474	0.8923	0.9264,0.9405,0.6742,0.8920,0.8543	60765,.	14215	16383	-2.8600			0.35						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	229432484	229432484	T	G	hom	hom	hom	off-target	QUAL=2169;DP=8,34,46;AF=1.00,1.00,1.00;MQM=60;SAP=194;ABP=0;SAR=88;SAF=0	ACTA1	intron	ACTA1:ENST00000684723.1:intron_variant:MODIFIER:intron2/5:c.320-53A>C::,ACTA1:ENST00000366684.7:intron_variant:MODIFIER:intron3/6:c.455-53A>C::,ACTA1:ENST00000366683.4:intron_variant:MODIFIER:intron3/6:c.455-53A>C::	regulatory_region_variant:enhancer	102610_[GENE=ACTA1_PHENOS=?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, actin, congenital, with cores, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion 1, 255310 (3), Autosomal recessive, Autosomal dominant]	676564 [benign DISEASE=Actin accumulation myopathy,Congenital myopathy with fiber type disproportion,Progressive scapulohumeroperoneal distal myopathy,not provided];			rs527621	0.9984	0.9997,0.9989,1.0000,0.9990,0.9966	72810,.	228	228	-1.3790			3.26				0.03	19562689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229434056	229434056	A	G	het	het	het		QUAL=3207;DP=64,74,110;AF=0.56,0.49,0.55;MQM=60;SAP=38;ABP=5;SAR=89;SAF=43	ACTA1	5'UTR	ACTA1:ENST00000684723.1:5_prime_UTR_variant:MODIFIER:exon1/6:c.-59T>C::,ACTA1:ENST00000366684.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::,ACTA1:ENST00000366683.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::	regulatory_region_variant:promoter	102610_[GENE=ACTA1_PHENOS=?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, actin, congenital, with cores, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion 1, 255310 (3), Autosomal recessive, Autosomal dominant]	296060 [benign DISEASE=Actin accumulation myopathy,Congenital myopathy with fiber type disproportion,Familial restrictive cardiomyopathy,not provided];			rs605430	0.6324	0.7583,0.6564,0.4574,0.5801,0.6552	30966,.	33954	55736	0.5810			19.39			COSV64203106	0	19562689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229434057	229434057	G	A	het	het	het		QUAL=3207;DP=64,74,110;AF=0.56,0.49,0.55;MQM=60;SAP=38;ABP=5;SAR=89;SAF=43	ACTA1	5'UTR	ACTA1:ENST00000684723.1:5_prime_UTR_variant:MODIFIER:exon1/6:c.-60C>T::,ACTA1:ENST00000366684.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::,ACTA1:ENST00000366683.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::	regulatory_region_variant:promoter	102610_[GENE=ACTA1_PHENOS=?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, actin, congenital, with cores, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion 1, 255310 (3), Autosomal recessive, Autosomal dominant]	296062 [benign DISEASE=Actin accumulation myopathy,Congenital myopathy with fiber type disproportion,Familial restrictive cardiomyopathy,not provided];			rs605428	0.6322	0.7580,0.6564,0.4567,0.5800,0.6548	30962,.	33957	55781	0.2370			17.21			COSV64204088	0	19562689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	231241335	231241335	C	T	hom	hom	het		QUAL=18934;DP=293,250,316;AF=0.98,0.99,0.55;MQM=60;SAP=187;ABP=10;SAR=232;SAF=477	GNPAT	5'UTR	GNPAT:ENST00000366647.9:5_prime_UTR_variant:MODIFIER:exon1/16:c.-44C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	296108 [benign DISEASE=Rhizomelic chondrodysplasia punctata type 2,not specified];			rs518686	0.5488	0.5688,0.5924,0.6164,0.5335,0.6243	23065,.	37246	68560	0.1320			10.49			COSV59641814	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF131 (inh=n/a oe_syn=0.99 oe_mis=1.03 oe_lof=1.12), GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231250866	231250866	T	A	hom	hom	het	off-target	QUAL=9491;DP=204,74,92;AF=1.00,1.00,0.48;MQM=60;SAP=700;ABP=3;SAR=0;SAF=321	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron1/15:c.79-95T>A::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1244833 [benign DISEASE=not provided];			rs508908	0.5910	0.6908,0.6103,0.6211,0.5449,0.6280	26965,.	35831	62117	-0.4300			0.93				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231260370	231260370	-	TA	hom	hom	het	off-target	QUAL=3025;DP=86,19,37;AF=0.92,0.95,0.41;MQM=60;SAP=246;ABP=6;SAR=0;SAF=112	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron2/15:c.262-136_262-135insAT::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1274329 [benign DISEASE=not provided];			rs3215759	0.5906	0.6899,0.6099,0.6196,0.5448,0.6294	26919,.	35831	62153				3.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231260888	231260888	T	C	hom	n/a	n/a	off-target	QUAL=1779;DP=57,0,0;AF=1.00,,;MQM=60;SAP=127;ABP=0;SAR=57;SAF=0	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron3/15:c.438+205T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671164 [benign DISEASE=not provided];			rs531592	0.5011	0.4629,0.5644,0.5514,0.5141,0.5779	19246,.	37617	75785	-0.1680			2.06			COSV64153471	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231265159	231265159	A	G	hom	hom	het	off-target	QUAL=2516;DP=66,17,15;AF=1.00,1.00,0.67;MQM=60;SAP=205;ABP=7;SAR=0;SAF=93	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron4/15:c.569-134A>G::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671168 [benign DISEASE=not provided];		FLAM_C (SINE/Alu)	rs849714	0.5794	0.6497,0.6079,0.6214,0.5452,0.6200	25840,.	36367	63929	-0.7750			1.40				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231265458	231265458	T	C	hom	het	het	off-target	QUAL=12319;DP=212,178,232;AF=1.00,0.48,0.51;MQM=60;SAP=114;ABP=3;SAR=281;SAF=135	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron5/15:c.696+38T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1256935 [benign DISEASE=not provided];			rs6702011	0.2676	0.2804,0.3266,0.2361,0.2539,0.2628	5526,.	29624	111314	-0.6780			7.53			COSV64154015	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231265850	231265850	T	C	hom	het	het	off-target	QUAL=14384;DP=274,163,252;AF=1.00,0.48,0.48;MQM=60;SAP=139;ABP=5;SAR=322;SAF=150	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron6/15:c.772+63T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1244648 [benign DISEASE=not provided];			rs532226	0.5439	0.5617,0.5904,0.6178,0.5293,0.6097	22658,.	37337	69307	0.0210			5.84			COSV64153524	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231266156	231266156	G	A	hom	het	het		QUAL=17595;DP=348,202,257;AF=1.00,0.49,0.50;MQM=60;SAP=91;ABP=3;SAR=364;SAF=211	GNPAT	synonymous	GNPAT:ENST00000366647.9:synonymous_variant:LOW:exon7/16:c.915G>A:p.Glu305=:PF19277 [Glycerol-3-phosphate acyltransferase C-terminal region]		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	260363 [benign DISEASE=Rhizomelic chondrodysplasia punctata type 2,not specified,not provided];			rs574553	0.5883	0.6896,0.6079,0.6204,0.5412,0.6209	26756,.	35868	62554	1.6320			5.21			COSV64153484	0.04	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231267519	231267519	T	C	hom	hom	het	off-target	QUAL=4211;DP=110,22,17;AF=1.00,1.00,0.53;MQM=60;SAP=309;ABP=3;SAR=0;SAF=141	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron8/15:c.1056-161T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671169 [benign DISEASE=not provided];			rs474297	0.5464	0.5626,0.5924,0.6167,0.5332,0.6093	22823,.	37304	68860	-0.4310			1.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231268084	231268084	C	T	hom	hom	het	off-target	QUAL=2629;DP=85,7,14;AF=1.00,1.00,0.43;MQM=43;SAP=207;ABP=4;SAR=97;SAF=1	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron9/15:c.1279+181C>T::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671188 [benign DISEASE=not provided];		AluY (SINE/Alu)	rs579924	0.5462	0.5625,0.5921,0.6155,0.5331,0.6102	22822,.	37287	68891	-0.9420			0.72				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231270549	231270549	T	C	hom	het	n/a	off-target	QUAL=2044;DP=66,11,2;AF=1.00,0.36,0.50;MQM=60;SAP=157;ABP=5;SAR=0;SAF=71	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron9/15:c.1280-209T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671190 [benign DISEASE=not provided];			rs3767758	0.5439	0.5617,0.5904,0.6169,0.5293,0.6099	22649,.	37334	69298	2.2510			8.55				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231364607	231364607	-	T	hom	het	hom		QUAL=17883;DP=350,162,185;AF=0.97,0.44,0.97;MQM=60;SAP=15;ABP=7;SAR=324;SAF=267	EGLN1	3'UTR	EGLN1:ENST00000366641.4:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1803dup::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]				rs541569859	0.5742	0.4096,0.5530,0.5601,0.6535,0.5781	25902,.	35393	64653				7.84				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231366499	231366499	T	-	het	wt	het	off-target;low_conf_region	QUAL=9735;DP=158,167,198;AF=0.65,0.32,0.69;MQM=60;SAP=50;ABP=587;SAR=57;SAF=17	EGLN1	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron4/4:c.1217-24del::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1243379 [benign DISEASE=not provided];			rs371204614	0.0009	0.0003,0.0011,0.0014,0.0007,0.0002	0,.	140	149942	-0.5900			2.38			COSV64150067	0		0	40	0 / 0					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231366499	231366499	T	A	het	het	het	off-target;low_conf_region	QUAL=9735;DP=158,167,198;AF=0.65,0.32,0.69;MQM=60;SAP=211;ABP=17;SAR=229;SAF=62	EGLN1	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron4/4:c.1217-24A>T::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1292828 [benign DISEASE=not provided];			rs1435167	0.5720	0.4195,0.5471,0.5576,0.6486,0.5768	25166,.	35803	64463	-0.5900			5.73			COSV64150067	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231366564	231366564	T	C	hom	het	hom	off-target	QUAL=11803;DP=213,113,126;AF=1.00,0.42,1.00;MQM=60;SAP=671;ABP=9;SAR=366;SAF=21	EGLN1	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron4/4:c.1217-89A>G::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1257712 [benign DISEASE=not provided];			rs1435166	0.5236	0.2616,0.5308,0.5538,0.6416,0.5653	22835,.	33868	72370	-0.6810			0.82			COSV64149252	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231370811	231370811	G	A	hom	het	hom	off-target	QUAL=9230;DP=189,58,98;AF=1.00,0.36,1.00;MQM=60;SAP=672;ABP=13;SAR=308;SAF=0	EGLN1	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron2/4:c.1012-113C>T::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1265678 [benign DISEASE=not provided];			rs2256908	0.5465	0.3173,0.5417,0.5600,0.6516,0.5758	24289,.	34472	68914	1.5660			6.51			COSV64149687	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231421509	231421509	C	G	het	hom	wt		QUAL=206;DP=3,9,3;AF=0.67,1.00,0.00;MQM=60;SAP=27;ABP=4;SAR=11;SAF=0	EGLN1	missense	EGLN1:ENST00000366641.4:missense_variant:MODERATE:exon1/5:c.380G>C:p.Cys127Ser:	regulatory_region_variant:promoter	606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	242640 [benign DISEASE=Erythrocytosis, familial, 3,not provided]; 156155 [affects DISEASE=Hemoglobin, high altitude adaptation];	CM140742 [CLASS=DFP MUT=ALT PHEN="Reduced haemoglobin levels" GENE=EGLN1];	(GCC)n (Simple_repeat)	rs12097901	0.1558	0.3066,0.1346,0.4427,0.0602,0.2319	2912,.	17741	127717	1.2680	T(0.74)	B(0.00)	12.82	0.21		COSV64149723	0	31712437,29625625,25129147,28116332,30719713,31824328,24711448,28096303,24030663,30188897,28036300,27325755,28819001,33282179,32414920,33282944,32377332,25319824,33370224	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231423480	231423480	A	G	het	hom	wt		QUAL=5114;DP=197,71,82;AF=0.51,1.00,0.02;MQM=60;SAP=19;ABP=3;SAR=105;SAF=69	EGLN1	upstream_gene	EGLN1:ENST00000366641.4:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	296223 [benign DISEASE=Erythrocytosis, familial, 3];			rs12406290	0.1928	0.2127,0.2109,0.4809,0.1545,0.3475	3232,.	22855	122765	2.9670			10.08				0	32185192,25431923	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231424474	231424474	A	G	het	hom	wt		QUAL=15143;DP=598,209,205;AF=0.52,1.00,0.00;MQM=60;SAP=357;ABP=5;SAR=114;SAF=405	EGLN1	upstream_gene	EGLN1:ENST00000366641.4:upstream_gene_variant:MODIFIER::::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	296240 [benign DISEASE=Erythrocytosis, familial, 3];			rs2153364	0.1935	0.2126,0.2115,0.4823,0.1551,0.3578	3262,.	22902	122686	0.2220			4.11				0	32185192,25431923,32478477,32718338	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	235379947	235379947	-	A	wt	het	wt	off-target	QUAL=919;DP=59,43,62;AF=0.22,0.12,0.37;MQM=56;SAP=64;ABP=157;SAR=0;SAF=28	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34469dup::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron4/19:c.-31-55dup::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron3/18:c.-31-55dup::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron3/18:c.-31-55dup::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron4/19:c.-31-55dup::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron1/16:c.-31-55dup::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron1/15:c.-341-55dup::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron1/16:c.-31-55dup::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron1/15:c.-31-55dup::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron1/15:c.-31-55dup::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron1/16:c.-31-55dup::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron1/17:c.-31-55dup::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron1/14:c.-31-55dup::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1174300 [benign DISEASE=not provided];		AluSz6 (SINE/Alu)	rs36068852	0.7212	0.8605,0.6928,0.6479,0.6688,0.5882	34104,.	27457	36977				1.86				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235379948	235379948	A	-	het	wt	het	off-target	QUAL=919;DP=59,43,62;AF=0.17,0.35,0.05;MQM=58;SAP=92;ABP=92;SAR=0;SAF=41	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34469del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron4/19:c.-31-55del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron3/18:c.-31-55del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron3/18:c.-31-55del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron4/19:c.-31-55del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron1/16:c.-31-55del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron1/15:c.-341-55del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron1/16:c.-31-55del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron1/15:c.-31-55del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron1/15:c.-31-55del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron1/16:c.-31-55del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron1/17:c.-31-55del::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron1/14:c.-31-55del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]			AluSz6 (SINE/Alu)	rs36068852	0.0009	0.0003,0.0009,0.0007,0.0008,0.0003	0,.	125	132581	0.5660			1.58				0		0	87	0 / 0					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380165	TGTG	-	wt	wt	het	off-target;low_conf_region	QUAL=1646;DP=25,93,30;AF=0.04,0.37,0.00;MQM=60;SAP=4;ABP=10;SAR=6;SAF=4	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34222_-210-34219del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+62_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+62_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+62_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+62_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+62_-211+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+62_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+62_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+62_100+65del::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+62_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+62_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1601254 [benign DISEASE=not provided];		(TG)n (Simple_repeat)	rs10524346	0.0584	0.0493,0.0468,0.0808,0.0584,0.0740	275,.	7596	131308	0.5040			1.36				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380175	TGTGTGTGTGTGTG	-	wt	het	wt	off-target;low_conf_region	QUAL=1646;DP=25,93,30;AF=0.04,0.37,0.00;MQM=60;SAP=8;ABP=45;SAR=22;SAF=13	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34232_-210-34219del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+52_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+52_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+52_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+52_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+52_-211+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+52_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+52_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+52_100+65del::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+52_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+52_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1245486 [benign DISEASE=not provided];		(TG)n (Simple_repeat)	rs10524346	0.2817	0.1515,0.2548,0.1174,0.3724,0.1215	6200,.	26941	100307	0.6670			1.46				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380177	TGTGTGTGTGTGTGTG	-	het	wt	wt	off-target;low_conf_region	QUAL=1646;DP=25,93,30;AF=0.04,0.37,0.00;MQM=59;SAP=38;ABP=78;SAR=24;SAF=3	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34234_-210-34219del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+50_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+50_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+50_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+50_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+50_-211+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+50_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+50_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+50_100+65del::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+50_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+50_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1232644 [benign DISEASE=not provided];		(TG)n (Simple_repeat)	rs10524346	0.0455	0.0756,0.0326,0.0895,0.0281,0.0421	199,.	5961	133353	0.6670			1.54				0.02		3	14	0 / 0					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380179	TGTGTGTGTGTGTGTGTG	-	wt	het	wt	off-target;low_conf_region	QUAL=1646;DP=25,93,30;AF=0.04,0.37,0.00;MQM=60;SAP=6;ABP=11;SAR=22;SAF=15	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34236_-210-34219del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+48_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+48_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+48_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+48_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+48_-211+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+48_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+48_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+48_100+65del::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+48_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+48_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	403520 [benign/likely benign DISEASE=not specified,not provided];		(TG)n (Simple_repeat)	rs10524346	0.1407	0.1572,0.2296,0.4308,0.0865,0.2725	1830,.	16003	120077	0.6670			1.55				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235430867	235430867	A	G	het	hom	wt	off-target	QUAL=5130;DP=157,98,90;AF=0.50,1.00,0.00;MQM=60;SAP=177;ABP=3;SAR=148;SAF=29	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron5/14:c.321+63A>G::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron10/19:c.660+63A>G::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron9/18:c.660+63A>G::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron9/18:c.660+63A>G::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron10/19:c.660+63A>G::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron7/16:c.660+63A>G::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron6/15:c.321+63A>G::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron7/16:c.660+63A>G::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron7/15:c.660+63A>G::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron6/15:c.474+63A>G::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron7/16:c.660+63A>G::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron7/17:c.660+63A>G::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron5/14:c.471+63A>G::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron6/15:c.660+63A>G::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1229298 [benign DISEASE=not provided];			rs2291687	0.7245	0.9097,0.7218,0.6611,0.6401,0.5863	41061,.	28028	41882	-0.2960			0.94			COSV64005596	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), RPS21P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235430935	235430935	A	G	het	hom	wt	off-target	QUAL=2970;DP=115,45,37;AF=0.59,1.00,0.00;MQM=60;SAP=248;ABP=11;SAR=113;SAF=0	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron5/14:c.321+131A>G::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron10/19:c.660+131A>G::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron9/18:c.660+131A>G::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron9/18:c.660+131A>G::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron10/19:c.660+131A>G::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron7/16:c.660+131A>G::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron6/15:c.321+131A>G::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron7/16:c.660+131A>G::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron7/15:c.660+131A>G::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron6/15:c.474+131A>G::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron7/16:c.660+131A>G::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron7/17:c.660+131A>G::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron5/14:c.471+131A>G::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron6/15:c.660+131A>G::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1245648 [benign DISEASE=not provided];			rs2291688	0.4877	0.4013,0.5715,0.6434,0.4998,0.4662	18475,.	37139	77815	-0.3340			1.46			COSV64005600	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), RPS21P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235435658	235435658	C	T	het	hom	wt	off-target	QUAL=3958;DP=155,79,111;AF=0.43,1.00,0.00;MQM=60;SAP=176;ABP=9;SAR=19;SAF=127	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron6/14:c.399-87C>T::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron11/19:c.738-87C>T::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron10/18:c.738-87C>T::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron10/18:c.738-87C>T::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron11/19:c.738-87C>T::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron8/16:c.738-87C>T::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron7/15:c.399-87C>T::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron8/16:c.738-87C>T::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron8/15:c.738-87C>T::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron7/15:c.552-87C>T::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron8/16:c.738-87C>T::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron9/17:c.891-87C>T::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron6/14:c.549-87C>T::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron7/15:c.738-87C>T::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1265656 [benign DISEASE=not provided];			rs2055127	0.4973	0.3983,0.5785,0.6513,0.5159,0.4716	19251,.	37033	76357	-0.4370			0.32			COSV64005614	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), RPS21P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235436814	235436814	T	C	het	hom	wt	off-target	QUAL=2200;DP=154,14,9;AF=0.53,1.00,0.00;MQM=60;SAP=211;ABP=4;SAR=96;SAF=0	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron9/14:c.624+206T>C::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron14/19:c.963+206T>C::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron13/18:c.963+206T>C::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron13/18:c.963+206T>C::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron14/19:c.963+206T>C::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron11/16:c.963+206T>C::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron10/15:c.624+206T>C::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron11/16:c.963+206T>C::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron11/15:c.963+206T>C::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron10/15:c.777+206T>C::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron11/16:c.963+206T>C::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron12/17:c.1116+206T>C::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron9/14:c.774+206T>C::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron10/15:c.963+206T>C::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1251326 [benign DISEASE=not provided];			rs6429082	0.5496	0.5448,0.6025,0.6522,0.5332,0.4828	23129,.	37213	68397	-4.3450			0.09				0	21976109,19557161,30595370,31844048	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), RPS21P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235438643	235438643	G	T	het	hom	wt	off-target	QUAL=2236;DP=70,46,63;AF=0.53,1.00,0.00;MQM=60;SAP=183;ABP=4;SAR=0;SAF=83	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron10/14:c.778-126G>T::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron15/19:c.1117-126G>T::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron14/18:c.1117-126G>T::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron14/18:c.1117-126G>T::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron15/19:c.1117-126G>T::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron12/16:c.1117-126G>T::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron11/15:c.778-126G>T::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron12/16:c.1117-126G>T::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron12/15:c.1117-126G>T::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron11/15:c.931-126G>T::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron12/16:c.1117-126G>T::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron13/17:c.1270-126G>T::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron10/14:c.928-126G>T::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron11/15:c.1117-126G>T::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1285897 [benign DISEASE=not provided];			rs3819974	0.7176	0.8875,0.7171,0.6688,0.6383,0.5831	40116,.	28791	42915	-3.3610			0.02			COSV64005625	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235439089	235439089	G	A	het	hom	wt	off-target	QUAL=1582;DP=82,28,32;AF=0.43,1.00,0.00;MQM=60;SAP=131;ABP=7;SAR=62;SAF=1	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron11/14:c.931+167G>A::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron16/19:c.1270+167G>A::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron15/18:c.1270+167G>A::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron15/18:c.1270+167G>A::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron16/19:c.1270+167G>A::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron13/16:c.1270+167G>A::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron12/15:c.931+167G>A::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron13/16:c.1270+167G>A::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron13/15:c.1270+167G>A::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron12/15:c.1150+101G>A::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron13/16:c.1270+167G>A::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron14/17:c.1423+167G>A::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron11/14:c.1081+167G>A::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron12/15:c.1336+101G>A::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1262727 [benign DISEASE=not provided];			rs2270538	0.6841	0.7937,0.6934,0.6695,0.6321,0.5684	35997,.	31871	47973	-1.5350			0.07			COSV64005629	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235442009	235442009	T	-	het	het	het	off-target	QUAL=452;DP=70,22,35;AF=0.29,0.23,0.37;MQM=58;SAP=86;ABP=47;SAR=38;SAF=0	TBCE	intron	TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron12/14:c.1000+143del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron17/19:c.1339+143del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron16/18:c.1339+143del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron16/18:c.1339+143del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron17/19:c.1339+143del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron14/16:c.1339+143del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron13/15:c.1000+143del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron14/16:c.1339+143del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron14/15:c.1339+143del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron13/15:c.1219+143del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron14/16:c.1339+143del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron15/17:c.1492+143del::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron12/14:c.1150+143del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron13/15:c.1405+143del::	regulatory_region_variant:enhancer	604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]			AluSx3 (SINE/Alu)	rs376999568	0.0038	0.0061,0.0030,0.0008,0.0023,0.0007	1,.	542	141846	-5.0460			0.01				0		2	49	0 / 0					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235449005	235449005	C	T	het	hom	wt	off-target	QUAL=4405;DP=134,84,91;AF=0.54,0.99,0.00;MQM=60;SAP=268;ABP=5;SAR=147;SAF=9	TBCE,B3GALNT2	3'UTR	TBCE:ENST00000406207.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,TBCE:ENST00000642610.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,B3GALNT2:ENST00000366600.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1201G>A::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]&610194_[GENE=B3GALNT2_PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, 615181 (3), Autosomal recessive]				rs704705	0.7373	0.9237,0.7277,0.6689,0.6528,0.6105	42460,.	27164	39946	0.6550			9.48			COSV64003592			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), B3GALNT2 (inh=AR oe_syn=0.91 oe_mis=0.84 oe_lof=0.55)
chr1	235660889	235660889	-	A	wt	n/a	het	off-target;low_conf_region	QUAL=155;DP=18,2,5;AF=0.33,0.00,0.20;MQM=56;SAP=14;ABP=19;SAR=0;SAF=5	LYST	downstream_gene	LYST:ENST00000389793.7:downstream_gene_variant:MODIFIER::::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]			AluSc8 (SINE/Alu)	rs11430102	0.5150	0.4653,0.4196,0.0747,0.5855,0.1857	11868,.	25142	46040				0.48						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235660890	235660890	A	-	het	n/a	het	off-target;low_conf_region	QUAL=155;DP=18,2,5;AF=0.11,0.00,0.60;MQM=54;SAP=18;ABP=11;SAR=0;SAF=7	LYST	downstream_gene	LYST:ENST00000389793.7:downstream_gene_variant:MODIFIER::::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]			AluSc8 (SINE/Alu)	rs11430102	0.0018	0.0009,0.0008,0.0311,0.0008,0.0004	0,.	167	95089	-0.7480			0.13						0	12	0 / 0					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235662343	235662343	G	A	het	het	wt		QUAL=2801;DP=205,30,66;AF=0.47,0.33,0.00;MQM=60;SAP=20;ABP=7;SAR=39;SAF=68	LYST	3'UTR	LYST:ENST00000389793.7:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]				rs1400168809	0.0001	0.0000,0.0000,0.0000,0.0001,0.0000	0,.	3	152139	1.0680			4.70				0		0	2	0 / 0					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235663083	235663083	A	-	hom	het	hom		QUAL=15554;DP=238,195,277;AF=0.90,0.51,0.91;MQM=60;SAP=137;ABP=3;SAR=376;SAF=189	LYST	splice_region&intron	LYST:ENST00000389793.7:splice_region_variant&intron_variant:LOW:intron52/52:c.11268-5del::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	403065 [benign/likely benign DISEASE=Chediak-Higashi syndrome,Autoinflammatory syndrome,not specified,not provided];	CD181021 [CLASS=DM? MUT=ALT PHEN="Haemophagocytic lymphohistiocytosis" GENE=LYST];		rs36014994	0.5533	0.7731,0.3903,0.0496,0.5259,0.1768	24831,.	32904	66654	-0.6940			1.92				0.05	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235663283	235663283	G	A	wt	het	wt	off-target	QUAL=219;DP=121,23,31;AF=0.00,0.52,0.00;MQM=60;SAP=29;ABP=3;SAR=12;SAF=0	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron52/52:c.11268-205C>T::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1283354 [benign DISEASE=not provided];			rs3754230	0.1218	0.1052,0.1712,0.1243,0.1196,0.1956	1157,.	16199	133455	0.2250			1.62				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235664143	235664143	T	C	hom	het	hom	off-target	QUAL=8892;DP=167,68,91;AF=0.99,0.54,1.00;MQM=60;SAP=465;ABP=4;SAR=272;SAF=22	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron51/52:c.11196-88A>G::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1276755 [benign DISEASE=not provided];			rs3819013	0.4046	0.2664,0.3338,0.0459,0.5227,0.1568	14015,.	33446	90464	-0.2940			2.92			COSV67704793	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235664341	235664341	C	T	hom	het	hom	off-target	QUAL=3714;DP=85,14,25;AF=1.00,0.50,1.00;MQM=60;SAP=86;ABP=3;SAR=25;SAF=92	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron51/52:c.11195+124G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684368 [benign DISEASE=not provided];			rs12092604	0.5375	0.7246,0.3882,0.0456,0.5244,0.1757	23817,.	34001	70243	-0.5320			0.87			COSV67704799	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235693238	235693238	-	C	hom	hom	hom	off-target	QUAL=3847;DP=67,34,48;AF=0.87,1.00,1.00;MQM=56;SAP=307;ABP=0;SAR=0;SAF=140	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron47/52:c.10701+111dup::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684366 [benign DISEASE=not provided];		AluY (SINE/Alu)	rs5781839	0.9505	0.9880,0.9447,0.9904,0.9270,0.9831	68790,.	7081	7539				0.30				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235693601	235693601	G	A	hom	het	hom	off-target	QUAL=9700;DP=200,84,85;AF=1.00,0.50,1.00;MQM=60;SAP=711;ABP=3;SAR=326;SAF=0	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron46/52:c.10565-115C>T::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1249412 [benign DISEASE=not provided];			rs3754232	0.4040	0.2573,0.3562,0.0450,0.5215,0.1612	13985,.	33392	90530	0.4190			2.65			COSV67704843	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235697040	235697040	C	T	hom	het	hom	off-target	QUAL=3255;DP=69,29,23;AF=1.00,0.59,1.00;MQM=60;SAP=190;ABP=5;SAR=6;SAF=103	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron46/52:c.10564+43G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254908 [benign DISEASE=not specified,not provided];			rs7541057	0.5321	0.7215,0.3814,0.0451,0.5169,0.1720	23439,.	34003	71123	-1.8750			0.01				0.02	25741868,34469753	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235709365	235709365	T	C	hom	het	hom	off-target;low_conf_region	QUAL=7693;DP=179,47,56;AF=0.99,0.51,1.00;MQM=60;SAP=563;ABP=3;SAR=258;SAF=0	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron43/52:c.9926-57A>G::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684363 [benign DISEASE=not provided];			rs2275856	0.4999	0.8221,0.3630,0.0693,0.4096,0.1974	22426,.	31098	75976	-0.7320			1.43				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235715131	235715131	-	GTT	wt	het	wt	off-target	QUAL=1089;DP=135,117,141;AF=0.01,0.44,0.00;MQM=60;SAP=94;ABP=6;SAR=3;SAF=50	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron42/52:c.9784+67_9784+69dup::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1221305 [benign DISEASE=not provided];			rs3831362	0.1071	0.0260,0.1781,0.1610,0.1288,0.2033	1091,.	14061	135357				2.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235723976	235723976	G	T	hom	het	hom	off-target	QUAL=9236;DP=134,99,116;AF=0.99,0.52,1.00;MQM=60;SAP=399;ABP=3;SAR=33;SAF=267	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron39/52:c.9315+52C>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684361 [benign DISEASE=not provided];			rs6667717	0.4978	0.8209,0.3613,0.0632,0.4066,0.1956	22275,.	31050	76278	-2.6600			0.00			COSV67704991	0	18485661	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235733426	235733426	C	T	hom	het	hom	off-target	QUAL=6719;DP=118,63,84;AF=0.99,0.51,1.00;MQM=60;SAP=509;ABP=3;SAR=0;SAF=233	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron34/52:c.8801+77G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684360 [benign DISEASE=not provided];			rs6429275	0.4995	0.8212,0.3629,0.0622,0.4093,0.1972	22358,.	31095	75953	-0.6810			4.46			COSV67705001	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24), LDHAP2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235746185	235746185	T	C	het	wt	het	off-target	QUAL=1939;DP=145,15,21;AF=0.47,0.07,0.57;MQM=60;SAP=179;ABP=3;SAR=0;SAF=81	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron29/52:c.7972+151A>G::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1268311 [benign DISEASE=not provided];			rs10926565	0.2727	0.3364,0.2116,0.0191,0.2697,0.1608	5978,.	29473	110515	-0.0390			4.07				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235752840	235752840	C	T	hom	n/a	n/a	off-target	QUAL=373;DP=14,1,0;AF=1.00,0.00,;MQM=60;SAP=33;ABP=0;SAR=0;SAF=14	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron26/52:c.7460+204G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1226819 [benign DISEASE=not provided];			rs2273585	0.4077	0.4944,0.3275,0.0623,0.4130,0.1970	13283,.	35219	89753	-0.1980			5.01			COSV67705022	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235755389	235755393	AAAAG	-	hom	hom	hom	off-target	QUAL=2848;DP=28,34,41;AF=1.00,0.97,0.98;MQM=60;SAP=222;ABP=0;SAR=0;SAF=101	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron25/52:c.7229+85_7229+89del::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	801635 [benign DISEASE=Chediak-Higashi syndrome,not provided];		AluSx3 (SINE/Alu), (AAAAG)n (Simple_repeat)	rs71174459	0.3561	0.3147,0.3062,0.0737,0.4051,0.2079	9221,.	31674	90614	0.1310			0.76				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235758928	235758928	T	C	het	wt	het	off-target	QUAL=2274;DP=140,28,43;AF=0.56,0.04,0.44;MQM=60;SAP=216;ABP=4;SAR=0;SAF=98	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254935 [benign DISEASE=not specified,not provided];			rs3738519	0.2969	0.4167,0.2240,0.0193,0.2708,0.1627	7328,.	30461	106847	-3.8310			0.03				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235765937	235765937	A	G	hom	het	hom	off-target	QUAL=4256;DP=98,22,35;AF=0.99,0.55,1.00;MQM=60;SAP=316;ABP=3;SAR=0;SAF=144	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron21/52:c.6121+142T>C::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1287899 [benign DISEASE=not provided];		L2d2 (LINE/L2)	rs12565325	0.4065	0.4952,0.3322,0.0627,0.4090,0.1960	13233,.	35210	90052	-0.1930			1.14			COSV67705039	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235770048	235770048	-	A	het	het	het	off-target	QUAL=387;DP=33,6,4;AF=0.45,0.50,0.50;MQM=59;SAP=46;ABP=3;SAR=0;SAF=20	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron20/52:c.5922+111dup::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1286384 [benign DISEASE=not provided];			rs11443965	0.1612	0.2449,0.1315,0.0452,0.1425,0.0358	2034,.	19213	121155				3.89			COSV67714644	0.06		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235777150	235777150	C	T	hom	het	hom		QUAL=17693;DP=240,202,237;AF=1.00,0.43,1.00;MQM=60;SAP=220;ABP=13;SAR=162;SAF=399	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254927 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs2273584	0.4042	0.4929,0.3269,0.0626,0.4075,0.1890	13083,.	35163	90409	0.6210			6.01			COSV67705051	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235781886	235781886	G	A	het	het	het	off-target	QUAL=4553;DP=135,92,152;AF=0.44,0.53,0.51;MQM=60;SAP=171;ABP=3;SAR=33;SAF=153	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254924 [benign DISEASE=not specified,not provided];		AluJo (SINE/Alu)	rs72763416	0.1070	0.0707,0.1059,0.0433,0.1374,0.0332	971,.	14312	135698	-0.9540			0.38			COSV67705060	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235781994	235781994	T	C	hom	het	hom		QUAL=15483;DP=184,150,232;AF=0.99,0.51,1.00;MQM=60;SAP=5;ABP=3;SAR=255;SAF=235	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254923 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs6696123	0.4050	0.4943,0.3264,0.0631,0.4078,0.1958	13154,.	35190	90358	-0.3850			2.91			COSV67705068	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235782202	235782202	A	G	hom	het	hom	off-target	QUAL=1972;DP=57,8,8;AF=1.00,0.50,1.00;MQM=57;SAP=153;ABP=3;SAR=69;SAF=0	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron14/52:c.4863-115T>C::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684345 [benign DISEASE=not provided];		AluY (SINE/Alu)	rs2011390	0.8031	0.8983,0.7641,0.8417,0.7569,0.7721	48436,.	23204	29446	-1.8820			0.53				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235791850	235791850	G	A	wt	wt	het		QUAL=6557;DP=587,414,524;AF=0.00,0.00,0.48;MQM=60;SAP=8;ABP=4;SAR=115;SAF=138	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254921 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs11583387	0.0908	0.0642,0.0921,0.0433,0.1128,0.0314	711,.	12387	138325	3.0790			8.58				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235800154	235800154	C	A	het	het	het	off-target	QUAL=1049;DP=62,11,23;AF=0.52,0.45,0.39;MQM=60;SAP=103;ABP=3;SAR=0;SAF=46	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron10/52:c.4006+166G>T::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1251917 [benign DISEASE=not provided];		AluJr (SINE/Alu)	rs72763422	0.1068	0.0698,0.1054,0.0433,0.1376,0.0332	956,.	14146	134316	-0.4020			1.64			COSV67705088	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235800584	235800584	C	T	hom	n/a	n/a	off-target	QUAL=1358;DP=43,2,0;AF=1.00,0.50,;MQM=60;SAP=67;ABP=3;SAR=40;SAF=4	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron9/52:c.3940-198G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1265120 [benign DISEASE=not provided];			rs7552221	0.4051	0.4942,0.3270,0.0626,0.4078,0.1958	13127,.	35201	90257	-1.1150			0.24				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235806982	235806982	A	G	het	het	het	off-target	QUAL=1323;DP=115,4,6;AF=0.46,0.25,0.83;MQM=60;SAP=131;ABP=4;SAR=59;SAF=0	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron5/52:c.2364-210T>C::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1222779 [benign DISEASE=not provided];			rs41315862	0.1086	0.0754,0.1072,0.0436,0.1380,0.0334	997,.	14529	135575	1.0580			5.78				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235808463	235808463	A	G	het	het	het		QUAL=8421;DP=201,197,267;AF=0.53,0.51,0.51;MQM=60;SAP=50;ABP=4;SAR=128;SAF=214	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254915 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs3768066	0.1073	0.0710,0.1058,0.0435,0.1381,0.0338	975,.	14305	135199	-0.0390			6.68				0.07	25741868,32450446	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235809135	235809135	T	C	hom	het	hom		QUAL=27836;DP=481,195,286;AF=0.99,0.52,1.00;MQM=60;SAP=24;ABP=4;SAR=387;SAF=479	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254912 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs3820553	0.4052	0.4945,0.3279,0.0626,0.4081,0.1948	13166,.	35199	90337	-0.4290			0.53			COSV67705097	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235809567	235809567	T	C	hom	het	hom		QUAL=27986;DP=456,190,307;AF=1.00,0.56,0.99;MQM=60;SAP=22;ABP=10;SAR=476;SAF=390	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254910 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs1063128	0.4054	0.4947,0.3279,0.0623,0.4082,0.1959	13165,.	35203	90257	-0.0510			4.14			COSV67705101	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235866977	235866977	C	G	n/a	n/a	het	off-target	QUAL=40;DP=0,1,6;AF=,0.00,0.50;MQM=60;SAP=4;ABP=3;SAR=2;SAF=1	LYST	intron	LYST:ENST00000697181.1:intron_variant:MODIFIER:intron1/3:c.-98+16210G>C::,LYST:ENST00000697182.1:intron_variant:MODIFIER:intron1/2:c.-98+16210G>C::,LYST:ENST00000468107.5:intron_variant:MODIFIER:intron1/3:c.-98+16210G>C::	regulatory_region_variant:promoter	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]				rs3820556	0.0876	0.0253,0.0967,0.0452,0.1247,0.0337	745,.	11817	138639	0.7070			16.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	236394471	236394471	G	A	hom	hom	hom		QUAL=24570;DP=251,225,289;AF=1.00,1.00,1.00;MQM=60;SAP=104;ABP=0;SAR=477;SAF=288	EDARADD	intron,missense	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-14745G>A::,EDARADD:ENST00000334232.9:missense_variant:MODERATE:exon1/6:c.27G>A:p.Met9Ile:	regulatory_region_variant:promoter	606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	262600 [benign DISEASE=Hypohidrotic ectodermal dysplasia,Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive,not specified,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs966365	0.7664	0.5515,0.8579,0.9190,0.8408,0.9170	46074,.	24391	35515	-0.0690	 ,T(0.45)	 ,B(0.00)	9.15	0.13		COSV62061862	0.07	25741868,18466582,31452656	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236394628	236394628	G	A	hom	hom	hom	off-target	QUAL=5071;DP=94,33,41;AF=1.00,1.00,1.00;MQM=60;SAP=368;ABP=0;SAR=168;SAF=0	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-14588G>A::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron1/5:c.61+123G>A::	regulatory_region_variant:promoter	606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	439637 [benign DISEASE=not specified,not provided];			rs966364	0.7623	0.5369,0.8563,0.9192,0.8409,0.9165	45725,.	24443	36147	0.3730			4.73				0	17160898	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236409069	236409069	A	-	het	het	het	off-target	QUAL=696;DP=49,17,9;AF=0.27,0.47,0.44;MQM=60;SAP=49;ABP=21;SAR=1;SAF=24	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-129del::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron1/5:c.62-129del::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron1/5:c.32-129del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]			FRAM (SINE/Alu)	rs772223735	0.0043	0.0027,0.0037,0.0023,0.0025,0.0252	1,.	553	128541	0.3360			0.47				0		15	47	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236409089	236409089	G	A	hom	hom	hom	off-target	QUAL=696;DP=49,17,9;AF=0.27,0.47,0.44;MQM=60;SAP=38;ABP=57;SAR=0;SAF=16	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-127G>A::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron1/5:c.62-127G>A::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron1/5:c.32-127G>A::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1295882 [benign DISEASE=not provided];			rs659901	0.6769	0.6700,0.6789,0.3732,0.6997,0.6729	34655,.	32057	48385	-0.9900			0.10			COSV62066165	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236409175	236409175	A	G	het	hom	het	off-target	QUAL=10261;DP=180,171,161;AF=0.50,1.00,0.55;MQM=60;SAP=68;ABP=5;SAR=124;SAF=226	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-41A>G::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron1/5:c.62-41A>G::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron1/5:c.32-41A>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1255368 [benign DISEASE=Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive,not provided];			rs669710	0.5331	0.4796,0.4876,0.2632,0.5898,0.4927	22044,.	36820	70854	0.2780			4.54			COSV62061755	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236414461	236414461	T	C	het	hom	het	off-target	QUAL=1817;DP=44,13,14;AF=0.45,1.00,0.36;MQM=60;SAP=86;ABP=5;SAR=38;SAF=0	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.94+162T>C::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.160+162T>C::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.130+162T>C::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1295767 [benign DISEASE=not provided];			rs625444	0.6621	0.5016,0.6445,0.5603,0.7056,0.6636	17402,.	32819	34519	0.2880			3.93			COSV105889711	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236414462	236414462	-	T	het	wt	het	off-target	QUAL=1817;DP=44,13,14;AF=0.45,1.00,0.36;MQM=60;SAP=72;ABP=4;SAR=32;SAF=0	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.94+169dup::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.160+169dup::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.130+169dup::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1278018 [benign DISEASE=not provided];			rs61021118	0.5480	0.7897,0.5494,0.7719,0.4130,0.5104	24949,.	33342	68658				0.85				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236414462	236414462	C	T	het	hom	het	off-target	QUAL=1817;DP=44,13,14;AF=0.52,0.00,0.64;MQM=60;SAP=86;ABP=5;SAR=38;SAF=0	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.94+163C>T::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.160+163C>T::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.130+163C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1290224 [benign DISEASE=not provided];			rs625443	0.4458	0.1885,0.4486,0.2280,0.5869,0.4890	17454,.	32822	84216	-0.4690			0.64				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236414500	236414500	G	A	het	hom	het	off-target	QUAL=562;DP=43,6,6;AF=0.40,1.00,0.33;MQM=60;SAP=57;ABP=8;SAR=25;SAF=0	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.94+201G>A::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.160+201G>A::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.130+201G>A::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1295803 [benign DISEASE=not provided];			rs665150	0.4367	0.1562,0.4458,0.2281,0.5869,0.4886	17193,.	31951	85575	0.4660			3.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427197	236427197	C	G	het	hom	het	off-target	QUAL=1034;DP=52,13,33;AF=0.44,1.00,0.36;MQM=60;SAP=107;ABP=9;SAR=0;SAF=48	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-195C>G::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-195C>G::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-195C>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1224591 [benign DISEASE=not provided];		LTR53 (LTR/ERVL)	rs1759388	0.4791	0.2999,0.4613,0.2296,0.5882,0.4708	18766,.	35218	79090	-2.2650			0.07			COSV62063292	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427263	236427263	C	T	het	hom	het	off-target	QUAL=2667;DP=95,33,77;AF=0.44,1.00,0.44;MQM=60;SAP=240;ABP=8;SAR=0;SAF=109	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-129C>T::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-129C>T::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-129C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1295875 [benign DISEASE=not provided];		LTR53 (LTR/ERVL)	rs1778861	0.4496	0.1966,0.4522,0.2295,0.5877,0.4706	17640,.	33011	83609	1.0310			6.49				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427329	236427329	C	T	het	hom	het	off-target	QUAL=5887;DP=121,77,140;AF=0.51,1.00,0.51;MQM=60;SAP=134;ABP=3;SAR=49;SAF=162	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-63C>T::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-63C>T::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-63C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1237172 [benign DISEASE=not provided];		LTR53 (LTR/ERVL)	rs636378	0.4493	0.1962,0.4521,0.2299,0.5877,0.4709	17602,.	32936	83510	-0.1690			1.79				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427359	236427359	G	C	het	hom	het	off-target	QUAL=6538;DP=150,89,153;AF=0.51,0.99,0.51;MQM=60;SAP=87;ABP=3;SAR=73;SAF=170	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-33G>C::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-33G>C::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-33G>C::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1255369 [benign DISEASE=Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive,not provided];		(T)n (Simple_repeat)	rs636048	0.4489	0.1969,0.4523,0.2305,0.5869,0.4664	17437,.	32889	83191	0.8960			5.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427516	236427516	T	G	het	hom	het	off-target	QUAL=3803;DP=117,42,74;AF=0.50,1.00,0.55;MQM=60;SAP=168;ABP=4;SAR=123;SAF=19	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron4/5:c.153+66T>G::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron4/5:c.219+66T>G::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron4/5:c.189+66T>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1222286 [benign DISEASE=not provided];			rs635487	0.4788	0.2993,0.4613,0.2291,0.5880,0.4710	18735,.	35244	79170	0.7230			7.04				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236482115	236482115	A	-	het	het	wt	off-target	QUAL=178;DP=24,16,12;AF=0.17,0.25,0.00;MQM=60;SAP=20;ABP=34;SAR=0;SAF=8	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron5/5:c.200-136del::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron5/5:c.266-136del::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron5/5:c.236-136del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]			AluYk3 (SINE/Alu)	rs374553103	0.0402	0.1080,0.0235,0.0699,0.0065,0.0053	69,.	2806	70332	2.3530			1.95				0		1	6	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236482140	236482140	C	T	wt	wt	hom	off-target	QUAL=178;DP=24,16,12;AF=0.17,0.25,0.00;MQM=60;SAP=25;ABP=52;SAR=0;SAF=10	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron5/5:c.200-127C>T::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron5/5:c.266-127C>T::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron5/5:c.236-127C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1247629 [benign DISEASE=not provided];			rs603158	0.6624	0.6678,0.5977,0.4174,0.6852,0.6692	33216,.	33195	50767	-0.1690			0.25				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236482370	236482370	C	T	wt	wt	het		QUAL=5233;DP=210,356,479;AF=0.00,0.01,0.44;MQM=60;SAP=4;ABP=17;SAR=113;SAF=103	EDARADD	synonymous	EDARADD:ENST00000637660.1:synonymous_variant:LOW:exon6/6:c.303C>T:p.Asp101=:,EDARADD:ENST00000334232.9:synonymous_variant:LOW:exon6/6:c.369C>T:p.Asp123=:,EDARADD:ENST00000359362.6:synonymous_variant:LOW:exon6/6:c.339C>T:p.Asp113=:		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	262602 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive,not specified,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs604070	0.1848	0.0756,0.1529,0.0920,0.2504,0.1413	3128,.	21811	123855	0.1980			4.39			COSV62061161	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484211	236484211	T	C	het	het	hom		QUAL=13064;DP=276,142,225;AF=0.54,0.49,1.00;MQM=60;SAP=16;ABP=4;SAR=247;SAF=195	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1047T>C::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296476 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs7513402	0.3140	0.2306,0.3294,0.1077,0.3679,0.3387	8022,.	31665	104237	-1.7820			3.08			COSV62064204			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484250	236484250	C	G	het	het	hom		QUAL=13847;DP=328,127,225;AF=0.54,0.53,1.00;MQM=60;SAP=3;ABP=8;SAR=236;SAF=233	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1086C>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296479 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs3916983	0.2326	0.1534,0.2687,0.1042,0.2779,0.2731	4538,.	26285	116657	0.7020			3.23			COSV62063742			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484436	236484436	C	T	het	het	hom		QUAL=7196;DP=153,73,129;AF=0.55,0.53,0.99;MQM=60;SAP=3;ABP=7;SAR=124;SAF=127	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1272C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296481 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs6428955	0.1786	0.0624,0.2017,0.0519,0.2413,0.2271	2989,.	21142	124706	-0.0630			0.74			COSV62066249			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484708	236484708	G	-	het	het	wt	low_conf_region	QUAL=140;DP=14,12,19;AF=0.21,0.17,0.42;MQM=59;SAP=23;ABP=8;SAR=9;SAF=0	EDARADD	3'UTR	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296489 [uncertain significance DISEASE=Hypohidrotic Ectodermal Dysplasia, Recessive];		AluSc (SINE/Alu)	rs886046200	0.0001	0.0001,0.0000,0.0000,0.0001,0.0000	0,.	9	99393	-4.5470			0.09						1	5	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484709	236484709	A	-	wt	wt	het		QUAL=140;DP=14,12,19;AF=0.21,0.17,0.42;MQM=60;SAP=27;ABP=29;SAR=11;SAF=0	EDARADD	3'UTR	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1270976 [benign DISEASE=not provided];		AluSc (SINE/Alu)	rs11358746	0.4615	0.2875,0.4353,0.1524,0.5671,0.4508	12220,.	30321	63911	-2.6210			0.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484709	236484710	AA	-	het	wt	het		QUAL=140;DP=14,12,19;AF=0.29,0.42,0.00;MQM=60;SAP=31;ABP=20;SAR=13;SAF=0	EDARADD	3'UTR	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]			AluSc (SINE/Alu)	rs11358746	0.0009	0.0003,0.0014,0.0000,0.0008,0.0006	0,.	102	118614	-2.3440			0.11						4	38	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236795232	236795232	G	T	het	het	hom	off-target	QUAL=1137;DP=14,23,29;AF=0.50,0.48,1.00;MQM=60;SAP=105;ABP=3;SAR=0;SAF=47	MTR	upstream_gene	MTR:ENST00000366577.10:upstream_gene_variant:MODIFIER::::,MTR:ENST00000674797.2:upstream_gene_variant:MODIFIER::::,MTR:ENST00000535889.6:upstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:upstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:upstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1249677 [benign DISEASE=not provided];	CR1417888 [CLASS=DP MUT=ALT PHEN="Congenital heart disease association with" GENE=MTR];		rs28372871	0.4633	0.5346,0.4731,0.4859,0.4260,0.4129	16574,.	37249	81547	-0.5370			2.91					27808252,32819312	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236808886	236808886	A	G	het	het	wt	off-target	QUAL=4789;DP=201,168,219;AF=0.51,0.54,0.01;MQM=60;SAP=342;ABP=4;SAR=184;SAF=10	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron4/32:c.409+113A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron3/31:c.61+113A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron4/31:c.409+113A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron4/30:c.409+113A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron4/31:c.409+113A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron4/29:c.409+113A>G::	regulatory_region_variant:enhancer	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1232929 [benign DISEASE=not provided];			rs12759827	0.1828	0.0529,0.1996,0.0012,0.2697,0.0626	3384,.	21022	124254	-0.5500			0.83				0	18381459,21274745,23940529,22941668,29763473,33499176	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236815692	236815692	-	TCTG	het	het	het	off-target;low_conf_region	QUAL=7150;DP=161,110,172;AF=0.46,0.48,0.90;MQM=60;SAP=80;ABP=75;SAR=191;SAF=91	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron7/32:c.669+32_669+33insGTCT::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron6/31:c.321+32_321+33insGTCT::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron7/30:c.669+32_669+33insGTCT::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron7/29:c.669+32_669+33insGTCT::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1263040 [benign DISEASE=not provided];			rs5781924	0.7224	0.9147,0.6772,0.8155,0.6297,0.7373	40879,.	27766	42088				2.49				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46), RPSAP21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236816297	236816297	A	G	het	het	hom	off-target	QUAL=1494;DP=60,13,19;AF=0.55,0.54,1.00;MQM=60;SAP=131;ABP=4;SAR=0;SAF=59	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron7/32:c.670-152A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron6/31:c.322-152A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron7/31:c.670-152A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron7/30:c.670-152A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron7/31:c.670-152A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron7/29:c.670-152A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1241010 [benign DISEASE=not provided];			rs3795708	0.3501	0.2075,0.4084,0.4041,0.4095,0.3026	10062,.	33041	98707	-2.4980			0.01			COSV63969853	0	25598430	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46), RPSAP21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236825293	236825293	-	T	het	het	hom	off-target	QUAL=3942;DP=137,36,48;AF=0.56,0.67,1.00;MQM=60;SAP=209;ABP=14;SAR=15;SAF=134	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron9/32:c.866-40dup::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron8/31:c.518-40dup::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron9/31:c.866-40dup::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron9/30:c.866-40dup::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron9/31:c.866-40dup::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron9/29:c.866-40dup::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1236260 [benign DISEASE=not provided];			rs5781926	0.3468	0.2077,0.4024,0.4009,0.4090,0.2930	9854,.	32834	98962				0.79				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46), RPSAP21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236826841	236826841	G	A	wt	het	wt		QUAL=1794;DP=295,153,221;AF=0.00,0.47,0.00;MQM=60;SAP=3;ABP=4;SAR=38;SAF=35	MTR	missense	MTR:ENST00000366577.10:missense_variant:MODERATE:exon11/33:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000674797.2:missense_variant:MODERATE:exon10/32:c.592G>A:p.Asp198Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000535889.6:missense_variant:MODERATE:exon11/32:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000679842.1:missense_variant:MODERATE:exon11/31:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000681102.1:missense_variant:MODERATE:exon11/32:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000681177.1:missense_variant:MODERATE:exon11/30:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase]		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296556 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified,not provided];			rs2229274	0.0182	0.0093,0.0193,0.0000,0.0235,0.0039	30,.	2702	149382	4.1030	T(0.26),T(0.26),T(0.26),T(0.30),T(0.16),T(0.37)	B(0.19),B(0.19),B(0.19),B(0.01),B(0.01),B(0.05)	22.50	0.12			0	19112534	20	992	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236838626	236838626	A	G	het	het	hom	off-target	QUAL=12894;DP=177,180,256;AF=0.51,0.51,1.00;MQM=60;SAP=492;ABP=3;SAR=376;SAF=62	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron15/32:c.1515+27A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron14/31:c.1167+27A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron15/30:c.1515+27A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1515+27A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1278171 [benign DISEASE=not provided];			rs3820568	0.3559	0.2118,0.4133,0.4326,0.4138,0.2956	10400,.	33289	97911	-0.9150			0.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236838732	236838732	A	C	het	het	hom	off-target	QUAL=6702;DP=305,56,85;AF=0.47,0.64,1.00;MQM=60;SAP=574;ABP=3;SAR=263;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron15/32:c.1515+133A>C::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron14/31:c.1167+133A>C::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron15/31:c.1515+133A>C::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron15/30:c.1515+133A>C::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1515+133A>C::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1515+133A>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1178281 [benign DISEASE=not provided];		(ATATAC)n (Simple_repeat)	rs55748381	0.3558	0.2119,0.4129,0.4348,0.4138,0.2957	10387,.	33292	97872	0.5030			2.62			COSV63964088	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236850615	236850617	TGA	-	het	het	hom	off-target	QUAL=2676;DP=54,42,56;AF=0.57,0.48,0.98;MQM=60;SAP=233;ABP=4;SAR=106;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron16/32:c.1695+95_1695+97del::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron15/31:c.1347+95_1347+97del::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron16/31:c.1695+95_1695+97del::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron16/30:c.1695+95_1695+97del::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1516-1903_1516-1901del::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1516-9215_1516-9213del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1229225 [benign DISEASE=not provided];			rs35913043	0.4696	0.5291,0.4751,0.6604,0.4329,0.4059	17048,.	36977	80261	0.6900			2.72				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236852328	236852328	C	T	het	het	hom	off-target	QUAL=767;DP=60,3,4;AF=0.45,0.33,1.00;MQM=60;SAP=72;ABP=5;SAR=0;SAF=32	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron16/32:c.1696-193C>T::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron15/31:c.1348-193C>T::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron16/31:c.1696-193C>T::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron16/30:c.1696-193C>T::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1516-193C>T::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1516-7505C>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1262193 [benign DISEASE=not provided];			rs2275568	0.4256	0.4050,0.4556,0.4580,0.4320,0.3832	13917,.	36667	87047	0.0500			1.34				0	19834535,29445423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236860033	236860033	T	C	het	het	hom	off-target	QUAL=4793;DP=67,76,98;AF=0.57,0.59,1.00;MQM=60;SAP=277;ABP=11;SAR=166;SAF=15	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron19/32:c.2043+111T>C::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron18/31:c.1695+111T>C::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron19/31:c.2043+111T>C::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron19/30:c.2043+111T>C::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron18/31:c.1863+111T>C::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron16/29:c.1605+111T>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1183329 [benign DISEASE=not provided];			rs10925254	0.6536	0.6881,0.6582,0.6309,0.6345,0.7295	28858,.	29054	45988	1.0330			7.87			COSV63965200	0	32492698	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236860070	236860077	CCCCCCCC	-	n/a	hom	hom	off-target;low_conf_region	QUAL=57;DP=0,4,3;AF=,0.75,0.67;MQM=60;SAP=14;ABP=0;SAR=5;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron19/32:c.2043+161_2043+168del::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron18/31:c.1695+161_1695+168del::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron19/31:c.2043+161_2043+168del::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron19/30:c.2043+161_2043+168del::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron18/31:c.1863+161_1863+168del::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron16/29:c.1605+161_1605+168del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]			(C)n (Simple_repeat)	rs59525673	0.2753	0.2420,0.2995,0.2574,0.2828,0.4701	341,.	11263	31449	0.0960			0.44				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236860094	236860094	A	G	n/a	hom	hom	off-target	QUAL=57;DP=0,4,3;AF=,0.75,0.67;MQM=60;SAP=14;ABP=0;SAR=5;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron19/32:c.2043+172A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron18/31:c.1695+172A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron19/31:c.2043+172A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron19/30:c.2043+172A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron18/31:c.1863+172A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron16/29:c.1605+172A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1290727 [benign DISEASE=not provided];		MER20 (DNA/hAT-Charlie)	rs45534439	0.4469	0.2572,0.5085,0.5715,0.5100,0.3314	4834,.	17727	33907	-0.9390			0.74			COSV63966199	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874528	236874528	G	A	het	n/a	hom	off-target	QUAL=547;DP=31,0,3;AF=0.65,,1.00;MQM=48;SAP=53;ABP=9;SAR=0;SAF=23	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron23/32:c.2474-198G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron22/31:c.2126-198G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron22/31:c.2321-198G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6227G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron22/31:c.2294-198G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron20/29:c.2036-198G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1286676 [benign DISEASE=not provided];		AluSx1 (SINE/Alu)	rs4659737	0.6453	0.6751,0.6422,0.6133,0.6295,0.7081	31530,.	33954	53332	-1.7780			0.41				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874553	236874553	C	A	hom	n/a	hom	off-target	QUAL=1476;DP=43,0,7;AF=1.00,,1.00;MQM=53;SAP=112;ABP=0;SAR=0;SAF=50	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron23/32:c.2474-173C>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron22/31:c.2126-173C>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron22/31:c.2321-173C>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6202C>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron22/31:c.2294-173C>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron20/29:c.2036-173C>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1246495 [benign DISEASE=not provided];		AluSx1 (SINE/Alu)	rs2712831	0.9994	0.9981,0.9997,1.0000,1.0000,1.0000	75354,.	88	88	-0.6200			1.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874571	236874571	A	-	het	n/a	wt	off-target	QUAL=44;DP=32,2,9;AF=0.16,0.00,0.00;MQM=60;SAP=14;ABP=36;SAR=0;SAF=5	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron23/32:c.2474-141del::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron22/31:c.2126-141del::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron22/31:c.2321-141del::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6170del::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron22/31:c.2294-141del::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron20/29:c.2036-141del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs763802762	0.0033	0.0042,0.0035,0.0010,0.0019,0.0005	3,.	385	118907	0.3080			0.46				0		0	14	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874699	236874699	T	-	het	het	hom	off-target;low_conf_region	QUAL=1451;DP=47,24,46;AF=0.30,0.46,0.74;MQM=60;SAP=14;ABP=16;SAR=21;SAF=38	MTR	splice_region&intron,intron	MTR:ENST00000366577.10:splice_region_variant&intron_variant:LOW:intron23/32:c.2474-18del::,MTR:ENST00000674797.2:splice_region_variant&intron_variant:LOW:intron22/31:c.2126-18del::,MTR:ENST00000535889.6:splice_region_variant&intron_variant:LOW:intron22/31:c.2321-18del::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6047del::,MTR:ENST00000681102.1:splice_region_variant&intron_variant:LOW:intron22/31:c.2294-18del::,MTR:ENST00000681177.1:splice_region_variant&intron_variant:LOW:intron20/29:c.2036-18del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1220586 [benign DISEASE=Methylcobalamin deficiency type cblG,not provided];			rs150727404	0.6418	0.7470,0.6342,0.7969,0.5818,0.7017	30382,.	32905	52287	0.3150			0.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874708	236874708	T	A	het	het	hom	off-target;low_conf_region	QUAL=1451;DP=47,24,46;AF=0.30,0.46,0.74;MQM=60;SAP=14;ABP=16;SAR=21;SAF=38	MTR	splice_region&intron,intron	MTR:ENST00000366577.10:splice_region_variant&intron_variant:LOW:intron23/32:c.2474-18T>A::,MTR:ENST00000674797.2:splice_region_variant&intron_variant:LOW:intron22/31:c.2126-18T>A::,MTR:ENST00000535889.6:splice_region_variant&intron_variant:LOW:intron22/31:c.2321-18T>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6047T>A::,MTR:ENST00000681102.1:splice_region_variant&intron_variant:LOW:intron22/31:c.2294-18T>A::,MTR:ENST00000681177.1:splice_region_variant&intron_variant:LOW:intron20/29:c.2036-18T>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	378884 [benign DISEASE=Methylcobalamin deficiency type cblG,not specified];			rs10925256	0.4559	0.5341,0.4643,0.4979,0.4172,0.3888	12428,.	35521	72055	-0.6490			1.12		-1.58>-1.77	COSV63966075	0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874861	236874861	T	C	het	het	wt	off-target	QUAL=2570;DP=81,126,168;AF=0.47,0.52,0.00;MQM=60;SAP=38;ABP=3;SAR=72;SAF=31	MTR	splice_region&intron,intron	MTR:ENST00000366577.10:splice_region_variant&intron_variant:LOW:intron24/32:c.2594+15T>C::,MTR:ENST00000674797.2:splice_region_variant&intron_variant:LOW:intron23/31:c.2246+15T>C::,MTR:ENST00000535889.6:splice_region_variant&intron_variant:LOW:intron23/31:c.2441+15T>C::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-5894T>C::,MTR:ENST00000681102.1:splice_region_variant&intron_variant:LOW:intron23/31:c.2414+15T>C::,MTR:ENST00000681177.1:splice_region_variant&intron_variant:LOW:intron21/29:c.2156+15T>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138288 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs1770449	0.2756	0.0817,0.3231,0.1872,0.3686,0.2727	7111,.	27690	110150	-0.1570			3.53			COSV63964725	0	25741868,19493349,21254359,22496743,20180013,21743092,30911047	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236885262	236885262	G	A	het	het	hom	off-target	QUAL=11132;DP=332,113,149;AF=0.55,0.50,1.00;MQM=60;SAP=438;ABP=9;SAR=334;SAF=55	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron26/32:c.2775+43G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron25/31:c.2427+43G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron25/31:c.2622+43G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron24/30:c.2586+43G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron25/31:c.2595+43G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron23/29:c.2337+43G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1258762 [benign DISEASE=not provided];			rs2275566	0.7161	0.8939,0.6721,0.8142,0.6307,0.7262	40112,.	28586	43136	-1.2850			0.29				0	21146954	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236886153	236886153	C	T	het	wt	het	off-target	QUAL=2040;DP=106,64,90;AF=0.47,0.00,0.57;MQM=60;SAP=222;ABP=3;SAR=0;SAF=101	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron26/32:c.2776-139C>T::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron25/31:c.2428-139C>T::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron25/31:c.2623-139C>T::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron24/30:c.2587-139C>T::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron25/31:c.2596-139C>T::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron23/29:c.2338-139C>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1187579 [likely benign DISEASE=not provided];			rs41295948	0.0156	0.0044,0.0236,0.0000,0.0235,0.0023	21,.	2324	149818	-0.6570			1.24				0		10	311	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236889492	236889492	T	A	het	het	hom	off-target	QUAL=2710;DP=95,26,43;AF=0.52,0.46,1.00;MQM=60;SAP=229;ABP=3;SAR=104;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron28/32:c.3007+156T>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron27/31:c.2659+156T>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron27/31:c.2854+156T>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron26/30:c.2818+156T>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron27/31:c.2827+156T>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron25/29:c.2569+156T>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1278175 [benign DISEASE=not provided];			rs3768150	0.6917	0.8108,0.6627,0.8155,0.6294,0.7248	37027,.	31054	46860	-1.5090			0.04				0	21274745,22941668,29763473	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236891269	236891269	A	G	het	het	hom		QUAL=7199;DP=98,101,144;AF=0.55,0.50,1.00;MQM=60;SAP=21;ABP=4;SAR=147;SAF=102	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon29/33:c.3144A>G:p.Ala1048=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon28/32:c.2796A>G:p.Ala932=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon28/32:c.2991A>G:p.Ala997=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon27/31:c.2955A>G:p.Ala985=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon28/32:c.2964A>G:p.Ala988=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon26/30:c.2706A>G:p.Ala902=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138290 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs2229276	0.3473	0.1956,0.4013,0.4408,0.4066,0.3027	9993,.	32777	99159	-1.1170			0.76			COSV63966508	0.01	19493349,22496743,19683694,21960995,20718043,18842806,21597034	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236891499	236891499	A	G	het	het	hom	off-target	QUAL=895;DP=43,11,17;AF=0.42,0.36,1.00;MQM=60;SAP=88;ABP=7;SAR=39;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron29/32:c.3204+170A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron28/31:c.2856+170A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron28/31:c.3051+170A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron27/30:c.3015+170A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron28/31:c.3024+170A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron26/29:c.2766+170A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1235800 [benign DISEASE=not provided];			rs2282369	0.6784	0.8246,0.6376,0.7597,0.6095,0.6396	35812,.	31445	48871	-1.8070			0.09				0	22941668,29763473,25950259	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236894308	236894308	G	A	het	het	hom	off-target	QUAL=7988;DP=96,140,175;AF=0.51,0.50,1.00;MQM=60;SAP=510;ABP=3;SAR=16;SAF=278	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron29/32:c.3205-49G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron28/31:c.2857-49G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron28/31:c.3052-49G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron27/30:c.3016-49G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron28/31:c.3025-49G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron26/29:c.2767-49G>A::	regulatory_region_variant:open_chromatin_region	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1270532 [benign DISEASE=not provided];			rs2297965	0.5597	0.4581,0.5846,0.5562,0.6022,0.6091	24176,.	36537	66791	-0.5020			2.45			COSV63966743	0	22941668,29763473	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236895444	236895444	C	A	het	het	hom		QUAL=14604;DP=215,222,309;AF=0.50,0.45,1.00;MQM=60;SAP=12;ABP=5;SAR=282;SAF=236	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon31/33:c.3492C>A:p.Arg1164=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon30/32:c.3144C>A:p.Arg1048=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon30/32:c.3339C>A:p.Arg1113=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon29/31:c.3303C>A:p.Arg1101=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon30/32:c.3312C>A:p.Arg1104=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon28/30:c.3054C>A:p.Arg1018=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138283 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs12070777	0.3489	0.2021,0.4041,0.4321,0.4069,0.2966	10032,.	32959	98933	0.0910			2.36			COSV63966512	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236895528	236895528	C	T	wt	het	het		QUAL=4192;DP=136,168,182;AF=0.00,0.43,0.53;MQM=60;SAP=117;ABP=4;SAR=131;SAF=37	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon31/33:c.3576C>T:p.Leu1192=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon30/32:c.3228C>T:p.Leu1076=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon30/32:c.3423C>T:p.Leu1141=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon29/31:c.3387C>T:p.Leu1129=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon30/32:c.3396C>T:p.Leu1132=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon28/30:c.3138C>T:p.Leu1046=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138284 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs1131449	0.5444	0.4565,0.5603,0.5516,0.5784,0.6059	22891,.	36890	69192	-3.3670			0.04			COSV63964165	0	19683694,20615890,21274745,21960995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236895696	236895696	-	TATT	het	het	hom	off-target	QUAL=794;DP=86,12,8;AF=0.30,0.58,1.00;MQM=60;SAP=92;ABP=26;SAR=41;SAF=0	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron31/32:c.3598+147_3598+150dup::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron30/31:c.3250+147_3250+150dup::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron30/31:c.3445+147_3445+150dup::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron29/30:c.3409+147_3409+150dup::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron30/31:c.3418+147_3418+150dup::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron28/29:c.3160+147_3160+150dup::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1239035 [benign DISEASE=not provided];			rs75739277	0.7183	0.9095,0.6682,0.8150,0.6260,0.7270	40435,.	28167	42773				1.97				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897133	236897133	G	T	het	het	hom	off-target	QUAL=12444;DP=205,200,245;AF=0.42,0.50,0.99;MQM=60;SAP=228;ABP=9;SAR=320;SAF=109	MTR	splice_region&intron	MTR:ENST00000366577.10:splice_region_variant&intron_variant:LOW:intron32/32:c.3711+15G>T::,MTR:ENST00000674797.2:splice_region_variant&intron_variant:LOW:intron31/31:c.3363+15G>T::,MTR:ENST00000535889.6:splice_region_variant&intron_variant:LOW:intron31/31:c.3558+15G>T::,MTR:ENST00000679842.1:splice_region_variant&intron_variant:LOW:intron30/30:c.3522+15G>T::,MTR:ENST00000681102.1:splice_region_variant&intron_variant:LOW:intron31/31:c.3531+15G>T::,MTR:ENST00000681177.1:splice_region_variant&intron_variant:LOW:intron29/29:c.3273+15G>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138285 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs3820571	0.7079	0.8772,0.6619,0.8136,0.6252,0.7258	39138,.	29282	44392	-0.2020			0.40				0.08	19493349,23430981	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897310	236897310	G	A	het	het	het	off-target;low_conf_region	QUAL=160;DP=45,11,11;AF=0.13,0.18,0.73;MQM=52;SAP=8;ABP=43;SAR=5;SAF=11	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron32/32:c.3711+192G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron31/31:c.3363+192G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron31/31:c.3558+192G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron30/30:c.3522+192G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron31/31:c.3531+192G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron29/29:c.3273+192G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]			(CA)n (Simple_repeat)	rs12120433	0.0002	0.0003,0.0002,0.0000,0.0002,0.0006	0,.	31	128579	0.0750			1.32			COSV63964742	0		520	3838	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897646	236897646	T	-	het	het	het	low_conf_region	QUAL=502;DP=153,73,117;AF=0.18,0.19,0.11;MQM=60;SAP=8;ABP=347;SAR=33;SAF=22	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*16del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::,MTR:ENST00000535889.6:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296586 [likely benign(replaced by megSAP based on classifications:2x1,1x3) DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not provided];		(T)n (Simple_repeat)	rs67705775	0.1799	0.1960,0.1367,0.0826,0.1867,0.1973	1955,.	21471	115741	1.2650			10.14				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897756	236897756	A	C	het	het	hom		QUAL=10723;DP=308,80,153;AF=0.54,0.53,1.00;MQM=60;SAP=19;ABP=7;SAR=155;SAF=206	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*112A>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::,MTR:ENST00000535889.6:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296587 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not provided];			rs2853522	0.5619	0.4640,0.5849,0.5573,0.6027,0.6151	24345,.	36486	66402	-1.1490			3.07				0	22856873,30884202,33033524	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898405	236898405	T	-	het	het	hom		QUAL=2222;DP=96,26,38;AF=0.55,0.58,0.82;MQM=58;SAP=90;ABP=6;SAR=81;SAF=18	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*773del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*773del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296595 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluY (SINE/Alu)	rs796166778	0.6811	0.8409,0.6377,0.8029,0.6030,0.7035	32753,.	30219	44825	0.1060			0.92				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898549	236898549	G	A	het	het	wt		QUAL=1308;DP=82,34,65;AF=0.44,0.59,0.00;MQM=51;SAP=71;ABP=3;SAR=7;SAF=49	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*905G>A::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*905G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296598 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];	CR1417889 [CLASS=DP MUT=ALT PHEN="Congenital heart disease association with" GENE=MTR];	AluY (SINE/Alu)	rs1131450	0.2844	0.1344,0.3211,0.1873,0.3588,0.2520	6957,.	29081	108207	0.1710			1.57				0	27808252,32819312	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898898	236898898	A	C	het	het	hom		QUAL=16901;DP=263,243,297;AF=0.55,0.47,1.00;MQM=60;SAP=15;ABP=4;SAR=250;SAF=305	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1254A>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1254A>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296610 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs2853523	0.7192	0.9110,0.6692,0.8127,0.6266,0.7276	40590,.	28101	42669	-0.2280			4.71				0.08	21146954,22856873,18381459,23940529,20871623	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236899005	236899005	A	G	het	het	hom		QUAL=22005;DP=413,294,370;AF=0.53,0.52,0.99;MQM=60;SAP=5;ABP=7;SAR=358;SAF=382	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1361A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1361A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296611 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs1050993	0.7193	0.9110,0.6693,0.8132,0.6268,0.7276	40616,.	28105	42661	-0.4520			1.96				0	19493349,21254359,22496743,18381459,19064578,20180013,21743092,30911047,23430981	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900035	236900035	G	C	het	het	hom		QUAL=12882;DP=227,207,221;AF=0.49,0.53,1.00;MQM=60;SAP=134;ABP=3;SAR=302;SAF=139	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2391G>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2391G>C::	regulatory_region_variant:CTCF_binding_site	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296631 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs1050996	0.6886	0.8084,0.6564,0.8167,0.6253,0.7265	36703,.	31250	47322	-0.1630			3.37				0	22941668,29763473	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900204	236900204	A	G	het	het	hom		QUAL=11976;DP=379,107,148;AF=0.50,0.54,1.00;MQM=60;SAP=7;ABP=3;SAR=184;SAF=212	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2560A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2560A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296633 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs9779	0.3459	0.2021,0.4021,0.4377,0.4044,0.2956	9841,.	32861	99349	-1.1570			0.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900409	236900409	-	A	het	het	hom		QUAL=13769;DP=188,138,184;AF=0.41,0.42,0.94;MQM=60;SAP=3;ABP=22;SAR=154;SAF=155	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2774dup::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2774dup::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296635 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs34686098	0.7261	0.7414,0.7232,0.6305,0.7216,0.7599	32750,.	33321	37281				0.29				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900418	236900419	AG	-	het	het	wt		QUAL=13769;DP=188,138,184;AF=0.41,0.42,0.94;MQM=60;SAP=11;ABP=4;SAR=97;SAF=72	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2775_*2776del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2775_*2776del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296637 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs1553332314	0.2796	0.0871,0.3301,0.1840,0.3727,0.2722	7193,.	27959	109089	0.5750			1.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236901326	236901326	T	G	het	het	hom		QUAL=33907;DP=419,512,670;AF=0.50,0.48,0.99;MQM=60;SAP=22;ABP=4;SAR=610;SAF=511	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*3682T>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*3682T>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296655 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs6676866	0.5628	0.4686,0.5853,0.5552,0.6024,0.6098	24374,.	36540	66252	1.5210			7.27				0	21146954,19493349,18381459,21274745	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902026	236902026	C	T	het	het	hom		QUAL=8138;DP=170,112,157;AF=0.55,0.47,1.00;MQM=60;SAP=141;ABP=4;SAR=82;SAF=221	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4382C>T::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4382C>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296668 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs4659746	0.5684	0.4830,0.5910,0.5569,0.6034,0.6094	24904,.	36500	65534	-0.6270			0.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902283	236902283	G	T	het	het	hom		QUAL=13218;DP=219,175,256;AF=0.51,0.57,1.00;MQM=60;SAP=8;ABP=8;SAR=217;SAF=251	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4639G>T::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4639G>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296673 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs10925264	0.7190	0.9108,0.6689,0.8135,0.6265,0.7269	40491,.	28061	42611	-0.3300			0.95				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902510	236902510	T	G	het	wt	het		QUAL=4890;DP=179,178,171;AF=0.53,0.00,0.55;MQM=60;SAP=145;ABP=8;SAR=150;SAF=39	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4866T>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4866T>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296677 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L2c (LINE/L2)	rs45563435	0.0156	0.0044,0.0234,0.0000,0.0236,0.0023	21,.	2328	149800	-0.3180			2.04				0		8	313	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902814	236902814	A	G	het	het	wt		QUAL=3170;DP=157,84,113;AF=0.50,0.58,0.00;MQM=60;SAP=99;ABP=5;SAR=26;SAF=101	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*5170A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*5170A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296679 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs6680753	0.0197	0.0061,0.0213,0.0000,0.0273,0.0008	53,.	2888	149098	0.5290			2.80				0		2	257	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	240775321	240775321	G	A	het	n/a	n/a	off-target	QUAL=199;DP=17,0,0;AF=0.53,,;MQM=60;SAP=23;ABP=3;SAR=0;SAF=9	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-7043C>T::						rs6700378	0.1720	0.3303,0.0978,0.1302,0.1200,0.1030	3022,.	20106	125852	-2.3970			0.01					20627871	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240775804	240775804	G	A	het	hom	wt		QUAL=9113;DP=345,146,165;AF=0.48,0.99,0.00;MQM=60;SAP=178;ABP=4;SAR=76;SAF=234	RGS7	intron,3'UTR	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-7526C>T::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*416C>T::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000693043.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*416C>T::,RGS7:ENST00000691979.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:ENST00000685936.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*416C>T::,RGS7:ENST00000688703.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:ENST00000689640.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*416C>T::,RGS7:ENST00000690614.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*416C>T::,RGS7:ENST00000687448.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*359C>T::,RGS7:ENST00000689602.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000691485.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000692410.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000690019.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:ENST00000688633.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:ENST00000689115.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*416C>T::,RGS7:ENST00000691989.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*416C>T::,RGS7:ENST00000686465.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:ENST00000686908.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:ENST00000688737.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:ENST00000688863.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::						rs35557904	0.1723	0.3308,0.0979,0.1301,0.1202,0.1029	3026,.	20113	125711	0.6560			19.19		11.28>2.53		0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240775852	240775852	A	G	het	hom	wt		QUAL=9495;DP=318,181,209;AF=0.44,0.99,0.00;MQM=60;SAP=90;ABP=13;SAR=103;SAF=216	RGS7	intron,3'UTR	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-7574T>C::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*368T>C::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000693043.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*368T>C::,RGS7:ENST00000691979.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:ENST00000685936.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*368T>C::,RGS7:ENST00000688703.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:ENST00000689640.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*368T>C::,RGS7:ENST00000690614.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*368T>C::,RGS7:ENST00000687448.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*311T>C::,RGS7:ENST00000689602.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000691485.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000692410.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000690019.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:ENST00000688633.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:ENST00000689115.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*368T>C::,RGS7:ENST00000691989.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*368T>C::,RGS7:ENST00000686465.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:ENST00000686908.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:ENST00000688737.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:ENST00000688863.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::						rs16840577	0.1721	0.3304,0.0979,0.1302,0.1201,0.1028	3026,.	20106	125870	2.4410			16.55				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240776091	240776091	C	T	het	het	wt		QUAL=12747;DP=505,550,687;AF=0.46,0.47,0.00;MQM=60;SAP=22;ABP=16;SAR=277;SAF=211	RGS7	intron,3'UTR	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-7813G>A::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*129G>A::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000693043.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*129G>A::,RGS7:ENST00000691979.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:ENST00000685936.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*129G>A::,RGS7:ENST00000688703.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:ENST00000689640.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*129G>A::,RGS7:ENST00000690614.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*129G>A::,RGS7:ENST00000687448.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*72G>A::,RGS7:ENST00000689602.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000691485.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000692410.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000690019.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:ENST00000688633.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:ENST00000689115.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*129G>A::,RGS7:ENST00000691989.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*129G>A::,RGS7:ENST00000686465.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:ENST00000686908.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:ENST00000688737.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:ENST00000688863.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::						rs12757054	0.0610	0.0390,0.0458,0.0241,0.0823,0.0844	353,.	8570	142814	1.5850			10.68			COSV58544216	0	21698121	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240776374	240776374	T	C	het	hom	wt	off-target	QUAL=1264;DP=84,32,63;AF=0.38,0.97,0.00;MQM=60;SAP=140;ABP=13;SAR=63;SAF=0	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-8096A>G::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron18/18:c.*7-161A>G::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron14/14:c.*7-161A>G::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron17/17:c.*7-161A>G::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron16/16:c.1360-161A>G::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron17/17:c.1414-161A>G::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron15/15:c.*7-161A>G::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron17/17:c.*7-161A>G::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron19/19:c.*7-161A>G::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron18/18:c.*7-161A>G::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron13/13:c.*7-161A>G::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron19/19:c.*7-161A>G::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron19/19:c.1282-161A>G::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron17/17:c.1282-161A>G::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron17/17:c.1282-161A>G::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron17/17:c.1282-161A>G::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron15/15:c.1309-161A>G::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron16/16:c.1432-161A>G::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron16/16:c.*7-161A>G::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron16/16:c.*7-161A>G::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron15/15:c.1156-161A>G::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron15/15:c.1357-161A>G::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron15/15:c.1240-161A>G::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron17/17:c.1414-161A>G::					(CCTC)n (Simple_repeat)	rs3795681	0.1629	0.3145,0.0905,0.1188,0.1174,0.0947	2664,.	18833	124203	0.4360			8.87			COSV58530577	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240805960	240805960	A	-	wt	het	wt	off-target	QUAL=20;DP=14,6,7;AF=0.00,0.50,0.00;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron15/16:c.1269+180del::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron15/18:c.1269+180del::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron12/14:c.1110+180del::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron15/17:c.1269+180del::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron15/16:c.1269+180del::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron15/17:c.1269+180del::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron13/15:c.1110+180del::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron15/17:c.1269+180del::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron17/19:c.1191+180del::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron16/18:c.1191+180del::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron11/13:c.993+180del::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron17/19:c.1191+180del::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron18/19:c.1191+180del::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron16/17:c.1191+180del::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron16/17:c.1191+180del::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron16/17:c.1191+180del::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron14/15:c.1218+180del::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron15/16:c.1341+180del::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron13/16:c.1110+180del::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron14/16:c.1158+180del::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron14/15:c.1065+180del::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron14/15:c.1266+180del::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron14/15:c.1149+180del::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron16/17:c.1323+180del::						rs142377602	0.0926	0.2277,0.0471,0.1045,0.0368,0.0270	1197,.	11684	137932	0.3760			0.30				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240811913	240811913	T	C	het	wt	hom		QUAL=11013;DP=254,201,238;AF=0.54,0.00,1.00;MQM=60;SAP=132;ABP=6;SAR=113;SAF=262	RGS7	splice_region&intron,intron	RGS7:ENST00000690539.1:splice_region_variant&intron_variant:LOW:intron14/16:c.1082+5A>G::,RGS7:ENST00000440928.6:splice_region_variant&intron_variant:LOW:intron14/18:c.1082+5A>G::,RGS7:ENST00000348120.6:splice_region_variant&intron_variant:LOW:intron11/14:c.923+5A>G::,RGS7:ENST00000366563.5:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000366564.5:splice_region_variant&intron_variant:LOW:intron14/16:c.1082+5A>G::,RGS7:ENST00000366565.5:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000693043.1:splice_region_variant&intron_variant:LOW:intron12/15:c.923+5A>G::,RGS7:ENST00000691979.1:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000685936.1:splice_region_variant&intron_variant:LOW:intron16/19:c.1004+5A>G::,RGS7:ENST00000688703.1:splice_region_variant&intron_variant:LOW:intron15/18:c.1004+5A>G::,RGS7:ENST00000689640.1:splice_region_variant&intron_variant:LOW:intron10/13:c.806+5A>G::,RGS7:ENST00000690614.1:splice_region_variant&intron_variant:LOW:intron16/19:c.1004+5A>G::,RGS7:ENST00000687448.1:splice_region_variant&intron_variant:LOW:intron17/19:c.1004+5A>G::,RGS7:ENST00000689602.1:splice_region_variant&intron_variant:LOW:intron15/17:c.1004+5A>G::,RGS7:ENST00000691485.1:splice_region_variant&intron_variant:LOW:intron15/17:c.1004+5A>G::,RGS7:ENST00000692410.1:splice_region_variant&intron_variant:LOW:intron15/17:c.1004+5A>G::,RGS7:ENST00000690019.1:splice_region_variant&intron_variant:LOW:intron13/15:c.1031+5A>G::,RGS7:ENST00000688633.1:splice_region_variant&intron_variant:LOW:intron14/16:c.1154+5A>G::,RGS7:ENST00000689115.1:splice_region_variant&intron_variant:LOW:intron12/16:c.923+5A>G::,RGS7:ENST00000691989.1:splice_region_variant&intron_variant:LOW:intron13/16:c.971+5A>G::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron13/15:c.878+1705A>G::,RGS7:ENST00000686908.1:splice_region_variant&intron_variant:LOW:intron13/15:c.1079+5A>G::,RGS7:ENST00000688737.1:splice_region_variant&intron_variant:LOW:intron13/15:c.962+5A>G::,RGS7:ENST00000688863.1:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::	regulatory_region_variant:CTCF_binding_site					rs2275742	0.4700	0.2601,0.4296,0.4628,0.5795,0.4301	18434,.	34505	80475	0.2170			8.97		8.38>10.57	COSV58534718	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240812135	240812135	C	T	het	wt	hom	off-target	QUAL=4760;DP=172,66,94;AF=0.47,0.02,1.00;MQM=60;SAP=383;ABP=5;SAR=175;SAF=0	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron13/16:c.957-92G>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron13/18:c.957-92G>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron10/14:c.798-92G>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron13/17:c.957-92G>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron13/16:c.957-92G>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron13/17:c.957-92G>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron11/15:c.798-92G>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron13/17:c.957-92G>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron15/19:c.879-92G>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron14/18:c.879-92G>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron9/13:c.681-92G>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron15/19:c.879-92G>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron16/19:c.879-92G>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron14/17:c.879-92G>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron14/17:c.879-92G>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron14/17:c.879-92G>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron12/15:c.906-92G>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron13/16:c.1029-92G>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron11/16:c.798-92G>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron12/16:c.846-92G>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron13/15:c.878+1483G>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron12/15:c.954-92G>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron12/15:c.837-92G>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron13/17:c.957-92G>A::						rs2275744	0.4701	0.2600,0.4298,0.4633,0.5796,0.4311	18446,.	34493	80481	0.1520			7.28			COSV58543544	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240814664	240814664	G	T	hom	het	hom	off-target	QUAL=9579;DP=169,64,108;AF=0.99,0.44,1.00;MQM=60;SAP=300;ABP=5;SAR=50;SAF=254	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron12/18:c.845+52C>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron9/14:c.686+52C>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron10/15:c.686+52C>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron14/19:c.767+52C>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron13/18:c.767+52C>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron8/13:c.569+52C>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron14/19:c.767+52C>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron15/19:c.767+52C>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron13/17:c.767+52C>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron13/17:c.767+52C>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron13/17:c.767+52C>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron11/15:c.794+52C>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron12/16:c.917+52C>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron10/16:c.686+52C>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron12/15:c.767+52C>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron11/15:c.842+52C>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron11/15:c.725+52C>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron12/17:c.845+52C>A::						rs12744536	0.6105	0.4059,0.5857,0.4790,0.7290,0.5835	29908,.	32951	59187	-1.0950			0.01			COSV58534726	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240814977	240814977	T	-	wt	het	wt	off-target	QUAL=54;DP=78,11,16;AF=0.00,0.55,0.00;MQM=60;SAP=16;ABP=3;SAR=6;SAF=0	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron11/16:c.784-200del::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron11/18:c.784-200del::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron8/14:c.625-200del::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron11/17:c.784-200del::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron11/16:c.784-200del::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron11/17:c.784-200del::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron9/15:c.625-200del::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron11/17:c.784-200del::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron13/19:c.706-200del::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron12/18:c.706-200del::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron7/13:c.508-200del::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron13/19:c.706-200del::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron14/19:c.706-200del::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron12/17:c.706-200del::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron12/17:c.706-200del::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron12/17:c.706-200del::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron10/15:c.733-200del::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron11/16:c.856-200del::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron9/16:c.625-200del::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron11/16:c.784-200del::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron11/15:c.706-200del::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron10/15:c.781-200del::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron10/15:c.685-221del::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron11/17:c.784-200del::						rs199649548	0.0441	0.0434,0.0268,0.1020,0.0450,0.0271	148,.	6416	145470	0.0080			0.14			COSV58541930	0		2	14	0 / 0					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240816503	240816503	G	A	hom	hom	hom	off-target	QUAL=8679;DP=180,39,56;AF=1.00,1.00,1.00;MQM=60;SAP=525;ABP=0;SAR=266;SAF=9	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron10/16:c.685-88C>T::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron10/18:c.685-88C>T::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron7/14:c.526-88C>T::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron10/17:c.685-88C>T::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron10/16:c.685-88C>T::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron10/17:c.685-88C>T::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron8/15:c.526-88C>T::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron10/17:c.685-88C>T::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron12/19:c.607-88C>T::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron11/18:c.607-88C>T::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron6/13:c.409-88C>T::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron12/19:c.607-88C>T::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron13/19:c.607-88C>T::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron11/17:c.607-88C>T::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron11/17:c.607-88C>T::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron11/17:c.607-88C>T::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron9/15:c.634-88C>T::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron10/16:c.757-88C>T::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron8/16:c.526-88C>T::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron10/16:c.685-88C>T::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron10/15:c.607-88C>T::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron9/15:c.682-88C>T::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron10/15:c.685-1747C>T::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron10/17:c.685-88C>T::						rs3738068	0.7569	0.7979,0.6560,0.5889,0.7759,0.6369	43877,.	27329	36961	-2.2010			0.00			COSV58537200	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240816570	240816570	A	T	het	hom	wt	off-target	QUAL=792;DP=54,11,14;AF=0.44,1.00,0.00;MQM=60;SAP=79;ABP=4;SAR=35;SAF=0	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron10/16:c.685-155T>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron10/18:c.685-155T>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron7/14:c.526-155T>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron10/17:c.685-155T>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron10/16:c.685-155T>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron10/17:c.685-155T>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron8/15:c.526-155T>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron10/17:c.685-155T>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron12/19:c.607-155T>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron11/18:c.607-155T>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron6/13:c.409-155T>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron12/19:c.607-155T>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron13/19:c.607-155T>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron11/17:c.607-155T>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron11/17:c.607-155T>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron11/17:c.607-155T>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron9/15:c.634-155T>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron10/16:c.757-155T>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron8/16:c.526-155T>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron10/16:c.685-155T>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron10/15:c.607-155T>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron9/15:c.682-155T>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron10/15:c.685-1814T>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron10/17:c.685-155T>A::						rs3738069	0.2110	0.2769,0.1980,0.1199,0.1958,0.1783	3597,.	24892	119984	0.9480			5.37				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240870308	240870308	C	T	wt	wt	het	off-target	QUAL=34;DP=68,7,12;AF=0.00,0.00,0.42;MQM=60;SAP=14;ABP=4;SAR=5;SAF=0	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron6/16:c.386-189G>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron6/18:c.386-189G>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron3/14:c.227-189G>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron6/17:c.386-189G>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron6/16:c.386-189G>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron6/17:c.386-189G>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron4/15:c.227-189G>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron6/17:c.386-189G>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron8/19:c.308-189G>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron7/18:c.308-189G>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron5/13:c.334-43136G>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron8/19:c.308-189G>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron9/19:c.308-189G>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron7/17:c.308-189G>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron7/17:c.308-189G>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron7/17:c.308-189G>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron5/15:c.335-189G>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron6/16:c.386-189G>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron4/16:c.227-189G>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron6/16:c.386-189G>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron6/15:c.308-189G>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron6/15:c.386-189G>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron6/15:c.386-189G>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron6/17:c.386-189G>A::						rs261800	0.3575	0.5083,0.2360,0.1871,0.3151,0.2811	10511,.	33207	97445	-0.6470			0.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240936822	240936822	G	T	hom	het	hom	off-target	QUAL=1546;DP=39,8,10;AF=0.97,0.75,1.00;MQM=60;SAP=112;ABP=7;SAR=53;SAF=1	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron4/16:c.227-116C>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron4/18:c.227-116C>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron3/14:c.226+46257C>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron4/17:c.227-116C>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron4/16:c.227-116C>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron4/17:c.227-116C>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron4/15:c.226+46257C>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron4/17:c.227-116C>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron6/19:c.149-116C>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron5/18:c.149-116C>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron4/13:c.227-116C>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron6/19:c.149-116C>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron7/19:c.149-116C>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron5/17:c.149-116C>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron5/17:c.149-116C>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron5/17:c.149-116C>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron3/15:c.176-116C>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron4/16:c.227-116C>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron4/16:c.226+46257C>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron4/16:c.227-116C>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron4/15:c.149-116C>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron4/15:c.227-116C>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron4/15:c.227-116C>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron4/17:c.227-116C>A::					LTR10B1 (LTR/ERV1)	rs261857	0.3938	0.2822,0.4591,0.2561,0.4353,0.3757	12295,.	35262	92132	-1.4410			7.91			COSV58539328	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240983022	240983022	A	G	het	wt	het	off-target	QUAL=4096;DP=215,57,82;AF=0.52,0.00,0.54;MQM=60;SAP=217;ABP=5;SAR=16;SAF=140	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron4/18:c.226+57T>C::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron3/14:c.226+57T>C::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron6/19:c.148+57T>C::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron5/18:c.148+57T>C::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron4/13:c.226+57T>C::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron6/19:c.148+57T>C::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron7/19:c.148+57T>C::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron5/17:c.148+57T>C::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron5/17:c.148+57T>C::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron5/17:c.148+57T>C::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron3/15:c.176-46316T>C::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron4/15:c.148+57T>C::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron4/17:c.226+57T>C::						rs7520707	0.3710	0.3194,0.4079,0.2895,0.3969,0.3944	10701,.	34971	95579	0.7580			3.57				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241355798	241355798	T	A	hom	hom	hom		QUAL=35403;DP=440,286,418;AF=1.00,1.00,1.00;MQM=60;SAP=68;ABP=0;SAR=479;SAF=664	RGS7	5'UTR	RGS7:ENST00000690539.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000440928.6:5_prime_UTR_variant:MODIFIER:exon2/19:c.-22A>T::,RGS7:ENST00000366563.5:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000366564.5:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000366565.5:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000693043.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:ENST00000691979.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000685936.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-288A>T::,RGS7:ENST00000688703.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-218A>T::,RGS7:ENST00000689640.1:5_prime_UTR_variant:MODIFIER:exon2/14:c.-22A>T::,RGS7:ENST00000690614.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-562A>T::,RGS7:ENST00000687448.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-393A>T::,RGS7:ENST00000689602.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-216A>T::,RGS7:ENST00000691485.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-444A>T::,RGS7:ENST00000692410.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-204A>T::,RGS7:ENST00000690019.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:ENST00000688633.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000689115.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000691989.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000686465.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-100A>T::,RGS7:ENST00000686908.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:ENST00000688737.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:ENST00000688863.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::						rs4659599	0.9556	0.8750,0.9804,0.9967,0.9874,0.9880	69621,.	6092	6760	1.4650			12.93				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241356017	241356017	A	G	het	het	hom	off-target	QUAL=3312;DP=131,28,56;AF=0.47,0.39,1.00;MQM=60;SAP=283;ABP=5;SAR=129;SAF=0	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron1/18:c.-50-191T>C::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron1/17:c.-50-191T>C::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron1/17:c.-50-191T>C::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron1/15:c.-50-191T>C::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron1/17:c.-160-81T>C::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron1/19:c.-316-191T>C::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron1/18:c.-246-191T>C::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron1/13:c.-50-191T>C::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron1/19:c.-590-191T>C::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron1/19:c.-421-191T>C::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron1/17:c.-244-191T>C::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron1/17:c.-472-191T>C::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron1/17:c.-232-191T>C::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron1/15:c.-50-191T>C::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron1/15:c.-128-191T>C::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron1/15:c.-50-191T>C::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron1/15:c.-50-191T>C::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron1/17:c.-50-191T>C::	regulatory_region_variant:promoter					rs6677041	0.8438	0.7654,0.8212,0.9360,0.8871,0.7777	54438,.	19452	23756	0.9460			6.41				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241356888	241356888	T	C	n/a	hom	hom	off-target	QUAL=980;DP=0,17,16;AF=,1.00,1.00;MQM=60;SAP=14;ABP=0;SAR=10;SAF=23	RGS7	splice_region&intron	RGS7:ENST00000690539.1:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000440928.6:splice_region_variant&intron_variant:LOW:intron1/18:c.-51+11A>G::,RGS7:ENST00000366563.5:splice_region_variant&intron_variant:LOW:intron1/17:c.-51+11A>G::,RGS7:ENST00000366564.5:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000366565.5:splice_region_variant&intron_variant:LOW:intron1/17:c.-51+11A>G::,RGS7:ENST00000691979.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-161+11A>G::,RGS7:ENST00000685936.1:splice_region_variant&intron_variant:LOW:intron1/19:c.-317+11A>G::,RGS7:ENST00000688703.1:splice_region_variant&intron_variant:LOW:intron1/18:c.-247+11A>G::,RGS7:ENST00000689640.1:splice_region_variant&intron_variant:LOW:intron1/13:c.-51+11A>G::,RGS7:ENST00000690614.1:splice_region_variant&intron_variant:LOW:intron1/19:c.-591+11A>G::,RGS7:ENST00000687448.1:splice_region_variant&intron_variant:LOW:intron1/19:c.-422+11A>G::,RGS7:ENST00000689602.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-245+11A>G::,RGS7:ENST00000691485.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-473+11A>G::,RGS7:ENST00000692410.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-233+11A>G::,RGS7:ENST00000690019.1:splice_region_variant&intron_variant:LOW:intron1/15:c.-51+11A>G::,RGS7:ENST00000688633.1:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000689115.1:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000691989.1:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000686465.1:splice_region_variant&intron_variant:LOW:intron1/15:c.-129+11A>G::,RGS7:ENST00000686908.1:splice_region_variant&intron_variant:LOW:intron1/15:c.-51+11A>G::,RGS7:ENST00000688737.1:splice_region_variant&intron_variant:LOW:intron1/15:c.-51+11A>G::,RGS7:ENST00000688863.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-51+11A>G::	regulatory_region_variant:promoter					rs1891130	0.9558	0.8759,0.9806,0.9968,0.9875,0.9880	69329,.	6040	6698	-0.1090			15.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241500602	241500602	-	GAGA	wt	het	het	off-target;low_conf_region	QUAL=1184;DP=3,59,94;AF=0.00,0.17,0.28;MQM=60;SAP=38;ABP=96;SAR=30;SAF=6	FH	splice_region&intron	FH:ENST00000366560.4:splice_region_variant&intron_variant:LOW:intron8/9:c.1237-16_1237-13dup::,FH:ENST00000683521.1:splice_region_variant&intron_variant:LOW:intron8/8:c.1237-16_1237-13dup::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	296866 [uncertain significance(replaced by megSAP based on classifications:1x1,1x2,4x3) DISEASE=Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency,not specified,not provided];			rs144131869	0.2551	0.1523,0.3168,0.1696,0.2932,0.3678	4472,.	25141	99523				0.08				0.04	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241500602	241500602	-	GAGAGA	wt	het	wt	off-target;low_conf_region	QUAL=1184;DP=3,59,94;AF=0.00,0.00,0.26;MQM=60;SAP=22;ABP=191;SAR=16;SAF=3	FH	splice_region&intron	FH:ENST00000366560.4:splice_region_variant&intron_variant:LOW:intron8/9:c.1237-18_1237-13dup::,FH:ENST00000683521.1:splice_region_variant&intron_variant:LOW:intron8/8:c.1237-18_1237-13dup::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	296867 [uncertain significance(replaced by megSAP based on classifications:1x1,4x3) DISEASE=Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency,not specified,not provided];			rs144131869	0.2022	0.1752,0.1884,0.1717,0.2258,0.2127	2678,.	21638	106508				0.07				0.02	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241500602	241500602	-	GAGAGAGAGA	wt	wt	het	off-target;low_conf_region	QUAL=1184;DP=3,59,94;AF=0.00,0.20,0.07;MQM=60;SAP=16;ABP=52;SAR=18;SAF=6	FH	splice_region&intron	FH:ENST00000366560.4:splice_region_variant&intron_variant:LOW:intron8/9:c.1237-22_1237-13dup::,FH:ENST00000683521.1:splice_region_variant&intron_variant:LOW:intron8/8:c.1237-22_1237-13dup::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	296869 [likely benign(replaced by megSAP based on classifications:2x1,3x3) DISEASE=Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency,not specified,not provided];			rs144131869	0.0401	0.0573,0.0296,0.0350,0.0342,0.0624	146,.	5058	128174				0.07				0.08	24033266	37	261	0 / 0					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241503933	241503933	C	T	het	hom	het	off-target	QUAL=6077;DP=119,113,140;AF=0.49,1.00,0.49;MQM=60;SAP=522;ABP=3;SAR=0;SAF=239	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron7/9:c.1108+109G>A::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron7/8:c.1108+109G>A::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	1270362 [benign DISEASE=not provided];			rs4660099	0.2739	0.1017,0.2497,0.2097,0.3720,0.2317	6754,.	28155	110453	-1.7330			0.18			COSV63818865	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241503944	241503944	G	T	het	hom	het	off-target	QUAL=6462;DP=116,117,157;AF=0.48,1.00,0.48;MQM=60;SAP=542;ABP=4;SAR=0;SAF=248	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron7/9:c.1108+98C>A::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron7/8:c.1108+98C>A::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	1264123 [benign DISEASE=not provided];			rs4659607	0.7373	0.7823,0.6888,0.5649,0.7248,0.8476	41503,.	29159	39969	-0.6400			0.55			COSV63818713	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241511819	241511819	G	C	het	hom	het	off-target	QUAL=1419;DP=84,14,14;AF=0.46,1.00,0.36;MQM=60;SAP=129;ABP=5;SAR=0;SAF=58	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron4/9:c.555+148C>G::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron4/8:c.555+148C>G::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	1291013 [benign DISEASE=not provided];			rs6673988	0.3356	0.3138,0.2681,0.2110,0.3742,0.2334	8693,.	33574	100880	0.4080			7.27			COSV63819132	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241513458	241513458	C	T	het	hom	het	off-target	QUAL=5567;DP=172,66,91;AF=0.60,1.00,0.46;MQM=60;SAP=463;ABP=10;SAR=0;SAF=212	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron3/9:c.378+145G>A::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron3/8:c.378+145G>A::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	1181498 [benign DISEASE=not provided];			rs10926500	0.3995	0.4369,0.3303,0.3519,0.4003,0.3275	12181,.	36278	91146	-0.0780			6.00				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	247417907	247417907	T	C	het	het	het	off-target	QUAL=2989;DP=134,68,53;AF=0.50,0.46,0.51;MQM=60;SAP=274;ABP=3;SAR=0;SAF=125	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron1/10:c.-106-322T>C::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron1/8:c.-748-146T>C::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron1/9:c.-748-146T>C::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs12137901	0.2581	0.3355,0.2648,0.2977,0.2175,0.2031	5328,.	28580	112780	-0.9840			2.33				0	26722603,33922655,26662437,33015616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418258	247418258	A	T	het	wt	het		QUAL=12752;DP=501,340,454;AF=0.51,0.00,0.53;MQM=60;SAP=51;ABP=7;SAR=302;SAF=197	NLRP3	5'UTR	NLRP3:ENST00000391828.8:5_prime_UTR_variant:MODIFIER:exon2/11:c.-77A>T::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-543A>T::,NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-543A>T::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-543A>T::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-543A>T::,NLRP3:ENST00000697350.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-77A>T::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296927 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];			rs116502550	0.0069	0.0007,0.0014,0.0000,0.0085,0.0008	13,.	1009	149955	0.2370			6.13				0.01		1	137	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418390	247418390	T	C	hom	hom	hom		QUAL=17863;DP=268,161,168;AF=1.00,1.00,1.00;MQM=59;SAP=749;ABP=0;SAR=525;SAF=72	NLRP3	intron,5'UTR	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron2/10:c.-45+100T>C::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-411T>C::,NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-411T>C::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-411T>C::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-411T>C::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron1/9:c.-45+100T>C::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296931 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];		AluSx1 (SINE/Alu)	rs7523422	0.9978	0.9925,0.9991,1.0000,1.0000,1.0000	75709,.	319	329	-2.9180			2.76				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418570	247418570	G	A	het	het	het		QUAL=5099;DP=217,68,85;AF=0.54,0.56,0.44;MQM=59;SAP=22;ABP=5;SAR=76;SAF=117	NLRP3	intron,5'UTR	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron2/10:c.-44-187G>A::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-231G>A::,NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-231G>A::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-231G>A::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-231G>A::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron1/9:c.-44-187G>A::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296932 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];		AluSx1 (SINE/Alu)	rs138900557	0.0347	0.0071,0.0173,0.0014,0.0514,0.0217	139,.	5002	146888	0.3990			4.10				0		1	29	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418761	247418761	G	T	het	het	het		QUAL=9847;DP=332,231,285;AF=0.48,0.41,0.50;MQM=60;SAP=28;ABP=11;SAR=164;SAF=232	NLRP3	5'UTR	NLRP3:ENST00000391828.8:5_prime_UTR_variant:MODIFIER:exon3/11:c.-40G>T::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-40G>T::,NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-40G>T::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-40G>T::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-40G>T::,NLRP3:ENST00000697350.1:5_prime_UTR_variant:MODIFIER:exon2/10:c.-40G>T::,NLRP3:ENST00000474792.2:5_prime_UTR_variant:MODIFIER:exon1/3:c.-40G>T::,NLRP3:ENST00000643234.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-40G>T::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296937 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Autoinflammatory syndrome,not provided];			rs73136263	0.0437	0.0379,0.0215,0.0017,0.0515,0.0217	166,.	6310	145470	-0.3700			2.48				0.01	33015616	50	1450	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247424175	247424175	G	A	het	het	het		QUAL=6254;DP=161,152,190;AF=0.48,0.41,0.57;MQM=60;SAP=66;ABP=3;SAR=167;SAF=82	NLRP3	synonymous	NLRP3:ENST00000391828.8:synonymous_variant:LOW:exon5/11:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000391827.3:synonymous_variant:LOW:exon4/9:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000336119.8:synonymous_variant:LOW:exon4/10:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000348069.7:synonymous_variant:LOW:exon3/7:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000366496.7:synonymous_variant:LOW:exon3/8:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000697350.1:synonymous_variant:LOW:exon4/10:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000474792.2:synonymous_variant:LOW:exon3/3:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000643234.2:synonymous_variant:LOW:exon3/9:c.726G>A:p.Ala242=:PF05729 [NACHT domain]		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	138528 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Keratitis fugax hereditaria,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Cryopyrin associated periodic syndrome,not specified,not provided];			rs3806268	0.4205	0.1156,0.4104,0.5446,0.5609,0.5514	16379,.	31050	87926	-2.2250			1.72			COSV60221462	0	25741868,24033266,30131971,30123371,28116820,31467293,28847925,26722603,20940146,22318840,33922655,34354741,32313131,32576967,32499599,32871918,34390315,34791504,34830358	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247424229	247424229	A	G	hom	hom	hom		QUAL=14061;DP=154,117,161;AF=1.00,1.00,1.00;MQM=60;SAP=49;ABP=0;SAR=264;SAF=168	NLRP3	synonymous	NLRP3:ENST00000391828.8:synonymous_variant:LOW:exon5/11:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000391827.3:synonymous_variant:LOW:exon4/9:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000336119.8:synonymous_variant:LOW:exon4/10:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000348069.7:synonymous_variant:LOW:exon3/7:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000366496.7:synonymous_variant:LOW:exon3/8:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000697350.1:synonymous_variant:LOW:exon4/10:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000474792.2:synonymous_variant:LOW:exon3/3:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000643234.2:synonymous_variant:LOW:exon3/9:c.780A>G:p.Arg260=:PF05729 [NACHT domain]		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	403243 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Keratitis fugax hereditaria,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Cryopyrin associated periodic syndrome,not specified,not provided];			rs4925543	0.9285	0.8552,0.9522,0.9975,0.9584,0.8899	65724,.	9700	10868	-0.0360			6.58				0	24033266,28847925,33015616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247425793	247425793	-	A	het	het	het	off-target	QUAL=1616;DP=88,54,61;AF=0.36,0.39,0.51;MQM=60;SAP=185;ABP=16;SAR=84;SAF=0	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron5/10:c.2150+204dup::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2150+204dup::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron4/9:c.2150+204dup::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2150+204dup::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron3/7:c.2150+204dup::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron4/9:c.2150+204dup::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron3/8:c.2150+204dup::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs369266215	0.0372	0.0079,0.0199,0.0644,0.0528,0.0262	148,.	5270	143886				1.91				0.06		0	6	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433906	247433906	T	G	het	hom	n/a	off-target;low_conf_region	QUAL=1087;DP=95,15,0;AF=0.44,0.93,;MQM=43;SAP=125;ABP=6;SAR=0;SAF=56	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-197T>G::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-197T>G::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-197T>G::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-197T>G::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-197T>G::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-197T>G::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-257T>G::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs113966299	0.0430	0.0842,0.0289,0.0323,0.0086,0.0107	0,.	930	20690	-2.6030			0.52			COSV60223933	0.01		52	51	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433909	247433909	T	C	het	hom	n/a	off-target;low_conf_region	QUAL=1087;DP=95,15,0;AF=0.44,0.93,;MQM=43;SAP=125;ABP=6;SAR=0;SAF=56	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-194T>C::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-194T>C::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-194T>C::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-194T>C::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-194T>C::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-194T>C::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-254T>C::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs112695411	0.0455	0.0879,0.0303,0.0336,0.0093,0.0097	0,.	927	19441	-1.0810			1.70			COSV60223939	0.02		51	50	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433914	247433914	C	G	het	wt	n/a	off-target;low_conf_region	QUAL=10;DP=102,15,0;AF=0.15,0.07,;MQM=57;SAP=38;ABP=113;SAR=0;SAF=16	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-189C>G::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-189C>G::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-189C>G::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-189C>G::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-189C>G::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-189C>G::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-249C>G::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs113503382	0.0648	0.0879,0.0778,0.0005,0.0644,0.0225	748,.	4584	87704	-0.6430			0.31				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433921	247433921	G	A	het	hom	n/a	off-target;low_conf_region	QUAL=722;DP=100,14,1;AF=0.41,1.00,0.00;MQM=43;SAP=122;ABP=10;SAR=0;SAF=55	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-182G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-182G>A::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-182G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-182G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-182G>A::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-182G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-242G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs111632834	0.0011	0.0008,0.0000,0.0000,0.0019,0.0000	0,.	10	9340	-0.7870			1.99			COSV60221409	0.27		213	1628	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433937	247433937	G	A	het	het	n/a	off-target;low_conf_region	QUAL=935;DP=79,16,2;AF=0.46,0.88,1.00;MQM=45;SAP=116;ABP=4;SAR=0;SAF=52	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-166G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-166G>A::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-166G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-166G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-166G>A::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-166G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-226G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs78648901	0.0316	0.0067,0.0230,0.0000,0.0454,0.0160	11,.	1256	39162	-3.5040			0.76			COSV60223954	0.01		32	65	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433956	247433956	G	C	het	het	het	off-target;low_conf_region	QUAL=1058;DP=69,20,5;AF=0.62,0.15,0.20;MQM=55;SAP=105;ABP=3;SAR=0;SAF=47	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-147G>C::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-147G>C::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-147G>C::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-147G>C::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-147G>C::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-147G>C::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-207G>C::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs10802498	0.6628	0.4450,0.6632,0.8218,0.7168,0.7392	22494,.	24305	35253	-2.7440			0.41			COSV60231833	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433974	247433974	A	G	het	wt	wt	off-target;low_conf_region	QUAL=127;DP=94,8,8;AF=0.19,0.00,0.00;MQM=60;SAP=42;ABP=81;SAR=0;SAF=18	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-129A>G::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-129A>G::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-129A>G::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-129A>G::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-129A>G::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-129A>G::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-189A>G::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs77795397	0.1784	0.1218,0.2343,0.4156,0.1712,0.1998	3305,.	10060	76772	-2.8280			1.76			COSV60228530	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433990	247433990	T	G	het	wt	wt	off-target;low_conf_region	QUAL=873;DP=125,12,8;AF=0.42,0.00,0.00;MQM=57;SAP=118;ABP=9;SAR=0;SAF=53	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-113T>G::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-113T>G::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-113T>G::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-113T>G::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-113T>G::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-113T>G::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-173T>G::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs1335841375	0.0018	0.0015,0.0024,0.0052,0.0015,0.0046	1,.	107	62073	-3.8310			0.74				0.03		15	281	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247433993	247433993	T	C	het	wt	wt	off-target;low_conf_region	QUAL=873;DP=125,12,8;AF=0.42,0.00,0.00;MQM=57;SAP=118;ABP=9;SAR=0;SAF=53	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-110T>C::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-110T>C::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-110T>C::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-110T>C::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-110T>C::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-110T>C::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-170T>C::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs1380076253	0.0016	0.0016,0.0018,0.0052,0.0012,0.0035	1,.	107	69411	0.3540			4.90				0.09		15	284	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434027	247434027	C	T	hom	hom	hom	off-target;low_conf_region	QUAL=1189;DP=39,8,10;AF=0.00,0.88,1.00;MQM=60;SAP=68;ABP=0;SAR=0;SAF=30	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-76C>T::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-76C>T::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-76C>T::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-76C>T::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-76C>T::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-76C>T::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-136C>T::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs12124866	0.9173	0.8320,0.9462,0.9890,0.9490,0.8811	60305,.	10413	11809	-2.1460			1.86				0.05		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434047	247434047	-	GAGCTCTCTGGTCAGATGTGTTCTGAGGCCTTCTCTATTCCA	wt	hom	hom	off-target;low_conf_region	QUAL=1189;DP=39,8,10;AF=0.00,0.88,1.00;MQM=56;SAP=40;ABP=0;SAR=0;SAF=17	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-41_2151-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-41_2151-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-101_2322-100insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs566064212	0.0001	0.0000,0.0000,0.0000,0.0001,0.0000	0,.	1	44853				0.35				0.03		6287	3254	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434063	247434063	G	A	hom	hom	hom	off-target	QUAL=9015;DP=131,70,114;AF=1.00,1.00,1.00;MQM=57;SAP=579;ABP=0;SAR=13;SAF=302	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-40G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-40G>A::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-40G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-40G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-40G>A::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-40G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-100G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs10925022	0.3091	0.4316,0.2549,0.3577,0.2588,0.1869	10045,.	21862	93756	-1.8440			0.36				0.03	33015616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434355	247434355	G	-	hom	hom	hom	off-target	QUAL=7430;DP=77,85,101;AF=1.00,1.00,1.00;MQM=60;SAP=574;ABP=0;SAR=263;SAF=0	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron7/10:c.2492+85del::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron5/8:c.2321+85del::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron6/9:c.2492+85del::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron4/6:c.2321+85del::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron5/7:c.2492+85del::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron6/9:c.2492+85del::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron5/8:c.2432+85del::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs3835304	0.5332	0.3142,0.4813,0.5186,0.6460,0.5916	23243,.	34549	70957	-1.0870			0.10				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247435768	247435768	T	C	hom	hom	hom	off-target	QUAL=2514;DP=49,19,18;AF=1.00,1.00,1.00;MQM=60;SAP=190;ABP=0;SAR=0;SAF=86	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron7/10:c.2493-202T>C::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron5/8:c.2322-202T>C::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron6/9:c.2493-202T>C::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron4/6:c.2321+1495T>C::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron5/7:c.2492+1495T>C::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron6/9:c.2493-202T>C::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron5/8:c.2433-202T>C::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	1169053 [benign DISEASE=Cryopyrin associated periodic syndrome];			rs4612666	0.6490	0.4569,0.6561,0.5480,0.7490,0.6555	33319,.	31965	53335	0.4010			3.12			COSV60223405	0	27417569,22110538,22112657,24901306,27446957,29214547,24971461,28503575,20650817,30208882,18576390,21258359,29102545,29430721,28116820,19767079,23973727,24967817,26444566,26854620,27455015,29573224,29850543,29888470,30811631,31978095,26440629,32152480,31751447,30447690,26722603,29026154,25101079,28366820,24003382,28607508,29734345,34596590,33922655,26118952,34354741,34210954,21083527,34199122,33424869,33533549,33849530,34367252,34172780,32499599,32733479,32871918,32922288,34504564,34501201,33951966,33855388,34769275,35095918,34830358	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247435930	247435930	G	A	het	het	het	off-target	QUAL=1373;DP=46,38,62;AF=0.50,0.39,0.50;MQM=60;SAP=29;ABP=4;SAR=20;SAF=49	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron7/10:c.2493-40G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron5/8:c.2322-40G>A::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron6/9:c.2493-40G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron4/6:c.2321+1657G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron5/7:c.2492+1657G>A::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron6/9:c.2493-40G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron5/8:c.2433-40G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	1259697 [benign DISEASE=not provided];			rs10754557	0.5161	0.2446,0.5022,0.6738,0.6237,0.6037	22556,.	33186	73424	-0.6010			1.37				0.09	29850521,32104685,22318840,33922655,34345180,33925158	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247448358	247448359	AG	-	het	het	wt	off-target	QUAL=2097;DP=181,39,76;AF=0.44,0.54,0.00;MQM=60;SAP=197;ABP=6;SAR=3;SAF=98	NLRP3	intron	NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron10/10:c.3006-45_3006-44del::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron8/8:c.2835-45_2835-44del::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron9/9:c.3006-45_3006-44del::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron6/6:c.2664-45_2664-44del::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron7/7:c.2835-45_2835-44del::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron9/9:c.3006-45_3006-44del::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron8/8:c.2946-45_2946-44del::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs201053423	0.0408	0.0107,0.0393,0.0325,0.0551,0.1047	185,.	5688	142412	-0.3360			1.81				0.01	33462484	46	1543	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chr1	247448734	247448734	G	C	hom	hom	hom		QUAL=50334;DP=702,384,501;AF=1.00,1.00,1.00;MQM=60;SAP=991;ABP=0;SAR=1217;SAF=368	NLRP3	3'UTR	NLRP3:ENST00000391828.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::,NLRP3:ENST00000391827.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:ENST00000336119.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::,NLRP3:ENST00000348069.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*230G>C::,NLRP3:ENST00000366496.7:3_prime_UTR_variant:MODIFIER:exon8/8:c.*230G>C::,NLRP3:ENST00000697350.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296956 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Cryopyrin associated periodic syndrome,Autoinflammatory syndrome];			rs10754558	0.6356	0.7435,0.7104,0.5853,0.5844,0.6114	31418,.	33787	55393	0.2860			7.16			COSV59510002	0	27810495,22110538,22112657,23110140,24901306,27446957,29214547,30728751,24144834,26833430,28503575,29385859,26698117,30208882,18576390,21258359,29102545,29430721,28116820,31405022,19767079,23973727,26444566,27455015,29850543,29888470,25297810,26440629,28139755,16642435,20370570,20502346,21245836,22227487,23031505,26236392,26689701,26945813,27060062,27110561,27942564,28456882,28764843,29230505,29732382,31448710,32020248,26273672,26462562,30783474,28702029,31751447,29507526,30447690,26722603,25788762,29171506,28337127,29026154,23658628,30182779,28740569,27021275,31276515,30618791,21163704,30873162,30214462,34596590,34161370,32973739,33922655,33193317,32689633,21083527,34177937,34345180,33613533,34595244,33424869,33533549,33849530,34367252,34367183,33434563,34064909,34172780,32903730,32499599,32733479,33868225,33143375,34471376,32871918,32033104,30264444,34571825,34504564,33202693,33951966,32784383,34390315,34467240,34769275,35000611,35022530,34956329,35095918,34636069,34881085,34830358,34834553,34705319,3492546	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chr1	247449133	247449133	A	T	hom	hom	n/a	off-target	QUAL=1339;DP=38,3,1;AF=1.00,1.00,1.00;MQM=60;SAP=78;ABP=0;SAR=40;SAF=2	OR2B11	3'UTR	OR2B11:ENST00000641527.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1896T>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs4925547	0.3635	0.2442,0.4731,0.5445,0.3959,0.4619	10790,.	33662	96736	0.5200			7.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chrMT	72	72	T	C	hom	hom	wt		QUAL=257337;DP=4341,4379,4604;AF=0.99,0.99,0.00;MQM=55;SAP=1233;ABP=0;SAR=5441;SAF=3225	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs879158303	0.0250					-0.0730									639	30	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	73	73	A	G	wt	wt	hom		QUAL=125386;DP=4274,4418,4697;AF=0.01,0.00,1.00;MQM=51;SAP=319;ABP=0;SAR=2778;SAF=1949	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs869183622	0.7157					-1.2370								34002094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	150	150	C	T	wt	wt	hom		QUAL=129626;DP=4145,3297,4003;AF=0.00,0.00,0.99;MQM=60;SAP=901;ABP=0;SAR=2629;SAF=1347	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs62581312	0.1663					-3.9110								33728047,29774306,24040623,34002094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	152	152	T	C	wt	wt	hom		QUAL=129626;DP=4145,3297,4003;AF=0.00,0.00,0.99;MQM=60;SAP=901;ABP=0;SAR=2629;SAF=1347	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs117135796	0.3173					-1.7640								33062421	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	195	195	T	C	wt	wt	hom		QUAL=109546;DP=3712,2438,3379;AF=0.00,0.00,1.00;MQM=60;SAP=968;ABP=0;SAR=2307;SAF=1080	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs2857291	0.2761					0.2630								22723804,27217714,31380278,26550561,33062421,24040623	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	215	215	A	G	wt	wt	hom		QUAL=101818;DP=3334,2041,3148;AF=0.00,0.00,0.99;MQM=60;SAP=1009;ABP=0;SAR=2169;SAF=964	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs879219259	0.0082					0.8940									243	20	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	263	263	A	G	hom	hom	hom		QUAL=199046;DP=2667,1158,2350;AF=1.00,1.00,1.00;MQM=60;SAP=2871;ABP=0;SAR=4511;SAF=1657	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::			441147 [not provided DISEASE=not provided];			rs2853515	0.9907					0.1780								22723804,33062421,29695379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	295	295	C	T	wt	wt	hom		QUAL=58324;DP=2186,774,1909;AF=0.00,0.00,0.99;MQM=60;SAP=792;ABP=0;SAR=1366;SAF=535	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs41528348	0.0560					-2.8920								31380278	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	302	302	-	CC	hom	het	wt		QUAL=52262;DP=771,308,1292;AF=0.06,0.06,0.00;MQM=60;SAP=1768;ABP=175;SAR=813;SAF=0	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::							0.0000														627	3087	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	302	302	-	CCC	wt	het	wt		QUAL=52262;DP=771,308,1292;AF=0.75,0.75,0.00;MQM=58;SAP=162;ABP=396;SAR=73;SAF=0	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::							0.0000														44	704	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	C	hom	hom	wt		QUAL=52262;DP=771,308,1292;AF=0.04,0.01,0.00;MQM=59;SAP=42;ABP=638;SAR=18;SAF=0	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs369786048	0.6255														n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	TC	wt	wt	hom		QUAL=52262;DP=771,308,1292;AF=0.06,0.06,0.00;MQM=60;SAP=452;ABP=655;SAR=884;SAF=374	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs1556422422	0.0043														170	12	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	319	319	T	C	wt	wt	hom		QUAL=50807;DP=1969,475,1656;AF=0.00,0.00,0.99;MQM=60;SAP=365;ABP=0;SAR=1085;SAF=561	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs879055956	0.0067					-0.2030									235	5	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	430	430	T	C	wt	wt	hom		QUAL=55481;DP=2897,1254,1857;AF=0.00,0.00,0.99;MQM=60;SAP=547;ABP=0;SAR=583;SAF=1263	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs1603218409	0.0002					-1.1600									9	1	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	489	489	T	C	wt	wt	hom		QUAL=66781;DP=3034,1850,2270;AF=0.00,0.00,0.99;MQM=60;SAP=361;ABP=0;SAR=822;SAF=1432	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs28625645	0.1094					-1.4590								26116242,31380278,24040623,34976016	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	513	513	G	A	wt	wt	hom		QUAL=66815;DP=3168,1837,2288;AF=0.00,0.00,0.99;MQM=60;SAP=69;ABP=0;SAR=1007;SAF=1270	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2,MT-TW	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::						rs879162984	0.0112					-2.2930								34976016	291	20	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	750	750	A	G	hom	hom	hom		QUAL=292478;DP=3350,2666,3125;AF=1.00,1.00,1.00;MQM=59;SAP=176;ABP=0;SAR=4995;SAF=4143	MT-RNR1	non_coding_transcript_exon	MT-RNR1:ENST00000389680.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.103A>G::			441148 [not provided DISEASE=not provided];			rs2853518	0.9834					6.9050								31380278	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1438	1438	A	G	hom	hom	hom		QUAL=712200;DP=8518,6306,7279;AF=1.00,1.00,1.00;MQM=56;SAP=599;ABP=0;SAR=12273;SAF=9812	MT-RNR1	non_coding_transcript_exon	MT-RNR1:ENST00000389680.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.791A>G::			42220 [benign DISEASE=not specified,not provided];			rs2001030	0.9561					0.2380								24033266,9519725,18830133,31380278,33728047,29695379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1850	1850	T	C	wt	wt	hom		QUAL=121813;DP=5784,3332,3825;AF=0.00,0.00,0.99;MQM=60;SAP=11;ABP=0;SAR=1838;SAF=1958	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.180T>C::						rs878878913	0.0044					2.0490									170	15	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	2706	2706	A	G	hom	hom	hom		QUAL=182068;DP=3107,1273,1453;AF=1.00,1.00,1.00;MQM=60;SAP=239;ABP=0;SAR=3309;SAF=2513	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1036A>G::					LSU-rRNA_Hsa (rRNA)	rs2854128	0.7395					-0.0780								30242290,31380278,32387288,29695379,34002094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4216	4216	T	C	wt	wt	hom		QUAL=106065;DP=3787,3101,3517;AF=0.00,0.00,0.99;MQM=45;SAP=243;ABP=0;SAR=2065;SAF=1442	MT-ND1	missense	MT-ND1:ENST00000361390.2:missense_variant:MODERATE:exon1/1:c.910T>C:p.Tyr304His:PF00146 [NADH dehydrogenase]			9724 [benign DISEASE=Leber optic atrophy,Leigh syndrome,not provided];			rs1599988	0.1176					0.2170	T(1.00)	B(0.01)				COSV62293824		1732158,1900003,7635294,20301353,22723804,29370225,1417830,31380278,30684245,27594409,33475980,34478492	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4580	4580	G	A	hom	hom	wt		QUAL=103062;DP=2456,1672,1946;AF=0.99,0.99,0.00;MQM=31;SAP=14;ABP=0;SAR=2119;SAF=1974	MT-ND2	synonymous	MT-ND2:ENST00000361453.3:synonymous_variant:LOW:exon1/1:c.111G>A:p.Met37=:PF00361 [Proton-conducting membrane transporter]						rs28357975	0.0242					-3.5290									428	10	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4769	4769	A	G	hom	hom	hom		QUAL=172337;DP=2340,2039,2312;AF=1.00,1.00,1.00;MQM=33;SAP=1560;ABP=0;SAR=2247;SAF=4436	MT-ND2	synonymous	MT-ND2:ENST00000361453.3:synonymous_variant:LOW:exon1/1:c.300A>G:p.Met100=:PF00361 [Proton-conducting membrane transporter]			441150 [benign DISEASE=Mitochondrial disease,not provided];			rs3021086	0.9839					-20.0000								31380278	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahharmf1 10.08.2021; most likely WT; NGSD: >13000 other homo samples; gnomAD 3.1: >98% are also homo"			MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7028	7028	C	T	hom	hom	hom		QUAL=310295;DP=3122,3481,4000;AF=0.99,1.00,1.00;MQM=43;SAP=343;ABP=0;SAR=4647;SAF=5934	MT-CO1	synonymous	MT-CO1:ENST00000361624.2:synonymous_variant:LOW:exon1/1:c.1125C>T:p.Ala375=:PF00115 [Cytochrome C and Quinol oxidase polypeptide I]			1676315 [benign DISEASE=Mitochondrial disease];			rs2015062	0.7494					-9.1980								24917144,31380278,24148579,29695379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7476	7476	C	T	wt	wt	hom		QUAL=46893;DP=4058,1392,1603;AF=0.00,0.00,0.99;MQM=43;SAP=195;ABP=0;SAR=608;SAF=983	MT-TS1	non_coding_transcript_exon	MT-TS1:ENST00000387416.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.39G>A::			42228 [benign DISEASE=Juvenile myopathy, encephalopathy, lactic acidosis AND stroke,Mitochondrial disease,not specified];		tRNA-Ser-TCA(m) (tRNA)	rs201950015	0.0110					-0.8360								24033266,15286157,18790089,8155739,8728705,9384601,19371214,21621438,31965079	317	16	0 / 0					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7789	7789	G	A	wt	wt	hom		QUAL=148947;DP=7840,5642,4982;AF=0.00,0.00,0.99;MQM=58;SAP=4418;ABP=0;SAR=884;SAF=4052	MT-CO2	synonymous	MT-CO2:ENST00000361739.1:synonymous_variant:LOW:exon1/1:c.204G>A:p.Leu68=:PF02790 [Cytochrome C oxidase subunit II transmembrane domain]			376897 [benign DISEASE=not provided];			rs386829014	0.0110					-9.8780								25741868,31380278	305	46	0 / 0					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	8860	8860	A	G	hom	hom	hom		QUAL=173501;DP=1893,2140,2331;AF=1.00,1.00,1.00;MQM=34;SAP=12;ABP=0;SAR=3261;SAF=3095	MT-ATP6	missense	MT-ATP6:ENST00000361899.2:missense_variant:MODERATE:exon1/1:c.334A>G:p.Thr112Ala:PF00119 [ATP synthase A chain]			693004 [benign DISEASE=Leigh syndrome];			rs2001031	0.9938					0.2660	T(0.10)	B(0.00)						33728047	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahharmf1 10.08.2021; most likely WT variant; MitoMap: in >99% of gnomAD 3.1 sequences homo; NGSD: almost existing in each sample homo"			MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10398	10398	A	G	wt	wt	hom		QUAL=120249;DP=4708,3107,3733;AF=0.00,0.00,0.99;MQM=60;SAP=202;ABP=0;SAR=1572;SAF=2157	MT-ND3	missense	MT-ND3:ENST00000361227.2:missense_variant:MODERATE:exon1/1:c.340A>G:p.Thr114Ala:			9713 [benign DISEASE=Leigh syndrome,Parkinson disease, resistance to];			rs2853826	0.4185					-0.3380	T(1.00)	B(0.00)						24437375,23133645,30713765,6343397,17066297,26116242,26336829,31380278,28826375,23944767,25580814,30275759,32396277,33585966,34120353,33062421,30531304,33116761,34976016	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10499	10499	A	G	wt	wt	hom		QUAL=122817;DP=4622,3081,3752;AF=0.00,0.00,0.99;MQM=60;SAP=6;ABP=0;SAR=1908;SAF=1831	MT-ND4L	synonymous	MT-ND4L:ENST00000361335.1:synonymous_variant:LOW:exon1/1:c.30A>G:p.Leu10=:PF00420 [NADH-ubiquinone/plastoquinone oxidoreductase chain 4L]			376866 [benign DISEASE=not provided];			rs1057520074	0.0074					-1.0050								25741868	227	21	0 / 0					MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11251	11251	A	G	wt	wt	hom		QUAL=179397;DP=6509,4782,5630;AF=0.00,0.00,0.99;MQM=60;SAP=79;ABP=0;SAR=2581;SAF=3023	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.492A>G:p.Leu164=:PF00361 [Proton-conducting membrane transporter]						rs869096886	0.1101					-6.9950						COSV62293827		29370225,33895935,32635923,35082309	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11377	11377	G	A	wt	wt	hom		QUAL=145967;DP=6159,4070,4560;AF=0.00,0.00,0.99;MQM=60;SAP=410;ABP=0;SAR=2727;SAF=1805	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.618G>A:p.Lys206=:PF00361 [Proton-conducting membrane transporter]						rs193302938	0.0136					1.9500									358	72	0 / 0					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11719	11719	G	A	wt	wt	hom		QUAL=166302;DP=6942,4183,5325;AF=0.00,0.01,1.00;MQM=57;SAP=15;ABP=0;SAR=2769;SAF=2595	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.960G>A:p.Gly320=:PF00361 [Proton-conducting membrane transporter]						rs2853495	0.7110					-12.2800						COSV104668829		27716073,31380278,27877219,24148579,33895935,29695379,34002094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	12612	12612	A	G	wt	wt	hom		QUAL=165037;DP=7635,4367,5142;AF=0.00,0.00,0.99;MQM=60;SAP=167;ABP=0;SAR=2248;SAF=2869	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.276A>G:p.Val92=:PF00662 [NADH-Ubiquinone oxidoreductase (complex I) chain 5 N-terminus]						rs28359172	0.0578					-3.2010								31380278,29695379,34002094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13708	13708	G	A	wt	wt	hom		QUAL=52637;DP=4575,1555,1715;AF=0.00,0.00,0.99;MQM=60;SAP=5;ABP=0;SAR=828;SAF=869	MT-ND5	missense	MT-ND5:ENST00000361567.2:missense_variant:MODERATE:exon1/1:c.1372G>A:p.Ala458Thr:PF06455 [NADH dehydrogenase subunit 5 C-terminus]			9696 [benign DISEASE=Leber optic atrophy,Leigh syndrome];			rs28359178	0.0756					0.6330	T(0.19)	B(0.00)						24917144,19387457,29594131,1732158,1900003,7635294,20301353,1417830,1764087,31380278,24148579,25925750,33585966,33475980,29695379,33491309,34002094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13722	13722	A	G	wt	wt	hom		QUAL=55395;DP=4657,1669,1807;AF=0.00,0.00,0.99;MQM=60;SAP=28;ABP=0;SAR=821;SAF=964	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.1386A>G:p.Leu462=:PF06455 [NADH dehydrogenase subunit 5 C-terminus]			377244 [benign DISEASE=not provided];			rs386829190	0.0076					-7.6180								25741868	232	19	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14133	14133	A	G	wt	wt	hom		QUAL=97329;DP=3887,2752,3083;AF=0.00,0.00,0.99;MQM=60;SAP=27;ABP=0;SAR=1629;SAF=1444	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.1797A>G:p.Leu599=:PF06455 [NADH dehydrogenase subunit 5 C-terminus]			377029 [benign DISEASE=not provided];			rs879100848	0.0079					-7.4090								25741868	227	29	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14370	14370	A	G	hom	hom	wt		QUAL=193206;DP=3958,2175,2360;AF=0.99,0.99,0.00;MQM=60;SAP=48;ABP=0;SAR=3222;SAF=2868	MT-ND6	synonymous	MT-ND6:ENST00000361681.2:synonymous_variant:LOW:exon1/1:c.304T>C:p.Leu102=:PF00499 [NADH-ubiquinone/plastoquinone oxidoreductase chain 6]						rs1603224697	0.0007					-11.2190									26	1	0 / 0					MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14766	14766	C	T	wt	wt	hom		QUAL=71859;DP=3291,2101,2288;AF=0.00,0.01,1.00;MQM=60;SAP=263;ABP=0;SAR=889;SAF=1414	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.20C>T:p.Thr7Ile:			140587 [benign DISEASE=Leigh syndrome,Familial cancer of breast];			rs193302980	0.7068					0.1160	D(0.04)	B(0.00)						32943110,34069212,34002094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15257	15257	G	A	wt	wt	hom		QUAL=122727;DP=4505,3615,3830;AF=0.00,0.00,0.99;MQM=60;SAP=23;ABP=0;SAR=1808;SAF=1997	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.511G>A:p.Asp171Asn:PF00033 [Cytochrome b/b6/petB]			9674 [benign DISEASE=Leber optic atrophy,Leigh syndrome];			rs41518645	0.0127					6.1030	D(0.01)	B(0.01)				COSV62378578		1732158,7635294,20301353,1764087,7901141,8240104,8321540,8755941,28993255,35118571,34002094	372	64	0 / 0					MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15326	15326	A	G	hom	hom	hom		QUAL=371097;DP=4451,3485,3653;AF=1.00,1.00,1.00;MQM=60;SAP=208;ABP=0;SAR=6313;SAF=5267	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.580A>G:p.Thr194Ala:PF00033 [Cytochrome b/b6/petB]			140592 [benign DISEASE=Leigh syndrome,Familial cancer of breast,Mitochondrial disease];			rs2853508	0.9934					-5.3890	T(0.28)	B(0.01)						31267007,34069212,35118571	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] harmuth 09.04.2018"		"most likely WT variant; in 98,6% of all full length sequences (MitoMap); FH 09.04.2018"	MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15452	15452	C	A	wt	wt	hom		QUAL=108107;DP=6681,3238,3396;AF=0.00,0.00,0.99;MQM=60;SAP=15;ABP=0;SAR=1620;SAF=1754	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.706C>A:p.Leu236Ile:			143925 [benign DISEASE=Neoplasm of ovary,Leigh syndrome];			rs193302994	0.1103					-2.5920	T(0.51)	B(0.24)						29594131,29370225,31380278,30684245,32635923	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15904	15904	C	T	hom	hom	wt		QUAL=302222;DP=5974,3321,3771;AF=0.99,0.99,0.00;MQM=60;SAP=21;ABP=0;SAR=4747;SAF=4470	MT-TT	non_coding_transcript_exon	MT-TT:ENST00000387460.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.17C>T::			690224 [benign DISEASE=Juvenile myopathy, encephalopathy, lactic acidosis AND stroke];			rs35788393	0.0224					-0.9230								31965079,32943110,34976016	499	18	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16069	16069	C	T	wt	wt	hom		QUAL=119508;DP=5768,3606,3741;AF=0.00,0.00,0.99;MQM=60;SAP=21;ABP=0;SAR=1770;SAF=1946	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs147903261	0.0562					-2.0290								31380278,28813576	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16126	16126	T	C	wt	wt	hom		QUAL=124429;DP=5728,4018,3919;AF=0.00,0.00,0.99;MQM=60;SAP=165;ABP=0;SAR=1680;SAF=2219	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs147029798	0.1432					-0.6180								31380278	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16145	16145	G	A	wt	wt	hom		QUAL=124984;DP=5664,4053,3945;AF=0.00,0.00,0.99;MQM=60;SAP=148;ABP=0;SAR=1701;SAF=2213	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs41419246	0.0284					-1.2640								31380278	669	93	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16231	16231	T	C	wt	wt	hom		QUAL=150265;DP=6609,4462,4804;AF=0.00,0.00,0.99;MQM=60;SAP=112;ABP=0;SAR=2127;SAF=2615	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::					(CAACTAT)n (Simple_repeat)	rs386829286	0.0078					-0.3440									226	32	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16261	16261	C	T	wt	wt	hom		QUAL=150402;DP=7144,4286,4789;AF=0.00,0.00,0.99;MQM=60;SAP=28;ABP=0;SAR=2249;SAF=2483	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs138126107	0.0365					-1.3990								31380278	783	129	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16298	16298	T	C	hom	hom	wt		QUAL=333018;DP=6107,4219,4816;AF=0.99,0.99,0.00;MQM=60;SAP=110;ABP=0;SAR=5456;SAF=4746	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs148377232	0.0498					-0.9170									885	136	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16519	16519	T	C	hom	hom	wt		QUAL=378831;DP=6991,5418,5370;AF=1.00,1.00,0.02;MQM=55;SAP=15;ABP=0;SAR=6108;SAF=6371	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs3937033	0.6573					-0.2250								22723804,26550561,24040623	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)		"hohe Frequenz [1] ahbecks1 15.09.2021 [n/a] ahbecks1 15.09.2021"			MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
